{"meta":{"query_hash":"7c96b6f5b4ee","filters":{"venue":"British Journal of Dermatology"},"cohort_total":688,"direct_labels_cover":4,"predictions_cover":688,"exported":688,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7c96b6f5b4ee","api":"https://metacan.xera.ac/api/v1/cohort?venue=British+Journal+of+Dermatology"},"results":[{"id":"W142975861","doi":"10.1111/j.1365-2133.2012.10935.x","title":"Main Plenary Sessions","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"Action Medical Research","keywords":"Citation; Library science; Plenary session; Medicine; Computer science","score_opus":0.01767040661360554,"score_gpt":0.28041839481695086,"score_spread":0.26274798820334533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W142975861","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026749382,0.007091758,0.0019191129,0.05736924,0.19787496,0.0014380908,0.0057216454,0.0029972885,0.72291285],"genre_scores_gemma":[0.002812066,0.0010919375,0.000305144,0.0065569854,0.02262284,0.00045857235,0.0011999212,0.00044422352,0.96450835],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886334,0.0002029539,0.000043790096,0.00018880526,0.00044147208,0.0002596122],"domain_scores_gemma":[0.99291986,0.0006487638,0.00022963635,0.000287293,0.0016433374,0.004271071],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017305245,0.0014307103,0.0012562608,0.0016147055,0.0027258783,0.004229938,0.0014446533,0.0037658555,0.8184015],"category_scores_gemma":[0.0065816953,0.0004967812,0.0010335481,0.00075828336,0.00033370225,0.0023624909,0.0049993354,0.0034044904,0.7162879],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075488366,0.000041194184,0.000052258005,0.00005467616,0.0000018369083,0.00002954614,0.000017031038,0.000012434472,0.0001473758,0.0002282379,0.983067,0.016273027],"study_design_scores_gemma":[0.00006570144,0.000048295835,0.000708543,0.00009725131,0.000003548661,0.00006077468,0.000097672826,0.000034312816,0.00009212883,0.000743324,0.99804175,0.0000067459514],"about_ca_topic_score_codex":0.0005108244,"about_ca_topic_score_gemma":0.0022843839,"teacher_disagreement_score":0.8184015,"about_ca_system_score_codex":0.0012486789,"about_ca_system_score_gemma":0.0016663847,"threshold_uncertainty_score":0.2590282},"labels":[],"label_agreement":null},{"id":"W1508752722","doi":"10.1111/bjd.12110","title":"Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":357,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"","keywords":"Secukinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Placebo; Interleukin 17; Internal medicine; Dose; Randomized controlled trial; Gastroenterology; Concomitant; Clinical trial; Plaque psoriasis; Adverse effect; Immunology; Cytokine; Psoriatic arthritis; Pathology","score_opus":0.02137471321531433,"score_gpt":0.28089163570398684,"score_spread":0.25951692248867253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508752722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881505,0.0032337552,0.0008808245,0.00032547273,0.0002928714,0.0054185144,0.0005357146,0.00012037095,0.0010420751],"genre_scores_gemma":[0.9864355,0.0023034748,0.002041223,0.0008519339,0.00034277237,0.005455513,0.00068569777,0.000022960287,0.0018608542],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991961,0.0003990636,0.00007174625,0.000118469296,0.00011589162,0.00009880692],"domain_scores_gemma":[0.998976,0.00022999187,0.00022432755,0.000097408374,0.000102961,0.00036922845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024196415,0.0015383199,0.003473337,0.0004796768,0.0004885328,0.0008747381,0.000955223,0.0018106056,0.004545883],"category_scores_gemma":[0.0015343247,0.000818541,0.0015111616,0.00041261694,0.0014425047,0.0008429002,0.00032093556,0.0020348227,0.0008815155],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9291242,0.03132299,0.0010823581,0.0007953273,0.000730846,0.000054980363,0.000077197474,0.00038071888,0.015031885,0.00008042754,0.00069335225,0.020625735],"study_design_scores_gemma":[0.8522834,0.14313975,0.002655799,0.00002572486,0.0002822567,0.00005155333,0.000015606101,0.0002777898,0.0007384001,0.00006158421,0.00045214788,0.00001595746],"about_ca_topic_score_codex":0.00030552657,"about_ca_topic_score_gemma":0.00075330253,"teacher_disagreement_score":0.004545883,"about_ca_system_score_codex":0.00040174962,"about_ca_system_score_gemma":0.001180213,"threshold_uncertainty_score":0.015207529},"labels":[],"label_agreement":null},{"id":"W1512287127","doi":"10.1111/j.1365-2133.2010.09972.x","title":"Skin responses to topical dehydroepiandrosterone: implications in antiageing treatment?","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Dehydroepiandrosterone; Immunocytochemistry; Medicine; Dermis; Internal medicine; Endocrinology; Placebo; Androgen receptor; Procollagen peptidase; Androgen; Pathology; Hormone","score_opus":0.017350434410318707,"score_gpt":0.310071384109432,"score_spread":0.29272094969911333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1512287127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8533777,0.14213404,0.00079309515,0.0011684725,0.00015408259,0.00014097028,0.00016502831,0.00001599298,0.0020505353],"genre_scores_gemma":[0.97843754,0.020051625,0.00042488595,0.00033919423,0.000280745,0.000053719883,0.000050037783,0.0000015688092,0.00036058965],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997867,0.00012691243,0.000017206585,0.000018124601,0.000030170457,0.000020932055],"domain_scores_gemma":[0.99932563,0.000421736,0.00014525131,0.000022207263,0.000041324947,0.000043890825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008411033,0.00021365765,0.00054436264,0.00016812643,0.00008654527,0.00020273049,0.00017245888,0.00040075698,0.0021385613],"category_scores_gemma":[0.0011858022,0.00007670969,0.0002218003,0.00021760605,0.00025027027,0.00021625994,0.000057128887,0.00024126362,0.00021326564],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058878098,0.002626852,0.106053546,0.0043025925,0.00044936128,0.0011629098,0.00024657522,0.00056259264,0.1672984,0.00037661588,0.001068827,0.65697366],"study_design_scores_gemma":[0.0047217705,0.10889161,0.82729775,0.0007116672,0.0015054202,0.0042311326,0.00070082553,0.0008487288,0.033438448,0.0008461099,0.016772449,0.000034148],"about_ca_topic_score_codex":0.00016440634,"about_ca_topic_score_gemma":0.00022132859,"teacher_disagreement_score":0.0021385613,"about_ca_system_score_codex":0.00012318014,"about_ca_system_score_gemma":0.0001285595,"threshold_uncertainty_score":0.0071541667},"labels":[],"label_agreement":null},{"id":"W1533901323","doi":"10.1111/j.1365-2133.2010.10061.x","title":"Portable video education for informed consent: the shape of things to come?","year":2010,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Music Therapy and Health","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Informed consent; Comprehension; Medical education; Patient education; General partnership; Medicine; Psychology; Family medicine; Alternative medicine; Computer science; Law; Pathology","score_opus":0.03001527572885988,"score_gpt":0.3457167961922946,"score_spread":0.31570152046343475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1533901323","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088679016,0.034911048,0.006677808,0.8865967,0.027369637,0.00018770822,0.00014972985,0.00018786134,0.043032806],"genre_scores_gemma":[0.07200059,0.14711067,0.034790486,0.6343836,0.0646582,0.0011674193,0.00051795965,0.0010373591,0.044333737],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9483314,0.037931576,0.0028018642,0.0012348634,0.008363911,0.001336425],"domain_scores_gemma":[0.805358,0.15947421,0.0064595477,0.008250034,0.014376423,0.0060817753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.050850898,0.0006947629,0.0007945256,0.0012562847,0.0026568626,0.012792163,0.0023765664,0.011562726,0.04562052],"category_scores_gemma":[0.18217202,0.00070362835,0.0009950214,0.0015535363,0.013400779,0.026728474,0.0076058046,0.02077381,0.010851314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017289759,0.00004579343,0.00040994294,0.0015520036,0.000029312434,0.00056901533,0.0026132003,0.00009007407,0.00024821697,0.067024216,0.61797065,0.30927464],"study_design_scores_gemma":[0.000102557955,0.000115140116,0.0006303982,0.0059001874,0.000023176119,0.0015916657,0.0030690094,0.00019291886,0.0003594651,0.064693585,0.92324847,0.000073325136],"about_ca_topic_score_codex":0.0020608783,"about_ca_topic_score_gemma":0.003069523,"teacher_disagreement_score":0.050850898,"about_ca_system_score_codex":0.004140988,"about_ca_system_score_gemma":0.008426143,"threshold_uncertainty_score":0.26892847},"labels":[],"label_agreement":null},{"id":"W1539577732","doi":"10.1111/j.1365-2133.2011.10373.x","title":"A case of monilethrix caused by novel compound heterozygous mutations in the desmoglein 4 (DSG4) gene","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Compound heterozygosity; Gene; Genetics; Mutation; Desmoglein 1; Dermatology; Medicine; Biology; Antibody; Autoantibody","score_opus":0.031699793575288994,"score_gpt":0.26691914363208913,"score_spread":0.23521935005680014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1539577732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949368,0.0006455711,0.0011012593,0.00036571754,0.00004851524,0.00005433988,0.00008199484,0.000072910756,0.0026928943],"genre_scores_gemma":[0.9979359,0.00020730744,0.0006385147,0.00012954076,0.00006139701,0.00000920693,0.00003147108,0.000011718116,0.0009750426],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996941,0.000032208758,0.000020570873,0.000091077345,0.00005244847,0.00010956561],"domain_scores_gemma":[0.9995127,0.000139744,0.00009859703,0.00003594222,0.000020775273,0.00019239355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021770834,0.0013690536,0.00069964415,0.0009913831,0.0012198985,0.0005057361,0.0005693785,0.0019361242,0.001633033],"category_scores_gemma":[0.00089178584,0.0007973504,0.00043556743,0.00069261267,0.0011452013,0.0005046278,0.00096715783,0.001133994,0.00025383916],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065298715,0.000026597723,0.003764157,0.000026103433,0.000012427287,0.98852146,0.00015160831,0.000067354165,0.005899573,0.0001929364,0.00011130918,0.0011612279],"study_design_scores_gemma":[0.000027661692,0.00010077097,0.010494304,0.000005114054,0.000017216535,0.98731947,0.00005610456,0.00026188302,0.0012107667,0.0001222018,0.00037494037,0.000009632259],"about_ca_topic_score_codex":0.0019098024,"about_ca_topic_score_gemma":0.0027723166,"teacher_disagreement_score":0.0019361242,"about_ca_system_score_codex":0.00058880606,"about_ca_system_score_gemma":0.0003853951,"threshold_uncertainty_score":0.005463004},"labels":[],"label_agreement":null},{"id":"W1549384169","doi":"10.1111/bjd.12018","title":"Functional studies for the<i>TRAF6</i>mutation associated with hypohidrotic ectodermal dysplasia","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"dental development and anomalies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Hypohidrotic ectodermal dysplasia; Mutant; Mutation; Ectodermal dysplasia; Signal transducing adaptor protein; Mutant protein; Wild type; Immunoprecipitation; Biology; Molecular biology; Receptor; Genetics; Gene","score_opus":0.018069687748174964,"score_gpt":0.2455849194724751,"score_spread":0.22751523172430013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1549384169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630886,0.0005786379,0.0017571953,0.000082921826,0.000030464967,0.000020482883,0.00049173454,0.000022856148,0.00070678047],"genre_scores_gemma":[0.9957562,0.00032053277,0.0021334768,0.000053193,0.000011715558,0.000014197122,0.00096769864,0.000014918837,0.000727986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983096,0.000028047083,0.000027754397,0.00003899214,0.000045753066,0.000028459868],"domain_scores_gemma":[0.99974793,0.000070891714,0.000058431615,0.000020420764,0.000042899737,0.00005948818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002708141,0.00046382446,0.00015552656,0.0003205399,0.00029368934,0.00017515018,0.00033502418,0.0005052971,0.0022353448],"category_scores_gemma":[0.00027099025,0.00009943508,0.00055048225,0.0001767025,0.00026068577,0.00017893665,0.00014573244,0.0004666892,0.0006019257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114463444,0.000038697654,0.001135903,0.00005301301,0.000011508915,0.00076638133,0.00002107811,0.000046510537,0.9971511,0.00007562866,0.0000375949,0.00054824504],"study_design_scores_gemma":[0.000044589655,0.0006321457,0.04354916,0.000018391585,0.00010425058,0.032947894,0.0001970441,0.0020059817,0.91477394,0.00013590358,0.0055750175,0.000015592905],"about_ca_topic_score_codex":0.0006052569,"about_ca_topic_score_gemma":0.00042542952,"teacher_disagreement_score":0.0022353448,"about_ca_system_score_codex":0.00026079244,"about_ca_system_score_gemma":0.00009816219,"threshold_uncertainty_score":0.0074779987},"labels":[],"label_agreement":null},{"id":"W1572999787","doi":"10.1111/j.1365-2133.2011.10399.x","title":"Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION study","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Cilag; Johnson and Johnson; Abbott Laboratories; Abbott Fund","keywords":"Methotrexate; Medicine; Psoriasis; Dosing; Psoriasis Area and Severity Index; Internal medicine; Placebo; Dose; Champion; Gastroenterology; Surgery; Dermatology","score_opus":0.043282077650785816,"score_gpt":0.28162148791945824,"score_spread":0.23833941026867242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572999787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969125,0.0015249413,0.00013409293,0.00009433887,0.00001640845,0.000075183176,0.0005905595,0.000010232202,0.0006417956],"genre_scores_gemma":[0.9981974,0.00016072052,0.00012806989,0.00008960522,0.00006856564,0.00006908641,0.0010278561,0.000004726479,0.0002539942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969836,0.0017748955,0.0002647709,0.00035150137,0.00048313284,0.00014211971],"domain_scores_gemma":[0.99398524,0.0020654788,0.0024455902,0.00054797274,0.0004527562,0.00050304655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004378477,0.00041841262,0.0011266635,0.0005307829,0.00027885844,0.00063437206,0.00039282552,0.0004691346,0.0019228176],"category_scores_gemma":[0.00510082,0.00020480176,0.0012625692,0.0006665432,0.00025779643,0.0003466511,0.00041647902,0.00062505057,0.000170021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05944639,0.0002840915,0.9215902,0.0002006603,0.005628938,0.00009211885,0.000107121035,0.00034528677,0.0012837759,0.000060699804,0.0011034613,0.009857251],"study_design_scores_gemma":[0.0021842755,0.0033931115,0.9917408,0.00001552372,0.001038505,0.00020643468,0.0000396925,0.00039884084,0.00014649401,0.000047916208,0.00077631214,0.000012027347],"about_ca_topic_score_codex":0.00057620957,"about_ca_topic_score_gemma":0.0009397433,"teacher_disagreement_score":0.004378477,"about_ca_system_score_codex":0.00033547677,"about_ca_system_score_gemma":0.00035744382,"threshold_uncertainty_score":0.023155928},"labels":[],"label_agreement":null},{"id":"W1576222573","doi":"10.1046/j.1365-2133.2000.03306.x","title":"Redefining Rowell’s syndrome","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Anti-nuclear antibody; Medicine; Erythema multiforme; Rheumatoid factor; Dermatology; Antibody; Pathology; Immunology; Autoantibody","score_opus":0.01616906899157267,"score_gpt":0.2762891581412653,"score_spread":0.26012008914969265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1576222573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89988816,0.048024543,0.006542849,0.0037598296,0.0008165557,0.00014174732,0.000312835,0.00036195727,0.040151402],"genre_scores_gemma":[0.9900478,0.004905388,0.0018614973,0.0011564039,0.00028491693,0.000014664524,0.00009701189,0.000021175318,0.0016111622],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995995,0.00007702436,0.00005016522,0.0000851978,0.00009283161,0.00009523954],"domain_scores_gemma":[0.9989743,0.00045658945,0.00023003077,0.00006146066,0.00015850303,0.00011912337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031537918,0.0007167356,0.0005606341,0.0008330707,0.00045957766,0.0005515211,0.0005289216,0.0013817396,0.001544527],"category_scores_gemma":[0.0023691559,0.00014952042,0.00022603638,0.00065093965,0.0009176264,0.00056320976,0.0005004167,0.00075238466,0.0004098383],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002319638,0.000048330305,0.038696904,0.00081703445,0.00009632055,0.81800175,0.0011526324,0.00026004095,0.05015821,0.005064596,0.006447133,0.07902512],"study_design_scores_gemma":[0.000019865553,0.000063296146,0.008323392,0.00005949299,0.000048791786,0.97765654,0.00012496344,0.00010831023,0.0030566247,0.0009491865,0.009572119,0.00001745488],"about_ca_topic_score_codex":0.0013967089,"about_ca_topic_score_gemma":0.0017665941,"teacher_disagreement_score":0.001544527,"about_ca_system_score_codex":0.0002934506,"about_ca_system_score_gemma":0.0004077138,"threshold_uncertainty_score":0.0051670074},"labels":[],"label_agreement":null},{"id":"W1580715943","doi":"10.1111/j.1365-2133.2011.10344.x","title":"A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group; Centre de Recherche Dermatologique du Québec Métropolitain","funders":"","keywords":"Adapalene; Acne; Medicine; Benzoyl peroxide; Dermatology; Library science; Computer science","score_opus":0.0063267002490228035,"score_gpt":0.2095494778434396,"score_spread":0.20322277759441681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1580715943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874657,0.008276475,0.00037459112,0.00039744264,0.00034480495,0.0019664352,0.00042865062,0.00006885105,0.00067703344],"genre_scores_gemma":[0.9900573,0.0041795173,0.0010167735,0.00048501903,0.00051162724,0.0023227148,0.00046083223,0.000014683515,0.0009515662],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984829,0.00088615983,0.00014465126,0.00020811039,0.00012970835,0.0001484594],"domain_scores_gemma":[0.9978186,0.0008944642,0.00046125453,0.00018823204,0.0001631729,0.00047424223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032320665,0.0010789144,0.0037197839,0.00045951063,0.00054929644,0.0009036461,0.0009989176,0.0019156985,0.0043330304],"category_scores_gemma":[0.002808558,0.0006003381,0.002724165,0.00058054994,0.001101512,0.00093786314,0.00034901212,0.001926302,0.0005452304],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9750006,0.0067198277,0.0008596434,0.0007661001,0.0016291104,0.00003153236,0.00005835312,0.000096464726,0.0016365444,0.00002622647,0.00026877373,0.012906857],"study_design_scores_gemma":[0.92766464,0.067215495,0.0035921517,0.00003668741,0.0008795347,0.000019678204,0.000022595366,0.00018054679,0.00016760213,0.000029200364,0.00018070372,0.000011114146],"about_ca_topic_score_codex":0.0009854335,"about_ca_topic_score_gemma":0.0015953074,"teacher_disagreement_score":0.0043330304,"about_ca_system_score_codex":0.0005392835,"about_ca_system_score_gemma":0.0008878705,"threshold_uncertainty_score":0.017093003},"labels":[],"label_agreement":null},{"id":"W1582804005","doi":"10.1111/j.1365-2133.2012.10962.x","title":"A novel mutation in the<i>PLCD1</i>gene, which leads to an aberrant splicing event, underlies autosomal recessive leuconychia","year":2012,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"RNA splicing; Event (particle physics); Genetics; Mutation; Gene; Alternative splicing; Computational biology; Content (measure theory); Biology; Computer science; Exon; Physics; Mathematics","score_opus":0.0222667225120318,"score_gpt":0.2971102231618257,"score_spread":0.2748435006497939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1582804005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8309635,0.0025280972,0.006534129,0.07255847,0.0044154148,0.00030693162,0.0034054115,0.0005746314,0.07871341],"genre_scores_gemma":[0.9764649,0.0007675159,0.0015762649,0.005341668,0.0017348872,0.00004239218,0.0004621235,0.000053528613,0.01355669],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999635,0.00005687898,0.00003929138,0.00011065834,0.000069516864,0.00008863422],"domain_scores_gemma":[0.9992235,0.00047913546,0.000105087856,0.000032283064,0.000043131753,0.00011689459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023713327,0.0007945044,0.00055697025,0.0005286555,0.00081744586,0.0005249833,0.000575617,0.003542421,0.009159646],"category_scores_gemma":[0.0017508484,0.00022286216,0.0004708859,0.00048397682,0.000900182,0.0005420411,0.0002680138,0.0021258623,0.0013579354],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023326537,0.000062449784,0.0074825776,0.000057746423,0.000020443764,0.9607354,0.00023594932,0.00015551128,0.007120919,0.0012068738,0.01700092,0.0056879353],"study_design_scores_gemma":[0.00012143549,0.00027101053,0.017806508,0.000055933117,0.000054819688,0.953102,0.00023784625,0.0012702995,0.005900542,0.0015104262,0.019632198,0.000036960686],"about_ca_topic_score_codex":0.0021090975,"about_ca_topic_score_gemma":0.0017445858,"teacher_disagreement_score":0.009159646,"about_ca_system_score_codex":0.0006964274,"about_ca_system_score_gemma":0.00033777987,"threshold_uncertainty_score":0.030642092},"labels":[],"label_agreement":null},{"id":"W1583872719","doi":"10.1111/j.1365-2133.2011.10537.x","title":"Transgrediens pachyonychia congenita (PC): case series of a nonclassical PC presentation","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Medicine; Dermatology; Keratoderma; Dorsum; Nail (fastener); Etiology; Foot (prosody); Hyperkeratosis; Surgery; Pathology; Anatomy","score_opus":0.022340927888889014,"score_gpt":0.26200998649899976,"score_spread":0.23966905861011073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1583872719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935114,0.0012438757,0.0012082553,0.00027524435,0.000055108965,0.00010300532,0.000117150776,0.0000562897,0.0034296557],"genre_scores_gemma":[0.9984158,0.00041801287,0.00055234774,0.00011065459,0.00010634476,0.00002139645,0.00006993482,0.0000126287105,0.0002928088],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99932086,0.000076866774,0.00009212128,0.00019540387,0.00011862564,0.0001961496],"domain_scores_gemma":[0.99731547,0.0008661607,0.0006274121,0.00034498045,0.00016752152,0.00067847705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003110292,0.0016472255,0.0006757878,0.0017526738,0.001823177,0.0012145176,0.0010199463,0.0018808632,0.0027374367],"category_scores_gemma":[0.0035400654,0.0009210329,0.00058819435,0.0013198741,0.0018589753,0.0009338377,0.0014874622,0.0014564319,0.0007007999],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004498216,0.000054577176,0.045684807,0.000051379175,0.000022495253,0.95047605,0.00025146813,0.00009965329,0.0009921319,0.00014265925,0.0002941278,0.0018855884],"study_design_scores_gemma":[0.0000075641556,0.000037983435,0.009023049,0.0000068331624,0.000008762708,0.99040246,0.00008573399,0.000081405284,0.00014920167,0.000041934953,0.0001494663,0.0000056243075],"about_ca_topic_score_codex":0.0019438325,"about_ca_topic_score_gemma":0.0020982418,"teacher_disagreement_score":0.0027374367,"about_ca_system_score_codex":0.00059142814,"about_ca_system_score_gemma":0.0006548679,"threshold_uncertainty_score":0.009157598},"labels":[],"label_agreement":null},{"id":"W1584376310","doi":"10.1111/j.1365-2133.2010.09851.x","title":"BRG1 expression is increased in human cutaneous melanoma","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Melanoma; SWI/SNF; Gene knockdown; Cancer research; Cell growth; Tissue microarray; Cyclin D1; Chromatin remodeling; Cell cycle; Immunohistochemistry; Cancer; Biology; Medicine; Pathology; Chromatin; Cell culture; Internal medicine; Gene; Genetics","score_opus":0.0048246649421337965,"score_gpt":0.2443027886571357,"score_spread":0.2394781237150019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1584376310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531686,0.0030436595,0.00033849946,0.000030620027,0.000007747968,0.0000139655995,0.00036717148,0.000054265896,0.00082738796],"genre_scores_gemma":[0.9974511,0.0008716352,0.0003975424,0.000025308123,0.000007001048,0.000013895006,0.0004646556,0.000009976064,0.0007588789],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999899,0.000011731586,0.0000072957578,0.000035645557,0.000028009032,0.000018275969],"domain_scores_gemma":[0.9998418,0.000023172806,0.000074527874,0.000010392221,0.000023070734,0.000026987113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010408373,0.0001779588,0.00022666226,0.0008653999,0.0001306504,0.00030198455,0.0001047069,0.0003005857,0.0018745414],"category_scores_gemma":[0.0002078072,0.00017579351,0.00013246597,0.00043034228,0.00013959427,0.00012074677,0.00013895138,0.00019738328,0.00039918817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061972823,0.000032855856,0.06832646,0.0001902891,0.00004525477,0.0010711211,0.00009421475,0.00007387008,0.92063105,0.000036420875,0.00020529037,0.008673493],"study_design_scores_gemma":[0.000029072784,0.00030552322,0.8890836,0.000022233467,0.00008430865,0.008808855,0.00012249347,0.00034589064,0.09833968,0.000057456884,0.0027951477,0.000005698336],"about_ca_topic_score_codex":0.0004615436,"about_ca_topic_score_gemma":0.0004494746,"teacher_disagreement_score":0.0018745414,"about_ca_system_score_codex":0.00018614961,"about_ca_system_score_gemma":0.000058900107,"threshold_uncertainty_score":0.006270945},"labels":[],"label_agreement":null},{"id":"W1585166895","doi":"10.1111/j.1365-2133.2011.10489.x","title":"CXCR3 ligands promote expression of functional indoleamine 2,3-dioxygenase in basal cell carcinoma keratinocytes","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; Vancouver General Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Indoleamine 2,3-dioxygenase; Downregulation and upregulation; Basal cell carcinoma; Kynurenine; Biology; Keratinocyte; Cancer research; CXCR3; Carcinogenesis; Western blot; Molecular biology; Immunology; Immune system; In vitro; Biochemistry; Medicine; Pathology; Chemokine; Gene; Basal cell","score_opus":0.02788231292972241,"score_gpt":0.2188410864020706,"score_spread":0.1909587734723482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1585166895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920142,0.0030995903,0.0011124136,0.00013950496,0.000038850863,0.000052092822,0.0005054306,0.00007094529,0.0029668252],"genre_scores_gemma":[0.9950897,0.00077074574,0.0009230335,0.000091506154,0.000012443264,0.00004154548,0.00041788592,0.000008690751,0.0026444925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998462,0.0000297333,0.000011091541,0.000019021292,0.000036174264,0.0000577933],"domain_scores_gemma":[0.999923,0.000012390069,0.00001795509,0.000007703021,0.000015957421,0.000022908844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011527275,0.00016971811,0.00016304207,0.000136823,0.00013750783,0.00030823488,0.00005812912,0.00017503282,0.0030788803],"category_scores_gemma":[0.000087486645,0.00008235379,0.00026553872,0.00007587227,0.00011704339,0.000121737794,0.00015071277,0.00040723212,0.0007466335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018971007,0.000047367263,0.0010875319,0.00010423935,0.0000053050007,0.00007798824,0.000029707051,0.00004479688,0.99608386,0.000058606627,0.00017822259,0.0020925854],"study_design_scores_gemma":[0.0000630301,0.0010244016,0.056384355,0.0000546074,0.000042293414,0.0008771113,0.00031701764,0.0012366131,0.9309786,0.00007800567,0.008931327,0.000012695214],"about_ca_topic_score_codex":0.00077022926,"about_ca_topic_score_gemma":0.001127819,"teacher_disagreement_score":0.0030788803,"about_ca_system_score_codex":0.000248451,"about_ca_system_score_gemma":0.0002036684,"threshold_uncertainty_score":0.010299861},"labels":[],"label_agreement":null},{"id":"W1591809044","doi":"10.1111/j.1365-2133.2012.11015.x","title":"A randomized, double‐blind, placebo‐controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"Pfizer; Amgen","keywords":"Etanercept; Medicine; Psoriasis Area and Severity Index; Psoriasis; Methotrexate; Internal medicine; Placebo; Combination therapy; Adverse effect; Gastroenterology; Randomized controlled trial; Clinical endpoint; Surgery; Dermatology; Tumor necrosis factor alpha; Pathology","score_opus":0.0201933887183919,"score_gpt":0.26993627326028996,"score_spread":0.24974288454189805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1591809044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97750443,0.0067485333,0.0012632068,0.0008539236,0.0014347329,0.008982689,0.0009320346,0.00018585894,0.0020946334],"genre_scores_gemma":[0.97692704,0.003822823,0.0028417993,0.0013724377,0.0010364318,0.010593281,0.0007320016,0.000021599692,0.0026525885],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99870217,0.0006587631,0.00012339429,0.00025440418,0.00014177777,0.00011948772],"domain_scores_gemma":[0.99839264,0.0005212105,0.00035450122,0.0001291598,0.00014506408,0.00045732214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025603704,0.0013365007,0.005025025,0.0006001902,0.00062808325,0.0010171623,0.001101872,0.0019830794,0.008604494],"category_scores_gemma":[0.002880843,0.0009666862,0.0015589931,0.00053551194,0.0013433191,0.0011217005,0.000485765,0.0024898446,0.0013479289],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97569114,0.010187422,0.0003941582,0.00061086944,0.0007120809,0.0000313428,0.000033057302,0.00009638236,0.0019854356,0.000040647687,0.00034554253,0.009871884],"study_design_scores_gemma":[0.9611885,0.037493218,0.0007220589,0.000013175948,0.00019299824,0.000014675007,0.0000059521785,0.000089994304,0.00007483786,0.000024774055,0.00017485677,0.0000049557516],"about_ca_topic_score_codex":0.00057966664,"about_ca_topic_score_gemma":0.0013007319,"teacher_disagreement_score":0.008604494,"about_ca_system_score_codex":0.0005950899,"about_ca_system_score_gemma":0.0013623928,"threshold_uncertainty_score":0.02878493},"labels":[],"label_agreement":null},{"id":"W1592628203","doi":"10.1111/j.1365-2133.2010.10139.x","title":"Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"Abbott Laboratories","keywords":"Adalimumab; Medicine; Psoriasis; Adverse effect; Internal medicine; Psoriasis Area and Severity Index; Dosing; Surgery; Dermatology; Disease","score_opus":0.00973151097607172,"score_gpt":0.23870295296334362,"score_spread":0.2289714419872719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1592628203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528015,0.003803435,0.00013534786,0.000059978054,0.000010930026,0.00009529125,0.000055376073,0.000009425867,0.0005501322],"genre_scores_gemma":[0.9990683,0.00040375956,0.00012401512,0.00006123125,0.000027105878,0.00003432918,0.00007843182,0.0000020683824,0.00020073661],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991854,0.00032621474,0.000091268834,0.00008512652,0.00023224352,0.00007973267],"domain_scores_gemma":[0.9988176,0.00035976755,0.00046063488,0.00007569425,0.000089720605,0.0001963854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002711449,0.00028341738,0.0009167861,0.00015677682,0.00029609908,0.00043498675,0.00023673545,0.0004093518,0.0011294913],"category_scores_gemma":[0.0016483025,0.00012586449,0.0005804675,0.00015667683,0.00023162193,0.00024459494,0.00016789671,0.00068427407,0.00023317075],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18659572,0.0075543486,0.27621296,0.0016868758,0.0016942438,0.0006797292,0.0005232178,0.00077301136,0.05703671,0.00015995988,0.0018005606,0.46528262],"study_design_scores_gemma":[0.019291626,0.14272265,0.82043725,0.000205346,0.0007645754,0.0029396468,0.00011810283,0.0020427944,0.0075549134,0.0001419562,0.0037407146,0.00004042986],"about_ca_topic_score_codex":0.00049466855,"about_ca_topic_score_gemma":0.0009962289,"teacher_disagreement_score":0.002711449,"about_ca_system_score_codex":0.000406551,"about_ca_system_score_gemma":0.0004183747,"threshold_uncertainty_score":0.014339685},"labels":[],"label_agreement":null},{"id":"W1593834521","doi":"10.1046/j.1365-2133.2000.03341.x","title":"What are some of the lessons learnt from in vitro studies of severe unpredictable drug reactions?","year":2000,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Australasian College of Dermatologists; Canadian Dermatology Foundation","keywords":"Drug; Medicine; In vitro; Intensive care medicine; Pharmacology; Chemistry; Biochemistry","score_opus":0.031451782462730976,"score_gpt":0.2921869687163445,"score_spread":0.26073518625361347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1593834521","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052010994,0.6537327,0.016293015,0.29376352,0.025932228,0.00010732297,0.00031360378,0.0003666085,0.0042899516],"genre_scores_gemma":[0.045316476,0.6838016,0.025366396,0.14773954,0.09377383,0.00027065282,0.0005263395,0.00026676134,0.0029384058],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98704123,0.0052486886,0.0019471964,0.0012151451,0.0038596299,0.0006880436],"domain_scores_gemma":[0.87149084,0.06915034,0.006484057,0.010351725,0.03619036,0.0063326764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.048156045,0.0026858258,0.00512032,0.00302658,0.0015585723,0.008057295,0.0062147602,0.009259453,0.0028396053],"category_scores_gemma":[0.06896732,0.0010242098,0.0028053082,0.002183452,0.0081915585,0.01789503,0.0027753382,0.01882124,0.0033362838],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008997405,0.0006607829,0.0139507055,0.013766848,0.0008180266,0.010100419,0.002582422,0.0023131755,0.009444702,0.032285035,0.3010663,0.6121119],"study_design_scores_gemma":[0.00032895463,0.0019563066,0.009689057,0.00969685,0.000769754,0.021953333,0.005691157,0.0026877022,0.011123389,0.15486185,0.7805755,0.0006662199],"about_ca_topic_score_codex":0.002182513,"about_ca_topic_score_gemma":0.0029531533,"teacher_disagreement_score":0.048156045,"about_ca_system_score_codex":0.0024505858,"about_ca_system_score_gemma":0.0023387915,"threshold_uncertainty_score":0.25467652},"labels":[],"label_agreement":null},{"id":"W1596650745","doi":"10.1111/bjd.12212","title":"Small-diameter melanocytic lesions: morphological analysis by means of<i>in vivo</i>confocal microscopy","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Dermatology; Library science; Computer science","score_opus":0.014314118538661333,"score_gpt":0.24886713085464662,"score_spread":0.2345530123159853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1596650745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907032,0.0007549651,0.0072125136,0.000025660745,0.0000034407253,0.00004942367,0.00013275024,0.00006623262,0.0010517499],"genre_scores_gemma":[0.9911,0.0003449484,0.0080968,0.000012972114,0.0000051392453,0.000024519815,0.00015173381,0.000009483173,0.00025447106],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99977285,0.00005616673,0.000026202013,0.00006112047,0.000054776592,0.00002882598],"domain_scores_gemma":[0.9993844,0.00014030733,0.00020156892,0.00005852116,0.00015199209,0.00006318698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006817865,0.00024040643,0.00014665767,0.0009063468,0.00020088325,0.00032687862,0.00019979446,0.00025302052,0.0010491667],"category_scores_gemma":[0.00086296047,0.00016253372,0.00014020351,0.0003050824,0.00034413315,0.00037454828,0.00025665382,0.00019230449,0.00027075136],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000465236,0.00010111376,0.2236318,0.00027615466,0.000051769002,0.00090859475,0.00026399436,0.0003529722,0.75860256,0.00013927415,0.00018012743,0.015026453],"study_design_scores_gemma":[0.000011849144,0.00069726113,0.79694355,0.000034107135,0.00009855663,0.01827703,0.00047449986,0.0049510533,0.1767971,0.00021491857,0.0014638342,0.000036193567],"about_ca_topic_score_codex":0.0007781646,"about_ca_topic_score_gemma":0.001128718,"teacher_disagreement_score":0.0010491667,"about_ca_system_score_codex":0.00022226266,"about_ca_system_score_gemma":0.00016232354,"threshold_uncertainty_score":0.0036056638},"labels":[],"label_agreement":null},{"id":"W1601300544","doi":"10.1111/j.1365-2133.2012.11097.x","title":"Clinicopathological comparisons of index and second primary melanomas in paediatric and adult populations","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Melanoma; Incidence (geometry); Epidemiology; Malignancy; Population; Relative risk; Dermatology; Retrospective cohort study; Internal medicine; Confidence interval","score_opus":0.021552750054649013,"score_gpt":0.27512171887440035,"score_spread":0.25356896881975133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1601300544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977162,0.000944034,0.00011467432,0.000030702122,0.0000075605703,0.000012338413,0.00038290265,0.0000049506834,0.0007865694],"genre_scores_gemma":[0.9989213,0.0004381885,0.00009399347,0.000010692566,0.000010861043,0.000012066485,0.00043869487,0.000003017326,0.000071326795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993604,0.00013276278,0.00008588239,0.00015119145,0.00016656391,0.000103190374],"domain_scores_gemma":[0.99712294,0.0004908981,0.0017072479,0.00012009315,0.0002246785,0.0003341273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008050109,0.00017274129,0.00031894076,0.001575131,0.0003049803,0.0004400394,0.00031671306,0.00027848486,0.0022876586],"category_scores_gemma":[0.0039003505,0.00021219692,0.00037360072,0.0012023419,0.00040238546,0.00040022953,0.00050112506,0.0004210997,0.00028616763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051732368,0.000005248545,0.9979097,0.000015456491,0.000016447704,0.00043481548,0.00007552123,0.000033785367,0.00011588611,0.00001838368,0.00009964098,0.001223325],"study_design_scores_gemma":[0.0000030069998,0.000058962723,0.9949227,0.000009694345,0.000009721843,0.0044187265,0.00019510256,0.00004746014,0.000059660146,0.00001922298,0.00025381029,0.0000019786075],"about_ca_topic_score_codex":0.0017956686,"about_ca_topic_score_gemma":0.0018428724,"teacher_disagreement_score":0.0022876586,"about_ca_system_score_codex":0.00037140137,"about_ca_system_score_gemma":0.0003548167,"threshold_uncertainty_score":0.007652998},"labels":[],"label_agreement":null},{"id":"W1606414399","doi":"10.1111/bjd.12074","title":"‘Is it safe?’ Safety is a process, not a question","year":2012,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Process (computing); Computer science; Programming language","score_opus":0.22544266542925703,"score_gpt":0.41292033014990404,"score_spread":0.187477664720647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1606414399","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012332472,0.00063057075,0.00006266247,0.9948102,0.0032468599,0.0000026352336,0.000016834969,0.000005249011,0.0011016779],"genre_scores_gemma":[0.0021561468,0.00039354857,0.00017591975,0.9815962,0.013324076,0.000011676094,0.000010596869,0.0000108148015,0.0023211034],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9848155,0.0057886993,0.0022981265,0.0016159203,0.0036948472,0.0017869226],"domain_scores_gemma":[0.9448809,0.037134066,0.0035791006,0.001531377,0.007910247,0.0049643307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018359004,0.0007899021,0.0027616078,0.0010031029,0.0054551363,0.0073617715,0.0024708877,0.098374784,0.008801369],"category_scores_gemma":[0.09237311,0.0010832389,0.0016254283,0.0011705004,0.011314282,0.01334267,0.0034906568,0.10035898,0.006527498],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004401467,0.00003698638,0.00051665306,0.00007821622,0.000022411352,0.0005007344,0.00030136737,0.000042911175,0.00010020965,0.012179294,0.97689205,0.009285049],"study_design_scores_gemma":[0.00021483017,0.00006865233,0.0020917712,0.000798483,0.00005283109,0.0019559402,0.0011208906,0.0004658916,0.00018751711,0.05351225,0.9393924,0.00013853452],"about_ca_topic_score_codex":0.013606306,"about_ca_topic_score_gemma":0.026389457,"teacher_disagreement_score":0.098374784,"about_ca_system_score_codex":0.007078362,"about_ca_system_score_gemma":0.010385309,"threshold_uncertainty_score":0.09709287},"labels":[],"label_agreement":null},{"id":"W1608707730","doi":"10.1111/j.1365-2133.2010.10095.x","title":"Dermatofibrosarcoma protuberans: 35 patients treated with Mohs micrographic surgery using paraffin sections","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Dermatofibrosarcoma protuberans; Medicine; Mohs surgery; Dermatofibrosarcoma; Dermatology; Surgery","score_opus":0.010768728362882419,"score_gpt":0.23991409823919907,"score_spread":0.22914536987631665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608707730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798656,0.0011391202,0.0001350439,0.000048988877,0.000007541114,0.000026317734,0.0000682224,0.0000065345416,0.0005816114],"genre_scores_gemma":[0.9988134,0.0006419296,0.00021463034,0.00005340177,0.000017234335,0.000011773829,0.00007102166,0.000002215205,0.00017438942],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9997334,0.00003478336,0.00005006908,0.00005279238,0.00004938468,0.00007965811],"domain_scores_gemma":[0.99955195,0.000117780466,0.0001873091,0.000022531616,0.000025259902,0.00009519451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031085312,0.00040163664,0.00033632186,0.0010908486,0.00088011345,0.0005138402,0.0002924641,0.0004498233,0.0018055189],"category_scores_gemma":[0.0011589178,0.00049266324,0.0004938787,0.001058269,0.00051356596,0.00039015673,0.00047662013,0.00031246117,0.00029342234],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048693054,0.00027524334,0.83942246,0.00015955344,0.00009662309,0.13816057,0.0015846321,0.00022916564,0.003933552,0.00010406041,0.00034678253,0.0152003085],"study_design_scores_gemma":[0.00011117789,0.0027876303,0.6228824,0.00008101031,0.00020651663,0.36582705,0.0021081276,0.0003059494,0.0024413904,0.00012261872,0.003085428,0.00004058642],"about_ca_topic_score_codex":0.001219608,"about_ca_topic_score_gemma":0.0022011446,"teacher_disagreement_score":0.0018055189,"about_ca_system_score_codex":0.0005764703,"about_ca_system_score_gemma":0.00045269373,"threshold_uncertainty_score":0.0060400367},"labels":[],"label_agreement":null},{"id":"W1628071823","doi":"10.1111/j.1365-2133.2012.10824.x","title":"Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"PTEN; PI3K/AKT/mTOR pathway; Cadherin; Downregulation and upregulation; Biology; Epithelial–mesenchymal transition; Cancer research; Protein kinase B; Adherens junction; Signal transduction; Cell biology; Cell; Gene","score_opus":0.008879717175272991,"score_gpt":0.24904167469232202,"score_spread":0.24016195751704902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1628071823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560875,0.0009741205,0.0013106081,0.000047899284,0.000010946468,0.000023356917,0.00026762436,0.000069589376,0.0016871768],"genre_scores_gemma":[0.99724007,0.00052592787,0.0005826217,0.000018185126,0.0000023752066,0.00001838824,0.00023572035,0.000003913806,0.0013727692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999436,0.000007135727,0.0000044547987,0.000009894909,0.000014870247,0.000020011994],"domain_scores_gemma":[0.9999491,0.0000042207275,0.000015991507,0.000003349944,0.0000072847142,0.000020084606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080414015,0.00020293663,0.00009664481,0.00021786243,0.00014838205,0.00022820295,0.00011996672,0.00011993468,0.0010943334],"category_scores_gemma":[0.000065817236,0.00011357154,0.00018832226,0.00013463809,0.00015034934,0.00016998015,0.00015126866,0.00029302007,0.00026294208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017429264,0.000027615944,0.00095755694,0.000029919218,0.0000033122308,0.00008392812,0.000011069309,0.00006599793,0.99748343,0.00013195263,0.000047431873,0.0009834602],"study_design_scores_gemma":[0.000043589873,0.00040287353,0.05443697,0.0000108153245,0.00002636286,0.00059207,0.00006318497,0.0027342841,0.9388775,0.00017099263,0.0026337018,0.0000075811145],"about_ca_topic_score_codex":0.0007674244,"about_ca_topic_score_gemma":0.0010569955,"teacher_disagreement_score":0.0010943334,"about_ca_system_score_codex":0.00020830393,"about_ca_system_score_gemma":0.00023826008,"threshold_uncertainty_score":0.0036609173},"labels":[],"label_agreement":null},{"id":"W1644093871","doi":"10.1046/j.1365-2133.2000.03287.x","title":"Characterization of an in vitro model of human melanoma invasion based on reconstructed human skin","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Dermis; Keratinocyte; Melanocyte; Melanoma; Human skin; Basement membrane; In vitro; Cell culture; Biology; Epidermis (zoology); Pathology; Cell biology; Medicine; Anatomy; Cancer research; Genetics","score_opus":0.010662076283442144,"score_gpt":0.24214197731450737,"score_spread":0.23147990103106522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1644093871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714704,0.001765566,0.023683608,0.00003984697,0.000051197472,0.00018472328,0.00034721737,0.00012468715,0.0023328732],"genre_scores_gemma":[0.978371,0.0009688773,0.01790999,0.00003091269,0.000007278186,0.000099006305,0.0005255215,0.000033065535,0.00205432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997563,0.000069637514,0.000016524576,0.000044934866,0.000085540094,0.000027019156],"domain_scores_gemma":[0.9997502,0.000072789495,0.00004123587,0.000080609825,0.000027969389,0.000027181244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041386572,0.0004670753,0.00030473442,0.0002869843,0.00013039327,0.00041800234,0.00033488078,0.0004128048,0.0012077793],"category_scores_gemma":[0.0002589266,0.00024914223,0.0004113288,0.0001888729,0.00017768635,0.00024104565,0.00024851048,0.00053725636,0.000494508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010104678,0.000074322634,0.0004156242,0.000101339196,0.000010559051,0.0003314941,0.000049783022,0.0011614314,0.99642485,0.0001394334,0.000023158544,0.0011669528],"study_design_scores_gemma":[0.000024753033,0.0014123116,0.007967653,0.00003504898,0.00008405376,0.0024277219,0.00012686678,0.011811362,0.97158504,0.00006984782,0.004436217,0.000018989818],"about_ca_topic_score_codex":0.00096424716,"about_ca_topic_score_gemma":0.00084796885,"teacher_disagreement_score":0.0012077793,"about_ca_system_score_codex":0.00018909201,"about_ca_system_score_gemma":0.00021119174,"threshold_uncertainty_score":0.0040403605},"labels":[],"label_agreement":null},{"id":"W1661616496","doi":"10.1111/bjd.12214","title":"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up","year":2013,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":410,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"","keywords":"Ustekinumab; Medicine; Mace; Adverse effect; Psoriasis; Population; Internal medicine; Dermatology; Disease; Environmental health","score_opus":0.023963248236928882,"score_gpt":0.2498224002245274,"score_spread":0.2258591519875985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1661616496","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709746,0.023903402,0.001349374,0.00014147144,0.000030120089,0.00025390802,0.0018855178,0.000029889226,0.0014318617],"genre_scores_gemma":[0.996427,0.0012535678,0.00026365757,0.0001068108,0.00003443769,0.00007494866,0.0016586592,0.0000049695254,0.00017607973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947877,0.001975231,0.00079917524,0.00057608867,0.0014306584,0.00043116754],"domain_scores_gemma":[0.9856866,0.0042950795,0.006431585,0.000996495,0.0019719426,0.00061831984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01562616,0.00056030607,0.0018215291,0.0009693307,0.00049235224,0.0012263189,0.00047693987,0.0007340179,0.0015633695],"category_scores_gemma":[0.009436183,0.00025036023,0.005332911,0.0010706506,0.00033189918,0.0009367815,0.00069175375,0.0009678718,0.00029054287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04785135,0.00077153003,0.8666051,0.0012372934,0.016039101,0.00023535542,0.00034398818,0.0018139605,0.0026210926,0.000076324744,0.000820498,0.06158442],"study_design_scores_gemma":[0.0015193687,0.017120484,0.96901023,0.00021752258,0.007858416,0.0004693821,0.000095131225,0.00065699476,0.0012778064,0.00012438087,0.0016133412,0.000036901667],"about_ca_topic_score_codex":0.00089862535,"about_ca_topic_score_gemma":0.0013570512,"teacher_disagreement_score":0.01562616,"about_ca_system_score_codex":0.0007064171,"about_ca_system_score_gemma":0.0006848622,"threshold_uncertainty_score":0.08264005},"labels":[],"label_agreement":null},{"id":"W1774383972","doi":"10.1111/j.1365-2133.2012.10895.x","title":"The quest for psoriasis susceptibility genes in the postgenome-wide association studies era: charting the road ahead","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Wellcome Trust","keywords":"Psoriasis; Association (psychology); Medicine; Dermatology; Genetics; Biology; Psychology","score_opus":0.02616040516835319,"score_gpt":0.280081891607258,"score_spread":0.2539214864389048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1774383972","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004008254,0.19932373,0.0066421865,0.77902526,0.009587429,0.000038021364,0.00028503407,0.00016653042,0.0009235355],"genre_scores_gemma":[0.07748102,0.3420788,0.06487346,0.4026104,0.10589058,0.0003629777,0.0011776589,0.00032850102,0.005196662],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9835471,0.00888359,0.0016917511,0.0014287444,0.0034531525,0.0009956025],"domain_scores_gemma":[0.82518953,0.122340165,0.0065886998,0.006741724,0.023643143,0.015496676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08597259,0.0016253974,0.004603992,0.004005388,0.0026510162,0.011913017,0.0030717375,0.020205837,0.006332221],"category_scores_gemma":[0.07970601,0.0012281565,0.0020713254,0.003724383,0.00756608,0.019592142,0.0057631284,0.027525939,0.0024502745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022132914,0.00052486215,0.026582269,0.0043682926,0.0012592877,0.0015703485,0.0023463124,0.0012273943,0.00790243,0.04945923,0.3930597,0.5094866],"study_design_scores_gemma":[0.00065820955,0.0013389969,0.051672064,0.005034816,0.0010675425,0.0024090824,0.0050868946,0.0025560423,0.0014279508,0.33354166,0.59452355,0.00068331184],"about_ca_topic_score_codex":0.0037190435,"about_ca_topic_score_gemma":0.006983383,"teacher_disagreement_score":0.08597259,"about_ca_system_score_codex":0.0031205483,"about_ca_system_score_gemma":0.009424997,"threshold_uncertainty_score":0.45467198},"labels":[],"label_agreement":null},{"id":"W1777365448","doi":"10.1111/j.1365-2133.2012.11142.x","title":"The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Janssen Pharmaceuticals; IC Design Education Center; Biogen; Amgen","keywords":"Ustekinumab; Medicine; Psoriasis; Discontinuation; Latent tuberculosis; Concomitant; Internal medicine; Adverse effect; Isoniazid; Tuberculosis; Dermatology; Mycobacterium tuberculosis; Adalimumab; Pathology; Disease","score_opus":0.007895784841891467,"score_gpt":0.20746878040034228,"score_spread":0.19957299555845082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1777365448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848341,0.01120552,0.0003751981,0.00040901147,0.000028490358,0.000099938356,0.00063841854,0.000024364448,0.0023848407],"genre_scores_gemma":[0.9982644,0.0008841237,0.00011075393,0.0002026348,0.000052402036,0.000033396485,0.0003323377,0.0000023875941,0.00011765814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975591,0.0011669426,0.00038260402,0.00018407329,0.00059437606,0.00011301818],"domain_scores_gemma":[0.99132746,0.0038079112,0.0034225653,0.00036951492,0.00060204644,0.00047040285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003610911,0.00018887433,0.000990498,0.00034263937,0.0002750328,0.0006745864,0.00027241395,0.0005591031,0.0016152144],"category_scores_gemma":[0.006982957,0.00013434223,0.00088028493,0.00052379916,0.0002916416,0.00037073914,0.00024791693,0.0008650112,0.000308548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09290907,0.0014197788,0.6368466,0.0018830551,0.002426817,0.000766215,0.0004118774,0.0010932045,0.008679068,0.00022739652,0.002028818,0.25130814],"study_design_scores_gemma":[0.012916463,0.05484429,0.9072481,0.00049105426,0.0020102814,0.005549326,0.0002620886,0.0023006508,0.005153331,0.00060136063,0.008581353,0.000041742616],"about_ca_topic_score_codex":0.00027005115,"about_ca_topic_score_gemma":0.00039662133,"teacher_disagreement_score":0.003610911,"about_ca_system_score_codex":0.00037104942,"about_ca_system_score_gemma":0.00058643776,"threshold_uncertainty_score":0.019096553},"labels":[],"label_agreement":null},{"id":"W1781511685","doi":"10.1046/j.1365-2133.2000.03292.x","title":"Refined localization of the gene for Clouston syndrome (hidrotic ectodermal dysplasia) in a large French family","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Pedigree chart; Haplotype; Genetics; Locus (genetics); Ectodermal dysplasia; Lod score; Genetic linkage; Hyperkeratosis; Biology; Gene mapping; Chromosome; Gene; Genotype","score_opus":0.005636440387815742,"score_gpt":0.2177497482849449,"score_spread":0.21211330789712915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1781511685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966757,0.0006174377,0.00088913494,0.00019536992,0.00000902145,0.00001166324,0.00011606989,0.000023559785,0.0014619993],"genre_scores_gemma":[0.9971951,0.00041907709,0.00099769,0.000086610205,0.000010206359,0.000011228386,0.00012672262,0.000008139872,0.0011451545],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997236,0.00006960543,0.000014580993,0.00009091264,0.000049716346,0.00005162292],"domain_scores_gemma":[0.9997887,0.000084220905,0.000035021316,0.000013075607,0.00003256665,0.00004647072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026605188,0.0008668759,0.0003660193,0.0010911422,0.000902472,0.0004426466,0.00026381042,0.00075984973,0.0023002524],"category_scores_gemma":[0.0007378134,0.00021387899,0.0003703746,0.00043966877,0.0006574384,0.00016064518,0.0003711729,0.00032858926,0.00022151247],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011915918,0.00037706058,0.2836107,0.00021943873,0.00044573116,0.20811735,0.008546934,0.0019003777,0.4231621,0.003144132,0.0022102657,0.06707433],"study_design_scores_gemma":[0.0001388713,0.00044499265,0.77974373,0.00008299947,0.00037331655,0.18479216,0.0015619997,0.0018315817,0.015164266,0.000414775,0.015377194,0.000074151685],"about_ca_topic_score_codex":0.061662473,"about_ca_topic_score_gemma":0.05697713,"teacher_disagreement_score":0.061662473,"about_ca_system_score_codex":0.0010909863,"about_ca_system_score_gemma":0.0005893234,"threshold_uncertainty_score":0.12260711},"labels":[],"label_agreement":null},{"id":"W1804278029","doi":"10.1111/bjd.12099","title":"Comparison of negative pressure wound therapy and secondary intention healing after excision of acral lentiginous melanoma on the foot","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Surgical site infection prevention","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acral lentiginous melanoma; Vascularity; Negative-pressure wound therapy; Surgery; Wound healing; Scars; Melanoma; Foot (prosody); Dermatology; Pathology","score_opus":0.02562243516809961,"score_gpt":0.30012782556553247,"score_spread":0.2745053903974329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1804278029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995036,0.00022394529,0.00005588801,0.0000041917165,0.000003895453,0.000011885691,0.0000055214323,7.9636527e-7,0.00019032182],"genre_scores_gemma":[0.9996971,0.0000960011,0.00009261287,0.0000072881658,0.00000933554,0.000012010139,0.000022339102,4.830761e-7,0.000062807274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963534,0.00013210584,0.000036741007,0.00003615063,0.00010998231,0.000049651168],"domain_scores_gemma":[0.99913776,0.00036543063,0.0002160909,0.000026466128,0.0000684945,0.00018575566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004860742,0.00017794932,0.0003175536,0.00037426042,0.00015525718,0.00021170967,0.00011846637,0.00022682201,0.0009894854],"category_scores_gemma":[0.001371633,0.00006366761,0.00033067877,0.00020118593,0.00018348797,0.00021934939,0.0001914094,0.00022918134,0.00008353514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041588277,0.008794673,0.7285839,0.00074129197,0.0007246634,0.003258296,0.00072057266,0.0010615627,0.03476802,0.00012649271,0.00019713977,0.17943516],"study_design_scores_gemma":[0.0006608785,0.081203915,0.90656793,0.00004178502,0.00021356021,0.0037786465,0.000470449,0.0011073439,0.005149421,0.00007176234,0.0007187011,0.000015655207],"about_ca_topic_score_codex":0.00014197368,"about_ca_topic_score_gemma":0.00021742105,"teacher_disagreement_score":0.0009894854,"about_ca_system_score_codex":0.00015213469,"about_ca_system_score_gemma":0.00015862427,"threshold_uncertainty_score":0.0033102036},"labels":[],"label_agreement":null},{"id":"W1809686743","doi":"10.1111/j.1365-2133.2012.10901.x","title":"Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Biotech; Janssen Research and Development","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Dermatology Life Quality Index; Randomized controlled trial; Dosing; Placebo; Internal medicine; Clinical trial; Gastroenterology; Dermatology; Surgery; Disease; Adalimumab","score_opus":0.01753720424858743,"score_gpt":0.24308242075807682,"score_spread":0.2255452165094894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1809686743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819212,0.0144678885,0.00017508508,0.0004409781,0.000071822506,0.00047025326,0.00070832885,0.00002512731,0.0017192794],"genre_scores_gemma":[0.99207824,0.0043360675,0.00027928152,0.00066784053,0.00017590329,0.00035177084,0.000985232,0.0000074384993,0.0011183146],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990766,0.00050036877,0.00005230452,0.00012642259,0.00011308782,0.00013114001],"domain_scores_gemma":[0.99875605,0.00027843012,0.00045933566,0.000110268105,0.00006624588,0.0003297578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038827036,0.000549874,0.0012548789,0.00018310206,0.0003822999,0.0007940813,0.00048122296,0.00090792077,0.0024674418],"category_scores_gemma":[0.0017175146,0.00021320951,0.0016186992,0.00031578564,0.00047710835,0.00085769757,0.00039674572,0.0019881593,0.00039999787],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8084776,0.012370908,0.03152903,0.0013228905,0.0043967166,0.00014482635,0.00026978613,0.0010494643,0.007605054,0.00014615864,0.0032464538,0.12944114],"study_design_scores_gemma":[0.52807456,0.269401,0.18843238,0.00040314274,0.0049806535,0.00037039365,0.00012123834,0.0007420278,0.0022649246,0.00029279097,0.0048655504,0.000051286508],"about_ca_topic_score_codex":0.000550268,"about_ca_topic_score_gemma":0.0011914666,"teacher_disagreement_score":0.0038827036,"about_ca_system_score_codex":0.00047797977,"about_ca_system_score_gemma":0.0005728408,"threshold_uncertainty_score":0.020533979},"labels":[],"label_agreement":null},{"id":"W1814149022","doi":"10.1111/bjd.14163","title":"Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16–17 years","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Dermatology Life Quality Index; Medicine; Dermatology; Psoriasis; Quality of life (healthcare); Index (typography); Computer science","score_opus":0.028597857370707472,"score_gpt":0.3066605187112383,"score_spread":0.2780626613405308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1814149022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99795425,0.0007315758,0.00009771624,0.00007448372,0.000018697554,0.000035985875,0.00033770766,0.0000028491354,0.0007466982],"genre_scores_gemma":[0.99899584,0.00017054923,0.00022327849,0.000031373784,0.000012930497,0.00003991494,0.00043249378,0.0000015366031,0.00009188331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998395,0.0005650927,0.00024117451,0.00017693316,0.00042500364,0.00019683357],"domain_scores_gemma":[0.99552983,0.0011165614,0.0019586845,0.00011244373,0.0005731894,0.00070928567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024775453,0.00032530402,0.0006468623,0.0014738799,0.00029085108,0.0007616157,0.00033572761,0.00051748723,0.001368482],"category_scores_gemma":[0.0068905153,0.0002090989,0.0010719269,0.001440237,0.00026283655,0.0007241367,0.0008069102,0.0009523433,0.00024107989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038491382,0.00006687186,0.9961675,0.000022494076,0.0001266304,0.000034457036,0.000078676036,0.00007434108,0.000056093064,0.000014762559,0.00010961687,0.0028636039],"study_design_scores_gemma":[0.00006341229,0.0004059443,0.99845123,0.000016012571,0.00004792448,0.00019538209,0.00021486254,0.0003210379,0.00004091375,0.000018755401,0.00021818161,0.00000640028],"about_ca_topic_score_codex":0.002445803,"about_ca_topic_score_gemma":0.0030547366,"teacher_disagreement_score":0.0024775453,"about_ca_system_score_codex":0.00068096723,"about_ca_system_score_gemma":0.00036476232,"threshold_uncertainty_score":0.013102651},"labels":[],"label_agreement":null},{"id":"W1824244227","doi":"10.1111/j.1365-2133.2010.09775.x","title":"Type 1 interferon signature in the scalp lesions of alopecia areata","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Child and Family Research Institute; University of British Columbia","funders":"Canadian Dermatology Foundation; Michael Smith Health Research BC; Dermatology Foundation","keywords":"Alopecia areata; Medicine; Alopecia universalis; Scalp; Interferon; Hair follicle; Scarring alopecia; CXCR3; Pathology; Immunology; Chemokine; Dermatology; Immune system; Chemokine receptor; Internal medicine","score_opus":0.010007479761875526,"score_gpt":0.264912808964199,"score_spread":0.25490532920232345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1824244227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838865,0.0006421874,0.00016675146,0.000012571913,0.000003922587,0.00001205713,0.000046551744,0.00001032031,0.00071711454],"genre_scores_gemma":[0.99943537,0.00018432914,0.00016913541,0.000012614437,0.000009119416,0.0000057346856,0.00006201304,0.0000020945454,0.00011950293],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999387,0.000011858104,0.000004784824,0.00001356117,0.000013116189,0.000018016126],"domain_scores_gemma":[0.99986684,0.000022490423,0.000048516766,0.000008792179,0.00002784365,0.000025437423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010293905,0.00020948844,0.00014566035,0.00066005765,0.00015935558,0.00021617851,0.00007435104,0.0001971433,0.0014119382],"category_scores_gemma":[0.00020902613,0.00007742019,0.000107773376,0.00023062434,0.00014702968,0.00012540756,0.00012033172,0.0001281798,0.00019212527],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014663503,0.00009159028,0.26984918,0.0002931769,0.00006186655,0.031442154,0.00048681564,0.00014319937,0.6762545,0.00013554716,0.0002742955,0.019501338],"study_design_scores_gemma":[0.00007115483,0.0005429079,0.8869435,0.00002980582,0.00008203902,0.09126213,0.0005184613,0.0007424798,0.017680617,0.0001982148,0.001918393,0.000010252575],"about_ca_topic_score_codex":0.00034688663,"about_ca_topic_score_gemma":0.0003321451,"teacher_disagreement_score":0.0014119382,"about_ca_system_score_codex":0.00012720596,"about_ca_system_score_gemma":0.00006176847,"threshold_uncertainty_score":0.0047234297},"labels":[],"label_agreement":null},{"id":"W1829483440","doi":"10.1046/j.1365-2133.2000.03294.x","title":"In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Health and Long Term Care; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Terbinafine; Malassezia; Ketoconazole; Voriconazole; Itraconazole; Azole; Microbiology; Biology; Minimum inhibitory concentration; Antifungal; Antimicrobial","score_opus":0.006654839223833021,"score_gpt":0.24233686956097036,"score_spread":0.23568203033713733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1829483440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956292,0.0022322957,0.00046914766,0.00005012189,0.000021002492,0.00003754482,0.0006229771,0.000016296624,0.0009213338],"genre_scores_gemma":[0.9885216,0.0029181847,0.003088449,0.00008310249,0.000026222053,0.000051278534,0.0034731736,0.000011424277,0.0018265607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995152,0.000088222536,0.00008645751,0.00008258831,0.0001610589,0.0000664759],"domain_scores_gemma":[0.9995957,0.00012280469,0.00006917468,0.000038952938,0.00013112121,0.000042245207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026998218,0.0006295306,0.00048309052,0.00030066623,0.00022135116,0.00041307134,0.00026571398,0.0003166198,0.0011547684],"category_scores_gemma":[0.0006975882,0.00024246551,0.00032712615,0.0004756525,0.00020198937,0.00030029353,0.00035536016,0.00022844176,0.000326993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040677257,0.00011334881,0.0074297483,0.00017712156,0.000053016047,0.00016081915,0.00010362333,0.0003480173,0.98542213,0.000041467694,0.000064555505,0.005679374],"study_design_scores_gemma":[0.000073237774,0.0044032964,0.10232764,0.000046788748,0.00019683794,0.0016901055,0.00035701037,0.0012133867,0.88411254,0.000072742994,0.005469405,0.000036973608],"about_ca_topic_score_codex":0.0020094842,"about_ca_topic_score_gemma":0.001837779,"teacher_disagreement_score":0.0020094842,"about_ca_system_score_codex":0.00016472394,"about_ca_system_score_gemma":0.0001363982,"threshold_uncertainty_score":0.003995657},"labels":[],"label_agreement":null},{"id":"W1845693806","doi":"10.1111/j.1365-2133.2010.10100.x","title":"Dermatological manifestations of inherited cancer syndromes in children","year":2010,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Xeroderma pigmentosum; Dyskeratosis congenita; Bloom syndrome; Medicine; Dermatology; Family history; Cancer; Ataxia-telangiectasia; Cockayne syndrome; Genetics; DNA repair; DNA damage; Biology; Telomere","score_opus":0.019282632286300134,"score_gpt":0.3096201196731533,"score_spread":0.29033748738685317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1845693806","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088229147,0.9950229,0.00025150666,0.00018536892,0.00015891275,0.0000059582085,0.000021291835,0.0000211145,0.0034506693],"genre_scores_gemma":[0.0051803393,0.99229795,0.00037017575,0.00017027004,0.00015038063,0.0000073125834,0.000040611925,0.0000030536046,0.0017798921],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984705,0.000029960269,0.00002196636,0.000026401596,0.000055535817,0.00001904454],"domain_scores_gemma":[0.99983263,0.00008168625,0.00003152374,0.000007198635,0.000029463023,0.000017584083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022103271,0.0008789992,0.001104373,0.0017320432,0.0002815803,0.00054297934,0.00040278575,0.0006988472,0.002592],"category_scores_gemma":[0.00041870808,0.00021565806,0.00029065783,0.0016343296,0.00036991743,0.00064203196,0.0004494103,0.00087411824,0.0014809665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006568005,0.000055463017,0.0014623887,0.0094732195,0.000081466285,0.0052215448,0.00014313593,0.0002790778,0.0027456945,0.0015226984,0.027159393,0.9517902],"study_design_scores_gemma":[0.000028105533,0.00008070926,0.0085735265,0.0038105492,0.00013123301,0.09103973,0.00021868592,0.00009041965,0.0011874806,0.0014587622,0.89335406,0.000026726111],"about_ca_topic_score_codex":0.0010088673,"about_ca_topic_score_gemma":0.0016883003,"teacher_disagreement_score":0.002592,"about_ca_system_score_codex":0.00039480568,"about_ca_system_score_gemma":0.0005331783,"threshold_uncertainty_score":0.008671105},"labels":[],"label_agreement":null},{"id":"W1869303064","doi":"10.1111/j.1365-2133.2010.10091.x","title":"Risk factors for genital lichen sclerosus in men","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genital Health and Disease","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Alopecia areata; Lichen sclerosus; Medicine; Odds ratio; Dermatology; Etiology; Vitiligo; Sex organ; Confidence interval; Family history; Logistic regression; Psoriasis; Internal medicine","score_opus":0.01369721011957613,"score_gpt":0.2826457582701073,"score_spread":0.26894854815053115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1869303064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971265,0.0016935886,0.000064754924,0.00012064688,0.000020998421,0.00000999281,0.00014627888,0.000007913728,0.0008093552],"genre_scores_gemma":[0.9994593,0.00025767236,0.000048409198,0.000025227133,0.000028790379,0.0000047331623,0.000059787417,0.00000103005,0.00011496301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996959,0.00008482479,0.000018543373,0.00007263008,0.00006787587,0.00006018719],"domain_scores_gemma":[0.99914193,0.00019273293,0.00037602463,0.0000330162,0.000037633585,0.00021866907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038504234,0.00030435348,0.00037316506,0.0006775684,0.00051370036,0.0005788184,0.00020560024,0.0004505973,0.00312152],"category_scores_gemma":[0.0015745035,0.00022452637,0.00037932562,0.00072625664,0.0003250631,0.00021464263,0.0002423354,0.0004304904,0.00023036348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007725956,0.000032701748,0.9982393,0.000011897731,0.0000354294,0.00020020273,0.000047987567,0.000025671934,0.000110233756,0.000020291889,0.00008266062,0.0011163788],"study_design_scores_gemma":[0.0000091460415,0.00016543118,0.99811614,0.000014235791,0.00004357012,0.0011081978,0.00014550977,0.00008904466,0.000043552132,0.000027410233,0.00023450369,0.000003307653],"about_ca_topic_score_codex":0.0023596964,"about_ca_topic_score_gemma":0.001603157,"teacher_disagreement_score":0.00312152,"about_ca_system_score_codex":0.00016791928,"about_ca_system_score_gemma":0.00032769458,"threshold_uncertainty_score":0.010442555},"labels":[],"label_agreement":null},{"id":"W1877047792","doi":"10.1111/j.1365-2133.2007.08236.x","title":"Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":167,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Abbott Laboratories","keywords":"Adalimumab; Medicine; Psoriasis; Dermatology Life Quality Index; Psoriasis Area and Severity Index; Visual analogue scale; Placebo; Quality of life (healthcare); Internal medicine; Randomized controlled trial; Severity of illness; Psoriatic arthritis; Methotrexate; Dermatology; Physical therapy; Disease; Pathology","score_opus":0.02183459601506674,"score_gpt":0.2774386911100152,"score_spread":0.2556040950949484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1877047792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97370976,0.01872968,0.0007454844,0.0006080762,0.0005626353,0.0034796733,0.0009042342,0.00009965922,0.0011608306],"genre_scores_gemma":[0.98042727,0.0073660165,0.002132265,0.0008116736,0.0006886108,0.0058204057,0.0010157624,0.000027092348,0.0017108184],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968913,0.0020096132,0.00029929687,0.00035193606,0.00024696457,0.00020081676],"domain_scores_gemma":[0.99650407,0.0013698109,0.0010269531,0.00025676566,0.00020782398,0.00063463626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005405267,0.0016735808,0.00459796,0.0005550468,0.0004948348,0.001289367,0.001073153,0.002233237,0.0053901505],"category_scores_gemma":[0.0050623105,0.0007704874,0.0040658703,0.00063598965,0.0013468824,0.0009677509,0.0005945658,0.0026470956,0.00057085435],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98601115,0.0028590332,0.00040747944,0.00093119877,0.0013685934,0.000016146274,0.000022146804,0.00014277175,0.0010598579,0.000018297838,0.0001490726,0.007014332],"study_design_scores_gemma":[0.96188635,0.034602553,0.0021678517,0.000047265592,0.0007999117,0.000017263636,0.000007329793,0.000119903576,0.00015113945,0.00002716775,0.00016337816,0.000009796363],"about_ca_topic_score_codex":0.00061241566,"about_ca_topic_score_gemma":0.0009777946,"teacher_disagreement_score":0.005405267,"about_ca_system_score_codex":0.00064595544,"about_ca_system_score_gemma":0.0010470384,"threshold_uncertainty_score":0.02858609},"labels":[],"label_agreement":null},{"id":"W1880144017","doi":"10.1111/j.1365-2133.2010.09911.x","title":"A novel fibrotic disorder associated with increased dermal fibroblast proliferation and downregulation of genes of the microfibrillar network","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; National Institutes of Health","keywords":"Connective Tissue Disorder; Fibrosis; Pathology; Skeletal disorder; Biology; MMP2; Phenotype; Candidate gene; Genetic disorder; ADAMTS; Gene; Medicine; Genetics; Matrix metalloproteinase; Downregulation and upregulation; Metalloproteinase","score_opus":0.004395808283259205,"score_gpt":0.2141999921679469,"score_spread":0.20980418388468772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1880144017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908618,0.0014242855,0.003715708,0.00022627812,0.000043094973,0.00007651099,0.00028311348,0.0001413825,0.0032278537],"genre_scores_gemma":[0.9954007,0.000465082,0.0018375536,0.00010490599,0.00004171547,0.000027410297,0.00011946902,0.000015383115,0.0019876976],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9998467,0.000015599011,0.000011714046,0.000064345775,0.00002806069,0.000033631328],"domain_scores_gemma":[0.99975735,0.00006710662,0.00006607242,0.000017290695,0.00001439935,0.000077856566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008944823,0.00075925764,0.00026821444,0.00084217876,0.00040916182,0.00023436296,0.00020876204,0.0006595166,0.0017425474],"category_scores_gemma":[0.0004262755,0.00025494638,0.00018870296,0.00036498113,0.00045467983,0.00023285217,0.0002463129,0.00044542557,0.00033984243],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003670324,0.00012435393,0.021788059,0.00015247281,0.000027187012,0.6793427,0.0003871892,0.00013175717,0.2855095,0.00084630895,0.0004347991,0.010888675],"study_design_scores_gemma":[0.00003573994,0.00034526916,0.0516216,0.000014422322,0.00003097332,0.9310018,0.000078706835,0.00039385597,0.014346086,0.00023023158,0.0018862296,0.000015118213],"about_ca_topic_score_codex":0.0005184391,"about_ca_topic_score_gemma":0.000979061,"teacher_disagreement_score":0.0017425474,"about_ca_system_score_codex":0.00015795743,"about_ca_system_score_gemma":0.00016840111,"threshold_uncertainty_score":0.005829394},"labels":[],"label_agreement":null},{"id":"W1885430784","doi":"10.1111/j.1365-2133.2010.09847.x","title":"Spindle cell liposarcoma of the face: case report and literature review","year":2010,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Liposarcoma; Forehead; Pathological; Soft tissue; Pathology; Medicine; Soft tissue sarcoma; Sarcoma; Myxoid liposarcoma; Dermatology; Anatomy","score_opus":0.019129675647188808,"score_gpt":0.3153792343696628,"score_spread":0.296249558722474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1885430784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012278049,0.97849864,0.0011795871,0.0010541652,0.0007921603,0.00007205904,0.00015983399,0.00007948007,0.005885993],"genre_scores_gemma":[0.05941695,0.9323552,0.002137544,0.0009774246,0.0020170778,0.00005346202,0.00028473663,0.00001378137,0.0027438195],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99971074,0.000036239522,0.000085326,0.00006169102,0.00007037351,0.00003549167],"domain_scores_gemma":[0.9994929,0.00017255198,0.00016321459,0.000024516197,0.00007018012,0.000076639466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002806797,0.001290254,0.0015236144,0.0059009907,0.0006131221,0.001095536,0.0012944575,0.0017557264,0.0038725203],"category_scores_gemma":[0.0007859415,0.00037882564,0.00050097966,0.004217021,0.0008616167,0.002180543,0.00079149567,0.00094243855,0.0024689306],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096180884,0.00030135098,0.00573756,0.015560778,0.00020830621,0.4397305,0.000686772,0.0006616458,0.005470343,0.0012167055,0.03831786,0.49201196],"study_design_scores_gemma":[0.00001955099,0.000083629944,0.006079948,0.0029926682,0.00021703691,0.8569545,0.00059204956,0.000179573,0.0006181114,0.0009490235,0.13125858,0.00005519085],"about_ca_topic_score_codex":0.0010143346,"about_ca_topic_score_gemma":0.0017492606,"teacher_disagreement_score":0.0059009907,"about_ca_system_score_codex":0.000513219,"about_ca_system_score_gemma":0.0010489044,"threshold_uncertainty_score":0.012954831},"labels":[],"label_agreement":null},{"id":"W1892175722","doi":"10.1111/bjd.14018","title":"Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":322,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"Janssen Biotech; Allergan; LEO Pharma; Genentech; Celgene; Novartis; Pfizer; ApoPharma; Boehringer Ingelheim; Amgen; AbbVie; Merck; Abbott Laboratories; Eli Lilly and Company","keywords":"Tofacitinib; Janus kinase inhibitor; Placebo; Medicine; Adverse effect; Psoriasis; Internal medicine; Randomized controlled trial; Plaque psoriasis; Gastroenterology; Dermatology; Pathology","score_opus":0.04869677487528288,"score_gpt":0.31686382013012293,"score_spread":0.26816704525484003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1892175722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76968503,0.18993077,0.0039049988,0.005667901,0.0018047491,0.013536478,0.007548,0.0003631224,0.0075589567],"genre_scores_gemma":[0.9051706,0.06589696,0.0046473257,0.0043569235,0.0017185383,0.009068013,0.0060883737,0.00009247282,0.0029608707],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971129,0.0016057797,0.00035625932,0.0003436443,0.00036877536,0.00021273176],"domain_scores_gemma":[0.9946136,0.0019766316,0.0017635275,0.00036342675,0.000550144,0.0007325868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01149321,0.0017810693,0.0031576166,0.0005166149,0.0005552383,0.0017795643,0.0010690133,0.0021469502,0.005841935],"category_scores_gemma":[0.00900602,0.00060258695,0.0041983067,0.0008588683,0.00087376515,0.0011036772,0.00050244876,0.002291085,0.00063862634],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8934429,0.0065020546,0.002389591,0.005562372,0.008948058,0.0000671265,0.00014483348,0.00039363475,0.005317142,0.0001554806,0.0031643442,0.07391245],"study_design_scores_gemma":[0.94446564,0.037504338,0.007477082,0.00043863707,0.00601505,0.0001094228,0.000037743124,0.00017352254,0.0006727321,0.00016937799,0.0029056524,0.00003073347],"about_ca_topic_score_codex":0.0008011253,"about_ca_topic_score_gemma":0.002076551,"teacher_disagreement_score":0.01149321,"about_ca_system_score_codex":0.0010604499,"about_ca_system_score_gemma":0.0018670816,"threshold_uncertainty_score":0.06078261},"labels":[],"label_agreement":null},{"id":"W1895366991","doi":"10.1111/j.1365-2133.2011.10592.x","title":"Nutritional outcome in children with severe generalized recessive dystrophic epidermolysis bullosa: a short- and long-term evaluation of gastrostomy and enteral feeding","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Enteral administration; Malnutrition; Gastrostomy; Pediatrics; Epidermolysis bullosa; Parenteral nutrition; Head circumference; Internal medicine; Surgery; Dermatology; Birth weight","score_opus":0.026387520134017413,"score_gpt":0.2871117283294626,"score_spread":0.2607242081954452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895366991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99952424,0.00031240296,0.000014036035,0.000015336078,0.000001837356,0.0000027693604,0.000050000825,0.0000013305034,0.00007817451],"genre_scores_gemma":[0.9996358,0.00013588172,0.000029628436,0.000009364044,0.0000045982138,0.0000039703586,0.00014580847,8.346152e-7,0.000034114222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996506,0.00008086773,0.000048484722,0.000059128786,0.000077203535,0.00008368569],"domain_scores_gemma":[0.9987581,0.00020013645,0.0005622658,0.000034069028,0.00010568591,0.00033973542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006491313,0.00036538634,0.000474162,0.00074397295,0.00054764654,0.00049466314,0.00024477948,0.00046186356,0.00055576535],"category_scores_gemma":[0.0019976043,0.00018452626,0.0005612759,0.00081830623,0.00040379938,0.0004695504,0.00052662415,0.00055406516,0.00010107845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022339994,0.000043081694,0.9969422,0.000014711852,0.000029658027,0.0012911346,0.00016108858,0.000037446236,0.00018388825,0.00000491715,0.0000285929,0.0010398341],"study_design_scores_gemma":[0.000007774753,0.0005039131,0.9956821,0.000008738772,0.00003160526,0.0032960228,0.0002976245,0.00004836456,0.000051275994,0.0000060201255,0.00006178363,0.0000047790454],"about_ca_topic_score_codex":0.0038811364,"about_ca_topic_score_gemma":0.003636626,"teacher_disagreement_score":0.0038811364,"about_ca_system_score_codex":0.0005843491,"about_ca_system_score_gemma":0.00040330004,"threshold_uncertainty_score":0.007717073},"labels":[],"label_agreement":null},{"id":"W1895525610","doi":"10.1046/j.1365-2133.2002.04561.x","title":"Topical treatment of actinic keratoses with 3·0% diclofenac in 2·5% hyaluronan gel","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Western University; Centre de Recherche Dermatologique du Québec Métropolitain; Guenther Dermatology Research Centre; Sunnybrook Health Science Centre; Vancouver General Hospital; Health Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Diclofenac; Placebo; Actinic keratoses; Adverse effect; Lesion; Randomized controlled trial; Dermatology; Actinic keratosis; Internal medicine; Gastroenterology; Surgery; Basal cell; Anesthesia; Pathology","score_opus":0.02303155757989857,"score_gpt":0.263341211576664,"score_spread":0.24030965399676543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895525610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523973,0.0032873084,0.00027670574,0.00004645779,0.000048889837,0.00046377868,0.000051087685,0.000015970096,0.00057003304],"genre_scores_gemma":[0.99643886,0.0017543961,0.0008335809,0.000109332635,0.000080236634,0.00026803298,0.00011164395,0.0000027440883,0.00040127346],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99942124,0.00022329902,0.00008451084,0.00006996459,0.00012725354,0.000073756666],"domain_scores_gemma":[0.99944097,0.00016890731,0.00015752301,0.000034914778,0.000049637394,0.00014800049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010893875,0.00037923883,0.0012873374,0.00042278206,0.00027833172,0.00023331688,0.00033542863,0.0004189584,0.0018781321],"category_scores_gemma":[0.0007334457,0.00022690507,0.0006002168,0.00024481543,0.00032295028,0.00024173541,0.0001998642,0.0005694469,0.00028765955],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3675031,0.06719024,0.018984573,0.003531008,0.0017028364,0.0003875179,0.000305563,0.0012964878,0.2867197,0.00016383304,0.0012893424,0.25092587],"study_design_scores_gemma":[0.08744469,0.82952666,0.05500116,0.0001454195,0.00078038994,0.00056668115,0.00008154098,0.00093401514,0.023288755,0.000069412985,0.0021338793,0.000027394402],"about_ca_topic_score_codex":0.00033561094,"about_ca_topic_score_gemma":0.0005877169,"teacher_disagreement_score":0.0018781321,"about_ca_system_score_codex":0.00022016447,"about_ca_system_score_gemma":0.00040475745,"threshold_uncertainty_score":0.006282985},"labels":[],"label_agreement":null},{"id":"W1904896785","doi":"10.1111/bjd.14220","title":"Darier disease in Israel: combined evaluation of genetic and neuropsychiatric aspects","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Legacy Heritage Fund","keywords":"Medicine; Psychiatry; Disease; Mood disorders; Mood; Genodermatosis; Family history; Cohort; Genetic testing; Bipolar disorder; Genotype-phenotype distinction; Genotype; Genetics; Pathology; Internal medicine; Biology; Gene; Anxiety","score_opus":0.011970074457752576,"score_gpt":0.253156087289656,"score_spread":0.2411860128319034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1904896785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800605,0.00041547307,0.00007279464,0.00007759634,0.0000068001996,0.0000135961,0.00009616574,0.000004451941,0.0013071976],"genre_scores_gemma":[0.99912244,0.00022596987,0.0001535837,0.00007458991,0.00001810401,0.0000058837595,0.00014675688,0.0000020907248,0.00025058948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997414,0.00004227724,0.00002396648,0.00007496032,0.00005599382,0.0000614255],"domain_scores_gemma":[0.9997359,0.00005547158,0.00007351146,0.000007819625,0.000040870436,0.000086429856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003114461,0.0006466022,0.00037878356,0.0009059311,0.0006891162,0.00042012363,0.00019988517,0.0004352406,0.0018728692],"category_scores_gemma":[0.0006053287,0.00015562373,0.00017686383,0.00044902193,0.00026582472,0.00024869133,0.0003929478,0.0003378464,0.00019101214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021312137,0.0001370815,0.9486436,0.000043346154,0.00005103949,0.035590187,0.00056416664,0.00011159644,0.0046916204,0.00016585409,0.0004504445,0.009337839],"study_design_scores_gemma":[0.00008581112,0.00044378533,0.8083937,0.00007159894,0.000093243085,0.18646014,0.0010800281,0.00043071582,0.0011315257,0.00029534128,0.0014964805,0.000017602824],"about_ca_topic_score_codex":0.0027668248,"about_ca_topic_score_gemma":0.0025458036,"teacher_disagreement_score":0.0027668248,"about_ca_system_score_codex":0.00030256383,"about_ca_system_score_gemma":0.00036965942,"threshold_uncertainty_score":0.0062653422},"labels":[],"label_agreement":null},{"id":"W1937411302","doi":"10.1111/bjd.14221","title":"Review of applications of fluorescence excitation spectroscopy to dermatology","year":2015,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Fluorescence; Fluorescence spectroscopy; Spectroscopy; Excitation; Time-resolved spectroscopy; Ultraviolet; Chemistry; Ultraviolet visible spectroscopy; Endogeny; Materials science; Physics; Optics; Optoelectronics; Biochemistry; Organic chemistry","score_opus":0.03831841648476294,"score_gpt":0.37922530624761375,"score_spread":0.34090688976285083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1937411302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011083395,0.9970402,0.00013280555,0.00019440541,0.0003525271,0.0000057293614,0.000023150733,0.000009797077,0.0021305694],"genre_scores_gemma":[0.0006199904,0.9976515,0.00021819281,0.00019074287,0.0002845065,0.0000057166267,0.000032611908,0.0000019183872,0.0009948808],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997538,0.000040302886,0.00003676064,0.00003706822,0.00011238924,0.000019718538],"domain_scores_gemma":[0.99949586,0.00025484196,0.000060625658,0.000015811558,0.00013319321,0.000039647082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004868154,0.0008216751,0.0010667894,0.0034709363,0.00035669035,0.00083313306,0.00071847875,0.0007835776,0.009273269],"category_scores_gemma":[0.00095151877,0.0003309033,0.0005239065,0.0028094195,0.00039205578,0.0012794244,0.00059511856,0.0013782864,0.003719842],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000605797,0.00008299182,0.00015124999,0.028332265,0.00006546987,0.00031817594,0.00009768415,0.00029237202,0.0035381017,0.0035748573,0.061735723,0.9017506],"study_design_scores_gemma":[0.0000064831065,0.00005268886,0.00053195906,0.0026668871,0.000046273035,0.0012536796,0.00003731044,0.00003790591,0.0004181798,0.0010319591,0.9939021,0.000014500026],"about_ca_topic_score_codex":0.0009468172,"about_ca_topic_score_gemma":0.0017541769,"teacher_disagreement_score":0.009273269,"about_ca_system_score_codex":0.00053561357,"about_ca_system_score_gemma":0.0009528056,"threshold_uncertainty_score":0.031022131},"labels":[],"label_agreement":null},{"id":"W1939041105","doi":"10.1111/j.1365-2133.2011.10205.x","title":"Preventing eczema flares with topical corticosteroids or tacrolimus: which is best?","year":2011,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Tacrolimus; Medicine; Randomized controlled trial; Thursday; Pediatrics; Dermatology; Surgery; Transplantation","score_opus":0.02178413770014885,"score_gpt":0.26944244534259,"score_spread":0.24765830764244112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1939041105","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020644376,0.006340092,0.0002304437,0.9775504,0.009966035,0.000009043547,0.000023600382,0.00002685488,0.003789181],"genre_scores_gemma":[0.040218886,0.0112866275,0.0015100194,0.81728345,0.12118116,0.00005374298,0.00007885097,0.000049789578,0.008337478],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973853,0.0006841706,0.0006034152,0.00023269918,0.0006698519,0.00042450297],"domain_scores_gemma":[0.9924079,0.003953934,0.0006680369,0.00018515385,0.0013934576,0.0013913462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002184729,0.0006059764,0.0020802915,0.0006230091,0.0023460032,0.0026347684,0.0013436549,0.037570238,0.005267734],"category_scores_gemma":[0.018281635,0.000494823,0.001702772,0.00057114987,0.00222032,0.005442725,0.001013335,0.030336365,0.0031254515],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047213314,0.00024268568,0.005996601,0.00044359892,0.0000818546,0.04290699,0.00044622342,0.00035149086,0.0009806328,0.0070413817,0.84944564,0.0915907],"study_design_scores_gemma":[0.0008225243,0.0004926994,0.0060900305,0.0018597428,0.00016058213,0.080343224,0.0012718856,0.0019025538,0.00055268663,0.016955234,0.88937837,0.000170507],"about_ca_topic_score_codex":0.0032628353,"about_ca_topic_score_gemma":0.0070064096,"teacher_disagreement_score":0.037570238,"about_ca_system_score_codex":0.0038764533,"about_ca_system_score_gemma":0.0024735394,"threshold_uncertainty_score":0.028125703},"labels":[],"label_agreement":null},{"id":"W1943930704","doi":"10.1111/j.1365-2133.2011.10257.x","title":"Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Ustekinumab; Medicine; Mace; Psoriasis; Placebo; Odds ratio; Internal medicine; Confidence interval; Incidence (geometry); Myocardial infarction; Adverse effect; Stroke (engine); Rate ratio; Clinical trial; Dermatology; Disease; Pathology; Percutaneous coronary intervention","score_opus":0.09309788346243057,"score_gpt":0.3296684587935555,"score_spread":0.2365705753311249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1943930704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5796105,0.40266106,0.0073298207,0.0007293662,0.00020784327,0.0014174748,0.005544843,0.00015674993,0.0023423482],"genre_scores_gemma":[0.96732324,0.025317855,0.0027881057,0.00045552896,0.00020003869,0.0003840959,0.0033157351,0.000058626694,0.00015671941],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.95817626,0.027897563,0.0052493354,0.0031164496,0.0049405294,0.0006198719],"domain_scores_gemma":[0.92783034,0.04314052,0.01808991,0.005054643,0.0049835825,0.0009009066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05996268,0.0017634488,0.0065393117,0.0026364694,0.00037179125,0.0032230832,0.0007919201,0.0011189535,0.0012928359],"category_scores_gemma":[0.041729536,0.00086235756,0.019557627,0.0039126244,0.00059373275,0.0013010795,0.001380876,0.0013819246,0.00015641502],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059223194,0.0004639116,0.217247,0.0106847985,0.6410883,0.00012476245,0.00029804697,0.0023025488,0.003011463,0.00013954288,0.00091153505,0.064504884],"study_design_scores_gemma":[0.011099203,0.010862799,0.46755323,0.0019391133,0.50028116,0.00046153477,0.00017310344,0.0019426856,0.001853393,0.0005005576,0.0031939852,0.00013924834],"about_ca_topic_score_codex":0.00076160155,"about_ca_topic_score_gemma":0.0016245864,"teacher_disagreement_score":0.05996268,"about_ca_system_score_codex":0.00086884695,"about_ca_system_score_gemma":0.0014426888,"threshold_uncertainty_score":0.31711674},"labels":[],"label_agreement":null},{"id":"W1948708496","doi":"10.1111/bjd.14222","title":"Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0·015% gel: a randomized, controlled 12-month study","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"LEO Pharma","keywords":"Actinic keratosis; Medicine; Dermatology; Randomized controlled trial; Surgery; Internal medicine","score_opus":0.019870865115153423,"score_gpt":0.28194205640140557,"score_spread":0.26207119128625217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1948708496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941339,0.0018604383,0.0004087663,0.00013193992,0.00015886211,0.0024121974,0.00029444788,0.000066330016,0.0005331826],"genre_scores_gemma":[0.991155,0.0016650605,0.0011815676,0.0003636856,0.00038079804,0.0036004668,0.0004912717,0.000019370469,0.0011426818],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982673,0.00096875627,0.00011945893,0.00028435054,0.00015822989,0.00020181324],"domain_scores_gemma":[0.996974,0.0010483443,0.0009256398,0.00029759287,0.0001809794,0.000573445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031575644,0.0014689316,0.0034798197,0.0005220006,0.0005377372,0.00093467487,0.0012597805,0.0024712991,0.0038479976],"category_scores_gemma":[0.002746807,0.0007315079,0.0018897931,0.0004653805,0.0014186605,0.0010031329,0.00038006148,0.0027369421,0.0007464319],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9633416,0.020314692,0.00069735455,0.00025170643,0.00033018098,0.000023252911,0.000040229726,0.00012524742,0.0027480535,0.000019284436,0.00016999827,0.011938394],"study_design_scores_gemma":[0.7359318,0.25924134,0.0033836572,0.000021208014,0.00028443703,0.000026221538,0.0000130030785,0.00024232337,0.00060045917,0.00003179928,0.00021200078,0.000011740123],"about_ca_topic_score_codex":0.0007053007,"about_ca_topic_score_gemma":0.0010552991,"teacher_disagreement_score":0.0038479976,"about_ca_system_score_codex":0.0007403017,"about_ca_system_score_gemma":0.0011147732,"threshold_uncertainty_score":0.016699016},"labels":[],"label_agreement":null},{"id":"W1948887633","doi":"10.1111/bjd.14068","title":"Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United States","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"Pfizer; Merck; Amgen; Abbott Laboratories","keywords":"Medicine; Etanercept; Psoriasis; Adalimumab; Internal medicine; Skin cancer; Population; Cohort; Hazard ratio; Retrospective cohort study; Dermatology; Incidence (geometry); Malignancy; Infliximab; Cumulative incidence; Confidence interval; Cancer; Tumor necrosis factor alpha","score_opus":0.007892005526998097,"score_gpt":0.2158179768008172,"score_spread":0.20792597127381912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1948887633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947271,0.00026499195,0.00023292912,0.00005678051,0.000013678779,0.000052851112,0.0042308196,0.0000084637295,0.00041247625],"genre_scores_gemma":[0.99537164,0.00023182487,0.00025722786,0.000080589954,0.000018739574,0.00007030147,0.0037747412,0.000004080135,0.00019079397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989317,0.0003347982,0.00012251473,0.00027820698,0.0002237909,0.000109021435],"domain_scores_gemma":[0.997532,0.00026694467,0.001215792,0.0002929824,0.00030864027,0.00038369276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012937585,0.00034285372,0.00050204666,0.001045123,0.0005616216,0.00075446104,0.00052034884,0.00041242072,0.0010617079],"category_scores_gemma":[0.0027910594,0.0004848241,0.00071137946,0.0019484959,0.0002114982,0.00054073916,0.0006054551,0.0008350079,0.00020405815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010377552,0.000047311412,0.99898905,0.000006645767,0.00013489739,0.00003032985,0.000038052494,0.000029107327,0.00005455111,0.000015009454,0.0002084712,0.00034269202],"study_design_scores_gemma":[0.0000328796,0.00013326174,0.99887675,0.000009117396,0.0000652279,0.0001819262,0.00012553966,0.00020812797,0.000026708401,0.0000146073735,0.0003212801,0.0000046715227],"about_ca_topic_score_codex":0.021207867,"about_ca_topic_score_gemma":0.018132105,"teacher_disagreement_score":0.021207867,"about_ca_system_score_codex":0.0004985639,"about_ca_system_score_gemma":0.0006846889,"threshold_uncertainty_score":0.042168856},"labels":[],"label_agreement":null},{"id":"W1953869513","doi":"10.1111/j.1365-2133.2011.10351.x","title":"A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Medicine; Vitiligo; Placebo; Clobetasol propionate; Tacrolimus; Adverse effect; Randomized controlled trial; Population; Dermatology; Mometasone furoate; Surgery; Internal medicine; Corticosteroid; Transplantation","score_opus":0.013738006213116187,"score_gpt":0.2558783349237193,"score_spread":0.24214032871060312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1953869513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98058766,0.0057133157,0.00081178936,0.0007172517,0.0019496672,0.007375189,0.0008223798,0.00016725801,0.0018553287],"genre_scores_gemma":[0.97611463,0.00469141,0.0021507076,0.0013682565,0.0011122457,0.010043206,0.0006851351,0.00002922019,0.0038051428],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99883705,0.000570911,0.00011701643,0.00020539081,0.000102698876,0.00016682841],"domain_scores_gemma":[0.99816257,0.00066350313,0.00041903867,0.00013317331,0.00012212912,0.0004995755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021290875,0.0016270278,0.0046358504,0.00064830773,0.0006713984,0.0012087403,0.0013519085,0.0024176121,0.008200931],"category_scores_gemma":[0.0029713279,0.0011033114,0.0014804538,0.0005126995,0.0016116588,0.0010906045,0.0005218198,0.0028608073,0.0013613495],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98695475,0.0060342485,0.00015304425,0.00036976294,0.00025154502,0.000020822206,0.000027202483,0.000058010548,0.0012950466,0.000047862835,0.00018718428,0.004600614],"study_design_scores_gemma":[0.9592257,0.03972347,0.0004935568,0.00001865083,0.00012289386,0.000010502264,0.000009871215,0.00009717208,0.00012770313,0.000033952227,0.00013131968,0.0000051721636],"about_ca_topic_score_codex":0.0011620041,"about_ca_topic_score_gemma":0.0019347463,"teacher_disagreement_score":0.008200931,"about_ca_system_score_codex":0.0006940534,"about_ca_system_score_gemma":0.0016355484,"threshold_uncertainty_score":0.027434886},"labels":[],"label_agreement":null},{"id":"W1957104829","doi":"10.1111/j.1365-2133.2005.06411.x","title":"Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin","year":2005,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Basal cell carcinoma; Cancer; Medicine; Skin cancer; Basal cell; Dermatology; Agency (philosophy); International agency; Internal medicine; Sociology","score_opus":0.012657992828450247,"score_gpt":0.22208265804553107,"score_spread":0.2094246652170808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1957104829","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04250649,0.52978176,0.0010027392,0.05741944,0.011631191,0.00036916762,0.0868756,0.0005464124,0.26986727],"genre_scores_gemma":[0.17946348,0.5640318,0.003371432,0.00797469,0.008033769,0.00020721178,0.059723314,0.00047847227,0.17671594],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980755,0.00020895181,0.00019772579,0.0001415405,0.0012135947,0.00016268731],"domain_scores_gemma":[0.994859,0.001275427,0.0012820954,0.00019251423,0.0018752211,0.0005156691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009084269,0.0004932511,0.001414523,0.004267292,0.0008629383,0.0023747697,0.00065412873,0.0012894407,0.06983822],"category_scores_gemma":[0.008472495,0.00036963014,0.0009373374,0.012174361,0.0005939772,0.0013267291,0.00068515923,0.00080200605,0.016032118],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063846225,0.00013710921,0.05398637,0.018253345,0.0005443313,0.0012929058,0.00047539044,0.00021455293,0.0016932085,0.0019401958,0.55180115,0.36902297],"study_design_scores_gemma":[0.00009729701,0.00018790366,0.18540886,0.009068673,0.0007661466,0.004330153,0.0010586792,0.00009940278,0.0008882652,0.003024344,0.79500026,0.000069923386],"about_ca_topic_score_codex":0.032643884,"about_ca_topic_score_gemma":0.054023508,"teacher_disagreement_score":0.06983822,"about_ca_system_score_codex":0.0011843217,"about_ca_system_score_gemma":0.0038750577,"threshold_uncertainty_score":0.23363215},"labels":[],"label_agreement":null},{"id":"W1960922507","doi":"10.1111/bjd.14267","title":"Biosimilars for psoriasis: preclinical analytical assessment to determine similarity","year":2015,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"AbbVie; Wyeth; Cilag; Amgen","keywords":"Biosimilar; Psoriasis; Medicine; Quality (philosophy); Risk analysis (engineering); Product (mathematics); Similarity (geometry); Biological drugs; Pharmacology; Intensive care medicine; Business; Computer science; Immunology; Disease; Artificial intelligence; Internal medicine","score_opus":0.15495882730655608,"score_gpt":0.4507569827974371,"score_spread":0.295798155490881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1960922507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029624885,0.996351,0.0005679118,0.0005144882,0.00024824595,0.000028839233,0.000027576201,0.000013083046,0.0019525805],"genre_scores_gemma":[0.0031561716,0.99321645,0.0013398238,0.00055284007,0.000222045,0.000034136403,0.000064986925,0.0000059765025,0.0014075005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863285,0.0002940538,0.00017459685,0.00013098017,0.0007068988,0.000060551996],"domain_scores_gemma":[0.99772745,0.0013105895,0.00031944542,0.00006956563,0.0004738176,0.00009905427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003595592,0.0008258102,0.0016542398,0.003840128,0.0003147616,0.0017478649,0.0010902274,0.0023484274,0.0040743807],"category_scores_gemma":[0.0030932967,0.0004049323,0.0009094826,0.0018291232,0.0010106663,0.0018929014,0.00077765714,0.0027971044,0.0024375953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012635328,0.00019279035,0.0003176221,0.0193909,0.00010351575,0.0003237378,0.00011966038,0.00038222654,0.006854144,0.008536651,0.017923372,0.945729],"study_design_scores_gemma":[0.000039689065,0.00029725523,0.0008160951,0.0039001522,0.00012313752,0.002434531,0.000089181165,0.00014618326,0.004078639,0.0025379234,0.9855053,0.000031917258],"about_ca_topic_score_codex":0.00065927935,"about_ca_topic_score_gemma":0.0010426855,"teacher_disagreement_score":0.0040743807,"about_ca_system_score_codex":0.0008845145,"about_ca_system_score_gemma":0.0012432146,"threshold_uncertainty_score":0.01901555},"labels":[],"label_agreement":null},{"id":"W1964607493","doi":"10.1111/j.1365-2133.2005.06776.x","title":"First case series on the use of imiquimod for morphoea","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Red Deer Regional Hospital; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Library science; Family medicine; Geography","score_opus":0.05295557854268711,"score_gpt":0.2599933048786729,"score_spread":0.20703772633598577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964607493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85624033,0.035709813,0.009283353,0.005161507,0.0027230207,0.0006716384,0.000557422,0.00090022484,0.08875266],"genre_scores_gemma":[0.98061347,0.0064022825,0.0019068194,0.0017132098,0.00257216,0.00014674116,0.0001561907,0.00008495035,0.0064042057],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99924064,0.00011165217,0.00010629669,0.00012052198,0.00016271282,0.00025826486],"domain_scores_gemma":[0.9979705,0.00061964587,0.00059770275,0.00032974395,0.00015160911,0.00033078712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034021604,0.0020122237,0.0012550935,0.0014244668,0.0021170508,0.0013223062,0.001051443,0.0032554576,0.00680553],"category_scores_gemma":[0.003972787,0.0007642104,0.001207387,0.0011191885,0.0011846585,0.0012764138,0.0010752794,0.0020620143,0.002744359],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011655874,0.00033693714,0.021635693,0.00025549807,0.00008784246,0.9492622,0.00081228296,0.00013247672,0.00247495,0.0003410859,0.0044576484,0.020086758],"study_design_scores_gemma":[0.000022457632,0.00012888484,0.0035990772,0.000031787535,0.000027201637,0.99188155,0.00013386676,0.00006922421,0.00048385037,0.00008342177,0.0035267447,0.000011890363],"about_ca_topic_score_codex":0.0012464415,"about_ca_topic_score_gemma":0.0021078365,"teacher_disagreement_score":0.00680553,"about_ca_system_score_codex":0.0007181198,"about_ca_system_score_gemma":0.00071931083,"threshold_uncertainty_score":0.022766769},"labels":[],"label_agreement":null},{"id":"W1965953118","doi":"10.1046/j.1365-2133.2002.05006.x","title":"Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dosing; Fluticasone propionate; Atopic dermatitis; Randomized controlled trial; Regimen; Adverse effect; Erythema; Surgery; Internal medicine; Pediatrics; Dermatology; Corticosteroid","score_opus":0.012695804495203565,"score_gpt":0.24653848008606824,"score_spread":0.23384267559086466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965953118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974482,0.0019722255,0.00006444709,0.000047217403,0.000016179953,0.00012223564,0.000039570314,0.000008474709,0.00028140793],"genre_scores_gemma":[0.99827313,0.0008856649,0.0003182866,0.00008307153,0.000052133226,0.00017077028,0.000089338115,0.0000012840846,0.00012639177],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99978775,0.0000870909,0.000024537792,0.000027737957,0.00003735855,0.000035629797],"domain_scores_gemma":[0.99962175,0.0001326799,0.000111863505,0.000019301966,0.00001957469,0.00009480279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006312618,0.00023414029,0.0008186576,0.00017113416,0.00020914197,0.0002252071,0.0002920868,0.00041633612,0.0018972983],"category_scores_gemma":[0.000774282,0.00013021384,0.0005064293,0.00015372413,0.00016458546,0.00017423157,0.00016588197,0.00051302556,0.00021732798],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35842767,0.018623803,0.079341285,0.0018126958,0.0010610219,0.00061434775,0.00043423907,0.0010157281,0.037034284,0.00017016314,0.0022437428,0.499221],"study_design_scores_gemma":[0.11060323,0.54724634,0.3246326,0.00029424648,0.0013788991,0.0018821424,0.00022612789,0.0022078257,0.007252048,0.00017669839,0.0040680123,0.000031735857],"about_ca_topic_score_codex":0.00038817048,"about_ca_topic_score_gemma":0.0007039896,"teacher_disagreement_score":0.0018972983,"about_ca_system_score_codex":0.00018982888,"about_ca_system_score_gemma":0.00026596745,"threshold_uncertainty_score":0.00634712},"labels":[],"label_agreement":null},{"id":"W1966064835","doi":"10.1111/j.1365-2133.2005.06895.x","title":"Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey-Outpatient Department data collected by the U.S. National Center for Health Statistics from 1995 to 2002","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Western University","funders":"","keywords":"Rosacea; Medicine; Depression (economics); Ambulatory care; Alcohol abuse; Ambulatory; National Comorbidity Survey; Alcohol dependence; Psychiatry; Odds ratio; Comorbidity; Health care; Dermatology; Internal medicine; Alcohol","score_opus":0.029091906492798077,"score_gpt":0.33531870243699574,"score_spread":0.30622679594419766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966064835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962297,0.0002619124,0.000085154265,0.000053881984,0.0000053548574,0.000017829516,0.0031683624,0.0000041658473,0.00017367063],"genre_scores_gemma":[0.99565244,0.00015689342,0.00015949749,0.000022647306,0.000008791474,0.00002782772,0.003915766,0.0000025958268,0.00005354713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984296,0.00053696823,0.00029196573,0.00024464077,0.00035861265,0.0001382298],"domain_scores_gemma":[0.99617416,0.0005678917,0.002265334,0.00020886149,0.000392831,0.00039095743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014963092,0.00026936663,0.0005706079,0.0016081663,0.0002993588,0.0005441852,0.0005016811,0.00039540004,0.0007817146],"category_scores_gemma":[0.0047842795,0.00034525516,0.0008429367,0.0030756549,0.00016636541,0.0003982571,0.0006896556,0.0005971108,0.00015533093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036792415,0.00001201735,0.99919325,0.000008295914,0.000096066906,0.000020737401,0.000030747255,0.000038402046,0.000028173914,0.0000056879576,0.00013407326,0.0003956816],"study_design_scores_gemma":[0.0000027987871,0.000017892988,0.9996045,0.0000031476795,0.000016397715,0.000052631658,0.00005582514,0.00017559453,0.0000059858485,0.0000030828028,0.000060789323,0.0000014426419],"about_ca_topic_score_codex":0.023077082,"about_ca_topic_score_gemma":0.033120524,"teacher_disagreement_score":0.023077082,"about_ca_system_score_codex":0.0007332461,"about_ca_system_score_gemma":0.00050145097,"threshold_uncertainty_score":0.045885503},"labels":[],"label_agreement":null},{"id":"W1968246079","doi":"10.1111/j.1365-2133.1973.tb07571.x","title":"Recurrent Kaposi's varicelliform eruption in Darier's disease","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Coxsackievirus; Darier's disease; Medicine; Dermatology; Virology; Enterovirus; Disease; Virus; Pathology","score_opus":0.0033179698617841246,"score_gpt":0.21108203851716276,"score_spread":0.20776406865537864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968246079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941924,0.0026613132,0.0002456335,0.00013442957,0.0000266947,0.000012649636,0.000032593507,0.0000373049,0.0026568908],"genre_scores_gemma":[0.998698,0.00051342905,0.00015245062,0.00009391834,0.000068694106,0.0000031307425,0.0000329796,0.0000044407375,0.00043292058],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99981207,0.000029261586,0.000016328237,0.0000340962,0.000033253167,0.000075008094],"domain_scores_gemma":[0.99969697,0.000059780075,0.00012939061,0.000020228266,0.000017841785,0.000075705066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017442655,0.00035625958,0.00036814137,0.0005242102,0.0006332171,0.00042356222,0.00016254938,0.0006926529,0.0017370766],"category_scores_gemma":[0.0008845996,0.00016711839,0.00031867786,0.0002849914,0.0002959385,0.0002866239,0.00027959852,0.00035967884,0.00031675718],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011060539,0.00040759728,0.49054345,0.00038428008,0.00017613366,0.39771864,0.005909977,0.00062938494,0.023305932,0.001564056,0.002607758,0.07564679],"study_design_scores_gemma":[0.000117341784,0.0009932825,0.227656,0.00005828883,0.00015070417,0.75545835,0.00059428473,0.00040764737,0.002036395,0.00034472535,0.012152949,0.00003001591],"about_ca_topic_score_codex":0.0010594234,"about_ca_topic_score_gemma":0.00093061576,"teacher_disagreement_score":0.0017370766,"about_ca_system_score_codex":0.00028168366,"about_ca_system_score_gemma":0.00010544224,"threshold_uncertainty_score":0.005811155},"labels":[],"label_agreement":null},{"id":"W1968731581","doi":"10.1111/j.0366-077x.2004.05949.x","title":"Ciclosporin in psoriasis clinical practice: an international consensus statement","year":2004,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novartis Pharma; Medical School, University of Michigan; National and Kapodistrian University of Athens; Universiteit Gent; Università degli Studi di Milano; Universitair Ziekenhuis Gent; Saint Louis University","keywords":"Ciclosporin; Psoriasis; Medicine; Statement (logic); Dermatology; Consensus conference; MEDLINE; Intensive care medicine; Internal medicine; Chemotherapy; Political science","score_opus":0.06158428926066879,"score_gpt":0.4470859468103464,"score_spread":0.38550165754967763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968731581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003121164,0.9761736,0.0012686759,0.014949918,0.0030854663,0.00013873441,0.0001304014,0.000045576995,0.0038955496],"genre_scores_gemma":[0.0028555188,0.9827252,0.0060290326,0.0040497994,0.0016018611,0.00020641068,0.00035826088,0.000013212986,0.0021607068],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977374,0.00053493795,0.00074342126,0.0001797001,0.00068660016,0.000117889555],"domain_scores_gemma":[0.99492633,0.0017938303,0.0008831659,0.000116179624,0.0019309921,0.00034954198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006420427,0.0011236779,0.0023778058,0.0035489968,0.00047547705,0.001840794,0.0023309316,0.0036901748,0.0034935358],"category_scores_gemma":[0.0063251415,0.00046401285,0.00094830047,0.004485635,0.00094408507,0.002116358,0.0015601469,0.0026432727,0.0024763448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006165209,0.0001092836,0.00040264105,0.01298324,0.000055565815,0.0002282293,0.000112729314,0.00037431353,0.0003451195,0.00187119,0.11066402,0.872792],"study_design_scores_gemma":[0.000098248696,0.00013023076,0.0028884362,0.030349296,0.00021915341,0.0017368633,0.00029607373,0.00030192768,0.00028435685,0.003535881,0.9601234,0.000036047633],"about_ca_topic_score_codex":0.003357869,"about_ca_topic_score_gemma":0.005126972,"teacher_disagreement_score":0.006420427,"about_ca_system_score_codex":0.0016764586,"about_ca_system_score_gemma":0.006408119,"threshold_uncertainty_score":0.03395492},"labels":[],"label_agreement":null},{"id":"W1968932142","doi":"10.1111/j.1365-2133.2006.07389.x","title":"A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"U.S. Food and Drug Administration; GlaxoSmithKline","keywords":"Psoriasis; Medicine; Psoriasis Area and Severity Index; Reliability (semiconductor); Index (typography); Dermatology; Severity of illness; Internal medicine; Physics; Computer science","score_opus":0.021414824926412654,"score_gpt":0.2664604296771659,"score_spread":0.2450456047507532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968932142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938305,0.0004576315,0.0036185342,0.000028532755,0.000068275454,0.00056804554,0.00015417882,0.000025550802,0.0012488659],"genre_scores_gemma":[0.9905663,0.00020170849,0.0075587,0.000042217744,0.000047819587,0.00097148935,0.00023943838,0.000017865807,0.00035435735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97018504,0.018311396,0.0027602264,0.0028735679,0.005487063,0.00038274264],"domain_scores_gemma":[0.86337423,0.08213527,0.015777165,0.0069763074,0.029700557,0.002036473],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.039860286,0.0006234138,0.00087370945,0.0012391849,0.0008134093,0.00096178544,0.00065720786,0.0005598438,0.0007284092],"category_scores_gemma":[0.07053442,0.00060117204,0.0009802871,0.00089474436,0.0012269089,0.0011111139,0.0012167715,0.0008761123,0.00036684738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006385526,0.0013285606,0.9123262,0.0010230081,0.0013267425,0.00016391452,0.016176226,0.0006476432,0.0062684687,0.0002585201,0.000724104,0.05337116],"study_design_scores_gemma":[0.000768787,0.009231808,0.9757092,0.00022554453,0.0007325233,0.0006458897,0.0038900385,0.00422613,0.002443919,0.0002773695,0.0017337115,0.00011515447],"about_ca_topic_score_codex":0.0015731496,"about_ca_topic_score_gemma":0.0025195733,"teacher_disagreement_score":0.9601397,"about_ca_system_score_codex":0.0007744096,"about_ca_system_score_gemma":0.0014526533,"threshold_uncertainty_score":0.21080393},"labels":[],"label_agreement":null},{"id":"W1969219294","doi":"10.1111/j.1365-2133.2007.08167.x","title":"Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Dermatology; Medical school; Family medicine; Library science; Medical education; Computer science","score_opus":0.010677437219917194,"score_gpt":0.25269426996723726,"score_spread":0.24201683274732005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969219294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988398,0.0004065809,0.00014647993,0.000029683295,0.0000060198167,0.000013805093,0.000040882278,0.000008165289,0.0005084978],"genre_scores_gemma":[0.9998191,0.000038976472,0.00005163972,0.000015673319,0.000008551606,0.0000020794516,0.00003235654,5.972776e-7,0.00003097333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954283,0.000110501045,0.00007240459,0.00008686132,0.00009082523,0.00009664876],"domain_scores_gemma":[0.9970919,0.0006128787,0.0012976151,0.0001557066,0.0002947264,0.0005470789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004988465,0.00044804087,0.00045481336,0.0006062193,0.00041090773,0.0003993851,0.00023021393,0.0004588672,0.0019929535],"category_scores_gemma":[0.0023511942,0.00023586603,0.00030617623,0.0004084572,0.00045595525,0.00039173316,0.00029009668,0.00063509954,0.0001931546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002087253,0.000035118082,0.993134,0.000023219385,0.000037427664,0.0026498968,0.00007341832,0.000044786466,0.002156356,0.00001810046,0.00006329592,0.0015556479],"study_design_scores_gemma":[0.000027530907,0.0004459067,0.97584337,0.00000997615,0.00004117696,0.022171082,0.00012794608,0.00027174933,0.00082158763,0.000034897876,0.00019493286,0.000009887741],"about_ca_topic_score_codex":0.0008051236,"about_ca_topic_score_gemma":0.000676098,"teacher_disagreement_score":0.0019929535,"about_ca_system_score_codex":0.00026374427,"about_ca_system_score_gemma":0.00017451288,"threshold_uncertainty_score":0.0066670775},"labels":[],"label_agreement":null},{"id":"W1971847145","doi":"10.1046/j.1365-2133.2000.03783.x","title":"Topical photodynamic therapy with 5‐aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"DUSA Pharmaceuticals; National Alopecia Areata Foundation","keywords":"Photosensitizer; Lotion; Photodynamic therapy; Erythema; Protoporphyrin IX; Alopecia areata; Dermatology; Phototoxicity; Medicine; Chemistry; Hair follicle; Scalp; Photochemistry; Pharmacology; Internal medicine; Biochemistry; In vitro","score_opus":0.00650929409779413,"score_gpt":0.22243143670518603,"score_spread":0.2159221426073919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971847145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977545,0.0011088924,0.00011555513,0.000027313034,0.0000053869458,0.000018336805,0.000012995912,0.00000962287,0.0009473754],"genre_scores_gemma":[0.99975187,0.00010877183,0.000033982415,0.00001489017,0.000004397821,0.0000034025265,0.000012147788,0.0000012019029,0.00006939602],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998385,0.000045191697,0.000014631732,0.00003694152,0.000034697787,0.000030053474],"domain_scores_gemma":[0.99960595,0.00018726618,0.000077410354,0.00002729306,0.000026236694,0.00007581869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022016383,0.00024453105,0.00046140177,0.00018886587,0.00032181278,0.0002340954,0.000121021236,0.00033454894,0.0012458112],"category_scores_gemma":[0.00096107007,0.00012200787,0.00022226838,0.00016582946,0.00026357232,0.00015223915,0.00013009024,0.00022712175,0.00018080039],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006642223,0.0013743697,0.6217092,0.00059481245,0.0003375878,0.03840261,0.0011773318,0.00083686475,0.18288477,0.00013982467,0.00094901037,0.14495136],"study_design_scores_gemma":[0.0005141828,0.008584383,0.9152111,0.00004475299,0.00018840509,0.06619367,0.00031053077,0.000606931,0.0059372643,0.0000548025,0.0023418597,0.00001215679],"about_ca_topic_score_codex":0.00063983264,"about_ca_topic_score_gemma":0.00089139,"teacher_disagreement_score":0.0012458112,"about_ca_system_score_codex":0.00018940799,"about_ca_system_score_gemma":0.0001661411,"threshold_uncertainty_score":0.0041676164},"labels":[],"label_agreement":null},{"id":"W1971859790","doi":"10.1111/j.1365-2133.2007.08192.x","title":"A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pimecrolimus; Atopic dermatitis; Medicine; Dermatology; Randomized controlled trial; Head and neck; Tacrolimus; Internal medicine; Surgery","score_opus":0.00779468475392059,"score_gpt":0.26240183618627777,"score_spread":0.2546071514323572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971859790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856147,0.0030151505,0.0004724047,0.00049279595,0.00076124084,0.007479281,0.00065172574,0.00008967543,0.0014229313],"genre_scores_gemma":[0.97963196,0.0028231211,0.0019665924,0.0011854296,0.0007430932,0.010641001,0.0007413936,0.000016220018,0.0022511622],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99888605,0.000632213,0.00010319314,0.00015773176,0.0000878314,0.00013287364],"domain_scores_gemma":[0.9986369,0.00047627094,0.00029945347,0.00008852596,0.00009934351,0.00039965738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020166086,0.0011433243,0.0036869682,0.0004166291,0.000496096,0.00079025404,0.00089177233,0.0017013906,0.0070580556],"category_scores_gemma":[0.0027963347,0.0007592016,0.0014726178,0.00036020714,0.0008995805,0.0008166221,0.00041317783,0.002334172,0.00081670185],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9833673,0.0070948163,0.0004971991,0.00039148313,0.00040934398,0.00003818447,0.000033509557,0.00008860544,0.0012204228,0.000046172903,0.00027232754,0.0065406687],"study_design_scores_gemma":[0.9471059,0.050917998,0.0012807901,0.000018625034,0.00017013308,0.000014843127,0.000010840538,0.0001315029,0.00010420478,0.000023714749,0.00021672892,0.0000046902774],"about_ca_topic_score_codex":0.00097140303,"about_ca_topic_score_gemma":0.0023853283,"teacher_disagreement_score":0.0070580556,"about_ca_system_score_codex":0.0005875007,"about_ca_system_score_gemma":0.0014826794,"threshold_uncertainty_score":0.023611546},"labels":[],"label_agreement":null},{"id":"W1971920401","doi":"10.1111/j.1365-2133.2005.06852.x","title":"Psychological factors in prurigo nodularis in comparison with psoriasis vulgaris: results of a case-control study","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Institute of Innovative Research, Tokyo Institute of Technology","keywords":"Psychosomatics; Prurigo nodularis; Medicine; Dermatology; Family medicine; Psychiatry","score_opus":0.01949863057359436,"score_gpt":0.3113678780365002,"score_spread":0.2918692474629058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971920401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991737,0.0003139076,0.00010159463,0.00001239489,0.000008717095,0.00004960316,0.000053158903,0.000002037812,0.00028495418],"genre_scores_gemma":[0.9994122,0.00016270351,0.000102309874,0.000020086498,0.000021750147,0.000045016834,0.00011952455,0.0000018432609,0.00011445602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836093,0.00053173513,0.0001770127,0.00045657376,0.00030646598,0.00016728711],"domain_scores_gemma":[0.9982856,0.00058977026,0.0004618953,0.00019630737,0.00016948482,0.0002969747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016834193,0.00065733783,0.00078566145,0.0019331734,0.0011713655,0.00093970966,0.0005198965,0.0010032973,0.0025300677],"category_scores_gemma":[0.0035849034,0.00055782375,0.00081692095,0.0013977315,0.00077643764,0.00060138607,0.00071724225,0.0007366984,0.00034108557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009092633,0.0009170897,0.99257237,0.000058109574,0.0002066596,0.0015263576,0.0007854229,0.000026774656,0.00067983154,0.00004866859,0.000075503565,0.0021939592],"study_design_scores_gemma":[0.00010179306,0.0010604764,0.99475265,0.0000121499015,0.00011421448,0.0029272735,0.0005981672,0.00010456101,0.00007590793,0.000028221984,0.0002139466,0.0000105929375],"about_ca_topic_score_codex":0.0035597817,"about_ca_topic_score_gemma":0.002539671,"teacher_disagreement_score":0.0035597817,"about_ca_system_score_codex":0.00045554098,"about_ca_system_score_gemma":0.00028516265,"threshold_uncertainty_score":0.008902848},"labels":[],"label_agreement":null},{"id":"W1972120867","doi":"10.1111/j.1365-2133.2006.07336.x","title":"Topical glycopyrrolate should not be overlooked in treatment of focal hyperhidrosis","year":2006,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glycopyrrolate; Hyperhidrosis; Medicine; Botulinum toxin; Dermatology; Anesthesia; Atropine","score_opus":0.040492355337163055,"score_gpt":0.28929107887351807,"score_spread":0.24879872353635502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972120867","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057333563,0.53909314,0.009060325,0.23125757,0.046434417,0.00018693872,0.0004121158,0.0010572746,0.115164645],"genre_scores_gemma":[0.5277908,0.1945406,0.014622785,0.13800527,0.07746886,0.00020789921,0.0004847244,0.00044187286,0.04643717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99951184,0.00013830682,0.000083468214,0.000044311244,0.00015902585,0.00006295045],"domain_scores_gemma":[0.9981908,0.0006695421,0.00031129815,0.00011669152,0.0004384167,0.0002732517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084256893,0.00036615174,0.00095178763,0.0003444223,0.00049878494,0.0007071468,0.0006212729,0.0029298225,0.007207245],"category_scores_gemma":[0.0058945743,0.00010587437,0.00042350992,0.00027001667,0.0005722923,0.0011345748,0.00037118068,0.0029933583,0.0041565476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077573303,0.00014579318,0.005403328,0.0018113593,0.00013326651,0.048858665,0.00043224663,0.00012011804,0.007091268,0.002597813,0.39828852,0.53434193],"study_design_scores_gemma":[0.00017437783,0.00044271027,0.017347915,0.002931393,0.00013920179,0.13423152,0.00076665176,0.00041556553,0.003126655,0.00415645,0.836178,0.00008949354],"about_ca_topic_score_codex":0.00061535195,"about_ca_topic_score_gemma":0.0012996516,"teacher_disagreement_score":0.007207245,"about_ca_system_score_codex":0.00031091686,"about_ca_system_score_gemma":0.0006534041,"threshold_uncertainty_score":0.024110615},"labels":[],"label_agreement":null},{"id":"W1972702833","doi":"10.1111/j.1365-2133.2005.06810.x","title":"Mutant p53 melanoma cell lines respond differently to CP-31398-induced apoptosis","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"National Cancer Institute; Foundation Medicine; University of British Columbia; Canadian Dermatology Foundation; Pfizer; Dermatology Foundation","keywords":"Apoptosis; Mutant; Melanoma; Cancer research; Cell culture; Cell growth; Biology; Genetics; Gene","score_opus":0.012303700609848282,"score_gpt":0.25254697020165295,"score_spread":0.24024326959180467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972702833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996058,0.00076721347,0.0018187031,0.000033312917,0.00001998673,0.000056359604,0.0003629248,0.00007133992,0.0008123073],"genre_scores_gemma":[0.9958364,0.0006100771,0.0015652298,0.00004070877,0.0000067095875,0.000089024645,0.00078620826,0.000016342072,0.0010491988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982905,0.000028265551,0.000028623266,0.00003226556,0.000057170884,0.000024623107],"domain_scores_gemma":[0.9998355,0.000043102602,0.000039085837,0.000029025417,0.000029416304,0.000023798591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012554193,0.00037689882,0.000302415,0.00032535644,0.0001244078,0.00024931785,0.00018196763,0.0003546165,0.0012635227],"category_scores_gemma":[0.00017711562,0.00011941054,0.00030513998,0.00026449267,0.0001678354,0.00019402734,0.00015727646,0.0006543379,0.00044231923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017218298,0.000042816388,0.00043481876,0.000028035896,0.0000071117897,0.000068499976,0.000018082976,0.000047742273,0.99846613,0.00003248439,0.000026508385,0.0006554853],"study_design_scores_gemma":[0.000025761898,0.0008295824,0.0073224744,0.0000051607344,0.00002664751,0.00085638155,0.000047163514,0.00056196953,0.9893505,0.000038970564,0.0009302182,0.000005183607],"about_ca_topic_score_codex":0.00033340175,"about_ca_topic_score_gemma":0.00031083505,"teacher_disagreement_score":0.0012635227,"about_ca_system_score_codex":0.00018960764,"about_ca_system_score_gemma":0.00009769108,"threshold_uncertainty_score":0.004226923},"labels":[],"label_agreement":null},{"id":"W1974038474","doi":"10.1111/j.1365-2133.2008.08461.x","title":"Beneficial effect of resin salve in treatment of severe pressure ulcers: a prospective, randomized and controlled multicentre trial","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Pressure Ulcer Prevention and Management","field":"Health Professions","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"Helsingin Yliopisto","keywords":"Medicine; Randomized controlled trial; Prospective cohort study; Surgery; Anesthesia","score_opus":0.01539109098758251,"score_gpt":0.3348134420135868,"score_spread":0.3194223510260043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974038474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97873735,0.0117465425,0.00071715936,0.000745262,0.0007553662,0.0055930438,0.000588286,0.00006605448,0.0010509389],"genre_scores_gemma":[0.9846809,0.0046234317,0.0019382599,0.0010473164,0.0008330026,0.0053969612,0.0004787639,0.0000117334475,0.0009896662],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99730194,0.0017751236,0.00021198078,0.00029981104,0.00019585023,0.00021527402],"domain_scores_gemma":[0.9970657,0.0009581697,0.0008783123,0.00022289259,0.0002128183,0.0006621249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004182055,0.0014078672,0.0037612377,0.00056405505,0.00073700846,0.0012409916,0.0008865024,0.0024272937,0.0052686087],"category_scores_gemma":[0.0045422073,0.00072982284,0.0026710632,0.000737379,0.0013032325,0.00095162034,0.00054326066,0.0020883926,0.00052187155],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9868341,0.0038695482,0.00083333626,0.00089464575,0.0012427354,0.000036804777,0.000035286048,0.00009644769,0.0007481178,0.00004431462,0.00020025903,0.0051644673],"study_design_scores_gemma":[0.95792145,0.039525207,0.0014626955,0.0000517387,0.00060089387,0.000022095503,0.000014416963,0.00009986153,0.00009702182,0.000034358058,0.00016278714,0.0000074195395],"about_ca_topic_score_codex":0.00074540253,"about_ca_topic_score_gemma":0.0016393001,"teacher_disagreement_score":0.0052686087,"about_ca_system_score_codex":0.0005917075,"about_ca_system_score_gemma":0.0014354221,"threshold_uncertainty_score":0.022117078},"labels":[],"label_agreement":null},{"id":"W1974998967","doi":"10.1111/bjd.13389","title":"When is onychomycosis onychomycosis? A cross-sectional study of fungi in normal-appearing nails","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Tel aviv; Library science; Medicine; History; Sociology; Computer science","score_opus":0.01652345686558986,"score_gpt":0.29457341811871,"score_spread":0.27804996125312015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974998967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993838,0.00018628578,0.0000393791,0.00003073623,0.000005402312,0.000010643126,0.000038868613,9.722497e-7,0.00030388357],"genre_scores_gemma":[0.99971,0.000119761135,0.000037631973,0.00003384961,0.0000061311,0.0000033448086,0.000034679142,6.1868906e-7,0.00005399957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988674,0.00031476782,0.00017792983,0.00024293976,0.00024676218,0.00015025563],"domain_scores_gemma":[0.99781114,0.00040443,0.001126718,0.0000852426,0.0002487027,0.00032381283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001346901,0.00035518556,0.00042280724,0.0009902815,0.00066592,0.0011018153,0.00046596065,0.0008736723,0.0014669906],"category_scores_gemma":[0.00317726,0.00062649685,0.00030729096,0.0009438975,0.0006718337,0.0013809581,0.0005847533,0.0008407784,0.00025712236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002310856,0.000040437295,0.9989353,0.000009873239,0.000014505844,0.00018356135,0.00019633867,0.000004708447,0.00016322642,0.0000064712012,0.000017528939,0.00040489275],"study_design_scores_gemma":[0.0000020420434,0.00018722394,0.99590874,0.000017980363,0.000015828968,0.0022380264,0.001430462,0.000040689178,0.000044565702,0.000015091565,0.00009577695,0.0000034822833],"about_ca_topic_score_codex":0.0022834092,"about_ca_topic_score_gemma":0.002190729,"teacher_disagreement_score":0.0022834092,"about_ca_system_score_codex":0.00023050759,"about_ca_system_score_gemma":0.00022687198,"threshold_uncertainty_score":0.0071231723},"labels":[],"label_agreement":null},{"id":"W1975297857","doi":"10.1111/j.1365-2133.1946.tb11322.x","title":"PEELIMINARY REPORT OF A DERMATOSIS DUE POSSIBLY TO MEPACRINE.* A DESCRIPTION OF 26 CASES SEEN IN ITALY.","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria General Hospital","funders":"","keywords":"Citation; Medicine; General hospital; Library science; Dermatology; Family medicine; Computer science","score_opus":0.014783211876540888,"score_gpt":0.27058817056795664,"score_spread":0.25580495869141573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975297857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9319581,0.008733433,0.0024230792,0.0013877817,0.00039778042,0.0003212,0.0007232909,0.00022082248,0.05383455],"genre_scores_gemma":[0.9930269,0.0015719819,0.00041476995,0.0004904631,0.00033588774,0.0000313989,0.0002205085,0.000024485877,0.0038834824],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99948955,0.00004169099,0.000041832256,0.00016958681,0.00007530912,0.000182072],"domain_scores_gemma":[0.9988187,0.00024383963,0.00031920153,0.00012405035,0.000075021526,0.0004191274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000265954,0.0022426057,0.0005341855,0.0021367914,0.002017604,0.0008494241,0.0010213368,0.0018575195,0.008633854],"category_scores_gemma":[0.0020590513,0.0013902521,0.00093861984,0.0009702172,0.0016828225,0.0009815533,0.0010618238,0.0017411859,0.0020627494],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012335548,0.00012156945,0.041373555,0.00006233361,0.000042759057,0.951903,0.00023310425,0.000116530726,0.0019953956,0.00013520032,0.001241992,0.0026511915],"study_design_scores_gemma":[0.000031414176,0.00020564439,0.03245196,0.00002005534,0.000022734825,0.9642893,0.00009254174,0.00007263497,0.00048886926,0.00005620316,0.0022531233,0.00001544803],"about_ca_topic_score_codex":0.0038681065,"about_ca_topic_score_gemma":0.0033343295,"teacher_disagreement_score":0.008633854,"about_ca_system_score_codex":0.00091648835,"about_ca_system_score_gemma":0.00059206266,"threshold_uncertainty_score":0.0288831},"labels":[],"label_agreement":null},{"id":"W1976464484","doi":"10.1046/j.1365-2133.2002.04641.x","title":"The novel tumour suppressor gene ING1 is overexpressed in human melanoma cell lines","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Library science; Medicine; Computer science","score_opus":0.010441454735486229,"score_gpt":0.22296552862349445,"score_spread":0.21252407388800823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976464484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978515,0.00087321503,0.0006174505,0.000023261651,0.0000063360326,0.000009672082,0.00016505989,0.00003697801,0.0004165167],"genre_scores_gemma":[0.9974625,0.0004738714,0.0007742568,0.000018934097,0.0000058476357,0.000011851684,0.00061588956,0.00000768011,0.00062917284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999905,0.000013609815,0.000007529068,0.00002329241,0.000030688272,0.0000199902],"domain_scores_gemma":[0.9998305,0.00003819676,0.000055129844,0.00002412242,0.000026634043,0.000025427547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011754434,0.00028264214,0.00014998965,0.0003953124,0.00015031322,0.00020540037,0.00012907578,0.00020824374,0.0010041934],"category_scores_gemma":[0.00023705981,0.00012256642,0.0001309907,0.00023190388,0.00013634514,0.00007726346,0.00015716089,0.00019426482,0.00040725502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021123962,0.000021854397,0.010782419,0.000056233435,0.00001803164,0.0005756302,0.00006883579,0.000039946768,0.98580927,0.000025277719,0.00009316947,0.0022980336],"study_design_scores_gemma":[0.000038618,0.0008556857,0.20746225,0.000022121574,0.000137231,0.015783887,0.00021334404,0.0011899555,0.7669963,0.0001221691,0.007165286,0.000013144327],"about_ca_topic_score_codex":0.0004188927,"about_ca_topic_score_gemma":0.00041450417,"teacher_disagreement_score":0.0010041934,"about_ca_system_score_codex":0.00014252316,"about_ca_system_score_gemma":0.000080125974,"threshold_uncertainty_score":0.0033593774},"labels":[],"label_agreement":null},{"id":"W1977350622","doi":"10.1111/bjd.13469","title":"Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":203,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Université Laval; Dalhousie University","funders":"Janssen Scientific Affairs","keywords":"Dosing; Medicine; Ustekinumab; Psoriasis; Placebo; Psoriasis Area and Severity Index; Population; Discontinuation; Randomized controlled trial; Adverse effect; Internal medicine; Dermatology; Disease; Alternative medicine","score_opus":0.011009835043840488,"score_gpt":0.22599502152068926,"score_spread":0.21498518647684878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977350622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685585,0.0020755255,0.000120069795,0.00008386828,0.000012017284,0.000059540354,0.00032041216,0.000007760791,0.00046488145],"genre_scores_gemma":[0.9982718,0.00048974593,0.000116111165,0.00012811583,0.00003493292,0.000048757214,0.0006255218,0.0000025150764,0.00028235864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984297,0.00068319344,0.00012912015,0.00024380282,0.0003140393,0.00020015998],"domain_scores_gemma":[0.99648273,0.0009403055,0.0014538453,0.00026132492,0.00025523457,0.000606523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006789475,0.00038769728,0.0010831656,0.00038492397,0.00037081726,0.00078013027,0.00043909828,0.0006985955,0.0013398527],"category_scores_gemma":[0.0037094972,0.00024074524,0.0017137211,0.0004598568,0.00032263945,0.0010065534,0.0004559635,0.0013787157,0.0002222099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26808062,0.0076567987,0.6365912,0.0003980273,0.004527014,0.00019658415,0.0005043872,0.00092154986,0.0040236614,0.00007535111,0.0014179134,0.07560687],"study_design_scores_gemma":[0.018619634,0.06106724,0.9151009,0.00007528088,0.0021871515,0.00023841468,0.000111798974,0.0006227122,0.00072200823,0.000067635585,0.0011515645,0.000035698362],"about_ca_topic_score_codex":0.0007650655,"about_ca_topic_score_gemma":0.0009072194,"teacher_disagreement_score":0.006789475,"about_ca_system_score_codex":0.00045599107,"about_ca_system_score_gemma":0.00041972773,"threshold_uncertainty_score":0.035906613},"labels":[],"label_agreement":null},{"id":"W1979000113","doi":"10.1111/j.1365-2133.2007.08205.x","title":"Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks","year":2007,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Etanercept; Medicine; Psoriasis; Placebo; Internal medicine; Depression (economics); Randomized controlled trial; Clinical trial; Tumor necrosis factor alpha; Dermatology; Pathology; Alternative medicine","score_opus":0.01695004558656602,"score_gpt":0.2591666758012743,"score_spread":0.24221663021470827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979000113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96763825,0.012930936,0.00017823048,0.007760171,0.0009065259,0.0003551429,0.00076798006,0.00006181577,0.009400923],"genre_scores_gemma":[0.9848711,0.0031514035,0.00036631094,0.0051327636,0.00081467093,0.00018374894,0.0003760582,0.000005439033,0.0050984765],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99967694,0.00016150736,0.000032754182,0.000038027494,0.000052879896,0.000037894013],"domain_scores_gemma":[0.99922156,0.00040066818,0.00011982837,0.000032690405,0.00007682704,0.00014846471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006914282,0.00030651037,0.0008495633,0.0001619136,0.0003315137,0.000193697,0.00026499724,0.0012819562,0.0029565939],"category_scores_gemma":[0.0017731714,0.0001410019,0.00040141155,0.00019608781,0.00013707491,0.00021790148,0.000088486755,0.00095487904,0.0005876849],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33515367,0.010543317,0.08015811,0.0015154262,0.00084954454,0.009329098,0.0006999114,0.0006109801,0.02856801,0.00028835304,0.049079303,0.48320433],"study_design_scores_gemma":[0.06412067,0.1395659,0.746273,0.00041175366,0.000640188,0.010155899,0.00032136875,0.0017609579,0.004549106,0.0005242467,0.031578127,0.00009889866],"about_ca_topic_score_codex":0.00066277763,"about_ca_topic_score_gemma":0.0021627727,"teacher_disagreement_score":0.0029565939,"about_ca_system_score_codex":0.00051813654,"about_ca_system_score_gemma":0.00023334644,"threshold_uncertainty_score":0.009890795},"labels":[],"label_agreement":null},{"id":"W1985189467","doi":"10.1111/j.1365-2133.2009.09217.x","title":"Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Vitiligo; Tacrolimus; Medicine; Dermatology; Depigmentation; Lesion; Cytokine; Pathology; Immunology; Internal medicine; Transplantation","score_opus":0.01202407514816698,"score_gpt":0.27904008044506173,"score_spread":0.26701600529689473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985189467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991025,0.00037846298,0.00012562973,0.000006170545,0.0000042460483,0.000018465009,0.000048590624,0.0000060205152,0.00030994444],"genre_scores_gemma":[0.99930274,0.00013371585,0.00024874214,0.000013545826,0.0000072868193,0.000018974202,0.00011059583,0.0000017631329,0.00016269422],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999845,0.00003149868,0.000016393715,0.000027814353,0.000046447552,0.000032744203],"domain_scores_gemma":[0.999619,0.00010599311,0.0001106703,0.000019305155,0.000076171105,0.000068838686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019145393,0.00020425962,0.00028768557,0.00041495546,0.00016048872,0.00028060155,0.00013235246,0.0002549408,0.000975931],"category_scores_gemma":[0.00045977157,0.000109843255,0.00014745763,0.0002333994,0.00019006486,0.00015122177,0.00012629827,0.00034655724,0.00017577273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005006376,0.0006583123,0.4281913,0.00022601127,0.00008190466,0.0027538824,0.0005329651,0.00018134191,0.54471374,0.000026083704,0.00014587236,0.017482344],"study_design_scores_gemma":[0.000052462437,0.0033757205,0.93623304,0.000009425554,0.00006507361,0.0048589357,0.0002879705,0.0004523233,0.054143604,0.000014646137,0.00049893453,0.000007998403],"about_ca_topic_score_codex":0.00027005014,"about_ca_topic_score_gemma":0.0003360539,"teacher_disagreement_score":0.000975931,"about_ca_system_score_codex":0.00016980745,"about_ca_system_score_gemma":0.00007337558,"threshold_uncertainty_score":0.0032648444},"labels":[],"label_agreement":null},{"id":"W1986097454","doi":"10.1046/j.1365-2133.2001.03952.x","title":"Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo","year":2001,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Medical Research Council","keywords":"Melanocyte; Vitiligo; Biology; Oxidative stress; Tyrosinase; Calnexin; Melanin; Programmed cell death; Pigmentation disorder; Melanosome; Cell biology; Molecular biology; Calreticulin; Endocrinology; Immunology; Cancer research; Biochemistry; Endoplasmic reticulum; Melanoma; Apoptosis; Enzyme; Genetics","score_opus":0.00562789210959756,"score_gpt":0.23370127897425957,"score_spread":0.22807338686466203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986097454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983063,0.0008209708,0.00049389177,0.000014057838,0.0000043728355,0.000007992623,0.000068132336,0.000020002864,0.00026415283],"genre_scores_gemma":[0.9989391,0.00032160056,0.00033989002,0.000010797351,0.0000036706367,0.000008312713,0.00010346509,0.0000039797146,0.00026911512],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999347,0.00000912815,0.000007001893,0.00001868479,0.00001572259,0.000014705439],"domain_scores_gemma":[0.99984586,0.000028670873,0.000055801942,0.00001543545,0.000021119256,0.000033187855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010729134,0.00019294585,0.00014509365,0.00044178474,0.00011110241,0.00020271639,0.00013747388,0.0002772633,0.0010640641],"category_scores_gemma":[0.00011963131,0.00009317551,0.00015126231,0.00014607803,0.0001871341,0.00015172803,0.00017489369,0.00034430245,0.00017658394],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012023045,0.000016778073,0.0038206698,0.000031703054,0.0000069782645,0.00025137403,0.000028920407,0.000015928712,0.99511296,0.00001739462,0.000009786778,0.0005672337],"study_design_scores_gemma":[0.000027204826,0.0006572358,0.36490065,0.000013673981,0.000069224334,0.007867884,0.00015939213,0.0006234922,0.62413865,0.00012083777,0.0014128546,0.000008892798],"about_ca_topic_score_codex":0.00022890659,"about_ca_topic_score_gemma":0.00017490753,"teacher_disagreement_score":0.0010640641,"about_ca_system_score_codex":0.00017788332,"about_ca_system_score_gemma":0.000051067902,"threshold_uncertainty_score":0.003559649},"labels":[],"label_agreement":null},{"id":"W1986974499","doi":"10.1046/j.1365-2133.2001.04292.x","title":"Dissatisfaction with skin appearance among patients with eating disorders and non-clinical controls","year":2001,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Eating Disorders and Behaviors","field":"Psychology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Psychosocial; Bulimia nervosa; Medicine; Eating disorders; Anorexia nervosa; Hyperpigmentation; Dermatology; Psychiatry","score_opus":0.006437944741882827,"score_gpt":0.2711685021682799,"score_spread":0.2647305574263971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986974499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99968433,0.00006492908,0.000009575497,0.000012676486,0.0000022236927,0.0000035133316,0.00004194424,0.0000011094658,0.00017967545],"genre_scores_gemma":[0.99969053,0.00005088404,0.000014815559,0.000017947817,0.000004075091,0.000005076725,0.00010091158,5.2609937e-7,0.000115293224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969554,0.0000928022,0.000031438452,0.000055484154,0.00006263133,0.00006208273],"domain_scores_gemma":[0.999064,0.00022537043,0.00037637382,0.00003121491,0.000076119446,0.00022692996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038779076,0.00026098668,0.00035251994,0.0010549126,0.00041050598,0.00053204974,0.00016983807,0.00036630084,0.00296244],"category_scores_gemma":[0.0018593707,0.00021446915,0.00018722369,0.0005836074,0.00044920732,0.00024788527,0.000395115,0.00027985216,0.00022687674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019564015,0.0001148176,0.99661714,0.000016220583,0.000023389182,0.00026314362,0.00042216585,0.00001744056,0.0003362203,0.000013397518,0.00010315984,0.0018773513],"study_design_scores_gemma":[0.000013341512,0.00019745882,0.9984584,0.000003131105,0.000010409542,0.0005869473,0.0005532656,0.000038335435,0.000031630705,0.0000071410736,0.00009775555,0.0000023589132],"about_ca_topic_score_codex":0.0041317306,"about_ca_topic_score_gemma":0.0025964738,"teacher_disagreement_score":0.0041317306,"about_ca_system_score_codex":0.00023000836,"about_ca_system_score_gemma":0.00010643639,"threshold_uncertainty_score":0.009910345},"labels":[],"label_agreement":null},{"id":"W1987912342","doi":"10.1111/j.1365-2133.2000.03724.x","title":"Cutaneous<i>Cryptococcus</i>infection due to<i>C. albidus</i>associated with Sézary syndrome","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Fungal Infections and Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Cryptococcus neoformans; Cryptococcus; Biology; Disease; Cerebrospinal fluid; Cryptococcosis; Yeast; Immunology; Microbiology; Pathology; Medicine; Genetics","score_opus":0.007604452630857988,"score_gpt":0.23067019590327822,"score_spread":0.22306574327242024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987912342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880074,0.0009543925,0.00080109877,0.00043509895,0.00008236158,0.00006259241,0.000085900974,0.00011170867,0.009459509],"genre_scores_gemma":[0.9989248,0.0002521777,0.00017017384,0.00010909431,0.00006172264,0.0000042660977,0.000015492587,0.0000060947923,0.00045621642],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998004,0.000019553727,0.000015786627,0.000042218046,0.000028181517,0.00009399063],"domain_scores_gemma":[0.99927205,0.00020024709,0.00021145912,0.00004579531,0.000047931826,0.00022261744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107617794,0.0010662869,0.0005244981,0.0007781906,0.0011883887,0.0005527015,0.00030872133,0.0010192737,0.002972273],"category_scores_gemma":[0.0010595229,0.0004247605,0.0003574835,0.00048307577,0.0011581917,0.000422877,0.00046735408,0.0013234825,0.00046627058],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006420838,0.000046814584,0.01978633,0.00006359168,0.000014504723,0.97264344,0.00019014611,0.000076248034,0.00435216,0.00015809224,0.00030062726,0.0023039235],"study_design_scores_gemma":[0.000019538713,0.00014989647,0.019367594,0.000013911372,0.000016366314,0.97835404,0.00012733687,0.00011869294,0.0012243766,0.00008137786,0.0005168431,0.000010018858],"about_ca_topic_score_codex":0.0036742506,"about_ca_topic_score_gemma":0.0028357382,"teacher_disagreement_score":0.0036742506,"about_ca_system_score_codex":0.00034986643,"about_ca_system_score_gemma":0.00036500304,"threshold_uncertainty_score":0.009943247},"labels":[],"label_agreement":null},{"id":"W1988320219","doi":"10.1046/j.1365-2133.2000.03679.x","title":"Mycosis fungoides and chronic lymphocytic leukaemia - composite T-cell and B-cell lymphomas presenting in the skin","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Mycosis fungoides; Lymphoproliferative disorders; Lymphoma; Gene rearrangement; Cutaneous lymphoma; Medicine; Immunophenotyping; B cell; Chronic lymphocytic leukemia; Pathology; Antibody; Immunology; Biology; Leukemia; Gene; Antigen","score_opus":0.008322272312694822,"score_gpt":0.2529159958058913,"score_spread":0.24459372349319647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988320219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793703,0.009495875,0.0015701709,0.0002800116,0.000107820546,0.000067585584,0.00011304087,0.00007785659,0.008917399],"genre_scores_gemma":[0.9972779,0.0010825817,0.00047285834,0.000097451775,0.00019475928,0.000012312686,0.00005256482,0.0000066159723,0.0008029037],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993198,0.00013585729,0.00007443529,0.00014726118,0.00010549413,0.00021709417],"domain_scores_gemma":[0.9983808,0.00037128615,0.0005319821,0.00015585184,0.000077686804,0.0004823741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003554632,0.00083233794,0.00058569177,0.00079190504,0.00088356604,0.0010751648,0.00026182138,0.0017540475,0.00403547],"category_scores_gemma":[0.0024529523,0.0006202916,0.00031843793,0.0006781772,0.00087823486,0.0010452997,0.0010663063,0.0010632313,0.0011675679],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001202029,0.00008881563,0.1394502,0.00033825304,0.0000666129,0.8181082,0.00052589487,0.000081188235,0.022150753,0.0009608027,0.0006298397,0.01639748],"study_design_scores_gemma":[0.000038450224,0.00015179627,0.023333484,0.000018323635,0.00002743881,0.9727181,0.00015859926,0.00007037129,0.0016342717,0.00018769254,0.0016537805,0.000007652084],"about_ca_topic_score_codex":0.00064014003,"about_ca_topic_score_gemma":0.000861595,"teacher_disagreement_score":0.00403547,"about_ca_system_score_codex":0.0002180353,"about_ca_system_score_gemma":0.00031780254,"threshold_uncertainty_score":0.013499975},"labels":[],"label_agreement":null},{"id":"W1993371097","doi":"10.1046/j.1365-2133.2002.04766.x","title":"The hairless gene in androgenetic alopecia: results of a systematic mutation screening and a family-based association approach","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Deutsche Forschungsgemeinschaft","keywords":"Genetics; Missense mutation; Male-pattern baldness; Hairless; Biology; Exon; Mutation; Hair loss; Scalp; Single-nucleotide polymorphism; Gene; Internal medicine; Medicine; Genotype; Dermatology","score_opus":0.018226690520261254,"score_gpt":0.2280402590151711,"score_spread":0.20981356849490984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993371097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648297,0.00090584374,0.0018870197,0.000029383698,0.000006121061,0.00005574228,0.00013574839,0.000020110843,0.00047710215],"genre_scores_gemma":[0.9967943,0.00047506383,0.002031421,0.00003866146,0.000008741978,0.000038508788,0.00033146143,0.00000804199,0.00027380057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915934,0.0002471943,0.00006736237,0.000274384,0.00019892059,0.000052783256],"domain_scores_gemma":[0.99929786,0.00029750558,0.00008611215,0.00007895511,0.0001246876,0.000114840346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087093114,0.0006002271,0.0004719887,0.0016992643,0.0006240395,0.0003520519,0.0003122164,0.00035909246,0.0011091591],"category_scores_gemma":[0.0014631136,0.00023488801,0.0006274188,0.0009991731,0.00039161148,0.00013385684,0.00051515223,0.00032903912,0.00030514755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006265524,0.0002664425,0.9227946,0.00010718331,0.0004971884,0.0079063,0.00089040725,0.00050693564,0.037490115,0.00012537083,0.00023006658,0.028558942],"study_design_scores_gemma":[0.00009323334,0.00066888303,0.96444225,0.000051035942,0.0007850099,0.026376635,0.00031713865,0.0015008432,0.0039181123,0.000099700206,0.001723159,0.000023987637],"about_ca_topic_score_codex":0.0039391997,"about_ca_topic_score_gemma":0.003757896,"teacher_disagreement_score":0.0039391997,"about_ca_system_score_codex":0.00020052139,"about_ca_system_score_gemma":0.0006256409,"threshold_uncertainty_score":0.007832587},"labels":[],"label_agreement":null},{"id":"W1993807965","doi":"10.1111/bjd.12815","title":"Psoriatic arthritis screening tools: study design and methodological challenges","year":2014,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psoriatic arthritis; Medicine; Psoriasis; Family medicine; CONTEST; Alternative medicine; Arthritis; Dermatology; Internal medicine; Pathology; Political science","score_opus":0.16380652254540934,"score_gpt":0.33965743542428917,"score_spread":0.17585091287887983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993807965","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06796997,0.099755146,0.18392374,0.44259763,0.06938134,0.096806385,0.015881777,0.00067732146,0.023006788],"genre_scores_gemma":[0.40441155,0.011903654,0.1573718,0.14434406,0.01869853,0.25557747,0.003001377,0.00047422398,0.0042172726],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.3647221,0.53120357,0.056056425,0.0077131004,0.037913065,0.0023917577],"domain_scores_gemma":[0.3335857,0.54384905,0.040168628,0.032332942,0.04582405,0.0042395755],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4672026,0.0017645218,0.004384811,0.0047639003,0.0024751967,0.0061145173,0.006413626,0.004287294,0.006629135],"category_scores_gemma":[0.7030254,0.0016162174,0.0027727317,0.008447093,0.0039384365,0.0040727365,0.004179683,0.004182514,0.00165221],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011428317,0.0015145619,0.14280859,0.059524566,0.009973508,0.0017432417,0.007909387,0.00342781,0.00049800647,0.050865095,0.3597536,0.3505533],"study_design_scores_gemma":[0.011824032,0.0046531223,0.1509219,0.14569825,0.012365374,0.0034322015,0.007048746,0.02556542,0.0022698927,0.1645365,0.47075593,0.0009286292],"about_ca_topic_score_codex":0.0071288296,"about_ca_topic_score_gemma":0.015899995,"teacher_disagreement_score":0.5327974,"about_ca_system_score_codex":0.008982054,"about_ca_system_score_gemma":0.013424257,"threshold_uncertainty_score":0.65703404},"labels":[],"label_agreement":null},{"id":"W1994024278","doi":"10.1046/j.1365-2133.2001.04181.x","title":"Rethinking the role of tumour necrosis factor-alpha in ultraviolet (UV) B-induced immunosuppression: altered immune response in UV-irradiated TNFR1R2 gene-targeted mutant mice","year":2001,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Immunosuppression; Immune system; Cancer research; Ultraviolet b; Tumor necrosis factor alpha; Mutant; Immunology; Gene; Alpha (finance); Medicine; Biology; Genetics; Dermatology","score_opus":0.016064890542055347,"score_gpt":0.2600533102320043,"score_spread":0.24398841968994894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994024278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448353,0.0013905102,0.002596338,0.00020358377,0.000052975814,0.00005568797,0.00040297245,0.00011177364,0.0007025143],"genre_scores_gemma":[0.98936975,0.0012531881,0.005312936,0.00012805444,0.000045628745,0.000104874736,0.00043394422,0.0000805746,0.0032710251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995921,0.000070295006,0.00005499452,0.000109321074,0.00010235376,0.00007091299],"domain_scores_gemma":[0.99945027,0.000064254724,0.00024040723,0.00006308215,0.000031090312,0.00015091636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003814357,0.00096021517,0.000492168,0.00074190984,0.0002420853,0.00053668185,0.00056362565,0.0008942305,0.0019244308],"category_scores_gemma":[0.00017084068,0.00037547294,0.0005716063,0.00024873187,0.0009161718,0.00053244137,0.0003132746,0.0018454759,0.000557104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021055278,0.00005614663,0.00014480136,0.000026846323,0.0000039083434,0.000058228452,0.000014586643,0.000029647612,0.9990415,0.00006660612,0.000011247739,0.00033586897],"study_design_scores_gemma":[0.000109161585,0.0012204718,0.005614464,0.000031807303,0.000050318034,0.0009085437,0.00007689491,0.00080053473,0.9896355,0.000080228296,0.0014612757,0.000010763962],"about_ca_topic_score_codex":0.00042124628,"about_ca_topic_score_gemma":0.0006129421,"teacher_disagreement_score":0.0019244308,"about_ca_system_score_codex":0.000427304,"about_ca_system_score_gemma":0.0002126804,"threshold_uncertainty_score":0.006437838},"labels":[],"label_agreement":null},{"id":"W1997189639","doi":"10.1111/j.1365-2133.2009.09238.x","title":"Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Library science; Art; Art history; Classics; Computer science","score_opus":0.012791580294271805,"score_gpt":0.24806132362284522,"score_spread":0.23526974332857342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997189639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986045,0.00043987602,0.0002244444,0.000024063564,0.0000043482924,0.00012175036,0.00010779892,0.0000074382815,0.0004658184],"genre_scores_gemma":[0.9992021,0.00008178839,0.00023696656,0.000074290285,0.0000123700065,0.000052855485,0.0002160399,0.0000020160248,0.00012159143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979386,0.001084948,0.00021888425,0.00026933957,0.00028710585,0.00020120073],"domain_scores_gemma":[0.994869,0.002062644,0.0021823284,0.00035281252,0.00020733896,0.00032596858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029839778,0.00025959546,0.0011353029,0.00021076386,0.00034856272,0.0006388607,0.00027519933,0.00033916676,0.0018168497],"category_scores_gemma":[0.004373852,0.00015701694,0.0010379322,0.0003020142,0.00029343212,0.0003831495,0.00026848924,0.00047614402,0.00031127603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038890358,0.0010641451,0.9014285,0.0003907695,0.0010526465,0.00049291376,0.0002636324,0.0007919406,0.008437218,0.00007809445,0.0005605619,0.04654914],"study_design_scores_gemma":[0.0018939419,0.021287654,0.9666804,0.00004653042,0.0006654594,0.0039138026,0.00018346711,0.00097073254,0.0027984479,0.0000810511,0.0014537796,0.000024725745],"about_ca_topic_score_codex":0.00018934965,"about_ca_topic_score_gemma":0.00033905005,"teacher_disagreement_score":0.0029839778,"about_ca_system_score_codex":0.00030591217,"about_ca_system_score_gemma":0.00026732477,"threshold_uncertainty_score":0.015780926},"labels":[],"label_agreement":null},{"id":"W1997360117","doi":"10.1111/j.1365-2133.2005.06754.x","title":"Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Messenger RNA; Medicine; Pathology; Biology; Dermatology; Biochemistry; Enzyme; Gene","score_opus":0.006559460240498487,"score_gpt":0.2401886776562347,"score_spread":0.2336292174157362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997360117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935923,0.0037393267,0.0010361053,0.000023317773,0.000022756121,0.000013757578,0.00038003267,0.000044765064,0.0011476529],"genre_scores_gemma":[0.99678975,0.0010522981,0.0011674669,0.000012625097,0.0000137772595,0.000017957935,0.00027061743,0.000007448594,0.0006680218],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987984,0.000011336989,0.00001542376,0.000044044933,0.000030398322,0.000019054012],"domain_scores_gemma":[0.9998658,0.00003117769,0.00003397436,0.000011501826,0.000030016485,0.000027561886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011052273,0.00018548309,0.00013025221,0.00053719856,0.00012425616,0.00021431298,0.000117922005,0.00017431182,0.0016340215],"category_scores_gemma":[0.000169223,0.00009187983,0.00012327531,0.00026207187,0.0002008195,0.00019362666,0.0001445741,0.00017092263,0.00024501648],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007156216,0.000044368975,0.020814281,0.00030643513,0.00003600728,0.0013799152,0.00014995137,0.00008106168,0.964563,0.00010648102,0.00013591014,0.01166686],"study_design_scores_gemma":[0.00008642431,0.001157706,0.5802504,0.000056626577,0.00026301216,0.0229523,0.0006015421,0.0011433031,0.383526,0.0005646682,0.009378108,0.000019935585],"about_ca_topic_score_codex":0.00017400827,"about_ca_topic_score_gemma":0.00015855244,"teacher_disagreement_score":0.0016340215,"about_ca_system_score_codex":0.00012819961,"about_ca_system_score_gemma":0.00007076386,"threshold_uncertainty_score":0.0054664016},"labels":[],"label_agreement":null},{"id":"W1999580944","doi":"10.1046/j.1365-2133.2003.05298.x","title":"A tissue-engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary-like tube formation in vitro","year":2003,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Université Laval","funders":"National Institutes of Health; National Institute for Health and Care Research","keywords":"Dermis; Umbilical vein; Angiogenesis; Chemistry; Dermal fibroblast; In vitro; Basic fibroblast growth factor; Fibroblast; Endothelial stem cell; Cell biology; Biophysics; Biomedical engineering; Growth factor; Anatomy; Biology; Medicine; Biochemistry; Cancer research; Receptor","score_opus":0.012930067276865593,"score_gpt":0.2615254278762025,"score_spread":0.24859536059933687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999580944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98453414,0.0020812175,0.010895324,0.00004110525,0.00006411429,0.00011537964,0.00027248092,0.000060118873,0.0019362335],"genre_scores_gemma":[0.9839961,0.001018395,0.012876199,0.000038322814,0.000010370618,0.000074562486,0.00036414328,0.000009823358,0.0016122264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998982,0.00002324716,0.0000071786767,0.000026035137,0.00003159317,0.000013751082],"domain_scores_gemma":[0.99988616,0.000042786764,0.000026511932,0.000015188731,0.000013233602,0.000016174072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022300836,0.00027663962,0.0001597088,0.0001163641,0.000063774256,0.00018308338,0.0001780632,0.0002482003,0.000668957],"category_scores_gemma":[0.00010588205,0.00010768318,0.00018505592,0.00009670251,0.00011857137,0.00016917638,0.000098809265,0.00036200017,0.00013493125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002132706,0.000028983892,0.00007154623,0.000033209097,0.000003051153,0.000040399187,0.000009189421,0.00010622979,0.9990909,0.00005101727,0.00000855562,0.00053547363],"study_design_scores_gemma":[0.0000101432415,0.0005592583,0.001974455,0.0000060526777,0.000018071732,0.00024279533,0.000012284565,0.0016524078,0.99377877,0.000018508656,0.0017242861,0.0000029080115],"about_ca_topic_score_codex":0.00031066174,"about_ca_topic_score_gemma":0.00041592633,"teacher_disagreement_score":0.000668957,"about_ca_system_score_codex":0.0001291781,"about_ca_system_score_gemma":0.00010882051,"threshold_uncertainty_score":0.0022378564},"labels":[],"label_agreement":null},{"id":"W2000094621","doi":"10.1111/j.1365-2133.2009.09621.x","title":"Managing chronic hand eczema","year":2010,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Hand eczema; Medicine; Dermatology; Allergy; Immunology; Contact dermatitis","score_opus":0.00907226924250534,"score_gpt":0.23955549016638233,"score_spread":0.230483220923877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000094621","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04053739,0.083355695,0.0020135872,0.5982269,0.050498407,0.0002662989,0.00015451286,0.00036886992,0.22457847],"genre_scores_gemma":[0.2333232,0.07427291,0.0030012794,0.3726534,0.18177286,0.00026360087,0.00022182471,0.00010066217,0.13439032],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99929464,0.00013493597,0.00008802676,0.000058981317,0.0002874488,0.00013596691],"domain_scores_gemma":[0.99909973,0.0002881428,0.00013427887,0.0000273503,0.0002038128,0.00024674195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051480153,0.00071322924,0.0006332313,0.0009542443,0.0016246274,0.0011806356,0.00049074064,0.00644046,0.008211619],"category_scores_gemma":[0.005022951,0.00020824674,0.00044496555,0.0005224394,0.0006608227,0.00198908,0.00067652174,0.0049049775,0.0050688596],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111766625,0.00025638982,0.0074056853,0.00067808485,0.000033619934,0.14258078,0.00047590758,0.0001844897,0.0014924577,0.0014450097,0.7150215,0.13031437],"study_design_scores_gemma":[0.00013452028,0.00032718817,0.0069189887,0.0011417747,0.000032011754,0.54282737,0.0007145899,0.0005326879,0.00048304995,0.003563632,0.44328746,0.000036742],"about_ca_topic_score_codex":0.0011005077,"about_ca_topic_score_gemma":0.0019198514,"teacher_disagreement_score":0.008211619,"about_ca_system_score_codex":0.0011314146,"about_ca_system_score_gemma":0.00055564195,"threshold_uncertainty_score":0.027470589},"labels":[],"label_agreement":null},{"id":"W2002428083","doi":"10.1046/j.1365-2133.2002.04721.x","title":"p53-dependent regulation of heat shock protein 72","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Health Sciences Centre; University of British Columbia","funders":"","keywords":"Immunostaining; Heat shock protein; Western blot; Basal (medicine); Biology; Cancer research; Blot; Cellular stress response; Regulator; Immunohistochemistry; Transcription (linguistics); Transcription factor; Pathology; Gene; Immunology; Medicine; Endocrinology; Genetics","score_opus":0.014450711545768576,"score_gpt":0.25698150846663986,"score_spread":0.2425307969208713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002428083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99258244,0.0034638678,0.0020007696,0.00010111654,0.000023975588,0.000016359663,0.00028984953,0.0000958964,0.0014257442],"genre_scores_gemma":[0.997294,0.0008544884,0.000441113,0.000020364232,0.0000064416504,0.000012980824,0.00025904938,0.000008553338,0.0011030786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992824,0.000009872945,0.0000035140613,0.000012491396,0.00001648108,0.000029462468],"domain_scores_gemma":[0.9998666,0.00002184658,0.000038778737,0.000011123694,0.0000333696,0.000028275887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071332775,0.00027750316,0.0000984944,0.00023034087,0.00015955567,0.0002991237,0.00009519952,0.0001386504,0.0014560194],"category_scores_gemma":[0.00013793727,0.00006957417,0.00013989756,0.00011810601,0.00020563926,0.0001550724,0.00023596454,0.0002715005,0.0005100819],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010517161,0.000011956238,0.0005075299,0.00002815882,0.0000027295314,0.00008664416,0.000011981521,0.000031658874,0.99796104,0.00004946256,0.000069707974,0.0011339323],"study_design_scores_gemma":[0.000013330335,0.00020082468,0.04434836,0.0000126424475,0.000015052961,0.0005333401,0.000048572467,0.00068887585,0.9518286,0.00019765121,0.0021077208,0.000005147312],"about_ca_topic_score_codex":0.0003827326,"about_ca_topic_score_gemma":0.0003678209,"teacher_disagreement_score":0.0014560194,"about_ca_system_score_codex":0.0002747906,"about_ca_system_score_gemma":0.00008313629,"threshold_uncertainty_score":0.0048708916},"labels":[],"label_agreement":null},{"id":"W2002718216","doi":"10.1111/j.1365-2133.2004.06350.x","title":"Insulin-like growth factor binding protein-3 (IGFBP-3) localizes to and modulates proliferative epidermal keratinocytes in vivo","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Keratinocyte; Epidermis (zoology); Biology; Keratinocyte growth factor; Growth factor; Epidermal growth factor; In situ hybridization; Molecular biology; Insulin-like growth factor-binding protein; Messenger RNA; Cell biology; Insulin-like growth factor; Receptor; In vitro; Biochemistry; Anatomy; Gene","score_opus":0.011072059890789247,"score_gpt":0.2526969255039632,"score_spread":0.24162486561317398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002718216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987306,0.0044555017,0.005492041,0.00008522641,0.00005342934,0.0000304253,0.00045572998,0.00013367191,0.0019879618],"genre_scores_gemma":[0.99207264,0.0023136137,0.0027796482,0.00007896257,0.00001792016,0.000025320835,0.00040606793,0.000026722055,0.0022790134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999136,0.00000926889,0.000005923169,0.000022506774,0.000028201028,0.000020450287],"domain_scores_gemma":[0.99991286,0.000015445672,0.000022242148,0.000010225277,0.00001667044,0.000022435588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009465856,0.00024879142,0.00013892422,0.00022055041,0.00014286235,0.00027459758,0.0001423588,0.0002073591,0.0011950453],"category_scores_gemma":[0.00008795701,0.00013975236,0.00019688875,0.00015309323,0.00022687415,0.0001353498,0.0001412542,0.00036106008,0.00049041427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042355772,0.0000058412093,0.00015824365,0.00001879076,0.0000012471536,0.000016325648,0.0000051564275,0.000005915364,0.9993181,0.0000075519815,0.000011028139,0.00040951208],"study_design_scores_gemma":[0.000013643909,0.00032214142,0.03411874,0.000011209525,0.0000342493,0.0004864283,0.0000783765,0.000338391,0.9625814,0.000047622198,0.0019608596,0.000006952788],"about_ca_topic_score_codex":0.0010544745,"about_ca_topic_score_gemma":0.0013964962,"teacher_disagreement_score":0.0011950453,"about_ca_system_score_codex":0.0002937235,"about_ca_system_score_gemma":0.0001873001,"threshold_uncertainty_score":0.0039978027},"labels":[],"label_agreement":null},{"id":"W2003308576","doi":"10.1111/j.1365-2133.1989.tb07792.x","title":"The treatment of chilblains with nifedipine: the results of a pilot study, a double-blind placebo-controlled randomized study and a long-term open trial","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Nifedipine; Medicine; Placebo; Irritation; Open label; Anesthesia; Double blind; Vasodilation; Randomized controlled trial; Surgery; Internal medicine; Pathology; Calcium","score_opus":0.042067926427947974,"score_gpt":0.3274761934050284,"score_spread":0.28540826697708044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003308576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658916,0.024385534,0.0011456481,0.0013246848,0.001005536,0.0037066273,0.0007153513,0.0001726765,0.0016523714],"genre_scores_gemma":[0.9724807,0.014934943,0.0035631533,0.0012855284,0.0015509066,0.003591168,0.0006516823,0.000035438567,0.0019064073],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99836284,0.00096686074,0.0001874565,0.00015744302,0.00017173913,0.00015371064],"domain_scores_gemma":[0.9959241,0.0019128104,0.0007103385,0.00028896666,0.00027806463,0.00088569376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039514885,0.0012148578,0.0034340578,0.00067740754,0.0006529637,0.0009987868,0.0010649739,0.0028492608,0.003865089],"category_scores_gemma":[0.005364105,0.00050560065,0.0019132503,0.0006598397,0.0018363083,0.0013049062,0.00034179518,0.002693558,0.0005581803],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.925522,0.020412557,0.00062716607,0.0021609163,0.0012562141,0.00010054227,0.0000969994,0.00010948745,0.0077032945,0.00010240822,0.0005788446,0.04132949],"study_design_scores_gemma":[0.7718941,0.22354119,0.0021870306,0.000060531325,0.0005531855,0.00006188446,0.000023798635,0.00010382729,0.0007829079,0.00006976081,0.0007050654,0.000016693455],"about_ca_topic_score_codex":0.00092198513,"about_ca_topic_score_gemma":0.0015457695,"teacher_disagreement_score":0.0039514885,"about_ca_system_score_codex":0.0006603166,"about_ca_system_score_gemma":0.001070895,"threshold_uncertainty_score":0.020897746},"labels":[],"label_agreement":null},{"id":"W2005065341","doi":"10.1046/j.1365-2133.2003.05250.x","title":"Atypical exanthem: polymerase chain reaction spots the cause","year":2003,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Exanthem; Rash; Polymerase chain reaction; Virology; Medicine; Varicella zoster virus; Virus; Herpesviridae; Dermatology; Etiology; Viral disease; Immunology; Pathology; Biology","score_opus":0.02424379290135894,"score_gpt":0.295934575539828,"score_spread":0.2716907826384691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005065341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560883,0.009235224,0.006449562,0.0018151923,0.00051765644,0.00013478554,0.00055997586,0.000361163,0.024838105],"genre_scores_gemma":[0.9965785,0.0005698195,0.00076130417,0.00028227834,0.00015503523,0.000013502149,0.000059357135,0.000013411482,0.0015667055],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996785,0.000048479786,0.000024516306,0.00012234818,0.000060128314,0.000065959735],"domain_scores_gemma":[0.99909115,0.00042281664,0.0001782061,0.000079134756,0.000092775554,0.00013595892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001657133,0.00048739786,0.00028706857,0.0005897057,0.00032136607,0.00044513567,0.0002727612,0.0010344968,0.0072335987],"category_scores_gemma":[0.0023798575,0.00018491411,0.00016130075,0.00027959133,0.00038044067,0.00059153803,0.00025731634,0.0007433457,0.001806834],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004939742,0.00020910696,0.08131377,0.00034275703,0.000027364642,0.85243595,0.0005680185,0.00028530907,0.033187117,0.0010804841,0.0030112537,0.02704491],"study_design_scores_gemma":[0.000029786432,0.00012207232,0.027074108,0.00003403262,0.000012067447,0.96414965,0.000109392255,0.00046754463,0.0031572613,0.0003103906,0.0045239655,0.000009707253],"about_ca_topic_score_codex":0.00022747152,"about_ca_topic_score_gemma":0.00011280598,"teacher_disagreement_score":0.0072335987,"about_ca_system_score_codex":0.00018605059,"about_ca_system_score_gemma":0.00011114882,"threshold_uncertainty_score":0.02419877},"labels":[],"label_agreement":null},{"id":"W2008928589","doi":"10.1111/j.1365-2133.1975.tb03030.x","title":"Antireticulin antibodies in dermatitis herpetiformis and adult coeliac disease","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Red Cross Society","funders":"","keywords":"Dermatitis herpetiformis; Villous atrophy; Coeliac disease; Antibody; Medicine; Atrophy; Incidence (geometry); Gastroenterology; Pathology; Immunology; Dermatology; Disease","score_opus":0.004524267684815066,"score_gpt":0.24689224930858114,"score_spread":0.24236798162376608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008928589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978344,0.0015676107,0.000036305664,0.000027851096,0.000005963385,0.0000042266734,0.000020724334,0.0000025268891,0.00050045486],"genre_scores_gemma":[0.99959797,0.00022276481,0.000041921263,0.000022885635,0.0000074419972,0.0000016932092,0.000030985353,3.931612e-7,0.00007398275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995851,0.00010358197,0.000062902625,0.000057686477,0.00009465559,0.000096094576],"domain_scores_gemma":[0.9994184,0.00015278219,0.00020760727,0.000022596105,0.00007476164,0.00012377494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036379482,0.00027116263,0.00033384195,0.0013080799,0.00044933235,0.0003047687,0.00012226946,0.00044824337,0.0013457328],"category_scores_gemma":[0.0015554345,0.00021072807,0.00015065272,0.0007346481,0.00041742498,0.0002755204,0.00035807138,0.00025496996,0.00014705255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024797814,0.000043772165,0.9898051,0.000046751462,0.000028677947,0.0014871462,0.0002912474,0.00002752072,0.0021001673,0.000027399523,0.00009008014,0.005804245],"study_design_scores_gemma":[0.000023768835,0.00031096567,0.9843055,0.000020814812,0.000026106205,0.013995077,0.00029934238,0.00007011071,0.00037501627,0.000027755505,0.00054128066,0.000004266881],"about_ca_topic_score_codex":0.0015657315,"about_ca_topic_score_gemma":0.0016469016,"teacher_disagreement_score":0.0015657315,"about_ca_system_score_codex":0.000266728,"about_ca_system_score_gemma":0.00012471162,"threshold_uncertainty_score":0.004501879},"labels":[],"label_agreement":null},{"id":"W2014067251","doi":"10.1046/j.1365-2133.2002.04758.x","title":"Clinical characteristics of pruritus in chronic idiopathic urticaria","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sensation; Evening; Depression (economics); Itching; McGill Pain Questionnaire; Dermatology; Burning Sensation; Physical therapy; Visual analogue scale","score_opus":0.020718976238766437,"score_gpt":0.2891203630481781,"score_spread":0.26840138680941167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014067251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809927,0.00076858455,0.000084450105,0.000053337597,0.000007839576,0.00003405779,0.00012256847,0.0000038169605,0.00082607934],"genre_scores_gemma":[0.9994265,0.00014494367,0.00009654465,0.000029455492,0.000017133556,0.000019581881,0.00019367512,0.0000010360751,0.00007108796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943215,0.00013755236,0.00008431195,0.00007308682,0.00016745733,0.000105377185],"domain_scores_gemma":[0.99658054,0.0008556155,0.0015083294,0.000053387786,0.0004060514,0.00059605687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005652603,0.00032944497,0.00047687438,0.0010428384,0.00033724672,0.0003609133,0.00023298875,0.00061456446,0.001736898],"category_scores_gemma":[0.004185973,0.00014649861,0.00026088918,0.0009695884,0.0004356644,0.0003701741,0.00033527758,0.00028150054,0.0003549016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024260719,0.00006347163,0.99277014,0.00005905242,0.000022558112,0.0014069929,0.00011513521,0.000061589126,0.00162064,0.000015638874,0.00015284652,0.0034693202],"study_design_scores_gemma":[0.000019309246,0.000206962,0.99198395,0.000012699147,0.000008496089,0.007310531,0.000118357944,0.00007284843,0.00006191659,0.000012566923,0.00018804034,0.000004321759],"about_ca_topic_score_codex":0.00092422526,"about_ca_topic_score_gemma":0.0010938498,"teacher_disagreement_score":0.001736898,"about_ca_system_score_codex":0.00026063435,"about_ca_system_score_gemma":0.00023105726,"threshold_uncertainty_score":0.005810559},"labels":[],"label_agreement":null},{"id":"W2018130199","doi":"10.1046/j.1365-2133.2000.03619.x","title":"Efficacy of borage oil in patients with atopic eczema","year":2000,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Agriculture and Agri-Food Canada","funders":"","keywords":"Medicine; Corporation; Dermatology; Library science; Political science; Computer science","score_opus":0.005452804513457715,"score_gpt":0.22207250196905318,"score_spread":0.21661969745559545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018130199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7411209,0.0971586,0.00033875546,0.09118683,0.0035235628,0.00015929154,0.00033558885,0.00009877826,0.06607771],"genre_scores_gemma":[0.96312356,0.013856808,0.00023930898,0.014773885,0.003475557,0.000041379906,0.00017939095,0.000007189111,0.0043030167],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99968505,0.00010506304,0.000053224674,0.000024799356,0.000078549194,0.000053353044],"domain_scores_gemma":[0.99910873,0.00055178907,0.00010476331,0.000020907808,0.00009322792,0.00012050343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004515583,0.00018243791,0.00075179944,0.00033890543,0.0005095002,0.00035786864,0.0002002222,0.0017377464,0.0024576646],"category_scores_gemma":[0.003399062,0.00009080188,0.00037257926,0.0004239945,0.0002660326,0.00048098856,0.00011223731,0.0010296773,0.0006391811],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020496363,0.0019253877,0.39068407,0.0021501693,0.00044079518,0.11948629,0.0010005579,0.00034552475,0.008540973,0.0015748687,0.08601354,0.3673415],"study_design_scores_gemma":[0.0056112166,0.015955063,0.62807876,0.0018674548,0.00085799507,0.24401781,0.0014897815,0.0019606263,0.002934493,0.0027021754,0.094414935,0.0001097077],"about_ca_topic_score_codex":0.0007957489,"about_ca_topic_score_gemma":0.00141276,"teacher_disagreement_score":0.0024576646,"about_ca_system_score_codex":0.00045043835,"about_ca_system_score_gemma":0.00024526234,"threshold_uncertainty_score":0.0082217455},"labels":[],"label_agreement":null},{"id":"W2022190206","doi":"10.1111/j.1365-2133.1971.tb02543.x","title":"THE MECHANISM OF FOLATE DEFICIENCY IN PSORIASIS","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Psoriasis; Mechanism (biology); Medicine; Dermatology","score_opus":0.004366720909134776,"score_gpt":0.22438271057946152,"score_spread":0.22001598967032673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022190206","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15688297,0.76148784,0.010050177,0.044623956,0.002420259,0.00016827177,0.00042932102,0.0004002563,0.023536902],"genre_scores_gemma":[0.7488766,0.23164716,0.0033297983,0.003759661,0.0020110807,0.00009426874,0.00012002615,0.00003007796,0.010131458],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996526,0.00010261065,0.000045676636,0.000047474543,0.00009664517,0.00005495821],"domain_scores_gemma":[0.999619,0.000128861,0.00008087266,0.000037120353,0.000068219975,0.00006587717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079644145,0.0004634084,0.0006943978,0.0020000632,0.00049161783,0.0012766666,0.0006515653,0.0025634677,0.002371145],"category_scores_gemma":[0.001085783,0.00034449453,0.00044809747,0.00047632353,0.0012958298,0.000986385,0.0008567293,0.0010644505,0.0006779352],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008749562,0.00096237793,0.04486047,0.005149639,0.00095722364,0.035115615,0.0009686295,0.004054335,0.27425975,0.13231364,0.06439087,0.42821786],"study_design_scores_gemma":[0.0033431093,0.0051224916,0.11191637,0.0026545348,0.0016833309,0.17945966,0.0017504675,0.009345384,0.14138387,0.19160216,0.35141164,0.0003269563],"about_ca_topic_score_codex":0.0016177009,"about_ca_topic_score_gemma":0.0007962332,"teacher_disagreement_score":0.0025634677,"about_ca_system_score_codex":0.0012036803,"about_ca_system_score_gemma":0.0006290987,"threshold_uncertainty_score":0.008733392},"labels":[],"label_agreement":null},{"id":"W2022856743","doi":"10.1111/j.1365-2133.2006.07559.x","title":"Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Mycosis fungoides; Chills; Gastroenterology; Internal medicine; Surgery; myalgia; Alpha interferon; Adjuvant; Interferon; Lymphoma; Immunology","score_opus":0.008973412956973311,"score_gpt":0.26742643371985303,"score_spread":0.25845302076287974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022856743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91943705,0.077679254,0.00030819917,0.0008283901,0.00018811793,0.000050213384,0.00010561199,0.000024758087,0.0013785288],"genre_scores_gemma":[0.98404056,0.01459475,0.00035170963,0.00027051373,0.0003132061,0.000037180936,0.00015844096,0.0000038447456,0.00022980916],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998379,0.0000747409,0.000020811307,0.000017090724,0.000018644374,0.00003076316],"domain_scores_gemma":[0.99936455,0.00030023235,0.0001867297,0.000018673354,0.000031851683,0.00009810981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072078203,0.00019020266,0.00072324194,0.00016539883,0.00009110492,0.00028248644,0.00021480332,0.00047259824,0.0009110521],"category_scores_gemma":[0.0017019405,0.000057300535,0.00046672058,0.00024567053,0.00017951941,0.00028854483,0.00011357003,0.00031825612,0.00014058784],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08460389,0.0019231155,0.19779728,0.0029187463,0.0018775878,0.0011954181,0.00019022562,0.0014699,0.010422709,0.00015228575,0.0023966506,0.6950522],"study_design_scores_gemma":[0.016629225,0.16359761,0.7744538,0.003043586,0.00668809,0.007897958,0.0004224156,0.0024614353,0.006656132,0.0006407662,0.017433882,0.00007503099],"about_ca_topic_score_codex":0.00032414956,"about_ca_topic_score_gemma":0.0009690671,"teacher_disagreement_score":0.0009110521,"about_ca_system_score_codex":0.00022331883,"about_ca_system_score_gemma":0.00028819704,"threshold_uncertainty_score":0.0038118958},"labels":[],"label_agreement":null},{"id":"W2023505077","doi":"10.1111/j.1365-2133.2005.06788.x","title":"The place of botulinum toxin type A in the treatment of focal hyperhidrosis","year":2005,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Hyperhidrosis; Medicine; Botulinum toxin; Dermatology; Treatment modality; Surgery","score_opus":0.019658630623304394,"score_gpt":0.2733458037497783,"score_spread":0.2536871731264739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023505077","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0139007475,0.049896825,0.0009749132,0.8785176,0.033690367,0.000042533567,0.00006231915,0.000059985377,0.022854641],"genre_scores_gemma":[0.21834686,0.047142807,0.0023637349,0.44529074,0.26021025,0.0000933854,0.000088137036,0.000057513054,0.026406577],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990872,0.00034836028,0.00013513703,0.00008295529,0.00021293091,0.00013330215],"domain_scores_gemma":[0.99764156,0.0014588587,0.00018818447,0.00006173489,0.0003553516,0.00029434322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096710154,0.00041925802,0.0007624479,0.000578235,0.00089744193,0.00088353903,0.00093824294,0.010005798,0.0023347847],"category_scores_gemma":[0.0064946725,0.00028891093,0.0005735387,0.0005585031,0.0012126461,0.0016357268,0.00035046818,0.0077812364,0.0017423558],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006557191,0.00019959394,0.00734226,0.0008185872,0.000087782275,0.24713446,0.00045618523,0.0006270101,0.0026881068,0.007470871,0.620079,0.112440564],"study_design_scores_gemma":[0.0003995568,0.000560662,0.007348277,0.0013260236,0.00009648016,0.43947986,0.0006210373,0.0019931484,0.0012830242,0.012462382,0.5343448,0.00008476483],"about_ca_topic_score_codex":0.0013822865,"about_ca_topic_score_gemma":0.0027491655,"teacher_disagreement_score":0.010005798,"about_ca_system_score_codex":0.0021027685,"about_ca_system_score_gemma":0.0008661849,"threshold_uncertainty_score":0.015256703},"labels":[],"label_agreement":null},{"id":"W2025490383","doi":"10.1111/j.1365-2133.2008.08927.x","title":"A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"LEO Pharma","keywords":"Calcipotriol; Betamethasone dipropionate; Scalp; Medicine; Dermatology; Randomized controlled trial; Psoriasis; Betamethasone; Double blind; Surgery; Internal medicine; Placebo","score_opus":0.04040179878295714,"score_gpt":0.2816668870223897,"score_spread":0.24126508823943255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025490383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811668,0.006626318,0.00093662913,0.00039068327,0.0010845428,0.00753445,0.0006723392,0.00014298425,0.001445283],"genre_scores_gemma":[0.9756203,0.0057577267,0.0033164283,0.0007565134,0.0012773672,0.009471252,0.0006824707,0.000031847485,0.003086045],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999081,0.00041137615,0.00009068125,0.0002074543,0.0001024298,0.00010703862],"domain_scores_gemma":[0.99871206,0.0005502484,0.0002687393,0.00009959041,0.000096201016,0.0002732185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023075358,0.0016019205,0.0042437282,0.0007026464,0.0005143937,0.00094810943,0.0011469235,0.002223041,0.006878795],"category_scores_gemma":[0.0020150573,0.0007590309,0.0017878303,0.0006056718,0.0015718521,0.0011408172,0.00043462758,0.0027297207,0.0008805181],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97626436,0.009774799,0.00016020544,0.0007991006,0.00037569212,0.000021837915,0.000028111204,0.0000983498,0.0031323389,0.00005492633,0.00018958341,0.009100733],"study_design_scores_gemma":[0.9070781,0.09146287,0.00041638367,0.000019584055,0.00022666798,0.000016021933,0.000009169684,0.00013372634,0.00040236948,0.000030742187,0.00019838382,0.000006091009],"about_ca_topic_score_codex":0.00069306925,"about_ca_topic_score_gemma":0.0009336612,"teacher_disagreement_score":0.006878795,"about_ca_system_score_codex":0.0004978238,"about_ca_system_score_gemma":0.0010967175,"threshold_uncertainty_score":0.023011863},"labels":[],"label_agreement":null},{"id":"W2026249831","doi":"10.1111/bjd.13339","title":"Onychomadesis: literature review","year":2014,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Library science; Medicine; Dermatology; Family medicine; Computer science","score_opus":0.019921906923406063,"score_gpt":0.3463844856553183,"score_spread":0.32646257873191226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026249831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025777178,0.99907863,0.000032362685,0.000106759035,0.00006974792,0.000015566024,0.00005959685,0.000004514665,0.00037502244],"genre_scores_gemma":[0.0014951571,0.99796295,0.00012836074,0.0001312647,0.00008760299,0.000017678973,0.000060949693,0.0000011330465,0.000114800634],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915004,0.00011649316,0.0003893819,0.00011424456,0.00018568923,0.000044112585],"domain_scores_gemma":[0.9969511,0.0016863948,0.0008095818,0.00005078658,0.0004142221,0.00008792021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008499844,0.001122369,0.002311985,0.011211654,0.0005781383,0.001378828,0.0013310474,0.0010981958,0.0072816806],"category_scores_gemma":[0.0035391238,0.0004670606,0.0012454115,0.013144218,0.00054902316,0.001977587,0.00086850463,0.00070022146,0.0010857007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013888539,0.00006600199,0.0011018002,0.5999192,0.0006362073,0.0016137913,0.00035944444,0.00019336799,0.00067858776,0.00089142297,0.020492397,0.37390894],"study_design_scores_gemma":[0.00008208195,0.00027988688,0.009338133,0.505204,0.0068965233,0.017451433,0.0008924147,0.00013078685,0.0007847219,0.001460168,0.45740008,0.00007968769],"about_ca_topic_score_codex":0.0029598526,"about_ca_topic_score_gemma":0.0053449846,"teacher_disagreement_score":0.011211654,"about_ca_system_score_codex":0.001096739,"about_ca_system_score_gemma":0.0041599795,"threshold_uncertainty_score":0.024359703},"labels":[],"label_agreement":null},{"id":"W2028158273","doi":"10.1046/j.1365-2133.2001.04232.x","title":"Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice","year":2001,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hôpital Notre-Dame; Université de Montréal","funders":"Canadian Dermatology Foundation; Dermatology Foundation","keywords":"Hairless; Photodynamic therapy; Skin cancer; Medicine; Skin tumours; In vivo; Intraperitoneal injection; Fluorescence; Pathology; Dermatology; Cancer; Chemistry; Internal medicine; Biology; Biochemistry","score_opus":0.014004208071746476,"score_gpt":0.28150466226595894,"score_spread":0.2675004541942125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028158273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898573,0.0040506017,0.0032972293,0.00010183239,0.000039170427,0.000065516535,0.00027110177,0.00018539673,0.0021318845],"genre_scores_gemma":[0.98743963,0.0026061914,0.0033978552,0.000063206004,0.000018395645,0.000102521095,0.00037624317,0.000048317877,0.0059475955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998807,0.000019199111,0.000007958262,0.000034627057,0.000025914936,0.00003163947],"domain_scores_gemma":[0.9998747,0.000019950021,0.000046375855,0.000015306165,0.000012539961,0.000031144627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021194942,0.00043097982,0.000320345,0.00027316168,0.0001211464,0.00020384288,0.0002321335,0.0003515366,0.0014897735],"category_scores_gemma":[0.00008640114,0.00015224468,0.0002203562,0.0001242679,0.00024902564,0.00023525019,0.00011982437,0.0005870073,0.00036109038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041167112,0.000113554284,0.00012341127,0.00004433786,0.0000050664958,0.000017099459,0.000009982323,0.00007431103,0.99725395,0.000042968153,0.000043213284,0.0018602844],"study_design_scores_gemma":[0.00006978156,0.0029993195,0.002208912,0.000010737611,0.000023275466,0.00014988203,0.000011367542,0.0003513579,0.99239796,0.000025830239,0.0017482266,0.0000033127026],"about_ca_topic_score_codex":0.00035694073,"about_ca_topic_score_gemma":0.0005389875,"teacher_disagreement_score":0.0014897735,"about_ca_system_score_codex":0.0002239015,"about_ca_system_score_gemma":0.00018792675,"threshold_uncertainty_score":0.0049838424},"labels":[],"label_agreement":null},{"id":"W2028648418","doi":"10.1111/bjd.13551","title":"Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Plaque psoriasis; Tofacitinib; Medicine; Randomized controlled trial; Dermatology; Psoriasis; Surgery; Internal medicine","score_opus":0.006669906811866754,"score_gpt":0.22138959867279262,"score_spread":0.21471969186092588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028648418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93027884,0.045284785,0.0010507208,0.002526837,0.0023370069,0.011072542,0.0027278636,0.00025942313,0.0044618365],"genre_scores_gemma":[0.9617968,0.015438077,0.001648047,0.0024841968,0.0015614919,0.011440467,0.0015637703,0.000027374315,0.0040397574],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99894565,0.00056158943,0.000094659554,0.00018320017,0.00009497559,0.00011989632],"domain_scores_gemma":[0.99860555,0.0004631286,0.00039806744,0.00008283515,0.00010407746,0.00034644018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026454686,0.001231431,0.0037366552,0.0004837665,0.0005573489,0.0013811607,0.00095783774,0.0022608074,0.009717066],"category_scores_gemma":[0.0028525735,0.00057029317,0.0032400184,0.0006853529,0.0010307605,0.0009815262,0.000398758,0.0026078247,0.00079043367],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98365533,0.0023464286,0.00039788996,0.0016061198,0.0017529647,0.00004003641,0.000021604512,0.000085435364,0.00065082574,0.00006738902,0.00077244727,0.008603484],"study_design_scores_gemma":[0.9859616,0.011749801,0.00093814905,0.000090360576,0.0006369267,0.000026265427,0.000011047041,0.00010177773,0.00004930463,0.00006821126,0.00035925137,0.000007395571],"about_ca_topic_score_codex":0.0011841074,"about_ca_topic_score_gemma":0.0025708743,"teacher_disagreement_score":0.009717066,"about_ca_system_score_codex":0.0008185137,"about_ca_system_score_gemma":0.0014666015,"threshold_uncertainty_score":0.032506883},"labels":[],"label_agreement":null},{"id":"W2031487819","doi":"10.1111/j.1365-2133.2006.07377.x","title":"Interferon-<i>γ</i>-deficient mice are resistant to the development of alopecia areata","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Alopecia areata; CD8; Hair follicle; Cytokine; Interferon gamma; T cell; Immunology; Immune system; Biology; Interferon; Major histocompatibility complex; Molecular biology; Endocrinology","score_opus":0.009967412245066391,"score_gpt":0.23447625199526398,"score_spread":0.2245088397501976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031487819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879376,0.0030348555,0.0031494019,0.000209801,0.00012824718,0.0000871929,0.0020341233,0.0006532331,0.0027656176],"genre_scores_gemma":[0.97997403,0.0017456124,0.0033840467,0.0003145276,0.00007380143,0.00021321514,0.0024659282,0.0003689505,0.011459837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995554,0.00005103067,0.00006146405,0.00012343012,0.0000908774,0.00011774438],"domain_scores_gemma":[0.99887305,0.00008364907,0.00061860663,0.00008939948,0.000055438977,0.00027983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027859668,0.0014045634,0.0006175452,0.0012634444,0.00029579547,0.0006593528,0.00044965718,0.0012399311,0.0036295573],"category_scores_gemma":[0.00023863134,0.0003971633,0.0005269324,0.0002893288,0.0006183273,0.00043446897,0.00028123765,0.0015994803,0.0018088269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047148345,0.00008285425,0.00049006403,0.000054198958,0.000018056578,0.00019901725,0.000021439324,0.000058317823,0.997174,0.00008537759,0.00009686126,0.0012482487],"study_design_scores_gemma":[0.0004284973,0.002550934,0.027851008,0.00015616285,0.00019080374,0.0057575805,0.00021231524,0.0014355225,0.95250386,0.00035850037,0.008503182,0.00005163769],"about_ca_topic_score_codex":0.00031099483,"about_ca_topic_score_gemma":0.00037523304,"teacher_disagreement_score":0.0036295573,"about_ca_system_score_codex":0.00041384384,"about_ca_system_score_gemma":0.00017671195,"threshold_uncertainty_score":0.012142122},"labels":[],"label_agreement":null},{"id":"W2032719042","doi":"10.1111/j.1365-2133.2008.08936.x","title":"Isotretinoin therapy and the incidence of acne relapse: a nested case-control study: reply from authors","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Royal Victoria Hospital","funders":"","keywords":"Medicine; Isotretinoin; Pharmacy; Incidence (geometry); Acne; Dermatology; Family medicine; Library science; Computer science; Mathematics","score_opus":0.014780756564892427,"score_gpt":0.25925935191002686,"score_spread":0.24447859534513444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032719042","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031975433,0.033364486,0.0017500765,0.8762425,0.054415897,0.0001028418,0.0009407865,0.00009318775,0.0011147456],"genre_scores_gemma":[0.22693382,0.013594282,0.003151678,0.6057418,0.14654368,0.00040219355,0.00049651164,0.00008259538,0.0030534384],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9939761,0.0026212628,0.0014791911,0.00075747585,0.00092042884,0.00024539843],"domain_scores_gemma":[0.89328307,0.07550076,0.0070489063,0.005780359,0.01648907,0.001897751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015938258,0.0005303101,0.0014778663,0.00094963954,0.00074276223,0.00130262,0.0021539796,0.0070498623,0.002221585],"category_scores_gemma":[0.09420091,0.0005201411,0.0013445364,0.0012682719,0.0013566039,0.0026356094,0.00081768853,0.0061015454,0.00085319363],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017629565,0.00022850138,0.16150568,0.002078841,0.001500281,0.013609724,0.0030678804,0.00047520563,0.0010242241,0.0029593974,0.7552415,0.056545723],"study_design_scores_gemma":[0.0020013128,0.0016185206,0.28700995,0.0071385717,0.0048551913,0.07089767,0.00765704,0.008806389,0.0034649828,0.031724617,0.5736628,0.0011629396],"about_ca_topic_score_codex":0.0044981237,"about_ca_topic_score_gemma":0.0029161258,"teacher_disagreement_score":0.015938258,"about_ca_system_score_codex":0.00081028306,"about_ca_system_score_gemma":0.0010968858,"threshold_uncertainty_score":0.084290564},"labels":[],"label_agreement":null},{"id":"W2033941563","doi":"10.1111/j.1365-2133.2007.08180.x","title":"A case of do-it-yourself Mohs’ surgery using bloodroot obtained from the internet","year":2007,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Boulevard; Queen (butterfly); The Internet; Medical library; Library science; Medicine; Computer science; History; World Wide Web","score_opus":0.037210172860954994,"score_gpt":0.29407819728294327,"score_spread":0.25686802442198825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033941563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6520448,0.0075425324,0.004477819,0.15654163,0.00919697,0.00044028403,0.00044818752,0.00054728537,0.1687606],"genre_scores_gemma":[0.9522691,0.0017283411,0.0020424076,0.021422332,0.0070473687,0.0000673328,0.00011134086,0.000102721184,0.015209031],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9976197,0.00048429592,0.00021303807,0.00035989232,0.0004297949,0.000893373],"domain_scores_gemma":[0.9947784,0.0025270947,0.0007072025,0.00042283232,0.000326639,0.0012377913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082926993,0.0022919104,0.0014704576,0.0030495292,0.0077596772,0.0034872035,0.0020570827,0.017008184,0.009513836],"category_scores_gemma":[0.011074479,0.0016502237,0.0029790294,0.0029316188,0.0029935176,0.0042690733,0.002737818,0.012760622,0.0020896748],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029088056,0.000061465646,0.0007526804,0.000023038565,0.000007664343,0.99665534,0.00023625532,0.000038995793,0.00012825345,0.00035182913,0.001152093,0.0005632848],"study_design_scores_gemma":[0.000034888104,0.00006934214,0.001370762,0.000032267082,0.000012543403,0.9950003,0.0005954256,0.000497081,0.00014066827,0.00048846035,0.0017446541,0.000013569638],"about_ca_topic_score_codex":0.0074335462,"about_ca_topic_score_gemma":0.009507319,"teacher_disagreement_score":0.017008184,"about_ca_system_score_codex":0.0047100866,"about_ca_system_score_gemma":0.0016410735,"threshold_uncertainty_score":0.034174263},"labels":[],"label_agreement":null},{"id":"W2037934880","doi":"10.1111/j.1365-2133.2005.06691.x","title":"In vitro evaluation of concurrent use of commercially available insect repellent and sunscreen preparations.","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Insect Pest Control Strategies","field":"Agricultural and Biological Sciences","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"DEET; Lotion; Permeation; Insect repellent; Penetration (warfare); Chemistry; Sun protection factor; Chromatography; Dermatology; Toxicology; Medicine; Organic chemistry; Biology","score_opus":0.06515268946176041,"score_gpt":0.26800500340502403,"score_spread":0.20285231394326364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037934880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870797,0.007567465,0.0025105595,0.000063089516,0.00007603287,0.00014461883,0.0004548143,0.000036465666,0.0020672383],"genre_scores_gemma":[0.9871737,0.004540972,0.005307464,0.00005923162,0.00003966268,0.00009830923,0.0010518408,0.000027922313,0.0017009242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937963,0.00021334311,0.00005114505,0.00013232658,0.000151123,0.0000725316],"domain_scores_gemma":[0.99924576,0.00035790622,0.00014824109,0.00006380331,0.00014125554,0.00004314358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005213333,0.00055222306,0.00041335868,0.00016727798,0.0001626559,0.00030941144,0.00029997018,0.00038080532,0.0015371485],"category_scores_gemma":[0.00052229426,0.00022883523,0.0005134967,0.0002871211,0.00018938794,0.00030944357,0.00018911384,0.00037611995,0.0003737557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096732524,0.00022768258,0.0004720269,0.00032101807,0.000035737794,0.00007094848,0.0000416724,0.00020768886,0.99421555,0.000023162838,0.00006639794,0.0033506341],"study_design_scores_gemma":[0.000052169322,0.008832481,0.004699851,0.000023034509,0.00011248183,0.0003288855,0.000042701027,0.0006880409,0.9836512,0.000011483327,0.0015495885,0.0000080372],"about_ca_topic_score_codex":0.0012616003,"about_ca_topic_score_gemma":0.0017221476,"teacher_disagreement_score":0.0015371485,"about_ca_system_score_codex":0.00030060203,"about_ca_system_score_gemma":0.00028215107,"threshold_uncertainty_score":0.0051422715},"labels":[],"label_agreement":null},{"id":"W2039443641","doi":"10.1111/bjd.12972","title":"Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Venereology; Medicine; Dermatology; Rituximab; Family medicine; Internal medicine; Lymphoma","score_opus":0.021031178401243446,"score_gpt":0.30521073622981026,"score_spread":0.2841795578285668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039443641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297404,0.0016502119,0.0007065768,0.00013960054,0.00028872298,0.0033667965,0.0002727923,0.000032684056,0.0005685591],"genre_scores_gemma":[0.98977506,0.0008269685,0.002454137,0.000405673,0.0007349986,0.00489529,0.0003793513,0.000011610877,0.00051685807],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99297637,0.0047399853,0.0005934635,0.00079737406,0.0005552311,0.00033749212],"domain_scores_gemma":[0.9901423,0.003540125,0.0026407856,0.0014336809,0.00091204635,0.0013311391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009388726,0.0020125275,0.0049722353,0.0006403667,0.0007676409,0.0015459122,0.0013351325,0.0028601398,0.003600692],"category_scores_gemma":[0.008553206,0.0010959171,0.002058202,0.00061357213,0.0027213828,0.001655717,0.0007216467,0.0022561583,0.00073539687],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9782823,0.013647977,0.001033917,0.00023635954,0.0004921052,0.000018357532,0.000045047236,0.00010975859,0.0017921707,0.000027781529,0.000090991416,0.0042231833],"study_design_scores_gemma":[0.7900762,0.20582153,0.0025155435,0.000024381201,0.0005304171,0.000027467608,0.000023010292,0.000235056,0.00044494003,0.000057042227,0.00022329294,0.000021098984],"about_ca_topic_score_codex":0.0004649748,"about_ca_topic_score_gemma":0.00067359227,"teacher_disagreement_score":0.009388726,"about_ca_system_score_codex":0.0012386929,"about_ca_system_score_gemma":0.0015125423,"threshold_uncertainty_score":0.049652934},"labels":[],"label_agreement":null},{"id":"W2039479173","doi":"10.1111/j.1365-2133.1989.tb07782.x","title":"Epithelioid cell histiocytoma: a new entity","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Epithelioid cell; Lesion; Pathology; Nodule (geology); Immunohistochemistry; Medicine; CD34; Factor XIIIa; Fibrocyte; Biology; Stem cell","score_opus":0.010809810883076877,"score_gpt":0.26034062528872665,"score_spread":0.24953081440564978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039479173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9424936,0.038156483,0.006008138,0.0012540396,0.0010630551,0.00012512806,0.00025009114,0.0002506618,0.010398705],"genre_scores_gemma":[0.9867128,0.0068335272,0.0021947357,0.0005107024,0.001934005,0.00005829077,0.00020141687,0.000028676825,0.0015257915],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9991013,0.00007651495,0.00016389844,0.00023028588,0.00018092038,0.00024712333],"domain_scores_gemma":[0.9975973,0.0006789057,0.0005477666,0.00040064377,0.00025212902,0.00052325864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047022876,0.0009597455,0.0008789662,0.002248061,0.0015297009,0.0015527605,0.0010453281,0.002018598,0.003770173],"category_scores_gemma":[0.0029204865,0.00058373425,0.00049569353,0.0020978274,0.0020858163,0.0021455165,0.0015887227,0.0015903565,0.0017473607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042392054,0.00021730621,0.15220673,0.0003344918,0.000098921046,0.7784719,0.0014589749,0.00034491954,0.009357465,0.0020706237,0.002917673,0.052097168],"study_design_scores_gemma":[0.000038377068,0.0000725523,0.012066706,0.000040334322,0.000038256443,0.979594,0.00018933933,0.00024242103,0.00044754308,0.00040530227,0.0068469713,0.000018174731],"about_ca_topic_score_codex":0.00064400653,"about_ca_topic_score_gemma":0.0009967991,"teacher_disagreement_score":0.003770173,"about_ca_system_score_codex":0.00045165216,"about_ca_system_score_gemma":0.0004951283,"threshold_uncertainty_score":0.012612462},"labels":[],"label_agreement":null},{"id":"W2041128924","doi":"10.1111/j.1365-2133.2007.08249.x","title":"Evidence that dysregulated DNA mismatch repair characterizes human nonmelanoma skin cancer","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Calgary Laboratory Services; University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; University of Calgary","keywords":"MSH2; DNA mismatch repair; MSH6; Carcinogenesis; DNA repair; Skin cancer; Biology; Microsatellite instability; Basal cell carcinoma; MLH1; DNA damage; Cancer research; Nucleotide excision repair; PMS2; Genetics; Cancer; Pathology; DNA; Medicine; Basal cell; Microsatellite; Gene","score_opus":0.0370050769851945,"score_gpt":0.3116001870892478,"score_spread":0.2745951101040533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041128924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918121,0.005376021,0.00051154377,0.00007624834,0.00001184164,0.000012955302,0.00042797576,0.00003320982,0.0017381718],"genre_scores_gemma":[0.9978332,0.0010421642,0.0003496177,0.00004156359,0.00001728761,0.000008316897,0.0004258383,0.0000046357604,0.00027744877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978274,0.000030267227,0.000027543123,0.00006537553,0.00006994053,0.000024174671],"domain_scores_gemma":[0.99939513,0.00016187657,0.00022207462,0.00005488294,0.00010220523,0.00006383708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024276762,0.00014619593,0.00018078402,0.0014566587,0.00019274304,0.00035091714,0.00020168589,0.0003142839,0.0023246685],"category_scores_gemma":[0.00057797215,0.000111301975,0.00011743802,0.000952684,0.00026010931,0.00018373832,0.00020027663,0.00018287855,0.00038184426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006089362,0.00006013671,0.767787,0.0004102401,0.00013055326,0.0021737078,0.00021297514,0.00007669957,0.21083753,0.00012636567,0.00047712223,0.017098788],"study_design_scores_gemma":[0.000005324283,0.00011647245,0.97315097,0.000012758924,0.00005777771,0.010761479,0.00014323692,0.00010284256,0.013511145,0.000064530665,0.0020700556,0.0000033167573],"about_ca_topic_score_codex":0.0005760586,"about_ca_topic_score_gemma":0.0011382359,"teacher_disagreement_score":0.0023246685,"about_ca_system_score_codex":0.00014093281,"about_ca_system_score_gemma":0.00011802337,"threshold_uncertainty_score":0.007776797},"labels":[],"label_agreement":null},{"id":"W2045034709","doi":"10.1111/bjd.13379","title":"Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Propranolol; Medicine; Adverse effect; Psychomotor learning; Pediatrics; Intensive care medicine; Mood; Cognition; Anesthesia; Internal medicine; Psychiatry","score_opus":0.003564067646307629,"score_gpt":0.19110914229658488,"score_spread":0.18754507465027725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045034709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00814687,0.9842031,0.00031399273,0.0040325155,0.00017534758,0.000010212033,0.000042875028,0.000008264894,0.0030667349],"genre_scores_gemma":[0.14630078,0.8466114,0.0017787372,0.0025014207,0.0011465332,0.00004043737,0.00010477808,0.0000076180036,0.0015083161],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995627,0.00022466082,0.000068570436,0.000032595144,0.00008671918,0.000024846078],"domain_scores_gemma":[0.99697363,0.0023130784,0.0004274034,0.000023637798,0.0001917859,0.00007043805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007755525,0.00021077512,0.00060003065,0.00045129386,0.0001379291,0.00056770165,0.00024364807,0.00061896467,0.0029212032],"category_scores_gemma":[0.0048041707,0.000090980946,0.00044974845,0.0005254959,0.00029489104,0.0005718768,0.00024243756,0.0007972437,0.00031068097],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010408583,0.00012691754,0.022510516,0.014779667,0.000355982,0.01292905,0.0004908484,0.00039369243,0.0022047004,0.00294192,0.010177043,0.9320488],"study_design_scores_gemma":[0.0008189568,0.0026217687,0.18275087,0.045308877,0.0029176683,0.15563494,0.002599241,0.0010306687,0.0038264235,0.011150597,0.59119684,0.00014314214],"about_ca_topic_score_codex":0.0009617405,"about_ca_topic_score_gemma":0.001868325,"teacher_disagreement_score":0.0029212032,"about_ca_system_score_codex":0.0002874783,"about_ca_system_score_gemma":0.0007365826,"threshold_uncertainty_score":0.00977236},"labels":[],"label_agreement":null},{"id":"W2047011925","doi":"10.1111/bjd.13235","title":"Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12–17 years of age","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Astellas Pharma; LEO Pharma; Galderma; Dermira; Celgene; Amgen; Pfizer; Kyowa Hakko Kirin; Eli Lilly and Company","keywords":"Medicine; Dermatology; Calcipotriol; Scalp; Psoriasis","score_opus":0.013583323941817375,"score_gpt":0.24151719145665604,"score_spread":0.22793386751483866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047011925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435705,0.0048420206,0.00013324987,0.00007034778,0.000017921799,0.00014579053,0.000059166046,0.0000104424125,0.0003640369],"genre_scores_gemma":[0.99672395,0.0021226495,0.00049114926,0.00009518009,0.00006091967,0.0001779674,0.00011369131,0.000003854492,0.00021062764],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99959546,0.00019747982,0.000034997756,0.000040872335,0.000093106966,0.00003805269],"domain_scores_gemma":[0.9993142,0.00025122653,0.00021827481,0.000019983781,0.00005051364,0.00014581243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096786895,0.00032344882,0.0010673734,0.00022234618,0.00016617707,0.00029867233,0.0002663001,0.00050734484,0.00087357033],"category_scores_gemma":[0.0009097752,0.00016534931,0.0005159429,0.00016598466,0.00025289753,0.00021785162,0.00014448067,0.000894282,0.00015053927],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33546636,0.019167034,0.049433492,0.004251164,0.0015959236,0.0014715852,0.00069254905,0.0016285384,0.10459065,0.00015311627,0.0012295209,0.48031998],"study_design_scores_gemma":[0.16272436,0.67422765,0.13784535,0.00040431245,0.0014534476,0.003309811,0.00025735717,0.0016664431,0.014026353,0.00011284469,0.0039434982,0.00002859052],"about_ca_topic_score_codex":0.00026780766,"about_ca_topic_score_gemma":0.00047042177,"teacher_disagreement_score":0.0010673734,"about_ca_system_score_codex":0.000192512,"about_ca_system_score_gemma":0.00036564612,"threshold_uncertainty_score":0.005118668},"labels":[],"label_agreement":null},{"id":"W2047454818","doi":"10.1111/bjd.12385","title":"An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Windsor Clinical Research","funders":"","keywords":"Rosacea; Medicine; Dermatology; Epidemiology; Cross-sectional study; Itching; Demographics; Internal medicine; Pathology; Demography","score_opus":0.11508349845175621,"score_gpt":0.4295678299170698,"score_spread":0.3144843314653136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047454818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99937564,0.00013447297,0.000043423664,0.000014377445,0.0000023803113,0.000011711085,0.00027414935,0.0000018468603,0.00014204232],"genre_scores_gemma":[0.9995227,0.0000626085,0.000052158077,0.000020904707,0.0000042203037,0.000008935066,0.00027772007,7.1446203e-7,0.000049984967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914074,0.0002940143,0.00009167527,0.00019761467,0.00015757201,0.00011830873],"domain_scores_gemma":[0.9980405,0.00026327628,0.0010088803,0.00014621844,0.0002017724,0.0003393489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011354111,0.00020474904,0.0003693938,0.0006477615,0.0003225832,0.0004640042,0.00038609633,0.0004498222,0.0014414006],"category_scores_gemma":[0.0020861567,0.0003135758,0.0002941893,0.00089997024,0.00027538542,0.000509936,0.0004675007,0.00043393398,0.0003201969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038004273,0.000018782071,0.9995697,0.0000045300203,0.0000158321,0.000015285394,0.00004096212,0.0000047329095,0.000049591406,0.00000227747,0.000022590217,0.00021757052],"study_design_scores_gemma":[0.0000027936455,0.000055667504,0.99969876,0.0000029034886,0.0000069816397,0.00006991931,0.00009455654,0.00002500226,0.0000063871,0.0000033056833,0.00003274303,9.328315e-7],"about_ca_topic_score_codex":0.0077645388,"about_ca_topic_score_gemma":0.007264349,"teacher_disagreement_score":0.0077645388,"about_ca_system_score_codex":0.00029210185,"about_ca_system_score_gemma":0.00029597178,"threshold_uncertainty_score":0.0154387355},"labels":[],"label_agreement":null},{"id":"W2049388747","doi":"10.1046/j.1365-2133.2002.04800.x","title":"Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders: experimental studies in a murine model","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Psoriasis; Systemic administration; Penetration (warfare); Immune system; Tacrolimus; Liposome; Pharmacology; Immunology; Chemistry; Surgery; Transplantation; In vivo; Biology","score_opus":0.1599082507375588,"score_gpt":0.44483770198040484,"score_spread":0.2849294512428461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049388747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773162,0.01073981,0.008261745,0.00037410547,0.00015638213,0.00046119574,0.00036599228,0.00023344862,0.00209108],"genre_scores_gemma":[0.9783482,0.008394088,0.009482876,0.00013637154,0.00009170329,0.00039749942,0.0006121554,0.000044149103,0.0024930998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974245,0.00007291754,0.000019220457,0.000046896494,0.00007102315,0.000047536894],"domain_scores_gemma":[0.9998055,0.000034479664,0.000055791603,0.00002581595,0.000020862895,0.000057611276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005188756,0.0006739789,0.0005517569,0.00051345804,0.00025271432,0.00042634585,0.0004427069,0.0006539336,0.0011487637],"category_scores_gemma":[0.00015008851,0.00016765993,0.00040441073,0.000250934,0.0005046663,0.0006395714,0.00018501976,0.0009216004,0.00039946323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000479809,0.0007224043,0.0000770325,0.00015622089,0.000012959984,0.00008628622,0.00001769009,0.00014551228,0.9934876,0.00012357041,0.000087918095,0.0046030423],"study_design_scores_gemma":[0.00029729123,0.014839995,0.0014847567,0.000024298832,0.00011871134,0.0005490183,0.000015752688,0.0009463122,0.9783191,0.000042814365,0.0033517396,0.0000101888445],"about_ca_topic_score_codex":0.00038854696,"about_ca_topic_score_gemma":0.000533631,"teacher_disagreement_score":0.0011487637,"about_ca_system_score_codex":0.00034557396,"about_ca_system_score_gemma":0.000286669,"threshold_uncertainty_score":0.0038430095},"labels":[],"label_agreement":null},{"id":"W2049798709","doi":"10.1111/j.0366-077x.2004.05950.x","title":"The use of ciclosporin in psoriasis: a clinical review","year":2004,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ciclosporin; Psoriasis; Skin cancer; Dermatology; Adverse effect; Quality of life (healthcare); Population; Disease; Malignancy; Clinical trial; PUVA therapy; Intensive care medicine; Internal medicine; Cancer; Transplantation","score_opus":0.09772538025185368,"score_gpt":0.35004147090312127,"score_spread":0.2523160906512676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049798709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006872262,0.99934596,0.000038090497,0.00009899738,0.00010702026,0.0000043278105,0.000010252395,0.000003860609,0.0003229058],"genre_scores_gemma":[0.0003692937,0.9992465,0.00008801716,0.00007996036,0.000073109906,0.0000042124398,0.000014157777,9.1442473e-7,0.00012386464],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996817,0.000057253463,0.000071571536,0.000057483245,0.000111235524,0.000020788162],"domain_scores_gemma":[0.99928844,0.00038609342,0.00012323922,0.000018406849,0.00013695212,0.000046747118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006568891,0.00096967025,0.0016051381,0.0036403134,0.0003869977,0.0010947145,0.0010735876,0.0010448452,0.003398858],"category_scores_gemma":[0.0012880076,0.00032837412,0.0007180561,0.004556901,0.00048154045,0.0013745085,0.0007144671,0.0014049809,0.0013699966],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080968704,0.000071987524,0.00018993048,0.05768465,0.000116740914,0.00022152856,0.00010890638,0.00030937672,0.00066515803,0.0012068542,0.029351708,0.90999216],"study_design_scores_gemma":[0.000029052315,0.00014739188,0.0017597156,0.029774448,0.00041027006,0.002976921,0.00015807502,0.00010365844,0.0002841969,0.001697221,0.9626291,0.000029870176],"about_ca_topic_score_codex":0.0016198184,"about_ca_topic_score_gemma":0.0025670303,"teacher_disagreement_score":0.0036403134,"about_ca_system_score_codex":0.0006049045,"about_ca_system_score_gemma":0.0013209758,"threshold_uncertainty_score":0.011370361},"labels":[],"label_agreement":null},{"id":"W2050002232","doi":"10.1111/j.1365-2133.2007.08110.x","title":"Fast and sensitive detection of Trichophyton rubrum DNA from the nail samples of patients with onychomycosis by a double-round polymerase chain reaction-based assay","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Trichophyton rubrum; Microbiology; Polymerase chain reaction; Biology; Nail (fastener); Molecular biology; DNA extraction; Agarose; DNA; Gene; Antifungal; Biochemistry","score_opus":0.0059319939154741505,"score_gpt":0.2181120213315096,"score_spread":0.21218002741603545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050002232","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942492,0.000618708,0.0040726885,0.00004327708,0.000019299578,0.0000953963,0.00028624584,0.000054840766,0.0005602701],"genre_scores_gemma":[0.9890682,0.00029862823,0.009615672,0.00006483275,0.000013683304,0.00008034903,0.0004385442,0.00000829886,0.00041182016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989108,0.00023062521,0.00013739933,0.00031463834,0.00032370814,0.00008283233],"domain_scores_gemma":[0.99918705,0.00029626873,0.00018953298,0.0000541869,0.0002066619,0.0000663098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043635414,0.00053095596,0.00041362902,0.00086091214,0.00016581318,0.0004786471,0.00029260412,0.0005458965,0.0009135641],"category_scores_gemma":[0.0017427712,0.00031864658,0.00017597983,0.00038010604,0.0002754684,0.00026530694,0.00024525044,0.00033996068,0.00041799562],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007583622,0.0002371806,0.34657988,0.00027765025,0.00006208552,0.0012422351,0.0006571689,0.00014735054,0.61726815,0.000032070908,0.00022062613,0.032517266],"study_design_scores_gemma":[0.0001267672,0.003770723,0.76109064,0.00011313296,0.00016701737,0.022973433,0.0012892575,0.0031230028,0.20485224,0.000075684606,0.002374424,0.000043685828],"about_ca_topic_score_codex":0.00048131836,"about_ca_topic_score_gemma":0.0006657179,"teacher_disagreement_score":0.0009135641,"about_ca_system_score_codex":0.00012690888,"about_ca_system_score_gemma":0.0001331827,"threshold_uncertainty_score":0.0030561686},"labels":[],"label_agreement":null},{"id":"W2050106566","doi":"10.1111/j.1365-2133.2008.08680.x","title":"A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"U.S. Food and Drug Administration","keywords":"Psoriasis; Medicine; Index (typography); Library science; Family medicine; Dermatology; Computer science","score_opus":0.043202111919481895,"score_gpt":0.28073312112201226,"score_spread":0.23753100920253037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050106566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906164,0.0006263052,0.0062302095,0.00005239442,0.00011946958,0.0007386899,0.00019523205,0.000027340406,0.0013939731],"genre_scores_gemma":[0.9918229,0.00021385057,0.006382313,0.00004619192,0.000053491654,0.0009165563,0.00025047772,0.000022344875,0.00029194442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.94693923,0.033870228,0.005388955,0.004372057,0.00875904,0.00067051663],"domain_scores_gemma":[0.8402835,0.09479722,0.017133856,0.008745809,0.037235837,0.0018038448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.061878808,0.00059914513,0.0010423791,0.0013576095,0.0010271632,0.0012523673,0.00082699495,0.00057697156,0.0006565633],"category_scores_gemma":[0.09879101,0.00054734934,0.0011149585,0.0010090105,0.0013634872,0.0013487784,0.0014257847,0.0007837143,0.0003074454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051826527,0.0008872039,0.8990616,0.0010131723,0.0016135672,0.00020184176,0.02786499,0.0007284725,0.006784434,0.00039170028,0.0011222347,0.05514804],"study_design_scores_gemma":[0.00065940025,0.0078056725,0.9670698,0.00027968572,0.0008543402,0.0009517847,0.008144312,0.0070733777,0.0034598669,0.00037993604,0.0031205483,0.00020131332],"about_ca_topic_score_codex":0.0019836994,"about_ca_topic_score_gemma":0.0028271729,"teacher_disagreement_score":0.061878808,"about_ca_system_score_codex":0.0010351046,"about_ca_system_score_gemma":0.0013612598,"threshold_uncertainty_score":0.32725036},"labels":[],"label_agreement":null},{"id":"W2050243251","doi":"10.1111/j.1365-2133.2005.06674.x","title":"Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Pimecrolimus; Medicine; Tolerability; Atopic dermatitis; Eczema Area and Severity Index; Randomized controlled trial; Placebo; Dermatology Life Quality Index; Calcineurin; Dermatology; Adverse effect; SCORAD; Internal medicine; Psoriasis; Transplantation","score_opus":0.015374750972260636,"score_gpt":0.2785592612875164,"score_spread":0.26318451031525575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050243251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744641,0.01262659,0.00085836084,0.0008628383,0.0009375534,0.0068463543,0.0011421884,0.00014382509,0.002118133],"genre_scores_gemma":[0.979544,0.0051386473,0.0017222052,0.0012523091,0.0007802729,0.008687912,0.0009422031,0.000023177465,0.0019093767],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980463,0.0011139484,0.00019424927,0.00027408643,0.0001824871,0.00018891421],"domain_scores_gemma":[0.99792117,0.0007861351,0.0004721257,0.0001721302,0.00013037617,0.00051801116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029781926,0.0013851804,0.004510818,0.00051139924,0.00060474075,0.0013941022,0.0013423682,0.0024963776,0.0064253104],"category_scores_gemma":[0.0030818705,0.00068837806,0.0027402614,0.0006651268,0.0013629502,0.0009691696,0.00045822532,0.0026067311,0.00077322795],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9877852,0.00355929,0.0002499576,0.00062668807,0.000725284,0.000019290552,0.000019143754,0.00008662823,0.00091584167,0.000039945724,0.00020733365,0.0057653547],"study_design_scores_gemma":[0.9729234,0.025401479,0.0008524564,0.000025513813,0.00036115592,0.0000135616865,0.0000074574946,0.00011621257,0.00010685165,0.000036940044,0.00014813534,0.000006832576],"about_ca_topic_score_codex":0.0009295337,"about_ca_topic_score_gemma":0.0016528072,"teacher_disagreement_score":0.0064253104,"about_ca_system_score_codex":0.0008386301,"about_ca_system_score_gemma":0.0014044798,"threshold_uncertainty_score":0.021494865},"labels":[],"label_agreement":null},{"id":"W2051641690","doi":"10.1111/j.1365-2133.2007.08025.x","title":"Inhibition of tumour necrosis factor-? secretion from EpiDerm<sup>TM</sup>tissues by a novel small molecule, UTL-5d","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"","keywords":"Psoriasis; Lotion; Tumor necrosis factor alpha; Epidermis (zoology); Secretion; Necrosis; Cell; Medicine; Cancer research; In vitro; Pharmacology; Chemistry; Immunology; Pathology; Internal medicine; Biochemistry","score_opus":0.017621404559757834,"score_gpt":0.22872303095357402,"score_spread":0.2111016263938162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051641690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846784,0.0077552972,0.005265029,0.00009777648,0.00005940462,0.00006962253,0.00035450055,0.00009086501,0.0016290743],"genre_scores_gemma":[0.99052936,0.0024179937,0.0049105836,0.000083448635,0.000016052647,0.00004120902,0.0005311962,0.000007635373,0.0014625655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999281,0.000013457034,0.000009988219,0.000012819868,0.000018617538,0.000017048997],"domain_scores_gemma":[0.9999558,0.00001008867,0.000016826201,0.0000040942377,0.0000048253323,0.000008521772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011137661,0.00034497617,0.00018636911,0.00012691929,0.00008843623,0.00026699054,0.00018814208,0.00023132021,0.0008632812],"category_scores_gemma":[0.00007734027,0.00007741864,0.00024459168,0.00008757696,0.00020576536,0.00016685933,0.00010801845,0.0003149285,0.00026857117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015177755,0.000025641322,0.00009440048,0.00008500075,0.0000055524742,0.000045266555,0.000005601624,0.00005717439,0.9976482,0.000035929956,0.000027706272,0.0018177013],"study_design_scores_gemma":[0.000030067562,0.00078770483,0.0010478729,0.0000054763996,0.000017340806,0.00027154284,0.000009131916,0.0003183374,0.996128,0.0000065495055,0.0013757311,0.000002196041],"about_ca_topic_score_codex":0.0002026781,"about_ca_topic_score_gemma":0.00030996386,"teacher_disagreement_score":0.0008632812,"about_ca_system_score_codex":0.00026161424,"about_ca_system_score_gemma":0.00014700824,"threshold_uncertainty_score":0.0028879642},"labels":[],"label_agreement":null},{"id":"W2053248776","doi":"10.1111/bjd.13237","title":"Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME)","year":2014,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Programme Grants for Applied Research; National Institute for Health and Care Research","keywords":"Medicine; Atopic dermatitis; Clinical trial; Quality of life (healthcare); Pediatrics; Scale (ratio); Randomized controlled trial; Erythema; MEDLINE; Family medicine; Physical therapy; Dermatology; Surgery; Pathology; Nursing","score_opus":0.2840139127202188,"score_gpt":0.48605393439295247,"score_spread":0.20204002167273366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053248776","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034637824,0.7160375,0.054024138,0.079600014,0.046334628,0.05787674,0.023641467,0.00077890704,0.01824281],"genre_scores_gemma":[0.021229813,0.6097326,0.16887558,0.033920866,0.0064783343,0.10279269,0.04556415,0.000859711,0.010546175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8878966,0.045249175,0.032391496,0.0046870583,0.02687172,0.0029039672],"domain_scores_gemma":[0.84009135,0.049821332,0.033006705,0.008739857,0.06110898,0.0072316695],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2292758,0.002813675,0.011641532,0.011028898,0.001923148,0.0076559605,0.013305083,0.008684787,0.0070835585],"category_scores_gemma":[0.16849916,0.0025291436,0.016892457,0.010071848,0.0022778278,0.004601962,0.00947137,0.011810327,0.004686736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022131747,0.00031226917,0.0016112663,0.31274652,0.008585652,0.0005038231,0.0017666772,0.0014691651,0.0026981793,0.011148717,0.2953988,0.3615458],"study_design_scores_gemma":[0.0028203365,0.000550841,0.00851503,0.30295932,0.015642516,0.0006146103,0.00065144175,0.0005427361,0.001983786,0.0069883163,0.658463,0.00026804747],"about_ca_topic_score_codex":0.006049308,"about_ca_topic_score_gemma":0.006979238,"teacher_disagreement_score":0.7707242,"about_ca_system_score_codex":0.0118790455,"about_ca_system_score_gemma":0.05208388,"threshold_uncertainty_score":0.95044017},"labels":[],"label_agreement":null},{"id":"W2053952900","doi":"10.1046/j.1365-2133.148.s63.1.x","title":"International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategies","year":2003,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; Technische Universität München; University of California, San Diego; Université de Genève; School of Medicine, University of California, San Diego; Instituto Nacional de Pediatria","keywords":"Atopic dermatitis; Medicine; Dermatology; Library science; Family medicine; Computer science","score_opus":0.08834798399718323,"score_gpt":0.40612397775430337,"score_spread":0.3177759937571201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053952900","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046672084,0.9733117,0.0010029353,0.014003908,0.00776542,0.00017762353,0.0003285423,0.000032110092,0.0029109402],"genre_scores_gemma":[0.0044285655,0.97981745,0.005350751,0.0047239494,0.0022173657,0.0002804458,0.0009767185,0.000017626091,0.002187098],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962753,0.00086957717,0.001111341,0.00024665007,0.0013093561,0.00018784558],"domain_scores_gemma":[0.98848057,0.0037314093,0.0017098371,0.00021829423,0.0052723805,0.000587515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011148455,0.0011478947,0.0041391677,0.003565542,0.0006574966,0.0018392684,0.0031569686,0.0031027042,0.004016175],"category_scores_gemma":[0.013244354,0.00049970456,0.0019786656,0.004195718,0.00070793845,0.0020363901,0.0014771888,0.0032212713,0.0017917772],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026540828,0.00009214762,0.0008505775,0.032088734,0.00031331545,0.0002891759,0.0001199832,0.00028882065,0.00042704956,0.0010137069,0.23920241,0.72504854],"study_design_scores_gemma":[0.00028094763,0.00017108987,0.0037468781,0.042432006,0.0015841875,0.0020836317,0.00027519403,0.00016083753,0.0005383084,0.0013293999,0.94735205,0.000045403922],"about_ca_topic_score_codex":0.0043631485,"about_ca_topic_score_gemma":0.00867841,"teacher_disagreement_score":0.011148455,"about_ca_system_score_codex":0.0020597177,"about_ca_system_score_gemma":0.009966189,"threshold_uncertainty_score":0.058959365},"labels":[],"label_agreement":null},{"id":"W2054669733","doi":"10.1111/j.1365-2133.2009.09312.x","title":"Optimizing technique in elliptical excisional surgery: some pearls for practice","year":2009,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Surgical Sutures and Adhesives","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Magnification; Trunk; Fibrous joint; Surgery; Lesion; Computer science","score_opus":0.02247801261517803,"score_gpt":0.301356126454342,"score_spread":0.278878113839164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054669733","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011219949,0.31658357,0.07657685,0.5235547,0.04155272,0.00095281197,0.00016497841,0.0016631796,0.027731355],"genre_scores_gemma":[0.07356488,0.31500036,0.37248203,0.13658617,0.0868024,0.001578433,0.00034103228,0.000975954,0.012668856],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9779834,0.007319449,0.0033297746,0.0012127379,0.009557343,0.00059723],"domain_scores_gemma":[0.9180222,0.041007016,0.005358504,0.006125584,0.024109513,0.0053771893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041547783,0.0020082453,0.0018879953,0.003936699,0.0023390672,0.0071205357,0.0056233895,0.010361921,0.0064629233],"category_scores_gemma":[0.08041031,0.00082398497,0.0015586532,0.0021705364,0.008794114,0.012959177,0.004182357,0.01653047,0.006454631],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025608603,0.0008341447,0.006834691,0.0044232174,0.000113055394,0.0039510992,0.0033952945,0.0016022711,0.0022981262,0.011886743,0.21853298,0.7458723],"study_design_scores_gemma":[0.00014096074,0.0011277078,0.011951933,0.015050647,0.00012616169,0.021480763,0.007314806,0.0041292133,0.0021226967,0.07202099,0.8639436,0.0005906846],"about_ca_topic_score_codex":0.0017954559,"about_ca_topic_score_gemma":0.0038798833,"teacher_disagreement_score":0.041547783,"about_ca_system_score_codex":0.0025056647,"about_ca_system_score_gemma":0.0039073075,"threshold_uncertainty_score":0.21972835},"labels":[],"label_agreement":null},{"id":"W2054717635","doi":"10.1111/bjd.12266","title":"A randomized phase 2a efficacy and safety trial of the topical <scp>J</scp> anus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Université de Montréal; Innovaderm (Canada)","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Janus kinase inhibitor; Adverse effect; Tolerability; Discontinuation; Erythema; Dermatology; Psoriasis; Plaque psoriasis; Randomized controlled trial; Clinical endpoint; Internal medicine; Pharmacology; Rheumatoid arthritis","score_opus":0.013713880296584411,"score_gpt":0.24996373882449766,"score_spread":0.23624985852791325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054717635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870804,0.002239621,0.0006334507,0.0006457814,0.0003653498,0.005755494,0.0013383551,0.000111294554,0.0018302333],"genre_scores_gemma":[0.98178893,0.0021077164,0.0018058488,0.0012651081,0.0006794665,0.007367332,0.001963366,0.000042405227,0.0029798155],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99917597,0.00041233323,0.000040725256,0.00014985993,0.00008832525,0.00013274993],"domain_scores_gemma":[0.9987822,0.00023838373,0.00034444,0.000102034785,0.000078154924,0.00045482692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026281518,0.0020764482,0.0025695025,0.00042423565,0.0005911579,0.0013496804,0.0009264868,0.0016891588,0.008687427],"category_scores_gemma":[0.0015671813,0.0008994195,0.0011955234,0.00046857723,0.0014522141,0.0011400654,0.0004291555,0.0033276032,0.0012903338],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96541744,0.015803825,0.00070803915,0.0002452913,0.00039420792,0.00005477962,0.000042200056,0.00024150456,0.006355759,0.00009005898,0.0010237964,0.009622999],"study_design_scores_gemma":[0.92128325,0.07593725,0.0013068479,0.000010881419,0.00013618707,0.00005126324,0.000014605132,0.00024279428,0.00043296488,0.000081956314,0.0004929996,0.000009105284],"about_ca_topic_score_codex":0.0009828007,"about_ca_topic_score_gemma":0.002271187,"teacher_disagreement_score":0.008687427,"about_ca_system_score_codex":0.0011829844,"about_ca_system_score_gemma":0.0019838458,"threshold_uncertainty_score":0.02906239},"labels":[],"label_agreement":null},{"id":"W2056006467","doi":"10.1111/j.1365-2133.2008.08895.x","title":"Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Retinoic acid; Retinoid; Downregulation and upregulation; Tretinoin; Retinol; Biology; Epidermis (zoology); Proinflammatory cytokine; Molecular biology; Inflammation; Cancer research; Chemistry; Biochemistry; Immunology; Vitamin; Gene","score_opus":0.009414241412423512,"score_gpt":0.2320890324613776,"score_spread":0.2226747910489541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056006467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966822,0.0021231081,0.0004704117,0.000046351386,0.00003179365,0.0000835807,0.00012254465,0.00004506111,0.00039485196],"genre_scores_gemma":[0.9971554,0.00081112655,0.0006275454,0.00004710785,0.000019614525,0.00005839699,0.00020038743,0.000008269762,0.001072045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998271,0.000034071163,0.000013256542,0.00005585451,0.000038115377,0.000031690648],"domain_scores_gemma":[0.99990284,0.000016428188,0.000035063214,0.0000126862,0.000009278697,0.000023728986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000182267,0.0003290821,0.00041372175,0.00021129182,0.00013956738,0.00023671515,0.00014182903,0.00025403043,0.0021638512],"category_scores_gemma":[0.00013662354,0.00015545584,0.00026704732,0.0001571543,0.00026582446,0.00014519179,0.00009192339,0.00043281895,0.00035032252],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042819246,0.00067645713,0.00037328005,0.00007628887,0.000022637741,0.000035273617,0.000011689429,0.00007239422,0.988811,0.000009648899,0.00008828101,0.005541022],"study_design_scores_gemma":[0.0018918914,0.06036238,0.013710247,0.000012540716,0.00016435036,0.0005985343,0.0000639625,0.000604506,0.92064035,0.000026247151,0.0019137497,0.000011187757],"about_ca_topic_score_codex":0.00032096557,"about_ca_topic_score_gemma":0.00049939053,"teacher_disagreement_score":0.0021638512,"about_ca_system_score_codex":0.00016115657,"about_ca_system_score_gemma":0.00016639127,"threshold_uncertainty_score":0.0072388053},"labels":[],"label_agreement":null},{"id":"W2056787110","doi":"10.1111/j.1365-2133.2004.06099.x","title":"Irradiance and light dose influence histological localization of photodamage induced by photodynamic therapy with aminolaevulinic acid","year":2004,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"Canadian Dermatology Foundation; Dermatology Foundation","keywords":"Photodynamic therapy; Irradiance; Medicine; Pathology; Dermatology; Chemistry; Optics; Physics","score_opus":0.011832456445917095,"score_gpt":0.2748666580562967,"score_spread":0.2630342016103796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056787110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949523,0.0024653275,0.0012421499,0.000026772388,0.000015227876,0.000041320578,0.000088083005,0.000033357723,0.0011355225],"genre_scores_gemma":[0.99699056,0.0010023802,0.0010118015,0.000031230204,0.0000066523057,0.000032637457,0.00009271266,0.000009566895,0.0008224493],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982435,0.00004721889,0.000013439427,0.00003149845,0.000049366474,0.000034194276],"domain_scores_gemma":[0.9997631,0.00005744841,0.0000801604,0.000020318215,0.00004428406,0.0000346623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020807385,0.000260418,0.00017878182,0.00019664993,0.0000911928,0.00021385554,0.00013794936,0.00031830985,0.001421606],"category_scores_gemma":[0.00016851549,0.00015972921,0.00020901079,0.0001018623,0.00022793331,0.00019785757,0.00016237076,0.0004120038,0.00018867815],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000235532,0.000025206424,0.00072020054,0.000038472543,0.0000075367143,0.000035032757,0.0000142707795,0.00004508357,0.9980914,0.000013114975,0.000011231246,0.0007629523],"study_design_scores_gemma":[0.000028021497,0.0015869568,0.051854625,0.000016471056,0.000049128117,0.00035446367,0.000079297875,0.00051024393,0.9444027,0.000034751178,0.0010756315,0.000007658606],"about_ca_topic_score_codex":0.0003445599,"about_ca_topic_score_gemma":0.0003409643,"teacher_disagreement_score":0.001421606,"about_ca_system_score_codex":0.0002252391,"about_ca_system_score_gemma":0.000114212955,"threshold_uncertainty_score":0.0047557354},"labels":[],"label_agreement":null},{"id":"W2057417368","doi":"10.1111/j.1365-2133.2006.07736.x","title":"Itch Severity Scale: a self-report instrument for the measurement of pruritus severity","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"Canada Research Chairs","keywords":"Construct validity; Quality of life (healthcare); Reliability (semiconductor); Medicine; Dermatology Life Quality Index; Exploratory factor analysis; Psychometrics; Internal consistency; Severity of illness; Clinical psychology; Scale (ratio); Physical therapy; Psoriasis; Psychiatry; Dermatology","score_opus":0.017663357402825992,"score_gpt":0.27396279125558193,"score_spread":0.25629943385275594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057417368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8016207,0.015717974,0.05767986,0.0035158382,0.0006083891,0.020667812,0.044847388,0.0021303801,0.053211633],"genre_scores_gemma":[0.88595,0.006148195,0.06398319,0.0012253522,0.00035568178,0.008877429,0.019247599,0.00011078134,0.014101733],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99716324,0.00089565205,0.00038558381,0.0001821647,0.0012381412,0.00013514524],"domain_scores_gemma":[0.9956749,0.0008164719,0.0019275951,0.00022186535,0.0010052641,0.0003539726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024365587,0.00050192076,0.00093931716,0.002167625,0.00025847004,0.00038640475,0.0007927922,0.0005082379,0.0060644993],"category_scores_gemma":[0.0050728214,0.00018545777,0.00070461177,0.0012543859,0.00029101915,0.00065889553,0.00077921496,0.0012691577,0.0012226397],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023895765,0.002957496,0.44492635,0.0037470045,0.0015479008,0.0006413708,0.001395626,0.00208669,0.022235526,0.0014277839,0.06882626,0.44781843],"study_design_scores_gemma":[0.0005524941,0.0022087216,0.9595912,0.0005043887,0.00029385614,0.0020506924,0.0002944225,0.0022460911,0.0021324824,0.0005879862,0.029434849,0.000102722835],"about_ca_topic_score_codex":0.0014647432,"about_ca_topic_score_gemma":0.0031470533,"teacher_disagreement_score":0.0060644993,"about_ca_system_score_codex":0.00055273966,"about_ca_system_score_gemma":0.0008892438,"threshold_uncertainty_score":0.020287812},"labels":[],"label_agreement":null},{"id":"W2057877473","doi":"10.1046/j.1365-2133.2003.05418.x","title":"In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity","year":2003,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Itraconazole; Terbinafine; Ketoconazole; Microbiology; In vitro; Broth microdilution; Antifungal; Dermatophyte; Griseofulvin; Pharmacology; Minimum inhibitory concentration; Biology; Chemistry; Medicine; Dermatology; Antimicrobial; Biochemistry","score_opus":0.019732299801595677,"score_gpt":0.28459500914168157,"score_spread":0.2648627093400859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057877473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98470944,0.007550208,0.003934053,0.00008743047,0.000054811295,0.0002471492,0.00089234544,0.000059813072,0.0024647706],"genre_scores_gemma":[0.9766183,0.0050203814,0.014712374,0.00006525893,0.00004555925,0.000245749,0.0019441114,0.000017596678,0.0013306926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99734026,0.0008994175,0.0005357666,0.00028249735,0.0008049604,0.0001370238],"domain_scores_gemma":[0.9983639,0.00063960813,0.0003110091,0.00015845784,0.00040484237,0.00012213626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001011592,0.0008536816,0.0008577053,0.00078664394,0.0003543838,0.00040294707,0.0004394029,0.00058043736,0.0016902431],"category_scores_gemma":[0.0014185957,0.0004227498,0.00073105213,0.00107208,0.00033013886,0.00032772083,0.00040264506,0.00041596754,0.000581877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001143847,0.000594558,0.008002839,0.0005240008,0.00012799232,0.00019664897,0.00015901974,0.00036625587,0.980198,0.000037014313,0.00012569735,0.008524074],"study_design_scores_gemma":[0.000111195666,0.009666659,0.039056055,0.000058485006,0.000380008,0.0019194665,0.00019887605,0.0008994896,0.9458698,0.000041042666,0.0017678983,0.000031074134],"about_ca_topic_score_codex":0.0015028608,"about_ca_topic_score_gemma":0.0025386503,"teacher_disagreement_score":0.0016902431,"about_ca_system_score_codex":0.00029094314,"about_ca_system_score_gemma":0.00039438476,"threshold_uncertainty_score":0.0056543946},"labels":[],"label_agreement":null},{"id":"W2059576098","doi":"10.1111/j.1365-2133.1976.tb07918.x","title":"(30) Benign hyperglobulinaemic purpura of Waldenstrom","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Citation; Medicine; Library science; Classics; History; Computer science","score_opus":0.004409450661732599,"score_gpt":0.21081282209350716,"score_spread":0.20640337143177456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059576098","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15340059,0.14336729,0.005301864,0.079761475,0.028099319,0.00066777924,0.00191427,0.0008460404,0.5866413],"genre_scores_gemma":[0.4564598,0.08889803,0.0036726203,0.03338647,0.03752709,0.0002833293,0.0019284526,0.00015749047,0.37768674],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99972695,0.00003190234,0.000027239465,0.00003317571,0.00010761659,0.00007303228],"domain_scores_gemma":[0.9997508,0.000048271802,0.000060943752,0.000010812516,0.00004139054,0.00008790382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024024122,0.00081309414,0.0004717105,0.0017518005,0.0008283388,0.00047307464,0.00036501576,0.0019111589,0.011951466],"category_scores_gemma":[0.0012086481,0.00016625726,0.0006476883,0.0005917495,0.00060415117,0.00050398416,0.0005907901,0.0011469945,0.0036761225],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008271167,0.00041311354,0.03156144,0.00088856585,0.0001607636,0.38204822,0.0007353993,0.00025161068,0.006041729,0.013090246,0.3912279,0.17275389],"study_design_scores_gemma":[0.00017646601,0.00046883346,0.063070804,0.00026674327,0.00014722101,0.45244977,0.00018653141,0.0002429142,0.002121407,0.0029369604,0.47788745,0.00004491983],"about_ca_topic_score_codex":0.0050999923,"about_ca_topic_score_gemma":0.01097186,"teacher_disagreement_score":0.011951466,"about_ca_system_score_codex":0.0005361951,"about_ca_system_score_gemma":0.000623956,"threshold_uncertainty_score":0.039981663},"labels":[],"label_agreement":null},{"id":"W2060268129","doi":"10.1111/bjd.13163","title":"The Hidradenitis Suppurativa Priority Setting Partnership","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Hidradenitis suppurativa; Medicine; General partnership; Library science; Political science; Law; Computer science","score_opus":0.010793316099065309,"score_gpt":0.2707435683111784,"score_spread":0.2599502522121131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060268129","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13091566,0.01668405,0.115283586,0.6115007,0.005723758,0.015823392,0.0025638468,0.00054197264,0.10096311],"genre_scores_gemma":[0.67613673,0.008859751,0.2290489,0.051176634,0.0014558285,0.013577796,0.0016616074,0.00012193845,0.017960832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.82725024,0.15029664,0.005414271,0.002819012,0.008186145,0.006033665],"domain_scores_gemma":[0.71926326,0.13242342,0.012851676,0.009935728,0.036258582,0.08926735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.17506893,0.00048301357,0.00069553166,0.0016944921,0.0056006913,0.0077872276,0.0026439554,0.0031860254,0.008254077],"category_scores_gemma":[0.12370856,0.00068842527,0.00080880005,0.0023565702,0.003390091,0.0049484856,0.023640335,0.0058861254,0.0015707075],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017030342,0.002276445,0.052432105,0.009281184,0.0003398014,0.003825213,0.09822795,0.004261922,0.0042795558,0.11294864,0.16444948,0.54597473],"study_design_scores_gemma":[0.0010316094,0.0028526436,0.020387042,0.0069271135,0.00012856074,0.0018851164,0.07579586,0.0041755484,0.0021024158,0.0803292,0.8041615,0.00022348596],"about_ca_topic_score_codex":0.0023892792,"about_ca_topic_score_gemma":0.0027426903,"teacher_disagreement_score":0.17506893,"about_ca_system_score_codex":0.007436981,"about_ca_system_score_gemma":0.09846481,"threshold_uncertainty_score":0.92586404},"labels":[],"label_agreement":null},{"id":"W2062348457","doi":"10.1111/bjd.12583","title":"The interpretation of long-term trials of biologic treatments for psoriasis: trial designs and the choices of statistical analyses affect ability to compare outcomes across trials","year":2013,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Ustekinumab; Medicine; Etanercept; Adalimumab; Psoriasis; Clinical trial; Infliximab; Clinical study design; Research design; Intensive care medicine; Disease; Medical physics; Internal medicine; Dermatology; Rheumatoid arthritis","score_opus":0.2213100421307294,"score_gpt":0.46960002834956105,"score_spread":0.24828998621883164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062348457","genre_codex":"review","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013074378,0.90382004,0.07705916,0.009292007,0.0038933358,0.0023985575,0.00043495308,0.00017414906,0.001620296],"genre_scores_gemma":[0.039591007,0.66714585,0.25340822,0.013627419,0.0064405743,0.017750956,0.0007200668,0.00035851705,0.00095748896],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.39709908,0.50601155,0.06149689,0.0073430417,0.027282557,0.0007668613],"domain_scores_gemma":[0.17750728,0.761914,0.033122662,0.0124900555,0.014428097,0.0005378411],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.36746517,0.0025799861,0.009803608,0.0060273795,0.0010748693,0.011239684,0.0047082403,0.0052112415,0.0018438858],"category_scores_gemma":[0.6081477,0.0014503145,0.007030229,0.008089746,0.005470185,0.007364145,0.002437012,0.008346372,0.00069646095],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017993663,0.00013945485,0.002676618,0.28440297,0.01764682,0.00026796854,0.0013074816,0.0059336377,0.0013105696,0.074044146,0.013380301,0.5970908],"study_design_scores_gemma":[0.0029915015,0.003952932,0.010023993,0.38900694,0.032322276,0.0014964341,0.001328055,0.008887369,0.0034896901,0.3141363,0.23161511,0.0007493632],"about_ca_topic_score_codex":0.00059779297,"about_ca_topic_score_gemma":0.0010393898,"teacher_disagreement_score":0.63253486,"about_ca_system_score_codex":0.0044763605,"about_ca_system_score_gemma":0.008695833,"threshold_uncertainty_score":0.7800281},"labels":[],"label_agreement":null},{"id":"W2066048636","doi":"10.1111/j.1365-2133.2009.09374.x","title":"Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Melanoma; Basal cell carcinoma; Referral; Biopsy; Dermatology; Primary care; Psychological intervention; Skin cancer; Radiology; Surgery; Basal cell; Pathology; Cancer; Internal medicine","score_opus":0.015618427519693827,"score_gpt":0.3092356060656229,"score_spread":0.29361717854592906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066048636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401927,0.0029955937,0.00015778301,0.00045304015,0.00014674113,0.0011007459,0.0001524281,0.000021080976,0.00095337414],"genre_scores_gemma":[0.99517363,0.0014184067,0.0008574649,0.00036353292,0.00025224691,0.0012799129,0.0001673155,0.0000030322474,0.00048445753],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982603,0.0009969267,0.00014645078,0.00025384407,0.00016571405,0.00017661328],"domain_scores_gemma":[0.9971957,0.0009897174,0.0007079559,0.00014221587,0.00013546695,0.00082896714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017395921,0.00064312055,0.001660736,0.00034927056,0.00043401774,0.00085833814,0.0007315999,0.0017568901,0.0048623965],"category_scores_gemma":[0.0040896875,0.00041661796,0.0015905086,0.0003645991,0.00065666,0.0006213801,0.00056742487,0.0018827466,0.00031899734],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93171495,0.022768687,0.005785033,0.0015226342,0.0013442583,0.000089320936,0.00015027402,0.0003918439,0.00090051105,0.00010621963,0.00043599436,0.034790244],"study_design_scores_gemma":[0.7259115,0.24121946,0.028722351,0.00030288365,0.0014841335,0.00008612596,0.00009546767,0.0009032481,0.0003731798,0.00016227274,0.00071769033,0.000021660953],"about_ca_topic_score_codex":0.0018624194,"about_ca_topic_score_gemma":0.0024708041,"teacher_disagreement_score":0.0048623965,"about_ca_system_score_codex":0.00094687537,"about_ca_system_score_gemma":0.001444678,"threshold_uncertainty_score":0.016266346},"labels":[],"label_agreement":null},{"id":"W2066966639","doi":"10.1111/j.1365-2133.2009.09572.x","title":"Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guenther Dermatology Research Centre; Innovaderm (Canada)","funders":"Division of Chemistry; Basilea Pharmaceutica","keywords":"Medicine; Placebo; Randomized controlled trial; Adverse effect; Dermatology; Physical therapy; Surgery; Internal medicine; Alternative medicine","score_opus":0.002944624182156752,"score_gpt":0.21106614131133408,"score_spread":0.20812151712917734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066966639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784374,0.0014064672,0.00010469185,0.00005679179,0.000014932828,0.000093530834,0.00003134328,0.000010222157,0.0004381972],"genre_scores_gemma":[0.99890935,0.00040969645,0.00023715597,0.0001267805,0.000030930805,0.000052732772,0.0000856683,0.0000020608634,0.00014562554],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999613,0.00013337522,0.00004387841,0.00005624372,0.00009020772,0.00006331013],"domain_scores_gemma":[0.99933714,0.00028779078,0.00015147282,0.000055963494,0.000044267854,0.0001233568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009785546,0.00027146656,0.0012525092,0.0001821572,0.00030777857,0.00024305574,0.00026180787,0.00041658402,0.0011676591],"category_scores_gemma":[0.001765025,0.00014646786,0.0005903499,0.00016678727,0.0002641565,0.00025133387,0.00014138116,0.000483719,0.00029009336],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09508272,0.009306219,0.32840228,0.0016480237,0.0016670979,0.005852946,0.0012896797,0.0013638207,0.08574791,0.00010716887,0.0020807516,0.4674514],"study_design_scores_gemma":[0.024474882,0.17665274,0.76433533,0.00020735728,0.001219204,0.014937966,0.000427906,0.0022064336,0.010726607,0.00012959616,0.0046267407,0.000055237273],"about_ca_topic_score_codex":0.00041966507,"about_ca_topic_score_gemma":0.00087316753,"teacher_disagreement_score":0.0012525092,"about_ca_system_score_codex":0.00020930755,"about_ca_system_score_gemma":0.00025937677,"threshold_uncertainty_score":0.0051751733},"labels":[],"label_agreement":null},{"id":"W2067033715","doi":"10.1111/j.1365-2133.2006.07466.x","title":"Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Dysplasia; Dermatology; Odds ratio; Melanoma; Risk factor; Dysplastic nevus; Nevus; Confidence interval; Family history; Grading (engineering); Pathology; Internal medicine","score_opus":0.009083285836853385,"score_gpt":0.22601710826591484,"score_spread":0.21693382242906145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067033715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998002,0.00096185313,0.00018579948,0.00010910907,0.000009991955,0.000007977381,0.00007186356,0.000008923938,0.0006424456],"genre_scores_gemma":[0.999432,0.00015478468,0.00018650346,0.0000127166295,0.00002356468,0.0000029314176,0.000044968983,0.000002136106,0.00014039969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964356,0.00010761984,0.000030840423,0.00008126748,0.00009224686,0.000044396955],"domain_scores_gemma":[0.99767894,0.000673578,0.0010117614,0.00012924423,0.0001363729,0.0003700987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005134213,0.00039632161,0.0003058305,0.00071522593,0.0003940411,0.00048871496,0.00033132,0.0005879827,0.003270759],"category_scores_gemma":[0.002731068,0.00026901966,0.00041275326,0.000682891,0.00038540777,0.00029574896,0.00032979567,0.0007920982,0.00031418327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117612944,0.000024480229,0.9983292,0.000007850114,0.00003352797,0.00014877514,0.000016630232,0.000025295305,0.00034842562,0.000014548358,0.000032512475,0.0009011001],"study_design_scores_gemma":[0.000006117352,0.00011555406,0.99769104,0.0000072773496,0.00004810922,0.0016538076,0.000048813035,0.00016941167,0.000095052266,0.000045919933,0.00011604151,0.0000029353728],"about_ca_topic_score_codex":0.0011578657,"about_ca_topic_score_gemma":0.0011832634,"teacher_disagreement_score":0.003270759,"about_ca_system_score_codex":0.00013690823,"about_ca_system_score_gemma":0.00026566052,"threshold_uncertainty_score":0.010941744},"labels":[],"label_agreement":null},{"id":"W2067243972","doi":"10.1111/bjd.13462","title":"A global perspective on the epidemiology of acne","year":2015,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":748,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Windsor Clinical Research","funders":"Les Laboratories Pierre Fabre","keywords":"Acne; Epidemiology; Disease; Medicine; Population; Perspective (graphical); Environmental health; Dermatology; Pathology; Computer science","score_opus":0.09316110181563922,"score_gpt":0.41973472231953557,"score_spread":0.3265736205038964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067243972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010628001,0.9944307,0.00013893527,0.0037001933,0.00050151825,0.0000026520042,0.000036730158,0.0000046487426,0.0010783293],"genre_scores_gemma":[0.0011992807,0.9967319,0.00017123845,0.0009882806,0.0005699447,0.0000036505653,0.00003778692,0.0000012757635,0.00029670482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991278,0.0003317745,0.00013857472,0.00010510185,0.00024218504,0.000054701693],"domain_scores_gemma":[0.9978052,0.001217067,0.00026493805,0.00004836292,0.00055740314,0.00010709296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016634269,0.0007342765,0.0013000756,0.0035302257,0.0003086216,0.001434107,0.0005578434,0.0015912183,0.0044965525],"category_scores_gemma":[0.0032439986,0.00026074593,0.00091412495,0.004103521,0.0006403261,0.002251798,0.00095095014,0.0023286275,0.0013047708],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006218197,0.00004309705,0.0018603507,0.030343255,0.00034085667,0.00030507141,0.000464803,0.0004071065,0.000649107,0.013403367,0.07262045,0.8795003],"study_design_scores_gemma":[0.000009430915,0.00005407258,0.005057885,0.022064086,0.00024600117,0.0016840901,0.00045569826,0.000060788076,0.00009535986,0.0046710516,0.9655749,0.000026525213],"about_ca_topic_score_codex":0.003988702,"about_ca_topic_score_gemma":0.0056688655,"teacher_disagreement_score":0.0044965525,"about_ca_system_score_codex":0.0009902456,"about_ca_system_score_gemma":0.0025563159,"threshold_uncertainty_score":0.015042424},"labels":[],"label_agreement":null},{"id":"W2067426415","doi":"10.1111/j.1365-2133.1973.tb07562.x","title":"Skin lesions in tyrosinosis: response to dietary treatment","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Tyrosine; Medicine; Abnormality; Hyperkeratosis; Concomitant; Skin lesion; Phenylalanine; Internal medicine; Physiology; Dermatology; Biology; Biochemistry","score_opus":0.009675249115818563,"score_gpt":0.25975792247437973,"score_spread":0.25008267335856116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067426415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904929,0.002785369,0.0004146969,0.00047464206,0.000056845478,0.00004841208,0.0001147417,0.00008050698,0.005531943],"genre_scores_gemma":[0.99794084,0.0004355875,0.0001431028,0.00017502398,0.00003743869,0.000009953349,0.00007691906,0.000011488126,0.0011696084],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9999002,0.000021161715,0.000007992935,0.000019393226,0.000019576708,0.000031685413],"domain_scores_gemma":[0.9995559,0.00013740065,0.00008894879,0.000026868267,0.000056115572,0.00013481338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014961511,0.00028146568,0.0003639405,0.00026656783,0.00041757003,0.0002053941,0.00018360627,0.0008133453,0.001104835],"category_scores_gemma":[0.0011688815,0.00013552194,0.00022583325,0.00021830824,0.00022138367,0.00011944597,0.00012897416,0.00069471187,0.00030211385],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057994374,0.0012820107,0.14489627,0.0005646355,0.00020252305,0.63139385,0.00091417244,0.00090720016,0.13964923,0.0003796489,0.0020691205,0.0719419],"study_design_scores_gemma":[0.0005002434,0.004100992,0.40972924,0.00009026317,0.00015517816,0.5571507,0.00034245456,0.001318123,0.015765026,0.00030502822,0.0105053,0.000037390375],"about_ca_topic_score_codex":0.0010017453,"about_ca_topic_score_gemma":0.0011663757,"teacher_disagreement_score":0.001104835,"about_ca_system_score_codex":0.00027127512,"about_ca_system_score_gemma":0.00012737904,"threshold_uncertainty_score":0.0036960244},"labels":[],"label_agreement":null},{"id":"W2069236338","doi":"10.1111/bjd.13745","title":"A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"U.S. Food and Drug Administration; Astellas Pharma","keywords":"Medicine; Psoriasis; Placebo; Psoriasis Area and Severity Index; Dosing; Adverse effect; Body surface area; Internal medicine; Clinical endpoint; Dermatology Life Quality Index; Clinical trial; Gastroenterology; Randomized controlled trial; Janus kinase; Urology; Cytokine; Dermatology; Pathology","score_opus":0.026855971073515394,"score_gpt":0.28088120055266036,"score_spread":0.25402522947914496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069236338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843933,0.0015331125,0.0011979875,0.0004979037,0.00037767072,0.009182281,0.001020278,0.00014471477,0.0016529035],"genre_scores_gemma":[0.9768296,0.0013053564,0.004071506,0.001518955,0.0005272125,0.01128622,0.0016439968,0.000035337143,0.0027819467],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989285,0.0005577556,0.000070359296,0.00020988945,0.00011799517,0.00011542682],"domain_scores_gemma":[0.9985164,0.00035786963,0.0003496733,0.0001593553,0.00012839973,0.00048824633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029195675,0.0020156961,0.0032913084,0.00056324434,0.00058099173,0.000961971,0.0011712244,0.001695494,0.006293921],"category_scores_gemma":[0.0023864121,0.00095405243,0.001419172,0.00046308732,0.0014625404,0.0012529871,0.00050154945,0.0030663481,0.0010685801],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94451076,0.031302724,0.000804318,0.00032104296,0.00051702,0.000033903976,0.000066306486,0.00034671315,0.0073943567,0.000078462566,0.0006796874,0.013944778],"study_design_scores_gemma":[0.90865296,0.08916122,0.0012652149,0.0000072874245,0.00011029334,0.000020223879,0.0000078075955,0.00018774631,0.00028563506,0.0000534414,0.00024058917,0.000007559173],"about_ca_topic_score_codex":0.0005520046,"about_ca_topic_score_gemma":0.0012642713,"teacher_disagreement_score":0.006293921,"about_ca_system_score_codex":0.0007156313,"about_ca_system_score_gemma":0.0015539031,"threshold_uncertainty_score":0.021055281},"labels":[],"label_agreement":null},{"id":"W2069588504","doi":"10.1111/j.1365-2133.2005.06877.x","title":"Pathogenetic mechanisms of vitiligo in a patient with Sezary syndrome","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Vitiligo; Medicine; Dermatology","score_opus":0.0032796574327813408,"score_gpt":0.20010785059721187,"score_spread":0.19682819316443054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069588504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987268,0.00044324313,0.00017409315,0.00007486554,0.0000059887084,0.000010977074,0.000019888688,0.00001776846,0.0005264455],"genre_scores_gemma":[0.9996711,0.00010371365,0.00007024942,0.000025129675,0.000013761484,0.000002596589,0.000015465106,0.0000018551003,0.00009619133],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998386,0.000030886444,0.0000146613875,0.00004081792,0.000024981828,0.000049941482],"domain_scores_gemma":[0.9997166,0.000111225185,0.000071809845,0.000020578065,0.000015251307,0.00006450881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014181618,0.0005913498,0.00038233455,0.0009517246,0.00056530396,0.000387468,0.00024043395,0.0010942557,0.0017403208],"category_scores_gemma":[0.00086858746,0.00032154075,0.00022469705,0.00047706056,0.0005290537,0.00036170485,0.00031660078,0.00055159023,0.00020989391],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009877451,0.0001993087,0.43110836,0.00013203423,0.00007108584,0.49867833,0.0011832825,0.0003346025,0.056934852,0.0004191232,0.00034840323,0.009602883],"study_design_scores_gemma":[0.000084360356,0.00060607935,0.2797569,0.000021229023,0.00006632283,0.7138525,0.00033141262,0.0009186459,0.0032655934,0.00026139314,0.0008117047,0.000023768554],"about_ca_topic_score_codex":0.000585218,"about_ca_topic_score_gemma":0.0003850978,"teacher_disagreement_score":0.0017403208,"about_ca_system_score_codex":0.00023544092,"about_ca_system_score_gemma":0.000116121366,"threshold_uncertainty_score":0.0058218837},"labels":[],"label_agreement":null},{"id":"W2074314525","doi":"10.1111/j.1365-2133.2009.09145.x","title":"Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary","funders":"","keywords":"Eczema Area and Severity Index; Pimecrolimus; Medicine; Atopic dermatitis; Randomized controlled trial; Dermatology; Staphylococcus aureus; Tacrolimus; Clinical trial; Superantigen; Internal medicine; Allergy; Erythema; Immunology; Transplantation","score_opus":0.007860142340897273,"score_gpt":0.27181637742829534,"score_spread":0.2639562350873981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074314525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861087,0.008102706,0.00037036758,0.00039119078,0.00052290503,0.0029552195,0.00039054552,0.000077246645,0.0010811656],"genre_scores_gemma":[0.9898656,0.0041037,0.0009449051,0.00067025924,0.00054697297,0.0023094686,0.0003808992,0.000011652319,0.0011666168],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99928975,0.00035080957,0.000063315856,0.000114580034,0.00007655413,0.00010485726],"domain_scores_gemma":[0.99930656,0.00022875615,0.00017570818,0.000053583262,0.000057326968,0.00017811079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001488476,0.0013498932,0.0032759896,0.0005683025,0.00047482373,0.00096091756,0.00088954845,0.0018107393,0.0039631324],"category_scores_gemma":[0.0014880501,0.00064637914,0.00183325,0.00054013665,0.0008186381,0.00083912717,0.00031543,0.0017663327,0.0006176158],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.969143,0.008201001,0.000741988,0.000976877,0.00092349254,0.00006489314,0.00003617252,0.00016030112,0.0029660463,0.000043043077,0.00031673672,0.016426543],"study_design_scores_gemma":[0.9345711,0.061632935,0.0024199071,0.0000331346,0.00046933364,0.0000309009,0.000013740637,0.00022979997,0.0002915827,0.000029145856,0.00026891383,0.000009527486],"about_ca_topic_score_codex":0.0009061581,"about_ca_topic_score_gemma":0.0020778833,"teacher_disagreement_score":0.0039631324,"about_ca_system_score_codex":0.000633139,"about_ca_system_score_gemma":0.0010048657,"threshold_uncertainty_score":0.01325804},"labels":[],"label_agreement":null},{"id":"W2074749048","doi":"10.1111/j.1365-2133.2004.05696.x","title":"Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme","year":2004,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Novartis Pharma; Novartis","keywords":"Eczema Area and Severity Index; Pimecrolimus; Atopic dermatitis; Medicine; SCORAD; Dermatology; Placebo; Dermatology Life Quality Index; Population; Randomized controlled trial; Clinical endpoint; Severity of illness; Calcineurin; Internal medicine; Psoriasis; Pathology","score_opus":0.029370789385876794,"score_gpt":0.32502904911414104,"score_spread":0.29565825972826426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074749048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827587,0.00951451,0.0012734133,0.0001370667,0.0001815115,0.004197646,0.0011475271,0.000027244709,0.00076246803],"genre_scores_gemma":[0.990765,0.0014895555,0.0020283035,0.00023836353,0.00017308848,0.0032894355,0.0017254207,0.000013805998,0.000277008],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.98130244,0.011588304,0.002801316,0.001903501,0.0019880056,0.00041642273],"domain_scores_gemma":[0.97820354,0.009826333,0.0071028643,0.0022904351,0.001518138,0.0010586411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0339409,0.0013112787,0.0033567173,0.00063847145,0.00063794776,0.0014344369,0.00091568666,0.0012594825,0.001730868],"category_scores_gemma":[0.033010628,0.0009354536,0.0023585956,0.00072253647,0.0010538182,0.0011153276,0.00062462623,0.0011611218,0.00039884925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6928578,0.0037140506,0.24980514,0.002038685,0.012509115,0.00023039886,0.00040550774,0.0005892032,0.005990091,0.00017025493,0.0011200828,0.03056968],"study_design_scores_gemma":[0.339424,0.122814074,0.51921624,0.0003841405,0.0097938115,0.00061732315,0.00011572375,0.0013066892,0.0022443256,0.00016240157,0.0038218824,0.00009928015],"about_ca_topic_score_codex":0.00053517416,"about_ca_topic_score_gemma":0.0006603877,"teacher_disagreement_score":0.0339409,"about_ca_system_score_codex":0.0007173623,"about_ca_system_score_gemma":0.0011499352,"threshold_uncertainty_score":0.17949879},"labels":[],"label_agreement":null},{"id":"W2078226469","doi":"10.1111/bjd.12517","title":"Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Janus kinase inhibitor; Medicine; Psoriasis; Placebo; Internal medicine; Gastroenterology; Ruxolitinib; Hematology; Pharmacology; Immunology; Myelofibrosis; Bone marrow; Pathology; Rheumatoid arthritis","score_opus":0.011939957086453021,"score_gpt":0.2302836348210307,"score_spread":0.2183436777345777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078226469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970227,0.0016641924,0.00007317274,0.000078585814,0.000041768384,0.000075344156,0.00015569772,0.00002147761,0.0008670423],"genre_scores_gemma":[0.9985398,0.00031289723,0.00009844228,0.00007165592,0.00004452677,0.0000747029,0.00019645103,0.000003798074,0.00065776246],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99956983,0.00017750749,0.000028491426,0.000059577666,0.0000707858,0.00009379902],"domain_scores_gemma":[0.9993544,0.00015468517,0.00017670117,0.000043226977,0.00006292086,0.00020811433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071828195,0.00040313456,0.0010860515,0.00021100474,0.00021231471,0.00037251285,0.0002503187,0.0005452265,0.0019804188],"category_scores_gemma":[0.0014152412,0.00013136507,0.00042298503,0.00020633196,0.00021261573,0.0002848086,0.0001955488,0.0014176368,0.00033569703],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5917325,0.02116248,0.04259921,0.00059911225,0.0008460338,0.000686457,0.00030755094,0.0014940848,0.15479575,0.00005605883,0.0020450621,0.18367572],"study_design_scores_gemma":[0.01751471,0.31158853,0.6217765,0.00013492466,0.00087091856,0.0010738595,0.00023544938,0.0019378985,0.040264837,0.00013757283,0.0043855775,0.00007918963],"about_ca_topic_score_codex":0.00080085435,"about_ca_topic_score_gemma":0.0011668047,"teacher_disagreement_score":0.0019804188,"about_ca_system_score_codex":0.00037933266,"about_ca_system_score_gemma":0.00031701726,"threshold_uncertainty_score":0.0066251755},"labels":[],"label_agreement":null},{"id":"W2079101710","doi":"10.1111/j.1365-2133.2009.09116.x","title":"Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"LEO Pharma","keywords":"Calcipotriol; Scalp; Medicine; Betamethasone; Betamethasone dipropionate; Dermatology; Adverse effect; Randomized controlled trial; Psoriasis; Randomization; Surgery; Internal medicine","score_opus":0.014460332997114416,"score_gpt":0.25436953819956776,"score_spread":0.23990920520245335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079101710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817616,0.007434697,0.0006655686,0.0005477896,0.00074860826,0.0065090973,0.0007575095,0.00013799813,0.0014371565],"genre_scores_gemma":[0.98133564,0.0040275864,0.002001826,0.00076715177,0.0010438742,0.008107295,0.00080242514,0.00002948083,0.001884723],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99803466,0.0011339802,0.00017375729,0.00030831437,0.00017440376,0.00017495283],"domain_scores_gemma":[0.99778336,0.00088671286,0.00059981743,0.0001483967,0.00013746145,0.00044420583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029575878,0.0017578537,0.0050772205,0.0006541263,0.00055373204,0.0012270163,0.00134119,0.0027426395,0.0075434525],"category_scores_gemma":[0.0030106225,0.00087479106,0.0024265642,0.0006899728,0.0015464467,0.0009842414,0.0004251737,0.0028552276,0.00092915434],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9895726,0.0033494462,0.00020151307,0.00040075486,0.00045443422,0.000016757247,0.0000149569605,0.00006696503,0.0009246838,0.000023332414,0.00011777009,0.0048568496],"study_design_scores_gemma":[0.95653015,0.042085435,0.0005392581,0.000017407865,0.00033680277,0.000013030206,0.000006259269,0.00014253437,0.00017566873,0.000027821905,0.00012036344,0.000005112975],"about_ca_topic_score_codex":0.0008035321,"about_ca_topic_score_gemma":0.0010471949,"teacher_disagreement_score":0.0075434525,"about_ca_system_score_codex":0.00075706164,"about_ca_system_score_gemma":0.0013986975,"threshold_uncertainty_score":0.025235355},"labels":[],"label_agreement":null},{"id":"W2079960625","doi":"10.1111/j.1365-2133.2007.08227.x","title":"Usefulness of the QuantiFERON<sup>®</sup>test in the confirmation of latent tuberculosis in association with erythema induratum","year":2007,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Infectious Diseases and Tuberculosis","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Histopathology; Medicine; Dermatology; Queen (butterfly); Pathology; Biology","score_opus":0.012837998284444572,"score_gpt":0.23521678231300897,"score_spread":0.2223787840285644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079960625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6415188,0.21935207,0.010232743,0.014100322,0.0064207255,0.0008391089,0.002715009,0.001240875,0.103580385],"genre_scores_gemma":[0.94965065,0.02591337,0.010470461,0.0026564584,0.0021474764,0.000061920815,0.0009702429,0.00015960995,0.007969907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578494,0.0011246789,0.0006714855,0.00033276467,0.0017946421,0.00029150242],"domain_scores_gemma":[0.9875772,0.0066117933,0.0017191428,0.00050946744,0.0027008292,0.00088153966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050185607,0.00062922976,0.0008515765,0.006188648,0.0006361794,0.0019976604,0.0008348213,0.002031717,0.009996331],"category_scores_gemma":[0.020591464,0.00047415117,0.0006490966,0.0014810701,0.0009550229,0.0016669458,0.0006933041,0.0011714525,0.0071097226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036010654,0.0005706342,0.55641955,0.003757474,0.00025169677,0.072005965,0.00093922205,0.00033137115,0.05008219,0.0005810323,0.036519606,0.2749402],"study_design_scores_gemma":[0.00029139672,0.0028075674,0.55145544,0.0061983643,0.0008025384,0.32599723,0.0031355722,0.0029113872,0.034725647,0.0013559675,0.07005312,0.0002657158],"about_ca_topic_score_codex":0.0017182506,"about_ca_topic_score_gemma":0.0022099486,"teacher_disagreement_score":0.009996331,"about_ca_system_score_codex":0.00056807726,"about_ca_system_score_gemma":0.0006484934,"threshold_uncertainty_score":0.033441067},"labels":[],"label_agreement":null},{"id":"W2080237150","doi":"10.1111/bjd.13814","title":"Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE)","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Novartis Pharma","keywords":"Secukinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Dosing; Randomized controlled trial; Interleukin 17; Internal medicine; Dermatology; Cytokine; Psoriatic arthritis","score_opus":0.01857271942566301,"score_gpt":0.2995247510734746,"score_spread":0.2809520316478116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080237150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97125727,0.01690511,0.0010377262,0.0011027507,0.0005292005,0.0047719604,0.0015550372,0.00024659722,0.0025943858],"genre_scores_gemma":[0.98147464,0.0070179286,0.0018724249,0.0012364754,0.00043891344,0.00497259,0.00093081786,0.00003603941,0.0020202084],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99906605,0.0005913934,0.000060594557,0.0001062915,0.000082748404,0.00009286793],"domain_scores_gemma":[0.9989454,0.00037662085,0.0003277543,0.000082491184,0.00006152774,0.0002062617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024894588,0.0010131762,0.0021899252,0.000371097,0.00030942823,0.00091586116,0.00058001984,0.0012682677,0.0076663825],"category_scores_gemma":[0.0019348605,0.00042255883,0.0018176404,0.00044173878,0.00071449426,0.00068617635,0.00028589956,0.001964638,0.0008008051],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9549966,0.005578031,0.00076310616,0.001749353,0.0017836911,0.00005238341,0.000050667408,0.00038867263,0.0042036236,0.00013348053,0.0011693627,0.029131003],"study_design_scores_gemma":[0.93005645,0.06509881,0.0025529321,0.00007653806,0.00060012966,0.00006343237,0.000015038517,0.0003157579,0.0004073781,0.0001271805,0.0006754241,0.0000109221655],"about_ca_topic_score_codex":0.00037196832,"about_ca_topic_score_gemma":0.0010414207,"teacher_disagreement_score":0.0076663825,"about_ca_system_score_codex":0.0003696955,"about_ca_system_score_gemma":0.00061566953,"threshold_uncertainty_score":0.025646567},"labels":[],"label_agreement":null},{"id":"W2081479967","doi":"10.1111/j.1365-2133.2008.08962.x","title":"Economic evaluation of systemic therapies for moderate to severe psoriasis","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Advancing Health Outcomes; St. Paul's Hospital","funders":"Abbott Laboratories","keywords":"Medicine; Adalimumab; Infliximab; Etanercept; Efalizumab; Ciclosporin; Psoriasis; Psoriasis Area and Severity Index; Confidence interval; Quality-adjusted life year; Methotrexate; Internal medicine; Cost effectiveness; Transplantation; Dermatology; Rheumatoid arthritis; Tumor necrosis factor alpha","score_opus":0.030662793363812158,"score_gpt":0.26129945777624486,"score_spread":0.2306366644124327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081479967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46889085,0.43387058,0.03075588,0.009348777,0.0010008666,0.0048411046,0.0051680347,0.00014264938,0.04598124],"genre_scores_gemma":[0.9677357,0.023904424,0.0049161557,0.00045801324,0.0001809453,0.001018317,0.0008535229,0.000020720894,0.0009122552],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.983576,0.014675209,0.00036361674,0.00019878651,0.00097506994,0.0002112815],"domain_scores_gemma":[0.98106223,0.016321402,0.0014436962,0.00022528808,0.0005571139,0.00039027154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01446468,0.0011402864,0.0021628137,0.0019353642,0.00022813444,0.0018289499,0.00057681266,0.0011310359,0.0053473734],"category_scores_gemma":[0.037559185,0.0003575846,0.0027416444,0.0016047026,0.0006706959,0.0008104537,0.00082166574,0.0015199287,0.00019703673],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.092044696,0.0024696651,0.034224305,0.039433997,0.029391095,0.0007800051,0.00022679643,0.27419692,0.001278048,0.029577669,0.016042825,0.480334],"study_design_scores_gemma":[0.046704583,0.0399875,0.080014974,0.032203194,0.044821315,0.0036502834,0.0011647396,0.6087292,0.0033399784,0.086831845,0.052164588,0.00038782298],"about_ca_topic_score_codex":0.0022563278,"about_ca_topic_score_gemma":0.0015082483,"teacher_disagreement_score":0.01446468,"about_ca_system_score_codex":0.0034040501,"about_ca_system_score_gemma":0.0028776336,"threshold_uncertainty_score":0.076497436},"labels":[],"label_agreement":null},{"id":"W2082530084","doi":"10.1111/bjd.12343","title":"Network meta-analysis of the outcome ‘participant complete clearance’ in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review","year":2013,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Imiquimod; Actinic keratosis; Medicine; Cryotherapy; Placebo; Psychological intervention; Meta-analysis; Dermatology; Randomized controlled trial; Internal medicine; Surgery; Pathology; Alternative medicine; Psychiatry","score_opus":0.4646027338780947,"score_gpt":0.4694573342131769,"score_spread":0.0048546003350822264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082530084","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016124971,0.9793792,0.0018378556,0.0003508206,0.00041465857,0.0007544817,0.00055246457,0.00006089273,0.0005246942],"genre_scores_gemma":[0.54331434,0.44233593,0.0067098676,0.0018009588,0.00047015064,0.0031670015,0.001344115,0.00009723318,0.00076042],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9741398,0.01779728,0.004253218,0.0017042946,0.0015804151,0.0005249755],"domain_scores_gemma":[0.96442264,0.028119463,0.0035503863,0.0015981806,0.0019837234,0.0003256466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030464567,0.0037191405,0.019571759,0.005476674,0.0006285545,0.0034658127,0.00187048,0.0027757462,0.0031391645],"category_scores_gemma":[0.05587218,0.0017857407,0.05661029,0.0048214486,0.00082291075,0.0021126976,0.0019310337,0.0024975082,0.00033408936],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005786032,0.000029585715,0.0019035969,0.10512216,0.8793415,0.00009624006,0.00004136621,0.00049434777,0.00019502976,0.00013641706,0.00030345548,0.0065503023],"study_design_scores_gemma":[0.0015377739,0.0002629336,0.0016766934,0.00477266,0.9905252,0.00004477514,0.0000193306,0.0002025618,0.00012706275,0.00018663748,0.00062761636,0.000016767108],"about_ca_topic_score_codex":0.0061704246,"about_ca_topic_score_gemma":0.009905834,"teacher_disagreement_score":0.030464567,"about_ca_system_score_codex":0.0036442776,"about_ca_system_score_gemma":0.002623363,"threshold_uncertainty_score":0.16111398},"labels":[],"label_agreement":null},{"id":"W2082814239","doi":"10.1046/j.1365-2133.2003.05160.x","title":"Computerized morphometry and three-dimensional image reconstruction in the evaluation of scalp biopsy from patients with non-cicatricial alopecias","year":2003,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia; St. Thomas Hospital; Vancouver General Hospital; Western University","funders":"","keywords":"Scalp; Medicine; Biopsy; Dermatology; Pathology","score_opus":0.010561696971454405,"score_gpt":0.2411759458217928,"score_spread":0.2306142488503384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082814239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756914,0.00015145408,0.0018557541,0.000022998478,0.000003865321,0.00002800104,0.00004026248,0.000032061496,0.00029638564],"genre_scores_gemma":[0.9957912,0.00009063789,0.0039747227,0.0000102603335,0.0000039486627,0.000014227168,0.00004597319,0.0000059788213,0.00006307096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977046,0.00008462184,0.00002268098,0.00003424102,0.0000722044,0.000015800646],"domain_scores_gemma":[0.99941254,0.00024622743,0.000119870245,0.000049021648,0.00012768386,0.000044616674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005998725,0.00023074837,0.0001679774,0.0011272792,0.00014228484,0.0003087487,0.00022559676,0.00027555798,0.00086882454],"category_scores_gemma":[0.0026075616,0.0002034072,0.0001392627,0.00034548386,0.00024311505,0.00028076183,0.00021721757,0.00017811889,0.00022533255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016809716,0.00014605085,0.8094785,0.00014272051,0.000066318564,0.007802352,0.000703396,0.0024474794,0.0889484,0.00013219495,0.0003885707,0.08806308],"study_design_scores_gemma":[0.00005930132,0.00075256504,0.94230837,0.000019985995,0.000048967493,0.026917873,0.0005658807,0.020199696,0.008479795,0.000110677094,0.0005145012,0.000022381226],"about_ca_topic_score_codex":0.000804953,"about_ca_topic_score_gemma":0.0011878326,"teacher_disagreement_score":0.0011272792,"about_ca_system_score_codex":0.00012819679,"about_ca_system_score_gemma":0.00013878333,"threshold_uncertainty_score":0.0031724572},"labels":[],"label_agreement":null},{"id":"W2083054661","doi":"10.1046/j.1365-2133.149.s65.5.x","title":"Onychomycosis in clinical practice: factors contributing to recurrence","year":2003,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"Galderma","keywords":"Medicine; Disease; Psoriasis; Dermatology; Population; Nail disease; Diabetes mellitus; Nail (fastener); Intensive care medicine; Internal medicine","score_opus":0.07794931063022224,"score_gpt":0.4641900335995579,"score_spread":0.38624072296933565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083054661","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97230726,0.014446646,0.00042373233,0.006198508,0.00016402495,0.00009977188,0.00024193419,0.000049039725,0.0060691065],"genre_scores_gemma":[0.99620515,0.0021589654,0.00029269874,0.00063461775,0.00018219215,0.00002573609,0.00012371704,0.00001365606,0.00036343842],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99511766,0.0015466299,0.0010491073,0.0003808917,0.0014471882,0.00045856956],"domain_scores_gemma":[0.9727529,0.005684421,0.01551864,0.0007420231,0.0025992794,0.0027027186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019258242,0.00020899207,0.00051850337,0.0011724371,0.001032896,0.0014044511,0.0007207082,0.0009930113,0.003731495],"category_scores_gemma":[0.031534713,0.00022320962,0.0004910256,0.0024389555,0.00059652544,0.0010215129,0.0009640956,0.001334634,0.00068148767],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051020972,0.00009928107,0.98168415,0.000110074,0.00004160749,0.0022680757,0.0008175404,0.00006234015,0.000091943,0.00011185999,0.0015364507,0.013125664],"study_design_scores_gemma":[0.000021793068,0.00022532778,0.9569996,0.00052087905,0.00012409769,0.029667426,0.0048003937,0.0011207194,0.00010532859,0.0004583825,0.005901677,0.00005439486],"about_ca_topic_score_codex":0.005752041,"about_ca_topic_score_gemma":0.0061036623,"teacher_disagreement_score":0.005752041,"about_ca_system_score_codex":0.000691246,"about_ca_system_score_gemma":0.0016356792,"threshold_uncertainty_score":0.01248306},"labels":[],"label_agreement":null},{"id":"W2083117221","doi":"10.1111/j.1365-2133.1978.tb06543.x","title":"Erythema gyratum repens with pulmonary tuberculosis","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Clearance; Pathology; Lung; Erythema multiforme; Repens; Dermatology; Internal medicine; Biology","score_opus":0.004004797568197451,"score_gpt":0.20833120747884123,"score_spread":0.2043264099106438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083117221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982896,0.0044006286,0.0005456469,0.0012054647,0.00024142975,0.00007828022,0.000091188835,0.0000891884,0.010452196],"genre_scores_gemma":[0.99802893,0.00058084656,0.000085087944,0.00031297794,0.00028398674,0.0000050187646,0.000029195922,0.0000061028954,0.00066780375],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996462,0.000063133404,0.000032742617,0.000089838024,0.00004841414,0.00011968487],"domain_scores_gemma":[0.99910283,0.00027810104,0.00022752259,0.00009833785,0.00005434638,0.00023897864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035507334,0.0010706144,0.0008654247,0.0008980514,0.0017967587,0.0008123945,0.00035171548,0.002162498,0.004200235],"category_scores_gemma":[0.0024424617,0.00062358147,0.0005258396,0.0007797111,0.0010121737,0.00085680233,0.0010223697,0.0016606537,0.0010458749],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032631008,0.00019589429,0.076464005,0.00006201813,0.000028035724,0.91732603,0.0004115274,0.000047025165,0.0016443955,0.00015823147,0.00040166275,0.0029348885],"study_design_scores_gemma":[0.00006458889,0.00035363936,0.06658356,0.000027268048,0.000041407584,0.9305937,0.00026619586,0.00018621697,0.0002991365,0.00023018403,0.00133815,0.000015887756],"about_ca_topic_score_codex":0.0015281376,"about_ca_topic_score_gemma":0.0016239539,"teacher_disagreement_score":0.004200235,"about_ca_system_score_codex":0.00035956607,"about_ca_system_score_gemma":0.00028870138,"threshold_uncertainty_score":0.014051259},"labels":[],"label_agreement":null},{"id":"W2083481300","doi":"10.1111/j.1365-2133.2010.10013.x","title":"Induction of p38, tumour necrosis factor-α and RANTES by mechanical stretching of keratinocytes expressing mutant keratin 10R156H","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Keratin; Mutant; Keratinocyte; Tumor necrosis factor alpha; Necrosis; Molecular biology; Medicine; Cancer research; Dermatology; Chemistry; Immunology; Pathology; Biology; Cell culture; Genetics; Gene","score_opus":0.008619020893956176,"score_gpt":0.2523322071968302,"score_spread":0.24371318630287403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083481300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99870634,0.00020285932,0.00042026432,0.000020928708,0.000012996628,0.000013630887,0.0001165133,0.000018781782,0.00048770139],"genre_scores_gemma":[0.99798596,0.00017059551,0.0006449099,0.000011886831,0.0000039798506,0.000023645716,0.00020929963,0.0000062157724,0.0009435143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998952,0.000013386653,0.00001232599,0.000019175275,0.000030110032,0.000029725597],"domain_scores_gemma":[0.99990666,0.000012437445,0.000033691933,0.000017012657,0.000007121038,0.000023026223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009877817,0.00033232218,0.00012811748,0.00010039067,0.00008080519,0.00015825217,0.00014590514,0.00018821617,0.0014783442],"category_scores_gemma":[0.00007003354,0.000101177,0.00023519546,0.00007185314,0.00016880414,0.000114791204,0.00013725068,0.00032819543,0.00034500496],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010824245,0.000026398786,0.00008938032,0.000022246591,0.000002458985,0.00004373157,0.000006796892,0.000025195568,0.9994413,0.000016640426,0.0000094116995,0.00020812766],"study_design_scores_gemma":[0.000019022835,0.00042479357,0.0028442142,0.0000046417963,0.0000075161724,0.0001982654,0.000027471393,0.0004455156,0.9956045,0.000019659263,0.00040214774,0.0000024073859],"about_ca_topic_score_codex":0.0002107074,"about_ca_topic_score_gemma":0.00022072312,"teacher_disagreement_score":0.0014783442,"about_ca_system_score_codex":0.000161588,"about_ca_system_score_gemma":0.00009622235,"threshold_uncertainty_score":0.004945576},"labels":[],"label_agreement":null},{"id":"W2084768692","doi":"10.1111/j.1365-2133.1975.tb03119.x","title":"The effect of the activity of psoriasis on the response to autologous ground skin extract","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Psoriasis; Stimulant; Medicine; Inhibitory postsynaptic potential; DNA synthesis; Dermatology; Pharmacology; DNA; Internal medicine; Chemistry; Biochemistry","score_opus":0.007098427813098961,"score_gpt":0.2267103106540354,"score_spread":0.21961188284093644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084768692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961683,0.001230365,0.00026970156,0.00004452735,0.000038195056,0.000021404185,0.000123456,0.000013268353,0.0020906564],"genre_scores_gemma":[0.99796164,0.0005330975,0.00017155343,0.00003411443,0.000031073778,0.000010490046,0.000151719,0.0000059148433,0.0011004651],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99978477,0.00008212537,0.0000119678225,0.000020470654,0.00004247832,0.000058297897],"domain_scores_gemma":[0.9994254,0.00036267913,0.000036548685,0.00004861361,0.00003719736,0.00008956996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002280994,0.00025715228,0.00025383284,0.00019696928,0.000116542105,0.00026647534,0.00009902318,0.00027426894,0.0029944812],"category_scores_gemma":[0.00053496205,0.00010914412,0.0002502922,0.00013947985,0.0002947109,0.0001223476,0.00011279136,0.00071018597,0.00039324275],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025673585,0.00027825707,0.00087154726,0.000075264914,0.00001623402,0.00008932169,0.000054481414,0.00013972883,0.9922794,0.000071821705,0.00003569794,0.0035209125],"study_design_scores_gemma":[0.00011196523,0.0146412635,0.029149532,0.000017410126,0.00006311741,0.000449539,0.00009036902,0.0005785623,0.95349294,0.00007928688,0.0013167395,0.000009325094],"about_ca_topic_score_codex":0.00032290284,"about_ca_topic_score_gemma":0.00036564594,"teacher_disagreement_score":0.0029944812,"about_ca_system_score_codex":0.00010147634,"about_ca_system_score_gemma":0.00015999337,"threshold_uncertainty_score":0.010017514},"labels":[],"label_agreement":null},{"id":"W2085238780","doi":"10.1111/bjd.13191","title":"A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; SKiN Health; University of British Columbia; Occupational Cancer Research Centre; Dermatrials Research; Windsor Clinical Research; Western University","funders":"Galderma","keywords":"Medicine; Adapalene; Acne; Benzoyl peroxide; Adverse effect; Randomized controlled trial; Doxycycline; Fixed-dose combination; Population; Isotretinoin; Papulopustular; Dermatology; Confidence interval; Internal medicine; Surgery; Gastroenterology","score_opus":0.029301897707804354,"score_gpt":0.30113028524355123,"score_spread":0.2718283875357469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085238780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98662126,0.004505144,0.0007664078,0.0005844764,0.0008136225,0.0045095114,0.00072662585,0.0001446108,0.0013283809],"genre_scores_gemma":[0.9834833,0.0029977642,0.0027965829,0.0010022549,0.0008465184,0.0055136555,0.00071197125,0.00002996975,0.0026181098],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99861765,0.0008443085,0.000094491494,0.0002256105,0.00009868241,0.00011923549],"domain_scores_gemma":[0.9983783,0.00046041646,0.00038080098,0.00014333383,0.000119415476,0.0005177564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002573595,0.0018237187,0.0037659914,0.00067426794,0.0005821288,0.0011251651,0.001378247,0.002397601,0.006096568],"category_scores_gemma":[0.0025922316,0.0009669109,0.0018387362,0.0004719306,0.0014991431,0.0011695059,0.00051134103,0.002296099,0.0008983142],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9839851,0.0060634217,0.00011994154,0.00053573743,0.00040292548,0.00001998309,0.000024013256,0.00008248305,0.002900029,0.000039223207,0.00021210944,0.0056150826],"study_design_scores_gemma":[0.95821434,0.04069966,0.00050625997,0.000015283922,0.00014324798,0.00001315402,0.0000067903343,0.000110423534,0.00013254906,0.000029668749,0.00012334036,0.0000053261515],"about_ca_topic_score_codex":0.00080201594,"about_ca_topic_score_gemma":0.0016932599,"teacher_disagreement_score":0.006096568,"about_ca_system_score_codex":0.00058824534,"about_ca_system_score_gemma":0.0011246443,"threshold_uncertainty_score":0.02039504},"labels":[],"label_agreement":null},{"id":"W2085929759","doi":"10.1111/j.1365-2133.2009.09626.x","title":"Keratin mutations in patients with epidermolysis bullosa simplex: correlations between phenotype severity and disturbance of intermediate filament molecular structure","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université Laval","keywords":"Epidermolysis bullosa simplex; Keratin 5; Keratin 14; Intermediate filament; Keratin; Epidermolysis bullosa; Genetics; Biology; Mutation; Gene; Molecular biology; Cytoskeleton; Cell; Transgene; Genetically modified mouse","score_opus":0.004352177017664982,"score_gpt":0.23194460173512743,"score_spread":0.22759242471746244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085929759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994241,0.00016662315,0.000117998905,0.000011038654,0.0000022301956,0.0000059126182,0.000083541956,0.000008303086,0.00018013321],"genre_scores_gemma":[0.9997116,0.00004805211,0.00011426462,0.0000059937447,0.000001911183,0.0000028502138,0.00005840236,0.0000018901244,0.00005508277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997633,0.000030276453,0.00003839806,0.000077990124,0.000060758637,0.000029300258],"domain_scores_gemma":[0.999554,0.00011177018,0.00018409749,0.000024824261,0.000040485924,0.00008484325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020976445,0.00056328,0.00034305052,0.00090792414,0.0003957238,0.0003439688,0.00026038644,0.000462853,0.001803399],"category_scores_gemma":[0.0010468693,0.00021838631,0.0003125756,0.0006943058,0.00029733303,0.0002205485,0.00033785877,0.00026966317,0.00015250026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005147091,0.0000678518,0.96478814,0.000060483293,0.00014060894,0.008130375,0.00032230924,0.00058205304,0.018763188,0.000071882285,0.00014857156,0.0064099394],"study_design_scores_gemma":[0.00006276692,0.00028365682,0.9525376,0.00002771032,0.00015204908,0.041793015,0.00024845876,0.0007485973,0.0035419674,0.00014384229,0.00044011627,0.000020263176],"about_ca_topic_score_codex":0.0018195872,"about_ca_topic_score_gemma":0.001580766,"teacher_disagreement_score":0.0018195872,"about_ca_system_score_codex":0.00025217157,"about_ca_system_score_gemma":0.00021433484,"threshold_uncertainty_score":0.0060329437},"labels":[],"label_agreement":null},{"id":"W2086043494","doi":"10.1111/j.1365-2133.2004.06336.x","title":"Henna tattoos for children: a potential source of para-phenylenediamine and thiuram sensitization","year":2004,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Dermatology; Medicine; Citation; Library science; Computer science","score_opus":0.0064250238686300205,"score_gpt":0.23093993707256572,"score_spread":0.22451491320393568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086043494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789792,0.009709063,0.0013713783,0.0014443508,0.00010255483,0.00008140563,0.00011590702,0.000146627,0.008049522],"genre_scores_gemma":[0.99483734,0.002593466,0.0006900364,0.00020846288,0.000065423264,0.000012476547,0.000041514828,0.000017295262,0.0015338573],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9995233,0.00010045218,0.000043160584,0.00006132811,0.00013926958,0.00013256463],"domain_scores_gemma":[0.9992854,0.000265966,0.00025174022,0.000041492578,0.000054044267,0.000101322184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032186526,0.00081641006,0.00068839156,0.0012530253,0.0013817837,0.00061051524,0.00034418184,0.0030142013,0.0041487706],"category_scores_gemma":[0.0012890017,0.00059951475,0.0007090711,0.00067893515,0.0007835919,0.0008628273,0.0005597168,0.0016509993,0.0007413335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047636504,0.00043609907,0.2480876,0.00070127886,0.00006730414,0.7005617,0.0030084036,0.00012781368,0.018629758,0.0011796907,0.0024129704,0.024310945],"study_design_scores_gemma":[0.000025765105,0.00049892045,0.057797026,0.00014762316,0.00009030634,0.92746043,0.00090035686,0.00022793477,0.0053805155,0.0002270825,0.007221918,0.000022087803],"about_ca_topic_score_codex":0.0030711943,"about_ca_topic_score_gemma":0.0027261465,"teacher_disagreement_score":0.0041487706,"about_ca_system_score_codex":0.0005811703,"about_ca_system_score_gemma":0.0004393537,"threshold_uncertainty_score":0.013879061},"labels":[],"label_agreement":null},{"id":"W2086861262","doi":"10.1111/j.1365-2133.2006.07237.x","title":"Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dermatology Life Quality Index; Infliximab; Psoriasis; Medicine; Maintenance therapy; Placebo; Quality of life (healthcare); Internal medicine; Randomized controlled trial; Regimen; Psoriasis Area and Severity Index; Physical therapy; Surgery; Dermatology; Chemotherapy; Pathology; Tumor necrosis factor alpha","score_opus":0.007955155368587987,"score_gpt":0.21694139133958537,"score_spread":0.20898623597099739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086861262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94093525,0.042402454,0.0010911515,0.0019990893,0.0014687943,0.006908448,0.0015623511,0.00023271026,0.0033996608],"genre_scores_gemma":[0.9696363,0.013678862,0.0020360646,0.0020328371,0.0011225247,0.008457164,0.0012487803,0.000020497042,0.0017670213],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983846,0.0009529204,0.00016469997,0.00020310169,0.00014291679,0.00015167418],"domain_scores_gemma":[0.9980969,0.0006882698,0.0005723951,0.000102231854,0.000102657425,0.00043756724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029828006,0.0010115384,0.0037595227,0.0005820761,0.00055520126,0.0013008317,0.0011780637,0.0022784597,0.007051482],"category_scores_gemma":[0.0033685444,0.0005025055,0.002226499,0.00076590985,0.0012067213,0.0007335446,0.0004306515,0.0023280627,0.00046796887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9798226,0.0024570206,0.0007350273,0.0014910907,0.0014592498,0.000030878033,0.000030087527,0.000091084374,0.00059812353,0.00006582176,0.0005949822,0.012624076],"study_design_scores_gemma":[0.98232585,0.015074333,0.001482706,0.00007408798,0.00056281226,0.000020039755,0.000008925648,0.00010479913,0.000053033247,0.000036705464,0.00025055325,0.0000061778765],"about_ca_topic_score_codex":0.0010598137,"about_ca_topic_score_gemma":0.0016872518,"teacher_disagreement_score":0.007051482,"about_ca_system_score_codex":0.0007487176,"about_ca_system_score_gemma":0.0012656521,"threshold_uncertainty_score":0.023589492},"labels":[],"label_agreement":null},{"id":"W2086898224","doi":"10.1111/j.1365-2133.1983.tb06814.x","title":"Leukotrienes as mediators of skin inflammation","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Guinea pig; Vascular permeability; Leukotriene; Leukotriene B4; Leukotriene D4; Chemistry; Arachidonic acid; Chemotaxis; Frog Skin; Immunology; Histamine; Inflammation; Biology; Endocrinology; Biochemistry; Enzyme; Receptor","score_opus":0.004166143960058501,"score_gpt":0.23694931201149394,"score_spread":0.23278316805143545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086898224","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17936689,0.7907625,0.004774311,0.0010805775,0.00065844314,0.0002857307,0.0003349001,0.00012007814,0.022616498],"genre_scores_gemma":[0.6900394,0.28895733,0.003245866,0.0005901141,0.00066849554,0.00023371282,0.00039245008,0.00002094927,0.015851682],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99957997,0.00015096586,0.000028441384,0.000047517744,0.000097976575,0.00009517648],"domain_scores_gemma":[0.9998442,0.000030832787,0.000034549204,0.000009114746,0.00003146839,0.000049753886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045378204,0.0005214782,0.00049549795,0.0006510873,0.00038308228,0.001131992,0.00043855968,0.0007061778,0.0038211606],"category_scores_gemma":[0.00030226336,0.00016969819,0.00025795327,0.00048122957,0.0003900284,0.001066196,0.0006222762,0.0008781265,0.001138713],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023620678,0.0005980484,0.004311282,0.005091436,0.00007921286,0.0047002593,0.0007244382,0.00048598228,0.813261,0.019922186,0.0032196252,0.1452446],"study_design_scores_gemma":[0.0004840471,0.006048991,0.05151622,0.0017195428,0.00049683766,0.015710667,0.001784352,0.0016598222,0.50622284,0.02410107,0.39015782,0.00009778174],"about_ca_topic_score_codex":0.00037626913,"about_ca_topic_score_gemma":0.0003577363,"teacher_disagreement_score":0.0038211606,"about_ca_system_score_codex":0.00047893572,"about_ca_system_score_gemma":0.00030196065,"threshold_uncertainty_score":0.012783051},"labels":[],"label_agreement":null},{"id":"W2088155036","doi":"10.1111/j.1365-2133.2008.08771.x","title":"Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Etanercept; Medicine; Placebo; Psoriasis; Clinical endpoint; Psoriasis Area and Severity Index; Internal medicine; Randomized controlled trial; Gastroenterology; Surgery; Dermatology; Tumor necrosis factor alpha; Pathology","score_opus":0.013127596193070683,"score_gpt":0.23315935662622386,"score_spread":0.22003176043315317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088155036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806404,0.0075841956,0.0012524836,0.00055582327,0.00061134447,0.0067256135,0.0006256475,0.00022712153,0.0017772865],"genre_scores_gemma":[0.98021406,0.0044202735,0.002988248,0.0009401124,0.0010404082,0.0072041843,0.00073214876,0.000027832117,0.0024327147],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99853194,0.0008539865,0.0001312733,0.00019639813,0.00014886666,0.00013742899],"domain_scores_gemma":[0.99859685,0.00041330073,0.0003872722,0.0001130734,0.00008756697,0.00040187794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003457875,0.0012351573,0.0030834663,0.00065039925,0.0005095313,0.00093523884,0.00091938896,0.002106058,0.0066843354],"category_scores_gemma":[0.0024243135,0.0008901348,0.0015427183,0.0005827975,0.0012731962,0.0011510552,0.00039561608,0.0021308234,0.001016584],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9666316,0.010785862,0.0004929159,0.0005222924,0.0004222656,0.000026522324,0.000031271145,0.00012195126,0.0028722333,0.000050178267,0.00032167594,0.01772116],"study_design_scores_gemma":[0.95335925,0.044450663,0.001452161,0.000021180796,0.00012248075,0.000020082338,0.0000063216594,0.00014847815,0.00018618838,0.000025962863,0.00019997988,0.0000071843415],"about_ca_topic_score_codex":0.00047125857,"about_ca_topic_score_gemma":0.0009524154,"teacher_disagreement_score":0.0066843354,"about_ca_system_score_codex":0.0004973483,"about_ca_system_score_gemma":0.00092524954,"threshold_uncertainty_score":0.022361338},"labels":[],"label_agreement":null},{"id":"W2091162745","doi":"10.1111/j.1365-2133.2008.08678.x","title":"Identification of categories at risk for high quality of life impairment in patients with vitiligo","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Unit (ring theory); Medicine; Identification (biology); Vitiligo; Library science; Psychology; Dermatology; Computer science; Mathematics education; Biology","score_opus":0.007790009760276121,"score_gpt":0.2405824887110398,"score_spread":0.23279247895076366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091162745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993038,0.00018465905,0.000040718038,0.000047352958,0.0000021839933,0.0000073408764,0.000068945075,0.0000016870607,0.00034337208],"genre_scores_gemma":[0.9997819,0.00003927711,0.00005484321,0.000010719377,0.0000034186546,0.000004429383,0.00007563233,3.765819e-7,0.000029347451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996493,0.00010752124,0.000038767866,0.000042437867,0.000069766786,0.00009232731],"domain_scores_gemma":[0.99870026,0.00032391597,0.00058810104,0.000038257644,0.00010136014,0.00024812703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005282928,0.00023381547,0.00033073177,0.0010096114,0.0003867631,0.00049785443,0.0001840327,0.0003756432,0.0023601511],"category_scores_gemma":[0.0025055765,0.00010452514,0.0002933703,0.000752665,0.0002676124,0.00040199765,0.0006627369,0.0004892209,0.0002468153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065080814,0.000022687931,0.99723107,0.000013366019,0.000009374574,0.00007426667,0.000107437234,0.000033199223,0.00013419591,0.000008273017,0.000058731956,0.0022423095],"study_design_scores_gemma":[0.000005387642,0.00009720372,0.99873275,0.000008315246,0.000010822715,0.0005996677,0.00027049822,0.00011287739,0.000045445166,0.000035572142,0.00007829339,0.000003135803],"about_ca_topic_score_codex":0.0008732333,"about_ca_topic_score_gemma":0.0008363365,"teacher_disagreement_score":0.0023601511,"about_ca_system_score_codex":0.0002047543,"about_ca_system_score_gemma":0.00021158859,"threshold_uncertainty_score":0.007895529},"labels":[],"label_agreement":null},{"id":"W2091320760","doi":"10.1111/j.1365-2133.2007.07681.x","title":"The antiwrinkle effect of topical concentrated 2-dimethylaminoethanol involves a vacuolar cytopathology","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Centre hospitalier universitaire de Québec","funders":"Health Canada","keywords":"Library science; Humanities; Cytopathology; Art; Medicine; Computer science; Cytology","score_opus":0.006906920331438601,"score_gpt":0.27463349319129104,"score_spread":0.26772657285985246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091320760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98814976,0.0054457863,0.0037737472,0.00005451582,0.000036781126,0.00008825403,0.00019075148,0.000109301436,0.0021512439],"genre_scores_gemma":[0.99588734,0.0012552963,0.001593639,0.000029121717,0.000011211372,0.00002458631,0.000104491075,0.000007786975,0.0010864892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998882,0.000022059216,0.000008851622,0.000027499673,0.00003188312,0.000021598247],"domain_scores_gemma":[0.9998368,0.000060377817,0.00003700133,0.000023451925,0.00002801362,0.000014326389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015416421,0.00032360922,0.00020401903,0.0001611286,0.00009546479,0.00021113557,0.0002005692,0.00031880912,0.0024547335],"category_scores_gemma":[0.0001284224,0.00008289303,0.00023710389,0.000072920644,0.00021378316,0.0002457598,0.00013849634,0.00035924467,0.00037813486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068113615,0.000013371574,0.00010793509,0.00004949052,0.0000034099871,0.000040796498,0.000006271244,0.0000121662515,0.9987023,0.00002096302,0.0000081986755,0.0009669963],"study_design_scores_gemma":[0.00000992137,0.00050243275,0.0046478803,0.000005484015,0.000010348341,0.00031226513,0.000014390245,0.00013931558,0.99346703,0.000012862149,0.000875978,0.0000021139253],"about_ca_topic_score_codex":0.00033934013,"about_ca_topic_score_gemma":0.00032250385,"teacher_disagreement_score":0.0024547335,"about_ca_system_score_codex":0.00020089342,"about_ca_system_score_gemma":0.00011836429,"threshold_uncertainty_score":0.008211911},"labels":[],"label_agreement":null},{"id":"W2091824266","doi":"10.1111/bjd.12687","title":"Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review","year":2013,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Critical appraisal; Family medicine; Library science; General hospital; Alternative medicine; Pathology","score_opus":0.12013446466045938,"score_gpt":0.4242890843564514,"score_spread":0.304154619695992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091824266","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002489853,0.99726874,0.00008818986,0.0012850108,0.0003323338,0.00015864037,0.00019271843,0.0000049519663,0.00042037255],"genre_scores_gemma":[0.003263311,0.9946195,0.0006765514,0.0007932323,0.000117062984,0.00020493395,0.0001899252,0.0000042586016,0.00013131429],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9911062,0.0023715151,0.0033135125,0.00038192945,0.0025602286,0.00026672194],"domain_scores_gemma":[0.96837956,0.014927077,0.0067520146,0.00034422742,0.009024464,0.00057265634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016100472,0.0013341805,0.004826457,0.01643556,0.00084524584,0.0029469696,0.0023952422,0.0018910706,0.0036087413],"category_scores_gemma":[0.055587217,0.0009081556,0.0042269067,0.01500944,0.0009401741,0.002538113,0.0015285464,0.0017708248,0.00041851474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023091726,0.000040730585,0.001188276,0.6594704,0.0029418669,0.00025394707,0.0006224393,0.00035031565,0.00022443326,0.0016700167,0.03257362,0.30043307],"study_design_scores_gemma":[0.00014611035,0.00013006706,0.0041250717,0.8290701,0.010640329,0.00038652617,0.0006553984,0.00013094823,0.00016339833,0.0008616676,0.15363806,0.00005239661],"about_ca_topic_score_codex":0.030317465,"about_ca_topic_score_gemma":0.074976794,"teacher_disagreement_score":0.9696825,"about_ca_system_score_codex":0.009458137,"about_ca_system_score_gemma":0.030575646,"threshold_uncertainty_score":0.085148394},"labels":[],"label_agreement":null},{"id":"W2095370280","doi":"10.1046/j.1365-2133.2003.05728.x","title":"Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis","year":2004,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Western University; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Itraconazole; Terbinafine; Medicine; Fluconazole; Dermatophyte; Meta-analysis; Internal medicine; Griseofulvin; Randomized controlled trial; Confidence interval; Regimen; Dermatology; Surgery; Antifungal","score_opus":0.16510020542580864,"score_gpt":0.41439880283074104,"score_spread":0.2492985974049324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095370280","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022290744,0.96854436,0.0049827914,0.0006138744,0.0007543379,0.00042007497,0.0014193155,0.00017017878,0.00080438994],"genre_scores_gemma":[0.7145134,0.26923156,0.009220802,0.0011218409,0.00085237785,0.0015880306,0.0024096193,0.0001498042,0.0009126209],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9579501,0.03043559,0.0045502773,0.0034670488,0.0029510804,0.00064595276],"domain_scores_gemma":[0.9434477,0.045413952,0.0052724984,0.0026889828,0.0024491653,0.0007276544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03861301,0.0050737746,0.022242688,0.01066403,0.00070243044,0.0045579844,0.0028363154,0.0034648373,0.003931749],"category_scores_gemma":[0.065660425,0.0023855155,0.06727151,0.008208044,0.0007402393,0.002138069,0.0021742987,0.0030896303,0.00045093094],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036987083,0.000017290733,0.0027745774,0.017210098,0.97137624,0.0000691913,0.000015023737,0.0016893916,0.00011042364,0.00009172226,0.00024300745,0.0027042604],"study_design_scores_gemma":[0.0009017377,0.00026068147,0.002312518,0.0010937605,0.9935183,0.00006215067,0.000012149057,0.0008895067,0.000103703795,0.00026207586,0.0005672585,0.000016186812],"about_ca_topic_score_codex":0.0070043863,"about_ca_topic_score_gemma":0.0068972143,"teacher_disagreement_score":0.03861301,"about_ca_system_score_codex":0.0030771596,"about_ca_system_score_gemma":0.0024642022,"threshold_uncertainty_score":0.20420754},"labels":[],"label_agreement":null},{"id":"W2096882452","doi":"10.1111/j.1365-2133.2010.09755.x","title":"British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology","year":2010,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Aberdeen","keywords":"Acitretin; Dermatology; Medicine; Dermatologic agents; Association (psychology); MEDLINE; Family medicine; Psoriasis; Psychology; Biology","score_opus":0.056650671493028666,"score_gpt":0.3478676417949854,"score_spread":0.29121697030195676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096882452","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022426948,0.42658675,0.005964412,0.14323772,0.035253372,0.0013677271,0.0047709243,0.0008101239,0.37976626],"genre_scores_gemma":[0.04179157,0.47768536,0.04037019,0.1112843,0.023263987,0.0039377427,0.012997749,0.0010262365,0.2876428],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99273336,0.0021219682,0.0013813733,0.00031945916,0.0029552893,0.0004884876],"domain_scores_gemma":[0.98087007,0.0056382082,0.0018678198,0.00091129896,0.009063203,0.0016493689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069188895,0.00066500576,0.0012281366,0.00259784,0.0012660893,0.0023073163,0.0023843788,0.0044831485,0.03961583],"category_scores_gemma":[0.01607625,0.00062638277,0.0015242645,0.0030979381,0.0010731836,0.0016104432,0.0014747784,0.0058994973,0.021667697],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008688819,0.00012198179,0.0003892592,0.001531338,0.000017857268,0.00027335578,0.00007157643,0.000103434686,0.00063086307,0.002206067,0.73868674,0.25588056],"study_design_scores_gemma":[0.000043592125,0.000028331113,0.0017582661,0.0022019427,0.000011957143,0.00058196764,0.00003046833,0.000043775926,0.000092948554,0.0009123439,0.9942821,0.000012307231],"about_ca_topic_score_codex":0.012623843,"about_ca_topic_score_gemma":0.024861244,"teacher_disagreement_score":0.03961583,"about_ca_system_score_codex":0.002581783,"about_ca_system_score_gemma":0.00672873,"threshold_uncertainty_score":0.13252819},"labels":[],"label_agreement":null},{"id":"W2096935199","doi":"10.1111/j.1365-2133.1995.tb08705.x","title":"U1RNP positive neonatal lupus erythematosus: association with anti-La antibodies?","year":2006,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Antibody; Lupus erythematosus; Immunology; Systemic lupus erythematosus; Association (psychology); Dermatology; Internal medicine; Disease; Psychology","score_opus":0.017190050764987076,"score_gpt":0.3126523946781687,"score_spread":0.2954623439131816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096935199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016326358,0.99631196,0.00013342046,0.00038362754,0.00019007664,0.000004123501,0.0000115088305,0.000009675514,0.0013229856],"genre_scores_gemma":[0.011661397,0.9865399,0.00019756524,0.00035283653,0.0005083211,0.000006189828,0.000037359536,0.0000026238195,0.0006936859],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997588,0.00005061594,0.000053796593,0.00004254407,0.00006473445,0.000029612163],"domain_scores_gemma":[0.99966,0.00015576265,0.00009181314,0.000009516091,0.00005343975,0.0000295531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033606673,0.0007898129,0.0016528921,0.0020657335,0.00021165397,0.0006668113,0.0007046091,0.0012201483,0.001986715],"category_scores_gemma":[0.00080812984,0.00029814144,0.00034322016,0.0020432675,0.000522675,0.0009895123,0.0003390449,0.00064649375,0.0014736468],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016159154,0.00006889155,0.00572317,0.013753783,0.00013029322,0.028918093,0.00014481561,0.0002107153,0.0024056928,0.0006845624,0.021599596,0.92619884],"study_design_scores_gemma":[0.00011261872,0.00029990115,0.027387459,0.0094956085,0.00048334867,0.4988855,0.00052016694,0.0003072798,0.0016464886,0.001538696,0.4592544,0.000068584646],"about_ca_topic_score_codex":0.0010415452,"about_ca_topic_score_gemma":0.0016938089,"teacher_disagreement_score":0.0020657335,"about_ca_system_score_codex":0.00034983005,"about_ca_system_score_gemma":0.00047640575,"threshold_uncertainty_score":0.006646216},"labels":[],"label_agreement":null},{"id":"W2098835966","doi":"10.1111/j.1365-2133.2005.06948.x","title":"Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Etanercept; Dermatology Life Quality Index; Medicine; Psoriasis; Placebo; Psoriasis Area and Severity Index; Internal medicine; Randomized controlled trial; Quality of life (healthcare); Physical therapy; Surgery; Dermatology; Tumor necrosis factor alpha; Pathology; Nursing","score_opus":0.01380888393346637,"score_gpt":0.25708492088982243,"score_spread":0.24327603695635605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098835966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704047,0.015732417,0.0013288552,0.0011512601,0.000467623,0.005755242,0.0019874186,0.00014587224,0.0030267285],"genre_scores_gemma":[0.9774865,0.0056894384,0.0022427875,0.0015200853,0.0006193666,0.009268229,0.001873611,0.000035434532,0.0012646266],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963325,0.0025135935,0.00027603382,0.0003489398,0.00031772966,0.00021111674],"domain_scores_gemma":[0.99446446,0.00197354,0.0020422712,0.00042389805,0.00033124693,0.00076466065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070447107,0.0011702763,0.002951601,0.00036742192,0.0005036139,0.001416541,0.000996424,0.002063967,0.0043017156],"category_scores_gemma":[0.0057804384,0.0005269874,0.0031196317,0.00063808454,0.0012385577,0.0009309093,0.00040974768,0.0027335875,0.0005435303],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9690457,0.0056750407,0.0018370331,0.0006866917,0.0026700036,0.00002649003,0.00004754429,0.00031935365,0.00083507353,0.00007223504,0.00075051654,0.018034248],"study_design_scores_gemma":[0.967709,0.026804158,0.0035610953,0.000060097977,0.0009900699,0.000025476591,0.000012612344,0.00021940329,0.00017456425,0.000074526004,0.00035963865,0.000009387226],"about_ca_topic_score_codex":0.0006028305,"about_ca_topic_score_gemma":0.0008212727,"teacher_disagreement_score":0.0070447107,"about_ca_system_score_codex":0.0008979081,"about_ca_system_score_gemma":0.001407144,"threshold_uncertainty_score":0.03725648},"labels":[],"label_agreement":null},{"id":"W2099237146","doi":"10.1111/bjd.12751","title":"Skin cancer: more than skin deep?","year":2014,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada; University of British Columbia; SKiN Health","funders":"","keywords":"Medicine; Dermatology; Cancer; Skin cancer; Internal medicine","score_opus":0.012944552021130557,"score_gpt":0.27685709269329345,"score_spread":0.2639125406721629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099237146","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004468715,0.0840081,0.000060309787,0.84214604,0.04016033,0.000013590209,0.00021061469,0.0000052324517,0.028927172],"genre_scores_gemma":[0.08764699,0.10593557,0.00016670769,0.6294091,0.13830459,0.00004132759,0.00013836997,0.000020092213,0.038337283],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845386,0.000754376,0.00019503746,0.00012518375,0.00032843955,0.00014313323],"domain_scores_gemma":[0.9939122,0.0040150885,0.0005614594,0.00016073168,0.00076932844,0.0005811789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022687356,0.0003496242,0.00080873223,0.0008950654,0.0014812985,0.0028767213,0.00047464497,0.005287806,0.018001886],"category_scores_gemma":[0.01057187,0.00022735314,0.00032416935,0.0018024498,0.0017478083,0.0031527756,0.0010228296,0.0047605895,0.0019907288],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033070563,0.00006165236,0.009030658,0.0014823981,0.00007639102,0.0023158574,0.0006998638,0.00002122257,0.00026423292,0.01038125,0.92497176,0.050364062],"study_design_scores_gemma":[0.00024725212,0.00019394181,0.029975304,0.0043582367,0.00020227818,0.010037634,0.004833101,0.000051440657,0.00024138059,0.013562163,0.936258,0.000039297345],"about_ca_topic_score_codex":0.006201812,"about_ca_topic_score_gemma":0.012307659,"teacher_disagreement_score":0.018001886,"about_ca_system_score_codex":0.0014842107,"about_ca_system_score_gemma":0.0015735038,"threshold_uncertainty_score":0.060222328},"labels":[],"label_agreement":null},{"id":"W2106026283","doi":"10.1111/j.1365-2133.2006.07741.x","title":"Idiopathic facial aseptic granuloma: a multicentre prospective study of 30 cases","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Bartonella species infections research","field":"Immunology and Microbiology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Dermatology; Granuloma; Lesion; Bartonella; Etiology; Prospective cohort study; Nodule (geology); Surgery; Outpatient clinic; Pathology; Internal medicine","score_opus":0.013307541731414293,"score_gpt":0.2823753806552936,"score_spread":0.2690678389238793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106026283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994758,0.00020252095,0.00005837734,0.000007824221,0.000002388304,0.0000366209,0.000066317254,0.0000030904503,0.00014701796],"genre_scores_gemma":[0.9994019,0.00016659833,0.00012614756,0.000021416316,0.000012374404,0.000038219987,0.00017827684,0.0000026182915,0.000052417192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988518,0.00023509341,0.00014536365,0.00031091753,0.00022956842,0.00022729345],"domain_scores_gemma":[0.9979087,0.0004505499,0.0007847699,0.00019037163,0.00017851897,0.0004870828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009893841,0.0006908983,0.00087224867,0.0016889955,0.0009306313,0.00082181994,0.0005491456,0.0008040043,0.0018327084],"category_scores_gemma":[0.002649708,0.00089965214,0.00057828956,0.0012150013,0.0007700906,0.00083217106,0.00095813384,0.0004480774,0.0005616872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014271996,0.00012873916,0.9934371,0.000028987411,0.00002566453,0.004239418,0.00035575137,0.000024036497,0.00039084058,0.000012742989,0.000060758914,0.0011532569],"study_design_scores_gemma":[0.000044039378,0.00088335417,0.97656095,0.0000195602,0.000036213994,0.021117933,0.0008032836,0.000109775065,0.0000953033,0.000015011133,0.00030252858,0.0000119927345],"about_ca_topic_score_codex":0.0022328405,"about_ca_topic_score_gemma":0.0019990099,"teacher_disagreement_score":0.0022328405,"about_ca_system_score_codex":0.00048776317,"about_ca_system_score_gemma":0.00048611267,"threshold_uncertainty_score":0.0061309934},"labels":[],"label_agreement":null},{"id":"W2106171751","doi":"10.1111/j.1365-2133.2004.05986.x","title":"Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris","year":2004,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Calcipotriol; Medicine; Betamethasone dipropionate; Psoriasis; Betamethasone; Dermatology; Psoriasis Area and Severity Index; Internal medicine","score_opus":0.013239316774461081,"score_gpt":0.23853204966403918,"score_spread":0.2252927328895781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106171751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99698526,0.0017501656,0.00016964834,0.000075694516,0.00006254057,0.00032753072,0.00009195121,0.000021224487,0.0005160677],"genre_scores_gemma":[0.9968451,0.00071419525,0.0007461176,0.00017745991,0.00015184481,0.00063486106,0.00022548297,0.0000069870252,0.0004978979],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990495,0.0004558976,0.00008343708,0.00014661494,0.0001869944,0.00007754247],"domain_scores_gemma":[0.99851984,0.000631216,0.00032444388,0.00014515716,0.00005744711,0.00032178365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001586419,0.0004593396,0.0018671314,0.00052244414,0.00033373534,0.00046891658,0.00057655346,0.0008557881,0.0026281045],"category_scores_gemma":[0.0023048467,0.00030685595,0.0007383638,0.0003165627,0.00055906444,0.0005595832,0.00023725606,0.0011387358,0.000327838],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68175524,0.065336205,0.0075196815,0.000835721,0.00130608,0.00011578291,0.00017638294,0.0018903811,0.031054808,0.00017259766,0.0007463141,0.20909066],"study_design_scores_gemma":[0.27271816,0.6819262,0.03549439,0.00008379343,0.00079591793,0.0002456586,0.00006053295,0.0019797431,0.0049465005,0.00022975048,0.0014814446,0.000037968006],"about_ca_topic_score_codex":0.00027364286,"about_ca_topic_score_gemma":0.00043291735,"teacher_disagreement_score":0.0026281045,"about_ca_system_score_codex":0.00037381594,"about_ca_system_score_gemma":0.00048921944,"threshold_uncertainty_score":0.0087919235},"labels":[],"label_agreement":null},{"id":"W2106886047","doi":"10.1111/j.1365-2133.2012.10994.x","title":"Homeopathy for eczema: a systematic review of controlled clinical trials","year":2012,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Park","funders":"","keywords":"Homeopathy; Alternative medicine; Medicine; Clinical trial; Family medicine; Classics; History; Internal medicine; Pathology","score_opus":0.337114868072886,"score_gpt":0.540665372948514,"score_spread":0.20355050487562804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106886047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045244631,0.9986082,0.00010019782,0.00011591105,0.00008227668,0.00038749047,0.00009837862,0.0000059065464,0.00014932522],"genre_scores_gemma":[0.007846631,0.9900468,0.0008412876,0.0002928612,0.0000707549,0.00070479553,0.000100597426,0.000004191983,0.00009206896],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98674715,0.005469502,0.0044717407,0.00068744645,0.0023736283,0.0002506041],"domain_scores_gemma":[0.95457006,0.03246963,0.0086226845,0.0006135442,0.0032844807,0.00043966615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014668355,0.0019236534,0.01173691,0.010902728,0.00079367124,0.0028316693,0.0022082836,0.0022521098,0.0059252973],"category_scores_gemma":[0.05319336,0.0012097291,0.006932631,0.0117604565,0.0012598861,0.0023910028,0.001396788,0.0013069615,0.00040126676],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029959242,0.000019001955,0.00025682454,0.96168524,0.0077971043,0.00007140839,0.00009588836,0.00005607063,0.00012698627,0.00012091532,0.00091179024,0.02855925],"study_design_scores_gemma":[0.00087270833,0.0004394233,0.0025426259,0.8723295,0.105523154,0.00039027177,0.00023533066,0.00009607481,0.00024525652,0.0003872603,0.016894039,0.000044284716],"about_ca_topic_score_codex":0.0049148975,"about_ca_topic_score_gemma":0.016881222,"teacher_disagreement_score":0.014668355,"about_ca_system_score_codex":0.0038663188,"about_ca_system_score_gemma":0.0103844525,"threshold_uncertainty_score":0.07757461},"labels":[],"label_agreement":null},{"id":"W2110447511","doi":"10.1111/j.1365-2133.1989.tb07783.x","title":"Histiocytoma cutis: a tumour of dermal dendrocytes (dermal dendrocytoma)","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Histogenesis; Pathology; Vimentin; Population; Connective tissue; S100 protein; Biology; Dermis; Immunohistochemistry; Monoclonal antibody; Antibody; Medicine; Immunology","score_opus":0.009447492113769034,"score_gpt":0.244238658606278,"score_spread":0.23479116649250897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110447511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994286,0.0011405888,0.0009719088,0.000050621456,0.000016215643,0.0000387675,0.000069657566,0.000030123478,0.003396035],"genre_scores_gemma":[0.9983005,0.00028766887,0.00056498236,0.000012722467,0.0000081735525,0.000006449197,0.000051251744,0.0000025860966,0.00076572824],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990094,0.000012079102,0.000008390946,0.000025912199,0.000025068446,0.00002773374],"domain_scores_gemma":[0.99983275,0.000038682865,0.000052497384,0.000016209538,0.000017229282,0.000042661468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012450166,0.0003501988,0.0001623432,0.00044924457,0.00028336173,0.00030527293,0.000100590565,0.0004121664,0.0009099962],"category_scores_gemma":[0.00028781645,0.00018228228,0.000065222055,0.00023718143,0.00043435692,0.00020536532,0.00027010293,0.00022337974,0.0005040168],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009380065,0.00015834326,0.0907218,0.00061569613,0.000046459558,0.16545136,0.00053008844,0.00018227179,0.7166884,0.0008412006,0.0004958173,0.023330588],"study_design_scores_gemma":[0.00017621065,0.0008362761,0.30073753,0.00004482887,0.000056421057,0.6138834,0.00046645827,0.0010057138,0.071066014,0.0004983889,0.01119858,0.000030216723],"about_ca_topic_score_codex":0.0007020366,"about_ca_topic_score_gemma":0.0010618985,"teacher_disagreement_score":0.0009099962,"about_ca_system_score_codex":0.00021352038,"about_ca_system_score_gemma":0.00015091065,"threshold_uncertainty_score":0.003044188},"labels":[],"label_agreement":null},{"id":"W2111537744","doi":"10.1111/j.1365-2133.1976.tb07921.x","title":"(33) Pyoderma gangrenosum with cellular immunity deficit treated with plasmaphoresis and leukocyte transfusion","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Pyoderma gangrenosum; Carboxylesterase; Isozyme; Immunology; Globulin; Biology; Medicine; Enzyme; Biochemistry; Pathology; Disease","score_opus":0.004122588779252667,"score_gpt":0.18627306750658615,"score_spread":0.18215047872733348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111537744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93154943,0.003358162,0.00776857,0.0079234075,0.0011134293,0.00071905815,0.00079713034,0.00047391356,0.046296984],"genre_scores_gemma":[0.98136616,0.0009978403,0.0014782678,0.0028466461,0.00040301212,0.00008349899,0.00034413065,0.00003314709,0.012447237],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997961,0.00002792744,0.000016995984,0.000040287832,0.00003340699,0.000085318796],"domain_scores_gemma":[0.99978644,0.00003377516,0.00004475702,0.000024329793,0.000018938072,0.00009166289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022254109,0.00076598104,0.0005664266,0.00097515626,0.0011384344,0.00028960506,0.000351936,0.001687591,0.0031570287],"category_scores_gemma":[0.0008279403,0.0002684117,0.00069690443,0.00043830415,0.00073497376,0.00038578102,0.0005923801,0.001767172,0.0008215435],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011484971,0.0009420757,0.022126526,0.0001522942,0.00008369758,0.94437635,0.00041408755,0.00031972962,0.008341653,0.0016465266,0.0022934636,0.018155104],"study_design_scores_gemma":[0.0003736934,0.003623196,0.07859938,0.000087940396,0.00015152137,0.8875922,0.00030341116,0.0013215193,0.006896948,0.0019119311,0.01907382,0.000064431835],"about_ca_topic_score_codex":0.0024073115,"about_ca_topic_score_gemma":0.0020613933,"teacher_disagreement_score":0.0031570287,"about_ca_system_score_codex":0.00033727774,"about_ca_system_score_gemma":0.00045496144,"threshold_uncertainty_score":0.010561287},"labels":[],"label_agreement":null},{"id":"W2116561250","doi":"10.1111/j.1365-2133.2007.08092.x","title":"Repeat liposuction-curettage treatment of axillary hyperhidrosis is safe and effective","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Liposuction; Surgery; Curettage; Scars; Hyperhidrosis; Cannula; Patient satisfaction","score_opus":0.008366073237409722,"score_gpt":0.26609275320390535,"score_spread":0.2577266799664956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116561250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908025,0.0045888135,0.0017508727,0.00019016846,0.000025050618,0.00005026191,0.000038304952,0.00014750105,0.0024065285],"genre_scores_gemma":[0.9975821,0.00070249155,0.0008798136,0.00008522417,0.00007485436,0.000023978204,0.000073332725,0.000010627302,0.0005675793],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998312,0.000033289725,0.000011090867,0.000029579141,0.0000667626,0.000028014478],"domain_scores_gemma":[0.9995198,0.00019460397,0.00011703569,0.000048078644,0.000036886035,0.00008356278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019701588,0.000263451,0.0004342404,0.00023007287,0.00016342403,0.00015164327,0.00023490301,0.00023726218,0.002543464],"category_scores_gemma":[0.0007691709,0.00007215368,0.0003980609,0.0001107937,0.0001644112,0.00013349598,0.0001455762,0.00032332764,0.0004185604],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003930055,0.002056879,0.17320083,0.0006165178,0.00030163128,0.0075087724,0.00046688278,0.0010108027,0.085838996,0.00011453015,0.0030634413,0.7218907],"study_design_scores_gemma":[0.0012195943,0.022525163,0.85316455,0.00024912713,0.0003879259,0.07640033,0.00042929736,0.003250115,0.027151529,0.00023475841,0.014933743,0.000053885225],"about_ca_topic_score_codex":0.00037057235,"about_ca_topic_score_gemma":0.0010441691,"teacher_disagreement_score":0.002543464,"about_ca_system_score_codex":0.00014224388,"about_ca_system_score_gemma":0.00020609699,"threshold_uncertainty_score":0.008508682},"labels":[],"label_agreement":null},{"id":"W2117159275","doi":"10.1111/j.1365-2133.2011.10775.x","title":"Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Welichem Biotech (Canada); University of British Columbia; Centre de Recherche Dermatologique du Québec Métropolitain; Innovaderm (Canada)","funders":"","keywords":"Placebo; Medicine; Atopic dermatitis; Internal medicine; Randomized controlled trial; Randomization; Clinical endpoint; Confidence interval; Double blind; Gastroenterology; Dermatology; Pathology","score_opus":0.020735843188581012,"score_gpt":0.253027453172948,"score_spread":0.232291609984367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117159275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806621,0.011628425,0.0006619389,0.0005404069,0.00041386398,0.0038982618,0.000843275,0.000099172496,0.0012524854],"genre_scores_gemma":[0.9853756,0.004658825,0.0015246989,0.0009809849,0.0005465531,0.0044359094,0.00086024776,0.000024273542,0.0015929694],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99829954,0.000948364,0.00017373943,0.00027631727,0.00014419421,0.00015783531],"domain_scores_gemma":[0.9974776,0.00086472795,0.0006791131,0.00023439525,0.00018184922,0.0005623289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037526907,0.0015144914,0.0046208207,0.00042257918,0.0006387648,0.0010857023,0.0010685947,0.0025923117,0.006190103],"category_scores_gemma":[0.0033192888,0.00076811505,0.002331025,0.0005637019,0.0014082179,0.0010450552,0.0004172173,0.0023092302,0.001214668],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9826173,0.0034152705,0.0006430578,0.0006998046,0.0007636565,0.000021748221,0.000035787372,0.0000884398,0.0020643931,0.000021517613,0.00020667855,0.009422308],"study_design_scores_gemma":[0.9573769,0.039521992,0.0021095276,0.000028116132,0.00045502852,0.000020950942,0.0000077407085,0.0000866774,0.00016754847,0.000030276316,0.00018630164,0.0000089892665],"about_ca_topic_score_codex":0.0004088649,"about_ca_topic_score_gemma":0.00084623223,"teacher_disagreement_score":0.006190103,"about_ca_system_score_codex":0.00059517723,"about_ca_system_score_gemma":0.0011334923,"threshold_uncertainty_score":0.020707905},"labels":[],"label_agreement":null},{"id":"W2117252673","doi":"10.1111/bjd.12042","title":"U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Bexarotene; Medicine; Dosing; Pharmacology; Retinoid X receptor; Internal medicine; Chemistry; Biochemistry; Nuclear receptor","score_opus":0.027984189372815126,"score_gpt":0.32428958093910853,"score_spread":0.29630539156629343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117252673","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007967841,0.07503584,0.030367512,0.7255668,0.036467124,0.0064683766,0.004915007,0.0012932128,0.111918375],"genre_scores_gemma":[0.082223855,0.06471836,0.1668964,0.5755895,0.013208989,0.009033284,0.008408933,0.0010343031,0.07888633],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9531165,0.018464891,0.01490941,0.0019845543,0.007916335,0.0036082738],"domain_scores_gemma":[0.8948563,0.020892777,0.015964637,0.003325566,0.054956213,0.010004553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.034543175,0.001278721,0.0025723602,0.002237241,0.0033024019,0.0040824744,0.0074629737,0.025136162,0.006990467],"category_scores_gemma":[0.043404687,0.0016169661,0.0049571716,0.0024575852,0.0021207742,0.002587306,0.0038535565,0.0123028075,0.008724674],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058616005,0.00029992036,0.0024282918,0.0038419967,0.00019117251,0.0013402514,0.0005756497,0.0015546173,0.0040742224,0.00622497,0.8149145,0.16396825],"study_design_scores_gemma":[0.00023901011,0.00027593636,0.0041278442,0.005889809,0.00016360947,0.0011827578,0.00054359064,0.00049466675,0.0017762757,0.0024932362,0.98269534,0.000117815165],"about_ca_topic_score_codex":0.013470405,"about_ca_topic_score_gemma":0.016153358,"teacher_disagreement_score":0.034543175,"about_ca_system_score_codex":0.0070994156,"about_ca_system_score_gemma":0.037545107,"threshold_uncertainty_score":0.18268394},"labels":[],"label_agreement":null},{"id":"W2118533896","doi":"10.1111/bjd.12190","title":"Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study)","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Nottingham; National Institute for Health and Care Research; Pfizer","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Receiver operating characteristic; Dermatology; Internal medicine; Epidemiology; Gold standard (test); Arthritis; Physical therapy","score_opus":0.02475089544807674,"score_gpt":0.27740036532054674,"score_spread":0.25264946987247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118533896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984164,0.00046321735,0.00017997218,0.000051840885,0.00001843734,0.00016759918,0.00020921604,0.000007104819,0.00048621788],"genre_scores_gemma":[0.9989925,0.00010139203,0.00035922125,0.00004116487,0.000017563025,0.00010963427,0.00030511434,0.0000023870807,0.0000710714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99546415,0.0023884187,0.00047736813,0.0005288515,0.00085806625,0.00028313376],"domain_scores_gemma":[0.9909768,0.00359186,0.002969493,0.0003728971,0.0011254265,0.0009633685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005382719,0.00064003083,0.00086397945,0.001148583,0.00034034628,0.0010336885,0.0005150813,0.0005940254,0.0009582511],"category_scores_gemma":[0.009856225,0.00039045102,0.0014284867,0.00070396543,0.0003510055,0.0005503262,0.00093984755,0.0006026165,0.00022385134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0093276715,0.0005877168,0.97779274,0.00020962534,0.001036562,0.00004339772,0.00021077521,0.00018426985,0.00040402182,0.00005057852,0.00025925078,0.009893524],"study_design_scores_gemma":[0.0016155387,0.0059875436,0.9894828,0.000049268398,0.0006266989,0.00031563712,0.0002732302,0.00093175704,0.0001982249,0.00006972444,0.00042276082,0.000026791487],"about_ca_topic_score_codex":0.001415628,"about_ca_topic_score_gemma":0.0019236186,"teacher_disagreement_score":0.005382719,"about_ca_system_score_codex":0.0005080243,"about_ca_system_score_gemma":0.0005397296,"threshold_uncertainty_score":0.02846688},"labels":[],"label_agreement":null},{"id":"W2119766232","doi":"10.1111/j.1365-2133.1995.tb02506.x","title":"A case of necrotizing fasciitis due to Streptococcus pnewnoniae","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria General Hospital; University of Manitoba","funders":"","keywords":"Fasciitis; Streptococcus pneumoniae; Medicine; Streptococcus; Pathogenesis; STREPTOCOCCAL INFECTIONS; Dermatology; Pathology; Microbiology; Surgery; Immunology; Biology; Bacteria; Antibiotics; Genetics","score_opus":0.011799329379802964,"score_gpt":0.2742067164965582,"score_spread":0.26240738711675526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119766232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9514351,0.009588551,0.005183054,0.00613851,0.0014174419,0.00032028108,0.00029026216,0.00028248676,0.025344385],"genre_scores_gemma":[0.9895884,0.0024453541,0.0020684402,0.001712427,0.001221111,0.000047968497,0.00008677263,0.000035141253,0.0027945926],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999238,0.00010687876,0.00008863147,0.00018593948,0.00012437352,0.0002561437],"domain_scores_gemma":[0.99798787,0.0007327886,0.00038674174,0.00017062805,0.00011017237,0.0006118263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042184524,0.0026073446,0.001500392,0.0020434766,0.0036142701,0.0016729453,0.00084311055,0.0056345435,0.0029409693],"category_scores_gemma":[0.004769936,0.0014598978,0.0010005578,0.0015723371,0.0018444896,0.0025692717,0.0021758347,0.00404122,0.0012321767],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023648197,0.00003487672,0.002806273,0.00003108731,0.0000050385943,0.9951841,0.00025291948,0.000040334,0.00043093972,0.00011323207,0.0001747805,0.0009028599],"study_design_scores_gemma":[0.000010252256,0.000064622356,0.0015977942,0.000010789761,0.0000059973304,0.9973653,0.00009491246,0.00007559644,0.00017068381,0.00012159939,0.00047589978,0.000006647341],"about_ca_topic_score_codex":0.0013132347,"about_ca_topic_score_gemma":0.001352358,"teacher_disagreement_score":0.0056345435,"about_ca_system_score_codex":0.0010846396,"about_ca_system_score_gemma":0.0008234363,"threshold_uncertainty_score":0.009838581},"labels":[],"label_agreement":null},{"id":"W2120155938","doi":"10.1046/j.1365-2133.2002.04975.x","title":"Differential expression of collagen integrin receptor on fetal vs. adult skin fibroblasts: implication in wound contraction during healing","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Wound Healing and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement","funders":"Medical Research Council; Fondation des pompiers du Québec pour les grands brûlés","keywords":"Contraction (grammar); Medicine; Wound healing; Humanities; Art; Surgery; Internal medicine","score_opus":0.011227314788184905,"score_gpt":0.26008299129265794,"score_spread":0.24885567650447304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120155938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966292,0.0013872809,0.001054279,0.000021812548,0.0000048593197,0.0000057660413,0.00020523721,0.0000076047313,0.0006840239],"genre_scores_gemma":[0.9967642,0.0008850902,0.00096731645,0.000020872636,0.000007796886,0.00001303461,0.00044035108,0.000006963403,0.00089431106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987817,0.000025979407,0.000014243172,0.000018840168,0.00002881978,0.00003395959],"domain_scores_gemma":[0.99978846,0.00007414237,0.000044053846,0.000020994348,0.000032073676,0.00004029821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015848533,0.00012748719,0.00010020494,0.00017445249,0.000076569086,0.00023509926,0.000091485796,0.00019974283,0.0015821017],"category_scores_gemma":[0.00025319765,0.00007678061,0.00011983706,0.0001336617,0.00009859813,0.00020291787,0.0000975268,0.0001867035,0.00031833808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014780283,0.000009510845,0.001550998,0.000020959238,0.0000024039775,0.0000772634,0.00003253306,0.000010807933,0.99677247,0.0000336805,0.0000149438365,0.0013267186],"study_design_scores_gemma":[0.00001924351,0.0006907371,0.1372573,0.000017628987,0.000042256925,0.0027641582,0.00018887233,0.00053865294,0.8563483,0.000084574436,0.0020379499,0.000010339084],"about_ca_topic_score_codex":0.0003118508,"about_ca_topic_score_gemma":0.0002498766,"teacher_disagreement_score":0.0015821017,"about_ca_system_score_codex":0.00012215234,"about_ca_system_score_gemma":0.000059057696,"threshold_uncertainty_score":0.0052927136},"labels":[],"label_agreement":null},{"id":"W2121157956","doi":"10.1046/j.1365-2133.2000.03479.x","title":"Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; St. Michael's Hospital; Ministry of Health and Long Term Care; Toronto Western Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Tinea capitis; Microsporum canis; Medicine; Microsporum; Trichophyton tonsurans; Fluconazole; Trichophyton; Mycosis; Griseofulvin; Dermatology; Dermatophyte; Dosing; Antifungal; Surgery; Internal medicine","score_opus":0.004481592176194673,"score_gpt":0.2612122906321673,"score_spread":0.25673069845597263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121157956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99866486,0.00094131374,0.000047327194,0.000034902645,0.000008539698,0.00007021928,0.00007979205,0.000004814298,0.00014824705],"genre_scores_gemma":[0.9988047,0.00047615907,0.00022878873,0.000105012165,0.000031094838,0.00008838215,0.00017566817,0.0000034122234,0.00008681149],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9975859,0.0012660046,0.0001647323,0.00024360232,0.00039133005,0.00034842847],"domain_scores_gemma":[0.9970086,0.0007681779,0.0010017036,0.00015235016,0.0003383601,0.0007307976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023592173,0.00090481696,0.0013070623,0.0006663831,0.00070937193,0.00081452844,0.0004899281,0.0011565302,0.00069234474],"category_scores_gemma":[0.003843223,0.0005751355,0.0011260777,0.00094484317,0.00080581446,0.00053791644,0.0002866936,0.0007651665,0.00017017574],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01743705,0.0052083284,0.9489343,0.00051017094,0.0007716704,0.0017363877,0.0009977594,0.00022599827,0.003861448,0.00004736788,0.0005270072,0.019742524],"study_design_scores_gemma":[0.005192084,0.05225869,0.93529254,0.00007994998,0.0005592686,0.003298208,0.00054001174,0.00025085185,0.00085063034,0.000016858245,0.0016208775,0.00003997021],"about_ca_topic_score_codex":0.0052281,"about_ca_topic_score_gemma":0.008455828,"teacher_disagreement_score":0.0052281,"about_ca_system_score_codex":0.00091440196,"about_ca_system_score_gemma":0.0009956791,"threshold_uncertainty_score":0.0124768615},"labels":[],"label_agreement":null},{"id":"W2121994209","doi":"10.1111/bjd.13980","title":"Prioritizing the global research agenda in psoriasis: an International Psoriasis Council Delphi consensus exercise","year":2015,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Biotech; AbbVie; Celgene; Novartis; Amgen; Pfizer; Eli Lilly and Company","keywords":"Psoriasis; Delphi method; Delphi; Medicine; Consensus conference; MEDLINE; Dermatology; Political science; Family medicine; Internal medicine; Computer science; Law","score_opus":0.3033537745233487,"score_gpt":0.468302712239089,"score_spread":0.16494893771574026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121994209","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008334927,0.0022834067,0.008530486,0.9666041,0.0072649606,0.001171693,0.00006720265,0.000043195905,0.0056999596],"genre_scores_gemma":[0.3256812,0.007848513,0.11656684,0.5179429,0.0140313,0.009137906,0.00020314244,0.00028806477,0.008300199],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.6852256,0.25250804,0.021774232,0.0042462912,0.024263345,0.011982355],"domain_scores_gemma":[0.5502875,0.37981227,0.008730429,0.0061337734,0.035634324,0.019401733],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.29120386,0.0010957057,0.0027676763,0.0030238563,0.01562977,0.013814236,0.0044437405,0.036275376,0.005863829],"category_scores_gemma":[0.3452965,0.0018847936,0.0032828301,0.0027030136,0.011481269,0.011158709,0.023275468,0.047850903,0.0013467431],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007088141,0.0007716009,0.003429035,0.005616202,0.00035929176,0.0067739743,0.19764802,0.0026447694,0.0043096,0.08960098,0.5115884,0.17654924],"study_design_scores_gemma":[0.0006067071,0.0005079129,0.0054393588,0.015172243,0.00025742262,0.0030632173,0.16783996,0.006155967,0.0014360374,0.16052374,0.63836217,0.0006352747],"about_ca_topic_score_codex":0.005219443,"about_ca_topic_score_gemma":0.0091280565,"teacher_disagreement_score":0.29120386,"about_ca_system_score_codex":0.017312964,"about_ca_system_score_gemma":0.08031525,"threshold_uncertainty_score":0.87407184},"labels":[],"label_agreement":null},{"id":"W2124603351","doi":"10.1111/j.1365-2133.2006.07343.x","title":"Update on the use of ciclosporin in immune-mediated dermatoses","year":2006,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novartis Pharma; Novartis","keywords":"Ciclosporin; Medicine; Atopic dermatitis; Psoriasis; Pyoderma gangrenosum; Dermatology; Adverse effect; Immunology; Population; Disease; Chemotherapy; Internal medicine","score_opus":0.05653462639228964,"score_gpt":0.30541151866331423,"score_spread":0.24887689227102458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124603351","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009882457,0.99814296,0.000062684405,0.00031545665,0.0004329784,0.0000055154096,0.000016704136,0.000006301463,0.0009185992],"genre_scores_gemma":[0.00041413863,0.9981481,0.00017214505,0.00030019935,0.0004136125,0.0000055080054,0.000031092866,0.0000015432025,0.00051369594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994729,0.0001153868,0.00010716857,0.00005560548,0.00021625868,0.00003269121],"domain_scores_gemma":[0.9986243,0.00067778165,0.00018183149,0.000030142912,0.0003951266,0.00009089983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001234568,0.0010625963,0.0023865574,0.004232078,0.00033046355,0.0010973236,0.0013471511,0.0017360027,0.005271001],"category_scores_gemma":[0.0019937218,0.00037718116,0.00080155145,0.0041921674,0.00043998443,0.0017249967,0.0006822479,0.0017595282,0.00300385],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095628675,0.00009168314,0.0002016432,0.023454221,0.00011973792,0.00065866066,0.00009661715,0.00027804635,0.00070981827,0.0010391726,0.07999885,0.893256],"study_design_scores_gemma":[0.00003265644,0.00010217151,0.0010627242,0.008191013,0.00021517086,0.003062628,0.000061686536,0.00007009786,0.00016769097,0.0005056212,0.9865118,0.000016684002],"about_ca_topic_score_codex":0.0023083603,"about_ca_topic_score_gemma":0.005110778,"teacher_disagreement_score":0.005271001,"about_ca_system_score_codex":0.00074694137,"about_ca_system_score_gemma":0.0011472267,"threshold_uncertainty_score":0.0176332},"labels":[],"label_agreement":null},{"id":"W2126457303","doi":"10.1111/j.1365-2133.2010.09707.x","title":"Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis","year":2010,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"Abbott Laboratories","keywords":"Psoriasis; Medicine; Risk factor; Necrosis; Oncology; Dermatology; Internal medicine","score_opus":0.027893241891942245,"score_gpt":0.3084209535246435,"score_spread":0.28052771163270124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126457303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2192384,0.65833116,0.09244991,0.004126462,0.00063743495,0.004428851,0.004722301,0.000261409,0.015804248],"genre_scores_gemma":[0.93206775,0.03115368,0.031916596,0.0011180332,0.0006571352,0.0015685852,0.0008473879,0.000048393413,0.00062246644],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.91800225,0.061220583,0.0057902304,0.0025607103,0.011998369,0.000427805],"domain_scores_gemma":[0.83750856,0.13772283,0.017270112,0.0020899167,0.0046402616,0.0007682387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.071960896,0.0014612986,0.0045124884,0.0062743663,0.00026523636,0.0025899138,0.0012559496,0.0014600188,0.004481155],"category_scores_gemma":[0.13642034,0.0005575231,0.01051579,0.0027091855,0.00081990944,0.0017525529,0.0023445394,0.00235127,0.00030730708],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04103727,0.0010182668,0.095168434,0.04826465,0.22927888,0.0005696612,0.0006480125,0.064821124,0.0032517852,0.0089754965,0.0030825979,0.5038838],"study_design_scores_gemma":[0.019978147,0.044752333,0.26026827,0.030562826,0.376154,0.0032758834,0.0006697929,0.10898096,0.0075092004,0.10180411,0.045439158,0.00060536084],"about_ca_topic_score_codex":0.00058255397,"about_ca_topic_score_gemma":0.000846233,"teacher_disagreement_score":0.071960896,"about_ca_system_score_codex":0.0022267734,"about_ca_system_score_gemma":0.0018561904,"threshold_uncertainty_score":0.3805701},"labels":[],"label_agreement":null},{"id":"W2129350137","doi":"10.1111/j.1365-2133.2010.10093.x","title":"Assessing peristomal skin changes in ostomy patients: validation of the Ostomy Skin Tool","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Stoma care and complications","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario; London Health Sciences Centre","funders":"","keywords":"Medicine; Health professionals; Scale (ratio); Categorical variable; Nursing assessment; Nursing; Nurse practitioners; Health care; MEDLINE; Family medicine; Physical therapy","score_opus":0.010410828228777065,"score_gpt":0.2750689416190242,"score_spread":0.2646581133902471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129350137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522346,0.00019932778,0.0023936026,0.000050213686,0.000040435847,0.00060376903,0.000121096426,0.000011548199,0.0013564719],"genre_scores_gemma":[0.9904013,0.00015888903,0.008363168,0.000054952856,0.000012148132,0.00042865562,0.0002501297,0.000010015037,0.00032065687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935628,0.0032084617,0.0007885242,0.00057631265,0.0016307625,0.00023325432],"domain_scores_gemma":[0.98478216,0.0074241944,0.0014142377,0.0010372599,0.004815032,0.0005270278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015856571,0.00036858927,0.0003946418,0.0007035523,0.00034187015,0.0006420231,0.0004748957,0.0005119452,0.0008410011],"category_scores_gemma":[0.020546934,0.00019162743,0.000554524,0.00039127356,0.0006711947,0.0004217558,0.001301677,0.00046234083,0.00032325863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015886127,0.001156843,0.911534,0.0005774823,0.00015311158,0.0003070314,0.007561924,0.00073572906,0.009632161,0.00015849445,0.0004715483,0.066123046],"study_design_scores_gemma":[0.00018413321,0.0050491057,0.9789778,0.00021015541,0.00008854959,0.0010360685,0.0038853511,0.0025529356,0.0039252206,0.00012606745,0.0039272946,0.000037279613],"about_ca_topic_score_codex":0.0010108809,"about_ca_topic_score_gemma":0.0016754749,"teacher_disagreement_score":0.015856571,"about_ca_system_score_codex":0.0004602664,"about_ca_system_score_gemma":0.00082053046,"threshold_uncertainty_score":0.08385861},"labels":[],"label_agreement":null},{"id":"W2130843061","doi":"10.1111/j.1365-2133.2008.08747.x","title":"A 4-year follow-up study of atopic dermatitis therapy with 0·1% tacrolimus ointment in children and adult patients","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Tacrolimus; Medicine; Tolerability; Atopic dermatitis; Population; Surgery; Clinical trial; Pediatrics; Adverse effect; Dermatology; Internal medicine; Transplantation","score_opus":0.006434480742738847,"score_gpt":0.22380721295109574,"score_spread":0.2173727322083569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130843061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99910647,0.00035045398,0.000033587687,0.000026211783,0.0000075509297,0.000045556048,0.00013080392,0.0000029873606,0.0002964441],"genre_scores_gemma":[0.99896264,0.0001496944,0.00007730102,0.00006683558,0.00002622461,0.000047040357,0.00041626077,0.0000017735398,0.00025218338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990922,0.00027438177,0.00008723965,0.00014427416,0.00017103367,0.0002309667],"domain_scores_gemma":[0.99828976,0.00029138997,0.0006232673,0.00011074175,0.00020736393,0.00047753574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017419843,0.00054402475,0.0012316791,0.00085078494,0.0010438219,0.0008746964,0.0003882735,0.0008198052,0.0015098513],"category_scores_gemma":[0.0022575045,0.00035511688,0.0010161061,0.00078341225,0.0004291567,0.0009558093,0.0004592249,0.0013791595,0.00041086203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077047837,0.001570891,0.982778,0.000041890522,0.0002489742,0.000743453,0.0004008114,0.00006835724,0.0008141441,0.000019351157,0.00018803863,0.0054213936],"study_design_scores_gemma":[0.0005683481,0.008555125,0.9889579,0.000011441358,0.00017681062,0.0007243864,0.00022461558,0.00011746885,0.00011248803,0.0000134503425,0.0005263835,0.000011622619],"about_ca_topic_score_codex":0.003067328,"about_ca_topic_score_gemma":0.0023298252,"teacher_disagreement_score":0.003067328,"about_ca_system_score_codex":0.00074501947,"about_ca_system_score_gemma":0.00056342606,"threshold_uncertainty_score":0.009212613},"labels":[],"label_agreement":null},{"id":"W2131020062","doi":"10.1111/j.1365-2133.2006.07585.x","title":"Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasis","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Amgen","keywords":"Etanercept; Psoriasis; Medicine; Pharmacokinetics; Internal medicine; Dermatology; Pharmacology; Tumor necrosis factor alpha","score_opus":0.018106902793602615,"score_gpt":0.29266588155561674,"score_spread":0.2745589787620141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131020062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99852306,0.00079031475,0.00010084257,0.000032619148,0.000007829976,0.00003930007,0.000050546532,0.0000056843214,0.00044986655],"genre_scores_gemma":[0.9993431,0.00022492273,0.00013033974,0.000072519746,0.000018996514,0.000025466758,0.00008824967,0.0000013713028,0.0000950237],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99945754,0.00024018738,0.000055845365,0.00008804817,0.000104809376,0.00005352144],"domain_scores_gemma":[0.99897975,0.0004338149,0.0002614125,0.0000477789,0.00007184888,0.00020536942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010795539,0.00022496565,0.00069874927,0.00026790725,0.00020273203,0.00038891216,0.00014033123,0.00032617227,0.00091658876],"category_scores_gemma":[0.001853908,0.00016653124,0.0004808898,0.0002691151,0.00018451606,0.0003424291,0.00013905237,0.00061415404,0.00021547226],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3114677,0.013459086,0.39236,0.00060975895,0.0022766152,0.0011479228,0.0006947076,0.0035215272,0.04920501,0.0001946774,0.0017241766,0.22333884],"study_design_scores_gemma":[0.034030125,0.19412814,0.75322443,0.00009301771,0.0014383656,0.0035673145,0.00036775024,0.0036994156,0.0054706545,0.00031925295,0.0036033995,0.00005804684],"about_ca_topic_score_codex":0.00032333535,"about_ca_topic_score_gemma":0.0005347935,"teacher_disagreement_score":0.0010795539,"about_ca_system_score_codex":0.0003343197,"about_ca_system_score_gemma":0.00031774255,"threshold_uncertainty_score":0.00570935},"labels":[],"label_agreement":null},{"id":"W2131727392","doi":"10.1111/bjd.14164","title":"Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":479,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; SKiN Health","funders":"Celgene","keywords":"Apremilast; Medicine; Psoriasis; Placebo; Adverse effect; Psoriasis Area and Severity Index; Internal medicine; Dermatology Life Quality Index; Nausea; Randomized controlled trial; Population; Tolerability; Dermatology; Psoriatic arthritis; Pathology; Alternative medicine","score_opus":0.007377866692009705,"score_gpt":0.2451757533723236,"score_spread":0.2377978866803139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131727392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859817,0.0057368465,0.00058268494,0.00067274785,0.00036480013,0.003952466,0.0008370259,0.00012303254,0.0017486202],"genre_scores_gemma":[0.9830766,0.0039538317,0.0018878676,0.0012308934,0.0006078091,0.0057402444,0.0011493108,0.000025930998,0.0023276974],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999212,0.00044442716,0.00006172508,0.0001365069,0.00006966747,0.00007567144],"domain_scores_gemma":[0.9990528,0.00028340213,0.00026720943,0.00006758742,0.000061384475,0.0002676172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028362775,0.0013616605,0.0024165325,0.00039970147,0.00039464651,0.0010298191,0.000690787,0.0015915661,0.005494689],"category_scores_gemma":[0.0019679328,0.0006258672,0.0019137857,0.00035854653,0.0008618195,0.00081727793,0.00030577628,0.0022948235,0.00073882454],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9705054,0.0070965975,0.000690725,0.00069266435,0.00071424106,0.00003624729,0.000043336506,0.00021014815,0.003630962,0.000067224035,0.00064849254,0.015664035],"study_design_scores_gemma":[0.95824677,0.039485913,0.0013921061,0.000022105745,0.00021697367,0.000028169521,0.000007477596,0.00015659299,0.00019552758,0.00004028319,0.00020112554,0.0000069442026],"about_ca_topic_score_codex":0.00032858708,"about_ca_topic_score_gemma":0.00074099307,"teacher_disagreement_score":0.005494689,"about_ca_system_score_codex":0.0004025347,"about_ca_system_score_gemma":0.0008928929,"threshold_uncertainty_score":0.018381536},"labels":[],"label_agreement":null},{"id":"W2132923004","doi":"10.1111/bjd.13013","title":"Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease‐based registry (PSOLAR)","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Janssen Biotech; Janssen Scientific Affairs","keywords":"Medicine; Psoriasis; Disease; Patient registry; Prospective cohort study; Baseline (sea); Longitudinal study; Internal medicine; Physical therapy; Pediatrics; Dermatology; Pathology","score_opus":0.00590134978092694,"score_gpt":0.188536144276712,"score_spread":0.18263479449578507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132923004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948068,0.0001684565,0.0001567436,0.00006327767,0.0000048991787,0.000041343188,0.0040463433,0.0000103579005,0.00070179504],"genre_scores_gemma":[0.9958371,0.00014147029,0.0001815247,0.000052463005,0.000011544614,0.00006339626,0.0035011382,0.0000034367724,0.00020784655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927276,0.0002283404,0.000119737175,0.00019847811,0.000097560136,0.00008317414],"domain_scores_gemma":[0.9978708,0.0002281575,0.0012114292,0.00019237834,0.00020144587,0.0002958505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009895468,0.00019578854,0.00033424448,0.0011568293,0.0004810523,0.00055220275,0.0003016893,0.0003451869,0.0026897588],"category_scores_gemma":[0.0024386216,0.0002501548,0.00041087205,0.0015509096,0.00019242006,0.00088467804,0.00048201875,0.0006075132,0.000539375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012473836,0.000039753355,0.99881065,0.00000871864,0.000025211482,0.000033155546,0.00006182516,0.000028000806,0.00006419163,0.000013576121,0.00023548424,0.0005547505],"study_design_scores_gemma":[0.000011833377,0.00012461873,0.9991173,0.000004646297,0.000014157297,0.00020556172,0.00016931942,0.000115484436,0.000024403525,0.0000152037055,0.00019324847,0.0000041572152],"about_ca_topic_score_codex":0.0061914343,"about_ca_topic_score_gemma":0.00582068,"teacher_disagreement_score":0.0061914343,"about_ca_system_score_codex":0.00035295356,"about_ca_system_score_gemma":0.00038148713,"threshold_uncertainty_score":0.012310803},"labels":[],"label_agreement":null},{"id":"W2135480474","doi":"10.1111/j.1365-2133.2004.05708.x","title":"Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma","year":2004,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":569,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Melanoma; Incidence (geometry); Epidemiology; Medicine; Etiology; Dermatology; Pathology; Cancer research","score_opus":0.03889809445399199,"score_gpt":0.3269901848030527,"score_spread":0.2880920903490607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135480474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017061553,0.99696344,0.00008583269,0.0014761222,0.00043198737,0.000002556798,0.000028946124,0.000007804828,0.0008326648],"genre_scores_gemma":[0.0011219332,0.9976955,0.00012024992,0.00038951333,0.0004118071,0.000003866862,0.000033326054,7.4894933e-7,0.00022295766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964774,0.000107580265,0.000052875323,0.000053167387,0.00011258585,0.000026002961],"domain_scores_gemma":[0.99908864,0.0003533665,0.00014643707,0.000018659011,0.00031764957,0.00007521031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000979823,0.00082053046,0.0014260868,0.0026618873,0.00025935945,0.0012466434,0.0007340214,0.0013080019,0.005477965],"category_scores_gemma":[0.0017094552,0.00024153567,0.0005762799,0.0044655744,0.0003706584,0.0018574197,0.00053345814,0.001357132,0.0018167807],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008449045,0.000038651902,0.0014532305,0.014855187,0.00017422384,0.00036922918,0.00018482079,0.00050531316,0.0005613699,0.0026606722,0.047484946,0.9316278],"study_design_scores_gemma":[0.000020857364,0.0001381605,0.010577759,0.012726097,0.00029753576,0.0026461212,0.00067292835,0.00019963285,0.00017187466,0.0028460934,0.9696604,0.000042537577],"about_ca_topic_score_codex":0.0029208893,"about_ca_topic_score_gemma":0.004436452,"teacher_disagreement_score":0.005477965,"about_ca_system_score_codex":0.0008565607,"about_ca_system_score_gemma":0.0013293441,"threshold_uncertainty_score":0.018325627},"labels":[],"label_agreement":null},{"id":"W2138315687","doi":"10.1111/j.1365-2133.2009.09436.x","title":"A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0·02% tretinoin product regimen","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Moisturizer; Niacinamide; Medicine; Wrinkle; Dermatology; Regimen; Tretinoin; Sensitive skin; Erythema; Tolerability; Surgery; Pharmacology; Adverse effect; Nicotinamide; Chemistry; Retinoic acid","score_opus":0.018211022899139253,"score_gpt":0.2702476302366969,"score_spread":0.25203660733755767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138315687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870099,0.0021079595,0.0005043136,0.00024834322,0.0006518396,0.0076643815,0.00057335506,0.0000822654,0.0011576994],"genre_scores_gemma":[0.9782452,0.001901244,0.002822571,0.00067219336,0.0007588975,0.012025655,0.0007357809,0.00002049512,0.002818067],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99824905,0.0009163212,0.00017642208,0.00031249961,0.00016230924,0.0001833006],"domain_scores_gemma":[0.9972493,0.0010825037,0.00057242706,0.00023424775,0.00024343375,0.00061803526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026928012,0.0014868532,0.004583877,0.0007024431,0.0007055925,0.0010580644,0.0015130363,0.0022499207,0.00890235],"category_scores_gemma":[0.0035647475,0.0009419364,0.001760003,0.00058355066,0.0016257811,0.0011492091,0.00046681537,0.002387893,0.001052339],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98151946,0.012222034,0.0001457511,0.00025740426,0.00026413918,0.000016823424,0.0000174516,0.000038543076,0.0015944041,0.000026219703,0.000085963955,0.0038117205],"study_design_scores_gemma":[0.8578685,0.14040136,0.0009039849,0.000014923334,0.0002604949,0.000009444992,0.00001346733,0.00012117189,0.0002207088,0.000032652242,0.00014618544,0.0000071450618],"about_ca_topic_score_codex":0.0009855931,"about_ca_topic_score_gemma":0.0017630443,"teacher_disagreement_score":0.00890235,"about_ca_system_score_codex":0.00071912754,"about_ca_system_score_gemma":0.0014965428,"threshold_uncertainty_score":0.029781282},"labels":[],"label_agreement":null},{"id":"W2140579099","doi":"10.1111/j.1365-2133.2006.07743.x","title":"Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Psoriasis; Editorial board; Medical school; Family medicine; Dermatology; Library science; Medical education","score_opus":0.017322771621634578,"score_gpt":0.26841306818914656,"score_spread":0.251090296567512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140579099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841344,0.0008732033,0.00015898762,0.000021108115,0.0000048798347,0.00000673265,0.000156153,0.000011680378,0.000353702],"genre_scores_gemma":[0.99954057,0.00013312577,0.000115816205,0.000012562387,0.0000052393248,0.0000034903658,0.00010493871,0.0000016543643,0.00008255017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997441,0.000047222307,0.000037316753,0.00007162968,0.00006695162,0.00003273365],"domain_scores_gemma":[0.99945456,0.000113557464,0.000232622,0.00002626619,0.000070672206,0.000102440645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001930386,0.0002500866,0.00031229947,0.000645509,0.00025849565,0.00044521884,0.00008566196,0.00032662475,0.00092447194],"category_scores_gemma":[0.0008944741,0.00012195437,0.00020522124,0.00052274327,0.0001692301,0.00025657285,0.00014413432,0.00032315386,0.00021825329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020041438,0.000102920516,0.950661,0.00007730314,0.00012494078,0.0008163527,0.00024356256,0.00011548987,0.035373118,0.000033340348,0.0001468962,0.010301039],"study_design_scores_gemma":[0.000021166856,0.0006326483,0.9927168,0.0000069494818,0.00007929571,0.0033666496,0.0001045558,0.00021172017,0.0025368757,0.000041701223,0.0002753565,0.0000061155674],"about_ca_topic_score_codex":0.00038876518,"about_ca_topic_score_gemma":0.0004021324,"teacher_disagreement_score":0.00092447194,"about_ca_system_score_codex":0.0001556831,"about_ca_system_score_gemma":0.0000937941,"threshold_uncertainty_score":0.0030926466},"labels":[],"label_agreement":null},{"id":"W2141045409","doi":"10.1111/j.1365-2133.2009.09491.x","title":"Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Western University","funders":"","keywords":"Ustekinumab; Psoriasis; Medicine; Quality of life (healthcare); Phoenix; Dermatology; Dermatologic agents; Physical therapy; Internal medicine; Disease; Pathology; Nursing","score_opus":0.0183358813007874,"score_gpt":0.24431816057660868,"score_spread":0.2259822792758213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141045409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9489225,0.04309361,0.00028627057,0.001295104,0.00018184652,0.001040694,0.0013283795,0.00004973114,0.0038017975],"genre_scores_gemma":[0.9798579,0.014165359,0.000498099,0.001412505,0.0003693257,0.00087174296,0.0015707542,0.000009890257,0.0012443162],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99929225,0.0004816739,0.00003437623,0.00006123516,0.00006622641,0.00006416105],"domain_scores_gemma":[0.9991341,0.00030510203,0.0002963706,0.00004596145,0.000036262652,0.0001823099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019204956,0.00053058995,0.001231962,0.00017880312,0.00020664698,0.0006992395,0.0004760639,0.0008644999,0.0032803502],"category_scores_gemma":[0.0017149647,0.00015743266,0.0014592627,0.00026935455,0.00039037512,0.00034135295,0.0002754235,0.0012886057,0.00030579205],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8571999,0.0067707947,0.012332974,0.0029363574,0.0055863834,0.000121476245,0.00013020223,0.0009953192,0.004654928,0.00027123644,0.005660341,0.10334009],"study_design_scores_gemma":[0.86165255,0.072687216,0.054733966,0.00041347896,0.0040694997,0.00024146933,0.00006530602,0.0007220212,0.001038302,0.00034245884,0.0040070578,0.000026685386],"about_ca_topic_score_codex":0.00036734852,"about_ca_topic_score_gemma":0.00081509334,"teacher_disagreement_score":0.0032803502,"about_ca_system_score_codex":0.0003669098,"about_ca_system_score_gemma":0.0003684846,"threshold_uncertainty_score":0.010973811},"labels":[],"label_agreement":null},{"id":"W2142329760","doi":"10.1111/bjd.12632","title":"Ustekinumab improves nail disease in patients with moderate‐to‐severe psoriasis: results from <scp>PHOENIX</scp> 1","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Moncton Hospital","funders":"Celgene; Janssen Research and Development; Pfizer; Amgen","keywords":"Ustekinumab; Medicine; Psoriasis; Dermatology; Nail (fastener); Placebo; Dosing; Psoriasis Area and Severity Index; Randomized controlled trial; Nail disease; Surgery; Internal medicine; Disease; Pathology","score_opus":0.006298647247534306,"score_gpt":0.18957286171401702,"score_spread":0.1832742144664827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142329760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751497,0.018795658,0.0002117905,0.0007449816,0.00009091542,0.00095241587,0.00048496874,0.000042356118,0.0035272252],"genre_scores_gemma":[0.9866911,0.008673599,0.0006962105,0.00095211796,0.00019391862,0.00037207472,0.0007401664,0.00000873002,0.0016720631],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99953616,0.00025028814,0.00003886398,0.000048901256,0.000073840456,0.000051962223],"domain_scores_gemma":[0.9993579,0.00021166977,0.0001611142,0.00003931842,0.000063048414,0.00016710223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002067372,0.00048425022,0.0009637571,0.00019683469,0.00023217757,0.00043269419,0.00036123363,0.00043523934,0.0034755706],"category_scores_gemma":[0.0009919651,0.0001790266,0.0010020077,0.00021710347,0.00025158562,0.00025791838,0.00020765231,0.0009293986,0.0003346038],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53255713,0.020244675,0.022827655,0.0034258745,0.003516947,0.0002280735,0.0002169171,0.00095279235,0.029815461,0.0002012469,0.0068956264,0.37911758],"study_design_scores_gemma":[0.4557592,0.337777,0.18269122,0.0006196509,0.0039608213,0.0009993403,0.00009348127,0.000993872,0.007915043,0.0002348794,0.008912404,0.000043086216],"about_ca_topic_score_codex":0.00051886745,"about_ca_topic_score_gemma":0.0015275731,"teacher_disagreement_score":0.0034755706,"about_ca_system_score_codex":0.00036228634,"about_ca_system_score_gemma":0.0004571455,"threshold_uncertainty_score":0.011626959},"labels":[],"label_agreement":null},{"id":"W2143097167","doi":"10.1111/j.1365-2133.2005.06847.x","title":"Gender differences and effects of sex steroids and dehydroepiandrosterone on androgen and oestrogen α receptors in mouse sebaceous glands","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Université Laval","funders":"","keywords":"Internal medicine; Endocrinology; Dihydrotestosterone; Dehydroepiandrosterone; Sebaceous gland; Androgen receptor; Androgen; Testosterone (patch); Estrogen; Intracrine; Basal (medicine); Biology; Hormone; Estrogen receptor; Sex steroid; Receptor; Steroid; Medicine; Paracrine signalling; Cancer; Breast cancer; Insulin","score_opus":0.008078751776596957,"score_gpt":0.23196927840746448,"score_spread":0.22389052663086753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143097167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891718,0.0063361917,0.0011848423,0.00006890834,0.000039266124,0.000026521471,0.00090626435,0.000068792375,0.0021975827],"genre_scores_gemma":[0.9807138,0.0045309523,0.0015038841,0.00010553729,0.000029973637,0.0001220704,0.0011170355,0.000067900306,0.011809026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975735,0.000031208227,0.000023219736,0.000081538055,0.000046758927,0.00005989148],"domain_scores_gemma":[0.99973637,0.000038728747,0.00008549077,0.00002552817,0.00003470659,0.00007919311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025032586,0.00047852984,0.00028694162,0.001045463,0.00014673725,0.00037354697,0.00023105991,0.00031776348,0.0026216903],"category_scores_gemma":[0.00012802967,0.0003179074,0.00044918698,0.0002714373,0.0003546138,0.00034130318,0.00021210143,0.0004323046,0.00068032544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030968597,0.000022440745,0.00073280546,0.000030283642,0.000005293125,0.00006686197,0.000037457838,0.0000106949055,0.9977087,0.000043788765,0.00001553087,0.001016315],"study_design_scores_gemma":[0.00006008391,0.0014412536,0.084984615,0.000029351839,0.000093278184,0.0006860722,0.00026445015,0.00019283043,0.90771705,0.00011707664,0.0043902444,0.000023675508],"about_ca_topic_score_codex":0.0006384754,"about_ca_topic_score_gemma":0.0009204662,"teacher_disagreement_score":0.0026216903,"about_ca_system_score_codex":0.00025721407,"about_ca_system_score_gemma":0.00016910299,"threshold_uncertainty_score":0.008770406},"labels":[],"label_agreement":null},{"id":"W2144445655","doi":"10.1046/j.1365-2133.2002.04894.x","title":"Randomized comparison of the type 4 phosphodiesterase inhibitor cipamfylline cream, cream vehicle and hydrocortisone 17-butyrate cream for the treatment of atopic dermatitis","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital de l'Enfant-Jésus","funders":"","keywords":"Atopic dermatitis; Hydrocortisone; Medicine; Randomized controlled trial; Dermatology; Phosphodiesterase; Internal medicine; Gastroenterology; Chemistry; Enzyme; Biochemistry","score_opus":0.0232340344813625,"score_gpt":0.28565288522299986,"score_spread":0.26241885074163734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144445655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98376447,0.0062953737,0.0007719552,0.00047765733,0.0013696022,0.0049153585,0.0006762458,0.000080289974,0.0016490387],"genre_scores_gemma":[0.9867458,0.0028453227,0.0018759423,0.0006816185,0.0007506575,0.00390003,0.00056626834,0.000021783726,0.0026124918],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99855965,0.000770833,0.00012336255,0.00023909393,0.00012572683,0.00018139712],"domain_scores_gemma":[0.9979321,0.00082659576,0.00044123127,0.00019362783,0.00015028469,0.00045617355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025790476,0.0015400193,0.0049510836,0.00061835407,0.0004199877,0.0011987101,0.001268185,0.0024551093,0.0077072424],"category_scores_gemma":[0.0027873458,0.00093042507,0.0021649667,0.00049765233,0.0017956285,0.0010634616,0.00049137796,0.0024884203,0.0009831983],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99207956,0.0023085517,0.00012953932,0.00022588376,0.00034051415,0.000010806753,0.0000110686215,0.00006036111,0.0014031723,0.000038271566,0.000098813805,0.0032935613],"study_design_scores_gemma":[0.933429,0.06461546,0.00077295204,0.00002035498,0.00038483512,0.000011528159,0.000010960318,0.00017123923,0.0003170814,0.00005830501,0.0002009635,0.000007259737],"about_ca_topic_score_codex":0.0013735717,"about_ca_topic_score_gemma":0.0025130922,"teacher_disagreement_score":0.0077072424,"about_ca_system_score_codex":0.001160899,"about_ca_system_score_gemma":0.0014145769,"threshold_uncertainty_score":0.0257833},"labels":[],"label_agreement":null},{"id":"W2145156771","doi":"10.1111/j.1365-2133.2010.09809.x","title":"Trends in incidence of nonmelanoma skin cancers in Alberta, Canada, 1988-2007","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Medicine; Skin cancer; Incidence (geometry); Basal cell carcinoma; Head and neck; Malignancy; Basal cell; Cancer registry; Epidemiology; Retrospective cohort study; Dermatology; Cancer; Internal medicine; Surgery","score_opus":0.0056091210494941595,"score_gpt":0.24907783798402006,"score_spread":0.2434687169345259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145156771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96164554,0.0032009345,0.0002662841,0.0005295015,0.00003499122,0.00007603288,0.027958814,0.000075245815,0.0062126312],"genre_scores_gemma":[0.9788568,0.0022553608,0.0006845421,0.00019639955,0.000021928965,0.000034392244,0.014730382,0.000013880332,0.0032062617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993856,0.000022822847,0.00003406326,0.00007043071,0.00033435033,0.00015276654],"domain_scores_gemma":[0.99791676,0.000060122264,0.0003531764,0.000032936303,0.0013478177,0.00028917534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041843933,0.0003382492,0.00026340378,0.002362833,0.00085060624,0.0008030595,0.00096123305,0.0002980076,0.0012192009],"category_scores_gemma":[0.0010369617,0.0002092028,0.00035864513,0.004157807,0.00034002407,0.00020267694,0.0003937529,0.00041146175,0.00025530564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009883239,0.00002453455,0.9894633,0.000065728025,0.00004386769,0.00011815925,0.00022115977,0.00027884066,0.00026613532,0.00006701424,0.002860582,0.006491834],"study_design_scores_gemma":[0.0000062409404,0.000018647312,0.9972012,0.000024799438,0.000023767125,0.0001154295,0.00034616157,0.00020943645,0.000086358355,0.000010535449,0.0019530972,0.000004241454],"about_ca_topic_score_codex":0.9889204,"about_ca_topic_score_gemma":0.99399865,"teacher_disagreement_score":0.023095794,"about_ca_system_score_codex":0.023095794,"about_ca_system_score_gemma":0.019272504,"threshold_uncertainty_score":0.1675725},"labels":[],"label_agreement":null},{"id":"W2146675394","doi":"10.1111/j.1365-2133.2007.08250.x","title":"Isotretinoin therapy and the incidence of acne relapse: a nested case–control study","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Isotretinoin; Center (category theory); Pharmacy; Library science; Art; Art history; Family medicine; Acne; Dermatology","score_opus":0.009676895545310954,"score_gpt":0.2734383505836538,"score_spread":0.2637614550383428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146675394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99919254,0.00022817947,0.00024153134,0.00002001381,0.0000046645223,0.000040025345,0.00011337222,0.000002776074,0.00015685508],"genre_scores_gemma":[0.9993262,0.00007987772,0.0002840786,0.000021286134,0.000006063944,0.000028146642,0.00016203114,0.0000021303122,0.00009022701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806494,0.0005810038,0.00012188842,0.0006738206,0.00039044302,0.00016795371],"domain_scores_gemma":[0.9972372,0.00063872396,0.0008473184,0.00055913633,0.0004050648,0.00031255136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019816614,0.00038492715,0.00055230176,0.000692194,0.0008754798,0.00070290995,0.0007428539,0.000637443,0.00089048716],"category_scores_gemma":[0.004500396,0.0006151789,0.00078928965,0.0007070707,0.0005739833,0.00030262148,0.0004244828,0.00061796233,0.00014859656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046144845,0.00024158726,0.9955342,0.000022084683,0.00028549807,0.00036428668,0.0004649266,0.00004507768,0.0009954533,0.000054465247,0.00014320576,0.0013876922],"study_design_scores_gemma":[0.00011189789,0.0005021342,0.99575895,0.000022484377,0.0002619095,0.0013703407,0.00028016002,0.0008267776,0.00021431156,0.00005225756,0.00058618584,0.000012559995],"about_ca_topic_score_codex":0.042207804,"about_ca_topic_score_gemma":0.040037032,"teacher_disagreement_score":0.042207804,"about_ca_system_score_codex":0.0009957701,"about_ca_system_score_gemma":0.0008906896,"threshold_uncertainty_score":0.083924234},"labels":[],"label_agreement":null},{"id":"W2146843653","doi":"10.1111/j.1365-2133.2005.06688.x","title":"A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":692,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Probity Medical Research","funders":"","keywords":"SAINT; Medicine; Library science; Family medicine; Art history; Art","score_opus":0.006313327572443979,"score_gpt":0.26180500052152084,"score_spread":0.2554916729490769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146843653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92489713,0.02710774,0.003694914,0.0026574626,0.0016250872,0.026398221,0.0044546416,0.00072260335,0.008442177],"genre_scores_gemma":[0.9435095,0.0093378,0.006690502,0.005055564,0.0011271213,0.024751354,0.0030217317,0.000093016875,0.006413456],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982463,0.0011686734,0.00009242045,0.00023224863,0.00011292974,0.00014735937],"domain_scores_gemma":[0.99884206,0.000313103,0.0003378642,0.00010719382,0.000089163324,0.0003106516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038061533,0.002038815,0.0035606527,0.00061549176,0.00048265,0.0011838576,0.0008836788,0.001946079,0.008489746],"category_scores_gemma":[0.0026848135,0.0007391009,0.0017447344,0.0006256752,0.0014664221,0.0010477204,0.0004488732,0.0028061676,0.0010905697],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9765852,0.0043603503,0.00040518236,0.0007657037,0.0010549709,0.000028433527,0.00002626328,0.00018302536,0.001828898,0.00011516699,0.0012523938,0.013394375],"study_design_scores_gemma":[0.98491675,0.013573105,0.00066421257,0.000019011495,0.00019091138,0.000016094458,0.0000044737003,0.00009828326,0.00009849541,0.000053169926,0.0003609319,0.0000046150553],"about_ca_topic_score_codex":0.0006233025,"about_ca_topic_score_gemma":0.0018724728,"teacher_disagreement_score":0.008489746,"about_ca_system_score_codex":0.00070051313,"about_ca_system_score_gemma":0.0014137634,"threshold_uncertainty_score":0.028401077},"labels":[],"label_agreement":null},{"id":"W2149076399","doi":"10.1046/j.1365-2133.2000.03299.x","title":"Descriptive epidemiology of hand dermatitis at the St John’s contact dermatitis clinic 1983-97","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hand eczema; Medicine; Contact dermatitis; Epidemiology; Dermatology; Hand dermatitis; Irritant contact dermatitis; Population; Quarter (Canadian coin); Environmental health; Allergy; Internal medicine","score_opus":0.030696837710295133,"score_gpt":0.2862535420040539,"score_spread":0.25555670429375876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149076399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298215,0.0011427186,0.000078742676,0.00012077521,0.000012586217,0.000044983743,0.002238693,0.000020781028,0.003358752],"genre_scores_gemma":[0.99591905,0.0011509801,0.000113076676,0.00007517877,0.000027265596,0.000054006894,0.0012727208,0.000007946442,0.0013796398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909043,0.000116418465,0.00013227743,0.00013738028,0.00035487366,0.00016847473],"domain_scores_gemma":[0.9974728,0.00025168218,0.0014977807,0.000060025126,0.00038613522,0.00033162066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037578683,0.0002144573,0.00034652257,0.002713638,0.0007561471,0.00076049013,0.0005804786,0.00045415552,0.0031154023],"category_scores_gemma":[0.0015791127,0.0004429226,0.00027445494,0.0039507602,0.0003484506,0.0004269777,0.0005733015,0.00048488672,0.00089108094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058885904,0.000054496144,0.99203956,0.00006485207,0.000030416226,0.00091916835,0.0006106027,0.000058332505,0.0006027272,0.000030256386,0.0009721027,0.004558642],"study_design_scores_gemma":[0.0000020460452,0.000021053453,0.9985839,0.00001780943,0.000004057476,0.0006993649,0.00022985578,0.000026818012,0.000037357,0.0000040556424,0.00037105527,0.0000026075347],"about_ca_topic_score_codex":0.080133446,"about_ca_topic_score_gemma":0.10166666,"teacher_disagreement_score":0.080133446,"about_ca_system_score_codex":0.0016121469,"about_ca_system_score_gemma":0.0012291985,"threshold_uncertainty_score":0.159334},"labels":[],"label_agreement":null},{"id":"W2149530115","doi":"10.1111/j.1365-2133.2005.06529.x","title":"Surgery for basal cell carcinoma: study biases","year":2005,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Citation; SAINT; Library science; Medicine; History; Computer science; Art history","score_opus":0.040379261375525874,"score_gpt":0.28613934357973647,"score_spread":0.24576008220421058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149530115","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33349228,0.38155806,0.010744753,0.19427048,0.021583553,0.0026754509,0.013110268,0.00017334697,0.042391848],"genre_scores_gemma":[0.8687724,0.014432216,0.0032855277,0.0976865,0.007995471,0.0017811118,0.0016288975,0.00010442013,0.0043135216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8129428,0.13791952,0.030649219,0.0069831726,0.009407377,0.0020978388],"domain_scores_gemma":[0.6078171,0.30540922,0.047933176,0.02637645,0.009727405,0.0027365503],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12101876,0.0006388686,0.0020269773,0.001773802,0.0018217883,0.002572512,0.0018885983,0.005004471,0.0069837864],"category_scores_gemma":[0.28983995,0.0010533645,0.0030587427,0.0039673997,0.0015192508,0.0022582307,0.0017758886,0.0022220882,0.0007936444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014764915,0.00023624784,0.74462235,0.011266112,0.025306895,0.0028983164,0.0047515207,0.00027118853,0.00061337906,0.010497367,0.0816598,0.103111826],"study_design_scores_gemma":[0.014030515,0.0028864748,0.5891813,0.018653668,0.056782432,0.013543835,0.006406832,0.002695862,0.0027665822,0.04616169,0.24640791,0.00048282475],"about_ca_topic_score_codex":0.0067457883,"about_ca_topic_score_gemma":0.012100756,"teacher_disagreement_score":0.87898123,"about_ca_system_score_codex":0.001925741,"about_ca_system_score_gemma":0.0023815471,"threshold_uncertainty_score":0.640016},"labels":[],"label_agreement":null},{"id":"W2151105422","doi":"10.1111/bjd.12292","title":"No genetic support for a contribution of prostaglandins to the aetiology of androgenetic alopecia","year":2013,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"German; Library science; Medicine; History; Computer science","score_opus":0.008106671396456655,"score_gpt":0.2421247788481602,"score_spread":0.23401810745170354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151105422","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25405264,0.07738883,0.007307005,0.073632166,0.022210551,0.0006613399,0.08663778,0.0016216495,0.47648802],"genre_scores_gemma":[0.6751457,0.04267556,0.0062257205,0.012086911,0.0115617085,0.0002953457,0.047904722,0.0010594164,0.20304501],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9986381,0.0002205334,0.00018596242,0.00021209948,0.0005397273,0.0002036015],"domain_scores_gemma":[0.9926807,0.0028703804,0.0012326328,0.0008722956,0.0013392398,0.0010047101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012417731,0.00056137546,0.00086386304,0.0023327044,0.0011561156,0.0017926926,0.0008970487,0.002858636,0.1335667],"category_scores_gemma":[0.010376297,0.00024383237,0.0011996804,0.002570027,0.00094655337,0.0012722991,0.0007984997,0.001182598,0.023139816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004611614,0.00070311804,0.12112668,0.007212683,0.0013909277,0.06028655,0.0011079094,0.00046213745,0.01852775,0.023577182,0.38909572,0.3718977],"study_design_scores_gemma":[0.0007213025,0.0007462424,0.16781661,0.0046126666,0.001288069,0.09959635,0.0009815063,0.00038344882,0.0065628584,0.024015063,0.69311494,0.00016092857],"about_ca_topic_score_codex":0.0019739226,"about_ca_topic_score_gemma":0.001712392,"teacher_disagreement_score":0.1335667,"about_ca_system_score_codex":0.00062900584,"about_ca_system_score_gemma":0.00115193,"threshold_uncertainty_score":0.44682515},"labels":[],"label_agreement":null},{"id":"W2152124559","doi":"10.1111/bjd.12694","title":"Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Skin cancer; Dermatology; Confidence interval; Cancer; Cancer registry; Melanoma; Oncology; Internal medicine; Cancer research","score_opus":0.005183936699703287,"score_gpt":0.21043968080961953,"score_spread":0.20525574410991623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152124559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895489,0.0018170505,0.00014881656,0.0003019103,0.0000224977,0.000030666455,0.0048570065,0.000023274895,0.0032499102],"genre_scores_gemma":[0.99614537,0.0008098762,0.00012199219,0.00005618862,0.000009718521,0.0000059205086,0.002025543,0.000004627659,0.00082069205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994935,0.000027822665,0.000025247926,0.0000844103,0.00023042966,0.00013856436],"domain_scores_gemma":[0.9988091,0.000057318055,0.0003407959,0.00004073407,0.00047779194,0.0002743116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034236672,0.000254969,0.00024510012,0.0010682065,0.00091529795,0.00069190544,0.00084639835,0.00026103272,0.0017098514],"category_scores_gemma":[0.0011811728,0.0001991573,0.00045296326,0.0018887518,0.0003300816,0.00014158513,0.00052760437,0.0004978765,0.00014111676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005198838,0.000007887942,0.99695504,0.000018355326,0.00003905025,0.00014151138,0.000079807745,0.00012502958,0.000089030436,0.000037561418,0.0006168541,0.0018378341],"study_design_scores_gemma":[0.0000048633515,0.000016426182,0.9984706,0.00002282745,0.00003289922,0.00027776608,0.00026334706,0.0002558567,0.00005239317,0.000014270498,0.00058430753,0.000004584321],"about_ca_topic_score_codex":0.97742975,"about_ca_topic_score_gemma":0.98307586,"teacher_disagreement_score":0.022570252,"about_ca_system_score_codex":0.01067939,"about_ca_system_score_gemma":0.012380512,"threshold_uncertainty_score":0.07748479},"labels":[],"label_agreement":null},{"id":"W2154234582","doi":"10.1046/j.1365-2133.2002.04967.x","title":"Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Calcipotriol; Betamethasone dipropionate; Medicine; Psoriasis; Psoriasis Area and Severity Index; Betamethasone; Randomized controlled trial; Adverse effect; Dermatology; Corticosteroid; Surgery; Internal medicine","score_opus":0.06992348893430708,"score_gpt":0.32695770503985633,"score_spread":0.2570342161055492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154234582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901382,0.0041412185,0.00046432356,0.00029254708,0.0003796778,0.0032768468,0.0003721068,0.00007407867,0.0008610166],"genre_scores_gemma":[0.98787063,0.0026946238,0.0017755699,0.00048533466,0.000839661,0.004110198,0.0005674356,0.000019958909,0.0016365751],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981902,0.00090430386,0.00017710314,0.00031498246,0.0002542148,0.00015923702],"domain_scores_gemma":[0.9978968,0.0006974255,0.0005480345,0.00014015916,0.00016013121,0.0005574564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029806602,0.001944531,0.004865898,0.0010303338,0.0006837913,0.0013960167,0.001622108,0.0031244801,0.004440459],"category_scores_gemma":[0.0024180159,0.0013447258,0.0022784404,0.00074989296,0.0021355464,0.001378251,0.0005759183,0.0029047555,0.00092353125],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97728544,0.010475991,0.0003388396,0.0003996119,0.0004843249,0.000025107285,0.000030794872,0.000100824414,0.004396744,0.00003116037,0.000096571894,0.00633453],"study_design_scores_gemma":[0.86806285,0.13012598,0.0006409675,0.000012636182,0.00033189973,0.000021375732,0.000007740751,0.00012514928,0.00049851066,0.000024291789,0.00014037044,0.000008288529],"about_ca_topic_score_codex":0.00058063655,"about_ca_topic_score_gemma":0.00094470143,"teacher_disagreement_score":0.004865898,"about_ca_system_score_codex":0.0007305315,"about_ca_system_score_gemma":0.001350286,"threshold_uncertainty_score":0.015763462},"labels":[],"label_agreement":null},{"id":"W2156475253","doi":"10.1111/bjd.13004","title":"Long‐term efficacy and safety of infliximab maintenance therapy in patients with plaque‐type psoriasis in real‐world practice","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Schering-Plough","keywords":"Art history; Art; Medicine; Humanities","score_opus":0.008659925112616014,"score_gpt":0.23623426742092551,"score_spread":0.2275743423083095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156475253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952597,0.0034720334,0.00016125196,0.00022263637,0.000011117263,0.000056371926,0.000083315324,0.000008416757,0.000725172],"genre_scores_gemma":[0.99867296,0.00074843905,0.00023391175,0.00011250685,0.00003469074,0.000034758894,0.00010582949,0.0000013559118,0.000055564797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667406,0.0018118145,0.00040460526,0.0003604904,0.0005663028,0.00018284372],"domain_scores_gemma":[0.9903137,0.0023523625,0.005411001,0.00032620173,0.0006774083,0.0009193176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048682117,0.0002552723,0.00073464325,0.00033818278,0.0004956153,0.0009558804,0.00032600318,0.000797102,0.0010729505],"category_scores_gemma":[0.013499344,0.00021365192,0.00043199127,0.0005340182,0.00039925857,0.0005952028,0.00040350232,0.00075211225,0.0003126632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015798502,0.0028723858,0.8570521,0.0006855281,0.00064486364,0.000547463,0.0010437376,0.00042485367,0.0020539665,0.00008267442,0.0012907479,0.11750319],"study_design_scores_gemma":[0.0037714848,0.032433495,0.95460904,0.0002909787,0.00057460414,0.0031867807,0.000658211,0.001341205,0.00056620745,0.00016979614,0.002338445,0.000059711812],"about_ca_topic_score_codex":0.00042015564,"about_ca_topic_score_gemma":0.00051381934,"teacher_disagreement_score":0.0048682117,"about_ca_system_score_codex":0.0005767104,"about_ca_system_score_gemma":0.0006224426,"threshold_uncertainty_score":0.025745869},"labels":[],"label_agreement":null},{"id":"W2161654538","doi":"10.1046/j.1365-2133.2000.03293.x","title":"Sequential assessment of an antidrug antibody response in a patient with a systemic delayed-onset sulphonamide hypersensitivity syndrome reaction","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Prince Edward Island","funders":"","keywords":"Medicine; Methylprednisolone; Antibody; Rash; Prednisone; Immunology; Gastroenterology; Serum sickness; Eosinophilia; Internal medicine","score_opus":0.009053523655366682,"score_gpt":0.2892527244367183,"score_spread":0.28019920078135163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161654538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975012,0.0004627062,0.00028926836,0.00011046648,0.000017176846,0.000030659317,0.000036266207,0.000012476321,0.001539819],"genre_scores_gemma":[0.9994324,0.00013629335,0.00013000466,0.000084035666,0.000020967303,0.000003942023,0.000034050532,0.0000018061565,0.00015649165],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99967873,0.00007435721,0.000043643202,0.00006126218,0.00007189476,0.00007015529],"domain_scores_gemma":[0.9992567,0.00022034343,0.00013472445,0.000028210978,0.00009785506,0.00026218864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000426045,0.0004881467,0.00056145387,0.0007443325,0.0005075841,0.00051253213,0.00024992425,0.00086009305,0.001146834],"category_scores_gemma":[0.0020136635,0.00026787687,0.00035840727,0.0003301892,0.00032792924,0.00042818274,0.0002518991,0.0007903648,0.00038484015],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010039527,0.0004134656,0.54186296,0.000125356,0.00006124052,0.4296286,0.0011627456,0.00025217715,0.015075911,0.00011124901,0.0004333268,0.00986896],"study_design_scores_gemma":[0.00011449727,0.0040886705,0.5256957,0.000040466042,0.000105052764,0.46097478,0.00076104223,0.001477733,0.0041113864,0.00013981391,0.0024561284,0.000034794837],"about_ca_topic_score_codex":0.00088639674,"about_ca_topic_score_gemma":0.0009639339,"teacher_disagreement_score":0.001146834,"about_ca_system_score_codex":0.00035688077,"about_ca_system_score_gemma":0.00020511051,"threshold_uncertainty_score":0.0038365126},"labels":[],"label_agreement":null},{"id":"W2161955658","doi":"10.1111/j.1365-2133.1994.tb08556.x","title":"Local steroid therapy and bacterial skin flora in atopic dermatitis","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Atopic dermatitis; Staphylococcus aureus; Medicine; Clinical trial; Randomized controlled trial; Colonization; Dermatology; Skin flora; Micrococcaceae; Corticosteroid; Internal medicine; Surgery; Bacteria; Microbiology; Biology","score_opus":0.007875800932189042,"score_gpt":0.2322505170404579,"score_spread":0.22437471610826887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161955658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299616,0.0052371616,0.00021435972,0.00016618107,0.00020966586,0.0006002632,0.000100232,0.000022575558,0.00045339853],"genre_scores_gemma":[0.9936865,0.0030404553,0.0006975197,0.00036456226,0.00039872626,0.0010476863,0.00012748675,0.000006140362,0.00063093397],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99840957,0.0009875613,0.0001348689,0.00013274518,0.00016855141,0.00016679218],"domain_scores_gemma":[0.99772507,0.0012062587,0.00037988278,0.00011571824,0.00008452501,0.00048852176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018083706,0.0008540615,0.0025352717,0.00048175806,0.00041261324,0.0005161736,0.00054281193,0.0014311676,0.002673231],"category_scores_gemma":[0.0027080006,0.0005113249,0.00095296546,0.00036329537,0.001338205,0.00045301486,0.00027830704,0.0013669769,0.0003348709],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94743013,0.014673242,0.0022473237,0.0010773381,0.0006480031,0.00013724422,0.000056470453,0.00020950906,0.006076145,0.00010875916,0.00022547698,0.027110389],"study_design_scores_gemma":[0.64203715,0.34876508,0.0059718154,0.000060219936,0.00059865555,0.00010490262,0.000033465156,0.0003123779,0.0013403277,0.00011083739,0.0006510111,0.0000141563705],"about_ca_topic_score_codex":0.00056438684,"about_ca_topic_score_gemma":0.0012325698,"teacher_disagreement_score":0.002673231,"about_ca_system_score_codex":0.0004337731,"about_ca_system_score_gemma":0.0008394435,"threshold_uncertainty_score":0.009563744},"labels":[],"label_agreement":null},{"id":"W2163232748","doi":"10.1111/j.1365-2133.2007.08315.x","title":"Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":722,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Abbott Laboratories","keywords":"Champion; SAINT; Medicine; Nice; Humanities; Library science; Art; Political science; Art history; Law","score_opus":0.011530061312799737,"score_gpt":0.2450423416198201,"score_spread":0.23351228030702037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163232748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93075705,0.04921631,0.0022287308,0.0016934605,0.0019178105,0.006969595,0.0021794715,0.00021125391,0.0048262216],"genre_scores_gemma":[0.9780247,0.008831748,0.0026443065,0.0012379428,0.0015252886,0.0049903276,0.0012263522,0.000031999865,0.0014872394],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9897086,0.008121951,0.0007228863,0.00058746,0.00058366405,0.00027539057],"domain_scores_gemma":[0.98946863,0.005993031,0.0026677626,0.00042780762,0.0006763166,0.0007664486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0103562595,0.0015343416,0.00422554,0.00081980985,0.0004816954,0.0010795066,0.00093679817,0.002303893,0.007989733],"category_scores_gemma":[0.0125956,0.00065045967,0.0040998124,0.0006584727,0.0011699783,0.0010331371,0.00040794842,0.0020611766,0.000600286],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9866723,0.001105832,0.0003365071,0.00071515876,0.0024373592,0.000013196742,0.00001736253,0.000103777755,0.00039893127,0.00005261117,0.00023672463,0.007910287],"study_design_scores_gemma":[0.9499905,0.045081872,0.0017364711,0.00007961498,0.0022576721,0.0000229601,0.000011376917,0.00025322664,0.0001706651,0.000089169655,0.0002952053,0.000011233483],"about_ca_topic_score_codex":0.0005820889,"about_ca_topic_score_gemma":0.00081608735,"teacher_disagreement_score":0.0103562595,"about_ca_system_score_codex":0.00090695795,"about_ca_system_score_gemma":0.0010167302,"threshold_uncertainty_score":0.054769814},"labels":[],"label_agreement":null},{"id":"W2163901561","doi":"10.1111/j.1365-2133.2008.08487.x","title":"Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":408,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Innovaderm (Canada); Lynde Centre for Dermatology","funders":"","keywords":"Medicine; Placebo; Refractory (planetary science); Adverse effect; Randomized controlled trial; Internal medicine; Placebo-controlled study; Clinical trial; Dermatology; Surgery; Double blind","score_opus":0.013525113201406801,"score_gpt":0.25456753004195853,"score_spread":0.24104241684055172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163901561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920157,0.004994596,0.0002725537,0.00025152875,0.00014796178,0.0013766009,0.00030944202,0.00003457114,0.0005971213],"genre_scores_gemma":[0.9948284,0.0017355053,0.0006944322,0.00037092864,0.0003057928,0.0011292243,0.00040668942,0.000008959997,0.00052000297],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981451,0.0011197216,0.00017564846,0.00027196482,0.00013382743,0.00015375497],"domain_scores_gemma":[0.9972197,0.0009597161,0.00073575316,0.00024043294,0.00019766783,0.0006467146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036801135,0.0013823643,0.003522975,0.00040011777,0.0005487946,0.0010694518,0.00086917036,0.0023807394,0.0032079099],"category_scores_gemma":[0.0031521493,0.00073161663,0.0023029735,0.00049736566,0.001380886,0.00084137666,0.0003428269,0.0019636725,0.00054473506],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98153263,0.0041166586,0.0012907231,0.0004789103,0.0009162313,0.000031354222,0.000044304343,0.00013840017,0.0028297224,0.000021555894,0.00015732496,0.008442196],"study_design_scores_gemma":[0.937229,0.05910002,0.0025252707,0.000019607613,0.0005084554,0.000031408443,0.000010606463,0.00013722766,0.0002666629,0.000021139707,0.0001417952,0.000008846562],"about_ca_topic_score_codex":0.0009250182,"about_ca_topic_score_gemma":0.0016075762,"teacher_disagreement_score":0.0036801135,"about_ca_system_score_codex":0.00076136214,"about_ca_system_score_gemma":0.0011435171,"threshold_uncertainty_score":0.019462526},"labels":[],"label_agreement":null},{"id":"W2166018121","doi":"10.1046/j.1365-2133.2003.05241.x","title":"The British Association of Dermatologists therapeutic guidelines: can we AGREE?","year":2003,"lang":"en","type":"editorial","venue":"British Journal of Dermatology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality (philosophy); Family medicine; Alternative medicine; Randomized controlled trial; MEDLINE; Medical education; Political science; Law; Pathology","score_opus":0.08183156640259864,"score_gpt":0.4236325965968229,"score_spread":0.34180103019422425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166018121","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013560036,0.025103584,0.0014920948,0.94246536,0.026590249,0.000090479756,0.00022262594,0.0001090723,0.0037909085],"genre_scores_gemma":[0.0057716765,0.059904177,0.031951297,0.8629103,0.027949473,0.0010063434,0.0023307663,0.00046966464,0.0077062906],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8693014,0.04392051,0.035526045,0.00584309,0.039656512,0.005752499],"domain_scores_gemma":[0.61619025,0.11259759,0.028307563,0.018963411,0.18322003,0.04072116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10043947,0.0018998041,0.0056752115,0.009659085,0.006640295,0.02120991,0.012485095,0.053574506,0.016497232],"category_scores_gemma":[0.3734151,0.0027473646,0.004673974,0.010607808,0.011364061,0.027702358,0.008574331,0.052076507,0.01936458],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005097849,0.00008329962,0.0003317106,0.0019631379,0.00008224353,0.00014266529,0.0005280102,0.00012888233,0.00008412206,0.01275122,0.9339274,0.04992635],"study_design_scores_gemma":[0.00014501164,0.00005485063,0.0008645298,0.022882018,0.00011636898,0.00025715536,0.0011388636,0.00024414246,0.00006947663,0.045297988,0.9287972,0.00013251624],"about_ca_topic_score_codex":0.01834671,"about_ca_topic_score_gemma":0.03037031,"teacher_disagreement_score":0.10043947,"about_ca_system_score_codex":0.010711803,"about_ca_system_score_gemma":0.052905675,"threshold_uncertainty_score":0.531181},"labels":[],"label_agreement":null},{"id":"W2167141300","doi":"10.1111/bjd.12129","title":"Skin tumours in the West of Scotland renal transplant population","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology","funders":"","keywords":"Renal transplant; Medicine; Population; Dermatology; Transplantation; Pathology; Surgery; Environmental health","score_opus":0.012648881811785214,"score_gpt":0.2659796348748114,"score_spread":0.2533307530630262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167141300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990404,0.0002603083,0.00003324728,0.0000823247,0.000006317531,0.0000073779734,0.00022910323,0.0000026841133,0.0003381797],"genre_scores_gemma":[0.99938726,0.00024958182,0.000027351547,0.00006074314,0.000012654556,0.000004001614,0.00015802206,8.8948457e-7,0.0000994724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959666,0.000059601374,0.00003571548,0.00005377556,0.0001266029,0.00012772504],"domain_scores_gemma":[0.9991605,0.00006911245,0.00042003643,0.000024166886,0.000120656754,0.00020557041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038315624,0.00014438205,0.00026700762,0.0009151868,0.00061275373,0.00075530156,0.0002759476,0.00018583483,0.0018472272],"category_scores_gemma":[0.0008715961,0.000138668,0.00032241465,0.0010593428,0.0003434974,0.00033241534,0.00059891073,0.00026823388,0.00016288964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005737177,0.000036492558,0.9935509,0.00003430242,0.000030010144,0.0006163945,0.0005586147,0.000039013827,0.00050894445,0.000026503136,0.00036533002,0.0041761007],"study_design_scores_gemma":[0.0000049173177,0.00010315233,0.9981073,0.0000101108135,0.000010258847,0.0007439096,0.0005831696,0.000042533095,0.000035781566,0.0000080692735,0.00034739822,0.0000033491674],"about_ca_topic_score_codex":0.07336479,"about_ca_topic_score_gemma":0.068375126,"teacher_disagreement_score":0.07336479,"about_ca_system_score_codex":0.0007333831,"about_ca_system_score_gemma":0.0007472385,"threshold_uncertainty_score":0.14587551},"labels":[],"label_agreement":null},{"id":"W2167305078","doi":"10.1111/j.1365-2133.2012.11168.x","title":"Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":336,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Janus kinase inhibitor; Medicine; Placebo; Psoriasis; Adverse effect; Psoriasis Area and Severity Index; Dose-ranging study; Internal medicine; Gastroenterology; Randomized controlled trial; Clinical endpoint; Dermatology; Double blind; Pathology","score_opus":0.01880262927208139,"score_gpt":0.28178375465673705,"score_spread":0.2629811253846557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167305078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863224,0.004802087,0.0008061509,0.00039682921,0.00022873332,0.004859712,0.0012681893,0.00011359159,0.0012023115],"genre_scores_gemma":[0.98493004,0.003099181,0.0021761535,0.0009304896,0.00054871145,0.0053842934,0.0013510195,0.00003811429,0.0015419683],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99779886,0.0013028916,0.00016551113,0.00029324667,0.00026395157,0.0001755192],"domain_scores_gemma":[0.99793065,0.0005831495,0.00068501936,0.00017290543,0.00015507363,0.0004731809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004866872,0.0016870045,0.003012461,0.000684546,0.00048037252,0.0013262496,0.0010873434,0.0020113583,0.006247609],"category_scores_gemma":[0.0029117505,0.0008689719,0.0021176625,0.00067833916,0.0010872419,0.0011534349,0.0004531851,0.0032264641,0.0011416466],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94823515,0.021120787,0.0009948835,0.00053548004,0.00081200525,0.000039560444,0.000052354073,0.00030144877,0.008707815,0.000037259986,0.0004932551,0.018670026],"study_design_scores_gemma":[0.8588905,0.13619427,0.0030367596,0.000020649648,0.00039225613,0.000054666132,0.00001238168,0.00023992274,0.0007117433,0.00005767515,0.0003747531,0.0000145482245],"about_ca_topic_score_codex":0.00035891554,"about_ca_topic_score_gemma":0.000772342,"teacher_disagreement_score":0.006247609,"about_ca_system_score_codex":0.00079392537,"about_ca_system_score_gemma":0.0011683924,"threshold_uncertainty_score":0.025738776},"labels":[],"label_agreement":null},{"id":"W2169005742","doi":"10.1111/j.1365-2133.2011.10280.x","title":"Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"National Institute for Health and Care Research","keywords":"Life course approach; Psoriasis; Medicine; Course (navigation); Disease; Perception; Gerontology; Psychology; Dermatology; Internal medicine; Developmental psychology; Neuroscience","score_opus":0.01610294237770836,"score_gpt":0.2565166595212557,"score_spread":0.2404137171435473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169005742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932808,0.00079974136,0.00031964388,0.0012875625,0.000023203313,0.000021992038,0.0001156411,0.0000120464365,0.0041394625],"genre_scores_gemma":[0.9990828,0.0003243554,0.00015008394,0.00018453176,0.000009227547,0.0000050780054,0.000025352643,0.0000011047946,0.00021745167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993364,0.0003086615,0.000061672625,0.000041318654,0.00016146128,0.00009048921],"domain_scores_gemma":[0.9985275,0.00041670707,0.0004973303,0.00003573026,0.00017337388,0.00034927623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009944149,0.00010826017,0.00022883152,0.0003205185,0.00052766525,0.00074450736,0.00012654842,0.00044248687,0.002468003],"category_scores_gemma":[0.004167665,0.00008718284,0.00026934303,0.00035064796,0.00032854386,0.00075453223,0.0006314195,0.00068628363,0.00018365582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046478992,0.00023876876,0.8673815,0.00038466827,0.00012980294,0.0016147592,0.035580453,0.00045684364,0.0033755836,0.0005164788,0.0049690367,0.084887445],"study_design_scores_gemma":[0.00003284925,0.0013559379,0.9085077,0.0002165639,0.00009447209,0.010497855,0.06312902,0.0016707134,0.0006349301,0.0008063801,0.012956249,0.00009735845],"about_ca_topic_score_codex":0.0016807099,"about_ca_topic_score_gemma":0.0021697269,"teacher_disagreement_score":0.002468003,"about_ca_system_score_codex":0.0003404055,"about_ca_system_score_gemma":0.00024411012,"threshold_uncertainty_score":0.008256257},"labels":[],"label_agreement":null},{"id":"W2169708276","doi":"10.1111/j.1365-2133.2009.09094.x","title":"Nonlinear spectral imaging of human hypertrophic scar based on two-photon excited fluorescence and second-harmonic generation","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Elastin; Hypertrophic scar; Human skin; Ex vivo; Biomedical engineering; Supercontinuum; Pathology; Scars; Materials science; Microscopy; In vivo; Medicine; Biology; Optoelectronics; Wavelength","score_opus":0.020514164401071882,"score_gpt":0.3010947509442552,"score_spread":0.2805805865431833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169708276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141145,0.00044878077,0.0072094523,0.00002900928,0.0000041543435,0.000011512087,0.0000352201,0.00003937098,0.0008111175],"genre_scores_gemma":[0.9885467,0.00032095535,0.01003495,0.000026423268,0.000005613555,0.000019585666,0.000083033694,0.00001228263,0.00095043797],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99994683,0.000010471703,0.0000019731954,0.0000091670645,0.000022150694,0.000009366573],"domain_scores_gemma":[0.9998807,0.000049331647,0.00001907343,0.000014166343,0.000022154087,0.000014570133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017606409,0.00013690013,0.000092487615,0.00029044983,0.000100895,0.000085893196,0.00012155835,0.00020673408,0.0013618285],"category_scores_gemma":[0.00017803909,0.00010827214,0.00009712244,0.00009736762,0.00017592934,0.0001429493,0.00013875462,0.00018763938,0.0002067808],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024405275,0.000026088257,0.0031956644,0.00006142426,0.000004497395,0.0003615582,0.00009113793,0.00011682818,0.9896744,0.000047475667,0.00005295869,0.006123948],"study_design_scores_gemma":[0.000051237228,0.0013765624,0.103826396,0.00002715646,0.00003880838,0.016752291,0.00024353563,0.009139832,0.86658037,0.00016647775,0.0017718945,0.000025455236],"about_ca_topic_score_codex":0.00032905198,"about_ca_topic_score_gemma":0.00048435622,"teacher_disagreement_score":0.0013618285,"about_ca_system_score_codex":0.00008708296,"about_ca_system_score_gemma":0.00007739649,"threshold_uncertainty_score":0.004555762},"labels":[],"label_agreement":null},{"id":"W2169732146","doi":"10.1111/j.1365-2133.2005.07056.x","title":"Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in <i>PTCH</i> heterozygous mice","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Université de Montréal","funders":"","keywords":"Photosensitizer; Photodynamic therapy; Protoporphyrin IX; Basal cell carcinoma; Histopathology; Medicine; Skin cancer; Significant difference; Pathology; Dermatology; Basal cell; Cancer; Chemistry; Internal medicine","score_opus":0.012635211864949604,"score_gpt":0.2952521041559337,"score_spread":0.28261689229098413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169732146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963636,0.0003967013,0.0018302341,0.00006764988,0.00004156258,0.00012267652,0.00034801182,0.00015576287,0.00067384023],"genre_scores_gemma":[0.9891928,0.0006344595,0.004070002,0.00009110053,0.000042539854,0.00030878576,0.0006835822,0.00010641391,0.004870296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930704,0.00006294884,0.00007501069,0.00020783453,0.00017819175,0.00016896457],"domain_scores_gemma":[0.9992494,0.0000678213,0.00033428596,0.00006366776,0.000040163788,0.00024471886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037438067,0.00080942456,0.000793317,0.0010639066,0.00040075698,0.00038415272,0.0005503126,0.0008773696,0.0024447888],"category_scores_gemma":[0.00018689675,0.00044789354,0.0007577755,0.000264415,0.00053644815,0.00042689504,0.00035271107,0.001194854,0.00063318637],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008364932,0.00046387446,0.00038813942,0.000033073848,0.0000121041485,0.00011896898,0.000032077038,0.000058024994,0.9967344,0.000045455214,0.000055833178,0.0012216477],"study_design_scores_gemma":[0.00022339528,0.0092497645,0.009332986,0.000021950993,0.00009464186,0.0010204214,0.000066743305,0.00086207583,0.97750956,0.000045020075,0.0015521708,0.000021217722],"about_ca_topic_score_codex":0.0008143907,"about_ca_topic_score_gemma":0.001151637,"teacher_disagreement_score":0.0024447888,"about_ca_system_score_codex":0.0003795839,"about_ca_system_score_gemma":0.00027707804,"threshold_uncertainty_score":0.008178592},"labels":[],"label_agreement":null},{"id":"W2169787227","doi":"10.1111/j.1365-2133.2006.07344.x","title":"CLinical experience acquired with the efalizumab (Raptiva<sup>®</sup>) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Plaque psoriasis; Psoriasis; Placebo; Medicine; Randomized controlled trial; Clinical trial; Internal medicine; Dermatology; Alternative medicine; Pathology","score_opus":0.011873326462174835,"score_gpt":0.25914505403540095,"score_spread":0.2472717275732261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169787227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9472855,0.03598402,0.0015392251,0.002192862,0.0004664574,0.0043504597,0.001567988,0.00015436299,0.0064591174],"genre_scores_gemma":[0.9758075,0.009545682,0.0028397397,0.00297642,0.0006993998,0.004253691,0.001950742,0.00003132538,0.0018954946],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99696416,0.0022071085,0.00019832006,0.00024383159,0.0001883383,0.00019822306],"domain_scores_gemma":[0.9973078,0.0009633194,0.0007436399,0.00022054734,0.0001949541,0.0005697663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007700101,0.0013618895,0.0029514958,0.00022489019,0.0004968875,0.0011388698,0.0009263486,0.0019720814,0.0039488375],"category_scores_gemma":[0.0036607767,0.0006204989,0.0018489582,0.00043324,0.0013169685,0.0010558219,0.0003707618,0.0033083826,0.0008039055],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9257553,0.010315659,0.003440042,0.0018340434,0.0019917309,0.000097963566,0.0001654737,0.0006591267,0.0074250367,0.00024182432,0.0027181173,0.0453556],"study_design_scores_gemma":[0.87830174,0.11157655,0.006416031,0.00008434003,0.0007690262,0.00014061277,0.000026953196,0.000238199,0.0005630202,0.00012933377,0.0017368883,0.00001739363],"about_ca_topic_score_codex":0.00045938935,"about_ca_topic_score_gemma":0.0008579023,"teacher_disagreement_score":0.007700101,"about_ca_system_score_codex":0.00049469824,"about_ca_system_score_gemma":0.0009961511,"threshold_uncertainty_score":0.04072249},"labels":[],"label_agreement":null},{"id":"W2170428123","doi":"10.1111/j.1365-2133.2009.09209.x","title":"Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Initiatives Ontario North","funders":"","keywords":"Adapalene; Acne; Benzoyl peroxide; Dermatology; Medicine; Double blind; Randomized controlled trial; Internal medicine; Chemistry; Pathology; Organic chemistry; Placebo","score_opus":0.020477828992286742,"score_gpt":0.3020965266291488,"score_spread":0.2816186976368621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170428123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864668,0.007893491,0.0005650802,0.00016198962,0.00027828666,0.003403177,0.00045832605,0.0000610247,0.0007118128],"genre_scores_gemma":[0.9863456,0.004367818,0.0018691806,0.000595753,0.00052742194,0.0044748406,0.00047807983,0.000016437301,0.0013247418],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999188,0.0003629777,0.00007012112,0.00017849775,0.00008877515,0.00011156402],"domain_scores_gemma":[0.9991209,0.00026256056,0.00017201563,0.000057183486,0.00008183816,0.0003055726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022508148,0.0012602997,0.0038702032,0.00058133487,0.00046348327,0.0006808135,0.0005964021,0.0012218311,0.004591106],"category_scores_gemma":[0.0011913832,0.00079913647,0.001323311,0.00058951497,0.0012593822,0.0007680173,0.00035067272,0.0016206924,0.00064914394],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9330807,0.023924932,0.003280967,0.0016264253,0.0010682655,0.000088784174,0.00012791008,0.00021375704,0.009438841,0.00008081371,0.0007328857,0.026335794],"study_design_scores_gemma":[0.75595057,0.23574884,0.006080011,0.000038052633,0.00069779536,0.000057764337,0.000039439557,0.00022456398,0.0005062037,0.000034217675,0.0006067704,0.00001586046],"about_ca_topic_score_codex":0.00087260536,"about_ca_topic_score_gemma":0.0016483017,"teacher_disagreement_score":0.004591106,"about_ca_system_score_codex":0.00050161086,"about_ca_system_score_gemma":0.0011474846,"threshold_uncertainty_score":0.015358806},"labels":[],"label_agreement":null},{"id":"W2171278825","doi":"10.1111/j.1365-2133.2008.08976.x","title":"Kindler syndrome: a focal adhesion genodermatosis","year":2008,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Wellcome Trust","keywords":"Genodermatosis; Poikiloderma; Epidermolysis bullosa; Filamin; Focal adhesion; Keratinocyte; Extracellular matrix; Biology; Cell biology; Pathology; Medicine; Cytoskeleton; Genetics; Gene; Signal transduction","score_opus":0.02537034770262849,"score_gpt":0.3013689773690643,"score_spread":0.27599862966643585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171278825","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001948619,0.99149066,0.0007169061,0.0005297623,0.00032498685,0.000012351488,0.000040729898,0.000061945735,0.004874024],"genre_scores_gemma":[0.015114951,0.97700197,0.0010123089,0.0006951541,0.00042288305,0.000025169707,0.00016858682,0.000006841421,0.0055522216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990594,0.000012022412,0.000012496253,0.000018760225,0.00003895797,0.0000117138015],"domain_scores_gemma":[0.99993706,0.000019698544,0.000015601627,0.0000025890147,0.000012359253,0.0000126265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014984912,0.0008496289,0.00089192693,0.0010917895,0.00021178054,0.00037681602,0.0003917707,0.00077592506,0.001994349],"category_scores_gemma":[0.0002628293,0.00011287722,0.00017811466,0.0011548811,0.00023068965,0.0005492263,0.00033053505,0.00053982297,0.0017344333],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005054676,0.000030904863,0.00050604256,0.0033452013,0.00007090917,0.005488636,0.00006137134,0.0001706788,0.005130527,0.0011584878,0.027576115,0.9564104],"study_design_scores_gemma":[0.000045787183,0.00008522757,0.0040352694,0.00093627785,0.00010180161,0.07837775,0.00007475554,0.00006919444,0.0018746455,0.001413887,0.9129644,0.000021052696],"about_ca_topic_score_codex":0.0005862969,"about_ca_topic_score_gemma":0.0011700724,"teacher_disagreement_score":0.001994349,"about_ca_system_score_codex":0.00036663428,"about_ca_system_score_gemma":0.00041857097,"threshold_uncertainty_score":0.0066717267},"labels":[],"label_agreement":null},{"id":"W2286365142","doi":"10.1111/bjd.14495","title":"Dermoscopy, a useful tool for general practitioners in melanoma screening: a nationwide survey","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Hospices Civils de Lyon","keywords":"Medicine; Family medicine; Dermatology; Melanoma; MEDLINE; Political science","score_opus":0.023843283588133007,"score_gpt":0.2850041089268297,"score_spread":0.26116082533869667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286365142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903087,0.006974652,0.00011964646,0.0007325356,0.000014340408,0.000027130389,0.0011424565,0.00000778646,0.0006727733],"genre_scores_gemma":[0.99736893,0.0017906582,0.00014418349,0.00017818858,0.00001505401,0.000013080111,0.00038388054,0.0000014138986,0.000104607505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812883,0.0006822689,0.00021967723,0.0002999014,0.0005121154,0.00015721198],"domain_scores_gemma":[0.995518,0.00095015584,0.0025493351,0.0001381154,0.00054708467,0.00029730794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019574976,0.00016821077,0.00026030827,0.0009253443,0.0002528551,0.00059619837,0.000296336,0.00067040254,0.0012115712],"category_scores_gemma":[0.005749055,0.00022361049,0.0005304082,0.0017389073,0.0002911268,0.0007415667,0.0004553658,0.00040911013,0.0002401327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040008497,0.0000248327,0.99512863,0.00014104093,0.00005661717,0.000040701063,0.00013975223,0.000024730201,0.00007679583,0.0000072728917,0.00032882096,0.0039908127],"study_design_scores_gemma":[0.000004303829,0.0000596156,0.9990289,0.000060587914,0.000032956694,0.00011462815,0.00023548404,0.000051398278,0.000008433136,0.0000051026436,0.00039657863,0.0000019960012],"about_ca_topic_score_codex":0.014521903,"about_ca_topic_score_gemma":0.020563224,"teacher_disagreement_score":0.014521903,"about_ca_system_score_codex":0.00065854745,"about_ca_system_score_gemma":0.0006502464,"threshold_uncertainty_score":0.028874755},"labels":[],"label_agreement":null},{"id":"W2300677989","doi":"10.1111/bjd.14433","title":"The need to improve reporting of routinely collected dermatology data for patient benefit","year":2016,"lang":"en","type":"editorial","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"Canadian Institutes of Health Research; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Institute for Health and Care Research; National Institute on Handicapped Research","keywords":"Dermatology; Medicine; MEDLINE; Family medicine","score_opus":0.014835097528781727,"score_gpt":0.28730478234090695,"score_spread":0.27246968481212525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300677989","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000082994666,0.0049009514,0.00030486454,0.14683083,0.84668905,0.000030327732,0.00010645736,0.000086882486,0.00096776366],"genre_scores_gemma":[0.000892934,0.0048276945,0.0007569644,0.07006232,0.9202375,0.000058378486,0.0000762627,0.00006419233,0.0030237858],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95256627,0.015343033,0.013056486,0.002827793,0.014787728,0.0014185641],"domain_scores_gemma":[0.61916983,0.21323389,0.022432331,0.008073893,0.12508436,0.012005745],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03923784,0.0027216699,0.0049687405,0.005189762,0.0023454186,0.012699125,0.005265823,0.027623978,0.00910888],"category_scores_gemma":[0.22097367,0.0021123767,0.004204992,0.0029435025,0.0041731168,0.010625478,0.002818497,0.037802637,0.0075328043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005051644,0.000018276134,0.00016882662,0.00068731024,0.00006481826,0.00010565968,0.000052654024,0.000043363718,0.00006773197,0.00038972232,0.986244,0.012107099],"study_design_scores_gemma":[0.00019917171,0.00008209685,0.0020720202,0.0031670195,0.0002690469,0.0006246868,0.00032068184,0.0005733255,0.00028419207,0.0025773447,0.9897231,0.00010731052],"about_ca_topic_score_codex":0.0034239455,"about_ca_topic_score_gemma":0.006517162,"teacher_disagreement_score":0.96076214,"about_ca_system_score_codex":0.004615038,"about_ca_system_score_gemma":0.0069304584,"threshold_uncertainty_score":0.20751202},"labels":[],"label_agreement":null},{"id":"W2416237154","doi":"10.1111/bjd.14799","title":"Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis","year":2016,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto; University of New Brunswick; Canada Research Chairs; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Dermatology Foundation","keywords":"Toxic epidermal necrolysis; Medicine; Quality of life (healthcare); Dermatology; Nursing","score_opus":0.03790143397671786,"score_gpt":0.3160734435432042,"score_spread":0.27817200956648636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416237154","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23467885,0.17585126,0.001359474,0.4288279,0.1487361,0.00026076223,0.002880269,0.00013081622,0.0072745616],"genre_scores_gemma":[0.5182207,0.12392291,0.001549403,0.09115475,0.25482646,0.00020932645,0.0009801531,0.000053157437,0.009083137],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99946314,0.0002128628,0.00007723612,0.000044759832,0.00014884217,0.00005327917],"domain_scores_gemma":[0.9963182,0.0018481963,0.0007052079,0.00006835118,0.0007481862,0.0003118208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013015597,0.00038180896,0.00074544444,0.0005770934,0.00037379508,0.00097421877,0.0006332959,0.0016022247,0.0030612375],"category_scores_gemma":[0.006560985,0.00020999157,0.00029309688,0.0005871609,0.00047524873,0.0012607841,0.00033906268,0.002275469,0.0005092538],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016519368,0.00045717697,0.1296861,0.0041943914,0.0005736666,0.008429085,0.0014025061,0.00022090237,0.00086705614,0.00092428684,0.67535466,0.17623818],"study_design_scores_gemma":[0.00074929907,0.0022606028,0.53143734,0.009127251,0.0010986712,0.04533846,0.006837554,0.0030660206,0.0011711718,0.0023312788,0.39637697,0.00020539941],"about_ca_topic_score_codex":0.0008235427,"about_ca_topic_score_gemma":0.0020079901,"teacher_disagreement_score":0.0030612375,"about_ca_system_score_codex":0.0002620369,"about_ca_system_score_gemma":0.0004476998,"threshold_uncertainty_score":0.010240853},"labels":[],"label_agreement":null},{"id":"W2465799764","doi":"10.1111/bjd.14871","title":"Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Probity Medical Research; Innovaderm (Canada)","funders":"Pfizer","keywords":"Tofacitinib; Eczema Area and Severity Index; Tolerability; Medicine; Janus kinase inhibitor; Atopic dermatitis; Adverse effect; Randomized controlled trial; Clinical endpoint; Internal medicine; Pharmacodynamics; Dermatology; Pharmacokinetics; Onset of action; Rheumatoid arthritis","score_opus":0.01635605518526289,"score_gpt":0.30022126625121304,"score_spread":0.28386521106595014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465799764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90326905,0.046186518,0.0020467415,0.0033450671,0.0021307687,0.024406869,0.0058155805,0.00048409816,0.01231533],"genre_scores_gemma":[0.9377566,0.021851357,0.0039159735,0.005099938,0.0019765205,0.01699287,0.004003266,0.000054896176,0.0083485525],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99947315,0.0002661588,0.000040849096,0.00008415314,0.000059809227,0.00007585063],"domain_scores_gemma":[0.9993262,0.00016266794,0.00018644922,0.000050119186,0.00007208358,0.00020251614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019958178,0.0012242378,0.0020707005,0.0004061052,0.00034969603,0.0011839472,0.00064795656,0.0017229781,0.0115223],"category_scores_gemma":[0.0010798465,0.00045055753,0.0019567106,0.00046820156,0.0005729167,0.0006960658,0.0002441411,0.0019487407,0.0012752594],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.939725,0.006779573,0.00087314966,0.0026195426,0.0018751851,0.00008589673,0.000034162244,0.0003446767,0.006634839,0.00022938127,0.003629711,0.037168957],"study_design_scores_gemma":[0.9706862,0.026432684,0.00086455676,0.00007756732,0.0003947593,0.000038501315,0.0000065496724,0.00014410695,0.00019547975,0.00007787566,0.0010762189,0.000005505135],"about_ca_topic_score_codex":0.0006380323,"about_ca_topic_score_gemma":0.0015190062,"teacher_disagreement_score":0.0115223,"about_ca_system_score_codex":0.0006173006,"about_ca_system_score_gemma":0.001307812,"threshold_uncertainty_score":0.038545907},"labels":[],"label_agreement":null},{"id":"W2472098090","doi":"10.1111/bjd.14873","title":"Mosaicism for a <i>SPRED1</i> deletion revealed in a patient with clinically suspected mosaic neurofibromatosis","year":2016,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"Children's Tumor Foundation","keywords":"Neurofibromatosis; Medicine; Neurofibromatoses; Dermatology; Pathology","score_opus":0.013350272614719095,"score_gpt":0.24949402239279803,"score_spread":0.23614374977807892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472098090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674287,0.0019941002,0.0018701858,0.006768408,0.00036149248,0.00010643134,0.00030862083,0.00016028425,0.02100163],"genre_scores_gemma":[0.9963063,0.00049110973,0.0006998463,0.00055866234,0.00023654765,0.00001188294,0.000046436755,0.000013726705,0.0016355461],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996308,0.000045464258,0.000031769876,0.00012036476,0.00007435854,0.00009715566],"domain_scores_gemma":[0.9992256,0.00035902834,0.00009871151,0.000055455006,0.000059569193,0.00020156996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026026534,0.00095597823,0.00049626955,0.0011512942,0.0013118876,0.0008007845,0.0006100121,0.003111714,0.0026721468],"category_scores_gemma":[0.0020611433,0.0004404887,0.00041241167,0.0006070718,0.0011270811,0.0007012452,0.00065614237,0.0014762516,0.00067469897],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007667449,0.000022150569,0.007352956,0.000024849845,0.0000049918767,0.9842376,0.0003331411,0.000071339375,0.0050410405,0.00038521958,0.0005149518,0.0019349786],"study_design_scores_gemma":[0.000012223606,0.0001137145,0.008544968,0.000014137746,0.0000120064815,0.98814607,0.00014702452,0.00029541692,0.0010691513,0.00033795458,0.0012955178,0.000011917455],"about_ca_topic_score_codex":0.0019732595,"about_ca_topic_score_gemma":0.0020520156,"teacher_disagreement_score":0.003111714,"about_ca_system_score_codex":0.00072422647,"about_ca_system_score_gemma":0.00036581192,"threshold_uncertainty_score":0.008939207},"labels":[],"label_agreement":null},{"id":"W2472169523","doi":"10.1111/j.1365-2133.1976.tb07881.x","title":"Measurement of dermal atrophy induced by topical steroids using a radiographic technique","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Library science; Computer science","score_opus":0.015341087338458842,"score_gpt":0.25253337134620873,"score_spread":0.2371922840077499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472169523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86394686,0.023222847,0.09169029,0.00053427654,0.00047478746,0.0010564676,0.00060685776,0.0008962286,0.017571287],"genre_scores_gemma":[0.902723,0.010652237,0.07661218,0.00024358204,0.00017531827,0.00051939423,0.00043175227,0.00010162583,0.008540918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913424,0.00032905443,0.000046604993,0.00008715209,0.00035107156,0.00005187346],"domain_scores_gemma":[0.99880517,0.00031711938,0.0003412183,0.000108127024,0.00030686945,0.00012148334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009419768,0.0006127341,0.00029010553,0.0013428759,0.00023622948,0.00023818534,0.0002842498,0.00050471607,0.0024796333],"category_scores_gemma":[0.0014557019,0.0002998447,0.00042230915,0.0007141141,0.00040698645,0.00037756213,0.00025309724,0.0009783552,0.00048713476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051994534,0.0001256212,0.0031123396,0.00026309234,0.00003844106,0.00023227473,0.00007141385,0.00006874342,0.9834261,0.00015428996,0.0002797651,0.011707907],"study_design_scores_gemma":[0.0001966153,0.010856705,0.15201287,0.0001015959,0.00036039128,0.0044707335,0.000317287,0.0023699128,0.8215461,0.0001562597,0.0075562946,0.000055200187],"about_ca_topic_score_codex":0.0008946586,"about_ca_topic_score_gemma":0.0014322386,"teacher_disagreement_score":0.0024796333,"about_ca_system_score_codex":0.00014995132,"about_ca_system_score_gemma":0.00023021855,"threshold_uncertainty_score":0.008295238},"labels":[],"label_agreement":null},{"id":"W2512873140","doi":"10.1111/bjd.14965","title":"Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate-to-severe plaque psoriasis","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Novartis Pharma","keywords":"Secukinumab; Medicine; Immunogenicity; Psoriasis; Psoriasis Area and Severity Index; Monoclonal antibody; Immunology; Cytokine; Interleukin 17; Antibody; Internal medicine; Psoriatic arthritis","score_opus":0.007734141049989083,"score_gpt":0.22355477557271214,"score_spread":0.21582063452272304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512873140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978809,0.0012460763,0.00012757076,0.000035755267,0.000005907465,0.000015246925,0.000031523923,0.000009716246,0.000647335],"genre_scores_gemma":[0.9996762,0.00014070277,0.000051063715,0.000024898669,0.000007983825,0.0000042845695,0.000037061036,9.808482e-7,0.00005687379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996698,0.0001418633,0.000036971414,0.00004765254,0.000073821466,0.000030010027],"domain_scores_gemma":[0.99914753,0.000330233,0.00028523873,0.00006375544,0.00007700164,0.00009621176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094192737,0.00019964232,0.0004984508,0.00014194322,0.00016194479,0.00030976767,0.00009748208,0.00022893149,0.0012081538],"category_scores_gemma":[0.0018272218,0.00011766501,0.00022919224,0.00018393218,0.00016338554,0.00023041356,0.00012896972,0.00031147018,0.00020794019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0132526485,0.00072185276,0.8176362,0.00039838557,0.00042529404,0.0013081478,0.00030156743,0.00046363138,0.05860519,0.00008897932,0.00092363096,0.10587445],"study_design_scores_gemma":[0.00040063902,0.011642615,0.9763573,0.00002989441,0.00017211496,0.0052113114,0.00010925695,0.000455603,0.0037290265,0.00004850912,0.0018344455,0.000009244541],"about_ca_topic_score_codex":0.00015772325,"about_ca_topic_score_gemma":0.00021858171,"teacher_disagreement_score":0.0012081538,"about_ca_system_score_codex":0.0001187608,"about_ca_system_score_gemma":0.00013080286,"threshold_uncertainty_score":0.004981458},"labels":[],"label_agreement":null},{"id":"W2513381104","doi":"10.1111/bjd.14958","title":"Pre‐eclampsia and risk of infantile haemangioma","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Université de Sherbrooke; Université de Montréal; Institut National de Santé Publique du Québec","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Eclampsia; Medicine; Obstetrics; Pregnancy; Pediatrics; Biology; Genetics","score_opus":0.005931832682211824,"score_gpt":0.2333034888667877,"score_spread":0.2273716561845759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513381104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963967,0.0015265475,0.00014035734,0.00016012213,0.000008906985,0.000009091629,0.0007742059,0.000009915501,0.0009741685],"genre_scores_gemma":[0.9991955,0.00036352445,0.00008409335,0.00001694455,0.0000049183286,0.0000027493165,0.00021092793,0.0000017905045,0.000119547425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996784,0.000056350433,0.000028289038,0.000074665644,0.00008295127,0.00007942707],"domain_scores_gemma":[0.9975848,0.0003612235,0.0011874622,0.00011178578,0.0004013851,0.00035335857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004430594,0.00018255711,0.00017905426,0.0006265682,0.000266041,0.00043201228,0.00041913814,0.00028754273,0.001864092],"category_scores_gemma":[0.0029411202,0.00017928866,0.00031849046,0.00069288764,0.00026710716,0.00016418421,0.0002342716,0.00066586735,0.00013654344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032919874,0.0000048752486,0.99875915,0.000011427051,0.00002636799,0.0000762354,0.000024584864,0.000025602594,0.00008052407,0.000014780456,0.000076643555,0.0008669891],"study_design_scores_gemma":[0.0000013738209,0.000016123191,0.9993629,0.0000109184575,0.000013909308,0.00033847525,0.000019589377,0.000098353026,0.000022490816,0.00000989436,0.00010457781,0.0000014976494],"about_ca_topic_score_codex":0.13787583,"about_ca_topic_score_gemma":0.11897652,"teacher_disagreement_score":0.13787583,"about_ca_system_score_codex":0.00095140364,"about_ca_system_score_gemma":0.0009334401,"threshold_uncertainty_score":0.27414662},"labels":[],"label_agreement":null},{"id":"W2519779602","doi":"10.1111/bjd.15067","title":"Biosimilars for psoriasis: clinical studies to determine similarity","year":2016,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"Cilag; Galderma; Dermira; Celgene; Amgen; Pfizer; Eli Lilly and Company","keywords":"Biosimilar; Psoriasis; Similarity (geometry); Medicine; Dermatology; MEDLINE; Intensive care medicine; Computer science; Internal medicine; Artificial intelligence; Chemistry","score_opus":0.19206551971016245,"score_gpt":0.46453267096096384,"score_spread":0.2724671512508014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519779602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012989515,0.99808323,0.0001807195,0.00040805698,0.00016636265,0.000011125032,0.000016134794,0.00000386551,0.0010005508],"genre_scores_gemma":[0.0019202098,0.9963553,0.00046090854,0.0006065828,0.00018615855,0.00001949449,0.000035125304,0.0000031470702,0.00041321607],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9987754,0.00036137918,0.00020936395,0.00014713351,0.00046480307,0.000041917698],"domain_scores_gemma":[0.9965551,0.0024347412,0.0003057988,0.00007801814,0.00053650065,0.00008987664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003699798,0.0006622577,0.0018146217,0.0022144725,0.0002316776,0.0014335314,0.0007323376,0.0017146841,0.0040645865],"category_scores_gemma":[0.0043772175,0.0002648808,0.0009752338,0.0017287353,0.0007068608,0.0014530524,0.0006991609,0.0024853814,0.0015940184],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014431197,0.00008256248,0.00019812472,0.02989701,0.00015673554,0.00013851821,0.00008437921,0.00020794204,0.0023123114,0.005303954,0.013757835,0.94771636],"study_design_scores_gemma":[0.00009870716,0.00040982335,0.0009710491,0.015640123,0.00035519723,0.0020945675,0.000116494506,0.000097277916,0.0020397338,0.00397362,0.9741701,0.000033242497],"about_ca_topic_score_codex":0.00047202694,"about_ca_topic_score_gemma":0.00071685883,"teacher_disagreement_score":0.0040645865,"about_ca_system_score_codex":0.0006613107,"about_ca_system_score_gemma":0.0010754813,"threshold_uncertainty_score":0.019566596},"labels":[],"label_agreement":null},{"id":"W2530767409","doi":"10.1111/bjd.15122","title":"Updating the diagnosis, classification and assessment of rosacea: recommendations from the global <scp>ROS</scp> acea <scp>CO</scp> nsensus ( <scp>ROSCO</scp> ) panel","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":280,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Galderma","keywords":"Rosacea; Chemistry; Dermatology; Medicine","score_opus":0.03693367658517458,"score_gpt":0.32251941785432947,"score_spread":0.28558574126915487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530767409","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01253974,0.04239548,0.022015044,0.8817385,0.013909517,0.002825083,0.0009630685,0.00043051413,0.023182962],"genre_scores_gemma":[0.22875233,0.09451559,0.4461615,0.18803644,0.010613974,0.007847344,0.0058405586,0.0005281393,0.017704092],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9545201,0.022609523,0.009240128,0.0012832728,0.010328079,0.002018905],"domain_scores_gemma":[0.8592549,0.04104107,0.0087837735,0.0029978799,0.07755322,0.010369194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07013542,0.0009898103,0.0014393937,0.004584767,0.0033042498,0.0030406655,0.005802119,0.008574919,0.003153891],"category_scores_gemma":[0.0916116,0.0007052224,0.0022762734,0.0023501262,0.0032374184,0.0035243325,0.005575818,0.011062265,0.0024138407],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015802203,0.00034564032,0.010501114,0.0040992275,0.00010985175,0.000850385,0.0044089234,0.00092295255,0.0019724623,0.0046726465,0.54226506,0.42969382],"study_design_scores_gemma":[0.0002930208,0.0003706006,0.03925082,0.03154071,0.00038495116,0.002724684,0.012900142,0.0026808227,0.0014804247,0.01876837,0.8892771,0.00032835023],"about_ca_topic_score_codex":0.020540327,"about_ca_topic_score_gemma":0.023304181,"teacher_disagreement_score":0.07013542,"about_ca_system_score_codex":0.0058468776,"about_ca_system_score_gemma":0.027577791,"threshold_uncertainty_score":0.370916},"labels":[],"label_agreement":null},{"id":"W2552053986","doi":"10.1111/bjd.15186","title":"Risk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cellulitis; Odds ratio; Meta-analysis; Confidence interval; Observational study; Risk factor; Surgery; Abscess; Internal medicine; Body mass index; Dermatology","score_opus":0.06759241568192687,"score_gpt":0.36118000587718574,"score_spread":0.2935875901952589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552053986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053994576,0.9931768,0.00044837437,0.0001486902,0.00012034514,0.00022688294,0.00029270587,0.000017593013,0.00016924579],"genre_scores_gemma":[0.17068341,0.82447135,0.0019528859,0.0007340216,0.0002325061,0.0009184541,0.0006851174,0.000024143343,0.00029803085],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99351937,0.0031108428,0.0017520557,0.00071736414,0.000633482,0.0002668079],"domain_scores_gemma":[0.98470163,0.011123673,0.0022852751,0.00048582666,0.0011669716,0.00023672184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010826319,0.0027711962,0.015506275,0.0053091627,0.0006888233,0.0031459539,0.0019936373,0.0024018541,0.0038488093],"category_scores_gemma":[0.025575586,0.0017439722,0.03760546,0.006289768,0.00069893774,0.0016759449,0.0015081003,0.00201833,0.00031681274],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00178278,0.00003942801,0.0051707104,0.35457087,0.6283016,0.00015823028,0.00008918951,0.00049739063,0.00020603668,0.00013050358,0.00042812762,0.008625078],"study_design_scores_gemma":[0.00037423187,0.0001759921,0.0036231086,0.01881006,0.97546244,0.000091536975,0.00004564646,0.0001691307,0.00007237566,0.0001367493,0.0010181216,0.000020636055],"about_ca_topic_score_codex":0.007974852,"about_ca_topic_score_gemma":0.01579386,"teacher_disagreement_score":0.015506275,"about_ca_system_score_codex":0.0022918142,"about_ca_system_score_gemma":0.0031835656,"threshold_uncertainty_score":0.057255745},"labels":[],"label_agreement":null},{"id":"W2556344553","doi":"10.1111/bjd.15173","title":"Rosacea treatment update: recommendations from the global <scp>ROS</scp> acea <scp>CO</scp> nsensus ( <scp>ROSCO</scp> ) panel","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Galderma; Dermira","keywords":"Chemistry","score_opus":0.02276731997857802,"score_gpt":0.2835938768255624,"score_spread":0.2608265568469844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556344553","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048807412,0.2565417,0.00942794,0.5681578,0.034954462,0.0034076478,0.01736036,0.0012024932,0.10406692],"genre_scores_gemma":[0.036807362,0.45804277,0.10768671,0.24691664,0.01386771,0.00824797,0.050771542,0.000800578,0.07685877],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934115,0.0019314807,0.0013554465,0.00026281853,0.0024267957,0.00061194034],"domain_scores_gemma":[0.9859762,0.0027296802,0.0015027092,0.00020851227,0.008170093,0.0014127233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011432256,0.00086772675,0.0013491675,0.0032052046,0.0011785856,0.002883892,0.0041258545,0.005738841,0.010598363],"category_scores_gemma":[0.0135248825,0.00056660076,0.0034651621,0.002477186,0.0006488455,0.002320973,0.002669892,0.007878138,0.0070061176],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009029693,0.00018660046,0.00097548973,0.003061021,0.000060973744,0.00015152292,0.0001850449,0.00029465876,0.00041255346,0.0015854333,0.77335316,0.21964334],"study_design_scores_gemma":[0.00012301454,0.00006240081,0.003607962,0.011420899,0.0001735637,0.00023801846,0.00031764482,0.0001856768,0.00021197538,0.0013222786,0.9823078,0.00002872287],"about_ca_topic_score_codex":0.02157382,"about_ca_topic_score_gemma":0.027154572,"teacher_disagreement_score":0.02157382,"about_ca_system_score_codex":0.0041529513,"about_ca_system_score_gemma":0.014404767,"threshold_uncertainty_score":0.06046027},"labels":[],"label_agreement":null},{"id":"W2571703912","doi":"10.1111/bjd.14819","title":"Shortcomings in rosacea diagnosis and classification","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Rosacea; Dermatology; Medicine","score_opus":0.02743460161754105,"score_gpt":0.3085512398547808,"score_spread":0.28111663823723976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571703912","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054040026,0.31073353,0.15264514,0.39658564,0.034454893,0.0013351967,0.0026912412,0.000750973,0.04676333],"genre_scores_gemma":[0.53242874,0.1439305,0.21034457,0.068234906,0.032514773,0.0012287799,0.0045383414,0.00046348353,0.006315946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9464815,0.017300779,0.011644567,0.0040875655,0.018793164,0.0016923787],"domain_scores_gemma":[0.89319587,0.031615406,0.007369857,0.0067043016,0.058386937,0.0027276701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06383107,0.00079622556,0.0017037783,0.009625426,0.0023690613,0.004876459,0.009004012,0.00238534,0.0019146804],"category_scores_gemma":[0.11995871,0.0006024626,0.0009569935,0.003941408,0.0056661996,0.006479742,0.004922125,0.0062660445,0.0016817453],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001873649,0.000096470925,0.059551544,0.0029137738,0.00013428884,0.0004939813,0.0044584735,0.001021204,0.00064063305,0.047367513,0.13831964,0.7448152],"study_design_scores_gemma":[0.000066970126,0.0002700382,0.0525503,0.020815631,0.00027033116,0.008804388,0.014625129,0.009287178,0.0016938283,0.18411793,0.70716023,0.00033806253],"about_ca_topic_score_codex":0.014574002,"about_ca_topic_score_gemma":0.013955612,"teacher_disagreement_score":0.06383107,"about_ca_system_score_codex":0.0062007834,"about_ca_system_score_gemma":0.006286026,"threshold_uncertainty_score":0.33757502},"labels":[],"label_agreement":null},{"id":"W2581695738","doi":"10.1111/bjd.15319","title":"Cross-sectional evaluation of acute adverse reactions during ultraviolet A1 phototherapy","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Medicine; Cross-sectional study; Dermatology; Adverse effect; Internal medicine; Pathology","score_opus":0.034587363990815294,"score_gpt":0.3472183744248262,"score_spread":0.3126310104340109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581695738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973788,0.00060374854,0.00011912176,0.00027269844,0.000031522013,0.000027757656,0.00017622407,0.0000058347237,0.001384323],"genre_scores_gemma":[0.9990571,0.0001845719,0.00006797336,0.00026695765,0.0000461007,0.000009313385,0.00009193813,0.0000016677112,0.0002744229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993074,0.00026599693,0.00010371835,0.00010091937,0.00011718157,0.000104742874],"domain_scores_gemma":[0.99790514,0.0006730988,0.0007162824,0.000119518016,0.00032371702,0.00026232735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007203714,0.00020161225,0.00031307456,0.00042275325,0.0003998808,0.0004915665,0.00016624996,0.00074837916,0.0017353725],"category_scores_gemma":[0.002201574,0.00019751319,0.0004340798,0.00035439618,0.00014774418,0.00036725908,0.00019810579,0.000695964,0.00027383704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044699595,0.00022037738,0.9877737,0.000045107612,0.00007791749,0.004849565,0.00027634608,0.00003389732,0.0020186363,0.000016986161,0.00029464843,0.0039458717],"study_design_scores_gemma":[0.000007964286,0.00062612543,0.9905777,0.000012523846,0.000028334869,0.007569496,0.0003221415,0.00007213199,0.00024164702,0.000015102896,0.00052146823,0.0000053608105],"about_ca_topic_score_codex":0.0017598497,"about_ca_topic_score_gemma":0.0016833947,"teacher_disagreement_score":0.0017598497,"about_ca_system_score_codex":0.0003067518,"about_ca_system_score_gemma":0.00015559138,"threshold_uncertainty_score":0.005805373},"labels":[],"label_agreement":null},{"id":"W2588014405","doi":"10.1111/bjd.15381","title":"Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumab","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Adalimumab; Medicine; Etanercept; Dermatology Life Quality Index; Internal medicine; Psoriasis Area and Severity Index; Psoriasis; Clinical endpoint; Confidence interval; Quality of life (healthcare); Visual analogue scale; Severity of illness; Surgery; Gastroenterology; Physical therapy; Randomized controlled trial; Dermatology; Tumor necrosis factor alpha","score_opus":0.024319528757040982,"score_gpt":0.27268119109163624,"score_spread":0.24836166233459525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588014405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953708,0.0010259275,0.0005096256,0.00014262079,0.00009406004,0.0015198722,0.0005948126,0.00004601939,0.0006961897],"genre_scores_gemma":[0.9930795,0.00051991,0.0011474545,0.00041529164,0.00025897857,0.0023469853,0.0009230604,0.000011060246,0.001297738],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99843615,0.00091841957,0.00009688014,0.0002529706,0.0001474293,0.00014811476],"domain_scores_gemma":[0.99738747,0.0007938578,0.0005941299,0.0003182269,0.00014220143,0.000764182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033944922,0.0014358056,0.0029327075,0.00037867148,0.0004399096,0.0009877274,0.0008242304,0.0012652967,0.0053650388],"category_scores_gemma":[0.0025194846,0.00075201725,0.0016633826,0.0003409014,0.0010878408,0.0012250107,0.00044638448,0.002671574,0.0009666963],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.892094,0.061368685,0.0067622135,0.0004230103,0.0009673767,0.00013037266,0.0001528008,0.0005523225,0.006071488,0.00009242417,0.0006789835,0.030706303],"study_design_scores_gemma":[0.5975166,0.3849228,0.0145559935,0.00002490173,0.00026781842,0.00014672175,0.000040037503,0.0010427886,0.00050901907,0.00009339936,0.0008547922,0.00002513704],"about_ca_topic_score_codex":0.00043065028,"about_ca_topic_score_gemma":0.000628728,"teacher_disagreement_score":0.0053650388,"about_ca_system_score_codex":0.00068722473,"about_ca_system_score_gemma":0.0009448072,"threshold_uncertainty_score":0.017952025},"labels":[],"label_agreement":null},{"id":"W2591192302","doi":"10.1111/bjd.15403","title":"Cross-sectional comparisons of patient-reported disease control, disease severity and symptom frequency in children with atopic dermatitis","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Valeant Pharmaceuticals International","keywords":"Atopic dermatitis; Medicine; Disease; Patient-reported outcome; MEDLINE; Pediatrics; Dermatology; Quality of life (healthcare); Internal medicine","score_opus":0.009048142398290965,"score_gpt":0.2661719888662231,"score_spread":0.2571238464679322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591192302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988386,0.00028429195,0.00006022758,0.000031704338,0.000008063251,0.00001180168,0.0004231714,0.000003355248,0.00033874513],"genre_scores_gemma":[0.9989767,0.0000952721,0.000104656494,0.000023692475,0.00001733218,0.0000241893,0.00061796204,0.0000023740117,0.0001377456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981974,0.00075768225,0.00026192615,0.00031185022,0.00030368209,0.00016758687],"domain_scores_gemma":[0.9915047,0.003728109,0.0030072094,0.0005582457,0.00058190705,0.0006199247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027200112,0.00030843716,0.00034019427,0.0011484759,0.0002570851,0.00047364927,0.00044476113,0.00070329284,0.0025983069],"category_scores_gemma":[0.008180502,0.00031360658,0.0005251687,0.00085459143,0.0003130656,0.00073900016,0.00051442726,0.0006711624,0.00043772042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024300884,0.000057740523,0.99842465,0.000013326602,0.00008689258,0.00002817765,0.00006982028,0.000024968682,0.00007226685,0.000015419551,0.00009601525,0.0008675873],"study_design_scores_gemma":[0.000013827777,0.00022002007,0.9993358,0.0000039318506,0.000025296455,0.00013522983,0.0000755137,0.000052936917,0.00003346142,0.000009607762,0.00009230822,0.0000020286],"about_ca_topic_score_codex":0.0016280675,"about_ca_topic_score_gemma":0.0016378032,"teacher_disagreement_score":0.0027200112,"about_ca_system_score_codex":0.00033240204,"about_ca_system_score_gemma":0.00015344749,"threshold_uncertainty_score":0.014384985},"labels":[],"label_agreement":null},{"id":"W2592400639","doi":"10.1111/bjd.15252","title":"Taking steps to improve the assessment and management of rosacea","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Rosacea; Dermatology; Medicine","score_opus":0.017116407933621933,"score_gpt":0.31500771569186253,"score_spread":0.2978913077582406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592400639","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008091662,0.006745814,0.0005858582,0.96023774,0.024524158,0.000038984293,0.000034705798,0.00008484207,0.006938788],"genre_scores_gemma":[0.014558844,0.015167774,0.004119117,0.8187571,0.13187715,0.00010662708,0.00011413754,0.00006429819,0.015234922],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728537,0.00072832213,0.00046586656,0.0002527176,0.00093608355,0.000331589],"domain_scores_gemma":[0.99220157,0.0029186974,0.00042701306,0.00031184356,0.002563804,0.001577083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020468603,0.00090640294,0.0013551499,0.0010301836,0.0028997946,0.0029282267,0.0015785138,0.025973614,0.012263013],"category_scores_gemma":[0.0209659,0.00046408386,0.0017139089,0.00042835702,0.0017956798,0.008109766,0.002342447,0.03860032,0.0094515225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004200202,0.00023141109,0.0023505776,0.00031850726,0.000033296685,0.030777568,0.0002992855,0.00019381681,0.0007287325,0.0025282155,0.90803236,0.054464273],"study_design_scores_gemma":[0.00016340584,0.00019431609,0.004000927,0.0025782848,0.000053565098,0.09185656,0.0015475064,0.0010759401,0.0003772407,0.024496915,0.8734933,0.00016189796],"about_ca_topic_score_codex":0.0037407512,"about_ca_topic_score_gemma":0.0066479645,"teacher_disagreement_score":0.025973614,"about_ca_system_score_codex":0.0029836302,"about_ca_system_score_gemma":0.0031735622,"threshold_uncertainty_score":0.04102385},"labels":[],"label_agreement":null},{"id":"W2597329772","doi":"10.1111/bjd.15463","title":"Reaching complete or near-complete resolution of psoriasis: benefit and risk considerations","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute for Health and Care Research; Dermira; Valeant Pharmaceuticals International; Genentech; Celgene; Eli Lilly and Company; GlaxoSmithKline; Amgen","keywords":"Psoriasis; Medicine; Dermatology; Resolution (logic); Computer science; Artificial intelligence","score_opus":0.037536062191523216,"score_gpt":0.2521970647376623,"score_spread":0.21466100254613907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597329772","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030468844,0.009541522,0.00047567295,0.97763115,0.004016035,0.000019189692,0.000031900592,0.000021521011,0.0052161454],"genre_scores_gemma":[0.09139197,0.02334226,0.0020073215,0.76691943,0.10899852,0.000098713026,0.00007500093,0.000037991405,0.0071287174],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980465,0.0008397122,0.0002796174,0.00018010927,0.000449319,0.00020473269],"domain_scores_gemma":[0.99214774,0.0058178967,0.0003552451,0.00017085615,0.00097528903,0.00053290575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023717168,0.0004003158,0.0013494419,0.00040819446,0.0011206185,0.0023137366,0.00080510904,0.016840365,0.0056239762],"category_scores_gemma":[0.021090133,0.00025115517,0.00078508136,0.0004247637,0.0020420523,0.0027880801,0.0008221952,0.017669557,0.0035305158],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000650631,0.00023791942,0.009057909,0.0007166677,0.00009338853,0.08052224,0.0006305617,0.0010309558,0.0022536707,0.029059708,0.67603785,0.19970857],"study_design_scores_gemma":[0.00045479042,0.00051544607,0.006433001,0.0021938758,0.00011278827,0.20444366,0.0018220855,0.0024301563,0.0010586069,0.116116285,0.66427857,0.00014071494],"about_ca_topic_score_codex":0.00090035575,"about_ca_topic_score_gemma":0.0012651706,"teacher_disagreement_score":0.016840365,"about_ca_system_score_codex":0.002394003,"about_ca_system_score_gemma":0.0012435912,"threshold_uncertainty_score":0.018814027},"labels":[],"label_agreement":null},{"id":"W2604462359","doi":"10.1111/bjd.15549","title":"Burnout in dermatology residents: a Canadian perspective","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Healthcare professionals’ stress and burnout","field":"Health Professions","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Calgary","funders":"Canadian Dermatology Foundation","keywords":"Burnout; Perspective (graphical); Dermatology; Medicine; MEDLINE; Family medicine; Clinical psychology; Political science; Art","score_opus":0.040502429943785265,"score_gpt":0.3996074951409514,"score_spread":0.3591050651971661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604462359","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020150792,0.011278958,0.000027567447,0.9508055,0.004469934,0.000018724448,0.00016637384,0.000006561382,0.013075656],"genre_scores_gemma":[0.30470192,0.029669426,0.00021870526,0.6392615,0.010131098,0.000054566142,0.0001362112,0.000038590224,0.015788056],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99494654,0.00067311263,0.0002894011,0.00024058594,0.0012062761,0.002644175],"domain_scores_gemma":[0.9756174,0.0026471145,0.0014621216,0.00014813499,0.007670938,0.012454206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035273752,0.00040883332,0.0008537353,0.0019353965,0.020271957,0.00636427,0.0018887762,0.015853953,0.010100065],"category_scores_gemma":[0.013970542,0.00062336185,0.0007881705,0.0035829556,0.005617359,0.0025088356,0.0028623913,0.017707372,0.0008159213],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023965708,0.00035856766,0.062442824,0.0010448013,0.00011631588,0.014333695,0.038680576,0.00020913211,0.0004454973,0.009737575,0.83899295,0.033398394],"study_design_scores_gemma":[0.00022586969,0.00021453219,0.16197552,0.008907088,0.00017418836,0.007733087,0.26946715,0.0003208404,0.00017293372,0.004742387,0.5456345,0.00043185614],"about_ca_topic_score_codex":0.9541716,"about_ca_topic_score_gemma":0.9814307,"teacher_disagreement_score":0.06615125,"about_ca_system_score_codex":0.06615125,"about_ca_system_score_gemma":0.13024043,"threshold_uncertainty_score":0.47996312},"labels":[],"label_agreement":null},{"id":"W2607887215","doi":"10.1111/bjd.15604","title":"Dermoscopy use by Canadian dermatologists and dermatology residents: a cross‐sectional nationwide study","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"Canadian Dermatology Foundation","keywords":"Cross-sectional study; Medicine; Dermatology; Family medicine; Pathology","score_opus":0.021038590490452855,"score_gpt":0.29262979643376136,"score_spread":0.2715912059433085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607887215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99126726,0.0015367562,0.00007771733,0.0011064808,0.000042473403,0.00010499303,0.003735306,0.000013653503,0.0021154906],"genre_scores_gemma":[0.99615306,0.0011132773,0.00021830974,0.0007493832,0.000058998154,0.000043899938,0.0011529108,0.0000063820175,0.0005036828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982305,0.00013286548,0.00012104764,0.0002758632,0.00086168747,0.00037802884],"domain_scores_gemma":[0.99550617,0.00046976793,0.0014846758,0.00019237986,0.0013655617,0.0009813147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012834173,0.00030486024,0.00040830637,0.0016826495,0.0020818084,0.0010380702,0.0012761701,0.0010970269,0.0031422267],"category_scores_gemma":[0.0043130782,0.00063576933,0.0005751964,0.0046578525,0.00078619545,0.0008732254,0.00068807404,0.0008906183,0.0004431232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036201604,0.000065942324,0.9958411,0.00005342699,0.00004102942,0.000080533595,0.0005324071,0.000011964429,0.00006154243,0.000022374592,0.0016014156,0.0016520473],"study_design_scores_gemma":[0.0000067411474,0.000050978622,0.9981475,0.00003278783,0.000016765785,0.00016262257,0.0007661513,0.00008099733,0.000017154816,0.0000058702985,0.000703767,0.0000086242635],"about_ca_topic_score_codex":0.87162954,"about_ca_topic_score_gemma":0.8999726,"teacher_disagreement_score":0.12837046,"about_ca_system_score_codex":0.0062069604,"about_ca_system_score_gemma":0.0071961074,"threshold_uncertainty_score":0.25825286},"labels":[],"label_agreement":null},{"id":"W2624322160","doi":"10.1111/bjd.15723","title":"Infections from seven clinical trials of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriasis","year":2017,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Psoriasis; Medicine; Interleukin 17; Monoclonal antibody; Immunology; Clinical trial; Dermatology; Monoclonal; Interleukin; Plaque psoriasis; Antibody; Internal medicine; Cytokine; Secukinumab; Psoriatic arthritis","score_opus":0.09830212884903328,"score_gpt":0.39601046185283323,"score_spread":0.29770833300379995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624322160","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6637675,0.31845632,0.0012087122,0.0005436008,0.00012233865,0.0041234973,0.0078078224,0.000080307356,0.0038899265],"genre_scores_gemma":[0.8933497,0.090388894,0.0022314878,0.0009838009,0.00023403515,0.003012517,0.009199252,0.000028250726,0.0005720914],"study_design_codex":"randomized_trial","study_design_gemma":"systematic_review","domain_scores_codex":[0.9906068,0.0043162247,0.0025908353,0.0007889535,0.0013855661,0.0003115514],"domain_scores_gemma":[0.98829865,0.00650814,0.0036953513,0.00050207553,0.00062738144,0.00036842003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00900782,0.0007310117,0.0036161197,0.00131066,0.00037150938,0.0015912979,0.0007465737,0.000811022,0.001961444],"category_scores_gemma":[0.010141664,0.00053521397,0.0042128866,0.0024692582,0.00045681835,0.0005915375,0.0007951735,0.0011174813,0.00017524858],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3865351,0.0029867617,0.0970273,0.086858325,0.11682641,0.0006341889,0.0006419871,0.0027517255,0.012024864,0.00055859366,0.0069566094,0.28619814],"study_design_scores_gemma":[0.39327726,0.123042285,0.2702949,0.013397579,0.15746146,0.002816617,0.00054532697,0.0009534841,0.005871661,0.0009157752,0.031197447,0.0002261801],"about_ca_topic_score_codex":0.0006233628,"about_ca_topic_score_gemma":0.0023157827,"teacher_disagreement_score":0.00900782,"about_ca_system_score_codex":0.0008200727,"about_ca_system_score_gemma":0.0017609113,"threshold_uncertainty_score":0.047638535},"labels":[],"label_agreement":null},{"id":"W2666466176","doi":"10.1111/bjd.15734","title":"Letter to the Editor re: ‘Long‐term complications of Stevens–Johnson syndrome/toxic epidermal necrolysis ( <scp>SJS</scp> / <scp>TEN</scp> ): the spectrum of chronic problems in patients who survive an episode of <scp>SJS</scp> / <scp>TEN</scp> necessitates multidisciplinary follow‐up’","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Alberta","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Dermatology; Erythroderma; Broad spectrum","score_opus":0.017180805148251467,"score_gpt":0.26822676363083975,"score_spread":0.25104595848258826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2666466176","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022660366,0.007508986,0.00020785902,0.887974,0.09862485,0.000034811448,0.000113770235,0.00009392639,0.0031756987],"genre_scores_gemma":[0.024565658,0.008319467,0.00041684165,0.76990473,0.18664443,0.000068856876,0.00009629232,0.000080964186,0.009902746],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828005,0.0005336784,0.00032781067,0.00024999364,0.00039995488,0.00020842381],"domain_scores_gemma":[0.9949451,0.002076506,0.00052995374,0.00010768153,0.0015184451,0.0008223967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015640238,0.0008818666,0.0015415546,0.0009819785,0.0015631,0.0022670934,0.0015602442,0.020796962,0.0056378385],"category_scores_gemma":[0.023605647,0.00061319274,0.000929257,0.000613464,0.0013871335,0.0038171692,0.00099779,0.018399265,0.0054441267],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007197346,0.00004610085,0.0013259469,0.00023065622,0.000026783227,0.02837248,0.00031179134,0.00007243025,0.00024923834,0.0008730198,0.95830333,0.010116289],"study_design_scores_gemma":[0.00015666343,0.00016865562,0.003221553,0.0011767157,0.0000846642,0.14996605,0.0014746398,0.0007983921,0.0006116827,0.0050452524,0.83712727,0.00016844262],"about_ca_topic_score_codex":0.0013236513,"about_ca_topic_score_gemma":0.001579303,"teacher_disagreement_score":0.020796962,"about_ca_system_score_codex":0.0019838656,"about_ca_system_score_gemma":0.0016484022,"threshold_uncertainty_score":0.0188604},"labels":[],"label_agreement":null},{"id":"W2684473450","doi":"10.1111/bjd.15756","title":"Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice","year":2017,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"AbbVie; Wyeth; Cilag; Amgen","keywords":"Psoriasis; Biosimilar; Medicine; Dermatology; Clinical Practice; Family medicine; Internal medicine","score_opus":0.2872613720546832,"score_gpt":0.5035942397088006,"score_spread":0.21633286765411736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2684473450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000113439615,0.9963523,0.0002515129,0.0016958084,0.00021280377,0.000016160388,0.000032254957,0.00001088512,0.0013148764],"genre_scores_gemma":[0.0010836186,0.99661034,0.00063756166,0.0010083468,0.00023760124,0.000022105269,0.000053464944,0.0000055489572,0.00034143424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965328,0.0008013426,0.0007629791,0.00035127543,0.001405676,0.00014577371],"domain_scores_gemma":[0.9901059,0.005885296,0.0014103523,0.00020352611,0.0020776596,0.00031726106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007513159,0.00086525065,0.0016198432,0.0052641546,0.0005394046,0.002442693,0.0019401376,0.0039057508,0.0038731203],"category_scores_gemma":[0.009483988,0.00050281885,0.0011753471,0.0057840785,0.0015580433,0.0027398265,0.0012661592,0.003507578,0.0016437325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059936527,0.0000816482,0.00029582737,0.0243518,0.00007140585,0.0001661435,0.00016045799,0.00032946566,0.0007246783,0.010229402,0.031902235,0.931627],"study_design_scores_gemma":[0.000029894829,0.00010139596,0.001055647,0.020478886,0.00011320225,0.001149732,0.00015260027,0.00012887713,0.0005053993,0.003935598,0.972315,0.000033620574],"about_ca_topic_score_codex":0.0024908562,"about_ca_topic_score_gemma":0.0025201172,"teacher_disagreement_score":0.007513159,"about_ca_system_score_codex":0.002498978,"about_ca_system_score_gemma":0.0061409664,"threshold_uncertainty_score":0.039733887},"labels":[],"label_agreement":null},{"id":"W2697574135","doi":"10.1111/bjd.15750","title":"Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase <scp>III NAVIGATE</scp> trial","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Janssen Research and Development","keywords":"Ustekinumab; Medicine; Psoriasis; Double blind; Dermatology; Randomized controlled trial; Randomization; Internal medicine; Alternative medicine; Disease; Pathology; Placebo","score_opus":0.01798615141328034,"score_gpt":0.2754203383737347,"score_spread":0.25743418696045434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2697574135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898858,0.0065036924,0.00034473152,0.00054889225,0.00013651396,0.0008633466,0.0005084427,0.000040057213,0.0011684505],"genre_scores_gemma":[0.9932633,0.0027624385,0.0006528092,0.0007337051,0.00024781414,0.0007941309,0.000736397,0.000014614822,0.0007947882],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99907863,0.0005930263,0.000075761556,0.00008764707,0.00008012623,0.000084823194],"domain_scores_gemma":[0.9982287,0.00072804006,0.00046591563,0.00012667333,0.00011314313,0.00033748194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003160799,0.0007803337,0.0019520452,0.00024265978,0.0003757456,0.00078735343,0.0005151061,0.0013510783,0.0031421024],"category_scores_gemma":[0.0021685173,0.00035966188,0.0017298508,0.00028400167,0.0007770427,0.0006682777,0.0002221684,0.0021622293,0.0005548603],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9502728,0.007305604,0.0030046643,0.00074116996,0.0015967448,0.000061590996,0.00008989024,0.00032759728,0.0044398624,0.00008848346,0.0011795174,0.030892085],"study_design_scores_gemma":[0.9156024,0.0742235,0.007162232,0.000056444824,0.0008425055,0.0001128162,0.000025199311,0.00037391606,0.0007248407,0.00009677846,0.0007672595,0.000012055806],"about_ca_topic_score_codex":0.00046466995,"about_ca_topic_score_gemma":0.0008927402,"teacher_disagreement_score":0.003160799,"about_ca_system_score_codex":0.00053392234,"about_ca_system_score_gemma":0.0008050216,"threshold_uncertainty_score":0.016716123},"labels":[],"label_agreement":null},{"id":"W2749695403","doi":"10.1111/bjd.15611","title":"Alopecia in Cronkhite-Canada syndrome","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dermatology; Medicine","score_opus":0.01314099627497874,"score_gpt":0.2466695192643888,"score_spread":0.23352852298941004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749695403","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20442836,0.027336495,0.00094385026,0.6372318,0.021330858,0.0001750746,0.00045835788,0.00021449853,0.107880585],"genre_scores_gemma":[0.8384956,0.00847599,0.0011792085,0.08615739,0.03685977,0.000069311485,0.0001612495,0.0000765222,0.028524958],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999185,0.0001635571,0.00009714809,0.00010397957,0.00018443381,0.00026589487],"domain_scores_gemma":[0.9979735,0.0008937686,0.00022929789,0.000064570806,0.000309264,0.00052954594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004895474,0.0007208648,0.0007467029,0.0010695236,0.002389196,0.0014162881,0.00096598227,0.01253918,0.0057245684],"category_scores_gemma":[0.0071273316,0.0004393332,0.0008791466,0.0009603996,0.0015973335,0.0011087419,0.00088794244,0.0066126296,0.0012519999],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012745324,0.000058145975,0.011634093,0.00014172068,0.00004160073,0.9390083,0.00028246362,0.00016685518,0.0008825006,0.0023810456,0.04012468,0.0051512537],"study_design_scores_gemma":[0.00021666646,0.00007234048,0.016516404,0.0003523165,0.00009418849,0.9385101,0.0006601388,0.0011638177,0.0003408096,0.0029890493,0.039037067,0.00004710662],"about_ca_topic_score_codex":0.025502905,"about_ca_topic_score_gemma":0.028257782,"teacher_disagreement_score":0.025502905,"about_ca_system_score_codex":0.004358362,"about_ca_system_score_gemma":0.0023151888,"threshold_uncertainty_score":0.05070895},"labels":[],"label_agreement":null},{"id":"W2751469248","doi":"10.1111/bjd.15928","title":"Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Chugai Pharmaceutical; LEO Pharma; LEO Fondet; Eli Lilly and Company; AstraZeneca; Galderma; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Celgene","keywords":"Atopic dermatitis; Medicine; Statement (logic); Dermatology; Dermatologic agents; Political science; Antibiotics","score_opus":0.06914032686386164,"score_gpt":0.309942794932204,"score_spread":0.24080246806834238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751469248","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013903512,0.24364425,0.03705558,0.5760151,0.05412185,0.013772133,0.006347333,0.0005720617,0.054568227],"genre_scores_gemma":[0.15046722,0.31540427,0.28296334,0.14300026,0.025616994,0.025895536,0.03560134,0.00044952554,0.020601518],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9329622,0.025009725,0.021688882,0.0022606358,0.015592438,0.0024861635],"domain_scores_gemma":[0.8552203,0.03323449,0.016135985,0.0036053376,0.08225043,0.00955339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08105135,0.0015202812,0.0027417631,0.0061338437,0.0019388971,0.0032368694,0.0064896373,0.008796129,0.0042023896],"category_scores_gemma":[0.09349964,0.0009357994,0.0041979677,0.004449852,0.0022185126,0.0031096837,0.0055721547,0.0094391955,0.0031559288],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004020434,0.0005785765,0.010567713,0.04018731,0.0006118153,0.0012065276,0.002232073,0.0013081506,0.0019512682,0.0044008414,0.5375523,0.3990014],"study_design_scores_gemma":[0.00044974455,0.00039131506,0.022464756,0.11248004,0.001346499,0.002930121,0.0027772125,0.0011705812,0.0015010512,0.009125454,0.8451572,0.00020604969],"about_ca_topic_score_codex":0.0069080796,"about_ca_topic_score_gemma":0.006947275,"teacher_disagreement_score":0.08105135,"about_ca_system_score_codex":0.0047770264,"about_ca_system_score_gemma":0.034815755,"threshold_uncertainty_score":0.4286456},"labels":[],"label_agreement":null},{"id":"W2755068232","doi":"10.1111/bjd.15993","title":"Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature","year":2017,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vital capacity; Diffusing capacity; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Cohort; Pulmonary function testing; Randomized controlled trial; Surgery; Lung; Lung function","score_opus":0.030916953434419307,"score_gpt":0.29006118937910613,"score_spread":0.25914423594468683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755068232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014720142,0.99772125,0.00010657811,0.00015941302,0.00007065132,0.00016571005,0.00017994072,0.0000046971622,0.000119678356],"genre_scores_gemma":[0.030305311,0.967397,0.00070992275,0.00063679076,0.00014936438,0.00046193486,0.00024043246,0.000006621191,0.00009263833],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9896365,0.0031082344,0.004871272,0.000728522,0.0014301484,0.00022526391],"domain_scores_gemma":[0.9614611,0.026588025,0.0075320476,0.00053123786,0.0035009494,0.00038661464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011508203,0.0015693682,0.011167553,0.012737199,0.0006427587,0.0027387168,0.0017993947,0.0023475785,0.0033389567],"category_scores_gemma":[0.03877924,0.0011075267,0.009409589,0.010388094,0.0010548292,0.0022643718,0.0014115497,0.0010695099,0.00028596827],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026768455,0.000016157906,0.00085783686,0.96414906,0.01718565,0.00010491069,0.000113762246,0.0000687223,0.00018718821,0.00008992702,0.00039285066,0.016566206],"study_design_scores_gemma":[0.0005264361,0.00051920075,0.006480989,0.724424,0.25645977,0.0006986673,0.00032391952,0.00013189172,0.00031607482,0.00030964141,0.009756662,0.000052865704],"about_ca_topic_score_codex":0.00432384,"about_ca_topic_score_gemma":0.012378128,"teacher_disagreement_score":0.012737199,"about_ca_system_score_codex":0.0027913565,"about_ca_system_score_gemma":0.00819524,"threshold_uncertainty_score":0.060861886},"labels":[],"label_agreement":null},{"id":"W2760959372","doi":"10.1111/bjd.16018","title":"Systemic retinoids and psychiatric disorders in patients with skin diseases: a multifactorial relationship","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Psychiatry; Dermatology","score_opus":0.008063970809050745,"score_gpt":0.22409785839275548,"score_spread":0.21603388758370473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760959372","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3554577,0.044036366,0.0014792895,0.55785185,0.0050756107,0.00006284711,0.0006119214,0.0001472579,0.035277177],"genre_scores_gemma":[0.9421238,0.010330275,0.0007516871,0.030281853,0.012573118,0.00002370965,0.00012768673,0.000014365181,0.0037735382],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966085,0.000093925904,0.000043809803,0.00006190658,0.00007648512,0.00006291699],"domain_scores_gemma":[0.9983575,0.0009585765,0.00027809717,0.00007480204,0.00018184098,0.0001491854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041014908,0.00027759685,0.00058801076,0.0005740662,0.00087026256,0.0007082546,0.0004798108,0.004665486,0.0037287218],"category_scores_gemma":[0.0035859768,0.00020593671,0.0004546731,0.0007343307,0.0006846462,0.00089913706,0.00038733578,0.0036612377,0.0008068594],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012563857,0.00032351172,0.3511042,0.00045264233,0.0003498011,0.5226708,0.00092790124,0.0004139951,0.0038950033,0.005348328,0.06433678,0.048920725],"study_design_scores_gemma":[0.00031429168,0.00029665921,0.19895193,0.0006678179,0.00032644093,0.74703676,0.0010036541,0.0025640721,0.00074083975,0.012837042,0.035154976,0.00010549723],"about_ca_topic_score_codex":0.0027136302,"about_ca_topic_score_gemma":0.003358645,"teacher_disagreement_score":0.004665486,"about_ca_system_score_codex":0.00086966733,"about_ca_system_score_gemma":0.0005174276,"threshold_uncertainty_score":0.012473822},"labels":[],"label_agreement":null},{"id":"W2764109025","doi":"10.1111/bjd.16050","title":"Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3)","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Etanercept; Medicine; Placebo; Psoriasis; Psoriasis Area and Severity Index; Internal medicine; Post-hoc analysis; Dosing; Dermatology; Secukinumab; Tumor necrosis factor alpha; Psoriatic arthritis; Pathology","score_opus":0.0660134355339033,"score_gpt":0.3257095382569747,"score_spread":0.25969610272307136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764109025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82772696,0.13339846,0.009722722,0.0004953287,0.00040792488,0.016675754,0.00822465,0.00044718818,0.0029009678],"genre_scores_gemma":[0.96611875,0.015349316,0.006527868,0.0005484627,0.00028446058,0.0065204673,0.0040039173,0.000076108925,0.0005706673],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.978779,0.013061541,0.0027318841,0.0017783984,0.0029707933,0.0006783664],"domain_scores_gemma":[0.977783,0.008976183,0.008350541,0.0019173694,0.0018705233,0.0011022899],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.029406318,0.0019840836,0.006850626,0.0025800783,0.000583509,0.0027964462,0.00092565955,0.0015930943,0.002563279],"category_scores_gemma":[0.019939065,0.0008749807,0.01393526,0.002510409,0.0010344116,0.0011800757,0.0012858681,0.001438438,0.00021262403],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7182478,0.002537148,0.021453775,0.012500195,0.1829815,0.00009882661,0.00021269126,0.0011250975,0.0066137286,0.00016454073,0.00084062637,0.05322412],"study_design_scores_gemma":[0.5349181,0.095469445,0.116608016,0.0014197456,0.2406488,0.0003407191,0.00015726013,0.0018965468,0.0033919776,0.00041853852,0.004536737,0.00019407722],"about_ca_topic_score_codex":0.00074785546,"about_ca_topic_score_gemma":0.0017539387,"teacher_disagreement_score":0.9931494,"about_ca_system_score_codex":0.0012087247,"about_ca_system_score_gemma":0.0020426938,"threshold_uncertainty_score":0.15551734},"labels":[],"label_agreement":null},{"id":"W2767163492","doi":"10.1111/bjd.16101","title":"Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"UCB Pharma; Health and Care Research Wales","keywords":"Hidradenitis suppurativa; Medicine; Population; Algorithm; Dermatology; Computer science; Internal medicine; Disease; Environmental health","score_opus":0.19675901393901296,"score_gpt":0.511889246454113,"score_spread":0.3151302325151001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767163492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97441643,0.0011927503,0.016006263,0.00075112766,0.000048903217,0.001446175,0.004643403,0.00011131855,0.001383534],"genre_scores_gemma":[0.98079646,0.00028534213,0.013193841,0.00031991932,0.000034552733,0.0015793166,0.0034756218,0.000041721578,0.00027320525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9238778,0.06113273,0.00408668,0.006181828,0.00358718,0.0011337438],"domain_scores_gemma":[0.87243426,0.08087113,0.022500843,0.013555246,0.008273506,0.0023649663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.048882548,0.00074456196,0.001182767,0.0022171838,0.00081566477,0.0032256378,0.0018859216,0.0016212164,0.0029879997],"category_scores_gemma":[0.13206744,0.0010517646,0.0021457318,0.004956073,0.00072198204,0.0025524294,0.0026426995,0.0017688897,0.001079574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002315151,0.00081647496,0.9749485,0.00050361495,0.0022520444,0.00016603895,0.0009925418,0.0024508247,0.00011590259,0.0009324024,0.0027804822,0.0117259985],"study_design_scores_gemma":[0.0044847145,0.004187629,0.77472895,0.0008504829,0.004368723,0.0014002029,0.0025044521,0.19305201,0.0006061072,0.003949546,0.009639091,0.0002280797],"about_ca_topic_score_codex":0.014958647,"about_ca_topic_score_gemma":0.008516838,"teacher_disagreement_score":0.048882548,"about_ca_system_score_codex":0.0031834655,"about_ca_system_score_gemma":0.003026898,"threshold_uncertainty_score":0.2585187},"labels":[],"label_agreement":null},{"id":"W2767470025","doi":"10.1111/bjd.15524","title":"British Society for Paediatric Dermatology and British Society for Allergy &amp; Clinical Immunology joint session","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"","keywords":"Session (web analytics); Medicine; Clinical immunology; Dermatology; Allergy; Family medicine; Immunology","score_opus":0.023433065312754166,"score_gpt":0.2850984189599192,"score_spread":0.26166535364716503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767470025","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017184385,0.94329447,0.00084254454,0.009011855,0.007760604,0.00064518733,0.0052591884,0.00010005526,0.031367645],"genre_scores_gemma":[0.01711447,0.93253785,0.0037070853,0.0050851433,0.00546326,0.0011859311,0.006033927,0.00009879966,0.0287735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973362,0.0007665967,0.0007405951,0.00025185107,0.0007583075,0.0001464748],"domain_scores_gemma":[0.9931732,0.0018192315,0.0017372122,0.00021135138,0.002527576,0.0005313208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041408977,0.00061487587,0.0022412445,0.0046192245,0.0005165657,0.0019788332,0.0008918309,0.001444987,0.06945328],"category_scores_gemma":[0.008315892,0.00049092126,0.0020987212,0.004883769,0.0004587511,0.0013922355,0.0013986556,0.0016758012,0.014401532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007031597,0.00006674779,0.0036402554,0.09213442,0.00103,0.0004712303,0.00016673315,0.00007518903,0.001352806,0.0011473327,0.44405586,0.45515615],"study_design_scores_gemma":[0.00023828857,0.00013822147,0.012407137,0.051632084,0.0009798838,0.0015677345,0.0001130084,0.000041736497,0.00033307038,0.00069868227,0.93181866,0.00003152456],"about_ca_topic_score_codex":0.0048911027,"about_ca_topic_score_gemma":0.0077077937,"teacher_disagreement_score":0.06945328,"about_ca_system_score_codex":0.0014133691,"about_ca_system_score_gemma":0.0057569216,"threshold_uncertainty_score":0.23234433},"labels":[],"label_agreement":null},{"id":"W2768998510","doi":"10.1111/bjd.16140","title":"Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab","year":2017,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"U.S. Food and Drug Administration; Gemeinsame Bundesausschuss; Eli Lilly and Company","keywords":"Secukinumab; Ixekizumab; Medicine; Plaque psoriasis; Psoriasis; Dermatology; Internal medicine; Psoriatic arthritis","score_opus":0.03443892017663107,"score_gpt":0.28688891720687554,"score_spread":0.25244999703024446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768998510","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79020846,0.1716607,0.019738255,0.00115177,0.0026399011,0.0025196213,0.0067108423,0.0003616761,0.005008773],"genre_scores_gemma":[0.98771477,0.004910526,0.003937319,0.00043738188,0.0002068163,0.0008952652,0.0012013639,0.000030504618,0.00066614075],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9703446,0.023426643,0.002254715,0.0022091847,0.0012781355,0.0004866839],"domain_scores_gemma":[0.98158574,0.01364303,0.002529952,0.0014399568,0.00057573256,0.00022562638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02503323,0.0021429649,0.0080543,0.0016965955,0.00032474252,0.0018608253,0.0017288917,0.0018920582,0.0052769673],"category_scores_gemma":[0.033575863,0.0011089721,0.030959431,0.0016561387,0.0006756725,0.0010174192,0.001414593,0.0023679165,0.0003306195],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24897851,0.00034169553,0.015525015,0.013281614,0.69607913,0.000095191914,0.0001164724,0.0047393017,0.000990863,0.0008076325,0.0006108802,0.018433638],"study_design_scores_gemma":[0.07760883,0.013850051,0.034174904,0.0010447933,0.85853374,0.0002000879,0.00008132829,0.00850451,0.001478176,0.0024654083,0.0019655826,0.000092570765],"about_ca_topic_score_codex":0.0027448235,"about_ca_topic_score_gemma":0.0016615828,"teacher_disagreement_score":0.02503323,"about_ca_system_score_codex":0.0011526528,"about_ca_system_score_gemma":0.000935196,"threshold_uncertainty_score":0.13238996},"labels":[],"label_agreement":null},{"id":"W2774562674","doi":"10.1111/bjd.16217","title":"Chronic pain in pachyonychia congenita: evidence for neuropathic origin","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dermatology; Neuropathic pain; Nail disease; Anesthesia; Psoriasis","score_opus":0.03969304816606819,"score_gpt":0.33561014422087254,"score_spread":0.2959170960548044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774562674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974946,0.001487933,0.0001108,0.00004503844,0.0000062780728,0.000010101225,0.00007437356,0.0000038040835,0.0007670341],"genre_scores_gemma":[0.99891305,0.00067105197,0.00013563245,0.000026631313,0.000017642726,0.0000117582385,0.00010423518,0.0000018087973,0.000118232485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997936,0.000047618913,0.000031066105,0.000038771464,0.00004743299,0.00004144299],"domain_scores_gemma":[0.9990157,0.00032149797,0.00041787486,0.00003402151,0.000092700975,0.000118287615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000301948,0.00046635748,0.0002840596,0.0012502177,0.00041145785,0.0003515961,0.00026124387,0.00041160142,0.0040446455],"category_scores_gemma":[0.0019476699,0.00015745187,0.00016019732,0.00092868565,0.00055168144,0.00028172127,0.000362151,0.0002892571,0.00022249675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007491896,0.0000952644,0.9365189,0.00041590736,0.00010622212,0.03687342,0.00038968844,0.00011173974,0.012600165,0.00010021063,0.00028492304,0.011754214],"study_design_scores_gemma":[0.00003861169,0.0004421673,0.8773248,0.000114584574,0.00011364148,0.12028425,0.00032514817,0.00017371857,0.000694395,0.00009609006,0.00038631563,0.000006281672],"about_ca_topic_score_codex":0.0015452441,"about_ca_topic_score_gemma":0.0016760628,"teacher_disagreement_score":0.0040446455,"about_ca_system_score_codex":0.0002207067,"about_ca_system_score_gemma":0.00025113745,"threshold_uncertainty_score":0.013530731},"labels":[],"label_agreement":null},{"id":"W2789298639","doi":"10.1111/bjd.16398","title":"Initial validation of the Burden of Disease in Atopic Eczema instrument, a quality-of-life measure for adult atopic dermatitis","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Eczema Society of Canada","keywords":"Atopic dermatitis; Medicine; Measure (data warehouse); Quality of life (healthcare); Dermatology; Atopy; Allergy; Immunology; Computer science","score_opus":0.03346211099179377,"score_gpt":0.3074571514843458,"score_spread":0.2739950404925521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789298639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79517996,0.0022032987,0.0032358484,0.16820027,0.005517108,0.0013263574,0.0026009441,0.0000504443,0.021685725],"genre_scores_gemma":[0.94036114,0.0008476532,0.005919992,0.043770414,0.0014922624,0.0013420266,0.0019498479,0.000040562078,0.0042760274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9894991,0.0054157022,0.0017453905,0.00046555707,0.0022273706,0.00064680655],"domain_scores_gemma":[0.9613374,0.023687197,0.0012896328,0.0016350378,0.011068454,0.0009823357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019645633,0.00032472736,0.0005293508,0.00032560155,0.0007695489,0.0012156994,0.0007373488,0.003043665,0.0011423521],"category_scores_gemma":[0.06844966,0.00024974658,0.00050355226,0.00044429017,0.00071839977,0.00078353466,0.00085898367,0.0035871016,0.00079491595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030954673,0.0026460502,0.67520636,0.0003596396,0.00019484262,0.008207552,0.008856061,0.00068590883,0.007141243,0.0033208188,0.135226,0.15506002],"study_design_scores_gemma":[0.0012815226,0.0046287514,0.84278405,0.00076556276,0.00019348318,0.007996199,0.0062146247,0.004622038,0.0043236134,0.002263843,0.12480149,0.00012489497],"about_ca_topic_score_codex":0.0045038713,"about_ca_topic_score_gemma":0.006357688,"teacher_disagreement_score":0.019645633,"about_ca_system_score_codex":0.0015476607,"about_ca_system_score_gemma":0.0016158535,"threshold_uncertainty_score":0.10389727},"labels":[],"label_agreement":null},{"id":"W2789403302","doi":"10.1111/bjd.16224","title":"Survival of the fittest","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Dermatrials Research","funders":"","keywords":"Survival of the fittest; Survival analysis; Medicine; Biology; Internal medicine; Genetics","score_opus":0.012995572759145311,"score_gpt":0.24644456402048684,"score_spread":0.23344899126134153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789403302","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060523562,0.020241026,0.0011996315,0.83190334,0.014664505,0.000027191047,0.0012723864,0.00013032522,0.070038065],"genre_scores_gemma":[0.68805957,0.013337324,0.0005594484,0.21606603,0.031936124,0.000051681858,0.0011282683,0.000097828866,0.0487638],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995982,0.00012369912,0.000018537212,0.000055693235,0.000045480294,0.0001583549],"domain_scores_gemma":[0.9983682,0.0006596362,0.00011363011,0.00007574929,0.00024523187,0.00053751346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004816848,0.00017308934,0.00044210994,0.00035260952,0.0009836054,0.0008979745,0.00029596925,0.0033232097,0.010210837],"category_scores_gemma":[0.008083798,0.00007596783,0.00024170776,0.00023656082,0.00034680136,0.00085445103,0.0004070171,0.0032534362,0.0046883263],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006268888,0.0001065871,0.05049169,0.00014253493,0.000051354968,0.028310291,0.00029607528,0.0006459981,0.0010445322,0.009988269,0.77113473,0.13716105],"study_design_scores_gemma":[0.00024469322,0.00085137726,0.07091354,0.0015095944,0.00016167683,0.16732118,0.0018004347,0.005001176,0.0015406266,0.058596645,0.691923,0.00013609271],"about_ca_topic_score_codex":0.0017016246,"about_ca_topic_score_gemma":0.0020143373,"teacher_disagreement_score":0.010210837,"about_ca_system_score_codex":0.0008469147,"about_ca_system_score_gemma":0.00048232212,"threshold_uncertainty_score":0.034158647},"labels":[],"label_agreement":null},{"id":"W2790811276","doi":"10.1111/bjd.16571","title":"Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health","keywords":"Aspirin; Medicine; Folic acid; Colorectal cancer; Randomized controlled trial; Internal medicine; Oncology; Gastroenterology; Cancer","score_opus":0.03206373877466592,"score_gpt":0.3573981421682029,"score_spread":0.32533440339353703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790811276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873634,0.0065733036,0.0004964613,0.00078327506,0.00093839265,0.0019707382,0.00040406254,0.00006470878,0.0014055743],"genre_scores_gemma":[0.9937609,0.0017634041,0.0006656575,0.00064816786,0.00046059658,0.0013096773,0.00031377864,0.0000069985404,0.0010707737],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979348,0.001259909,0.00017178227,0.00032589375,0.00014977487,0.00015785186],"domain_scores_gemma":[0.99754363,0.0007843358,0.00070206734,0.00023757211,0.00016149874,0.0005709084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003033579,0.0012765743,0.0027860329,0.00036774765,0.0005366202,0.0013451953,0.00069990224,0.002263845,0.0044969856],"category_scores_gemma":[0.0045751366,0.0010623337,0.0024707855,0.000307955,0.0010261417,0.00076223176,0.00042994865,0.0026708231,0.0005018316],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9928866,0.0016328098,0.0006653609,0.00022062038,0.0011063758,0.000015905585,0.000014718008,0.000047737813,0.00078140147,0.000030233366,0.00014459892,0.0024536892],"study_design_scores_gemma":[0.9551687,0.03799683,0.003857188,0.00003844521,0.0018806206,0.00002674317,0.000013839471,0.0003275016,0.00027300595,0.000118717886,0.00028538398,0.000012959819],"about_ca_topic_score_codex":0.0010257346,"about_ca_topic_score_gemma":0.00203934,"teacher_disagreement_score":0.0044969856,"about_ca_system_score_codex":0.00066277763,"about_ca_system_score_gemma":0.0011117163,"threshold_uncertainty_score":0.016043305},"labels":[],"label_agreement":null},{"id":"W2791629745","doi":"10.1111/bjd.16350","title":"Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB)","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"University of Colorado School of Medicine, Anschutz Medical Campus; National Center for Advancing Translational Sciences; National Institutes of Health; Dystrophic Epidermolysis Bullosa Research Association; Hospital for Sick Children; Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Epidermolysis bullosa; Medicine; Intraclass correlation; Cronbach's alpha; Construct validity; Quality of life (healthcare); Observational study; Reliability (semiconductor); Dermatology; Physical therapy; Patient satisfaction; Psychometrics; Surgery; Internal medicine; Clinical psychology","score_opus":0.09219870509020982,"score_gpt":0.40402842750019236,"score_spread":0.3118297224099825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791629745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881781,0.00074828375,0.005309556,0.00028381907,0.00014267456,0.0008344581,0.0011064498,0.00005851299,0.0033381952],"genre_scores_gemma":[0.99033535,0.00016251217,0.0069389595,0.00008366662,0.00004056683,0.00095364026,0.0011552304,0.0000225269,0.0003073853],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.97236943,0.012952448,0.003763569,0.0024443017,0.007667122,0.00080311636],"domain_scores_gemma":[0.9312218,0.027945828,0.016110763,0.0040020077,0.018298952,0.0024206087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032020062,0.00047283192,0.0008487824,0.0021383455,0.00052926404,0.0011955372,0.00067582,0.0007597307,0.0009882626],"category_scores_gemma":[0.054010946,0.00034793292,0.0012930909,0.0013832143,0.00086742867,0.00086864043,0.0022787082,0.0010114503,0.00041337698],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037019607,0.0001498515,0.98021185,0.00008015115,0.0002720757,0.000020305391,0.00069237984,0.000337625,0.0004484448,0.00014107754,0.0007376139,0.016538588],"study_design_scores_gemma":[0.00009127474,0.00058153365,0.99478215,0.000090559515,0.00008161654,0.00015166502,0.00044922612,0.0019200642,0.00029852553,0.00018245507,0.0013453291,0.000025653291],"about_ca_topic_score_codex":0.0017906211,"about_ca_topic_score_gemma":0.0021592325,"teacher_disagreement_score":0.032020062,"about_ca_system_score_codex":0.0009434835,"about_ca_system_score_gemma":0.0013527438,"threshold_uncertainty_score":0.16934031},"labels":[],"label_agreement":null},{"id":"W2792200490","doi":"10.1111/bjd.16426","title":"Efficacy and safety of continuous every-2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase III trial (IXORA-P)","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research; Dalhousie University","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Dosing; Psoriasis; Plaque psoriasis; Adverse effect; Psoriasis Area and Severity Index; Randomized controlled trial; Internal medicine; Dermatology","score_opus":0.008463195056420257,"score_gpt":0.23560179499714487,"score_spread":0.2271385999407246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792200490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945722,0.0014392803,0.0004554666,0.0003500261,0.00014133993,0.0018588576,0.0002868751,0.0000639926,0.0008319329],"genre_scores_gemma":[0.99375856,0.00075891364,0.0012050921,0.00039921634,0.00021600837,0.002411542,0.0004596442,0.000016602713,0.00077435066],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988244,0.0006584148,0.00007560502,0.0002216504,0.00009001947,0.00012982127],"domain_scores_gemma":[0.9986632,0.00031807862,0.00036879722,0.00015305424,0.000068396315,0.0004283938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003821362,0.0011666329,0.0019984837,0.00026377823,0.000446196,0.001117485,0.0007062222,0.0011992119,0.0035181358],"category_scores_gemma":[0.0022299592,0.0006574741,0.001811147,0.00031022992,0.0010214209,0.00079362665,0.00037432055,0.0029063274,0.0006704674],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95328623,0.011726748,0.0017483679,0.00028500278,0.0006477744,0.000035109122,0.00009385854,0.00040648464,0.006453751,0.00007145116,0.00072726497,0.024517909],"study_design_scores_gemma":[0.89277875,0.102081455,0.0036790418,0.00001660978,0.00021842695,0.000040546354,0.000010822331,0.00037404653,0.000455539,0.00006317263,0.00027137357,0.00001031249],"about_ca_topic_score_codex":0.00034728058,"about_ca_topic_score_gemma":0.0006670274,"teacher_disagreement_score":0.003821362,"about_ca_system_score_codex":0.0006583312,"about_ca_system_score_gemma":0.0013167296,"threshold_uncertainty_score":0.020209491},"labels":[],"label_agreement":null},{"id":"W2792723400","doi":"10.1111/bjd.16099","title":"Risk of depression among patients with acne in the U.K.: a population-based cohort study","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates - Health Solutions; Mach-Gaensslen Foundation of Canada","keywords":"Depression (economics); Acne; Medicine; Cohort; Cohort study; Population; Psychiatry; Internal medicine; Dermatology; Environmental health","score_opus":0.004598128683009221,"score_gpt":0.23339578804816635,"score_spread":0.22879765936515714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792723400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876715,0.0014283402,0.00012436576,0.0058689644,0.00014353383,0.00002510484,0.0023721952,0.000014803015,0.0023512815],"genre_scores_gemma":[0.99652725,0.00064112677,0.00010669357,0.0015614134,0.000092852875,0.000018755212,0.00038351963,0.000003939206,0.00066433713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995258,0.00012213796,0.00007201592,0.000103054605,0.00008590374,0.00009115803],"domain_scores_gemma":[0.99890053,0.00016315847,0.0003255419,0.00015620311,0.00023225616,0.0002223253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032721725,0.00021812785,0.0004565526,0.0003865403,0.0007224087,0.0008762447,0.0004633633,0.0014347928,0.0018101818],"category_scores_gemma":[0.0022587744,0.000489873,0.0005550415,0.0011395622,0.0002867458,0.0006584254,0.0003584476,0.0015738657,0.00050894666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023613633,0.00004735273,0.9936087,0.000019061552,0.00015117337,0.00067527755,0.00016580851,0.000029543611,0.0003416872,0.000033616532,0.0027516936,0.0019399091],"study_design_scores_gemma":[0.000039389462,0.00007620344,0.9966235,0.000023048928,0.00008195459,0.0016177256,0.00037936858,0.00014978134,0.000034301855,0.00005637956,0.00090480025,0.000013579855],"about_ca_topic_score_codex":0.047481343,"about_ca_topic_score_gemma":0.04730512,"teacher_disagreement_score":0.047481343,"about_ca_system_score_codex":0.00084209896,"about_ca_system_score_gemma":0.00042163298,"threshold_uncertainty_score":0.09440994},"labels":[],"label_agreement":null},{"id":"W2792844945","doi":"10.1111/bjd.16109","title":"Advances in the diagnosis of pigmented skin lesions","year":2018,"lang":"en","type":"editorial","venue":"British Journal of Dermatology","topic":"Advanced Chemical Sensor Technologies","field":"Engineering","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dermatoscopy; Melanoma; Skin cancer; Medicine; Dermatology; Teledermatology; Basal cell carcinoma; Cancer; Pathology; Basal cell; Internal medicine","score_opus":0.0059406965671506065,"score_gpt":0.2468536857086351,"score_spread":0.2409129891414845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792844945","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003313329,0.19955583,0.0013000512,0.046872284,0.74878925,0.000020659916,0.00003956573,0.000075238175,0.003015854],"genre_scores_gemma":[0.0026782062,0.16772383,0.0009794293,0.019899577,0.8028638,0.00001420547,0.000033727036,0.000041008214,0.0057662753],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973586,0.00046778942,0.00044423886,0.00031748504,0.0013267673,0.00008520272],"domain_scores_gemma":[0.9880215,0.005778763,0.00045359044,0.0002775796,0.004759409,0.0007091617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003767892,0.0013003914,0.0010420558,0.0023711335,0.00074105413,0.0021603,0.0013366834,0.0041369414,0.002873468],"category_scores_gemma":[0.009213047,0.0005036046,0.00086492585,0.00068177574,0.0016569124,0.0030762893,0.00072974566,0.009729376,0.0026040683],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018742438,0.00006767164,0.00030028494,0.002104322,0.000050025254,0.0005948211,0.000078120494,0.00011978595,0.0018825872,0.0028130957,0.79844904,0.19335277],"study_design_scores_gemma":[0.000016116435,0.00006367854,0.0004663152,0.00046785866,0.000029152412,0.0012720725,0.000044413515,0.000118914104,0.00056545885,0.0012644833,0.9956743,0.000017247954],"about_ca_topic_score_codex":0.0005092084,"about_ca_topic_score_gemma":0.0011630406,"teacher_disagreement_score":0.0041369414,"about_ca_system_score_codex":0.0011907195,"about_ca_system_score_gemma":0.0007868355,"threshold_uncertainty_score":0.019926786},"labels":[],"label_agreement":null},{"id":"W2792999790","doi":"10.1111/bjd.16449","title":"Children with facial morphoea managing everyday life: a qualitative study","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Psychosocial; Thematic analysis; Psychology; Qualitative research; Focus group; Quality of life (healthcare); Developmental psychology; Medicine; Psychiatry; Psychotherapist; Sociology","score_opus":0.016523858459272126,"score_gpt":0.29739996276983915,"score_spread":0.28087610431056703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792999790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308395,0.0014172154,0.000713876,0.0011669374,0.000052353353,0.00026575234,0.00023572167,0.000011571608,0.003052626],"genre_scores_gemma":[0.9941579,0.0023565467,0.00094374886,0.00048126414,0.000018550783,0.00054242427,0.00011934763,0.000018200899,0.0013619403],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9947707,0.0031846303,0.00019428984,0.00036541576,0.0003839079,0.001101128],"domain_scores_gemma":[0.9933141,0.004465686,0.00075844396,0.00018660692,0.0004916081,0.000783586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007430426,0.00077337236,0.0013785096,0.0016061539,0.008770043,0.0035619962,0.0016701977,0.0015372033,0.0036766117],"category_scores_gemma":[0.008814416,0.00085051014,0.00062722096,0.0022504185,0.006591954,0.0031972774,0.004403753,0.0030693873,0.0003042586],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023221228,0.00006409239,0.0042911717,0.00022152622,0.0000045247625,0.0011300116,0.9906455,0.000018342615,0.00029136462,0.00060507865,0.00030902997,0.0023961058],"study_design_scores_gemma":[0.0000036871575,0.00004227526,0.0027463494,0.00013441114,0.0000040312243,0.00038244072,0.99272317,0.000015743166,0.000064017855,0.000081564125,0.0037952848,0.0000071326654],"about_ca_topic_score_codex":0.014316896,"about_ca_topic_score_gemma":0.025312439,"teacher_disagreement_score":0.014316896,"about_ca_system_score_codex":0.0065652756,"about_ca_system_score_gemma":0.004843058,"threshold_uncertainty_score":0.0476346},"labels":[],"label_agreement":null},{"id":"W2800609435","doi":"10.1111/bjd.16737","title":"Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Psoriasis; Medicine; Cross-sectional study; Socioeconomic status; Correlation; Internal medicine; Dermatology; Environmental health; Pathology; Population","score_opus":0.014122502836669474,"score_gpt":0.2676546408851366,"score_spread":0.2535321380484671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800609435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98909515,0.00042886546,0.00018687207,0.007220697,0.00019888996,0.000011183937,0.00067231775,0.000009660254,0.002176424],"genre_scores_gemma":[0.99629563,0.00020838018,0.00015398936,0.0019284538,0.00028981728,0.000011079676,0.00021771366,0.0000042837733,0.00089058356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992538,0.0002968245,0.00010002671,0.00011802561,0.00011226599,0.00011901973],"domain_scores_gemma":[0.99761426,0.00092203484,0.0005488657,0.0002542245,0.00035122343,0.0003094223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085049355,0.00017646275,0.0003656362,0.00034540135,0.00045839243,0.0006654445,0.00038266947,0.0016163144,0.0019444053],"category_scores_gemma":[0.0050214333,0.00035577896,0.00034660616,0.0008352435,0.0002624059,0.0005431209,0.00031367264,0.0016012022,0.00043394495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016724806,0.000039048795,0.9956884,0.000006122028,0.000039294264,0.00093475526,0.00011747456,0.000016014714,0.0001861603,0.000041035102,0.0011644639,0.0015999365],"study_design_scores_gemma":[0.000027074091,0.00015023004,0.99391806,0.000012396309,0.000045893714,0.0035493928,0.0003610144,0.00034489256,0.00007636973,0.00010527781,0.001399752,0.000009685092],"about_ca_topic_score_codex":0.0048427107,"about_ca_topic_score_gemma":0.0049358467,"teacher_disagreement_score":0.0048427107,"about_ca_system_score_codex":0.0002613851,"about_ca_system_score_gemma":0.00029226535,"threshold_uncertainty_score":0.009629011},"labels":[],"label_agreement":null},{"id":"W2801085776","doi":"10.1111/bjd.16724","title":"Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research","funders":"Merck","keywords":"Medicine; Placebo; Adverse effect; Tolerability; Internal medicine; Etanercept; Psoriasis; Gastroenterology; Dermatology; Tumor necrosis factor alpha","score_opus":0.019734505675629236,"score_gpt":0.27073648183936555,"score_spread":0.2510019761637363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801085776","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12455845,0.85191566,0.00796715,0.0010675326,0.0010809556,0.004969632,0.0056431554,0.0004720069,0.0023254964],"genre_scores_gemma":[0.80630624,0.17104496,0.006483716,0.0018814872,0.0009892777,0.0069082216,0.005370793,0.00016130974,0.00085403107],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96508646,0.020829763,0.006859996,0.0032741036,0.0033100073,0.0006396293],"domain_scores_gemma":[0.96538836,0.018496664,0.010833731,0.0021370624,0.002500591,0.00064360036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.040047284,0.0027603828,0.015831262,0.0031501346,0.00040875966,0.003148708,0.0014362938,0.0024452994,0.003436951],"category_scores_gemma":[0.044351898,0.0014080683,0.03140145,0.003497248,0.00085679453,0.0015702246,0.0012438294,0.0019624524,0.00035793075],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16801845,0.00018894176,0.006466644,0.054338478,0.7378984,0.00008747362,0.00008755065,0.0010249251,0.0008994192,0.00011615691,0.0013695383,0.029504027],"study_design_scores_gemma":[0.12432414,0.006071527,0.02430812,0.004097105,0.8357959,0.0001948247,0.0000581493,0.0007941982,0.00056903576,0.00057724764,0.0031152042,0.00009458819],"about_ca_topic_score_codex":0.0012472016,"about_ca_topic_score_gemma":0.002104433,"teacher_disagreement_score":0.040047284,"about_ca_system_score_codex":0.0014874997,"about_ca_system_score_gemma":0.002324751,"threshold_uncertainty_score":0.21179283},"labels":[],"label_agreement":null},{"id":"W2802931074","doi":"10.1111/bjd.16736","title":"Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Guenther Dermatology Research Centre","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Placebo; Psoriasis; Clinical endpoint; Adverse effect; Internal medicine; Randomized controlled trial; Dermatology; Secukinumab; Pathology; Psoriatic arthritis","score_opus":0.012094035804152687,"score_gpt":0.2528384543173931,"score_spread":0.2407444185132404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802931074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97730917,0.007930818,0.0013430665,0.0011940338,0.0008779213,0.0072524934,0.0012386993,0.00019961702,0.002654242],"genre_scores_gemma":[0.98354256,0.0025118615,0.0020563467,0.0016695849,0.00051772257,0.0069119562,0.0008533091,0.00002575441,0.0019109017],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989875,0.00056045025,0.0000709233,0.00016880104,0.0000939057,0.00011835197],"domain_scores_gemma":[0.99883896,0.00028992686,0.00028849376,0.00008700867,0.00009352096,0.00040218743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029507382,0.0012317426,0.0031769807,0.00032433873,0.00051051966,0.0011355117,0.000867818,0.0017813407,0.005687843],"category_scores_gemma":[0.0024652316,0.0006789037,0.0014956269,0.00030239797,0.0009857946,0.00075010303,0.00028649028,0.0025678729,0.0009663081],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9672879,0.009419088,0.0008683231,0.00045436693,0.0008220569,0.00003704958,0.000046147266,0.00020378591,0.0043699457,0.000080058926,0.000931712,0.015479585],"study_design_scores_gemma":[0.9554499,0.041906953,0.0017333932,0.000015300568,0.00017623894,0.000023490435,0.000007048851,0.00015953218,0.00015922013,0.00005216762,0.00031022858,0.0000066287457],"about_ca_topic_score_codex":0.0003891204,"about_ca_topic_score_gemma":0.0007325341,"teacher_disagreement_score":0.005687843,"about_ca_system_score_codex":0.0004853598,"about_ca_system_score_gemma":0.0013347694,"threshold_uncertainty_score":0.01902771},"labels":[],"label_agreement":null},{"id":"W2803308785","doi":"10.1111/bjd.16815","title":"Applying the phenotype approach for rosacea to practice and research","year":2018,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Windsor","funders":"Galderma","keywords":"Rosacea; Subtyping; Medicine; Clinical phenotype; Phenotype; Computer science; Dermatology; Biology","score_opus":0.09634705907690584,"score_gpt":0.4344209756318519,"score_spread":0.33807391655494606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803308785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003438759,0.97778535,0.0026032222,0.012229206,0.0019346611,0.00007042575,0.000061556384,0.000040695984,0.004931057],"genre_scores_gemma":[0.008299132,0.9771917,0.006711788,0.0050609414,0.0013383152,0.00011798426,0.00011103559,0.000016613038,0.0011524962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935241,0.002718302,0.0011057167,0.000594035,0.001884603,0.0001732406],"domain_scores_gemma":[0.98006266,0.013075472,0.0015562567,0.00063828606,0.0042142915,0.00045314778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011632253,0.00092721224,0.001498605,0.0049396534,0.0007493179,0.0041381754,0.0017695331,0.0027788668,0.00463156],"category_scores_gemma":[0.023964945,0.00037707167,0.0014437952,0.0031332984,0.0031038253,0.0043768287,0.002388835,0.004244593,0.0016206516],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006161334,0.00006324884,0.0014326767,0.04842421,0.00017906266,0.00038298665,0.0010527299,0.0004127752,0.0006357355,0.036417753,0.04498218,0.865955],"study_design_scores_gemma":[0.000025598294,0.00007987404,0.0030869003,0.07295504,0.0002838126,0.0025656256,0.0015785393,0.00026521564,0.00035025398,0.025654227,0.89309794,0.000057043133],"about_ca_topic_score_codex":0.0034138788,"about_ca_topic_score_gemma":0.004889197,"teacher_disagreement_score":0.011632253,"about_ca_system_score_codex":0.002955235,"about_ca_system_score_gemma":0.0079608355,"threshold_uncertainty_score":0.061517954},"labels":[],"label_agreement":null},{"id":"W2803431177","doi":"10.1111/bjd.16671","title":"FACE-Q Skin Cancer Module for measuring patient-reported outcomes following facial skin cancer surgery","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institutes of Health; National Cancer Institute; Skin Cancer Foundation","keywords":"Medicine; Cancer; Skin cancer; Surgery; Dermatology; Internal medicine","score_opus":0.03715408956041201,"score_gpt":0.31067981324824845,"score_spread":0.27352572368783645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803431177","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95045936,0.00057224825,0.0058147246,0.0007459532,0.000113162336,0.009146175,0.021488262,0.0004891889,0.011170985],"genre_scores_gemma":[0.93904907,0.0005180683,0.023589756,0.00050869375,0.00011634032,0.014748046,0.016778091,0.000061603474,0.004630336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844116,0.00072913006,0.0001906626,0.00012141787,0.0003539134,0.0001637714],"domain_scores_gemma":[0.9955207,0.0013879044,0.0016090355,0.00019274942,0.0009048249,0.0003848657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003082546,0.00048003494,0.0005845493,0.001021564,0.00024874206,0.00033310978,0.00056833314,0.00039986573,0.009081917],"category_scores_gemma":[0.0065909615,0.00016736571,0.0008765074,0.0006601756,0.00014665793,0.00045915946,0.00092336757,0.0005991931,0.0013385261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035773928,0.0027965847,0.6938097,0.0009625209,0.00059054256,0.00023234446,0.0007960906,0.002959472,0.003862247,0.000490387,0.03679889,0.2531239],"study_design_scores_gemma":[0.0002269533,0.002082747,0.9884043,0.000075872595,0.000062656436,0.00030159648,0.00014381975,0.0019577262,0.0004910923,0.00017836956,0.0060493588,0.00002547006],"about_ca_topic_score_codex":0.00078729336,"about_ca_topic_score_gemma":0.0020629321,"teacher_disagreement_score":0.009081917,"about_ca_system_score_codex":0.000574052,"about_ca_system_score_gemma":0.00066670676,"threshold_uncertainty_score":0.030382097},"labels":[],"label_agreement":null},{"id":"W2803716254","doi":"10.1111/bjd.16673","title":"Is depression screening in patients with acne critical?: reply from authors","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates - Health Solutions; Mach-Gaensslen Foundation of Canada","keywords":"Acne; Depression (economics); Medicine; Dermatology; Psychiatry; Economics","score_opus":0.014269364124786276,"score_gpt":0.2723595729106663,"score_spread":0.25809020878588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803716254","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049122627,0.0019383377,0.00006286478,0.9840553,0.012732713,0.000009577096,0.000058088546,0.000020704132,0.00063125463],"genre_scores_gemma":[0.0059768227,0.002092637,0.00021077185,0.94650096,0.04376497,0.000035755038,0.000046626425,0.000015693562,0.0013558218],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99792945,0.0006936554,0.0004547147,0.0002768652,0.00042727924,0.00021807404],"domain_scores_gemma":[0.9847393,0.008976214,0.00079076225,0.000391513,0.0038459902,0.001256352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003031339,0.0007479948,0.0017247054,0.00101022,0.0025470594,0.0022009811,0.0017805768,0.039468654,0.0046521216],"category_scores_gemma":[0.033934396,0.0006596677,0.0011765222,0.00090690306,0.0017068441,0.0048517045,0.0011783212,0.03618736,0.0038743787],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010599638,0.00004899973,0.0022628095,0.0001282807,0.000033227454,0.0048123347,0.0003126109,0.00008349177,0.00017353929,0.0007340338,0.97921515,0.012089535],"study_design_scores_gemma":[0.0005335622,0.00033824448,0.009073724,0.002315327,0.00020852494,0.030442508,0.00293276,0.0014286207,0.0008515196,0.013160068,0.93831235,0.00040284995],"about_ca_topic_score_codex":0.005300075,"about_ca_topic_score_gemma":0.0057292664,"teacher_disagreement_score":0.039468654,"about_ca_system_score_codex":0.0028056283,"about_ca_system_score_gemma":0.0021957157,"threshold_uncertainty_score":0.020356417},"labels":[],"label_agreement":null},{"id":"W2804131537","doi":"10.1111/bjd.16798","title":"Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Plaque psoriasis; Psoriasis; Open label; Dermatology; Term (time); Extension (predicate logic); Internal medicine; Adverse effect; Computer science","score_opus":0.019806568419189007,"score_gpt":0.27153936439104526,"score_spread":0.25173279597185627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804131537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934115,0.0034910117,0.00026768647,0.00022651363,0.000055408425,0.0009809696,0.00065689476,0.000031918433,0.00087811874],"genre_scores_gemma":[0.99393976,0.0017178855,0.00057543436,0.0005444665,0.00028545677,0.0009927701,0.0012697735,0.0000067530473,0.0006677441],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990483,0.00043678927,0.00007794928,0.00012864037,0.00018095651,0.00012732015],"domain_scores_gemma":[0.9974492,0.00041488564,0.0007662947,0.00021013983,0.00026837748,0.0008910249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043875137,0.00076334213,0.0016551599,0.00032163336,0.0004931197,0.0008413815,0.00041581216,0.0011331695,0.002368286],"category_scores_gemma":[0.002044027,0.00031070973,0.0017220983,0.00042148668,0.00045074374,0.00071513565,0.00034541552,0.002096251,0.00059560256],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7056684,0.053474966,0.062927134,0.0014815117,0.0038707242,0.0008648877,0.0005287724,0.0007319617,0.02090826,0.0001731794,0.004122408,0.14524782],"study_design_scores_gemma":[0.46502808,0.34419692,0.17995423,0.00016415164,0.0015873682,0.0011859514,0.00011487698,0.0011048175,0.0015380693,0.00019110781,0.0048741535,0.00006032412],"about_ca_topic_score_codex":0.0005004098,"about_ca_topic_score_gemma":0.00079939544,"teacher_disagreement_score":0.0043875137,"about_ca_system_score_codex":0.0005450724,"about_ca_system_score_gemma":0.0010336338,"threshold_uncertainty_score":0.023203671},"labels":[],"label_agreement":null},{"id":"W2808308077","doi":"10.1111/bjd.16597","title":"Atopic dermatitis and cardiovascular disease: have we seen enough to refute a causal link?","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Atopic dermatitis; Link (geometry); Disease; Medicine; Dermatology; Internal medicine; Computer science","score_opus":0.014007600460468006,"score_gpt":0.25077546460503947,"score_spread":0.23676786414457146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808308077","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037868342,0.010790897,0.00015893705,0.9648134,0.015854973,0.000012181659,0.00008486835,0.000026987662,0.004470858],"genre_scores_gemma":[0.08459004,0.02256879,0.00066197646,0.6909107,0.1907579,0.000042014006,0.00020100402,0.00004547257,0.010222118],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982747,0.00061696675,0.00025899988,0.00023291001,0.00036071398,0.00025575986],"domain_scores_gemma":[0.99376935,0.003991837,0.00042892175,0.00019808387,0.0009513341,0.0006604924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016515158,0.0005920697,0.0014296991,0.0009127342,0.002125391,0.0017902419,0.0012755333,0.028804444,0.010906796],"category_scores_gemma":[0.020017402,0.0004931956,0.0010010893,0.00067629485,0.0017001178,0.004587686,0.0010426289,0.021423636,0.005081838],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039833464,0.0002356827,0.015131723,0.0004086576,0.00015568409,0.0848294,0.00059346337,0.00019833267,0.00068996,0.0073794806,0.84078723,0.049192104],"study_design_scores_gemma":[0.00085535203,0.0005166098,0.02108677,0.0035637664,0.00036258769,0.26941243,0.0027352294,0.0024032884,0.00069443334,0.049829505,0.6482552,0.0002848108],"about_ca_topic_score_codex":0.003512034,"about_ca_topic_score_gemma":0.0037508938,"teacher_disagreement_score":0.028804444,"about_ca_system_score_codex":0.0022828379,"about_ca_system_score_gemma":0.0013100249,"threshold_uncertainty_score":0.036486804},"labels":[],"label_agreement":null},{"id":"W2808777671","doi":"10.1111/bjd.16891","title":"Revisiting atopic dermatitis and cardiovascular disease","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Atopic dermatitis; Dermatology; Medicine; Disease; Internal medicine","score_opus":0.011519969796532463,"score_gpt":0.2384410021728599,"score_spread":0.22692103237632744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808777671","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028574984,0.02287257,0.00015614957,0.9238474,0.041023575,0.000025966223,0.0000868317,0.000055548284,0.009074528],"genre_scores_gemma":[0.048699673,0.027065283,0.00041464015,0.63364404,0.27830347,0.00004439823,0.000116936615,0.00005408242,0.011657474],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820185,0.00050447776,0.0002869883,0.0002545448,0.0004554196,0.00029671736],"domain_scores_gemma":[0.99650806,0.001866731,0.00024038398,0.00014167528,0.00066928955,0.0005737455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015960474,0.0010007003,0.0014643979,0.0015511549,0.003053729,0.0021743588,0.0014235366,0.020257857,0.0060367603],"category_scores_gemma":[0.012740448,0.000599455,0.0011363653,0.00085421413,0.0018272924,0.004125024,0.0014230737,0.022692375,0.003958292],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011131575,0.00013863819,0.004604093,0.00028398377,0.00006704776,0.12053917,0.0004250432,0.00016297151,0.0005150095,0.0037222428,0.83681536,0.032615133],"study_design_scores_gemma":[0.00032436757,0.00022218321,0.008621143,0.0029920212,0.00015928753,0.26523542,0.0014283151,0.0010779141,0.0004689682,0.01627183,0.70308024,0.00011826616],"about_ca_topic_score_codex":0.0053106584,"about_ca_topic_score_gemma":0.0070786336,"teacher_disagreement_score":0.020257857,"about_ca_system_score_codex":0.0034794009,"about_ca_system_score_gemma":0.0019251581,"threshold_uncertainty_score":0.025244951},"labels":[],"label_agreement":null},{"id":"W2810315811","doi":"10.1111/bjd.16929","title":"Genotype-phenotype data from a case series of patients with mosaic neurofibromatosis type 1","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neurofibromatosis; Mosaic; Series (stratigraphy); Genotype; Phenotype; Medicine; Type (biology); Genetics; Biology; Paleontology; Gene; Geography","score_opus":0.026954495917726078,"score_gpt":0.24805931601224543,"score_spread":0.22110482009451934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810315811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974171,0.000281032,0.00019688059,0.00015520772,0.000014693474,0.00001339305,0.00021361445,0.000010341385,0.0016977234],"genre_scores_gemma":[0.998953,0.00015876468,0.00020242043,0.000065680455,0.000045343742,0.000011181292,0.00022911945,0.000010705159,0.00032361658],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99915373,0.0001589043,0.00017682498,0.00020337218,0.00016180877,0.00014537598],"domain_scores_gemma":[0.9978695,0.0010473506,0.0003823703,0.0002189194,0.0001959387,0.000285928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036762952,0.00076795253,0.0006291584,0.0014606105,0.0010417755,0.00091498106,0.00051564304,0.0011271777,0.0030913814],"category_scores_gemma":[0.004111809,0.00040853702,0.00048286217,0.0012375183,0.00064452935,0.0006126556,0.00066871545,0.0005245301,0.0005874153],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064432545,0.00024230969,0.45484146,0.00006450327,0.00009488604,0.5212578,0.00247545,0.0003177634,0.0087767895,0.00027340525,0.0010172793,0.009993977],"study_design_scores_gemma":[0.00003352232,0.0002587946,0.22690333,0.000017937762,0.00005280847,0.76836914,0.0009309101,0.00030189776,0.00086002174,0.00019717556,0.0020406784,0.00003369302],"about_ca_topic_score_codex":0.0018879457,"about_ca_topic_score_gemma":0.0015962298,"teacher_disagreement_score":0.0030913814,"about_ca_system_score_codex":0.00039169437,"about_ca_system_score_gemma":0.00022908236,"threshold_uncertainty_score":0.0103417635},"labels":[],"label_agreement":null},{"id":"W2885233185","doi":"10.1111/bjd.17080","title":"The frequency of specific contact allergies is reduced in patients with psoriasis","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Psoriasis; Medicine; Allergy; Dermatology; Atopic dermatitis; Odds ratio; Contact dermatitis; Immunology; Allergic contact dermatitis; Sensitization; Nickel allergy; Confidence interval; Internal medicine","score_opus":0.008830557283445051,"score_gpt":0.23064724120972216,"score_spread":0.2218166839262771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885233185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735093,0.0012073839,0.00017648874,0.00007445417,0.000010660038,0.000005961144,0.00019602147,0.000016031987,0.00096205925],"genre_scores_gemma":[0.9994499,0.0002527741,0.000054787575,0.000018008574,0.000016594578,0.000002479252,0.00008467849,0.000002088807,0.00011871928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965537,0.00007105578,0.000042800635,0.00011433178,0.00007526022,0.000041142677],"domain_scores_gemma":[0.9982711,0.00031346883,0.0010257685,0.00007986342,0.00012813848,0.00018157485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022348561,0.00023606648,0.0004657424,0.000874039,0.0003421075,0.00055990944,0.0001868907,0.0003845913,0.004475755],"category_scores_gemma":[0.0024720798,0.00023531323,0.00031779316,0.0011011567,0.00023332576,0.0003196744,0.00021522935,0.00044923407,0.0005373573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022453551,0.000034373857,0.9935638,0.000033659824,0.00007006591,0.0003560274,0.00007824114,0.000031971555,0.0012376087,0.000018049119,0.00014217476,0.004209638],"study_design_scores_gemma":[0.000006406239,0.0000825325,0.9970095,0.0000059479635,0.000047134297,0.0023527166,0.0000769702,0.00006334096,0.000096717355,0.00003022919,0.00022598456,0.0000024916994],"about_ca_topic_score_codex":0.0007908631,"about_ca_topic_score_gemma":0.00058835023,"teacher_disagreement_score":0.004475755,"about_ca_system_score_codex":0.00013161634,"about_ca_system_score_gemma":0.00010725604,"threshold_uncertainty_score":0.014972866},"labels":[],"label_agreement":null},{"id":"W2885657058","doi":"10.1111/bjd.17076","title":"Laser treatments in early wound healing improve scar appearance: a randomized split-wound trial with nonablative fractional laser exposures vs. untreated controls","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Wound healing; Randomized controlled trial; Surgery; Laser; Dermatology; Optics","score_opus":0.013604813698110256,"score_gpt":0.29901435174939794,"score_spread":0.2854095380512877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885657058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99089545,0.0019940166,0.000512699,0.00023369321,0.00048831466,0.004892484,0.0002777874,0.0000614889,0.0006440439],"genre_scores_gemma":[0.9851391,0.0012767375,0.0018559512,0.0004786173,0.00059470604,0.00816664,0.00027542745,0.000017290526,0.002195515],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986091,0.00070151145,0.00013017746,0.00021850932,0.00013172001,0.00020900214],"domain_scores_gemma":[0.997877,0.00075014756,0.0005706381,0.00023470745,0.00016736204,0.00040014356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032135868,0.0018539778,0.0034652823,0.00070600683,0.0005200578,0.0011430868,0.0010452758,0.0023199508,0.0057566836],"category_scores_gemma":[0.0024098905,0.0008130853,0.0020245682,0.00045752153,0.0015565531,0.0011974518,0.0005368098,0.0022044028,0.00077782985],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9823913,0.011763543,0.00020023392,0.0002517414,0.00019411946,0.00001549644,0.000024653762,0.00006898952,0.0014303026,0.000040987787,0.000101231,0.003517355],"study_design_scores_gemma":[0.81469375,0.18317169,0.00094362814,0.000024364219,0.000211255,0.000016542035,0.000022405891,0.00019753216,0.00046854984,0.0000668294,0.00017412829,0.000009370204],"about_ca_topic_score_codex":0.00044904975,"about_ca_topic_score_gemma":0.00083864405,"teacher_disagreement_score":0.0057566836,"about_ca_system_score_codex":0.000625527,"about_ca_system_score_gemma":0.0010675758,"threshold_uncertainty_score":0.019258022},"labels":[],"label_agreement":null},{"id":"W2886710556","doi":"10.1111/bjd.17099","title":"Long‐term 52‐week trends in apremilast safety outcomes for treatment of psoriasis in clinical practice: a multicentre, retrospective case series","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Western University; Women's College Hospital; University of Toronto","funders":"","keywords":"Apremilast; Psoriasis; Medicine; Retrospective cohort study; Clinical Practice; Term (time); Series (stratigraphy); Pediatrics; Intensive care medicine; Dermatology; Family medicine; Surgery; Psoriatic arthritis","score_opus":0.030738576802847452,"score_gpt":0.3218042530086166,"score_spread":0.2910656762057691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886710556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955662,0.0012326712,0.00013919079,0.0012183014,0.000049446982,0.0000138297055,0.00044941384,0.000007128868,0.0013237287],"genre_scores_gemma":[0.9985024,0.00026645648,0.00008237726,0.00047182193,0.00008986558,0.000008772313,0.0002729489,0.000004763614,0.00030066067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986595,0.00025761646,0.0002840957,0.0002820473,0.00023460673,0.00028216807],"domain_scores_gemma":[0.99341124,0.0016837282,0.002944417,0.0004948511,0.00074872305,0.0007171551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073316327,0.00015754739,0.0004706402,0.00051239756,0.0005986933,0.0012970442,0.0003573019,0.0011712472,0.0021800012],"category_scores_gemma":[0.004920722,0.00026900938,0.00053104834,0.0010858248,0.00043917407,0.0010939186,0.0005167587,0.0012610939,0.0005583069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002818191,0.000072440096,0.9877652,0.000038865135,0.000069247464,0.006458577,0.00035537707,0.00004070185,0.00019897516,0.000055575456,0.00080758735,0.0038557316],"study_design_scores_gemma":[0.00004436412,0.0005025719,0.9535039,0.00009558545,0.00013400268,0.040662237,0.0015698986,0.0003786063,0.00023327037,0.0002038188,0.0026275413,0.000044357268],"about_ca_topic_score_codex":0.0023408027,"about_ca_topic_score_gemma":0.0019690562,"teacher_disagreement_score":0.0023408027,"about_ca_system_score_codex":0.0007689482,"about_ca_system_score_gemma":0.0005454375,"threshold_uncertainty_score":0.0072928667},"labels":[],"label_agreement":null},{"id":"W2889338440","doi":"10.1111/bjd.17084","title":"Comprehensive long‐term safety of adalimumab from 18 clinical trials in adult patients with moderate‐to‐severe plaque psoriasis","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"LEO Pharma; Mylan; Astellas Pharma; University of Connecticut; Valeant Pharmaceuticals International; National Cancer Institute; AbbVie; Celgene; Biogen; Amgen; Pfizer; Eli Lilly and Company","keywords":"Adalimumab; Medicine; Psoriasis; Plaque psoriasis; Dermatology; Clinical trial; Term (time); Internal medicine; Disease","score_opus":0.04027400225608697,"score_gpt":0.31018953441184344,"score_spread":0.2699155321557565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889338440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91659606,0.07294436,0.0013112368,0.0006012585,0.00010879221,0.0020693683,0.003072731,0.0000990399,0.0031971708],"genre_scores_gemma":[0.9818401,0.010369871,0.0012506704,0.0007693871,0.00023577317,0.0015852199,0.0033772306,0.000021537964,0.00055023155],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9940911,0.0030882228,0.0011751939,0.00052379386,0.0008741908,0.00024746777],"domain_scores_gemma":[0.99309206,0.0019538335,0.0030190523,0.00048208513,0.0008160705,0.0006369395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013882756,0.0007741123,0.0022440345,0.00064038043,0.00054199947,0.0014679437,0.00053077884,0.0007678223,0.0017686312],"category_scores_gemma":[0.008447136,0.00043241685,0.002322179,0.0008288982,0.0003925674,0.0008007075,0.0005447481,0.0015537278,0.00041648737],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43022028,0.00603663,0.16183475,0.009051999,0.023588926,0.00045579084,0.00083365577,0.0022936335,0.016824264,0.00037291463,0.009937171,0.33855],"study_design_scores_gemma":[0.22022198,0.2768401,0.43264008,0.0021281857,0.018325465,0.0025919636,0.00026505746,0.0016124164,0.0062624123,0.00068565935,0.038269915,0.00015684993],"about_ca_topic_score_codex":0.0002167531,"about_ca_topic_score_gemma":0.00069761515,"teacher_disagreement_score":0.013882756,"about_ca_system_score_codex":0.0006284087,"about_ca_system_score_gemma":0.001238027,"threshold_uncertainty_score":0.07341993},"labels":[],"label_agreement":null},{"id":"W2890430426","doi":"10.1111/bjd.17189","title":"Diagnostic accuracy of content‐based dermatoscopic image retrieval with deep classification features","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MetaOptima Technology (Canada); Simon Fraser University","funders":"MetaOptima Technology","keywords":"Softmax function; Convolutional neural network; Diagnostic accuracy; Medical diagnosis; Pattern recognition (psychology); Classifier (UML)","score_opus":0.01942943451022958,"score_gpt":0.2689061410456525,"score_spread":0.24947670653542295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890430426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96916294,0.0024229626,0.024255138,0.0003004181,0.00006168227,0.00006737496,0.00090944016,0.00061641727,0.0022036291],"genre_scores_gemma":[0.9926127,0.00017071629,0.0060625277,0.000039741604,0.000022674252,0.000015273783,0.0007361133,0.000009641372,0.00033052647],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99907035,0.0002710132,0.00009338361,0.0002271752,0.00023736799,0.000100752164],"domain_scores_gemma":[0.9970716,0.0017128123,0.00038248874,0.00023952077,0.0004973144,0.000096183976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00213974,0.0007126148,0.0005180459,0.0020154908,0.00014573078,0.00078083907,0.0005633332,0.0008205942,0.001105504],"category_scores_gemma":[0.0067659975,0.00016199404,0.0004652301,0.0005487726,0.00027112928,0.00069834414,0.0005561233,0.0004166734,0.00050627557],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005814716,0.00094795803,0.3009004,0.00078374275,0.0010431329,0.000339112,0.00014375825,0.08345289,0.06249058,0.00040557332,0.004467229,0.53921086],"study_design_scores_gemma":[0.00010189985,0.0011779006,0.13352273,0.00010666209,0.0004292825,0.0009865275,0.00012375416,0.81871986,0.04266359,0.0010705303,0.0010278486,0.0000693726],"about_ca_topic_score_codex":0.0020814647,"about_ca_topic_score_gemma":0.0021940898,"teacher_disagreement_score":0.00213974,"about_ca_system_score_codex":0.0006790497,"about_ca_system_score_gemma":0.00035126726,"threshold_uncertainty_score":0.01131618},"labels":[],"label_agreement":null},{"id":"W2891620699","doi":"10.1111/bjd.17149","title":"Benefit–risk profile of tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis across six clinical trials","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Plaque psoriasis; Medicine; Psoriasis; Dermatology; Clinical trial; Internal medicine; Rheumatoid arthritis","score_opus":0.023656340273300085,"score_gpt":0.3111337158610936,"score_spread":0.2874773755877935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891620699","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27350864,0.7041205,0.006265981,0.0008088342,0.000579547,0.002175906,0.008172131,0.0002662617,0.004102242],"genre_scores_gemma":[0.924212,0.06499496,0.002388311,0.000863904,0.00049323996,0.0019508534,0.0044089872,0.00008065478,0.00060708623],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9827938,0.009698106,0.0034099454,0.0019098504,0.0018532445,0.00033518436],"domain_scores_gemma":[0.9766915,0.015370128,0.005480644,0.0011375088,0.0009858811,0.00033434105],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.021590158,0.0017644563,0.010128505,0.0029670098,0.00031126564,0.0026700152,0.00089000707,0.001608742,0.0028094652],"category_scores_gemma":[0.026961781,0.0008468872,0.023088146,0.0036118221,0.0005390386,0.0012955792,0.0010360187,0.0013183891,0.0002727193],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12492124,0.00013947427,0.02921749,0.023725895,0.78738904,0.00015077573,0.00007918438,0.0020519083,0.00095777534,0.00014346113,0.0012287983,0.029994989],"study_design_scores_gemma":[0.0422269,0.0048642056,0.07702244,0.0020685948,0.86676896,0.0004401393,0.00009475771,0.0017708214,0.00050013425,0.0010087441,0.0031362632,0.00009802864],"about_ca_topic_score_codex":0.0007742816,"about_ca_topic_score_gemma":0.0011807121,"teacher_disagreement_score":0.9982355,"about_ca_system_score_codex":0.0006700178,"about_ca_system_score_gemma":0.0008098365,"threshold_uncertainty_score":0.11418104},"labels":[],"label_agreement":null},{"id":"W2891836054","doi":"10.1111/bjd.17195","title":"Granulocyte–macrophage colony‐stimulating factor ( <scp>GM</scp> ‐ <scp>CSF</scp> ) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐ <scp>GM</scp> ‐ <scp>CSF</scp> monoclonal antibody","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Dermatrials Research; Probity Medical Research","funders":"Department of Medicine, University of Toronto; University of Toronto; Gentofte Hospital; Takeda Pharmaceutical Company","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Clinical endpoint; Internal medicine; Granulocyte macrophage colony-stimulating factor; Immunology; Population; Granulocyte colony-stimulating factor; Clinical trial; Monoclonal antibody; Gastroenterology; Randomized controlled trial; Antibody; Pharmacology; Cytokine; Pathology; Chemotherapy","score_opus":0.020038037774897877,"score_gpt":0.27071297728936855,"score_spread":0.2506749395144707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891836054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783804,0.012679723,0.0006765195,0.0005296569,0.00039816034,0.0055390303,0.0005254265,0.0000807814,0.001190365],"genre_scores_gemma":[0.9869817,0.0054968907,0.0014000371,0.0005653271,0.000408193,0.00358611,0.00042481517,0.0000124286535,0.0011245405],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993742,0.00033573608,0.000056080225,0.00009413407,0.000080806065,0.000059032216],"domain_scores_gemma":[0.99945146,0.00017135986,0.00016306658,0.000033559638,0.0000421729,0.00013838976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020831006,0.00083034567,0.0018877903,0.0003643809,0.00025412053,0.00072336564,0.00052654406,0.0010586582,0.0035691676],"category_scores_gemma":[0.0012681336,0.0004047239,0.0009921986,0.00038349774,0.0007974712,0.0005132412,0.00027178435,0.0014368069,0.00044713018],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93154114,0.008187311,0.0010462659,0.0018624612,0.0006714323,0.000044598743,0.00004725689,0.00024439787,0.010730436,0.00009930615,0.00056371535,0.044961777],"study_design_scores_gemma":[0.9009518,0.0937612,0.0024737027,0.000070608214,0.00044849602,0.000048384132,0.000013118743,0.0002540775,0.0011008235,0.00006827591,0.00080095546,0.000008533874],"about_ca_topic_score_codex":0.00032493362,"about_ca_topic_score_gemma":0.00088955095,"teacher_disagreement_score":0.0035691676,"about_ca_system_score_codex":0.00047606323,"about_ca_system_score_gemma":0.00092067063,"threshold_uncertainty_score":0.011940002},"labels":[],"label_agreement":null},{"id":"W2891941421","doi":"10.1111/bjd.17201","title":"The utility of optical coherence tomography for diagnosis of basal cell carcinoma: a quantitative review","year":2018,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Optical Coherence Tomography Applications","field":"Engineering","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Optical coherence tomography; Concordance; Medicine; Histopathology; Basal cell carcinoma; Pathology; Basal cell; Nuclear medicine; Radiology; Internal medicine","score_opus":0.04004082900953006,"score_gpt":0.3119928536075381,"score_spread":0.27195202459800805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891941421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033836468,0.9991628,0.00012580468,0.00013664985,0.000058955487,0.000019654255,0.00004555058,0.0000024118922,0.00010972859],"genre_scores_gemma":[0.008178431,0.9906536,0.0006633946,0.0002267652,0.00008908974,0.00006304306,0.000076292374,0.0000038509957,0.000045512876],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99168795,0.002103425,0.0036508015,0.0007435609,0.0016894075,0.00012477783],"domain_scores_gemma":[0.9238252,0.0589248,0.008214335,0.0008528269,0.007847478,0.00033539758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01116301,0.0009777839,0.0034110148,0.019029325,0.0004602208,0.0025925534,0.0016487609,0.0013469856,0.0014900741],"category_scores_gemma":[0.048461754,0.000762327,0.0038720993,0.011372491,0.0012756857,0.002538678,0.0012346314,0.00089255394,0.00021603487],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002931907,0.000029943876,0.0028204226,0.58313453,0.0048264656,0.00014670359,0.0003819057,0.00031953419,0.0007495763,0.0008247661,0.0033241957,0.40314865],"study_design_scores_gemma":[0.000120611934,0.000450038,0.017231118,0.83004236,0.039349396,0.0021401292,0.0005850671,0.00044576547,0.0010181223,0.0012650292,0.107222594,0.0001296795],"about_ca_topic_score_codex":0.004300821,"about_ca_topic_score_gemma":0.0062980466,"teacher_disagreement_score":0.019029325,"about_ca_system_score_codex":0.0028564269,"about_ca_system_score_gemma":0.005997381,"threshold_uncertainty_score":0.059036374},"labels":[],"label_agreement":null},{"id":"W2897043380","doi":"10.1111/bjd.17318","title":"Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase <scp>III</scp> trials","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Ortho Dermatologics","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Adverse effect; Psoriasis; Internal medicine; Randomized controlled trial; Psoriatic arthritis; Subgroup analysis; Body surface area; Dermatology; Adalimumab; Meta-analysis; Disease","score_opus":0.016526440334536593,"score_gpt":0.2833830834402225,"score_spread":0.2668566431056859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897043380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86103946,0.12036165,0.002901386,0.0012277815,0.0011373358,0.0060205096,0.004113212,0.0001568665,0.0030418606],"genre_scores_gemma":[0.98498034,0.007040628,0.0010631362,0.0009523853,0.00036066858,0.0030068,0.0019079358,0.000036531994,0.00065157656],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99087465,0.004710562,0.0022716399,0.0009281939,0.00077004003,0.000444994],"domain_scores_gemma":[0.9936039,0.003309054,0.0015809243,0.00079538074,0.00041596923,0.00029478414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0108259935,0.0016601067,0.006126046,0.0011366106,0.00040390622,0.0017791206,0.00085377187,0.0016048906,0.0021994256],"category_scores_gemma":[0.011959583,0.00055454305,0.0155344205,0.0011386805,0.00050827424,0.00076609815,0.00068408204,0.0013643308,0.00025946903],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7796111,0.0005781048,0.025859473,0.008287317,0.14973153,0.0002889471,0.00017853199,0.0007189284,0.0036821577,0.00018102743,0.0015408059,0.029341953],"study_design_scores_gemma":[0.5469075,0.029665764,0.11337952,0.0015490331,0.2954687,0.00064926705,0.00032557308,0.002064868,0.0023634445,0.0014900755,0.005964101,0.00017211953],"about_ca_topic_score_codex":0.0008575954,"about_ca_topic_score_gemma":0.0023851036,"teacher_disagreement_score":0.0108259935,"about_ca_system_score_codex":0.00086217676,"about_ca_system_score_gemma":0.0010700027,"threshold_uncertainty_score":0.057254016},"labels":[],"label_agreement":null},{"id":"W2897116385","doi":"10.1111/bjd.17038","title":"Ixekizumab in genital psoriasis","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Ixekizumab; Psoriasis; Dermatology; Medicine; Sex organ; Biology; Psoriatic arthritis; Secukinumab","score_opus":0.013219328369075627,"score_gpt":0.22586833331081116,"score_spread":0.21264900494173553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897116385","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00952139,0.039982747,0.00033091183,0.8797462,0.052469388,0.000036406,0.000114856455,0.00008251659,0.017715586],"genre_scores_gemma":[0.18357904,0.040355634,0.0006880158,0.47189152,0.27575988,0.00006147187,0.00019201817,0.00006367554,0.027408678],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9993899,0.00016329974,0.00008469214,0.00008635661,0.0001521352,0.0001236223],"domain_scores_gemma":[0.99896634,0.00056981185,0.000084028215,0.00003999633,0.00016078712,0.00017899198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008606768,0.000511091,0.0009268139,0.00062294875,0.0011688983,0.0012658836,0.0006900632,0.010329248,0.0031863265],"category_scores_gemma":[0.0054950174,0.0002721624,0.0005665508,0.00035370322,0.0007887652,0.0013169803,0.0005686068,0.009041523,0.0021600116],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026354782,0.0001386362,0.0037586933,0.0002912766,0.000047819496,0.11435706,0.00016242565,0.00034431237,0.0007052482,0.0038416611,0.8274748,0.04861457],"study_design_scores_gemma":[0.0006260246,0.00042183744,0.007923151,0.0013943455,0.000119404045,0.2783001,0.00047622697,0.0020006956,0.0010228254,0.013400397,0.6942364,0.00007865715],"about_ca_topic_score_codex":0.0014175484,"about_ca_topic_score_gemma":0.0016453571,"teacher_disagreement_score":0.010329248,"about_ca_system_score_codex":0.0020284015,"about_ca_system_score_gemma":0.000673351,"threshold_uncertainty_score":0.014717162},"labels":[],"label_agreement":null},{"id":"W2897199008","doi":"10.1111/bjd.17335","title":"Network meta‐analyses of systemic treatments for psoriasis: a critical appraisal","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Critical appraisal; Psoriasis; Systemic risk; Systemic therapy; Medicine; Psychology; Dermatology; Internal medicine; Alternative medicine; Economics; Pathology","score_opus":0.07494401286254536,"score_gpt":0.3382779030980835,"score_spread":0.2633338902355381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897199008","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058059377,0.9959325,0.0012416684,0.0008005739,0.00040491082,0.00039862926,0.0003044729,0.000031383923,0.00030528035],"genre_scores_gemma":[0.061355937,0.92445385,0.0069158105,0.0022807433,0.001343191,0.0025991362,0.000711029,0.00008840703,0.0002519073],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.9356562,0.046049308,0.0091532795,0.0025887117,0.0059461724,0.000606275],"domain_scores_gemma":[0.78825766,0.18482162,0.012520501,0.004558564,0.00922605,0.0006156609],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07890436,0.0037028084,0.018843794,0.009127103,0.0006994304,0.0046069194,0.003585781,0.0028081296,0.005232978],"category_scores_gemma":[0.1749355,0.002271987,0.035436504,0.0074466984,0.0011488517,0.003381573,0.0020669468,0.0033591953,0.0005319321],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020765,0.000024996554,0.0015032048,0.4595438,0.48858297,0.00010578369,0.000088313966,0.0014784271,0.00012263226,0.00080269115,0.0033183198,0.04235245],"study_design_scores_gemma":[0.0017221061,0.0005195596,0.0033941618,0.16480339,0.8113674,0.000188621,0.0000748261,0.0009904678,0.00020731537,0.003045211,0.013611852,0.00007516203],"about_ca_topic_score_codex":0.0054003242,"about_ca_topic_score_gemma":0.009035795,"teacher_disagreement_score":0.9210956,"about_ca_system_score_codex":0.0057736626,"about_ca_system_score_gemma":0.0061359983,"threshold_uncertainty_score":0.4172911},"labels":[],"label_agreement":null},{"id":"W2897668014","doi":"10.1111/bjd.16943","title":"Generating new evidence for old medications: the TREAT trial in paediatric atopic dermatitis","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; MEDLINE; Pediatrics","score_opus":0.04033806836309275,"score_gpt":0.31859535119345556,"score_spread":0.27825728283036283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897668014","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026964217,0.016204037,0.00012807775,0.95890516,0.015827637,0.00003305945,0.00019110738,0.0000311528,0.005983311],"genre_scores_gemma":[0.036576107,0.016418573,0.0006920584,0.8697167,0.06891904,0.00014247544,0.00018511199,0.00003979658,0.007310113],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99581546,0.0026588612,0.00045784266,0.00020932518,0.00062290387,0.00023564731],"domain_scores_gemma":[0.980495,0.015130538,0.0009899242,0.00028275882,0.0013884576,0.0017133916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004925765,0.00038093567,0.0011367183,0.000553968,0.0012435064,0.0019269409,0.0009086897,0.017111683,0.0071880757],"category_scores_gemma":[0.035539724,0.000260311,0.00090621464,0.00049801223,0.0014539175,0.002585064,0.0010072873,0.014629027,0.0032150075],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013261777,0.00010660965,0.0019387929,0.0007305036,0.00011494034,0.006723162,0.00019462268,0.00011798768,0.000480771,0.0036192653,0.90651196,0.07813518],"study_design_scores_gemma":[0.0053210366,0.0012922618,0.0046995822,0.0042621996,0.00032683858,0.0133799175,0.00044859567,0.00066798023,0.0009205371,0.015662907,0.9529324,0.00008580484],"about_ca_topic_score_codex":0.0009905465,"about_ca_topic_score_gemma":0.0021826457,"teacher_disagreement_score":0.017111683,"about_ca_system_score_codex":0.0022769275,"about_ca_system_score_gemma":0.0019951758,"threshold_uncertainty_score":0.02605027},"labels":[],"label_agreement":null},{"id":"W2898564948","doi":"10.1111/bjd.17347","title":"Pyoderma gangrenosum and its impact on quality of life: a multicentre, prospective study","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Pyoderma gangrenosum; Medicine; Dermatology; Quality of life (healthcare); Prospective cohort study; Pyoderma; Intensive care medicine; Surgery; Internal medicine; Disease","score_opus":0.01818263959690763,"score_gpt":0.31744323645646466,"score_spread":0.299260596859557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898564948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979381,0.0009514624,0.00006461262,0.00028323257,0.0000258986,0.00002417042,0.00031413627,0.0000023809937,0.00039586937],"genre_scores_gemma":[0.99849117,0.00038229336,0.00013076853,0.00032138033,0.00008544799,0.00004044091,0.0002868501,0.0000022877732,0.00025927724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988476,0.0005603462,0.00012255747,0.00017510634,0.00013412969,0.00016027768],"domain_scores_gemma":[0.9972663,0.0007601934,0.00091916317,0.00026447928,0.00022635447,0.0005635319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012663534,0.00070839503,0.0009932233,0.00072965486,0.0009116277,0.0013859399,0.00059307757,0.0020289256,0.0023963933],"category_scores_gemma":[0.003909914,0.0008576734,0.0013957868,0.0019455882,0.0007523212,0.001355802,0.00092923216,0.0017444994,0.00047446854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015568581,0.00036394436,0.99383414,0.00006478284,0.00056778255,0.0012388739,0.0002575897,0.00003291377,0.00021325855,0.000030209823,0.00022489025,0.0016148364],"study_design_scores_gemma":[0.0002557575,0.0011490508,0.9951722,0.00003489553,0.0003164294,0.0020719862,0.00046448148,0.00009089021,0.000025828347,0.00006429653,0.0003331319,0.000021026432],"about_ca_topic_score_codex":0.0027027081,"about_ca_topic_score_gemma":0.0028053415,"teacher_disagreement_score":0.0027027081,"about_ca_system_score_codex":0.00053628226,"about_ca_system_score_gemma":0.00039357448,"threshold_uncertainty_score":0.008016765},"labels":[],"label_agreement":null},{"id":"W2902260894","doi":"10.1111/bjd.17462","title":"Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"Allergan","keywords":"Erythema; Oxymetazoline; Medicine; Rosacea; Clinical trial; Randomized controlled trial; Dermatology; Surgery; Internal medicine","score_opus":0.09987158512007305,"score_gpt":0.45240620816703725,"score_spread":0.3525346230469642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902260894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8938479,0.003968396,0.016530177,0.0004570252,0.0020088102,0.07481962,0.0015976991,0.0003040958,0.00646632],"genre_scores_gemma":[0.89062405,0.0010112762,0.020449527,0.00060925004,0.0005357659,0.08402608,0.0006170069,0.00006362932,0.0020635],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9800504,0.014424509,0.00170911,0.0013346853,0.0020205365,0.0004606482],"domain_scores_gemma":[0.9816714,0.007346602,0.006238942,0.0019407121,0.0020560815,0.00074618746],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018847516,0.0017038252,0.002846761,0.0009614088,0.0005351719,0.0010448511,0.0012623197,0.0026063605,0.004835574],"category_scores_gemma":[0.015052707,0.0006594983,0.0023300946,0.0011485892,0.0011890914,0.0010404949,0.0005957709,0.0029351918,0.0008750299],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83522123,0.028684482,0.009366776,0.0022971865,0.002067051,0.00010167969,0.00031156756,0.0012447542,0.059966855,0.00066638325,0.0011555012,0.0589164],"study_design_scores_gemma":[0.21947496,0.7380931,0.020844089,0.0001217282,0.00090129575,0.000113888025,0.00006876713,0.0024000497,0.013898802,0.00032267979,0.0036863862,0.0000742946],"about_ca_topic_score_codex":0.000288266,"about_ca_topic_score_gemma":0.00047462527,"teacher_disagreement_score":0.9811525,"about_ca_system_score_codex":0.0008944167,"about_ca_system_score_gemma":0.0013569865,"threshold_uncertainty_score":0.09967637},"labels":[],"label_agreement":null},{"id":"W2902697340","doi":"10.1111/bjd.17454","title":"Safety of guselkumab in patients with moderate‐to‐severe psoriasis treated through 100 weeks: a pooled analysis from the randomized <scp>VOYAGE</scp> 1 and <scp>VOYAGE</scp> 2 studies","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Research and Development","keywords":"Medicine; Adalimumab; Adverse effect; Randomized controlled trial; Placebo; Clinical trial; Psoriasis; Internal medicine; Dermatology; Pathology; Alternative medicine; Disease","score_opus":0.010887670862251838,"score_gpt":0.23301051871707845,"score_spread":0.2221228478548266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902697340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8518471,0.13415746,0.004971256,0.00043632596,0.0003208723,0.001372467,0.00435813,0.00017121514,0.0023650932],"genre_scores_gemma":[0.9870459,0.008780369,0.0010087414,0.00027421754,0.00016863212,0.0006244401,0.0017038331,0.000027485597,0.0003663562],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99014974,0.0063801506,0.0012456711,0.0010635481,0.00089730194,0.0002635865],"domain_scores_gemma":[0.9886817,0.005272719,0.004134782,0.0010034406,0.0005955306,0.00031190467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016531711,0.0013807741,0.0051762,0.0012954643,0.00030902168,0.0016067236,0.0007694689,0.0011799093,0.0024123646],"category_scores_gemma":[0.010950598,0.00082497724,0.017393535,0.00133353,0.0004956817,0.0009962028,0.00081445894,0.0015219954,0.00025605917],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57426214,0.00075006037,0.042705093,0.008912388,0.32742736,0.000097302385,0.00013616076,0.0020519146,0.0033046799,0.00010794207,0.0010849324,0.039160028],"study_design_scores_gemma":[0.1926178,0.05308026,0.22901793,0.0013636637,0.51328343,0.0004390973,0.00015997217,0.002787468,0.002301593,0.0007880408,0.004011311,0.00014937975],"about_ca_topic_score_codex":0.00056909607,"about_ca_topic_score_gemma":0.0013342281,"teacher_disagreement_score":0.016531711,"about_ca_system_score_codex":0.00066133874,"about_ca_system_score_gemma":0.00075025426,"threshold_uncertainty_score":0.08742905},"labels":[],"label_agreement":null},{"id":"W2902753829","doi":"10.1111/bjd.16230","title":"Dermatomyositis: a slow path towards targeted therapies or will conventional therapies prevail?","year":2018,"lang":"en","type":"editorial","venue":"British Journal of Dermatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Dermatomyositis; Medicine; Intensive care medicine; Dermatology","score_opus":0.00807862611607661,"score_gpt":0.26085924316389303,"score_spread":0.2527806170478164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902753829","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007200042,0.022834286,0.00009370005,0.079311125,0.89627016,0.000016032682,0.000056559285,0.000048336813,0.001297864],"genre_scores_gemma":[0.0005931342,0.018014736,0.00007903759,0.03916112,0.93695104,0.000012809134,0.000032004562,0.000021796366,0.0051343557],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660057,0.00064053497,0.00063746027,0.00035102756,0.0014861252,0.00028427943],"domain_scores_gemma":[0.98129714,0.009309882,0.0011660166,0.00035168248,0.006071587,0.0018036227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062607997,0.0023263355,0.0033477861,0.0021663022,0.0018539645,0.0055326954,0.0027334134,0.015477301,0.012357417],"category_scores_gemma":[0.02583012,0.0007759809,0.0019215929,0.0009396479,0.0021321287,0.0060095205,0.0013195411,0.020732526,0.009561932],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056265057,0.000014019485,0.00004600636,0.00044876794,0.000027136042,0.00019383631,0.000021846341,0.000021267111,0.000055109424,0.00037687007,0.98862284,0.010116214],"study_design_scores_gemma":[0.00012505164,0.000055246157,0.000332774,0.0012748505,0.00010769735,0.00090269314,0.000100683916,0.0001089947,0.00014894856,0.0017761111,0.9950296,0.00003742026],"about_ca_topic_score_codex":0.0011056104,"about_ca_topic_score_gemma":0.0030686564,"teacher_disagreement_score":0.015477301,"about_ca_system_score_codex":0.002539922,"about_ca_system_score_gemma":0.0024741713,"threshold_uncertainty_score":0.041339695},"labels":[],"label_agreement":null},{"id":"W2906008486","doi":"10.1111/bjd.17590","title":"Interventions for rosacea based on the phenotype approach: an updated systematic review including<scp>GRADE</scp>assessments","year":2018,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Southwest Hospital; Army Medical University; Universiteit Leiden","keywords":"Rosacea; Brimonidine; Medicine; Dermatology; Minocycline; Isotretinoin; Metronidazole; Tolerability; Randomized controlled trial; Erythema; Acne; Surgery; Adverse effect; Internal medicine; Antibiotics","score_opus":0.12109585316626695,"score_gpt":0.4087974071537314,"score_spread":0.28770155398746444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906008486","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00092527136,0.99658185,0.00022265146,0.0005014072,0.00015950727,0.0006119025,0.0005940226,0.00001329697,0.00039011182],"genre_scores_gemma":[0.017838513,0.9765802,0.0017136629,0.0014317458,0.00016000254,0.0014702282,0.0005737562,0.000010332417,0.00022158063],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9893049,0.003754381,0.004204732,0.000682451,0.0017230703,0.00033054312],"domain_scores_gemma":[0.97457254,0.015540655,0.0062180976,0.0004088962,0.0029449037,0.00031490586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0111376,0.0019488939,0.010435805,0.009963249,0.0006778493,0.0028189514,0.0021015601,0.002362037,0.007489915],"category_scores_gemma":[0.04117009,0.001027201,0.011800736,0.0073450305,0.00078596175,0.0027608133,0.0016689156,0.0017176372,0.00043043296],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002812219,0.0000150007545,0.00043992983,0.9586491,0.010115545,0.000049946324,0.000096415926,0.00006644738,0.00011871309,0.000121886966,0.0013468082,0.028699014],"study_design_scores_gemma":[0.00081767805,0.00025774795,0.0036567764,0.86079735,0.118942365,0.0002404664,0.00015897512,0.00009685025,0.00013406096,0.00030894697,0.014548135,0.0000406784],"about_ca_topic_score_codex":0.009512147,"about_ca_topic_score_gemma":0.026187466,"teacher_disagreement_score":0.0111376,"about_ca_system_score_codex":0.004395394,"about_ca_system_score_gemma":0.011239816,"threshold_uncertainty_score":0.058901966},"labels":[],"label_agreement":null},{"id":"W2907063679","doi":"10.1111/bjd.17323","title":"Tofacitinib: a new oral Janus kinase inhibitor for psoriasis","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology","funders":"","keywords":"Tofacitinib; Janus kinase inhibitor; Psoriasis; Janus kinase; Dermatology; Medicine; Janus; Plaque psoriasis; Internal medicine; Materials science","score_opus":0.03670535944546116,"score_gpt":0.31420712493776765,"score_spread":0.2775017654923065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907063679","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009367762,0.028363012,0.00057010405,0.8973134,0.04211317,0.000049678412,0.00022583551,0.0001252976,0.021871818],"genre_scores_gemma":[0.116706595,0.043877512,0.0013939124,0.584811,0.1694085,0.000100103694,0.00037451764,0.0000876467,0.08324025],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958557,0.00007787734,0.0000486924,0.000060014456,0.0001417114,0.00008608832],"domain_scores_gemma":[0.99957496,0.00019928916,0.000045688466,0.000011022363,0.00007317175,0.00009594325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000396362,0.0005011824,0.0008255859,0.0005176175,0.0012042233,0.0012699389,0.00043831146,0.009404924,0.0039198026],"category_scores_gemma":[0.0021221158,0.00025416826,0.00065071136,0.00040331733,0.0008064136,0.0013981903,0.0003794963,0.009114856,0.0032187141],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054484536,0.00014397546,0.0014114637,0.00039024145,0.000049019203,0.08192561,0.00011479534,0.00032990114,0.002764305,0.004516257,0.83807504,0.06973464],"study_design_scores_gemma":[0.0009025144,0.00048635303,0.003851154,0.00059877406,0.00010507946,0.17370199,0.00022622674,0.0015197684,0.0020259358,0.010861959,0.8056523,0.00006785022],"about_ca_topic_score_codex":0.0011753154,"about_ca_topic_score_gemma":0.0019910603,"teacher_disagreement_score":0.009404924,"about_ca_system_score_codex":0.0018826213,"about_ca_system_score_gemma":0.0006795161,"threshold_uncertainty_score":0.013659477},"labels":[],"label_agreement":null},{"id":"W2909090268","doi":"10.1111/bjd.17624","title":"Risankizumab vs. ustekinumab for plaque psoriasis: a critical appraisal","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"LEO Pharma; Sun Pharma; National Institute for Health and Care Research; Celgene; Pfizer; Eli Lilly and Company","keywords":"Medicine; Ustekinumab; Psoriasis; Placebo; Psoriasis Area and Severity Index; Internal medicine; Adverse effect; Dermatology Life Quality Index; Randomized controlled trial; Plaque psoriasis; Physical therapy; Gastroenterology; Dermatology; Tumor necrosis factor alpha; Pathology","score_opus":0.011956762107803524,"score_gpt":0.26709302827115905,"score_spread":0.25513626616335555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909090268","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00096067076,0.9901073,0.00010409774,0.0054330854,0.0024578795,0.00020547844,0.000064200925,0.000009857162,0.00065735163],"genre_scores_gemma":[0.035148256,0.924148,0.0017256136,0.025910366,0.011099709,0.0007088651,0.00020490722,0.00003143832,0.0010228774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918046,0.0041951453,0.0018779634,0.00043248985,0.0014208527,0.00026893298],"domain_scores_gemma":[0.95175004,0.033027455,0.0058768704,0.0007833082,0.0075866077,0.00097577844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025796773,0.00096716697,0.006220426,0.001588905,0.0007201888,0.003037624,0.0027913142,0.004255789,0.003721295],"category_scores_gemma":[0.034901615,0.000602645,0.0057233097,0.0017604069,0.0011807886,0.0021544266,0.000877983,0.0051701195,0.0008596579],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031645257,0.0003888728,0.0008635998,0.31013706,0.014556007,0.00027392668,0.000379072,0.00043519677,0.0015964217,0.0037295313,0.049712915,0.58628213],"study_design_scores_gemma":[0.036229126,0.013837378,0.0070113,0.49607903,0.051506467,0.0006716747,0.00067126553,0.00074700837,0.0015384865,0.0063643632,0.3851828,0.00016111908],"about_ca_topic_score_codex":0.0019354555,"about_ca_topic_score_gemma":0.0040013553,"teacher_disagreement_score":0.025796773,"about_ca_system_score_codex":0.0041727223,"about_ca_system_score_gemma":0.0052160565,"threshold_uncertainty_score":0.136428},"labels":[],"label_agreement":null},{"id":"W2909378861","doi":"10.1111/bjd.16952","title":"Pyoderma gangrenosum and systemic treatment","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pyoderma gangrenosum; Regimen; Quality of life (healthcare); Systemic therapy; Intensive care medicine; Dermatology; Disease; Surgery; Internal medicine; Cancer","score_opus":0.009232885061978497,"score_gpt":0.24759179167958095,"score_spread":0.23835890661760245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909378861","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004668571,0.9772759,0.00038423148,0.00647286,0.0005239435,0.00006108681,0.00014707979,0.0000065123663,0.0104598105],"genre_scores_gemma":[0.151578,0.8322522,0.0017291292,0.008243399,0.0022206504,0.00016617989,0.00029742334,0.000010324944,0.0035025908],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99648005,0.0014554547,0.00056047266,0.00029957743,0.0009978126,0.00020670082],"domain_scores_gemma":[0.993086,0.0044329083,0.0013518434,0.00013165838,0.000772586,0.00022501303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022745477,0.00030172238,0.0011048065,0.0017086945,0.0005304559,0.0014809389,0.00039357613,0.0010843952,0.0068326993],"category_scores_gemma":[0.009403053,0.00015380433,0.00094620895,0.0025657755,0.0012306636,0.0012744786,0.00081003335,0.001768032,0.00040518426],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006894854,0.0002389226,0.020549677,0.0842474,0.001033054,0.003062853,0.0010954725,0.0005237538,0.00078262493,0.016050998,0.032719586,0.8390062],"study_design_scores_gemma":[0.0003912032,0.00077275845,0.07496966,0.16596974,0.0031828596,0.034038913,0.0034802696,0.0003957723,0.001271056,0.020131886,0.69528776,0.000108154796],"about_ca_topic_score_codex":0.004777684,"about_ca_topic_score_gemma":0.006553524,"teacher_disagreement_score":0.0068326993,"about_ca_system_score_codex":0.0015347471,"about_ca_system_score_gemma":0.004280915,"threshold_uncertainty_score":0.022857606},"labels":[],"label_agreement":null},{"id":"W2911434758","doi":"10.1111/bjd.17628","title":"Efficacy and safety of mirikizumab ( <scp>LY</scp> 3074828) in the treatment of moderate‐to‐severe plaque psoriasis: results from a randomized phase <scp>II</scp> study","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Innovaderm (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Placebo; Psoriasis Area and Severity Index; Psoriasis; Adverse effect; Internal medicine; Clinical endpoint; Gastroenterology; Plaque psoriasis; Randomized controlled trial; Surgery; Immunology; Pathology","score_opus":0.013537018109192079,"score_gpt":0.251430133745222,"score_spread":0.2378931156360299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911434758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914255,0.0036451602,0.0005125799,0.00043087735,0.00016961037,0.0018777138,0.00085936283,0.000064573105,0.0010146411],"genre_scores_gemma":[0.9923717,0.0019802821,0.0009469415,0.0005585505,0.00026892486,0.0017512231,0.0010777696,0.000021379172,0.0010233218],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990471,0.00062144443,0.00006689129,0.0001053619,0.00008934669,0.00006983116],"domain_scores_gemma":[0.9983632,0.0004239728,0.0004967823,0.00011966094,0.000112993264,0.0004835101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002976531,0.0011468956,0.0021409406,0.00028002885,0.00034847134,0.00079626765,0.00070342794,0.0011885461,0.003991463],"category_scores_gemma":[0.0016694345,0.0005846541,0.0018520233,0.0002819077,0.0007192307,0.0006040944,0.00028873523,0.0021484504,0.0007935317],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95903367,0.007859737,0.0015746091,0.00064702664,0.001033716,0.00003885703,0.000058871727,0.00028273714,0.010189133,0.000043368407,0.00085307274,0.018385109],"study_design_scores_gemma":[0.8769511,0.113897964,0.0066055483,0.000035212623,0.00064644736,0.000091027556,0.00001336379,0.00028147447,0.0008723378,0.000055300956,0.0005365924,0.000013650182],"about_ca_topic_score_codex":0.000386467,"about_ca_topic_score_gemma":0.0007364317,"teacher_disagreement_score":0.003991463,"about_ca_system_score_codex":0.0005026399,"about_ca_system_score_gemma":0.000970086,"threshold_uncertainty_score":0.015741646},"labels":[],"label_agreement":null},{"id":"W2914540870","doi":"10.1111/bjd.17397","title":"<i> <scp>BJD</scp> </i> Medical Student Editors: reaching out to undergraduates in a rapidly evolving world of digital dermatology publishing","year":2019,"lang":"en","type":"editorial","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cardiff University; University of Birmingham","keywords":"Publishing; Dermatology; Medical education; Medicine; Art; Literature","score_opus":0.012374547424337837,"score_gpt":0.29027664196031044,"score_spread":0.2779020945359726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914540870","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021108624,0.0022667057,0.000029359266,0.034439232,0.96128285,0.000014242615,0.000052421474,0.00003354059,0.0018604657],"genre_scores_gemma":[0.00025653787,0.0023403212,0.000054345925,0.022381155,0.96529806,0.000018020788,0.00004416005,0.000047899503,0.009559531],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905882,0.001235941,0.0012507496,0.0006860206,0.0055938526,0.00064524694],"domain_scores_gemma":[0.9478906,0.012894574,0.0038550163,0.0013198156,0.023715949,0.010324059],"candidate_categories":["scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.008963533,0.0040624714,0.0039983103,0.007956415,0.005830722,0.016013196,0.0040282705,0.01806737,0.040349465],"category_scores_gemma":[0.04871299,0.0015224875,0.0029337395,0.0038139466,0.0027654513,0.0052117435,0.002611896,0.01893765,0.02903208],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010506295,0.0000041536227,0.000019398816,0.000078492645,0.000005001642,0.000033935576,0.000006426279,0.000004443943,0.000012101568,0.000058349196,0.9981578,0.0016094084],"study_design_scores_gemma":[0.000055502518,0.000019560832,0.00042281087,0.0006453235,0.000041143117,0.00022153695,0.00008465513,0.00007292379,0.000058057958,0.00052875665,0.9978277,0.000021833344],"about_ca_topic_score_codex":0.0055505326,"about_ca_topic_score_gemma":0.022110743,"teacher_disagreement_score":0.9839868,"about_ca_system_score_codex":0.0060293116,"about_ca_system_score_gemma":0.006858414,"threshold_uncertainty_score":0.13498235},"labels":[],"label_agreement":null},{"id":"W2914630598","doi":"10.1111/bjd.17738","title":"Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta‐analysis","year":2019,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Psoriasis; Discontinuation; Meta-analysis; Persistence (discontinuity); Medicine; Drug; Systematic review; Intensive care medicine; Internal medicine; MEDLINE; Pharmacology; Immunology; Biology","score_opus":0.07836011503659017,"score_gpt":0.296998066237931,"score_spread":0.21863795120134083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914630598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005204604,0.9932234,0.00047298067,0.00019046212,0.000088262976,0.00014980198,0.00046442953,0.000022906372,0.00018317507],"genre_scores_gemma":[0.21346305,0.781362,0.0020731334,0.0006629982,0.00026133098,0.00076287193,0.0010907782,0.000033958117,0.00028993984],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99166566,0.003958354,0.0021896057,0.0009577376,0.00090836425,0.00032033463],"domain_scores_gemma":[0.9733661,0.020450171,0.0037775938,0.0007894711,0.0013293674,0.00028724238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013285635,0.0024232457,0.014928163,0.0059448723,0.00063733093,0.0031580867,0.0019809373,0.0019840337,0.0033045167],"category_scores_gemma":[0.028266113,0.0013810371,0.04183376,0.0075395657,0.00060797477,0.0015590918,0.0013752051,0.0019176077,0.00031845312],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016778721,0.000029813194,0.009979587,0.25548023,0.7199471,0.00016007168,0.00006808823,0.0006173209,0.00016910891,0.0001151349,0.00057720934,0.011178553],"study_design_scores_gemma":[0.00027754667,0.00013928107,0.0057453774,0.015670586,0.976542,0.00010286047,0.000026706819,0.00020832155,0.00007137375,0.00015611688,0.0010428547,0.000017023633],"about_ca_topic_score_codex":0.0063920505,"about_ca_topic_score_gemma":0.012051968,"teacher_disagreement_score":0.014928163,"about_ca_system_score_codex":0.0020071026,"about_ca_system_score_gemma":0.0032200164,"threshold_uncertainty_score":0.070262015},"labels":[],"label_agreement":null},{"id":"W2920674058","doi":"10.1111/bjd.17853","title":"Different definitions of atopic dermatitis: impact on prevalence estimates and associated risk factors","year":2019,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council","keywords":"Atopic dermatitis; Medicine; Environmental health; Dermatology","score_opus":0.0449560202204928,"score_gpt":0.3308570608658106,"score_spread":0.28590104064531785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920674058","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7307995,0.14916764,0.10480647,0.005314397,0.0007190016,0.00084388163,0.002915595,0.00025551373,0.0051780087],"genre_scores_gemma":[0.9629871,0.007221972,0.02728742,0.00074082514,0.00020282355,0.00024476674,0.0011262588,0.000108840824,0.0000800285],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.5672769,0.31037295,0.05823383,0.030129842,0.03186686,0.0021196513],"domain_scores_gemma":[0.268358,0.6384053,0.04913416,0.02864205,0.01425757,0.0012028035],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.29914925,0.0017676136,0.0031459928,0.009875341,0.00087115396,0.0057298555,0.0038630113,0.0018222391,0.00089280657],"category_scores_gemma":[0.4808752,0.0012202314,0.00632373,0.00905058,0.004076202,0.004178558,0.0047174534,0.0024576075,0.00015867979],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012554585,0.0000735108,0.9167573,0.00471303,0.010407834,0.0003859187,0.0024476845,0.003986663,0.0010354712,0.0025040118,0.0010040986,0.05542899],"study_design_scores_gemma":[0.000380542,0.001001908,0.9291634,0.0078049325,0.011555316,0.0046212273,0.003402336,0.018130578,0.003228068,0.012776964,0.007623622,0.00031102673],"about_ca_topic_score_codex":0.003519117,"about_ca_topic_score_gemma":0.0029572898,"teacher_disagreement_score":0.29914925,"about_ca_system_score_codex":0.0019674357,"about_ca_system_score_gemma":0.0014470043,"threshold_uncertainty_score":0.8642738},"labels":[],"label_agreement":null},{"id":"W2924174256","doi":"10.1111/bjd.17929","title":"Regardless of how risks are framed, patients seem hesitant to use topical steroids for atopic dermatitis","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology","score_opus":0.2573558088244633,"score_gpt":0.37580356111300917,"score_spread":0.11844775228854587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924174256","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008958037,0.0005763976,0.000058682806,0.98986524,0.002570284,0.0000036813774,0.000028306526,0.000008713101,0.0059928177],"genre_scores_gemma":[0.013172267,0.00077876815,0.00016613776,0.9643547,0.01015359,0.0000111874915,0.000021317612,0.00001648891,0.011325603],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99734807,0.00079294795,0.00041811177,0.00021199019,0.0007194875,0.0005092986],"domain_scores_gemma":[0.98885894,0.0070652156,0.000900875,0.00029406886,0.0015670417,0.0013139356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031068309,0.00029058885,0.00071287795,0.00046764017,0.0028755686,0.0032262467,0.0006069234,0.036607914,0.008509605],"category_scores_gemma":[0.026439657,0.0003509809,0.00084693806,0.0006257607,0.0022012754,0.0023366471,0.0011655082,0.02433092,0.0048608873],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008576768,0.00005446565,0.00364456,0.000055262088,0.000018260593,0.0035621936,0.00030822423,0.00010460033,0.0003488068,0.008424514,0.9635703,0.019823005],"study_design_scores_gemma":[0.0001486976,0.00007912981,0.006227013,0.00064075686,0.000036899357,0.008621175,0.0010955718,0.0006615343,0.0004156446,0.025204135,0.9567882,0.00008131631],"about_ca_topic_score_codex":0.007629975,"about_ca_topic_score_gemma":0.015542078,"teacher_disagreement_score":0.036607914,"about_ca_system_score_codex":0.0034930215,"about_ca_system_score_gemma":0.0029495207,"threshold_uncertainty_score":0.028467476},"labels":[],"label_agreement":null},{"id":"W2924781650","doi":"10.1111/bjd.17919","title":"Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"LEO Pharma; Eli Lilly and Company; AstraZeneca; Galderma; Medac; AbbVie; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Celgene; Biogen; Gilead Sciences; Amgen; Pfizer","keywords":"Adalimumab; Medicine; Placebo; Dosing; Adverse effect; Hidradenitis suppurativa; Randomized controlled trial; Post-hoc analysis; Internal medicine; Clinical trial; Post hoc; Tumor necrosis factor alpha","score_opus":0.025221703626630166,"score_gpt":0.3089418987806154,"score_spread":0.2837201951539852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924781650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8893764,0.084992364,0.0054940595,0.0014332801,0.0007004892,0.010955081,0.0021268344,0.00020870157,0.0047127753],"genre_scores_gemma":[0.94700885,0.021472765,0.013901965,0.0016276581,0.001491128,0.009866542,0.002547335,0.000074622556,0.0020091143],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9926358,0.0053676935,0.000554464,0.0004392748,0.000699953,0.00030283624],"domain_scores_gemma":[0.9938632,0.002545055,0.0015910129,0.0006995364,0.0006301715,0.0006710166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020735787,0.0010684192,0.0033694424,0.0005634167,0.00034833635,0.0016784973,0.0009867662,0.0013535814,0.0019733198],"category_scores_gemma":[0.008201987,0.00048259506,0.0035571777,0.0005937908,0.0008789812,0.0010529126,0.0007182361,0.0019838014,0.00028418205],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8876585,0.0073609566,0.0027275987,0.002985683,0.008832668,0.000040562634,0.00016110124,0.0008423338,0.0079540275,0.00037793664,0.0013356952,0.07972286],"study_design_scores_gemma":[0.83436227,0.14571154,0.008706396,0.00044600936,0.005976641,0.00007220278,0.000036712787,0.0004231488,0.0012554612,0.00035753284,0.0026052853,0.000046801775],"about_ca_topic_score_codex":0.0005552796,"about_ca_topic_score_gemma":0.0015128469,"teacher_disagreement_score":0.020735787,"about_ca_system_score_codex":0.0006967653,"about_ca_system_score_gemma":0.0020685547,"threshold_uncertainty_score":0.10966265},"labels":[],"label_agreement":null},{"id":"W2925250388","doi":"10.1111/bjd.17918","title":"Assessment of the effects of immunogenicity on the pharmacokinetics, efficacy and safety of tildrakizumab","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Merck","keywords":"Medicine; Pharmacokinetics; Immunogenicity; Monoclonal; Interleukin 23; Monoclonal antibody; Clinical trial; Internal medicine; Pharmacology; Antibody; Interleukin 17; Immunology; Cytokine","score_opus":0.00609147270162685,"score_gpt":0.2360848474658084,"score_spread":0.22999337476418155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925250388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980414,0.001083223,0.0002910345,0.000050917042,0.000008973688,0.000049271013,0.000037588332,0.000007258858,0.00043034123],"genre_scores_gemma":[0.99956125,0.000113061455,0.00013773539,0.000025099034,0.000015863901,0.000020024116,0.000037882222,0.0000016906009,0.00008735004],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990559,0.00053268106,0.00007958826,0.00008866891,0.00016434943,0.00007885835],"domain_scores_gemma":[0.9982173,0.0007987789,0.00054842967,0.00013187404,0.00012787229,0.00017569617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026779799,0.00028546486,0.00041113084,0.00009354809,0.00012482774,0.00036327218,0.00015248774,0.00021644807,0.0009927294],"category_scores_gemma":[0.002185834,0.00013517414,0.00044246553,0.000084677304,0.00019571258,0.00031100315,0.00013293744,0.00067430397,0.00018481117],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18646124,0.009319361,0.20724441,0.00066039164,0.0016316255,0.00041083718,0.00032630895,0.0041013435,0.27486658,0.00036319863,0.00079292624,0.3138219],"study_design_scores_gemma":[0.016190978,0.4126082,0.42097446,0.00008137882,0.0015156002,0.0024104277,0.000103651626,0.006860317,0.13318126,0.00029461473,0.005737599,0.000041510357],"about_ca_topic_score_codex":0.00010543842,"about_ca_topic_score_gemma":0.00013674292,"teacher_disagreement_score":0.0026779799,"about_ca_system_score_codex":0.00029720546,"about_ca_system_score_gemma":0.00022338165,"threshold_uncertainty_score":0.01416266},"labels":[],"label_agreement":null},{"id":"W2926521451","doi":"10.1111/bjd.17935","title":"Pain perception in patients with hidradenitis suppurativa","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"InflaRx; LEO Pharma; Galderma; Cilag; Region Sjælland; Pfizer; Coloplast; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Sanofi","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Perception; MEDLINE; Psychology; Internal medicine; Neuroscience; Disease; Biology","score_opus":0.0037115843970377334,"score_gpt":0.2085867444786881,"score_spread":0.20487516008165038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2926521451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988412,0.0006525233,0.00003143286,0.00003655949,0.0000051420466,0.000010211084,0.00007273636,0.0000021722665,0.00034802916],"genre_scores_gemma":[0.9996768,0.00015059998,0.0000319032,0.000025498352,0.00000692118,0.000004927366,0.000056717938,3.623784e-7,0.000046248362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997571,0.00006572217,0.000029084264,0.00003850387,0.000055934343,0.000053746196],"domain_scores_gemma":[0.9994204,0.0001257462,0.00029602947,0.000011210682,0.000040428353,0.00010615797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003000254,0.00018534076,0.00035856958,0.000428187,0.00022671088,0.00040795017,0.000122994,0.00021806672,0.0018000192],"category_scores_gemma":[0.0017557273,0.00010321072,0.00020394337,0.00049717486,0.00018415556,0.00025582247,0.0002686836,0.00025451116,0.00017289422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042314915,0.000067672554,0.9910947,0.00007554857,0.000047094072,0.0008903958,0.00043263065,0.00003224989,0.0011162576,0.000012880427,0.00015367538,0.0056536123],"study_design_scores_gemma":[0.00002306117,0.00040675967,0.9960731,0.000010898448,0.00002115449,0.0027880967,0.0004142672,0.000060981056,0.00004963558,0.000013243812,0.00013452776,0.000004231882],"about_ca_topic_score_codex":0.0008144179,"about_ca_topic_score_gemma":0.0010046891,"teacher_disagreement_score":0.0018000192,"about_ca_system_score_codex":0.0002037387,"about_ca_system_score_gemma":0.00011049754,"threshold_uncertainty_score":0.0060216784},"labels":[],"label_agreement":null},{"id":"W2928021446","doi":"10.1111/bjd.17927","title":"Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross‐sectional study among 2465 patients","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York Central Hospital","funders":"LEO Pharma; Cilag; Galderma; Regeneron Pharmaceuticals; Sanofi","keywords":"Hidradenitis suppurativa; Medicine; Acne; Dermatology; Cross-sectional study; Disease; Internal medicine; Pathology","score_opus":0.009877143291401335,"score_gpt":0.27083539868066986,"score_spread":0.26095825538926853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2928021446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994128,0.00017212925,0.000040250427,0.000013586287,0.0000043759705,0.0000117291465,0.00015411963,0.0000011373892,0.00018986475],"genre_scores_gemma":[0.9996784,0.00008092815,0.000046225687,0.000019847621,0.0000062473628,0.0000070270667,0.00011915708,5.665985e-7,0.000041668773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952495,0.00009933877,0.00007070753,0.00014466503,0.0000898974,0.000070501825],"domain_scores_gemma":[0.99892396,0.00019476119,0.00054590305,0.00007099973,0.00008203893,0.0001823609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065598293,0.00028408074,0.00033325303,0.0005660591,0.00047025408,0.00064867054,0.000251436,0.00048149275,0.0020443334],"category_scores_gemma":[0.0013566576,0.00045808818,0.0003285238,0.0007246876,0.00031858217,0.0007142516,0.00039443572,0.0004767358,0.00035081682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003473563,0.00002229694,0.99932635,0.0000072270986,0.000012254565,0.00012939841,0.00006327629,0.000007863518,0.00011752458,0.0000049104847,0.000022570228,0.0002516519],"study_design_scores_gemma":[0.000007078804,0.00022293041,0.99757737,0.000010229666,0.000019789653,0.0015852475,0.000333634,0.00006346213,0.000047979855,0.0000060153334,0.00012292921,0.000003353492],"about_ca_topic_score_codex":0.0017460802,"about_ca_topic_score_gemma":0.001539753,"teacher_disagreement_score":0.0020443334,"about_ca_system_score_codex":0.00023644514,"about_ca_system_score_gemma":0.00017280603,"threshold_uncertainty_score":0.0068389177},"labels":[],"label_agreement":null},{"id":"W2932169608","doi":"10.1111/bjd.17932","title":"The oral Janus kinase/spleen tyrosine kinase inhibitor<scp>ASN</scp>002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Asana Biosciences","keywords":"Placebo; Eczema Area and Severity Index; Medicine; Atopic dermatitis; Gastroenterology; Internal medicine; Adverse effect; Biomarker; Randomized controlled trial; Systemic inflammation; Pharmacokinetics; Inflammation; Immunology; Pharmacology; Pathology","score_opus":0.006940791390641539,"score_gpt":0.2301773568234335,"score_spread":0.22323656543279194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2932169608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607486,0.0022024834,0.00022277134,0.00011316602,0.00008032734,0.000503646,0.00018240874,0.000038077927,0.0005823088],"genre_scores_gemma":[0.9962574,0.0014470741,0.0006072666,0.00024627525,0.00020715839,0.00036445278,0.0003083788,0.0000070148976,0.0005550236],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99957377,0.00022158539,0.000048171474,0.00005787113,0.000054902488,0.000043660806],"domain_scores_gemma":[0.9993574,0.00019241027,0.00016339243,0.000052713876,0.000044301483,0.00018968845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001376667,0.0007812894,0.0019149847,0.000252703,0.00027239812,0.0005202108,0.00047777646,0.00074776355,0.0029075297],"category_scores_gemma":[0.0007910885,0.00035834816,0.0009420001,0.00027282437,0.0008152064,0.00052048033,0.00018665721,0.0012135492,0.00040464752],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9051905,0.018154543,0.002763571,0.00083587226,0.0010231582,0.00008835649,0.000058100824,0.00030136373,0.027179638,0.000068089015,0.00055265677,0.043784037],"study_design_scores_gemma":[0.6738389,0.30741528,0.013727605,0.00003512217,0.0006369789,0.00015625858,0.000031115153,0.00048619584,0.0028786764,0.000076159944,0.0006956379,0.000021955262],"about_ca_topic_score_codex":0.00039159186,"about_ca_topic_score_gemma":0.0009685613,"teacher_disagreement_score":0.0029075297,"about_ca_system_score_codex":0.0003151066,"about_ca_system_score_gemma":0.0005946355,"threshold_uncertainty_score":0.009726703},"labels":[],"label_agreement":null},{"id":"W2933704068","doi":"10.1111/bjd.17941","title":"Health‐related quality of life and economic implications of cutaneous T‐cell lymphoma","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Quality of life (healthcare); Quality-adjusted life year; Population; Health Utilities Index; SF-36; Gerontology; Demography; Physical therapy; Health related quality of life; Cost effectiveness; Internal medicine; Environmental health; Disease","score_opus":0.01913976649523259,"score_gpt":0.31173505991366884,"score_spread":0.29259529341843626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2933704068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564314,0.002057088,0.000068802205,0.00061062054,0.000011653968,0.000008383582,0.0004771681,0.0000024333503,0.0011207411],"genre_scores_gemma":[0.99960655,0.00016102448,0.000021182552,0.000036663998,0.0000069575076,0.0000024839408,0.0001276921,4.9965945e-7,0.000037110334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934345,0.00028504175,0.000049765786,0.000044090928,0.0001481873,0.00012943789],"domain_scores_gemma":[0.9970475,0.0006567798,0.0014805913,0.000046674948,0.00030330967,0.0004651571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010328955,0.00017799021,0.00020307077,0.0006903086,0.00027446225,0.00075982546,0.00024254876,0.0002558105,0.0018553832],"category_scores_gemma":[0.006231542,0.00007471423,0.0004643642,0.0009381916,0.00039448176,0.00037506083,0.00041390047,0.00054036506,0.00012469188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019176748,0.00006972954,0.9911947,0.000040688865,0.00016609962,0.0001510394,0.00005527751,0.00036501008,0.00007445116,0.000055239987,0.00043227462,0.0072036255],"study_design_scores_gemma":[0.000009901545,0.000088472036,0.99867225,0.000015524327,0.00004948823,0.00028681813,0.00010511786,0.00046624357,0.000022446315,0.00008322902,0.00019702948,0.0000035783164],"about_ca_topic_score_codex":0.0073355343,"about_ca_topic_score_gemma":0.008027293,"teacher_disagreement_score":0.0073355343,"about_ca_system_score_codex":0.0012701935,"about_ca_system_score_gemma":0.0004671096,"threshold_uncertainty_score":0.014585674},"labels":[],"label_agreement":null},{"id":"W2936420507","doi":"10.1111/bjd.18005","title":"Development of a new patient‐reported outcome measure to evaluate treatments for acne and acne scarring: the <scp>ACNE</scp> ‐Q","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"Plastic Surgery Foundation","keywords":"Acne; Dermatology; Medicine; Measure (data warehouse); Patient-reported outcome; Computer science; Quality of life (healthcare); Data mining","score_opus":0.04120438314623499,"score_gpt":0.3063394034541947,"score_spread":0.2651350203079597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936420507","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.805792,0.0025610565,0.11592434,0.002731938,0.00070251623,0.03882314,0.013322588,0.0004475921,0.019694848],"genre_scores_gemma":[0.8354236,0.00089159136,0.120951705,0.0006785797,0.00014978553,0.035083763,0.005375156,0.00006683043,0.0013789779],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9825822,0.009991602,0.0024624998,0.00077158434,0.0038806596,0.00031153456],"domain_scores_gemma":[0.9708986,0.012725862,0.0070778974,0.0009407143,0.007303977,0.0010529138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023049131,0.000525235,0.0010186145,0.0025356624,0.00046125945,0.0009775893,0.0008952696,0.0006939632,0.0026480702],"category_scores_gemma":[0.026625263,0.00025581318,0.0017749318,0.0014291826,0.00051213364,0.001762471,0.0013672757,0.0014932639,0.00044143113],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028459511,0.0030573595,0.59083897,0.003680241,0.0019460028,0.00020092992,0.002512349,0.004111015,0.0051938887,0.0020265046,0.008604788,0.3749819],"study_design_scores_gemma":[0.0011330966,0.009875701,0.9572909,0.00076492195,0.00068973,0.0004597082,0.0013049633,0.00975071,0.002933247,0.0015300212,0.014107057,0.00015993456],"about_ca_topic_score_codex":0.00091604574,"about_ca_topic_score_gemma":0.0020186652,"teacher_disagreement_score":0.023049131,"about_ca_system_score_codex":0.0010788203,"about_ca_system_score_gemma":0.0017962005,"threshold_uncertainty_score":0.12189692},"labels":[],"label_agreement":null},{"id":"W2940378003","doi":"10.1111/bjd.18008","title":"Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Versus Arthritis; Medical Research Scotland; Alopecia UK; AstraZeneca","keywords":"Alopecia areata; Medicine; Immune dysregulation; Hospital Anxiety and Depression Scale; Depression (economics); Alopecia universalis; Immunology; Pathogenesis; Cytokine; Anxiety; Internal medicine; Cohort; Immune system; Psychiatry","score_opus":0.014190539026619573,"score_gpt":0.28469670553236553,"score_spread":0.27050616650574594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940378003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98707956,0.008909758,0.0018001664,0.00011534009,0.00003616788,0.00006681347,0.00041270265,0.00008335253,0.0014962053],"genre_scores_gemma":[0.99658054,0.002160777,0.0005244545,0.00008686171,0.000048802063,0.000027515505,0.00018748749,0.000008737995,0.00037484968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997304,0.00006171142,0.000026305379,0.000067067966,0.000072045375,0.00004239483],"domain_scores_gemma":[0.9992673,0.00014191616,0.00044474704,0.0000290113,0.0000651152,0.000051822164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002922163,0.00045017415,0.0005297798,0.00056453265,0.00019689926,0.0004162226,0.00010925669,0.00021448081,0.0020284362],"category_scores_gemma":[0.00076037744,0.00010577396,0.0004104185,0.00055921153,0.00022189741,0.00015677801,0.00022549504,0.00029241195,0.00024858725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010655827,0.0003003375,0.7510176,0.0009873703,0.00066349626,0.004217529,0.0003166701,0.0008096702,0.12972802,0.00030070305,0.0012766669,0.10931636],"study_design_scores_gemma":[0.00005182311,0.00063337304,0.9781341,0.00009650838,0.00018712512,0.01365951,0.00018173078,0.0005853622,0.0030431333,0.00036884405,0.0030446516,0.000013788815],"about_ca_topic_score_codex":0.0005163729,"about_ca_topic_score_gemma":0.0007139229,"teacher_disagreement_score":0.0020284362,"about_ca_system_score_codex":0.00015246608,"about_ca_system_score_gemma":0.00014670157,"threshold_uncertainty_score":0.00678581},"labels":[],"label_agreement":null},{"id":"W2942732521","doi":"10.1111/bjd.18096","title":"Developing classification criteria for skin‐predominant dermatomyositis: the Delphi process","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"U.S. Department of Veterans Affairs","keywords":"Dermatomyositis; Delphi; Dermatology; Medicine; Computer science; Delphi method; Process (computing); Artificial intelligence; Programming language","score_opus":0.022202479835067693,"score_gpt":0.3165257924529844,"score_spread":0.2943233126179167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942732521","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29767263,0.008569506,0.39159915,0.04390588,0.0051822476,0.19185182,0.0019372492,0.0007017106,0.058579803],"genre_scores_gemma":[0.273145,0.004311418,0.5906526,0.004757648,0.00075263134,0.119889945,0.0019193208,0.00020590037,0.0043656216],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.8011378,0.15232703,0.023457956,0.003105502,0.015355249,0.0046165073],"domain_scores_gemma":[0.8146562,0.08292452,0.010448835,0.009628802,0.075556695,0.006784904],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.24744017,0.0018838285,0.0014364375,0.010305372,0.004403964,0.0042311014,0.0034200344,0.0021935804,0.005798347],"category_scores_gemma":[0.22718047,0.001121389,0.0020532766,0.0047954335,0.0052108606,0.0046962607,0.012692048,0.004225901,0.0021506965],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001147752,0.0010346578,0.03116378,0.007352166,0.00028553695,0.0022508947,0.1998786,0.00612034,0.017943677,0.08304306,0.10791186,0.54186773],"study_design_scores_gemma":[0.0013330453,0.0022179051,0.06049815,0.025666835,0.0003063309,0.0070011574,0.21689364,0.024901554,0.0081638135,0.16478316,0.4870422,0.0011923017],"about_ca_topic_score_codex":0.00279145,"about_ca_topic_score_gemma":0.002449686,"teacher_disagreement_score":0.24744017,"about_ca_system_score_codex":0.006296015,"about_ca_system_score_gemma":0.022315321,"threshold_uncertainty_score":0.92804027},"labels":[],"label_agreement":null},{"id":"W2944340031","doi":"10.1111/bjd.17992","title":"Sunscreen photoprotection and vitamin D status","year":2019,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"Symrise; Galderma; L'Oreal USA","keywords":"Photoprotection; Sun exposure; Vitamin D and neurology; Vitamin; Sunlight; Medicine; Dermatology; Environmental health; Chemistry; Physics; Internal medicine; Optics; Biochemistry","score_opus":0.036576843923994226,"score_gpt":0.32316383523312575,"score_spread":0.2865869913091315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944340031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01610377,0.9746668,0.00028468005,0.0048081214,0.00025640818,0.000029216499,0.00037536933,0.0000066522252,0.0034690094],"genre_scores_gemma":[0.2919237,0.7020818,0.0010846136,0.0027328609,0.00071080716,0.000059219783,0.00042486234,0.000009678499,0.00097248715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99648714,0.0015431882,0.0006003954,0.00042917716,0.0008138913,0.00012632889],"domain_scores_gemma":[0.9862672,0.009112324,0.002848226,0.0002238951,0.00131291,0.00023550945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003342297,0.0003125762,0.0007199898,0.0015449522,0.00028079905,0.0017366525,0.0005562548,0.0011631415,0.005140411],"category_scores_gemma":[0.016664352,0.00023530179,0.0012406275,0.0017005776,0.00086278986,0.0009654605,0.00061602204,0.0010039676,0.00038109784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001862429,0.00021956205,0.2866223,0.09720546,0.007086793,0.000587329,0.0009972838,0.0006628411,0.0012747066,0.0030488814,0.016943036,0.5834894],"study_design_scores_gemma":[0.00031408342,0.001432747,0.60200256,0.115417875,0.01237254,0.0060333353,0.0018473621,0.0005680771,0.00279334,0.008163585,0.24892473,0.0001297975],"about_ca_topic_score_codex":0.00505203,"about_ca_topic_score_gemma":0.0062582428,"teacher_disagreement_score":0.005140411,"about_ca_system_score_codex":0.0009840468,"about_ca_system_score_gemma":0.0012166313,"threshold_uncertainty_score":0.017675996},"labels":[],"label_agreement":null},{"id":"W2946933084","doi":"10.1111/bjd.18165","title":"Electron microscopy in the diagnosis of Ehlers–Danlos syndromes: correlation with clinical and genetic investigations","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"North-West University","keywords":"Ehlers–Danlos syndrome; Medicine; Pathology; Dermatology","score_opus":0.017423616335589493,"score_gpt":0.32275276986576057,"score_spread":0.3053291535301711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946933084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656373,0.0014387959,0.000254766,0.00010886999,0.000012822093,0.000020360461,0.00008332446,0.000005913423,0.0015113602],"genre_scores_gemma":[0.9988175,0.00042163156,0.0005316429,0.000029387615,0.000019944137,0.0000070111328,0.00008219009,0.0000021897235,0.00008843429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877757,0.00040815785,0.00025585553,0.00012984291,0.00031155543,0.00011694252],"domain_scores_gemma":[0.9932961,0.002596217,0.0024519532,0.00024793434,0.0009926411,0.0004151658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024809474,0.00031413173,0.0002964064,0.0020401496,0.00034445626,0.0005534674,0.0004552241,0.0005176271,0.0013612302],"category_scores_gemma":[0.008113994,0.00022130599,0.0001979553,0.001134505,0.00069863175,0.0006315079,0.00071045774,0.0005123624,0.00035201386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000958709,0.000014816278,0.9967687,0.000015730055,0.000010339178,0.0012810112,0.000052791365,0.000040382234,0.0004619453,0.000018716655,0.000051802293,0.001187956],"study_design_scores_gemma":[0.000006929483,0.00011168101,0.9762699,0.000057453213,0.000029612338,0.02155202,0.0003682173,0.00046057501,0.0005905939,0.00008850321,0.00045785497,0.0000066165494],"about_ca_topic_score_codex":0.001092191,"about_ca_topic_score_gemma":0.0012985701,"teacher_disagreement_score":0.0024809474,"about_ca_system_score_codex":0.00028094582,"about_ca_system_score_gemma":0.00028714357,"threshold_uncertainty_score":0.013120711},"labels":[],"label_agreement":null},{"id":"W2948326073","doi":"10.1111/bjd.17946","title":"Anti‐GM‐CSF therapy in psoriasis","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psoriasis; Medicine; Itching; Disease; Rheumatoid arthritis; Placebo; Inflammation; Internal medicine; Dermatology; Psoriatic arthritis; Immunology; Pathology; Alternative medicine","score_opus":0.011001263949879712,"score_gpt":0.22774501016155635,"score_spread":0.21674374621167664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948326073","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634239,0.032148294,0.00018907856,0.00018945563,0.000057014808,0.00012579754,0.00009003489,0.0000147373175,0.0037617236],"genre_scores_gemma":[0.98793435,0.010553413,0.00025504816,0.00016220941,0.00004927811,0.000060225902,0.000114292496,0.0000017686106,0.0008694505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991226,0.000034269204,0.0000056541517,0.000007883216,0.00002009356,0.000019825891],"domain_scores_gemma":[0.9999485,0.000014449072,0.000008461039,0.0000032583152,0.0000063208977,0.000019013263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016731738,0.00013931716,0.00045061036,0.00015650752,0.00017082326,0.00018302666,0.000104595034,0.00016135507,0.00074956496],"category_scores_gemma":[0.00016123263,0.00005948433,0.00015963039,0.00020329046,0.00012634862,0.000087434935,0.00008902709,0.00032395494,0.00016139662],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04339918,0.0051798564,0.05325997,0.0024751113,0.00035740205,0.0021469886,0.00046593926,0.0009525615,0.20814563,0.00057041843,0.0042646,0.67878234],"study_design_scores_gemma":[0.018970778,0.096123636,0.71081126,0.0009323213,0.00090915215,0.010839113,0.0006299516,0.001812583,0.046571314,0.000754537,0.111586496,0.000058916172],"about_ca_topic_score_codex":0.0010603307,"about_ca_topic_score_gemma":0.002925335,"teacher_disagreement_score":0.0010603307,"about_ca_system_score_codex":0.00025344256,"about_ca_system_score_gemma":0.000365109,"threshold_uncertainty_score":0.0025075078},"labels":[],"label_agreement":null},{"id":"W2948733093","doi":"10.1111/bjd.17916","title":"How does the International League of Dermatological Societies promote skin health for the world?","year":2019,"lang":"en","type":"editorial","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"League; Dermatology; Dermatological diseases; Medicine; Political science","score_opus":0.015056354565532776,"score_gpt":0.2950096010108635,"score_spread":0.2799532464453307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948733093","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018732675,0.004467141,0.00003924839,0.046021,0.9478771,0.00001384233,0.00006041482,0.000035409677,0.0014671739],"genre_scores_gemma":[0.00037444636,0.005403911,0.00005547879,0.027839372,0.9566362,0.000018943389,0.00004207687,0.000030775085,0.009598825],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995272,0.0008928798,0.0006567835,0.00045680968,0.0023574736,0.00036404608],"domain_scores_gemma":[0.97559017,0.010673257,0.0012804184,0.00047087204,0.008843822,0.0031413452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007043991,0.0035574667,0.003908501,0.0037681728,0.003405856,0.008589257,0.0034536286,0.016208436,0.020550076],"category_scores_gemma":[0.03148483,0.0012405957,0.0025209577,0.0015433619,0.0022250367,0.005042985,0.0014762938,0.021551883,0.017950796],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025497895,0.0000054209668,0.000014218796,0.00012469116,0.00001119247,0.000051065457,0.000006302805,0.0000074083537,0.000013379583,0.00012523949,0.9975085,0.0021069366],"study_design_scores_gemma":[0.0001100667,0.00003749541,0.00036380198,0.0008577544,0.000087364955,0.0002470563,0.00007307423,0.00011822676,0.00009449521,0.0011118441,0.996869,0.000029782059],"about_ca_topic_score_codex":0.003564297,"about_ca_topic_score_gemma":0.009977958,"teacher_disagreement_score":0.020550076,"about_ca_system_score_codex":0.0038345687,"about_ca_system_score_gemma":0.0039181514,"threshold_uncertainty_score":0.068746865},"labels":[],"label_agreement":null},{"id":"W2952089805","doi":"10.1111/bjd.18220","title":"<scp>AURIEL</scp> ‐PsO: a randomized, double‐blind phase <scp>III</scp> equivalence trial to demonstrate the clinical similarity of the proposed biosimilar <scp>MSB</scp> 11022 to reference adalimumab in patients with moderate‐to‐severe chronic plaque‐type psoriasis","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Fresenius Kabi; Merck","keywords":"Biosimilar; Equivalence (formal languages); Medicine; Double blind; Similarity (geometry); Adalimumab; Mathematics; Computer science; Internal medicine; Artificial intelligence; Discrete mathematics; Disease; Pathology","score_opus":0.03661824537907298,"score_gpt":0.32251316386995915,"score_spread":0.28589491849088616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952089805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98807937,0.0009064742,0.0008450107,0.00040938362,0.00029937967,0.0070697046,0.0005727774,0.00011496841,0.0017028882],"genre_scores_gemma":[0.9867308,0.0006404007,0.0019337672,0.00086494884,0.00035577003,0.0064271046,0.00080493564,0.000025216963,0.0022170527],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988225,0.00067820103,0.00007152203,0.0001753981,0.0001182679,0.00013408322],"domain_scores_gemma":[0.9987116,0.00028590608,0.00030460095,0.00013110484,0.00010283935,0.00046400764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026528512,0.0016523666,0.0020736558,0.00046104979,0.00054949126,0.0009357295,0.0008861379,0.0018703262,0.0080502555],"category_scores_gemma":[0.0019553758,0.0007064332,0.0013934473,0.0003085598,0.0015485545,0.0009346909,0.00056234316,0.002969379,0.0011084361],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96978116,0.016942743,0.00031297776,0.0002546708,0.000265893,0.000022373113,0.000037828097,0.00015232137,0.0036329785,0.00010671498,0.00051263534,0.007977726],"study_design_scores_gemma":[0.9326354,0.06583126,0.00053422165,0.000009309534,0.000102762315,0.000018520683,0.000005552714,0.0002186725,0.00037161686,0.000049915892,0.00021721612,0.0000054255706],"about_ca_topic_score_codex":0.0007439226,"about_ca_topic_score_gemma":0.0013554598,"teacher_disagreement_score":0.0080502555,"about_ca_system_score_codex":0.0007619137,"about_ca_system_score_gemma":0.0016520551,"threshold_uncertainty_score":0.026930809},"labels":[],"label_agreement":null},{"id":"W2953512757","doi":"10.1111/bjd.18064","title":"Evidence‐based treatments for rosacea based on phenotype approach","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosacea; Medicine; Isotretinoin; Minocycline; Doxycycline; Dermatology; Ivermectin; Metronidazole; Acne; Antibiotics","score_opus":0.03568559269790506,"score_gpt":0.29206318542559967,"score_spread":0.2563775927276946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953512757","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037983322,0.9956227,0.0002482396,0.0009330117,0.00026228558,0.000105352425,0.00017667373,0.000013813591,0.0022581285],"genre_scores_gemma":[0.0073154857,0.98929745,0.0010179868,0.0012034525,0.00019774259,0.00011043536,0.00022102697,0.000005290907,0.0006312914],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9987815,0.00035254032,0.00032883915,0.00012207462,0.00035779946,0.000057229077],"domain_scores_gemma":[0.9978204,0.0012659231,0.00044607473,0.000047040103,0.0003643173,0.000056320576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013850161,0.0009904989,0.0022545261,0.00251809,0.00032918534,0.0014345987,0.0012998645,0.0016212806,0.013128393],"category_scores_gemma":[0.004330505,0.0002881962,0.0039105937,0.0016295259,0.00034059378,0.0011594114,0.0006972775,0.0017742518,0.0018541878],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007866877,0.00026302744,0.000587439,0.3330828,0.003580359,0.00017762881,0.000069349146,0.0003022431,0.0010911386,0.0019097525,0.018559512,0.6395901],"study_design_scores_gemma":[0.0014872472,0.0012409257,0.007679539,0.5299585,0.022385858,0.0015109994,0.00022707645,0.00035438238,0.0012300544,0.004189055,0.42967224,0.00006417452],"about_ca_topic_score_codex":0.0014724181,"about_ca_topic_score_gemma":0.0035555165,"teacher_disagreement_score":0.013128393,"about_ca_system_score_codex":0.00096118683,"about_ca_system_score_gemma":0.0014974574,"threshold_uncertainty_score":0.043918848},"labels":[],"label_agreement":null},{"id":"W2953973901","doi":"10.1111/bjd.17863","title":"International and multidisciplinary scientific collaborations and networks are advancing knowledge about Stevens–Johnson syndrome and toxic epidermal necrolysis","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Medical Research Council","keywords":"Toxic epidermal necrolysis; Carr; Multidisciplinary approach; Dermatology; Medicine; Sociology; Social science; Biology","score_opus":0.01379527853086929,"score_gpt":0.27243921820337413,"score_spread":0.2586439396725048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953973901","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008110023,0.0051431437,0.00009353939,0.9715731,0.017034886,0.0000064009373,0.000021552769,0.000016270387,0.0053001763],"genre_scores_gemma":[0.021441221,0.01598912,0.000590861,0.82075006,0.124887444,0.000035004603,0.0000634921,0.00003230799,0.016210577],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99636734,0.0013193836,0.0005011721,0.00030335115,0.0010234745,0.00048533687],"domain_scores_gemma":[0.9848504,0.008134974,0.0013369714,0.00036850807,0.0030099032,0.0022992846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023774868,0.00055224175,0.00086477504,0.0008479462,0.0031040453,0.0029998918,0.0009501961,0.025017934,0.0124768615],"category_scores_gemma":[0.02059915,0.0003921158,0.0008575411,0.00087540934,0.0022895085,0.004814683,0.0016321337,0.023464067,0.00620762],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009352063,0.00007088269,0.002052444,0.00024561843,0.00002150632,0.009993264,0.00029194934,0.00006909893,0.000450462,0.0028348966,0.95266014,0.031216158],"study_design_scores_gemma":[0.00015849917,0.00012421799,0.003600125,0.0009053643,0.00004431799,0.028677322,0.0012726011,0.00037134573,0.00025833806,0.012435999,0.9520819,0.000069947884],"about_ca_topic_score_codex":0.003114268,"about_ca_topic_score_gemma":0.0069454326,"teacher_disagreement_score":0.025017934,"about_ca_system_score_codex":0.0031191215,"about_ca_system_score_gemma":0.002942582,"threshold_uncertainty_score":0.041739285},"labels":[],"label_agreement":null},{"id":"W2954357071","doi":"10.1111/bjd.18309","title":"Defining lesional, perilesional and unaffected skin in hidradenitis suppurativa: proposed recommendations for clinical trials and translational research studies","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Clinical trial; Translational research; Surgery; Pathology; Disease","score_opus":0.3585862039857243,"score_gpt":0.538722044539774,"score_spread":0.1801358405540497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954357071","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034351836,0.060131196,0.0032045182,0.897304,0.033639506,0.00078929425,0.0001644995,0.00010087157,0.004322588],"genre_scores_gemma":[0.007729858,0.034935284,0.030497702,0.8263075,0.093826905,0.0033674247,0.00026187015,0.00007823328,0.0029953052],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.84858257,0.10314779,0.026222594,0.005196797,0.014043903,0.0028062786],"domain_scores_gemma":[0.6117874,0.29049286,0.016966177,0.011448465,0.0580379,0.011267231],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1738181,0.0020107536,0.008094228,0.0040166825,0.0038890755,0.01277912,0.007756597,0.07246633,0.0073086596],"category_scores_gemma":[0.27063146,0.0015161537,0.0052062925,0.0036884083,0.01499996,0.019079551,0.006684345,0.048651524,0.010248238],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031633722,0.0007369254,0.002388465,0.014990842,0.00059078325,0.003059593,0.0011756194,0.00069683715,0.0014329907,0.07456569,0.6163162,0.28088272],"study_design_scores_gemma":[0.0034621686,0.0012028718,0.0025832825,0.025126748,0.00081440376,0.00251687,0.00089509744,0.0016088017,0.00057786127,0.14883777,0.8120188,0.00035527538],"about_ca_topic_score_codex":0.0013843094,"about_ca_topic_score_gemma":0.0025605895,"teacher_disagreement_score":0.8261819,"about_ca_system_score_codex":0.008797418,"about_ca_system_score_gemma":0.019926988,"threshold_uncertainty_score":0.91924894},"labels":[],"label_agreement":null},{"id":"W2956723919","doi":"10.1111/bjd.18335","title":"Hidradenitis Suppurativa Area and Severity Index ( <scp>HASI</scp> ): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Center for Advancing Translational Sciences","keywords":"Hidradenitis suppurativa; Measure (data warehouse); Medicine; Index (typography); Content (measure theory); Severity of illness; Dermatology; Computer science; World Wide Web; Data mining; Pathology; Internal medicine; Mathematics; Disease","score_opus":0.03722694733378218,"score_gpt":0.26658319016762916,"score_spread":0.22935624283384698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956723919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97550905,0.0008701434,0.00078311,0.0077154418,0.0005608954,0.0018236649,0.0003015783,0.000018596653,0.012417626],"genre_scores_gemma":[0.9858101,0.0007001438,0.0023569267,0.005522396,0.0002933468,0.0010880533,0.00014077293,0.000008848088,0.0040793596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977689,0.001541748,0.00011774653,0.00012626543,0.00030168678,0.00014368526],"domain_scores_gemma":[0.9968059,0.0017920366,0.00027118658,0.000115043236,0.0005740495,0.00044176055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024447958,0.0004384322,0.0006245599,0.00024537276,0.0010876894,0.0004992449,0.0003134577,0.0014886404,0.002576179],"category_scores_gemma":[0.0065365457,0.00020602568,0.00025806227,0.0004205726,0.00047701283,0.00060574454,0.00032755465,0.0017563995,0.0012345096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02038531,0.0642019,0.47824213,0.0012645628,0.00022796783,0.07859121,0.017303213,0.00051100855,0.037236534,0.0013461659,0.03549495,0.2651951],"study_design_scores_gemma":[0.005478537,0.1843799,0.6632393,0.00048254922,0.0002086152,0.07698436,0.012581147,0.0036538513,0.008035496,0.0014655148,0.043316845,0.0001738606],"about_ca_topic_score_codex":0.002807394,"about_ca_topic_score_gemma":0.0032037713,"teacher_disagreement_score":0.002807394,"about_ca_system_score_codex":0.0006554795,"about_ca_system_score_gemma":0.00078952505,"threshold_uncertainty_score":0.01292944},"labels":[],"label_agreement":null},{"id":"W2960529495","doi":"10.1111/bjd.18333","title":"Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, <scp>BADBIR</scp> )","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Manchester Biomedical Research Centre; NIHR Newcastle Biomedical Research Centre; Medical Research Council; National Institute for Health and Care Research; Psoriasis Association","keywords":"Interquartile range; Medicine; Psoriasis; Concordance; Psoriasis Area and Severity Index; Cohort; Internal medicine; Rank correlation; Severity of illness; Population; Dermatology; Statistics","score_opus":0.02617875109033765,"score_gpt":0.27468237432130155,"score_spread":0.2485036232309639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2960529495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869387,0.00034469555,0.0010158899,0.00009523155,0.00001875775,0.00010636966,0.010806494,0.00002035587,0.0006535087],"genre_scores_gemma":[0.98600096,0.00014279997,0.00090151967,0.00006291152,0.000025632966,0.00019826285,0.012344108,0.000018561828,0.00030522907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995439,0.0021846357,0.0004466117,0.0009632265,0.00072424585,0.00024225187],"domain_scores_gemma":[0.9917966,0.0014058579,0.004244303,0.0013456765,0.00064110255,0.00056647556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005877148,0.00039044453,0.0006021377,0.0016123672,0.00036701545,0.001476795,0.0006788549,0.000682918,0.0012762911],"category_scores_gemma":[0.009465966,0.0003662434,0.0010758118,0.0031363457,0.00035880963,0.0008008071,0.0010548432,0.0010496095,0.00048321232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011083783,0.00006443632,0.99519604,0.0000477324,0.00052247324,0.000036241727,0.00012887712,0.00020541836,0.00026670643,0.00007347441,0.0007106781,0.0016395391],"study_design_scores_gemma":[0.0001350749,0.00013427998,0.9980318,0.000014360386,0.00014435376,0.00010543899,0.00011061582,0.0005546979,0.000057413064,0.000035500292,0.0006667391,0.000009669385],"about_ca_topic_score_codex":0.02313216,"about_ca_topic_score_gemma":0.020743879,"teacher_disagreement_score":0.02313216,"about_ca_system_score_codex":0.0006927272,"about_ca_system_score_gemma":0.00061017496,"threshold_uncertainty_score":0.045994997},"labels":[],"label_agreement":null},{"id":"W2962832397","doi":"10.1111/bjd.18252","title":"Depression and anxiety in atopic dermatitis: increasing recognition and opportunities to intervene","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Atopic dermatitis; Anxiety; Depression (economics); Medicine; Dermatology; Psychology; Clinical psychology; Psychiatry","score_opus":0.032573844451728375,"score_gpt":0.2645143230528485,"score_spread":0.23194047860112013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962832397","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03194472,0.010488008,0.00017755647,0.9338056,0.008229217,0.000028594222,0.000046193225,0.00003758869,0.015242559],"genre_scores_gemma":[0.5292116,0.021367151,0.0007907311,0.36250034,0.0692111,0.00007856465,0.00009591148,0.00003152956,0.01671306],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938357,0.00019952576,0.00006908432,0.000060473107,0.0001243347,0.00016293877],"domain_scores_gemma":[0.9981989,0.00081369857,0.00021984459,0.000043779124,0.00027361224,0.00045015366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005943199,0.00022667176,0.0004647408,0.0004716154,0.0011721915,0.00094157836,0.00042369025,0.007625741,0.004280712],"category_scores_gemma":[0.0077499873,0.00019351368,0.00033274858,0.0003395197,0.0007957284,0.0013478184,0.00054364896,0.0058915266,0.0013059705],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050975353,0.0005732237,0.06939452,0.00047337564,0.000056775178,0.080570176,0.0011159958,0.00016228933,0.0014413687,0.0021039932,0.73646957,0.10712888],"study_design_scores_gemma":[0.00128484,0.0012538469,0.2638638,0.0047307503,0.00028634787,0.34786153,0.0076121385,0.002952497,0.0009514919,0.016813697,0.35216224,0.00022685294],"about_ca_topic_score_codex":0.006154074,"about_ca_topic_score_gemma":0.008311285,"teacher_disagreement_score":0.007625741,"about_ca_system_score_codex":0.0013900462,"about_ca_system_score_gemma":0.0009417443,"threshold_uncertainty_score":0.014320433},"labels":[],"label_agreement":null},{"id":"W2967093367","doi":"10.1111/bjd.18420","title":"Recommendations for rosacea diagnosis, classification and management: update from the global <scp>ROS</scp> acea <scp>CO</scp> nsensus 2019 panel","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"Galderma","keywords":"Rosacea; Medicine; Dermatology","score_opus":0.025511764923736906,"score_gpt":0.28558465721288434,"score_spread":0.26007289228914743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967093367","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066920756,0.062389217,0.03231589,0.70603526,0.036668885,0.0064708814,0.017850598,0.0018062582,0.1297709],"genre_scores_gemma":[0.06404216,0.15921539,0.30154073,0.28746852,0.013149552,0.015628658,0.057268646,0.0018034877,0.09988287],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97506785,0.008138423,0.0054669823,0.0009277234,0.008694994,0.0017039906],"domain_scores_gemma":[0.8973327,0.02289426,0.005472566,0.0016943408,0.06789733,0.0047088233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032211557,0.001097262,0.0016840646,0.0054238043,0.002317963,0.0032308502,0.005220732,0.0079660565,0.01441252],"category_scores_gemma":[0.06488641,0.0009656634,0.0047439705,0.0034264324,0.0017575502,0.003416808,0.004622742,0.011549165,0.010313492],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006488002,0.00010415505,0.0019962157,0.0023367365,0.000050644583,0.00022132293,0.0005366343,0.00028030024,0.0006344223,0.0026607516,0.8289439,0.16217001],"study_design_scores_gemma":[0.00008313869,0.000056400782,0.0049674953,0.011899022,0.00010876679,0.0004156499,0.0009255207,0.00028651394,0.0003754962,0.0038962984,0.9769135,0.00007227928],"about_ca_topic_score_codex":0.029991582,"about_ca_topic_score_gemma":0.028016511,"teacher_disagreement_score":0.032211557,"about_ca_system_score_codex":0.00617239,"about_ca_system_score_gemma":0.028438793,"threshold_uncertainty_score":0.17035306},"labels":[],"label_agreement":null},{"id":"W2967936177","doi":"10.1111/bjd.18321","title":"How I learned to stop worrying about antidrug antibodies","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Antibody; Immunology","score_opus":0.033651841188627934,"score_gpt":0.31008294319086827,"score_spread":0.2764311020022403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967936177","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012085726,0.0029371257,0.00020289361,0.9711058,0.01724137,0.000018717114,0.000033610668,0.000034565623,0.007217278],"genre_scores_gemma":[0.016973676,0.0037533008,0.0005458289,0.92901963,0.025664544,0.000039681545,0.000031468073,0.00003861238,0.023933193],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881196,0.0003972402,0.000116107316,0.00016472177,0.00026762183,0.00024236257],"domain_scores_gemma":[0.99683857,0.0012290444,0.00017742455,0.00010047697,0.00077269226,0.0008818664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016095487,0.00068645267,0.00085428864,0.00078912306,0.0039532003,0.0030236219,0.0009419071,0.020978045,0.011944114],"category_scores_gemma":[0.018014733,0.00057356444,0.00087742816,0.00036514693,0.0019746386,0.0056159715,0.0011716265,0.029466271,0.0065300674],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088595254,0.0001283844,0.0017067991,0.000087951834,0.000026766988,0.016814927,0.00064259826,0.00006525045,0.00033158407,0.0032763823,0.9597044,0.017126273],"study_design_scores_gemma":[0.00024917646,0.00027855756,0.002995072,0.0011002099,0.00007958676,0.07597688,0.0023977477,0.0007562974,0.00045360962,0.015238195,0.90034103,0.0001336762],"about_ca_topic_score_codex":0.008135891,"about_ca_topic_score_gemma":0.0072131064,"teacher_disagreement_score":0.020978045,"about_ca_system_score_codex":0.00313511,"about_ca_system_score_gemma":0.0020113238,"threshold_uncertainty_score":0.039957047},"labels":[],"label_agreement":null},{"id":"W2969152870","doi":"10.1111/bjd.18323","title":"The pain of hidradenitis suppurativa: ‘We only see what we know’","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Internal medicine; Disease","score_opus":0.012593371322565503,"score_gpt":0.2514064585942939,"score_spread":0.2388130872717284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969152870","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024596974,0.008615794,0.00013712811,0.94705576,0.029994085,0.000017032706,0.000061410705,0.000028209632,0.011630817],"genre_scores_gemma":[0.038172886,0.010383157,0.00046200032,0.8463233,0.08552982,0.000030822364,0.000051678286,0.000045385514,0.01900082],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987607,0.00040148036,0.00015689858,0.0001633539,0.0002780591,0.00023953902],"domain_scores_gemma":[0.99775237,0.0012176662,0.00020236657,0.000063817664,0.0004272855,0.00033657314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010827633,0.00063994,0.0010074059,0.00057456654,0.0028332775,0.0023709147,0.00091413624,0.02259692,0.005968691],"category_scores_gemma":[0.011180525,0.00057216495,0.0007861842,0.00057873066,0.0023137268,0.0042173136,0.0010880408,0.022171376,0.003088319],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018069465,0.00007191239,0.0021196564,0.00022092708,0.000037504607,0.06338184,0.0005628455,0.00010076421,0.0005261566,0.004384405,0.914647,0.013766361],"study_design_scores_gemma":[0.00037982207,0.0002105405,0.0062335213,0.0016378406,0.00008730419,0.17443888,0.0021269333,0.0009714872,0.0005089469,0.013218381,0.7999895,0.00019673741],"about_ca_topic_score_codex":0.010605476,"about_ca_topic_score_gemma":0.012029102,"teacher_disagreement_score":0.02259692,"about_ca_system_score_codex":0.0034529837,"about_ca_system_score_gemma":0.0018869352,"threshold_uncertainty_score":0.025053263},"labels":[],"label_agreement":null},{"id":"W2970810260","doi":"10.1111/bjd.18431","title":"Classifying primary paediatric cutaneous mucinoses","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Dermatology; Primary (astronomy); Pediatrics","score_opus":0.01140086464533488,"score_gpt":0.2334006468511879,"score_spread":0.221999782205853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970810260","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15367225,0.02165989,0.0019397399,0.6963649,0.039192308,0.00013159472,0.0005265014,0.00014344441,0.08636938],"genre_scores_gemma":[0.74727833,0.011338118,0.0043895566,0.16764331,0.053392336,0.00008346418,0.0006291864,0.00012388258,0.015121869],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99744797,0.00052103255,0.0005289502,0.00020628786,0.000644487,0.0006513183],"domain_scores_gemma":[0.9942585,0.0021548204,0.0010558093,0.00020522621,0.001219063,0.0011065276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016405955,0.00048296226,0.00068001915,0.001663678,0.0016903518,0.0018836359,0.000760066,0.008782293,0.0022791873],"category_scores_gemma":[0.013769569,0.0004347422,0.0005003824,0.0010591627,0.0017467154,0.0013669346,0.0014303289,0.0059156856,0.0013698075],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019123992,0.00009898384,0.13024387,0.00033786384,0.00003213516,0.3568468,0.0013484164,0.00078611757,0.0028123467,0.009341918,0.41502085,0.08293943],"study_design_scores_gemma":[0.00009637578,0.00015535146,0.05692404,0.0014817733,0.00007733199,0.6606992,0.002650026,0.0019283936,0.0015431775,0.0075993077,0.26678053,0.00006452856],"about_ca_topic_score_codex":0.0058959965,"about_ca_topic_score_gemma":0.008057658,"teacher_disagreement_score":0.008782293,"about_ca_system_score_codex":0.0027758544,"about_ca_system_score_gemma":0.0015488598,"threshold_uncertainty_score":0.02014029},"labels":[],"label_agreement":null},{"id":"W2970820653","doi":"10.1111/bjd.18469","title":"Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double‐blind, vehicle‐controlled phase <scp>II</scp> a study","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"LEO Pharma; LEO Pharma Research Foundation","keywords":"Medicine; Discontinuation; Adverse effect; Randomized controlled trial; Confidence interval; Clinical endpoint; Internal medicine; Odds ratio; Statistical significance; Incidence (geometry); Clinical trial; Severity of illness; Surgery","score_opus":0.015410334198645768,"score_gpt":0.27861650333811117,"score_spread":0.2632061691394654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970820653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98720443,0.008301468,0.00050514087,0.00031712576,0.00014360518,0.0016057034,0.0008938291,0.00005502815,0.00097359775],"genre_scores_gemma":[0.9926053,0.003486722,0.0007099098,0.00047390437,0.00024916138,0.0010802308,0.0007757853,0.000013360523,0.0006054506],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99878985,0.0006378123,0.00014596138,0.00015795861,0.00014826574,0.00012023702],"domain_scores_gemma":[0.9973097,0.0009391726,0.00086203375,0.0002046307,0.00020850716,0.00047592906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028212387,0.0008219707,0.0026736583,0.0002944261,0.0003727834,0.0008388762,0.000538627,0.0013927115,0.0040007927],"category_scores_gemma":[0.0021664517,0.00044804646,0.0020637675,0.00040193636,0.00087108096,0.0007905923,0.0002607283,0.0017693504,0.00061502773],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9360955,0.008595961,0.0039041094,0.0015562559,0.003017016,0.0000603991,0.000067311084,0.00032682222,0.0076030125,0.00006330851,0.00076008914,0.037950326],"study_design_scores_gemma":[0.8850735,0.10142496,0.010340374,0.00006400212,0.0013855647,0.00009948765,0.000023693685,0.00026436918,0.0006472862,0.000048344336,0.0006114404,0.000017033304],"about_ca_topic_score_codex":0.00047886113,"about_ca_topic_score_gemma":0.0010332735,"teacher_disagreement_score":0.0040007927,"about_ca_system_score_codex":0.00043298258,"about_ca_system_score_gemma":0.00080820377,"threshold_uncertainty_score":0.014920294},"labels":[],"label_agreement":null},{"id":"W2971816470","doi":"10.1111/bjd.18484","title":"Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research","funders":"Merck","keywords":"Dosing; Etanercept; Medicine; Plaque psoriasis; Psoriasis; Pharmacology; Dermatology; Internal medicine; Tumor necrosis factor alpha","score_opus":0.02410772837681473,"score_gpt":0.2871277570869232,"score_spread":0.26302002871010843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971816470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97835153,0.01730854,0.0008000381,0.00026082774,0.000052483712,0.0010405392,0.00051430345,0.000057418565,0.0016143484],"genre_scores_gemma":[0.98961735,0.0064494046,0.0012949558,0.00047330602,0.00017718635,0.0006690215,0.0008246129,0.000029622814,0.00046453846],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972537,0.0015989919,0.00029018396,0.0002401595,0.00041516346,0.00020186172],"domain_scores_gemma":[0.99341375,0.0027875898,0.0022171298,0.0005722957,0.00041980782,0.0005893906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008671308,0.0008098339,0.0021075637,0.0002605958,0.00029051266,0.0009538966,0.00063440774,0.0008572151,0.0017553412],"category_scores_gemma":[0.0042571733,0.0003248481,0.0026239993,0.00048550905,0.0006799929,0.0007142128,0.00021119899,0.002071497,0.0004086062],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58132875,0.027928442,0.02943771,0.0025961485,0.008952327,0.00011852139,0.0004949462,0.0019975274,0.042060696,0.00016593267,0.0016636945,0.30325526],"study_design_scores_gemma":[0.26480526,0.6159253,0.0977172,0.00043007426,0.0060556303,0.00051526685,0.00010561751,0.0009648598,0.009743267,0.0002249342,0.0034491904,0.00006346712],"about_ca_topic_score_codex":0.0005514057,"about_ca_topic_score_gemma":0.0010704731,"teacher_disagreement_score":0.008671308,"about_ca_system_score_codex":0.00065791915,"about_ca_system_score_gemma":0.0010715986,"threshold_uncertainty_score":0.04585886},"labels":[],"label_agreement":null},{"id":"W2971827843","doi":"10.1111/bjd.18483","title":"Weight change in patients with psoriasis using tumour necrosis factor‐α inhibitors","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; University of Toronto; Memorial University of Newfoundland; McGill University","funders":"","keywords":"Psoriasis; Medicine; Necrosis; Tumor necrosis factor alpha; Dermatology; Internal medicine","score_opus":0.013307073982252402,"score_gpt":0.21876449199317632,"score_spread":0.20545741801092393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971827843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923161,0.0046463697,0.00009653832,0.0003013072,0.00012172343,0.000012835785,0.00032950626,0.000014147886,0.002161284],"genre_scores_gemma":[0.9975454,0.0011148747,0.000072495415,0.00015351143,0.000066060726,0.000008565897,0.00038681534,0.000004301185,0.0006480101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972135,0.000058733593,0.000041389794,0.000044795226,0.00007208072,0.000061631574],"domain_scores_gemma":[0.99943787,0.00012599447,0.00021976256,0.000016774622,0.000055051147,0.0001444827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023106804,0.00033512033,0.00092725025,0.000610334,0.00032150184,0.00056227535,0.00019544833,0.00058861217,0.00184294],"category_scores_gemma":[0.0012575508,0.00020555769,0.00082175655,0.0009715771,0.0001197161,0.00036977307,0.00022613555,0.001182472,0.00024648983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008205304,0.0006116105,0.95734423,0.00017313518,0.00109096,0.0009907264,0.00012175193,0.00020012773,0.002391342,0.000047312664,0.000668695,0.028154839],"study_design_scores_gemma":[0.000114609094,0.0006420122,0.9975967,0.000013804662,0.00024235828,0.0005719778,0.000061884195,0.00016623049,0.00008829807,0.00002910487,0.00046556577,0.0000074727386],"about_ca_topic_score_codex":0.002996049,"about_ca_topic_score_gemma":0.0031059845,"teacher_disagreement_score":0.002996049,"about_ca_system_score_codex":0.00033090395,"about_ca_system_score_gemma":0.000138262,"threshold_uncertainty_score":0.006165266},"labels":[],"label_agreement":null},{"id":"W2971900016","doi":"10.1111/bjd.18482","title":"Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; Agence Nationale de la Recherche","keywords":"Pemphigus vulgaris; Rituximab; Medicine; Dermatology; Pemphigus; Steroid; Internal medicine; Lymphoma","score_opus":0.0030958986819212865,"score_gpt":0.21886601093164418,"score_spread":0.2157701122497229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971900016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5937136,0.35623354,0.0026995225,0.010296812,0.00069891557,0.0006513497,0.0008173856,0.00028671077,0.03460213],"genre_scores_gemma":[0.9544123,0.035854153,0.0018931768,0.0036420962,0.0010189876,0.00022997854,0.0006072502,0.000012953645,0.0023292094],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996517,0.00014492546,0.000025544077,0.00003762127,0.00010373567,0.00003645231],"domain_scores_gemma":[0.99967444,0.0000943154,0.00012917402,0.00001443426,0.000037696645,0.00005003424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071287487,0.00023809023,0.00045355523,0.00026238436,0.00019579973,0.0002645585,0.00016990108,0.00030322568,0.0019497585],"category_scores_gemma":[0.0007260044,0.000052455922,0.00027416935,0.00024951593,0.00017943146,0.00026198267,0.00011019859,0.00039287945,0.00052618334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008356542,0.0013048116,0.043193582,0.0021673567,0.0006896192,0.0018986453,0.000099171004,0.00035028285,0.036033936,0.00031670128,0.030568259,0.87502104],"study_design_scores_gemma":[0.020365024,0.053617645,0.5704337,0.0020580702,0.0020776002,0.034815688,0.00033560343,0.0012815688,0.02364163,0.0012197116,0.29007724,0.00007649423],"about_ca_topic_score_codex":0.00031036363,"about_ca_topic_score_gemma":0.000694108,"teacher_disagreement_score":0.0019497585,"about_ca_system_score_codex":0.00029789397,"about_ca_system_score_gemma":0.0002876793,"threshold_uncertainty_score":0.006522596},"labels":[],"label_agreement":null},{"id":"W2973074546","doi":"10.1111/bjd.18515","title":"Musculoskeletal ultrasound can improve referrals from dermatology to rheumatology for patients with psoriasis","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Rheumatology; Psoriasis; Medicine; Dermatology; Ultrasound; Internal medicine; Medical physics; Radiology","score_opus":0.008778593186146955,"score_gpt":0.22375239530891752,"score_spread":0.21497380212277056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973074546","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017448477,0.009889459,0.00030547148,0.91517615,0.014586772,0.000048052298,0.00009244232,0.00012019761,0.04233295],"genre_scores_gemma":[0.3051575,0.018351775,0.0017984833,0.5026097,0.14724086,0.000117810254,0.00020642909,0.00010087999,0.02441646],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9980786,0.0007424991,0.00030840942,0.000118281285,0.00035115393,0.0004011346],"domain_scores_gemma":[0.9896383,0.006686081,0.00064610504,0.00021934963,0.0012259298,0.0015841195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011947236,0.00043832566,0.0006842799,0.0010287714,0.0013947842,0.0015252852,0.00061164395,0.010660081,0.01574129],"category_scores_gemma":[0.025164263,0.00034150478,0.00075571594,0.0006336724,0.00070445566,0.0014048812,0.0007487205,0.005312253,0.0044926926],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005427535,0.0006397975,0.0427643,0.0005254117,0.000068934896,0.045948286,0.00072485214,0.00030693077,0.001099565,0.0017161536,0.7954361,0.110226884],"study_design_scores_gemma":[0.0017916337,0.001263982,0.13368139,0.004756803,0.00038090404,0.18078919,0.0041336473,0.0026208067,0.00089822273,0.019651445,0.64978284,0.00024921168],"about_ca_topic_score_codex":0.0048197736,"about_ca_topic_score_gemma":0.009033537,"teacher_disagreement_score":0.01574129,"about_ca_system_score_codex":0.0016280976,"about_ca_system_score_gemma":0.0015005892,"threshold_uncertainty_score":0.05265987},"labels":[],"label_agreement":null},{"id":"W2974374499","doi":"10.1111/bjd.18528","title":"Quality of reporting in systematic reviews published in dermatology journals","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Dermatology; Quality (philosophy); Medicine; Philosophy; Epistemology","score_opus":0.6679723516129221,"score_gpt":0.5441044734489416,"score_spread":0.12386787816398048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974374499","genre_codex":"review","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.079077,0.5663232,0.19455917,0.048571143,0.0076852506,0.03991662,0.05096285,0.001980449,0.010924313],"genre_scores_gemma":[0.52240306,0.11047421,0.24306528,0.01125815,0.0027323568,0.09121634,0.017300403,0.0006863512,0.000863917],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.10326216,0.5060185,0.3221005,0.019998316,0.046937212,0.001683298],"domain_scores_gemma":[0.026476461,0.6494193,0.2234158,0.042135835,0.057070494,0.0014821279],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6550193,0.0021902681,0.010246217,0.03546889,0.0036148191,0.012803688,0.0074456586,0.005031616,0.0048987623],"category_scores_gemma":[0.88032204,0.0051808306,0.012175131,0.051946014,0.009171099,0.009835668,0.009794654,0.0050309696,0.0011124326],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001208625,0.000120030236,0.088984005,0.73919165,0.054050352,0.00033315463,0.012266112,0.0022820842,0.0014850555,0.008435241,0.01908356,0.07256017],"study_design_scores_gemma":[0.003510134,0.0012693977,0.14582063,0.6199181,0.05799581,0.0019389018,0.007224038,0.009176651,0.0047892723,0.048535783,0.098622225,0.0011989464],"about_ca_topic_score_codex":0.009015204,"about_ca_topic_score_gemma":0.009363326,"teacher_disagreement_score":0.34498072,"about_ca_system_score_codex":0.013275399,"about_ca_system_score_gemma":0.045825485,"threshold_uncertainty_score":0.42542267},"labels":[],"label_agreement":null},{"id":"W2978721186","doi":"10.1111/bjd.18396","title":"Practice‐based differences in paediatric DLE","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hydroxychloroquine; Discoid lupus erythematosus; Dermatology; Lupus nephritis; Systemic lupus erythematosus; Lupus erythematosus; Disease; Pediatrics; Internal medicine; Immunology; Antibody","score_opus":0.01957930935059316,"score_gpt":0.2969754048982307,"score_spread":0.27739609554763756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978721186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917807,0.001107001,0.00063902664,0.0016294854,0.000041998795,0.00009892489,0.00029290552,0.000010589206,0.0043994193],"genre_scores_gemma":[0.9983368,0.0005728125,0.00043133734,0.0002676168,0.000011221127,0.000051758703,0.00012206752,0.000006521822,0.00019988269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9864341,0.00436875,0.0024891295,0.0014835529,0.0040534553,0.0011710959],"domain_scores_gemma":[0.961791,0.015501524,0.012845978,0.0011436328,0.005778471,0.0029393842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069784583,0.000105738975,0.00034146477,0.0015394614,0.0006472419,0.0011334264,0.00068965065,0.0006111163,0.001996384],"category_scores_gemma":[0.0429663,0.0002909437,0.00036213823,0.0025835424,0.00082667306,0.0010180857,0.0018211735,0.000639423,0.00016538322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063904066,0.000069881535,0.9531529,0.0003015195,0.000056621484,0.00035569278,0.022068268,0.00024877695,0.000263321,0.00064631493,0.0008778489,0.021894896],"study_design_scores_gemma":[0.000014817855,0.00014657399,0.97357154,0.00027999078,0.000015612224,0.00071695755,0.019927377,0.0004212337,0.0001661858,0.00025830886,0.0044620554,0.000019210214],"about_ca_topic_score_codex":0.019173307,"about_ca_topic_score_gemma":0.024006795,"teacher_disagreement_score":0.019173307,"about_ca_system_score_codex":0.0030720439,"about_ca_system_score_gemma":0.0037620845,"threshold_uncertainty_score":0.03812337},"labels":[],"label_agreement":null},{"id":"W2979570796","doi":"10.1111/bjd.18604","title":"Standardizing the classification of skin tears: validity and reliability testing of the International Skin Tear Advisory Panel Classification System in 44 countries","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Pressure Ulcer Prevention and Management","field":"Health Professions","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Western University; SKiN Health","funders":"","keywords":"Tears; Reliability (semiconductor); Medicine; Optometry; Dermatology; Ophthalmology; Surgery","score_opus":0.06360944030853781,"score_gpt":0.3388807698418896,"score_spread":0.27527132953335176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979570796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828924,0.00097407436,0.008246708,0.0005401313,0.00016920161,0.0016332688,0.0006054046,0.000050591047,0.0048883012],"genre_scores_gemma":[0.98330367,0.00033831323,0.014221098,0.00009477012,0.000028180715,0.0010737223,0.00072802225,0.000019689978,0.00019251136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9371638,0.04262359,0.0072338255,0.0030564535,0.008316043,0.0016064645],"domain_scores_gemma":[0.9039046,0.0392356,0.017535267,0.008090208,0.02963927,0.0015949971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10750009,0.0005430738,0.0006887144,0.005309847,0.0010436137,0.0018949124,0.0014871351,0.0009405921,0.000849514],"category_scores_gemma":[0.107001625,0.000522081,0.0010245406,0.003774079,0.0019898005,0.0017461859,0.004118029,0.0009806438,0.00027444994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048531353,0.00020727869,0.88085985,0.0007101374,0.0002696914,0.0001493408,0.01569532,0.0014011075,0.0013374594,0.00103454,0.0023976434,0.095452316],"study_design_scores_gemma":[0.00010818654,0.0008900405,0.97089505,0.0009215851,0.0001595842,0.0003276161,0.0144874705,0.0041086096,0.0014759332,0.0008283073,0.005710469,0.0000870791],"about_ca_topic_score_codex":0.0035029708,"about_ca_topic_score_gemma":0.0020769995,"teacher_disagreement_score":0.10750009,"about_ca_system_score_codex":0.0017853022,"about_ca_system_score_gemma":0.0028598623,"threshold_uncertainty_score":0.5685216},"labels":[],"label_agreement":null},{"id":"W2980603063","doi":"10.1111/bjd.18623","title":"Secukinumab for patients failing previous tumour necrosis factor‐α inhibitor therapy: results of a randomized open‐label study (SIGNATURE)","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Novartis Pharmaceuticals UK Limited","keywords":"Secukinumab; Medicine; Randomized controlled trial; Oncology; Open label; Tumor necrosis factor alpha; Signature (topology); Internal medicine; Necrosis","score_opus":0.018624505448480617,"score_gpt":0.264304644580543,"score_spread":0.24568013913206235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980603063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968419,0.0010177534,0.00021446445,0.00013743211,0.00007473871,0.0009625004,0.00038349934,0.00003305096,0.00033458913],"genre_scores_gemma":[0.99445915,0.0010398589,0.00089298305,0.00041146754,0.00023035344,0.0014152767,0.0010123678,0.000013239816,0.00052539137],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982722,0.0010818406,0.00013407135,0.00019402734,0.00014918477,0.00016855956],"domain_scores_gemma":[0.99666303,0.0009637531,0.00087207026,0.00037416353,0.00025933792,0.0008676082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004216254,0.0012858663,0.0035167765,0.00037615275,0.00035154098,0.00084615644,0.00057532825,0.0012925405,0.0041437363],"category_scores_gemma":[0.0032297263,0.0005167902,0.0021609673,0.00046441864,0.00116327,0.0008910652,0.000368758,0.0014059639,0.00065387384],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.963715,0.009822417,0.0033396233,0.00035868568,0.00095209724,0.00004561575,0.000061178216,0.00023565945,0.0029298773,0.00003464239,0.0003973143,0.018107852],"study_design_scores_gemma":[0.83229244,0.15600727,0.009569709,0.000030902873,0.0007340861,0.00008236673,0.000025200456,0.00035123335,0.00047646163,0.00004671538,0.00036520138,0.000018396686],"about_ca_topic_score_codex":0.0004994591,"about_ca_topic_score_gemma":0.00092726387,"teacher_disagreement_score":0.004216254,"about_ca_system_score_codex":0.00069843367,"about_ca_system_score_gemma":0.0012681959,"threshold_uncertainty_score":0.022297919},"labels":[],"label_agreement":null},{"id":"W2983911779","doi":"10.1111/bjd.18643","title":"The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group","year":2019,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; LEO Pharma; King's College London; Sanofi Genzyme; Incyte; Dermira; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Les Laboratories Pierre Fabre; Celgene; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Galderma; Eli Lilly and Company","keywords":"Skin infection; Atopic dermatitis; Staphylococcus aureus; Medicine; Dermatology; Immunology; Microbiome; Colonization; Erythema; Virulence; Microbiology; Biology; Bacteria; Bioinformatics","score_opus":0.02783365788754095,"score_gpt":0.3048529346464201,"score_spread":0.27701927675887916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983911779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036283483,0.9978956,0.000031545653,0.0007398387,0.00086636667,0.000005423805,0.0000203635,0.0000031113782,0.00040142573],"genre_scores_gemma":[0.000267279,0.99786645,0.0000863461,0.00054181746,0.0008262084,0.0000067030855,0.000045092456,0.0000010808631,0.00035905256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996024,0.00006564027,0.00009124486,0.000051406358,0.00015398723,0.000035329318],"domain_scores_gemma":[0.99879056,0.0005439413,0.00021316145,0.00002261083,0.00033591755,0.0000938513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011250869,0.0008259553,0.0014489534,0.0030804952,0.0002660326,0.0010684651,0.0010997076,0.001840355,0.0052026683],"category_scores_gemma":[0.0018518673,0.0002833704,0.0008816901,0.0022912584,0.00036976213,0.0016289202,0.0007961592,0.0016846322,0.0022852153],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109551016,0.000055862492,0.0002562932,0.03825481,0.00012183839,0.00028197467,0.00006134382,0.00015808917,0.00056698435,0.0009844118,0.14750211,0.8116467],"study_design_scores_gemma":[0.000035677313,0.00008169508,0.0013862207,0.025451079,0.00030023817,0.002364594,0.000077457255,0.00006105534,0.00019603648,0.00074441236,0.9692756,0.000025949037],"about_ca_topic_score_codex":0.0011530481,"about_ca_topic_score_gemma":0.0016778238,"teacher_disagreement_score":0.0052026683,"about_ca_system_score_codex":0.00050772296,"about_ca_system_score_gemma":0.0014623384,"threshold_uncertainty_score":0.017404675},"labels":[],"label_agreement":null},{"id":"W2989929492","doi":"10.1111/bjd.18627","title":"Dupilumab in adolescent atopic dermatitis: interpreting the data","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Dupilumab; Atopic dermatitis; Dermatology; Medicine","score_opus":0.026013691756835954,"score_gpt":0.28616456313947697,"score_spread":0.26015087138264104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989929492","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006274804,0.007812575,0.00028639473,0.9635246,0.0144196255,0.000020107931,0.000083453226,0.000044184977,0.007534233],"genre_scores_gemma":[0.1508998,0.012467997,0.0014402849,0.732436,0.0928736,0.000048984744,0.00011729792,0.00009437195,0.009621685],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973797,0.0011575979,0.0004532162,0.00019066362,0.00053840084,0.00028038703],"domain_scores_gemma":[0.986465,0.008862157,0.0009972276,0.00040645656,0.0022786856,0.0009905071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002884753,0.0003883653,0.0007302006,0.0010055198,0.0017510585,0.0025296586,0.0009627022,0.013357738,0.002476391],"category_scores_gemma":[0.028048659,0.0003877647,0.00059193204,0.00065339357,0.0012693094,0.0022930566,0.0009250486,0.012550273,0.0024787453],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017403376,0.00008205663,0.011940554,0.00020923463,0.000055472545,0.0793642,0.00066267356,0.00027493722,0.0006734932,0.0029097598,0.8703105,0.033343073],"study_design_scores_gemma":[0.00032548752,0.00024418422,0.014200611,0.0026838102,0.00022112948,0.26828855,0.0025413367,0.00394938,0.0016616083,0.023687638,0.68202096,0.00017532414],"about_ca_topic_score_codex":0.0060882005,"about_ca_topic_score_gemma":0.008077136,"teacher_disagreement_score":0.013357738,"about_ca_system_score_codex":0.0033603373,"about_ca_system_score_gemma":0.0016082481,"threshold_uncertainty_score":0.024381042},"labels":[],"label_agreement":null},{"id":"W2993854221","doi":"10.1111/bjd.18573","title":"The ACNE‐Q","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acne; Medicine; Dermatology; Acne scars; Distress; Quality of life (healthcare); Clinical psychology","score_opus":0.004165917996818942,"score_gpt":0.23669656340663028,"score_spread":0.23253064540981133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993854221","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5820636,0.027173711,0.008654127,0.018341748,0.0025766888,0.014493814,0.045136064,0.00052008143,0.3010401],"genre_scores_gemma":[0.86971,0.015802134,0.01662184,0.007626387,0.0007734412,0.0044960813,0.015265508,0.00012562986,0.069578886],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99593914,0.0010480605,0.00039644836,0.00017592104,0.0021803621,0.00026007206],"domain_scores_gemma":[0.99132174,0.0019962448,0.0014064489,0.0003219036,0.004180752,0.00077293196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003286658,0.00028299593,0.00065490446,0.0010259663,0.0008256237,0.00088274264,0.0006066163,0.0005637815,0.012053376],"category_scores_gemma":[0.010136036,0.00012646685,0.0010625093,0.0009581311,0.0005450233,0.0010593397,0.0011175073,0.0013710128,0.0018355716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010395735,0.0013509784,0.25621766,0.0030498048,0.00039284007,0.0003626271,0.0019343866,0.00043205652,0.0018901064,0.004649739,0.16346416,0.56521606],"study_design_scores_gemma":[0.00031258358,0.0017802106,0.587343,0.0010063788,0.00018734288,0.0018881845,0.0016512633,0.00026805804,0.00078827975,0.0010403894,0.403669,0.000065224696],"about_ca_topic_score_codex":0.010130092,"about_ca_topic_score_gemma":0.019270074,"teacher_disagreement_score":0.012053376,"about_ca_system_score_codex":0.0017690926,"about_ca_system_score_gemma":0.002000484,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2994439256","doi":"10.1111/bjd.18746","title":"The psychological impact of Stevens–Johnson syndrome and toxic epidermal necrolysis on patients’ lives: a Critically Appraised Topic*","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Limerick","keywords":"Toxic epidermal necrolysis; Anxiety; Medicine; Skin biopsy; Depression (economics); Inclusion (mineral); Psychiatry; Dermatology; Biopsy; Psychology; Pathology","score_opus":0.011611264403932117,"score_gpt":0.3012481988346902,"score_spread":0.28963693443075805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994439256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025982372,0.9880917,0.00004829076,0.007476567,0.0008610418,0.000113784175,0.000092998576,0.0000027775634,0.00071466033],"genre_scores_gemma":[0.02827516,0.96250594,0.00033946405,0.006527258,0.0018316451,0.00020443516,0.00012484458,0.000004071242,0.00018716778],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99156535,0.003881507,0.0027737261,0.00027761067,0.0012661954,0.00023553455],"domain_scores_gemma":[0.9149649,0.06941268,0.00868871,0.00049965555,0.0056957495,0.00073827757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006056167,0.0006887948,0.002033302,0.007555064,0.000924937,0.0032662817,0.00091460196,0.0034375372,0.0021121928],"category_scores_gemma":[0.035447996,0.00057833036,0.0014741878,0.0060173296,0.0016624476,0.0035534815,0.0015844791,0.0025451246,0.00035324052],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068135955,0.00014202384,0.009963261,0.6261617,0.0019817627,0.0055051562,0.005186752,0.00033291048,0.00084931235,0.0022140737,0.043931887,0.3030499],"study_design_scores_gemma":[0.00013941959,0.0006670943,0.013287964,0.7992661,0.003738388,0.011717902,0.013938636,0.00014441166,0.00024473775,0.002205242,0.1545404,0.00010965211],"about_ca_topic_score_codex":0.0017654367,"about_ca_topic_score_gemma":0.0041103275,"teacher_disagreement_score":0.007555064,"about_ca_system_score_codex":0.0023875432,"about_ca_system_score_gemma":0.004492394,"threshold_uncertainty_score":0.032028496},"labels":[],"label_agreement":null},{"id":"W2997184801","doi":"10.1111/bjd.18648","title":"How cutaneous T-cell lymphoma affects quality of life, and its cost to individual patients and the U.S. healthcare system","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Embarrassment; Health care; Rash; Dermatology Life Quality Index; Quality-adjusted life year; Population; Disease; Mycosis fungoides; Gerontology; Family medicine; Cost effectiveness; Lymphoma; Dermatology; Psychology; Environmental health; Internal medicine; Nursing","score_opus":0.029249451368623426,"score_gpt":0.2859054147810646,"score_spread":0.2566559634124412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997184801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86416095,0.031037534,0.0007457276,0.06496345,0.0003481723,0.000060468465,0.0019878428,0.00004466593,0.03665127],"genre_scores_gemma":[0.9918682,0.005333616,0.00028634816,0.0015623341,0.00007547382,0.000011381711,0.00020338694,0.0000039063752,0.00065534876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917054,0.0004119336,0.000060458773,0.000045869852,0.00020861649,0.00010266666],"domain_scores_gemma":[0.99877566,0.00027835622,0.00041317075,0.000031649593,0.0002909091,0.00021025559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008770658,0.00012736495,0.00015903014,0.00043293327,0.00048648907,0.0012562763,0.00016463836,0.00032346332,0.0030495583],"category_scores_gemma":[0.005419536,0.00008168468,0.00047224478,0.0008536242,0.00031374983,0.0006922698,0.00044985392,0.0004812307,0.00026668096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021188834,0.000196092,0.7426967,0.00017867988,0.00042528176,0.000298198,0.0004442671,0.002532606,0.00026718227,0.0019275468,0.034484986,0.21633652],"study_design_scores_gemma":[0.00004825197,0.00044001534,0.95900965,0.000467634,0.0003831822,0.0009900732,0.0024281782,0.0032897864,0.00030189194,0.0028860022,0.029707244,0.0000479424],"about_ca_topic_score_codex":0.02948823,"about_ca_topic_score_gemma":0.05330514,"teacher_disagreement_score":0.02948823,"about_ca_system_score_codex":0.0030537972,"about_ca_system_score_gemma":0.0011230472,"threshold_uncertainty_score":0.05863321},"labels":[],"label_agreement":null},{"id":"W2997875868","doi":"10.1111/bjd.18851","title":"A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Dalhousie University; Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Double blinded; Plaque psoriasis; Psoriasis; Randomized controlled trial; Dermatology; Head start; Internal medicine; Placebo; Secukinumab; Pathology","score_opus":0.019551203705524007,"score_gpt":0.26708486217334143,"score_spread":0.2475336584678174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997875868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802642,0.009365853,0.0010317236,0.0006571902,0.001158858,0.0045713414,0.0008912851,0.00020494014,0.0018546185],"genre_scores_gemma":[0.98444253,0.00370117,0.0015973089,0.0008957934,0.0009591657,0.004607802,0.00061378727,0.000038978043,0.0031434647],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99811375,0.0010452078,0.00016292893,0.00033158256,0.0001490803,0.00019746803],"domain_scores_gemma":[0.9981651,0.0006522856,0.00042355852,0.00019926671,0.0001427704,0.00041696877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034177322,0.0022867466,0.005622009,0.00057708984,0.000574339,0.0018978312,0.0012414231,0.0028875677,0.0074769603],"category_scores_gemma":[0.0030572366,0.001236998,0.0032174292,0.0005110267,0.0014891905,0.0015114811,0.0005414405,0.0034030974,0.0014970731],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99083906,0.0026351204,0.0001206101,0.00031321374,0.00053302525,0.000009884836,0.000018691355,0.000092326576,0.000864471,0.000023658908,0.0001628546,0.0043870537],"study_design_scores_gemma":[0.9444423,0.05396764,0.0005578983,0.000023177856,0.00042823036,0.000012448405,0.000008762381,0.00016687978,0.0001742125,0.000061662606,0.00014679343,0.0000100429215],"about_ca_topic_score_codex":0.0007399219,"about_ca_topic_score_gemma":0.0013531271,"teacher_disagreement_score":0.0074769603,"about_ca_system_score_codex":0.000808151,"about_ca_system_score_gemma":0.0014109852,"threshold_uncertainty_score":0.02501291},"labels":[],"label_agreement":null},{"id":"W2997936799","doi":"10.1111/bjd.18605","title":"British Association of Dermatologists centenary year: standing on the shoulders of giants","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Dermatology; Medicine; Family medicine","score_opus":0.029911043589218488,"score_gpt":0.2599010878940676,"score_spread":0.2299900443048491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997936799","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050671597,0.024704129,0.00032715264,0.29697996,0.5052195,0.000076524266,0.00063453946,0.0005446892,0.17100678],"genre_scores_gemma":[0.0062154536,0.033377804,0.00063737744,0.13068435,0.19144933,0.00012223884,0.0012266431,0.0005656084,0.6357212],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972531,0.000303799,0.00018813883,0.00028182767,0.0014420091,0.0005310591],"domain_scores_gemma":[0.98652595,0.0010911725,0.00056491065,0.0005452102,0.00416884,0.007103907],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0027013277,0.0009017607,0.00092964224,0.001284598,0.002234473,0.0075682146,0.0012020064,0.006777871,0.27592024],"category_scores_gemma":[0.012730353,0.0005279927,0.000634594,0.0011019586,0.0011840503,0.0035757686,0.0023605016,0.008336098,0.2503341],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007718227,0.000005571013,0.00003796379,0.000022432432,8.2582056e-7,0.000023706298,0.000004985249,0.0000025166858,0.000016611015,0.00020887035,0.98942393,0.010244926],"study_design_scores_gemma":[0.0000067579003,0.0000063998264,0.00024768634,0.00008551651,0.0000012910218,0.000113656315,0.000032526328,0.0000057277853,0.000015208902,0.00024356927,0.9992367,0.0000050228405],"about_ca_topic_score_codex":0.0031677159,"about_ca_topic_score_gemma":0.0083073005,"teacher_disagreement_score":0.99776554,"about_ca_system_score_codex":0.0018228967,"about_ca_system_score_gemma":0.003077714,"threshold_uncertainty_score":0.92304516},"labels":[],"label_agreement":null},{"id":"W2998173673","doi":"10.1111/bjd.18661","title":"A study of dupilumab in the treatment of adolescents with eczema","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Medicine; Itching; Atopic dermatitis; Dermatology; Quality of life (healthcare); Dermatology Life Quality Index; Young adult; Internal medicine; Psoriasis","score_opus":0.02077555368915389,"score_gpt":0.27324640356432106,"score_spread":0.25247084987516716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998173673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982447,0.011487228,0.00016067007,0.00091874984,0.00027703325,0.0011454339,0.00026514076,0.000008639808,0.0032902027],"genre_scores_gemma":[0.9840195,0.009863202,0.0014186178,0.0017227111,0.00031993978,0.0008097237,0.00021448545,0.0000065295476,0.0016253291],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99933076,0.0003469213,0.00007222455,0.000064187385,0.00011272385,0.00007332856],"domain_scores_gemma":[0.9986468,0.0004695775,0.00015237245,0.000038186266,0.00022624388,0.00046682966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011779362,0.00026263416,0.000915254,0.00029948124,0.0005142265,0.0004663708,0.00030913693,0.0008547047,0.0022063158],"category_scores_gemma":[0.0019519941,0.00019247655,0.0016024138,0.0003176196,0.0002183484,0.00034747118,0.00018112116,0.0014156079,0.00022655724],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18738833,0.09812326,0.046729647,0.0073489333,0.0038154915,0.0030022128,0.0038246685,0.0009337944,0.025694113,0.0012244787,0.0058081476,0.616107],"study_design_scores_gemma":[0.13856153,0.70958614,0.09866715,0.0010734127,0.004081318,0.0018853466,0.0014995735,0.0009831508,0.0058564167,0.00014847364,0.03760048,0.000057074667],"about_ca_topic_score_codex":0.0039939643,"about_ca_topic_score_gemma":0.006754964,"teacher_disagreement_score":0.0039939643,"about_ca_system_score_codex":0.00077331637,"about_ca_system_score_gemma":0.001171443,"threshold_uncertainty_score":0.007941425},"labels":[],"label_agreement":null},{"id":"W2998576867","doi":"10.1111/bjd.18662","title":"How many people develop anti-drug antibodies to the biologic drug tildrakizumab, and what impact does this have on the effectiveness of their treatment","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug; Clinical trial; Adverse effect; Antibody; Pharmacokinetics; Incidence (geometry); Internal medicine; Psoriasis; Pharmacology; Immunology","score_opus":0.016572192714455206,"score_gpt":0.2646796761144864,"score_spread":0.2481074834000312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998576867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.713479,0.18843377,0.001491178,0.04108588,0.001775952,0.00033592194,0.0012363631,0.0000739238,0.052088015],"genre_scores_gemma":[0.89214873,0.08711825,0.00079859345,0.011309707,0.0013193346,0.00007409429,0.0003749942,0.000013811166,0.0068424544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965953,0.001156139,0.00032783224,0.0002448564,0.0014507117,0.00022521008],"domain_scores_gemma":[0.99358255,0.0016931331,0.0021113956,0.00021903458,0.001891654,0.0005021535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00535008,0.00019933304,0.00070461177,0.0011582628,0.00057851477,0.0019414463,0.0002658574,0.0011307002,0.004342384],"category_scores_gemma":[0.011112583,0.0002558432,0.00097220944,0.0010185291,0.0004885256,0.0017271364,0.0003063751,0.0008084344,0.0011541112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010002702,0.00086574926,0.56699777,0.0017347555,0.0010295489,0.00035831117,0.0011350951,0.00011962725,0.0013260278,0.0007001086,0.013752816,0.41097993],"study_design_scores_gemma":[0.00040181476,0.0038025377,0.9132042,0.0019608582,0.0017669096,0.0046326485,0.0039373725,0.00027822223,0.0015158706,0.0010842875,0.0673438,0.00007147696],"about_ca_topic_score_codex":0.0025614775,"about_ca_topic_score_gemma":0.0057147196,"teacher_disagreement_score":0.00535008,"about_ca_system_score_codex":0.0008594131,"about_ca_system_score_gemma":0.00052968995,"threshold_uncertainty_score":0.028294265},"labels":[],"label_agreement":null},{"id":"W3003334583","doi":"10.1111/bjd.18898","title":"Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":379,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Lundbeckfonden; Eli Lilly and Company","keywords":"Medicine; Placebo; Atopic dermatitis; Concomitant; Adverse effect; Randomized controlled trial; Internal medicine; Gastroenterology; Clinical endpoint; Erythema; Phases of clinical research; Clinical trial; Dermatology","score_opus":0.019513080547020206,"score_gpt":0.2875085191582279,"score_spread":0.26799543861120767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003334583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9418753,0.048262723,0.0006894452,0.0016376751,0.0005861167,0.0029776804,0.0012002666,0.00008415726,0.0026865886],"genre_scores_gemma":[0.9812034,0.012171038,0.00091441843,0.0013951024,0.00046048302,0.0016549177,0.0013069584,0.000017385857,0.00087630545],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998522,0.00081178127,0.00017694943,0.00018775712,0.00014724329,0.00015427108],"domain_scores_gemma":[0.9975836,0.00082338403,0.00075787015,0.00019449095,0.0002492248,0.0003913762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00472845,0.0010640961,0.0035412295,0.00029054203,0.00040367275,0.0012816766,0.0007464393,0.0016186483,0.002483871],"category_scores_gemma":[0.003472251,0.00049793604,0.003199676,0.0005497424,0.00073009275,0.0007892118,0.00032583135,0.0018063294,0.00038277253],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9367341,0.0037884505,0.002957106,0.0027125916,0.0072440575,0.00007076086,0.000088163986,0.00028150177,0.0047906716,0.000091606824,0.0016550096,0.039586034],"study_design_scores_gemma":[0.9446081,0.04053284,0.008365287,0.00017182331,0.0043002884,0.00012139813,0.000033456487,0.00020538215,0.00042741274,0.00008607588,0.0011264784,0.000021391943],"about_ca_topic_score_codex":0.0011337396,"about_ca_topic_score_gemma":0.0038789986,"teacher_disagreement_score":0.00472845,"about_ca_system_score_codex":0.001047935,"about_ca_system_score_gemma":0.0013053654,"threshold_uncertainty_score":0.025006711},"labels":[],"label_agreement":null},{"id":"W3004695540","doi":"10.1111/bjd.18922","title":"Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17‐item Scleroderma Functional scale","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Scleroderma (fungus); Patient-reported outcome; Scale (ratio); Systemic scleroderma; Measure (data warehouse); Outcome (game theory); Medicine; Multiple sclerosis; Physical therapy; Physical medicine and rehabilitation; Psychology; Quality of life (healthcare); Internal medicine; Psychiatry; Computer science; Geography; Pathology; Cartography; Data mining; Nursing; Economics","score_opus":0.07790764148776234,"score_gpt":0.27151966259031857,"score_spread":0.1936120211025562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004695540","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585504,0.00095701386,0.015173377,0.001256914,0.00023028285,0.006620828,0.009237641,0.00014836011,0.007825303],"genre_scores_gemma":[0.9455557,0.000548313,0.032556817,0.00028347614,0.00009555998,0.013641702,0.0064592436,0.000019349385,0.00083975104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959435,0.0019307814,0.000621723,0.0002504926,0.0010896563,0.00016379976],"domain_scores_gemma":[0.99261284,0.002744582,0.0019286013,0.00022796357,0.0019886,0.00049734686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007119039,0.00042693454,0.00069347123,0.0017003906,0.00033099955,0.0006534969,0.00061622437,0.0004266664,0.0016699051],"category_scores_gemma":[0.012730533,0.00017613142,0.00095849443,0.0011550218,0.0002861286,0.00089972373,0.0010388042,0.0009606256,0.00023422067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010366587,0.0010585813,0.83569,0.0007078667,0.0006645139,0.00013008683,0.0011491443,0.0020747976,0.0015044189,0.00076495216,0.0061694793,0.14904939],"study_design_scores_gemma":[0.000323463,0.0019784488,0.9877238,0.00018596879,0.00015707962,0.00020529583,0.00046234333,0.0033042678,0.0004232309,0.00037759214,0.0048178453,0.00004054344],"about_ca_topic_score_codex":0.0011378835,"about_ca_topic_score_gemma":0.0024123956,"teacher_disagreement_score":0.007119039,"about_ca_system_score_codex":0.0007213482,"about_ca_system_score_gemma":0.0017257902,"threshold_uncertainty_score":0.037649572},"labels":[],"label_agreement":null},{"id":"W3004975025","doi":"10.1111/bjd.18755","title":"People with non‐blanchable erythema are at higher risk of pressure ulcers","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Pressure Ulcer Prevention and Management","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Erythema; Medicine; Dermatology; Pressure sores; Blanching; Surgery","score_opus":0.01821117619453831,"score_gpt":0.2931042001561561,"score_spread":0.2748930239616178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004975025","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16769302,0.8207319,0.0006472094,0.0029940302,0.00047675375,0.00028238268,0.0024497325,0.00003347557,0.004691527],"genre_scores_gemma":[0.6000688,0.3931413,0.0014710365,0.0026789017,0.00047601195,0.00024902084,0.0010936122,0.000017816848,0.0008035181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934575,0.002332008,0.001898511,0.0005462739,0.0015353188,0.00023039832],"domain_scores_gemma":[0.977,0.012270701,0.008408913,0.0004097396,0.0015097582,0.00040078978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004222668,0.00043480727,0.0023084865,0.00345848,0.00039385876,0.0016343932,0.00040977134,0.001359597,0.0031759068],"category_scores_gemma":[0.023032296,0.00058057404,0.0052620126,0.0045040185,0.00040917937,0.0015076172,0.00083965476,0.0013680272,0.00034940493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033898847,0.00028909446,0.41661045,0.29941016,0.06607456,0.0016650531,0.0035920704,0.0003076036,0.0013825712,0.0010161429,0.008928111,0.1973343],"study_design_scores_gemma":[0.0010353035,0.0013319727,0.8012274,0.10134064,0.052654836,0.005489399,0.0030007036,0.00018075833,0.0005610957,0.0017525991,0.03125905,0.00016624772],"about_ca_topic_score_codex":0.0033821883,"about_ca_topic_score_gemma":0.006112303,"teacher_disagreement_score":0.004222668,"about_ca_system_score_codex":0.00041447434,"about_ca_system_score_gemma":0.0011067605,"threshold_uncertainty_score":0.022331834},"labels":[],"label_agreement":null},{"id":"W3005031357","doi":"10.1111/bjd.18943","title":"The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies","year":2020,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatological diseases and infestations","field":"Medicine","cited_by":333,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Health and Medical Research Council; Medical Research Council; Pfizer","keywords":"Scabies; Medicine; Delphi method; Standardization; Intensive care medicine; Dermatology; Computer science; Artificial intelligence","score_opus":0.05561759819834139,"score_gpt":0.37920051202005417,"score_spread":0.3235829138217128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005031357","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017695758,0.10621355,0.21929382,0.32754976,0.039770942,0.057077788,0.01827776,0.0018042943,0.21231636],"genre_scores_gemma":[0.13531156,0.036676653,0.6081238,0.06121783,0.0042200857,0.08486026,0.03551058,0.000662265,0.033416916],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.82539505,0.08432554,0.03729158,0.0040037087,0.042078394,0.00690567],"domain_scores_gemma":[0.7383279,0.043034423,0.01926204,0.0061147097,0.1826459,0.010614976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.13517329,0.0026045314,0.0034597637,0.015584407,0.0038482682,0.006467643,0.010105315,0.01285497,0.008680162],"category_scores_gemma":[0.18288028,0.0015170779,0.006123234,0.0070681074,0.004574444,0.004581913,0.010874647,0.009998464,0.0046914048],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082013337,0.0007399098,0.017377539,0.0192842,0.0006097009,0.0007772698,0.0057232156,0.0031296054,0.0035210412,0.039956104,0.5763378,0.33172348],"study_design_scores_gemma":[0.0005363418,0.0006052596,0.026855763,0.04764139,0.0006004363,0.0016859072,0.004283471,0.0040573888,0.0017762055,0.022552889,0.8890309,0.00037412104],"about_ca_topic_score_codex":0.03071731,"about_ca_topic_score_gemma":0.016667549,"teacher_disagreement_score":0.13517329,"about_ca_system_score_codex":0.014453136,"about_ca_system_score_gemma":0.064894035,"threshold_uncertainty_score":0.7148732},"labels":[],"label_agreement":null},{"id":"W3005494339","doi":"10.1111/bjd.18757","title":"Which treatments for fungal nail infections work better, those taken by mouth work or those applied to the nail?","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Terbinafine; Itraconazole; Dermatology; Adverse effect; Nail (fastener); Clinical trial; Randomized controlled trial; Surgery; Dentistry; Antifungal; Internal medicine","score_opus":0.028958720128343822,"score_gpt":0.28919440659339024,"score_spread":0.2602356864650464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005494339","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024102297,0.92651016,0.0026511108,0.036189556,0.00305804,0.0006131966,0.0018172859,0.00005747797,0.005000883],"genre_scores_gemma":[0.4156044,0.5124524,0.012959504,0.046560008,0.005537878,0.0011410207,0.0015204971,0.0001718401,0.0040524187],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98351353,0.009510586,0.0027926005,0.0014359482,0.0022814178,0.00046582302],"domain_scores_gemma":[0.93635386,0.049852964,0.007392849,0.0011753622,0.0043883086,0.0008366341],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.020118259,0.00082182704,0.005258944,0.0034965232,0.00086430553,0.0036470694,0.0011869197,0.0032823482,0.008227938],"category_scores_gemma":[0.06521115,0.0005591097,0.010680534,0.0039078086,0.0015046397,0.005207725,0.0008747956,0.0025314232,0.0010032902],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01099732,0.00060098834,0.045175422,0.18387496,0.07158706,0.00042091587,0.001345543,0.00084028736,0.0010445404,0.0055027483,0.027559109,0.65105104],"study_design_scores_gemma":[0.015396321,0.00672094,0.14446309,0.1665401,0.3615138,0.0025587194,0.004970755,0.003384758,0.0034290522,0.036619503,0.2537364,0.00066659244],"about_ca_topic_score_codex":0.008317415,"about_ca_topic_score_gemma":0.015458211,"teacher_disagreement_score":0.9947411,"about_ca_system_score_codex":0.0028259836,"about_ca_system_score_gemma":0.004285906,"threshold_uncertainty_score":0.106396735},"labels":[],"label_agreement":null},{"id":"W3011453881","doi":"10.1111/bjd.19018","title":"Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to &lt; 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label <scp>CADMUS</scp> Jr study","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexus Clinical Research (Canada); Memorial University of Newfoundland","funders":"Janssen Research and Development","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Adverse effect; Dermatology Life Quality Index; Dosing; Internal medicine; Discontinuation; Gastroenterology; Dermatology; Infliximab; Disease","score_opus":0.03612339614048511,"score_gpt":0.273350417063129,"score_spread":0.23722702092264392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011453881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165416,0.007096297,0.00014527782,0.00012731996,0.000023944714,0.00020777606,0.00022398238,0.000010850356,0.0005103655],"genre_scores_gemma":[0.9914842,0.0062135197,0.0007543597,0.00026233942,0.00009505138,0.00020522739,0.0005305678,0.0000074897152,0.0004472879],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992662,0.00043934677,0.000061682,0.000055501383,0.00012512704,0.00005212779],"domain_scores_gemma":[0.9988747,0.00022343226,0.0004827909,0.00005017677,0.00009571515,0.00027307542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001375086,0.0005371686,0.0009932863,0.00021090498,0.00016990837,0.00045563874,0.00032219835,0.00051006995,0.0012662713],"category_scores_gemma":[0.0010340529,0.00024993476,0.0009831851,0.00023519635,0.00041789876,0.000379708,0.00024887823,0.0012422884,0.00026433385],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32490477,0.034732647,0.16837405,0.0048113177,0.005862296,0.0024685012,0.0011675985,0.0025164222,0.061190307,0.00031158404,0.005155422,0.388505],"study_design_scores_gemma":[0.15419959,0.37022296,0.4430885,0.0006018017,0.0029013702,0.005066067,0.00035069085,0.0012906413,0.0107917525,0.0001355442,0.011293848,0.00005727421],"about_ca_topic_score_codex":0.00060702435,"about_ca_topic_score_gemma":0.0019702467,"teacher_disagreement_score":0.001375086,"about_ca_system_score_codex":0.0004058532,"about_ca_system_score_gemma":0.0006139881,"threshold_uncertainty_score":0.007272184},"labels":[],"label_agreement":null},{"id":"W3014954599","doi":"10.1111/bjd.19089","title":"Adverse skin reactions among healthcare workers during the coronavirus disease 2019 outbreak: a survey in Wuhan and its surrounding regions","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Infection Control and Ventilation","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Tongji Medical College, Huazhong University of Science and Technology; Department of Medicine, University of Toronto; Zhongnan Hospital of Wuhan University; Hubei University of Medicine; Tongji University; Wuhan University; University of Toronto; Peking University; Huazhong University of Science and Technology; Hubei University; Renmin Hospital of Wuhan University; Peking University First Hospital","keywords":"Outbreak; Disease; Health care; Coronavirus disease 2019 (COVID-19); Coronavirus; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Environmental health; Virology; Infectious disease (medical specialty); Pathology; Economic growth","score_opus":0.03942157222490661,"score_gpt":0.30232677924604273,"score_spread":0.2629052070211361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014954599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980837,0.00043005668,0.000042401356,0.0007601482,0.00002380234,0.000043893757,0.00031129565,0.0000025432978,0.00030213964],"genre_scores_gemma":[0.9975827,0.0008511186,0.00017239703,0.0006649862,0.00010351811,0.00006133654,0.00024499148,0.0000016279735,0.00031745736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993235,0.00024149158,0.000092848815,0.000083033316,0.00014603074,0.00011310498],"domain_scores_gemma":[0.99824536,0.00036585922,0.00074903737,0.000048627808,0.00035474513,0.00023649281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012109055,0.00024441452,0.0002808459,0.00086744025,0.00047005602,0.0003587816,0.00050686754,0.0008780592,0.0010128696],"category_scores_gemma":[0.002713931,0.00028701604,0.00025973585,0.0009713808,0.00028897208,0.00051417504,0.000513515,0.0004096186,0.00016677279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005287912,0.00009018216,0.9900344,0.00013986962,0.000054729448,0.0005176664,0.0017964052,0.00003288767,0.00077321316,0.000012622044,0.0014400448,0.005055096],"study_design_scores_gemma":[0.0000029203004,0.00010148673,0.99765956,0.000031421616,0.000009206628,0.00022398794,0.0013066478,0.000065895365,0.000050183455,0.0000034030431,0.00054085057,0.000004280953],"about_ca_topic_score_codex":0.019724332,"about_ca_topic_score_gemma":0.016183691,"teacher_disagreement_score":0.019724332,"about_ca_system_score_codex":0.00045297173,"about_ca_system_score_gemma":0.00049489306,"threshold_uncertainty_score":0.03921908},"labels":[],"label_agreement":null},{"id":"W3015243915","doi":"10.1111/bjd.19132","title":"Long-term efficacy and safety of brodalumab in psoriasis through 120 weeks and after withdrawal and retreatment: subgroup analysis of a randomized phase III trial (AMAGINE-1)","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Bausch Health; Ortho Dermatologics","keywords":"Medicine; Placebo; Psoriasis Area and Severity Index; Randomized controlled trial; Internal medicine; Psoriasis; Dermatology; Pathology","score_opus":0.01067272546066037,"score_gpt":0.2536275253746416,"score_spread":0.24295479991398125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015243915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95149744,0.038318142,0.0018883708,0.00086677255,0.0008864748,0.0033756436,0.0016520091,0.0001619215,0.0013532257],"genre_scores_gemma":[0.98721296,0.0047450634,0.0012922606,0.00073583546,0.00044054462,0.0031969696,0.0012637136,0.00004336983,0.0010692456],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99633247,0.0020550853,0.00051456125,0.00051660335,0.0003125878,0.00026879174],"domain_scores_gemma":[0.9965115,0.001421174,0.0009616007,0.00052282616,0.00022021936,0.0003625834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008292395,0.0017492931,0.0059014712,0.00065952446,0.00045095713,0.0017027305,0.001028814,0.0017660124,0.0032489472],"category_scores_gemma":[0.00648046,0.0006731062,0.011913792,0.00063324824,0.0007148246,0.00088615186,0.0005996533,0.0023401792,0.00038814027],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9599409,0.0007265166,0.0026890745,0.0011600787,0.023521006,0.000049455994,0.000051557352,0.0002972846,0.0016505743,0.000049441092,0.00038579173,0.009478323],"study_design_scores_gemma":[0.9036934,0.036255438,0.017410196,0.00022162615,0.039388005,0.00011667409,0.00006926927,0.0009023816,0.00066901464,0.00039752814,0.00081856275,0.00005801358],"about_ca_topic_score_codex":0.00070993626,"about_ca_topic_score_gemma":0.0019467849,"teacher_disagreement_score":0.008292395,"about_ca_system_score_codex":0.0008806713,"about_ca_system_score_gemma":0.0011518515,"threshold_uncertainty_score":0.043854892},"labels":[],"label_agreement":null},{"id":"W3015607706","doi":"10.1111/bjd.19135","title":"High and discordant prevalences of clinical and sonographic enthesitis in patients with hidradenitis suppurativa","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Enthesitis; Medicine; Hidradenitis suppurativa; Spondyloarthropathy; Dermatology; Internal medicine; Psoriatic arthritis; Physical therapy; Arthritis; Psoriasis; Disease","score_opus":0.014241447572193752,"score_gpt":0.26236534689952123,"score_spread":0.24812389932732748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015607706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4203786,0.18318833,0.0034485303,0.28239512,0.10142752,0.00011064318,0.0029345164,0.00021323108,0.005903396],"genre_scores_gemma":[0.7201887,0.04520008,0.0020647252,0.0475164,0.18229766,0.00006309911,0.0005322826,0.00008975584,0.0020473625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806076,0.0007001447,0.00039522388,0.00034340363,0.00034295037,0.00015758326],"domain_scores_gemma":[0.9875196,0.006552161,0.0033914174,0.00032178868,0.0015992293,0.0006156879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031580087,0.00043294523,0.001026568,0.0013082032,0.00034180365,0.0013889307,0.0010594478,0.0026131049,0.0020963447],"category_scores_gemma":[0.017410774,0.0004888088,0.0002686982,0.0010714496,0.0010744085,0.0016049271,0.0005322967,0.0016757693,0.00062622613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025090037,0.0003095555,0.5448157,0.0067102103,0.0011579567,0.016298031,0.0019266886,0.000334104,0.0025320314,0.0011542236,0.30241698,0.1198355],"study_design_scores_gemma":[0.0005377481,0.0010186799,0.7627066,0.0050549046,0.0012163692,0.07345713,0.0025864998,0.0040950743,0.0019360435,0.0021140424,0.14501835,0.000258565],"about_ca_topic_score_codex":0.0007863996,"about_ca_topic_score_gemma":0.0012733357,"teacher_disagreement_score":0.0031580087,"about_ca_system_score_codex":0.00022879662,"about_ca_system_score_gemma":0.00030785223,"threshold_uncertainty_score":0.01670134},"labels":[],"label_agreement":null},{"id":"W3016397458","doi":"10.1111/bjd.19147","title":"Efficacy and safety of ixekizumab in a phase <scp>III</scp> , randomized, double‐blind, placebo‐controlled study in paediatric patients with moderate‐to‐severe plaque psoriasis ( <scp>IXORA</scp> ‐ <scp>PEDS</scp> )","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Cilag; UCB Pharma; Sanofi Genzyme; Genentech; Ortho Dermatologics; Gilead Sciences; LEO Pharma; Bausch Health; Astellas Pharma; Sanofi; Kyowa Hakko Kirin; Coherus Biosciences; Sun Pharma; Dermira; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Medac; Baxalta; Celgene; Pfizer; Biogen; Amgen; Meiji Seika Pharma; Galderma; Eli Lilly and Company; Bristol-Myers Squibb; Astellas Pharma US","keywords":"Ixekizumab; Placebo; Medicine; Psoriasis; Adverse effect; Psoriasis Area and Severity Index; Secukinumab; Internal medicine; Dermatology; Pathology","score_opus":0.012410969481534086,"score_gpt":0.23847296329299128,"score_spread":0.2260619938114572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016397458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876774,0.0046730377,0.0008370609,0.00039498368,0.00033711313,0.0040299934,0.0007462737,0.000105552404,0.0011986181],"genre_scores_gemma":[0.9861287,0.0035475092,0.0021458194,0.00085689034,0.00041290122,0.0043975664,0.0010538746,0.000030814484,0.0014260024],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991509,0.00044761578,0.000068452624,0.0001446538,0.000094662384,0.00009362978],"domain_scores_gemma":[0.9986766,0.0003219846,0.0003982632,0.000100800855,0.00009664008,0.00040573208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025368445,0.0012841081,0.0030087808,0.00032902657,0.00038707515,0.0010192659,0.00096323394,0.0017543841,0.0033428355],"category_scores_gemma":[0.0016974501,0.0007969387,0.001846278,0.00034575205,0.0012676917,0.00073501404,0.00027696078,0.0029233205,0.0006297001],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.943647,0.01466023,0.0013746332,0.0010847884,0.0011337708,0.00009663933,0.000111627785,0.00041943896,0.01424454,0.00013241319,0.0010666078,0.02202818],"study_design_scores_gemma":[0.88694465,0.10903488,0.0021751195,0.000026067142,0.00028485374,0.00006919663,0.000011844436,0.00022367234,0.0007696305,0.00003916315,0.00041220718,0.0000087135395],"about_ca_topic_score_codex":0.000628793,"about_ca_topic_score_gemma":0.00091851427,"teacher_disagreement_score":0.0033428355,"about_ca_system_score_codex":0.00063497457,"about_ca_system_score_gemma":0.0016099411,"threshold_uncertainty_score":0.01341629},"labels":[],"label_agreement":null},{"id":"W3017296821","doi":"10.1111/bjd.19152","title":"Global evidence on occupational sun exposure and keratinocyte cancers: a systematic review","year":2020,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Sun exposure; Keratinocyte; Systematic review; Occupational exposure; Medicine; Dermatology; Oncology; Environmental health; MEDLINE; Biology; Genetics","score_opus":0.058881188850304654,"score_gpt":0.3719527484577637,"score_spread":0.3130715596074591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017296821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00067882444,0.9983229,0.000057998317,0.00017758574,0.00007166059,0.000050291394,0.00045887995,0.0000042770967,0.00017755966],"genre_scores_gemma":[0.005190024,0.99405116,0.00015448993,0.00020697755,0.000046677043,0.00007086433,0.0002316684,0.0000024729952,0.000045652072],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963039,0.0009792896,0.0016426076,0.00034304836,0.0005877057,0.00014351563],"domain_scores_gemma":[0.98070586,0.013847245,0.0033383938,0.0002515227,0.0016194072,0.00023755507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045004324,0.0013231214,0.0064128265,0.013690888,0.00045866737,0.002208892,0.0015027785,0.0014013982,0.006051539],"category_scores_gemma":[0.020229923,0.0008668759,0.0059472905,0.015260741,0.0006649931,0.0017119722,0.0014239087,0.00089728634,0.00043639968],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014129153,0.000011841357,0.0017164818,0.9436043,0.0066385968,0.00011566551,0.0001609837,0.00008588827,0.00011021669,0.00016119448,0.002053532,0.0452],"study_design_scores_gemma":[0.00013433564,0.00014608291,0.012434022,0.8980026,0.059557542,0.00059547223,0.00035725298,0.000050415856,0.00012298141,0.00030845177,0.028254433,0.000036329977],"about_ca_topic_score_codex":0.008821175,"about_ca_topic_score_gemma":0.0225294,"teacher_disagreement_score":0.013690888,"about_ca_system_score_codex":0.0017619848,"about_ca_system_score_gemma":0.0068645123,"threshold_uncertainty_score":0.02380085},"labels":[],"label_agreement":null},{"id":"W3022063920","doi":"10.1111/bjd.19044","title":"Topical condyloma treatment: comparative evidence for a common problem","year":2020,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Dermatology; Medicine","score_opus":0.18485903225365494,"score_gpt":0.42316269157641656,"score_spread":0.23830365932276162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022063920","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03125598,0.9195984,0.0004602824,0.026070587,0.003904932,0.00027681678,0.0012741492,0.000017487217,0.017141452],"genre_scores_gemma":[0.40465584,0.54843163,0.0021033457,0.026731549,0.013725929,0.00038607756,0.00085964997,0.000039054565,0.0030669281],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917007,0.005395203,0.0010833156,0.00055835827,0.0010868878,0.00017538817],"domain_scores_gemma":[0.9277456,0.060808346,0.006637868,0.0015001838,0.0025907408,0.0007173185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009349616,0.0005340366,0.0032509614,0.0015504712,0.00060086616,0.0017073603,0.0011171408,0.0036531966,0.019426163],"category_scores_gemma":[0.036330227,0.00028348903,0.0033343642,0.001714387,0.001795085,0.0016639885,0.0008238743,0.0025337434,0.0011656615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13376647,0.0013975382,0.011250916,0.11477853,0.02259269,0.0014008168,0.00034766918,0.00032650778,0.0038162128,0.0054289936,0.026467312,0.67842627],"study_design_scores_gemma":[0.14507036,0.077838846,0.11380589,0.16149536,0.1648911,0.011918587,0.0037112196,0.0010443645,0.0066530686,0.02400582,0.28914812,0.00041731697],"about_ca_topic_score_codex":0.0014294282,"about_ca_topic_score_gemma":0.0035238436,"teacher_disagreement_score":0.019426163,"about_ca_system_score_codex":0.0014700517,"about_ca_system_score_gemma":0.0012071363,"threshold_uncertainty_score":0.064987004},"labels":[],"label_agreement":null},{"id":"W3022245210","doi":"10.1111/bjd.17239","title":"CONSORT 2010 statement: extension checklist for reporting within person randomised trials","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"Medical Research Council; Cancer Research UK","keywords":"Consolidated Standards of Reporting Trials; Checklist; Clinical trial; Medicine; Transparency (behavior); Psychological intervention; Randomized controlled trial; Quality (philosophy); Systematic review; Reliability (semiconductor); MEDLINE; Medical physics; Family medicine; Psychology; Computer science; Nursing; Surgery","score_opus":0.6750508357817939,"score_gpt":0.5191783007553237,"score_spread":0.15587253502647025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022245210","genre_codex":"protocol","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002897348,0.018458577,0.29576433,0.021823058,0.017230056,0.54422724,0.082039975,0.009269392,0.00828997],"genre_scores_gemma":[0.0043199635,0.0068805693,0.2599398,0.0022765063,0.0012143052,0.7091588,0.012580776,0.0011144005,0.0025148585],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.4153821,0.41659233,0.14187068,0.007228926,0.016587,0.0023389636],"domain_scores_gemma":[0.29114136,0.507597,0.07899606,0.04246331,0.07613203,0.0036701814],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3826928,0.006503172,0.01071292,0.016361587,0.002988005,0.008715936,0.008051512,0.007867583,0.04001379],"category_scores_gemma":[0.5836571,0.0067029493,0.018418305,0.017480861,0.005322185,0.0072056213,0.007477317,0.016426206,0.01623363],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00694253,0.0003331326,0.0023000163,0.2745706,0.0074334666,0.0005538156,0.0029197312,0.0040433095,0.0016300398,0.031646118,0.49599642,0.17163086],"study_design_scores_gemma":[0.023092505,0.0012495854,0.008556714,0.12945919,0.0062053506,0.0012652717,0.001140559,0.007582976,0.003106695,0.06674965,0.7504095,0.0011819775],"about_ca_topic_score_codex":0.0023049903,"about_ca_topic_score_gemma":0.0027069668,"teacher_disagreement_score":0.6173072,"about_ca_system_score_codex":0.010851182,"about_ca_system_score_gemma":0.03358692,"threshold_uncertainty_score":0.76124966},"labels":[],"label_agreement":null},{"id":"W3032957745","doi":"10.1111/bjd.19075","title":"A study of the drug tildrakizumab for plaque psoriasis","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psoriasis; Medicine; Dermatology; Plaque psoriasis; Drug; Dermatologic agents; Pharmacology; Antibiotics; Microbiology","score_opus":0.019651180493657584,"score_gpt":0.23760066452775977,"score_spread":0.2179494840341022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032957745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6785583,0.28661555,0.002190351,0.0067826384,0.00295838,0.005129417,0.0012716932,0.00007261104,0.01642107],"genre_scores_gemma":[0.9248793,0.057363562,0.0029425258,0.0050624707,0.0023566892,0.0014170515,0.0006646897,0.000022418391,0.005291326],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973283,0.0016515595,0.00028221498,0.0001908346,0.00042962158,0.00011737015],"domain_scores_gemma":[0.99633515,0.0023070755,0.0003678824,0.00015985212,0.00039966704,0.0004304407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005481439,0.0004309856,0.0013938175,0.0004374122,0.0003052488,0.0007577239,0.00031215718,0.0012158187,0.004524687],"category_scores_gemma":[0.004813033,0.00019816757,0.0019642154,0.00045223266,0.00034920083,0.00048960454,0.00022977122,0.0012528648,0.00047750532],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38073587,0.010734382,0.008945054,0.014776122,0.0077049434,0.0009260788,0.0006562481,0.0004292414,0.02557226,0.0024445977,0.007543439,0.53953177],"study_design_scores_gemma":[0.3737526,0.4541441,0.03495002,0.0023521292,0.010553522,0.0011841492,0.00020757804,0.00036263498,0.0072973077,0.00064430333,0.114490725,0.000060950355],"about_ca_topic_score_codex":0.00063239416,"about_ca_topic_score_gemma":0.001470385,"teacher_disagreement_score":0.005481439,"about_ca_system_score_codex":0.0006581741,"about_ca_system_score_gemma":0.0013658513,"threshold_uncertainty_score":0.028988957},"labels":[],"label_agreement":null},{"id":"W3034109117","doi":"10.1111/bjd.19072","title":"A study comparing the biologic drugs ixekizumab and guselkumab for the treatment of moderate‐to‐severe plaque psoriasis","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ixekizumab; Psoriasis; Medicine; Dermatology; Secukinumab; Psoriatic arthritis","score_opus":0.0377995545386855,"score_gpt":0.2587733163398282,"score_spread":0.2209737618011427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034109117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793858,0.01407877,0.00026994964,0.00048843585,0.0003639532,0.0016173,0.00047710122,0.000013982908,0.0033046498],"genre_scores_gemma":[0.9898977,0.005860677,0.0008836599,0.0006596533,0.00028909338,0.0007248211,0.0003630005,0.000006392755,0.0013150957],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99731135,0.0014013178,0.00032731652,0.00024397417,0.0005600729,0.00015599285],"domain_scores_gemma":[0.9928398,0.003991728,0.0011270798,0.0002693287,0.00085503684,0.0009170167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034119813,0.00037022438,0.0015367959,0.0004815579,0.00047294458,0.00067235535,0.00033673554,0.0008711183,0.0031553633],"category_scores_gemma":[0.0070643974,0.00036774622,0.003243032,0.00061773206,0.00040379862,0.00089154835,0.00029425128,0.0016630904,0.00028771357],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7305722,0.04957232,0.025697732,0.0077350936,0.010750898,0.00038612945,0.0009099806,0.00070669054,0.0073089334,0.00049347844,0.0030750902,0.16279142],"study_design_scores_gemma":[0.21257381,0.70511574,0.060451347,0.0004902933,0.008772909,0.0004176176,0.00053936866,0.0006822581,0.0014612989,0.00018606914,0.00924933,0.000059986196],"about_ca_topic_score_codex":0.0027412926,"about_ca_topic_score_gemma":0.004620948,"teacher_disagreement_score":0.0034119813,"about_ca_system_score_codex":0.0010064015,"about_ca_system_score_gemma":0.0018464538,"threshold_uncertainty_score":0.018044472},"labels":[],"label_agreement":null},{"id":"W3034204123","doi":"10.1111/bjd.19314","title":"Long‐term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo‐controlled studies","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"UCB Pharma; National Institute for Health and Care Research; Manchester Biomedical Research Centre; Dermira","keywords":"Certolizumab pegol; Medicine; Placebo; Psoriasis; Randomized controlled trial; Plaque psoriasis; Internal medicine; Term (time); Pooled analysis; Gastroenterology; Dermatology; Meta-analysis; Pathology; Alternative medicine; Disease; Adalimumab","score_opus":0.016365935629782575,"score_gpt":0.26628293293723104,"score_spread":0.24991699730744846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034204123","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45964676,0.5137378,0.008657794,0.00087018614,0.0007752345,0.003281396,0.010025987,0.00042355905,0.0025812297],"genre_scores_gemma":[0.928865,0.056030385,0.0026363616,0.001172813,0.00055808405,0.002826931,0.0072910115,0.00011877711,0.0005005933],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9798324,0.009948401,0.0040060277,0.002859748,0.002731777,0.0006216417],"domain_scores_gemma":[0.96006906,0.016712368,0.016881445,0.0026230083,0.0027516615,0.0009624115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.038905893,0.0025434254,0.01041133,0.0022570987,0.0006742101,0.0032431243,0.0013506254,0.002465397,0.002209324],"category_scores_gemma":[0.032251805,0.0013803928,0.030248808,0.0035923766,0.00093455246,0.001883358,0.0014164991,0.00213514,0.0003560888],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2458475,0.00052629877,0.03514653,0.017856808,0.6571484,0.0001543884,0.00015792744,0.0024547935,0.0024326877,0.00007600564,0.0014567999,0.036741823],"study_design_scores_gemma":[0.07316429,0.022072468,0.14398181,0.0019782272,0.75178164,0.00043363607,0.00011458687,0.0012510157,0.0011239451,0.00044508185,0.0034988807,0.00015442143],"about_ca_topic_score_codex":0.0010582317,"about_ca_topic_score_gemma":0.0017638332,"teacher_disagreement_score":0.038905893,"about_ca_system_score_codex":0.0013063616,"about_ca_system_score_gemma":0.002087407,"threshold_uncertainty_score":0.20575649},"labels":[],"label_agreement":null},{"id":"W3037060742","doi":"10.1111/bjd.19341","title":"Efficacy and safety of risankizumab vs. secukinumab in patients with moderate‐to‐severe plaque psoriasis (IMMerge): results from a phase III, randomized, open‐label, efficacy–assessor‐blinded clinical trial*","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre de Recherche Dermatologique du Québec Métropolitain","funders":"AbbVie","keywords":"Secukinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Interleukin 17; Internal medicine; Randomized controlled trial; Clinical endpoint; Confidence interval; Clinical trial; Dermatology; Psoriatic arthritis; Cytokine","score_opus":0.04242110571347812,"score_gpt":0.3147352210618506,"score_spread":0.27231411534837247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037060742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935361,0.0035004031,0.00028638772,0.00032547474,0.00021667815,0.00082326576,0.00038723173,0.00005048198,0.00087412825],"genre_scores_gemma":[0.99537766,0.0012429785,0.00069756026,0.00052611367,0.00023857833,0.0008335016,0.0004683236,0.000011556004,0.0006036299],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985251,0.0009587196,0.000110015746,0.0001853633,0.00009953285,0.00012132679],"domain_scores_gemma":[0.9981273,0.00077709754,0.00042077902,0.00013253144,0.00010099871,0.00044130767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037133307,0.001237585,0.0025524755,0.00030199377,0.00032857893,0.001139757,0.00062452327,0.0015869455,0.003535782],"category_scores_gemma":[0.002716729,0.00059086556,0.0024869246,0.0002918154,0.0010826178,0.00099899,0.00046740758,0.0024080982,0.00052798016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9766301,0.0055383537,0.00073410256,0.0003635196,0.0010660486,0.000019242927,0.000059848568,0.00024075081,0.0031270015,0.000057615012,0.00035573676,0.011807625],"study_design_scores_gemma":[0.8217445,0.17238142,0.0034053165,0.000038450526,0.00079463766,0.00004276363,0.000028388675,0.00035164293,0.00068190816,0.00009313253,0.0004207204,0.000017101936],"about_ca_topic_score_codex":0.0003234189,"about_ca_topic_score_gemma":0.0008584943,"teacher_disagreement_score":0.0037133307,"about_ca_system_score_codex":0.00042931136,"about_ca_system_score_gemma":0.0006996278,"threshold_uncertainty_score":0.01963818},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W3037583352","doi":"10.1111/bjd.19338","title":"COVID‐19 chilblain‐like lesion: immunohistochemical demonstration of SARS‐CoV‐2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction‐negative patient","year":2020,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Calgary","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Lesion; Pathology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Dermatology; Endothelium; Emergency department; 2019-20 coronavirus outbreak; Internal medicine; Outbreak; Disease","score_opus":0.021736448261101878,"score_gpt":0.26817749021407594,"score_spread":0.24644104195297406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037583352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9228473,0.004144416,0.0014630081,0.026516931,0.0019333074,0.0001689475,0.00019901263,0.000121081626,0.04260583],"genre_scores_gemma":[0.98761684,0.0010896479,0.00047951273,0.0049886764,0.0014154499,0.000015810623,0.00006042277,0.000017103253,0.004316391],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995534,0.00008245579,0.000052638203,0.00009881813,0.00008915264,0.00012346826],"domain_scores_gemma":[0.99916995,0.00036327363,0.00007310242,0.000062338055,0.000115858194,0.00021547948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037823364,0.0008488893,0.0005375753,0.0007415031,0.001159835,0.0009194648,0.00054119184,0.00419156,0.0026311984],"category_scores_gemma":[0.0024177055,0.00054990384,0.00041644883,0.00038680978,0.0009332907,0.0009598827,0.00041808127,0.002080136,0.0012312721],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011266826,0.00004982241,0.009053971,0.00004832174,0.000008369883,0.9826634,0.00036010324,0.000048123897,0.002964925,0.00023244125,0.0026891497,0.0017687356],"study_design_scores_gemma":[0.000037478672,0.00016647365,0.016822187,0.000043734683,0.000021079664,0.97341996,0.0004671495,0.0006225616,0.0012980899,0.00034665098,0.0067388313,0.00001581458],"about_ca_topic_score_codex":0.0024033755,"about_ca_topic_score_gemma":0.0019182722,"teacher_disagreement_score":0.00419156,"about_ca_system_score_codex":0.0009611937,"about_ca_system_score_gemma":0.00032984474,"threshold_uncertainty_score":0.0088021755},"labels":[],"label_agreement":null},{"id":"W3042003151","doi":"10.1111/bjd.19393","title":"Long‐term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3‐year results from two randomized phase III trials (CIMPASI‐1 and CIMPASI‐2)","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Psoriasis; Plaque psoriasis; Term (time); Randomized controlled trial; Internal medicine; Dermatology; Adalimumab; Disease","score_opus":0.043120984841270325,"score_gpt":0.30675068317116083,"score_spread":0.2636296983298905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042003151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701994,0.019505765,0.0014859912,0.0009631137,0.00035069173,0.003633899,0.0022622289,0.00012771881,0.0014712666],"genre_scores_gemma":[0.9785317,0.0083071375,0.0019946124,0.0013591999,0.00043780735,0.004615208,0.0031836447,0.000046636826,0.00152411],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976331,0.0014375829,0.00019072206,0.00025290434,0.0002195273,0.00026608465],"domain_scores_gemma":[0.9959734,0.0013040775,0.0012764656,0.00038384297,0.00026280794,0.00079935865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008580426,0.0014259659,0.002923739,0.0003980605,0.0005219424,0.0014794131,0.00090583356,0.0018856307,0.003441813],"category_scores_gemma":[0.0047592004,0.0006107131,0.004645165,0.0005546451,0.0009804954,0.0010387443,0.00052184664,0.0033672303,0.0006448157],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95687866,0.0072988416,0.0022262067,0.00081821217,0.0034920457,0.000045864665,0.000100018784,0.00061272294,0.0028140224,0.0000620221,0.00092059234,0.024730688],"study_design_scores_gemma":[0.9145849,0.07301625,0.0085426895,0.000082724,0.002184368,0.000043928394,0.00002292278,0.00029941212,0.0004970467,0.000091400834,0.0006123095,0.000022142534],"about_ca_topic_score_codex":0.0010167883,"about_ca_topic_score_gemma":0.0018853282,"teacher_disagreement_score":0.008580426,"about_ca_system_score_codex":0.0010688901,"about_ca_system_score_gemma":0.00165175,"threshold_uncertainty_score":0.04537821},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W3047954696","doi":"10.1111/bjd.19461","title":"Exploring the human hair follicle microbiome*","year":2020,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institute for Advanced Research; University of Miami","keywords":"Microbiome; Human Microbiome Project; Dysbiosis; Human microbiome; Human skin; Hair follicle; Alopecia areata; Biology; Cathelicidin; Immunology; Microbiology; Medicine; Dermatology; Antimicrobial peptides; Antimicrobial; Bioinformatics; Cell biology; Genetics","score_opus":0.10481497034995306,"score_gpt":0.3367475182305985,"score_spread":0.23193254788064543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047954696","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001435695,0.9982665,0.00008839065,0.00033850071,0.00022879065,0.0000022577196,0.0000115958,0.000004746995,0.0009157388],"genre_scores_gemma":[0.0012636821,0.99747425,0.00014614845,0.00021818878,0.00020106416,0.0000029750715,0.00002154021,0.0000013371999,0.00067082717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999824,0.00003813849,0.00002081711,0.000030801133,0.00006874579,0.00001741956],"domain_scores_gemma":[0.99974316,0.000111048175,0.000036838304,0.0000071160453,0.00007488371,0.000026980306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043789652,0.00052479864,0.00063333876,0.0015645988,0.00022653586,0.00090484624,0.00031642002,0.0009571858,0.0036053688],"category_scores_gemma":[0.0007053229,0.00014976085,0.000350532,0.0012053519,0.00027083606,0.0010441592,0.00068848766,0.0008701642,0.0018389681],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044939523,0.000023035927,0.00028183666,0.012739989,0.00005583381,0.00012999329,0.000067351066,0.00013436809,0.0018233943,0.0018537414,0.02081727,0.9620282],"study_design_scores_gemma":[0.000007892538,0.00007383669,0.0021124287,0.005673652,0.00008350364,0.001574913,0.00012475738,0.00006553632,0.0005814478,0.001233219,0.9884533,0.000015488911],"about_ca_topic_score_codex":0.0017981611,"about_ca_topic_score_gemma":0.0023925013,"teacher_disagreement_score":0.0036053688,"about_ca_system_score_codex":0.00047031773,"about_ca_system_score_gemma":0.0009813131,"threshold_uncertainty_score":0.012061179},"labels":[],"label_agreement":null},{"id":"W3049615455","doi":"10.1111/bjd.19490","title":"Intralesional rituximab in the treatment of indolent primary cutaneous B‐cell lymphoma","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Montréal; McGill University","funders":"","keywords":"Rituximab; Medicine; Dermatology; Lymphoma; Primary (astronomy); Oncology; Internal medicine","score_opus":0.02096061679933361,"score_gpt":0.2733077475475117,"score_spread":0.2523471307481781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049615455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5278083,0.43231258,0.00421488,0.0036206672,0.00083317806,0.00023688945,0.00028241694,0.00036988396,0.030321194],"genre_scores_gemma":[0.9473156,0.046564054,0.0012558678,0.0013008201,0.00039997013,0.00012934813,0.00027996916,0.00003172988,0.0027227255],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9998109,0.000079359226,0.000015209125,0.000015142406,0.00003522421,0.00004406021],"domain_scores_gemma":[0.99982387,0.00006584965,0.000025442709,0.000016413125,0.000016379741,0.000052167674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039023167,0.0003816805,0.0006670586,0.0004238876,0.000183858,0.00030427804,0.00041099917,0.0005173975,0.0012342093],"category_scores_gemma":[0.00045406786,0.00012463589,0.00030858952,0.0002782723,0.00019275499,0.00028812367,0.00018436956,0.0011303093,0.0005599329],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010891885,0.0015659183,0.0059455824,0.001907226,0.0005628614,0.00912786,0.00031892283,0.0023909416,0.035995133,0.0008581866,0.014735048,0.91570044],"study_design_scores_gemma":[0.028164523,0.086879976,0.20795596,0.0045161294,0.0033189123,0.13130076,0.0008397885,0.01213819,0.049362306,0.0036432857,0.47158152,0.0002986695],"about_ca_topic_score_codex":0.0005660933,"about_ca_topic_score_gemma":0.0013757509,"teacher_disagreement_score":0.0012342093,"about_ca_system_score_codex":0.0003960661,"about_ca_system_score_gemma":0.00024791955,"threshold_uncertainty_score":0.0041288137},"labels":[],"label_agreement":null},{"id":"W3084270130","doi":"10.1111/bjd.19538","title":"Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils","year":2020,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Conceptualization; Library science; Townsend; Hidradenitis suppurativa; Medicine; Computer science; Psychology; Artificial intelligence; Internal medicine; Disease","score_opus":0.041185504932253564,"score_gpt":0.3043674350963584,"score_spread":0.26318193016410485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084270130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008347015,0.9992415,0.000048509362,0.00010535547,0.00013485982,0.0000033723877,0.000007939921,0.0000035436753,0.00037156124],"genre_scores_gemma":[0.000519623,0.9987816,0.00010681171,0.000110656496,0.00011270059,0.000006213376,0.000019242021,8.9949623e-7,0.00034228057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998517,0.000029221419,0.000025312096,0.000023347791,0.00005467199,0.000015694035],"domain_scores_gemma":[0.99978596,0.00010708841,0.000033775013,0.0000059406957,0.000051531355,0.000015769592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038915582,0.00069273013,0.0011042584,0.0020303677,0.00021761641,0.00076472113,0.00057505304,0.00089867285,0.003400432],"category_scores_gemma":[0.0005540966,0.00019005545,0.0004964042,0.0016207488,0.00028441084,0.0009209974,0.0004982098,0.0013823977,0.0014010506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001190483,0.00010138633,0.00013801512,0.025700672,0.00009227263,0.00018873031,0.000059326056,0.0002567545,0.0020738023,0.002099594,0.023776216,0.9453943],"study_design_scores_gemma":[0.000041009363,0.0002245053,0.0012384463,0.0085556805,0.00022150113,0.001969885,0.00008110551,0.00012356303,0.00073828717,0.0014743785,0.9853129,0.000018770226],"about_ca_topic_score_codex":0.00064057426,"about_ca_topic_score_gemma":0.0010587622,"teacher_disagreement_score":0.003400432,"about_ca_system_score_codex":0.00038024902,"about_ca_system_score_gemma":0.00064014125,"threshold_uncertainty_score":0.011375606},"labels":[],"label_agreement":null},{"id":"W3087522660","doi":"10.1111/bjd.19561","title":"The global burden of chronic urticaria for the patient and society*","year":2020,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":340,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Medicine; Chronic urticaria; Dermatology; Intensive care medicine","score_opus":0.015063105415696382,"score_gpt":0.2944130739982385,"score_spread":0.27934996858254213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087522660","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047194,0.99608934,0.00006602572,0.0010708094,0.00034644778,0.0000041794538,0.00007911897,0.000009933688,0.0018622498],"genre_scores_gemma":[0.0068446966,0.9898207,0.00021091977,0.00073271943,0.0005593369,0.000010096023,0.0001564503,0.0000035398423,0.0016614652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970055,0.00007444369,0.00004450398,0.000036675137,0.000109256835,0.000034636636],"domain_scores_gemma":[0.99957436,0.00014311768,0.00011079366,0.000011871476,0.0001137509,0.000046054727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004919649,0.00053307135,0.000754611,0.0010853538,0.00021038338,0.0008009231,0.00031316737,0.0007225406,0.0071759713],"category_scores_gemma":[0.0007355322,0.00014036175,0.0005782656,0.0013821496,0.00018768142,0.00053574174,0.00049280835,0.0007729105,0.0016520473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092280054,0.000028942653,0.00085785624,0.014313854,0.0002321142,0.00013322043,0.000051015133,0.00016626797,0.00088564225,0.0015026698,0.05406031,0.92767584],"study_design_scores_gemma":[0.00003124191,0.00015677488,0.009766506,0.011678809,0.00041938573,0.0024048514,0.00015730204,0.00012858678,0.0003359299,0.0008383076,0.97406346,0.000018818662],"about_ca_topic_score_codex":0.0026322922,"about_ca_topic_score_gemma":0.0038488477,"teacher_disagreement_score":0.0071759713,"about_ca_system_score_codex":0.0005531773,"about_ca_system_score_gemma":0.0010327667,"threshold_uncertainty_score":0.024006069},"labels":[],"label_agreement":null},{"id":"W3090227268","doi":"10.1111/bjd.19573","title":"Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"LEO Pharma","keywords":"Medicine; Placebo; Atopic dermatitis; Double blind; Dermatology; Randomized controlled trial; Internal medicine; Alternative medicine; Pathology","score_opus":0.03726144453849478,"score_gpt":0.31077395832284244,"score_spread":0.27351251378434766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090227268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663069,0.021655312,0.0009969394,0.0014942834,0.0010703703,0.0037331409,0.0017597082,0.00018275094,0.0028005126],"genre_scores_gemma":[0.97803473,0.009741241,0.0016440806,0.0017998668,0.00070014695,0.0033048028,0.0014134876,0.000039594554,0.0033219843],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99924856,0.0004038345,0.00005551607,0.00011414103,0.000069267815,0.00010870784],"domain_scores_gemma":[0.9991935,0.0002293541,0.00021335769,0.00006304082,0.00006396886,0.00023684412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027761357,0.0015470542,0.002511608,0.00032294504,0.00039166785,0.001183826,0.0008074366,0.0015338813,0.0049760845],"category_scores_gemma":[0.001811978,0.00052259926,0.002417795,0.0003390174,0.00085677864,0.0008983111,0.00029523426,0.0027783595,0.00072106643],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.972937,0.0038413536,0.00050413935,0.0010867028,0.0014528444,0.000039865703,0.000049195703,0.00024233731,0.0032131036,0.00008466793,0.0011954112,0.01535339],"study_design_scores_gemma":[0.9737726,0.023476696,0.0012252271,0.0000420898,0.00065154495,0.000032146567,0.000012731011,0.00014738551,0.00017284586,0.0000613358,0.000396874,0.000008568465],"about_ca_topic_score_codex":0.0010137878,"about_ca_topic_score_gemma":0.0026289206,"teacher_disagreement_score":0.0049760845,"about_ca_system_score_codex":0.0006424268,"about_ca_system_score_gemma":0.0011126954,"threshold_uncertainty_score":0.016646683},"labels":[],"label_agreement":null},{"id":"W3091046625","doi":"10.1111/bjd.19574","title":"Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":595,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Université Laval; Probity Medical Research; Lynde Centre for Dermatology; University of Toronto","funders":"LEO Pharma","keywords":"Placebo; Atopic dermatitis; Double blind; Medicine; Randomized controlled trial; Physical therapy; Dermatology; Internal medicine; Alternative medicine","score_opus":0.04667870606626964,"score_gpt":0.33081951389425385,"score_spread":0.28414080782798423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091046625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8783116,0.086035304,0.0028156012,0.0028597373,0.0013456118,0.017632669,0.005627267,0.0004541364,0.00491813],"genre_scores_gemma":[0.9361024,0.032979723,0.0044508297,0.0033966566,0.000871539,0.014603273,0.004146019,0.00008425253,0.00336534],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99820685,0.00088387344,0.00021093336,0.00030234063,0.0002004228,0.00019554638],"domain_scores_gemma":[0.9979068,0.00058044627,0.000619914,0.00018997754,0.00022556863,0.0004773908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007724968,0.001953153,0.0032136007,0.00044274,0.00055619195,0.0016195563,0.0011421487,0.002432162,0.004680507],"category_scores_gemma":[0.0045035677,0.00077269797,0.0035742025,0.0006575696,0.0009747039,0.0012592443,0.00037842878,0.0025520555,0.0007337669],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.924148,0.009428669,0.0012387316,0.0045443904,0.004899068,0.00006538326,0.00016996512,0.00044078915,0.0072936434,0.0001362786,0.003157735,0.04447738],"study_design_scores_gemma":[0.9591829,0.033710465,0.0034364613,0.00014788177,0.0017641834,0.000055328568,0.000021218255,0.00012074283,0.00037691658,0.00007047314,0.0010931315,0.000020408608],"about_ca_topic_score_codex":0.0009681179,"about_ca_topic_score_gemma":0.0029123763,"teacher_disagreement_score":0.007724968,"about_ca_system_score_codex":0.00087721413,"about_ca_system_score_gemma":0.0016619588,"threshold_uncertainty_score":0.040854037},"labels":[],"label_agreement":null},{"id":"W3094557022","doi":"10.1111/bjd.19626","title":"Hidradenitis suppurativa and perceived stigmatization in a diverse Canadian clinic population: a pilot study","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto; Queen's University","funders":"LEO Fondet","keywords":"Hidradenitis suppurativa; Medicine; Population; Family medicine; Gerontology; Dermatology; Psychiatry; Environmental health; Pathology; Disease","score_opus":0.040006498285056966,"score_gpt":0.28687886405824575,"score_spread":0.24687236577318877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094557022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823356,0.00013930828,0.0000257353,0.00012385844,0.000008525791,0.00012209074,0.00022610389,0.000001463074,0.0011193238],"genre_scores_gemma":[0.99821943,0.00030177148,0.00012929871,0.00023492552,0.000012925119,0.000073786236,0.00025863774,0.0000035225353,0.000765608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836856,0.00021543255,0.00006141777,0.00016360244,0.0004479359,0.0007430343],"domain_scores_gemma":[0.99801886,0.00019340732,0.00027096045,0.00006152479,0.0008232359,0.00063203386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012602228,0.00082129316,0.0008409695,0.0015761715,0.009536339,0.0021693448,0.0015510782,0.0011736578,0.0032817272],"category_scores_gemma":[0.003033624,0.0007927495,0.0010199138,0.0038094565,0.0019635034,0.00087521545,0.0015847131,0.0018126613,0.00045792558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049375725,0.0018434012,0.9480574,0.00015608135,0.00010767451,0.0014097783,0.038272772,0.000052648502,0.0011042706,0.00021197202,0.0015306049,0.006759783],"study_design_scores_gemma":[0.000053643853,0.00034418234,0.9667976,0.00004084946,0.000048891936,0.00039332584,0.031183867,0.000089768895,0.0000499876,0.000033605695,0.0009251042,0.00003912366],"about_ca_topic_score_codex":0.96497405,"about_ca_topic_score_gemma":0.9768157,"teacher_disagreement_score":0.035025954,"about_ca_system_score_codex":0.01745541,"about_ca_system_score_gemma":0.01800478,"threshold_uncertainty_score":0.12664849},"labels":[],"label_agreement":null},{"id":"W3098806773","doi":"10.1111/bjd.19613","title":"Long‐term safety of dupilumab in children","year":2020,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Dupilumab; Dermatology; Term (time); Medicine; Atopic dermatitis; Physics; Astronomy","score_opus":0.00839095991920796,"score_gpt":0.24382186479428533,"score_spread":0.23543090487507737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098806773","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15633771,0.047540225,0.0012798201,0.7266479,0.009395901,0.000034627286,0.00072819024,0.00014317095,0.057892423],"genre_scores_gemma":[0.7765246,0.014414165,0.00055821,0.1762562,0.016685162,0.000034958364,0.00029978325,0.0000742029,0.015152736],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99909735,0.0002415438,0.00007522108,0.000108761895,0.00026755512,0.00020960726],"domain_scores_gemma":[0.9954407,0.0025946973,0.0006697928,0.00012227907,0.0005016802,0.00067082077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095086993,0.0001887071,0.0005531628,0.00021210183,0.00087774085,0.00088004384,0.00040823355,0.004172879,0.0023693566],"category_scores_gemma":[0.0071936925,0.00012909707,0.00039051077,0.00029859575,0.00073126785,0.0005711907,0.0003036243,0.0043369243,0.0012295435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018245133,0.00021027443,0.077958584,0.00052148575,0.00016219348,0.2031179,0.0008101249,0.0011033732,0.005637332,0.008160565,0.52473,0.17576356],"study_design_scores_gemma":[0.0007389068,0.0022127857,0.06763225,0.0015879247,0.00028891378,0.39870194,0.0009102848,0.0024909263,0.005371967,0.008508546,0.5114307,0.00012480587],"about_ca_topic_score_codex":0.0036572376,"about_ca_topic_score_gemma":0.004486704,"teacher_disagreement_score":0.004172879,"about_ca_system_score_codex":0.0029810441,"about_ca_system_score_gemma":0.0010047939,"threshold_uncertainty_score":0.021629035},"labels":[],"label_agreement":null},{"id":"W3103797363","doi":"10.1111/bjd.19675","title":"Identifying and appraising patient‐reported outcome measures on treatment satisfaction in acne: a systematic review*","year":2020,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Windsor Clinical Research","funders":"","keywords":"Acne; Patient satisfaction; Patient-reported outcome; Outcome (game theory); Systematic review; Medicine; Psychology; MEDLINE; Dermatology; Surgery; Quality of life (healthcare); Nursing; Political science; Mathematics","score_opus":0.09559344214986257,"score_gpt":0.37524820642767187,"score_spread":0.27965476427780933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103797363","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035737825,0.9928288,0.00047799057,0.00040078317,0.0001126507,0.0013791206,0.000843247,0.0000132876485,0.0003703079],"genre_scores_gemma":[0.080688745,0.90732616,0.0035384016,0.0012441722,0.00019684424,0.0058084205,0.0010122692,0.000016698761,0.0001683019],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.95884657,0.018577918,0.015041295,0.0016147638,0.00542389,0.00049559504],"domain_scores_gemma":[0.8567872,0.108305864,0.02508343,0.0017176021,0.007488165,0.00061779865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03201666,0.0014662343,0.010025226,0.014280752,0.0007160945,0.0034480088,0.0021611464,0.0022103703,0.0038916015],"category_scores_gemma":[0.12238179,0.0010197355,0.010792924,0.015074114,0.0013489011,0.0035580515,0.0021024174,0.0015294921,0.00025394058],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024922332,0.0000229091,0.0013903377,0.9594123,0.010142239,0.00003622322,0.00022761113,0.00007026047,0.00006355263,0.0001421503,0.00064437167,0.0275988],"study_design_scores_gemma":[0.0006809789,0.0004393157,0.009565519,0.9052321,0.07443067,0.0002444247,0.0005721225,0.00018757842,0.00017135267,0.00036110167,0.008058954,0.000055980574],"about_ca_topic_score_codex":0.0048878565,"about_ca_topic_score_gemma":0.012932751,"teacher_disagreement_score":0.03201666,"about_ca_system_score_codex":0.00458808,"about_ca_system_score_gemma":0.011658195,"threshold_uncertainty_score":0.16932231},"labels":[],"label_agreement":null},{"id":"W3105897515","doi":"10.1111/bjd.19686","title":"Hidradenitis suppurativa odour and drainage scale: a novel method for evaluating odour and drainage in patients with hidradenitis suppurativa","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Women's College Hospital; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Conceptualization; Medicine; Dermatology; Library science; Computer science; Artificial intelligence; Pathology","score_opus":0.033529507752379124,"score_gpt":0.2972846565370426,"score_spread":0.2637551487846635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105897515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823737,0.0041791745,0.0036616488,0.0005297492,0.000297332,0.00056280266,0.0011982223,0.00010919744,0.0070881783],"genre_scores_gemma":[0.9822123,0.0011816884,0.013295497,0.00025764643,0.00013207029,0.0004041786,0.00060926506,0.000018472441,0.0018888873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993623,0.00019462415,0.00009233813,0.000076766,0.00020903096,0.00006495665],"domain_scores_gemma":[0.9993019,0.00019972211,0.00019909453,0.000027514916,0.00015654376,0.00011522577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006768106,0.000574647,0.0008489677,0.0011545385,0.00028970698,0.0005217743,0.00033372678,0.0007337578,0.0016055607],"category_scores_gemma":[0.0016990516,0.00023657006,0.0005075814,0.00070401037,0.00021425985,0.00067286723,0.000751798,0.00070142833,0.00047741493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037431344,0.0009488702,0.8780653,0.00057524623,0.00035167416,0.0020367543,0.00043298592,0.00034468918,0.032703176,0.00021151897,0.0027850883,0.077801555],"study_design_scores_gemma":[0.00037968857,0.0024976586,0.9787491,0.00006139281,0.00018042784,0.007501273,0.0004032964,0.0031020725,0.004003782,0.00009369958,0.002953764,0.0000737435],"about_ca_topic_score_codex":0.0006389694,"about_ca_topic_score_gemma":0.00168355,"teacher_disagreement_score":0.0016055607,"about_ca_system_score_codex":0.00025352158,"about_ca_system_score_gemma":0.00026568712,"threshold_uncertainty_score":0.0053711534},"labels":[],"label_agreement":null},{"id":"W3121257303","doi":"10.1111/bjd.19808","title":"Inducible skin‐associated lymphoid tissue (iSALT) in a patient with Schnitzler syndrome who manifested wheals on recurrent localized erythema","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Erythema; Kyoto Protocol; Library science; Medicine; Medical education; Psychology; Computer science; Dermatology; Greenhouse gas","score_opus":0.007333987465562128,"score_gpt":0.22212702708737989,"score_spread":0.21479303962181776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121257303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.737649,0.008263699,0.0029392228,0.18440087,0.008516286,0.00022769817,0.0006468402,0.0004694934,0.056886803],"genre_scores_gemma":[0.9580409,0.0019676785,0.0016694518,0.020978734,0.008681362,0.00004994587,0.00013046373,0.00008613938,0.008395376],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991763,0.00016300801,0.000101295365,0.00019802582,0.00011985381,0.00024157026],"domain_scores_gemma":[0.9973308,0.0014715495,0.00027539412,0.00014095203,0.00016494229,0.0006165274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005964163,0.001687554,0.0010079282,0.0009857828,0.0017980533,0.0011419876,0.0013396197,0.011430241,0.0029888095],"category_scores_gemma":[0.005393948,0.00073293666,0.0011757078,0.0007734405,0.0015318847,0.0016494101,0.00094850705,0.005145203,0.00089689356],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090928566,0.000025270812,0.0022973989,0.000030345427,0.000009053014,0.99308586,0.00012187131,0.000042523334,0.00064268295,0.00035810287,0.0024207542,0.0008752528],"study_design_scores_gemma":[0.00006832715,0.00014333225,0.007279376,0.000050386567,0.000048612685,0.9857642,0.00019424557,0.0006011648,0.00047991358,0.0009106686,0.0044327136,0.000027074897],"about_ca_topic_score_codex":0.003465631,"about_ca_topic_score_gemma":0.002847951,"teacher_disagreement_score":0.011430241,"about_ca_system_score_codex":0.0015555412,"about_ca_system_score_gemma":0.00075837836,"threshold_uncertainty_score":0.011286318},"labels":[],"label_agreement":null},{"id":"W3127741312","doi":"10.1111/bjd.19874","title":"Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"University of California, San Francisco; Medical Research Council; National Institute for Health and Care Research; Wellcome Trust","keywords":"Atopic dermatitis; Dermatology; Consensus conference; Medicine; MEDLINE; Family medicine; Political science; Internal medicine; Law","score_opus":0.23209595287328302,"score_gpt":0.4617653728410365,"score_spread":0.2296694199677535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127741312","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056410697,0.011159197,0.011915859,0.9212312,0.041197274,0.0025504967,0.00031083575,0.00015491465,0.005839108],"genre_scores_gemma":[0.14865346,0.028014343,0.11345734,0.6369803,0.04221202,0.019082002,0.0012019358,0.00057980337,0.009818741],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.741999,0.18621664,0.033533186,0.0078453105,0.020352773,0.010053045],"domain_scores_gemma":[0.54667026,0.30054408,0.013631167,0.009592073,0.10277661,0.026785826],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.22619432,0.0014699474,0.0022815946,0.0042399904,0.0069719683,0.008599446,0.006737595,0.020653246,0.009634767],"category_scores_gemma":[0.37563893,0.0017206618,0.0029622612,0.0037638168,0.009657461,0.010375939,0.021555021,0.026659496,0.0024240944],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002690378,0.00029630787,0.0022811482,0.009652226,0.00018067798,0.002836912,0.053706698,0.0009246478,0.002177777,0.021120228,0.73340905,0.17314532],"study_design_scores_gemma":[0.00021497808,0.00023756652,0.0028696456,0.024444895,0.00009815914,0.0027412814,0.04142256,0.0020334604,0.0008178856,0.030706484,0.89407325,0.00033986213],"about_ca_topic_score_codex":0.0032853617,"about_ca_topic_score_gemma":0.0023817953,"teacher_disagreement_score":0.22619432,"about_ca_system_score_codex":0.008913532,"about_ca_system_score_gemma":0.050987117,"threshold_uncertainty_score":0.95424014},"labels":[],"label_agreement":null},{"id":"W3129022701","doi":"10.1111/bjd.19866","title":"Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)*","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Mediprobe Research (Canada); University of Toronto","funders":"Manchester Biomedical Research Centre; Merck Sharp and Dohme; Almirall; National Institute for Health and Care Research","keywords":"Medicine; Psoriasis Area and Severity Index; Internal medicine; Randomized controlled trial; Etanercept; Adverse effect; Placebo; Psoriasis; Gastroenterology; Surgery; Dermatology; Rheumatoid arthritis; Pathology","score_opus":0.038113802512536245,"score_gpt":0.34746219059349354,"score_spread":0.30934838808095727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129022701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84782124,0.13919571,0.0041487296,0.00042819613,0.0005075074,0.0015271538,0.0044964957,0.0002434873,0.0016314314],"genre_scores_gemma":[0.9875265,0.007043389,0.0012134524,0.00036823875,0.00027513842,0.00074918725,0.0024742063,0.00003456854,0.00031540982],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.983207,0.010579802,0.0024789404,0.0017219789,0.0014687235,0.00054355426],"domain_scores_gemma":[0.98334044,0.008470572,0.005275346,0.0014176766,0.0008166861,0.00067917776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028205547,0.002424062,0.0089834975,0.0019530014,0.00046911195,0.002464112,0.0010098452,0.0018449314,0.0018243567],"category_scores_gemma":[0.016389813,0.0012363549,0.022848295,0.0016820632,0.00075922516,0.0015735743,0.0011506588,0.002002731,0.0002608091],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5557351,0.00079650735,0.034292176,0.005271473,0.37377506,0.00009060647,0.00014048937,0.0018223595,0.0022759943,0.00009452524,0.00094115414,0.024764616],"study_design_scores_gemma":[0.22393313,0.058343872,0.19626959,0.00070039637,0.5112571,0.0003392647,0.00019387694,0.0034100285,0.0018819291,0.0004943112,0.0029758771,0.00020062416],"about_ca_topic_score_codex":0.00082333357,"about_ca_topic_score_gemma":0.0019025827,"teacher_disagreement_score":0.028205547,"about_ca_system_score_codex":0.0009184693,"about_ca_system_score_gemma":0.0009067644,"threshold_uncertainty_score":0.14916694},"labels":[],"label_agreement":null},{"id":"W3134902410","doi":"10.1111/bjd.20048","title":"Incidence of mycosis fungoides and Sézary syndrome in the Netherlands between 2000 and 2020","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mycosis fungoides; Conceptualization; Library science; Medicine; Computer science; Pathology","score_opus":0.01704176493645321,"score_gpt":0.2796455711869432,"score_spread":0.26260380625049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134902410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9562673,0.020420633,0.0005586612,0.0021843691,0.0003549174,0.000036448775,0.015914759,0.00002341894,0.0042395187],"genre_scores_gemma":[0.9792628,0.00989374,0.00049650646,0.00046927476,0.00022883694,0.00002988816,0.008319934,0.00001571053,0.0012832483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955374,0.00007790041,0.00008480269,0.0001024771,0.000119736585,0.00006131454],"domain_scores_gemma":[0.99852645,0.00017278937,0.00080313877,0.000030178786,0.00030411116,0.00016334301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006121633,0.00014552484,0.00026623686,0.0011332203,0.0001227771,0.0007952918,0.00038771445,0.0004985321,0.0012245103],"category_scores_gemma":[0.0020832245,0.00019208567,0.00035533035,0.0017922454,0.00016866144,0.0006975234,0.00030814618,0.0003583753,0.00027847162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015094827,0.000033705695,0.9680113,0.00029515874,0.00017427292,0.0017467809,0.00036466325,0.0003542601,0.000643583,0.00027626558,0.0063002664,0.021648835],"study_design_scores_gemma":[0.00002242956,0.000045716475,0.9799952,0.0002300678,0.00007970935,0.004275948,0.0006583787,0.0010125986,0.00018111643,0.00011710003,0.013364098,0.00001748676],"about_ca_topic_score_codex":0.041398104,"about_ca_topic_score_gemma":0.040056333,"teacher_disagreement_score":0.041398104,"about_ca_system_score_codex":0.00091005093,"about_ca_system_score_gemma":0.0005565892,"threshold_uncertainty_score":0.08231431},"labels":[],"label_agreement":null},{"id":"W3165137789","doi":"10.1111/bjd.20527","title":"Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Dermatology; Psoriasis; Eczematous dermatitis; Ustekinumab; Ixekizumab; Adverse effect; Population; Atopy; Etanercept; Allergy; Internal medicine; Secukinumab; Disease; Adalimumab; Immunology; Psoriatic arthritis","score_opus":0.010541554469904646,"score_gpt":0.20993748670632478,"score_spread":0.19939593223642013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165137789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7319248,0.13987257,0.019690404,0.06251649,0.007838863,0.003104548,0.024580834,0.00052208,0.009949467],"genre_scores_gemma":[0.9140719,0.021705354,0.0124525195,0.022578167,0.017902391,0.0010736161,0.008190796,0.0001236173,0.0019016131],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97712475,0.010594346,0.0039387415,0.0012443679,0.0065988507,0.0004990357],"domain_scores_gemma":[0.84921414,0.065945454,0.056125443,0.004589352,0.022024697,0.0021008027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031733375,0.00042719956,0.0017703504,0.0018153846,0.00030670007,0.0017924672,0.00083428464,0.0012098133,0.0019758118],"category_scores_gemma":[0.059797283,0.00025458762,0.0022812735,0.0020419843,0.0005068465,0.0009989662,0.00071205944,0.0014403613,0.00028590744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046346676,0.0012269922,0.37652805,0.010627137,0.018354021,0.0009062858,0.0005429104,0.0019116418,0.0034144528,0.0014429602,0.082565755,0.45613307],"study_design_scores_gemma":[0.009890886,0.02947462,0.708669,0.00624864,0.033871237,0.005566614,0.0005254194,0.018913891,0.008011343,0.003526366,0.17500106,0.00030103838],"about_ca_topic_score_codex":0.00036750248,"about_ca_topic_score_gemma":0.00068431906,"teacher_disagreement_score":0.031733375,"about_ca_system_score_codex":0.00086886145,"about_ca_system_score_gemma":0.0015768727,"threshold_uncertainty_score":0.16782415},"labels":[],"label_agreement":null},{"id":"W3167211705","doi":"10.1111/bjd.20571","title":"COVID‐19 outcomes in patients with autoimmune blistering disease","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Galderma; Regeneron Pharmaceuticals; Celgene; Sanofi; Valeant Pharmaceuticals International; Pfizer","keywords":"Coronavirus disease 2019 (COVID-19); Rituximab; Medicine; Pandemic; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Hydroxychloroquine; Population; Disease; Autoimmune disease; Immunology; Intensive care medicine; Infectious disease (medical specialty); Internal medicine; Virology; Antibody; Environmental health","score_opus":0.012355053018266282,"score_gpt":0.2501066067087263,"score_spread":0.23775155369046003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167211705","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31803727,0.039538186,0.0006020499,0.55214846,0.007517379,0.000058310477,0.0014913019,0.00009624588,0.08051086],"genre_scores_gemma":[0.8849216,0.008238077,0.00028243318,0.08711796,0.013295765,0.0000670874,0.0006883748,0.000027657381,0.0053610965],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9985494,0.00056378957,0.0001351555,0.00012670267,0.00029212137,0.0003329094],"domain_scores_gemma":[0.9959881,0.0019132561,0.00058224803,0.00012679344,0.0005584253,0.00083119987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001043474,0.0001691175,0.0005005605,0.0004064886,0.001017421,0.00089836295,0.0002875345,0.0030439398,0.0034217443],"category_scores_gemma":[0.009463132,0.0001082199,0.00028655096,0.0008172811,0.0005333163,0.0007628887,0.00043957718,0.0022912049,0.001119888],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017923528,0.00025505622,0.5038643,0.0004676452,0.00015342572,0.07678515,0.0012158098,0.00089607254,0.0013919655,0.0043379613,0.30093893,0.1079013],"study_design_scores_gemma":[0.0005762214,0.00088210986,0.5135287,0.0018933128,0.00018646824,0.28190488,0.0028325038,0.0020477488,0.000835931,0.024404114,0.17073849,0.00016952999],"about_ca_topic_score_codex":0.0031776633,"about_ca_topic_score_gemma":0.004279925,"teacher_disagreement_score":0.0034217443,"about_ca_system_score_codex":0.0016305145,"about_ca_system_score_gemma":0.0006343923,"threshold_uncertainty_score":0.01183027},"labels":[],"label_agreement":null},{"id":"W3173878348","doi":"10.1111/bjd.20595","title":"Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years of follow‐up","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Psoriasis Area and Severity Index; Medicine; Dermatology Life Quality Index; Psoriasis; Discontinuation; Adverse effect; Internal medicine; Randomized controlled trial; Quality of life (healthcare); Dermatology; Surgery","score_opus":0.03393482954166807,"score_gpt":0.2914853224965989,"score_spread":0.2575504929549308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173878348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860887,0.0046153967,0.00121282,0.00035829356,0.00017273678,0.001283199,0.0033456197,0.00012132752,0.0028020092],"genre_scores_gemma":[0.99031633,0.00068384816,0.0011370793,0.000451411,0.00017051441,0.0015602171,0.0041202516,0.000026398973,0.0015340577],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99720603,0.0014954543,0.00018448397,0.00034777037,0.00036769654,0.00039853554],"domain_scores_gemma":[0.9949255,0.0016214332,0.0014819389,0.0008666505,0.00044597284,0.00065848057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010600928,0.0011419778,0.0031372476,0.000506083,0.0005620179,0.0018206658,0.00090079807,0.0013866125,0.0036754834],"category_scores_gemma":[0.0057081534,0.00043871166,0.003954607,0.00049821025,0.0008327751,0.0015312028,0.00076646253,0.0026091794,0.0007173028],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9604674,0.0038372828,0.00861232,0.00044804162,0.0033174441,0.00008493021,0.0000878072,0.00091553945,0.0023230899,0.000130445,0.0018231515,0.017952483],"study_design_scores_gemma":[0.61233276,0.2668853,0.09556701,0.00021663154,0.012094776,0.00035598077,0.00011258364,0.0035389904,0.0038544515,0.00083946675,0.004097439,0.00010451314],"about_ca_topic_score_codex":0.00033424003,"about_ca_topic_score_gemma":0.0005661365,"teacher_disagreement_score":0.010600928,"about_ca_system_score_codex":0.0005831017,"about_ca_system_score_gemma":0.0011610361,"threshold_uncertainty_score":0.05606371},"labels":[],"label_agreement":null},{"id":"W3184945293","doi":"10.1111/bjd.20656","title":"The WHO ICD-11 Classification of Dermatological Diseases: a new comprehensive online skin disease taxonomy designed by and for dermatologists","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"World Health Organization","keywords":"Dermatology; Medicine; Dermatological diseases; Taxonomy (biology); Disease; Pathology; Biology","score_opus":0.03488992226106373,"score_gpt":0.292297492517278,"score_spread":0.25740757025621425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184945293","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26931036,0.012143123,0.0563078,0.015752865,0.010055508,0.015454056,0.5224362,0.0015355536,0.09700462],"genre_scores_gemma":[0.2626185,0.0095927585,0.19973423,0.0044908975,0.0012264389,0.018234836,0.48714897,0.000528289,0.016424915],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99507564,0.0010212624,0.0020281067,0.00025080022,0.0011022631,0.00052196137],"domain_scores_gemma":[0.99035674,0.0014107843,0.0027515898,0.00031578937,0.0043260665,0.0008389467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003601898,0.0010685582,0.0012113648,0.0084940735,0.000589222,0.0014742624,0.0010709628,0.00071861746,0.008609648],"category_scores_gemma":[0.011405289,0.000284744,0.0017917175,0.006686099,0.000505887,0.0019283363,0.0023691978,0.0018729147,0.00368093],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007733339,0.0006637949,0.3512532,0.0031444286,0.00033149493,0.000687165,0.0016540228,0.002142078,0.0031911207,0.011698818,0.41307914,0.2113814],"study_design_scores_gemma":[0.00035991214,0.00045163077,0.7221702,0.0024826254,0.00025080013,0.0017011394,0.003879463,0.0026332615,0.0010231836,0.009981746,0.25481224,0.0002539291],"about_ca_topic_score_codex":0.0065207225,"about_ca_topic_score_gemma":0.009138037,"teacher_disagreement_score":0.008609648,"about_ca_system_score_codex":0.0018527507,"about_ca_system_score_gemma":0.005814891,"threshold_uncertainty_score":0.028802156},"labels":[],"label_agreement":null},{"id":"W3186609223","doi":"10.1111/bjd.20661","title":"Association between atopic dermatitis and hypertension: a systematic review and meta‐analysis*","year":2021,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Lundbeckfonden","keywords":"Atopic dermatitis; Meta-analysis; Medicine; Dermatology; Association (psychology); MEDLINE; Internal medicine; Psychology; Biology","score_opus":0.043756712871461004,"score_gpt":0.3184358567561177,"score_spread":0.2746791438846567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186609223","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038341538,0.99503326,0.00028029535,0.00016972375,0.00012139829,0.00016032507,0.00024560015,0.000012100119,0.0001430903],"genre_scores_gemma":[0.12774849,0.86775225,0.0018741961,0.00077630463,0.0003502037,0.0007612198,0.00050610246,0.000019216362,0.00021203789],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9902368,0.004691423,0.0029002998,0.0008792057,0.0009941792,0.0002981596],"domain_scores_gemma":[0.97795916,0.016347239,0.0035839095,0.0005755397,0.0013131036,0.00022102651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01282518,0.0022971872,0.012848116,0.0061333785,0.000633701,0.0030326708,0.001696403,0.0018813476,0.0031843432],"category_scores_gemma":[0.028847013,0.0014265582,0.030729065,0.007217109,0.0006737332,0.0015674027,0.001221496,0.0016573288,0.00026156014],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014782873,0.000031947682,0.0066135176,0.4354569,0.5425278,0.00015660578,0.000084602936,0.0003290545,0.00022118236,0.00009341794,0.0006794615,0.01232723],"study_design_scores_gemma":[0.0004755683,0.00022087379,0.005766196,0.034953408,0.9565401,0.00015367477,0.000043627555,0.00015582587,0.00011250895,0.00014140128,0.0014157569,0.00002117465],"about_ca_topic_score_codex":0.0054872525,"about_ca_topic_score_gemma":0.01440141,"teacher_disagreement_score":0.012848116,"about_ca_system_score_codex":0.0020141725,"about_ca_system_score_gemma":0.0031906776,"threshold_uncertainty_score":0.06782681},"labels":[],"label_agreement":null},{"id":"W3190527361","doi":"10.1111/bjd.14773","title":"Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Institute for Health and Care Research","keywords":"Atopic dermatitis; Medicine; Clinical trial; Outcome (game theory); Family medicine; Dermatology; Pediatrics; Pathology","score_opus":0.24330472887355384,"score_gpt":0.43757963074610623,"score_spread":0.1942749018725524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190527361","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008702429,0.16151811,0.14441851,0.2692543,0.12953079,0.16170682,0.07636529,0.002335247,0.046168517],"genre_scores_gemma":[0.034278207,0.08734231,0.30887672,0.08677218,0.015733786,0.3658976,0.07749059,0.0021982042,0.021410318],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.68299156,0.17814049,0.06585146,0.010477086,0.054671895,0.00786751],"domain_scores_gemma":[0.60741067,0.11015324,0.062358405,0.022951085,0.17717971,0.019946868],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3982875,0.0035411776,0.010123031,0.011294164,0.0034955088,0.012374497,0.012434028,0.013690772,0.012282117],"category_scores_gemma":[0.32799348,0.0034523273,0.019930772,0.00978833,0.002053082,0.0055506015,0.015447758,0.018939957,0.0072861146],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037608685,0.0003998002,0.0025474275,0.113699585,0.008863821,0.0005940324,0.0032685013,0.0022557755,0.003436003,0.008371162,0.67626506,0.17653793],"study_design_scores_gemma":[0.006119994,0.00082931144,0.013438524,0.13608883,0.009272903,0.00040745325,0.0013369826,0.0013223587,0.0028489414,0.010801561,0.81702715,0.00050604844],"about_ca_topic_score_codex":0.005848011,"about_ca_topic_score_gemma":0.0069063925,"teacher_disagreement_score":0.60171247,"about_ca_system_score_codex":0.014303552,"about_ca_system_score_gemma":0.054999527,"threshold_uncertainty_score":0.74201864},"labels":[],"label_agreement":null},{"id":"W3200981700","doi":"10.1111/bjd.20760","title":"Transcriptomic changes during stage progression of mycosis fungoides","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Alberta","funders":"Faculty of Graduate Studies and Research, University of Alberta; Canadian Institutes of Health Research; Bispebjerg Hospital; Alberta Innovates; Kræftens Bekæmpelse; Canadian Dermatology Foundation","keywords":"Mycosis fungoides; Transcriptome; Laser capture microdissection; Biology; KEGG; Pathology; Cancer research; Lymphoma; Medicine; Gene expression; Gene; Immunology; Genetics","score_opus":0.017150419950369054,"score_gpt":0.31197931245031735,"score_spread":0.2948288924999483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200981700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99175537,0.0015647381,0.0008579836,0.000042841162,0.000015032785,0.000018629233,0.005256063,0.000029289482,0.00046000298],"genre_scores_gemma":[0.9867856,0.0009643554,0.0014186036,0.00007448115,0.00001539361,0.000079147714,0.009597096,0.00001820974,0.0010470535],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998859,0.0000087449735,0.0000066254975,0.000040530085,0.000027452681,0.0000306852],"domain_scores_gemma":[0.99986744,0.00003291824,0.000041642998,0.0000072065513,0.000033575845,0.000017204906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012850999,0.00017918219,0.00028224444,0.0005237365,0.00021946339,0.00037902198,0.00009068653,0.00028098063,0.0011200754],"category_scores_gemma":[0.00027154683,0.00010056678,0.0002685041,0.0005936354,0.0001210247,0.00018455778,0.00021343245,0.00024779522,0.00029859206],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009156247,0.000029092751,0.047153287,0.00030812243,0.00007977615,0.0003908633,0.00029639588,0.00033265958,0.9408486,0.000091910275,0.0004598311,0.009093827],"study_design_scores_gemma":[0.000022398579,0.00038075008,0.9417718,0.000060417253,0.00013382823,0.0013368225,0.00055113854,0.0016306291,0.047957577,0.00031436668,0.005813247,0.000027104817],"about_ca_topic_score_codex":0.0005684117,"about_ca_topic_score_gemma":0.00083605683,"teacher_disagreement_score":0.0011200754,"about_ca_system_score_codex":0.00018074161,"about_ca_system_score_gemma":0.00011825092,"threshold_uncertainty_score":0.0037469864},"labels":[],"label_agreement":null},{"id":"W3203661707","doi":"10.1111/bjd.20769","title":"Targeting the opioid pathway for the treatment of chronic kidney disease‐associated pruritus: a systematic review and meta‐analysis of randomized controlled trials","year":2021,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Manitoba; Ottawa Hospital; Dalhousie University; University of Ottawa","funders":"","keywords":"Conceptualization; Medicine; Biostatistics; Randomized controlled trial; Library science; Meta-analysis; Family medicine; Psychology; Public health; Internal medicine; Computer science; Artificial intelligence; Pathology","score_opus":0.042610205215862236,"score_gpt":0.346742159712007,"score_spread":0.3041319544961448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203661707","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028992926,0.99632037,0.00019682602,0.000079996586,0.000092389346,0.00012661796,0.00014147781,0.000008779277,0.00013437097],"genre_scores_gemma":[0.064071976,0.9336187,0.0010627706,0.00048539002,0.00011934526,0.0002186725,0.00022541841,0.000009627886,0.00018806271],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99711657,0.0013414732,0.0007596716,0.00032295912,0.00032304015,0.00013628002],"domain_scores_gemma":[0.99392337,0.0046627712,0.00093411544,0.0001231106,0.00025761948,0.00009900784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00501495,0.0021487745,0.012165808,0.002164463,0.00043406987,0.0020363096,0.001531345,0.0017275139,0.004097284],"category_scores_gemma":[0.013330641,0.00084794825,0.019552069,0.00263852,0.00054986007,0.0011977896,0.0010618985,0.0021717544,0.00023733571],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008380987,0.00010235762,0.0016282921,0.5640416,0.37870976,0.00010580994,0.0000773832,0.0005945016,0.00047614658,0.00016394464,0.0007833148,0.044935886],"study_design_scores_gemma":[0.004480711,0.00091204525,0.004458633,0.044935577,0.94093496,0.00013904364,0.000083235645,0.00023354123,0.00020077103,0.00031408164,0.0032615545,0.000045904493],"about_ca_topic_score_codex":0.0053853234,"about_ca_topic_score_gemma":0.016424503,"teacher_disagreement_score":0.012165808,"about_ca_system_score_codex":0.0014321656,"about_ca_system_score_gemma":0.0019679337,"threshold_uncertainty_score":0.026521921},"labels":[],"label_agreement":null},{"id":"W3207194448","doi":"10.1111/bjd.20818","title":"Long‐term safety of risankizumab from 17 clinical trials in patients with moderate‐to‐severe plaque psoriasis*","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"AbbVie","keywords":"Psoriasis; Medicine; Plaque psoriasis; Term (time); Clinical trial; Dermatology; Pediatrics; Internal medicine","score_opus":0.02992038853060693,"score_gpt":0.2943077013034289,"score_spread":0.264387312772822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207194448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91846335,0.066906504,0.0024626357,0.00072872505,0.00009720695,0.0035496028,0.0043680016,0.00009052626,0.0033333746],"genre_scores_gemma":[0.97112983,0.011640155,0.0036129362,0.00095684116,0.00022783177,0.004103918,0.007454933,0.000038566955,0.00083503756],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9834421,0.009042348,0.003490665,0.0010974557,0.0023756665,0.0005516933],"domain_scores_gemma":[0.9764056,0.0095975585,0.008602724,0.0017869996,0.0024343673,0.0011728033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0334112,0.00086324057,0.0027830428,0.0008651805,0.0005551044,0.0022261709,0.00066873105,0.0010383644,0.0021592653],"category_scores_gemma":[0.018641727,0.0005953237,0.0040528364,0.0019807892,0.0007563907,0.0011504326,0.0011557989,0.0018577176,0.00037309498],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4078292,0.003787311,0.22044545,0.011181422,0.05159426,0.00048112965,0.0009426225,0.003009846,0.012416209,0.00046597247,0.0048252563,0.28302127],"study_design_scores_gemma":[0.21424858,0.19998623,0.4883884,0.0036873254,0.047817543,0.0022605578,0.00043451475,0.0021191335,0.007994637,0.0012904701,0.031556696,0.00021594908],"about_ca_topic_score_codex":0.0004147364,"about_ca_topic_score_gemma":0.0011435252,"teacher_disagreement_score":0.0334112,"about_ca_system_score_codex":0.001053791,"about_ca_system_score_gemma":0.0025746883,"threshold_uncertainty_score":0.17669743},"labels":[],"label_agreement":null},{"id":"W3209037189","doi":"10.1111/bjd.20813","title":"Risankizumab vs. fumaric acid esters: a direct comparison","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Fumaric acid; Medicine; Dermatology; Chemistry; Organic chemistry","score_opus":0.018649059170808356,"score_gpt":0.23844152917481465,"score_spread":0.21979247000400629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209037189","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6312928,0.25072417,0.0019101123,0.030955141,0.013894786,0.0017438481,0.0046983534,0.00010065051,0.06468019],"genre_scores_gemma":[0.928853,0.040967885,0.00092265994,0.013230246,0.007372033,0.00059240486,0.0016145014,0.000037712813,0.006409641],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99771285,0.0013042463,0.00026275197,0.00022372747,0.00028355885,0.0002129355],"domain_scores_gemma":[0.9950218,0.0035354532,0.00044251513,0.00027717624,0.00033161536,0.00039135112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030677784,0.0005852272,0.0026192463,0.00035781885,0.00029505332,0.0012549578,0.0007671538,0.0025642214,0.010935961],"category_scores_gemma":[0.006363224,0.00024289358,0.002428838,0.00049842894,0.00059273595,0.0012103826,0.00037920303,0.0032872797,0.0025874611],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7833305,0.0023794114,0.0034312706,0.0035001577,0.003977915,0.00049935066,0.00017729843,0.0004216904,0.0027769275,0.001668478,0.010566538,0.18727042],"study_design_scores_gemma":[0.48365042,0.33643994,0.029230056,0.0023480437,0.014175095,0.002850632,0.00077522843,0.0015578535,0.004597312,0.0068868166,0.11732734,0.00016123461],"about_ca_topic_score_codex":0.0006476547,"about_ca_topic_score_gemma":0.0010713327,"teacher_disagreement_score":0.010935961,"about_ca_system_score_codex":0.0017016772,"about_ca_system_score_gemma":0.0005336659,"threshold_uncertainty_score":0.036584437},"labels":[],"label_agreement":null},{"id":"W3210606024","doi":"10.1111/bjd.20803","title":"The expected missing heritability of hidradenitis suppurativa in perspective","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Hidradenitis suppurativa; Missing heritability problem; Perspective (graphical); Heritability; Medicine; Dermatology; Biology; Computer science; Evolutionary biology; Genetics; Pathology; Artificial intelligence; Disease; Genotype; Genetic variants","score_opus":0.017800628307202998,"score_gpt":0.2801699338886474,"score_spread":0.26236930558144445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210606024","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15676251,0.015111374,0.004432845,0.7766676,0.013897836,0.0000319496,0.0023355552,0.00014415976,0.030616125],"genre_scores_gemma":[0.8567288,0.0057706772,0.001754212,0.10357628,0.021486871,0.00003301424,0.00049453805,0.00007326115,0.010082353],"study_design_codex":"case_report","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9990609,0.00033254354,0.000072204086,0.0002282243,0.00013901175,0.00016718374],"domain_scores_gemma":[0.99450123,0.004120648,0.00032846542,0.00027728628,0.0005019737,0.0002703205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011718749,0.00040305732,0.0006694675,0.0004093889,0.00086360535,0.000692923,0.00035687978,0.005312825,0.0051540504],"category_scores_gemma":[0.012481768,0.00024665016,0.00040372182,0.00036110106,0.0009885832,0.0010871326,0.00037767048,0.00413801,0.0013052294],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023746712,0.00027623892,0.1503345,0.00066499243,0.0003082829,0.3635672,0.001942009,0.0010489807,0.0101410225,0.023142053,0.34855166,0.09764845],"study_design_scores_gemma":[0.00058492174,0.000564212,0.19756196,0.0013077564,0.00042252938,0.5568229,0.002766744,0.004788997,0.0033305977,0.06288557,0.16877632,0.00018749485],"about_ca_topic_score_codex":0.0036794755,"about_ca_topic_score_gemma":0.0024572064,"teacher_disagreement_score":0.005312825,"about_ca_system_score_codex":0.00093260134,"about_ca_system_score_gemma":0.0004418793,"threshold_uncertainty_score":0.017242014},"labels":[],"label_agreement":null},{"id":"W3211175351","doi":"10.1111/bjd.20872","title":"IGAxBSA composite for assessing disease severity and response in patients with atopic dermatitis*","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"","keywords":"Eczema Area and Severity Index; Atopic dermatitis; SCORAD; Dupilumab; Medicine; Clinical trial; Post-hoc analysis; Placebo; Randomized controlled trial; Severity of illness; Disease; Dermatology; Internal medicine; Alternative medicine; Dermatology Life Quality Index; Pathology","score_opus":0.007535835295399717,"score_gpt":0.2585358083281043,"score_spread":0.2509999730327046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211175351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743878,0.013111882,0.0012753964,0.00035443058,0.00015316585,0.00052305666,0.0051556756,0.000074861804,0.004963745],"genre_scores_gemma":[0.9940301,0.0007336626,0.0016973426,0.00014975875,0.000113583286,0.0003591354,0.0024649366,0.000008975787,0.00044249505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969862,0.0014028891,0.00040635595,0.00046697413,0.0006091929,0.0001283456],"domain_scores_gemma":[0.9941538,0.002208374,0.002214733,0.00030984436,0.00063875096,0.00047443344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005356458,0.00063636346,0.0015510019,0.0015102244,0.00031621585,0.0007569358,0.00048471996,0.0005255851,0.0031440207],"category_scores_gemma":[0.0042668586,0.00017304777,0.0022084876,0.001589903,0.0002552499,0.00066315866,0.0006461685,0.0011748653,0.00046421768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02221053,0.0003367632,0.9361242,0.00095015153,0.0037676094,0.00007368218,0.000107544976,0.00076091866,0.0010648045,0.00008636159,0.0017451828,0.032772206],"study_design_scores_gemma":[0.00079982204,0.0039583566,0.98941004,0.00011240281,0.001237508,0.00049236364,0.00010653701,0.0016130345,0.00033073055,0.00018232115,0.0017310269,0.00002601288],"about_ca_topic_score_codex":0.0006572815,"about_ca_topic_score_gemma":0.0012410482,"teacher_disagreement_score":0.005356458,"about_ca_system_score_codex":0.00038380295,"about_ca_system_score_gemma":0.00041992162,"threshold_uncertainty_score":0.028328001},"labels":[],"label_agreement":null},{"id":"W3212200002","doi":"10.1111/bjd.20890","title":"Bullous pemphigoid after SARS‐CoV‐2 vaccination: spike‐protein‐directed immunofluorescence confocal microscopy and T‐cell‐receptor studies","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Library science; Dermatologic surgery; Dermatology; Computer science","score_opus":0.012643619235316888,"score_gpt":0.27296883556902196,"score_spread":0.2603252163337051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212200002","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09762987,0.0119209895,0.00246292,0.8177167,0.028041786,0.00049675425,0.00046262253,0.00043787147,0.040830527],"genre_scores_gemma":[0.50513923,0.013715029,0.0032588074,0.38310176,0.053372223,0.0004949852,0.000322655,0.00009551809,0.040499717],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9989096,0.00046686432,0.00013059135,0.00008755907,0.00024406752,0.00016124216],"domain_scores_gemma":[0.99733055,0.0016337095,0.00015008355,0.000112675276,0.0005495826,0.00022334507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025794315,0.00048733727,0.00078509486,0.0002910283,0.0007302211,0.0008063568,0.00046418695,0.0075365943,0.0028363112],"category_scores_gemma":[0.0055568903,0.00020143528,0.0006578919,0.0002415009,0.00068370043,0.0010782604,0.00020744946,0.0037562738,0.002027426],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002042421,0.00089246756,0.016695376,0.0007988314,0.00011977101,0.16197693,0.00063880644,0.00038318077,0.011752384,0.0031608995,0.6739916,0.12754735],"study_design_scores_gemma":[0.0016018109,0.0030841653,0.06631356,0.0011172716,0.00025014995,0.22292347,0.0010535484,0.0041233003,0.009505363,0.009232778,0.6806526,0.00014196748],"about_ca_topic_score_codex":0.0021441632,"about_ca_topic_score_gemma":0.0028523554,"teacher_disagreement_score":0.0075365943,"about_ca_system_score_codex":0.0017555108,"about_ca_system_score_gemma":0.00051979785,"threshold_uncertainty_score":0.013641536},"labels":[],"label_agreement":null},{"id":"W3214576279","doi":"10.1111/bjd.20885","title":"Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; ABB (Canada); Surrey Memorial Hospital; SKiN Health; University of British Columbia; Queen's University; Probity Medical Research","funders":"AbbVie Canada","keywords":"Adalimumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Adverse effect; Methotrexate; Dermatology Life Quality Index; Clinical endpoint; Internal medicine; Quality of life (healthcare); Patient satisfaction; Physical therapy; Clinical trial; Surgery; Dermatology; Disease","score_opus":0.010135586516618247,"score_gpt":0.24391609904802913,"score_spread":0.23378051253141088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214576279","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8175165,0.09244074,0.0010525812,0.06890413,0.008589129,0.00040610318,0.002548102,0.000086257554,0.008456386],"genre_scores_gemma":[0.9469,0.018234454,0.0021895005,0.018587504,0.011484646,0.00022503769,0.00066279026,0.000034714212,0.0016812349],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982968,0.0009377664,0.00019937912,0.00013127066,0.00035625944,0.00007851638],"domain_scores_gemma":[0.9859995,0.00868309,0.0029242223,0.00021523966,0.0014582169,0.00071974425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045614652,0.00021391366,0.0013256011,0.000323996,0.00047526025,0.0010866299,0.00040087622,0.0010129488,0.0048164446],"category_scores_gemma":[0.022176642,0.00018242035,0.00072743633,0.00057565817,0.00035493358,0.00070373295,0.0002477846,0.001750265,0.00045196866],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0687883,0.00447542,0.22700281,0.005059142,0.0024420286,0.0012778974,0.0009405728,0.0006156702,0.0012782911,0.00045599416,0.15991339,0.5277505],"study_design_scores_gemma":[0.036420543,0.054323893,0.7808523,0.0030993193,0.0053209085,0.00837645,0.0024986686,0.011734786,0.0019964029,0.0011452171,0.09389226,0.00033919222],"about_ca_topic_score_codex":0.0011987009,"about_ca_topic_score_gemma":0.0034345784,"teacher_disagreement_score":0.0048164446,"about_ca_system_score_codex":0.0008041595,"about_ca_system_score_gemma":0.0005515524,"threshold_uncertainty_score":0.024123669},"labels":[],"label_agreement":null},{"id":"W4206317343","doi":"10.1111/bjd.20969","title":"Janus kinase 1 inhibitor <scp>INCB054707</scp> for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase <scp>II</scp> studies*","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York Central Hospital","funders":"Incyte","keywords":"Hidradenitis suppurativa; Medicine; Tolerability; Internal medicine; Adverse effect; Clinical endpoint; Placebo; Gastroenterology; Clinical trial; Surgery; Disease; Pathology","score_opus":0.018912326871015076,"score_gpt":0.28713409122451755,"score_spread":0.2682217643535025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206317343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97979647,0.01663693,0.00042433676,0.0005708861,0.00009852722,0.00076083024,0.0004770141,0.00004735022,0.0011876703],"genre_scores_gemma":[0.9913449,0.0054134307,0.00094642286,0.0006067252,0.00016783459,0.00040145058,0.00076228305,0.000010437125,0.0003464574],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995648,0.0002441305,0.000054620403,0.00004039361,0.000046532015,0.000049459293],"domain_scores_gemma":[0.9988551,0.00038261077,0.00034731237,0.00007294862,0.00009762339,0.00024430524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019974464,0.00049359817,0.0013171178,0.00019571258,0.00021535745,0.0005875713,0.0003407492,0.0005702779,0.0013604182],"category_scores_gemma":[0.0011961272,0.00021806777,0.0014122125,0.00027537337,0.00036882586,0.00041978332,0.00016394595,0.0012208917,0.00023210431],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5823654,0.01828613,0.020738726,0.0038533425,0.004759902,0.00025942517,0.0003723679,0.0012404311,0.054729607,0.00021966796,0.0040765447,0.30909848],"study_design_scores_gemma":[0.5411123,0.3749827,0.06535447,0.0003073138,0.00381307,0.0007445684,0.00012533847,0.00093640096,0.007759939,0.00016613679,0.00464823,0.000049460385],"about_ca_topic_score_codex":0.0003223446,"about_ca_topic_score_gemma":0.0012303864,"teacher_disagreement_score":0.0019974464,"about_ca_system_score_codex":0.00036976743,"about_ca_system_score_gemma":0.00083540304,"threshold_uncertainty_score":0.010563612},"labels":[],"label_agreement":null},{"id":"W4206535562","doi":"10.1111/bjd.21015","title":"The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase <scp>III</scp> trials","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Conceptualization; Miami; Atopic dermatitis; Medicine; Dermatology; Library science; Psychology; Computer science; Artificial intelligence","score_opus":0.014567766244598716,"score_gpt":0.2948778005423152,"score_spread":0.2803100342977165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206535562","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41153657,0.07512628,0.0016055017,0.47675547,0.007747698,0.00038242157,0.0022690468,0.00011789145,0.02445909],"genre_scores_gemma":[0.89049906,0.008154336,0.0012238267,0.08512506,0.012231371,0.0002764519,0.00046897386,0.000026813566,0.0019941798],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9880227,0.008541409,0.0010702511,0.00057347753,0.0014101297,0.0003821058],"domain_scores_gemma":[0.94731873,0.042644545,0.004334,0.00096427096,0.0034600948,0.0012782875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009894821,0.0002875052,0.0015719674,0.0003941876,0.0005110674,0.0012236702,0.000441787,0.0024097129,0.0024200836],"category_scores_gemma":[0.03584373,0.00018852636,0.0011909605,0.0009481893,0.0006425419,0.00066128606,0.0002911812,0.002780622,0.00046030566],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08543376,0.0010127613,0.332572,0.0043930234,0.0066142217,0.0077610756,0.0006970993,0.0018055929,0.0066353045,0.0027804337,0.17137711,0.37891766],"study_design_scores_gemma":[0.038161956,0.018130466,0.701302,0.002574624,0.011006073,0.01881056,0.0010507216,0.011579926,0.007564658,0.01646348,0.17301483,0.00034078053],"about_ca_topic_score_codex":0.001085085,"about_ca_topic_score_gemma":0.0020480216,"teacher_disagreement_score":0.009894821,"about_ca_system_score_codex":0.0013491387,"about_ca_system_score_gemma":0.0010232355,"threshold_uncertainty_score":0.05232942},"labels":[],"label_agreement":null},{"id":"W4213146943","doi":"10.1111/bjd.16515","title":"Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"UCB Pharma; Health and Care Research Wales","keywords":"Hidradenitis suppurativa; Medicine; Acne; Population; Polycystic ovary; Dermatology; Acanthosis nigricans; Disease; Ulcerative colitis; Scars; Depression (economics); Pediatrics; Obesity; Internal medicine; Algorithm; Surgery; Insulin resistance","score_opus":0.1610779611514354,"score_gpt":0.4961405342960012,"score_spread":0.3350625731445658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213146943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9467987,0.002538477,0.017255502,0.0018005837,0.0001352865,0.0017358157,0.025749866,0.00021800374,0.0037676923],"genre_scores_gemma":[0.9728494,0.0004968025,0.011223637,0.00047230133,0.000051781386,0.0018798285,0.012350269,0.0000610277,0.00061497546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95891756,0.030847365,0.003073815,0.0043526758,0.0019438885,0.0008647154],"domain_scores_gemma":[0.8938125,0.072473474,0.01617068,0.008988519,0.0062654354,0.002289433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0281274,0.00064758677,0.0015669925,0.0029736583,0.00087235466,0.003623775,0.001627724,0.0020398856,0.0072780927],"category_scores_gemma":[0.12175148,0.00081274944,0.0034434344,0.007534558,0.000496285,0.00277397,0.0025833528,0.002557206,0.0017807437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035164088,0.0007534552,0.9677433,0.00085373025,0.0042483695,0.00027150396,0.0006290331,0.003234064,0.00007169045,0.0011332675,0.005430341,0.012114886],"study_design_scores_gemma":[0.004316805,0.003801916,0.7900543,0.00137439,0.0062594255,0.001430046,0.0023892955,0.17159252,0.00021967245,0.005804936,0.01253859,0.00021806148],"about_ca_topic_score_codex":0.014398113,"about_ca_topic_score_gemma":0.008663412,"teacher_disagreement_score":0.0281274,"about_ca_system_score_codex":0.0019464013,"about_ca_system_score_gemma":0.0020798885,"threshold_uncertainty_score":0.1487537},"labels":[],"label_agreement":null},{"id":"W4214654857","doi":"10.1111/bjd.20952","title":"From <scp> <i>FOS</i> </scp> fusions to somatic mutations in the <scp>MAPK</scp> pathway, heterogeneous genetic abnormalities cause distinct pathophysiology among subsets of epithelioid haemangiomas","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; University of Toronto; Stanford Bio-X; National Institute for Health and Care Research","keywords":"Pathophysiology; Somatic cell; Mutation; MAPK/ERK pathway; Genetics; Biology; Cancer research; Medicine; Signal transduction; Gene; Endocrinology","score_opus":0.012392616143037582,"score_gpt":0.22996201578552644,"score_spread":0.21756939964248886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214654857","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06894154,0.005480054,0.0015111892,0.8348243,0.026539799,0.00014549111,0.0004754635,0.00021192303,0.0618703],"genre_scores_gemma":[0.5042368,0.008053789,0.0018687282,0.3540585,0.065633014,0.00013620182,0.00032838623,0.000116310766,0.065568194],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.999548,0.000103570026,0.000057081932,0.00008051762,0.00011388065,0.00009684098],"domain_scores_gemma":[0.9991001,0.00051199936,0.000063576335,0.000050127055,0.00013555051,0.00013863352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005249037,0.0007822701,0.00056075,0.00051123666,0.0013758445,0.0012229092,0.0006157517,0.011533808,0.0038412407],"category_scores_gemma":[0.0041968934,0.00036877012,0.00068256044,0.00037052328,0.0012879327,0.0010590527,0.00044139725,0.007392506,0.0025895613],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054509466,0.00015514587,0.00900382,0.00021066901,0.000060360733,0.65114456,0.00057631783,0.00048091542,0.006657695,0.0055399532,0.30049968,0.025125816],"study_design_scores_gemma":[0.0003992044,0.0003479169,0.015832461,0.0002491827,0.000108951666,0.6498027,0.0007003433,0.0029866684,0.0031993235,0.014811351,0.31144696,0.000114961156],"about_ca_topic_score_codex":0.0028796499,"about_ca_topic_score_gemma":0.0031625994,"teacher_disagreement_score":0.011533808,"about_ca_system_score_codex":0.0017702433,"about_ca_system_score_gemma":0.00066114054,"threshold_uncertainty_score":0.012850285},"labels":[],"label_agreement":null},{"id":"W4224237183","doi":"10.1111/bjd.21615","title":"The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitis","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"National Center for Advancing Translational Sciences; Eli Lilly and Company","keywords":"Atopic dermatitis; Medicine; Dermatology; Skin barrier","score_opus":0.04372437995746584,"score_gpt":0.3598911613908305,"score_spread":0.31616678143336463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224237183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8698347,0.031195592,0.014315525,0.0015044917,0.000484488,0.008172369,0.03775088,0.00048773453,0.036254153],"genre_scores_gemma":[0.96401227,0.00412809,0.010583347,0.0005179718,0.0001712577,0.0038561167,0.013239174,0.000043260894,0.0034486123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938717,0.0028305948,0.00086594763,0.0005732444,0.0016709964,0.00018753471],"domain_scores_gemma":[0.9925904,0.0014817059,0.00384263,0.00036625878,0.00134164,0.00037728806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006651026,0.0007389812,0.0012069109,0.0019984504,0.0003976683,0.00081068353,0.00068199413,0.0006485747,0.0024540047],"category_scores_gemma":[0.00631376,0.00014775842,0.0019595798,0.0018610344,0.00043158012,0.00069872197,0.00081880967,0.0010600322,0.0006876142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009221643,0.0012666725,0.7894317,0.0034742877,0.004939347,0.00017020089,0.0005299421,0.001753854,0.0051035467,0.0009754525,0.016553305,0.16657995],"study_design_scores_gemma":[0.0010686346,0.0036507035,0.9810774,0.00041606303,0.0011182923,0.0008771507,0.00016638341,0.0012343965,0.0012429679,0.00055990234,0.008522735,0.0000652863],"about_ca_topic_score_codex":0.00097022654,"about_ca_topic_score_gemma":0.00243364,"teacher_disagreement_score":0.006651026,"about_ca_system_score_codex":0.000634783,"about_ca_system_score_gemma":0.0008484304,"threshold_uncertainty_score":0.03517443},"labels":[],"label_agreement":null},{"id":"W4225001772","doi":"10.1111/bjd.21628","title":"Longer dupilumab dosing intervals in adult patients with atopic dermatitis: experience from a French multicentre retrospective cohort study","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Société Française de Dermatologie et de Pathologie Sexuellement Transmissible; Université de Toulouse","keywords":"Dupilumab; Medicine; Dosing; Atopic dermatitis; Retrospective cohort study; Cohort; Young adult; Cohort study; Dermatology; Pediatrics; Internal medicine","score_opus":0.006241071681612049,"score_gpt":0.2392440382122407,"score_spread":0.23300296653062863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225001772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965463,0.0017452165,0.00016549975,0.00042725648,0.00004120298,0.000007932487,0.00045543892,0.0000072023145,0.00060389936],"genre_scores_gemma":[0.99816775,0.00047442084,0.00010209598,0.0004226616,0.00006344394,0.0000068558347,0.0003763935,0.000005357406,0.00038105444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911195,0.00032151915,0.00008615634,0.00021237746,0.00011093066,0.00015708523],"domain_scores_gemma":[0.9969132,0.00095721585,0.0011156339,0.0003907791,0.00032088257,0.00030218213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013236306,0.00032396914,0.0006434096,0.00034836703,0.0005688941,0.0012610513,0.00031287404,0.00071631395,0.0020181532],"category_scores_gemma":[0.003650797,0.00026167012,0.0008245906,0.00095689675,0.00029342878,0.0006078149,0.0002605556,0.0006280201,0.00035968504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009476307,0.000058167258,0.9906341,0.000031109135,0.0001823447,0.0020448533,0.00026486325,0.00003254481,0.00044927775,0.000042507847,0.0006875379,0.004625129],"study_design_scores_gemma":[0.00011574237,0.00057452987,0.9860708,0.00003345594,0.00030497342,0.00930308,0.00070780545,0.00020270092,0.00019714952,0.00006878474,0.0023991049,0.000021939559],"about_ca_topic_score_codex":0.0073406547,"about_ca_topic_score_gemma":0.0066141305,"teacher_disagreement_score":0.0073406547,"about_ca_system_score_codex":0.000720448,"about_ca_system_score_gemma":0.0005019095,"threshold_uncertainty_score":0.014595866},"labels":[],"label_agreement":null},{"id":"W4225128715","doi":"10.1111/bjd.21605","title":"Clinical practice guidelines for psoriasis: which ones are the best?","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Psoriasis; Medicine; Dermatology; Clinical Practice; MEDLINE; Intensive care medicine; Family medicine; Biology","score_opus":0.299294172863615,"score_gpt":0.5236842696513468,"score_spread":0.22439009678773186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225128715","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006835676,0.0010325477,0.00014213173,0.9902864,0.0065430896,0.0000119836,0.000027907541,0.000013289478,0.0018743164],"genre_scores_gemma":[0.00404438,0.0054341657,0.0028489653,0.9336417,0.04481253,0.00012992971,0.00016090609,0.00005636023,0.008871211],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9833317,0.006503306,0.0036771724,0.00063453155,0.004792183,0.0010611744],"domain_scores_gemma":[0.9212882,0.03404895,0.005276117,0.0019236556,0.029649872,0.007813179],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01080702,0.0006718084,0.0011477902,0.0016413493,0.0032455812,0.004164039,0.0026664548,0.041361324,0.01418803],"category_scores_gemma":[0.104494855,0.00081227993,0.0012679538,0.0013985584,0.0031343084,0.007958892,0.0029312815,0.042464904,0.0122927185],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019586496,0.000042969423,0.0003113861,0.00015021661,0.0000053264343,0.000679995,0.00013350521,0.000060310293,0.00011320589,0.0020444752,0.9810862,0.015352738],"study_design_scores_gemma":[0.0001011492,0.00004042059,0.00093318184,0.001996189,0.00001824446,0.0022128727,0.0005524358,0.00044479637,0.00015297199,0.011942985,0.9815384,0.000066403874],"about_ca_topic_score_codex":0.0088007,"about_ca_topic_score_gemma":0.019065866,"teacher_disagreement_score":0.98919296,"about_ca_system_score_codex":0.0052542784,"about_ca_system_score_gemma":0.012333909,"threshold_uncertainty_score":0.0571537},"labels":[],"label_agreement":null},{"id":"W4225383400","doi":"10.1111/bjd.21601","title":"Systemic treatments for psoriasis: not another network meta‐analysis!","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Department of Medicine, University of Toronto; University of Toronto; Women's College Hospital","keywords":"Psoriasis; Meta-analysis; Medicine; MEDLINE; Dermatology; Intensive care medicine; Internal medicine; Biology","score_opus":0.04115178157844975,"score_gpt":0.2568427037830461,"score_spread":0.21569092220459632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225383400","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007017574,0.88871855,0.015136334,0.06287186,0.014295657,0.0008124772,0.006101022,0.0004374859,0.004609129],"genre_scores_gemma":[0.4781525,0.3344725,0.04605433,0.096997656,0.024901757,0.0040295585,0.008312504,0.0011537637,0.005925452],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.93206716,0.05397627,0.005672471,0.0034730786,0.004197637,0.00061337167],"domain_scores_gemma":[0.8007241,0.16975412,0.009056144,0.012369332,0.007018117,0.0010781785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.064883195,0.0022342764,0.006790572,0.005694065,0.0007179152,0.0051198946,0.0026713817,0.00312655,0.0137546],"category_scores_gemma":[0.17898116,0.0011355139,0.01847421,0.0052017625,0.0006163421,0.0049630883,0.002529045,0.0049698083,0.001547808],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065205055,0.00006865258,0.013017936,0.099978216,0.67685246,0.0004503218,0.00037975635,0.0019316192,0.00038508239,0.0056869444,0.09856577,0.096162766],"study_design_scores_gemma":[0.0062524807,0.0006510526,0.013460816,0.047859535,0.8021878,0.000675858,0.00028953984,0.0048617106,0.00041987456,0.0324119,0.09064944,0.00027988982],"about_ca_topic_score_codex":0.0050053257,"about_ca_topic_score_gemma":0.010830645,"teacher_disagreement_score":0.064883195,"about_ca_system_score_codex":0.001835521,"about_ca_system_score_gemma":0.002990131,"threshold_uncertainty_score":0.34313923},"labels":[],"label_agreement":null},{"id":"W4230277598","doi":"10.1111/bjd.20033","title":"P68: Dupilumab provides improvement in sleep in children aged ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate‐to‐severe AD","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Atopic dermatitis; Medicine; Dermatology; Pediatrics","score_opus":0.0043051286011207765,"score_gpt":0.21272131542208195,"score_spread":0.20841618682096116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230277598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98485225,0.012549137,0.000054434204,0.0002197744,0.00008773291,0.000072621486,0.00038165526,0.000023328392,0.0017591488],"genre_scores_gemma":[0.9956994,0.0028722323,0.00020090326,0.00021418842,0.000050528775,0.000055113524,0.000356492,0.0000027660421,0.0005484222],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99984586,0.000047709134,0.000015563277,0.00002334712,0.000024982535,0.000042426098],"domain_scores_gemma":[0.99978095,0.000053794454,0.000053686417,0.000004682972,0.000017720608,0.00008919327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035090712,0.00036502565,0.0009281757,0.00015744948,0.00019666979,0.00023989104,0.00019587687,0.00026714895,0.0023544256],"category_scores_gemma":[0.0004845116,0.00014225839,0.00070273946,0.00017602298,0.000106986176,0.00023657524,0.00014616721,0.0005550494,0.00020620236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20480601,0.006616951,0.25552115,0.0049636904,0.003799047,0.0020702302,0.00046039367,0.00054728735,0.023555195,0.00019239655,0.01417483,0.48329282],"study_design_scores_gemma":[0.02494153,0.052955423,0.91018254,0.00034127347,0.0015619155,0.0025095125,0.0003466985,0.00050446857,0.0013753204,0.00005893259,0.0051942277,0.000028171298],"about_ca_topic_score_codex":0.0021576951,"about_ca_topic_score_gemma":0.011947835,"teacher_disagreement_score":0.0023544256,"about_ca_system_score_codex":0.0002771013,"about_ca_system_score_gemma":0.00027494732,"threshold_uncertainty_score":0.007876277},"labels":[],"label_agreement":null},{"id":"W4233501085","doi":"10.1111/j.1365-2133.2008.08935.x","title":"Isotretinoin therapy and the incidence of acne relapse: a nested case-control study","year":2008,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Isotretinoin; Family medicine; Incidence (geometry); Dermatology; Acne; Library science","score_opus":0.01278395999922658,"score_gpt":0.25340339318543864,"score_spread":0.24061943318621207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233501085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871147,0.00060053857,0.00013136327,0.000063446,0.000017493052,0.000022487888,0.00012855395,0.000004720258,0.00031990107],"genre_scores_gemma":[0.999223,0.00013734218,0.00015191147,0.00007397886,0.000028889146,0.000020693431,0.00011658369,0.000003964149,0.00024360008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739707,0.0012841336,0.00021920529,0.00056467997,0.0003418328,0.00019302155],"domain_scores_gemma":[0.9956863,0.001562464,0.0011483405,0.00084723317,0.00036881323,0.00038692492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019561015,0.00059785397,0.0011019653,0.00073017937,0.00087180996,0.0011173546,0.00084429234,0.0016644361,0.0017141886],"category_scores_gemma":[0.0056281807,0.0012256089,0.0013356927,0.0010462188,0.00078752334,0.0007554237,0.00049128616,0.001447628,0.00035818096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01167862,0.0015994445,0.9742595,0.00011150482,0.0018470271,0.0018042037,0.0008431054,0.00007897109,0.0034239844,0.00010464075,0.00041477018,0.0038343752],"study_design_scores_gemma":[0.0008119771,0.0026491787,0.99046654,0.00002565048,0.000986828,0.0032398235,0.0003609164,0.00054141716,0.00022301267,0.00007992795,0.0005818885,0.000032894368],"about_ca_topic_score_codex":0.0060642865,"about_ca_topic_score_gemma":0.0048160288,"teacher_disagreement_score":0.0060642865,"about_ca_system_score_codex":0.0006477738,"about_ca_system_score_gemma":0.00029983494,"threshold_uncertainty_score":0.01205802},"labels":[],"label_agreement":null},{"id":"W4233991869","doi":"10.1111/bjd.17055","title":"Applying the phenotype approach for rosacea to practice and research","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosacea; Telangiectases; Flexibility (engineering); Disease; Medicine; Nose; Argument (complex analysis); Dermatology; Rhinophyma; Telangiectasia; Intensive care medicine; Surgery; Pathology; Internal medicine","score_opus":0.040899040880977025,"score_gpt":0.37523142141444144,"score_spread":0.3343323805334644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233991869","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031214177,0.022135103,0.08475028,0.8377365,0.020377826,0.00036541943,0.00009596399,0.00022631438,0.031191245],"genre_scores_gemma":[0.25926894,0.03820362,0.24186252,0.4106827,0.030056747,0.0029786986,0.00022617831,0.00072900177,0.0159917],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.87394714,0.09974839,0.006702781,0.0052960473,0.011994755,0.0023108667],"domain_scores_gemma":[0.807727,0.12527484,0.008902459,0.017204035,0.028034039,0.012857657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14750963,0.00151143,0.0019076957,0.0104560135,0.005857347,0.021848368,0.0041667745,0.009069489,0.006999055],"category_scores_gemma":[0.15981612,0.0009015253,0.0015914418,0.004533112,0.058555543,0.022502236,0.017270474,0.019132143,0.002871389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099011624,0.00016328647,0.007288659,0.0022796402,0.00014162215,0.0012019677,0.022491053,0.0006770547,0.00062239217,0.7218689,0.0955437,0.14762269],"study_design_scores_gemma":[0.00006473776,0.00020232663,0.0032175095,0.0037463554,0.00007316054,0.0016910305,0.023169583,0.000714265,0.00025005292,0.6589743,0.30780342,0.00009335626],"about_ca_topic_score_codex":0.0051171314,"about_ca_topic_score_gemma":0.0059948517,"teacher_disagreement_score":0.14750963,"about_ca_system_score_codex":0.014457816,"about_ca_system_score_gemma":0.023736473,"threshold_uncertainty_score":0.7801148},"labels":[],"label_agreement":null},{"id":"W4235461058","doi":"10.1111/bjd.16744","title":"Computerized planimetry to assess clinical responsiveness in a phase II randomized trial of topical R333 for discoid lupus erythematosus","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Discoid lupus erythematosus; Syk; Dermatology; Lupus erythematosus; Scars; Autoimmune disease; Placebo; Systemic lupus erythematosus; Janus kinase; Disease; Surgery; Internal medicine; Immunology; Pathology; Tyrosine kinase; Antibody","score_opus":0.07007353733330347,"score_gpt":0.4229872516184881,"score_spread":0.35291371428518464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235461058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734934,0.007263911,0.0012216124,0.0017168304,0.0008570299,0.008239709,0.0015060599,0.00021840542,0.005483111],"genre_scores_gemma":[0.9835253,0.0015995788,0.0023544184,0.0014889707,0.00028947936,0.007464383,0.00091881223,0.00002483006,0.002334204],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99806696,0.0012474639,0.0001118876,0.00022569542,0.00017922933,0.00016890785],"domain_scores_gemma":[0.9975871,0.0011554676,0.00057727064,0.00015551274,0.00014845132,0.00037628686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026509294,0.0009511807,0.0024209965,0.00046269112,0.00032379376,0.0007319207,0.00082856696,0.0017508508,0.00704797],"category_scores_gemma":[0.0035856802,0.00048039822,0.0019559267,0.00053636124,0.0008536316,0.001016533,0.00040925117,0.0036832201,0.00064122933],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9601721,0.009336255,0.0009594869,0.00046531306,0.0011279412,0.000027958164,0.000042831114,0.0008166522,0.0014814846,0.00015666313,0.0011152634,0.024298148],"study_design_scores_gemma":[0.8876292,0.104862675,0.0044336636,0.000038054677,0.0004687255,0.000023868986,0.000020321915,0.0011178126,0.00032678986,0.00021405217,0.0008457587,0.000019025532],"about_ca_topic_score_codex":0.00094333244,"about_ca_topic_score_gemma":0.0016414885,"teacher_disagreement_score":0.00704797,"about_ca_system_score_codex":0.0009747818,"about_ca_system_score_gemma":0.0010628302,"threshold_uncertainty_score":0.023577869},"labels":[],"label_agreement":null},{"id":"W4236993097","doi":"10.1111/bjd.12981","title":"Historical Archives","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; History","score_opus":0.01117811099174698,"score_gpt":0.2371114572556818,"score_spread":0.22593334626393483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236993097","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010494962,0.016168043,0.0008365997,0.014757388,0.017297477,0.000058679845,0.0033191254,0.00046715414,0.946046],"genre_scores_gemma":[0.010053727,0.01242936,0.0010121582,0.004890752,0.004761606,0.000059644626,0.003411522,0.00039504023,0.9629862],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989666,0.00018052409,0.000076907265,0.00020583296,0.00042878313,0.00014136605],"domain_scores_gemma":[0.9981623,0.00025396713,0.000114231916,0.00038798925,0.0007013233,0.00038015822],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010302818,0.0005590943,0.00050630403,0.0034337947,0.0041733743,0.006801631,0.0013261638,0.0017249911,0.4178317],"category_scores_gemma":[0.00420805,0.00029105216,0.0003688123,0.00385664,0.0015352446,0.004525067,0.0030821005,0.0027868503,0.22567877],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023301205,0.00002063829,0.00035039368,0.00018091658,0.000003883638,0.00017653816,0.0005576849,0.000024448955,0.00009230125,0.04569139,0.8557028,0.09717572],"study_design_scores_gemma":[6.208263e-7,0.0000013915156,0.00010815072,0.000070426584,5.893622e-7,0.00007038348,0.00010055321,0.0000032539958,0.000015058842,0.0007766153,0.99885154,0.0000014389042],"about_ca_topic_score_codex":0.0049468824,"about_ca_topic_score_gemma":0.008145528,"teacher_disagreement_score":0.4178317,"about_ca_system_score_codex":0.0029068207,"about_ca_system_score_gemma":0.0031929153,"threshold_uncertainty_score":0.8303924},"labels":[],"label_agreement":null},{"id":"W4237473484","doi":"10.1111/bjd.15597","title":"News and Notices","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Human auditory perception and evaluation","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.021396689857333197,"score_gpt":0.2669231712785827,"score_spread":0.24552648142124953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237473484","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008183165,0.014328774,0.0007855823,0.1624971,0.40972412,0.00022475759,0.005055324,0.0021174252,0.40444854],"genre_scores_gemma":[0.0029821128,0.0076844995,0.00064901134,0.049052637,0.063394316,0.00011728491,0.0028588038,0.00060908706,0.87265223],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975255,0.00022407278,0.00014712776,0.00020497777,0.0016384083,0.00025992698],"domain_scores_gemma":[0.98953956,0.0018878703,0.00071707804,0.00070333894,0.004717689,0.0024344455],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0021671166,0.0010221652,0.00074907695,0.0016772273,0.0015862838,0.0069494857,0.0011810592,0.0046579987,0.39890313],"category_scores_gemma":[0.018838884,0.00046809262,0.00078436057,0.0016455185,0.0009203272,0.0032960689,0.0016434595,0.0054479134,0.3450661],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003191614,0.000011120831,0.00004018289,0.00006484735,0.0000014822954,0.00004965314,0.000014351104,0.0000053966196,0.00007921515,0.00032328177,0.97803956,0.02133896],"study_design_scores_gemma":[0.000005910901,0.000008662689,0.00019668057,0.000056693396,0.0000013396558,0.000049500806,0.00003262926,0.000008686779,0.000044349392,0.00011847954,0.99947304,0.0000039903985],"about_ca_topic_score_codex":0.0027739597,"about_ca_topic_score_gemma":0.0060968427,"teacher_disagreement_score":0.60109687,"about_ca_system_score_codex":0.0015393081,"about_ca_system_score_gemma":0.0025410408,"threshold_uncertainty_score":0.8573917},"labels":[],"label_agreement":null},{"id":"W4238105007","doi":"10.1111/bjd.19067","title":"Quality of reporting in systematic reviews published in dermatology journals","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Systematic review; Protocol (science); Transparency (behavior); Guideline; Medicine; MEDLINE; Family medicine; Alternative medicine; Health care; Medical literature; Quality (philosophy); Computer science; Pathology; Political science","score_opus":0.7758984387384652,"score_gpt":0.5525483587738867,"score_spread":0.22335007996457845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238105007","genre_codex":"review","genre_gemma":"empirical","domain_codex":"reporting","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":"reporting","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040262915,0.3554939,0.2187322,0.056929145,0.02554089,0.1758441,0.10790845,0.0038640252,0.015424382],"genre_scores_gemma":[0.18481374,0.087107904,0.27087298,0.016324664,0.0040582153,0.40781268,0.025347237,0.0016260503,0.0020366027],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.065941654,0.3748389,0.4866787,0.022387948,0.04814802,0.0020047924],"domain_scores_gemma":[0.025084492,0.6264413,0.21126305,0.05996519,0.075223096,0.0020229612],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6953804,0.00404285,0.022028083,0.07122959,0.005918785,0.018228581,0.009184863,0.010191439,0.012830372],"category_scores_gemma":[0.9189893,0.0073427116,0.018011574,0.086246036,0.012838239,0.016045468,0.0132044,0.008470261,0.0034455261],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013841251,0.00014157026,0.03145007,0.7807867,0.03542196,0.0006407656,0.015290004,0.0015870397,0.0013357842,0.010995027,0.0420288,0.07893825],"study_design_scores_gemma":[0.0035633116,0.0006023701,0.03572734,0.738589,0.029932192,0.0012808717,0.0064520254,0.0042499956,0.0035795341,0.036482908,0.13836956,0.0011708249],"about_ca_topic_score_codex":0.007672523,"about_ca_topic_score_gemma":0.00982923,"teacher_disagreement_score":0.3046196,"about_ca_system_score_codex":0.018719204,"about_ca_system_score_gemma":0.06935232,"threshold_uncertainty_score":0.3756503},"labels":[],"label_agreement":null},{"id":"W4239053007","doi":"10.1111/bjd.16195","title":"Efficacy and adverse events of oral isotretinoin for acne: a systematic review","year":2018,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Isotretinoin; Acne; Medicine; Adverse effect; Placebo; Dermatology; Randomized controlled trial; Clinical trial; Internal medicine; Alternative medicine; Pathology","score_opus":0.030212448862144258,"score_gpt":0.3555140972082674,"score_spread":0.32530164834612313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239053007","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018570563,0.9968131,0.00007679485,0.00014941889,0.000071684924,0.00027464467,0.0005090467,0.0000074466166,0.00024086564],"genre_scores_gemma":[0.034569196,0.96319777,0.00038747516,0.00065496436,0.00010221972,0.0005245269,0.00039064971,0.000007575074,0.0001656905],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9947523,0.0016172403,0.002179136,0.0003837244,0.0009346957,0.00013290932],"domain_scores_gemma":[0.97571325,0.017309893,0.004666997,0.00028213384,0.0017737073,0.00025406128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005615032,0.0011256342,0.00779772,0.0049837683,0.00042655802,0.0017007831,0.0013185561,0.0014842333,0.0045279246],"category_scores_gemma":[0.025051007,0.00067417254,0.007531047,0.0052936706,0.00066854776,0.0015331709,0.0009692527,0.0010591465,0.0002468393],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068834337,0.000021252428,0.00093055604,0.95266145,0.015652472,0.00007710443,0.00010591259,0.00007478315,0.00011044669,0.000102834885,0.0012571531,0.02831771],"study_design_scores_gemma":[0.0015838534,0.00065617537,0.010676283,0.7707637,0.19518438,0.0006297376,0.0002909991,0.00013851943,0.00031591373,0.00033314803,0.019363703,0.000063605796],"about_ca_topic_score_codex":0.005383227,"about_ca_topic_score_gemma":0.014506211,"teacher_disagreement_score":0.00779772,"about_ca_system_score_codex":0.0024119124,"about_ca_system_score_gemma":0.0043217936,"threshold_uncertainty_score":0.029695451},"labels":[],"label_agreement":null},{"id":"W4239586427","doi":"10.1046/j.1365-2133.2000.03724.x","title":"Cutaneous Cryptococcus infection due to C. albidus associated with Sezary syndrome","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Fungal Infections and Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Dermatology; Medicine; Mycosis fungoides; Library science; Pathology; Lymphoma; Computer science","score_opus":0.008117500037824634,"score_gpt":0.23689983504497591,"score_spread":0.22878233500715128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239586427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896293,0.0014559479,0.00081198197,0.00045262507,0.00008235638,0.00007448302,0.000075147924,0.0000995515,0.0073185856],"genre_scores_gemma":[0.9988612,0.0003985587,0.00016485373,0.00009491776,0.00006671328,0.000004885875,0.000013072313,0.000004791282,0.00039099716],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99974173,0.000031058513,0.000020584923,0.00005252355,0.000042713604,0.00011144437],"domain_scores_gemma":[0.99908495,0.00030418957,0.00020127324,0.00005656755,0.00005810168,0.00029487535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015057831,0.0014682239,0.0007103731,0.0012371365,0.0014282437,0.00060556876,0.00036743734,0.001359856,0.0032531251],"category_scores_gemma":[0.0015956714,0.00056946697,0.0003863981,0.0007128807,0.0013191213,0.0005728094,0.0005887535,0.0015948951,0.0004527166],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006428271,0.00004508354,0.018025178,0.000048473183,0.000013835807,0.976917,0.00017331654,0.000068517395,0.0025352177,0.00012333684,0.00016846418,0.0018172793],"study_design_scores_gemma":[0.000029004541,0.00014619736,0.018337091,0.000015535188,0.000019065576,0.9799983,0.00014106104,0.00013941566,0.0007400759,0.00009757651,0.0003262834,0.000010313612],"about_ca_topic_score_codex":0.0037180327,"about_ca_topic_score_gemma":0.0028594653,"teacher_disagreement_score":0.0037180327,"about_ca_system_score_codex":0.000424006,"about_ca_system_score_gemma":0.0005153386,"threshold_uncertainty_score":0.010882795},"labels":[],"label_agreement":null},{"id":"W4241667302","doi":"10.1111/bjd.16627","title":"Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB)","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epidermolysis bullosa; Medicine; Context (archaeology); Disease; Dermatology; Perspective (graphical); Severity of illness; Pathology; Internal medicine","score_opus":0.09219870509020982,"score_gpt":0.40402842750019236,"score_spread":0.3118297224099825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241667302","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908824,0.0004819873,0.0023484475,0.00025678644,0.0000946784,0.00044331313,0.0006582303,0.000035322708,0.004798858],"genre_scores_gemma":[0.9928532,0.00019909766,0.0049213343,0.00012296479,0.000028708517,0.0003543856,0.0009251756,0.0000185741,0.0005765303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98404354,0.005940764,0.0020183837,0.0012562261,0.00591099,0.0008300566],"domain_scores_gemma":[0.9579221,0.01689238,0.007491303,0.002563263,0.012895592,0.002235414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022543948,0.00032497512,0.00060314004,0.002130564,0.0006081858,0.0010084377,0.0006004391,0.00055576087,0.0008688473],"category_scores_gemma":[0.035941496,0.00022185573,0.00085939514,0.0014171535,0.0010233906,0.000513835,0.00163956,0.0006386827,0.00035415127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023951616,0.000109110515,0.97917306,0.000045396453,0.00013788075,0.000032310243,0.0009969595,0.00021617157,0.0005264783,0.00019248656,0.0006542628,0.01767632],"study_design_scores_gemma":[0.000034605866,0.00029952807,0.9959721,0.000046361805,0.000028313387,0.00010481866,0.00058226066,0.0008860423,0.00026348545,0.00015943356,0.0016082054,0.000014909439],"about_ca_topic_score_codex":0.010916359,"about_ca_topic_score_gemma":0.012727429,"teacher_disagreement_score":0.022543948,"about_ca_system_score_codex":0.0014232505,"about_ca_system_score_gemma":0.0019277426,"threshold_uncertainty_score":0.11922526},"labels":[],"label_agreement":null},{"id":"W4245510738","doi":"10.1111/bjd.12753","title":"Plain Language Summaries","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Natural Language Processing Techniques","field":"Computer Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.004832617028212291,"score_gpt":0.23732686511124645,"score_spread":0.23249424808303415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245510738","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010182639,0.009176437,0.008702595,0.040639903,0.052911445,0.0018310093,0.3182039,0.009513507,0.5580029],"genre_scores_gemma":[0.014041753,0.013178054,0.0068679717,0.027413787,0.018932428,0.0026872596,0.22943076,0.005670072,0.68177795],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99695134,0.0008663541,0.0008233959,0.000313302,0.00086697814,0.00017866687],"domain_scores_gemma":[0.9670903,0.0162412,0.002402497,0.0025505868,0.010701283,0.0010140968],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00263316,0.0013140748,0.001323018,0.004982147,0.0013176943,0.00474264,0.002316771,0.0023348904,0.7718204],"category_scores_gemma":[0.0524194,0.00051835284,0.0008116598,0.0053044152,0.0008233991,0.004411554,0.0020077254,0.0023077005,0.64778084],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037033093,0.00000809528,0.000033296856,0.00047002258,0.0000020770342,0.0000546588,0.00004679725,0.000030099076,0.0000569958,0.0010528428,0.98346657,0.014741435],"study_design_scores_gemma":[0.000012973818,0.000011471542,0.00014423137,0.00028016168,0.0000018342076,0.00009531194,0.000060937655,0.000032336473,0.000053591495,0.0013014181,0.99799806,0.000007759606],"about_ca_topic_score_codex":0.0025026654,"about_ca_topic_score_gemma":0.002496838,"teacher_disagreement_score":0.99736685,"about_ca_system_score_codex":0.0017163432,"about_ca_system_score_gemma":0.0023180908,"threshold_uncertainty_score":0.32547045},"labels":[],"label_agreement":null},{"id":"W4247068466","doi":"10.1111/bjd.20279","title":"PA03: Understanding phenotypic variations of pseudohypoparathyroidism and loss‐of‐function <i>GNAS</i> variants","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Congenital heart defects research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"GNAS complex locus; Pseudohypoparathyroidism; Phenotype; Medicine; Genetics; Internal medicine; Biology; Parathyroid hormone","score_opus":0.017472123474787944,"score_gpt":0.2562795952215628,"score_spread":0.23880747174677486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247068466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9156025,0.004941257,0.05863841,0.0026333185,0.00014427103,0.00009640724,0.008353447,0.0012053119,0.008385077],"genre_scores_gemma":[0.9560288,0.0018825751,0.034395996,0.0005026546,0.00009787562,0.000070569404,0.004482096,0.0002918403,0.0022475878],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997851,0.00003438997,0.000016517553,0.000090489266,0.000049767506,0.000023656828],"domain_scores_gemma":[0.9995987,0.00012289001,0.00012926874,0.00003802408,0.00004966213,0.000061451996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003876725,0.0005500501,0.00038844178,0.00068965,0.00021909607,0.0009796438,0.00065330416,0.00084120355,0.0041658324],"category_scores_gemma":[0.0011804423,0.00017277968,0.000449321,0.00050484145,0.0002139716,0.00065554824,0.00052815204,0.0010114812,0.00091947924],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015978215,0.000285458,0.27460578,0.0011196088,0.0006046916,0.008428627,0.0007511828,0.0060727173,0.45376801,0.0069699353,0.0141549455,0.23164122],"study_design_scores_gemma":[0.00016679321,0.0005273822,0.72702754,0.00041585334,0.0006279444,0.051486615,0.0008667162,0.055780195,0.07608648,0.016484065,0.070393786,0.00013672307],"about_ca_topic_score_codex":0.0020657836,"about_ca_topic_score_gemma":0.0017131626,"teacher_disagreement_score":0.0041658324,"about_ca_system_score_codex":0.00025233513,"about_ca_system_score_gemma":0.00034870714,"threshold_uncertainty_score":0.013936102},"labels":[],"label_agreement":null},{"id":"W4249995199","doi":"10.1111/bjd.19509","title":"A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial*","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Probity Medical Research; Dermatrials Research; Dalhousie University; Guenther Dermatology Research Centre","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Psoriasis; Double blinded; Randomized controlled trial; Dermatology; Plaque psoriasis; Head (geology); Physical therapy; Internal medicine; Alternative medicine; Placebo; Psoriatic arthritis; Secukinumab; Pathology","score_opus":0.031101962779269417,"score_gpt":0.2690927002085634,"score_spread":0.237990737429294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249995199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97869086,0.012793484,0.0009272077,0.00071516243,0.0011808838,0.002397534,0.0009840623,0.00016212434,0.002148615],"genre_scores_gemma":[0.9875309,0.00434937,0.0010870917,0.00076145836,0.0007250641,0.002113539,0.00055704627,0.00003968513,0.0028358102],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987519,0.000719497,0.00009850883,0.0002010734,0.00009947042,0.00012964803],"domain_scores_gemma":[0.9989385,0.0003994193,0.00023638792,0.00010527272,0.000086249645,0.0002341936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023282552,0.0016543013,0.003861575,0.00043131766,0.00042193977,0.0014970062,0.0007416716,0.0017717986,0.006096054],"category_scores_gemma":[0.0021590486,0.00080965593,0.0028218813,0.00040535792,0.0009890618,0.0011391947,0.00034687688,0.0027098646,0.0009925634],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98388267,0.00331472,0.0001613971,0.00050916965,0.0011251549,0.0000150398555,0.00003014313,0.00012107686,0.0017938963,0.000043304557,0.00043643056,0.008566992],"study_design_scores_gemma":[0.94159335,0.055334754,0.0010347923,0.000036095902,0.0008765254,0.000019335397,0.000017747405,0.0002455898,0.00037899296,0.000099373276,0.0003490413,0.000014357985],"about_ca_topic_score_codex":0.0007592638,"about_ca_topic_score_gemma":0.001405308,"teacher_disagreement_score":0.006096054,"about_ca_system_score_codex":0.0005682473,"about_ca_system_score_gemma":0.0009054651,"threshold_uncertainty_score":0.020393372},"labels":[],"label_agreement":null},{"id":"W4253956332","doi":"10.1111/bjd.19673","title":"Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Dermatology Life Quality Index; Atopic dermatitis; Medicine; Quality of life (healthcare); Eczema Area and Severity Index; Pediatrics; Family medicine; Physical therapy; Dermatology; Disease; Nursing; Pathology","score_opus":0.13085183247409027,"score_gpt":0.38162369681757974,"score_spread":0.25077186434348947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253956332","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026343549,0.31620252,0.15748003,0.13653313,0.027870344,0.24040377,0.04558712,0.0023510144,0.04722858],"genre_scores_gemma":[0.076004416,0.041486666,0.4813492,0.022979299,0.0029869184,0.34006664,0.029374124,0.0011820111,0.0045708152],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.53143716,0.3069046,0.10016091,0.006902275,0.04987117,0.0047238646],"domain_scores_gemma":[0.3935494,0.3168837,0.06512678,0.01862974,0.19502282,0.010787534],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4712541,0.0031900287,0.012960995,0.007092707,0.002926224,0.010129547,0.00981477,0.010669525,0.0045273895],"category_scores_gemma":[0.4574931,0.0020624627,0.020310624,0.009120274,0.003045862,0.004148534,0.008552134,0.015895862,0.0032323417],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01624196,0.0008606616,0.014146495,0.2477745,0.023828069,0.0003359857,0.003780081,0.0064649275,0.002569907,0.018233582,0.22448628,0.44127762],"study_design_scores_gemma":[0.046615,0.0053510787,0.09442282,0.37498152,0.043875936,0.0009075555,0.0032564662,0.013778005,0.009261531,0.04029699,0.36575732,0.001495851],"about_ca_topic_score_codex":0.005031285,"about_ca_topic_score_gemma":0.0052569234,"teacher_disagreement_score":0.5287459,"about_ca_system_score_codex":0.012785811,"about_ca_system_score_gemma":0.031843916,"threshold_uncertainty_score":0.65203786},"labels":[],"label_agreement":null},{"id":"W4255499790","doi":"10.1111/bjd.16749","title":"Systematic review of atopic dermatitis disease definition in studies using routinely collected health data","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atopic dermatitis; Medicine; Medical diagnosis; Medical record; Disease; Diagnosis code; MEDLINE; Family medicine; Health care; Dermatology; Pathology; Surgery; Environmental health; Population","score_opus":0.08715602629951488,"score_gpt":0.37006225061013576,"score_spread":0.28290622431062085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255499790","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026287735,0.9914083,0.00047144454,0.000461945,0.00027555507,0.001522238,0.0026374443,0.000020826794,0.0005734315],"genre_scores_gemma":[0.03538069,0.95305437,0.0028783572,0.0012665793,0.00015191076,0.0048140013,0.0021637944,0.000027759483,0.00026255762],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.95819443,0.012252593,0.021360498,0.0023958501,0.00523467,0.00056191685],"domain_scores_gemma":[0.8742694,0.092302084,0.022453725,0.002443742,0.007840607,0.00069047697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019382825,0.0019715296,0.01289983,0.025773223,0.0011573348,0.0036788324,0.0031274608,0.0022926964,0.005995491],"category_scores_gemma":[0.11900318,0.0016162428,0.009514497,0.026151005,0.0017247013,0.0038147983,0.002856283,0.0014800077,0.00048672306],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085263215,0.000008134061,0.0011860819,0.9786961,0.0071185892,0.00009054755,0.00023125546,0.00005054657,0.000083010564,0.00020105201,0.001118208,0.011131254],"study_design_scores_gemma":[0.0001489816,0.000080961974,0.0041999733,0.9465768,0.0370874,0.00020943017,0.0003150799,0.00004501973,0.000122377,0.0002862776,0.010894765,0.000032933367],"about_ca_topic_score_codex":0.014179177,"about_ca_topic_score_gemma":0.04178122,"teacher_disagreement_score":0.025773223,"about_ca_system_score_codex":0.006737193,"about_ca_system_score_gemma":0.020445254,"threshold_uncertainty_score":0.10250735},"labels":[],"label_agreement":null},{"id":"W4256582461","doi":"10.1111/bjd.20280","title":"PA04 (P16): An assessment of the experiences of general practitioners and general practitioner trainees of referrals to paediatric dermatology services","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Family medicine; Dermatology; Medical education","score_opus":0.017734771065999914,"score_gpt":0.32692870187651013,"score_spread":0.3091939308105102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256582461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847394,0.00021847099,0.000059463273,0.00023481493,0.000010850258,0.00001962859,0.00023673518,0.00000526684,0.00074091024],"genre_scores_gemma":[0.99644756,0.0006426346,0.00028682075,0.0002632399,0.000016879863,0.000038671533,0.00036610942,0.00001034555,0.0019276923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933726,0.00020375007,0.00003961846,0.00010150336,0.00011475346,0.00020303935],"domain_scores_gemma":[0.9976616,0.00033685478,0.0006309288,0.000038530823,0.00024788547,0.0010842043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087087427,0.00022604522,0.00026598267,0.0009098419,0.0006715757,0.000783814,0.0003599821,0.0006015925,0.003365709],"category_scores_gemma":[0.0034813343,0.000190027,0.00026386025,0.0008963224,0.0004473766,0.00082210195,0.001559599,0.00069895206,0.0008783018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002040566,0.00015301917,0.89802176,0.00020434501,0.000048635116,0.005216364,0.0595738,0.00010563867,0.0016441182,0.00010036821,0.005975488,0.028752508],"study_design_scores_gemma":[0.000010887865,0.00052612735,0.881072,0.00013415945,0.00001803942,0.013842994,0.095271215,0.00017311295,0.0001632332,0.000084458356,0.008665662,0.0000380741],"about_ca_topic_score_codex":0.010523394,"about_ca_topic_score_gemma":0.014077406,"teacher_disagreement_score":0.010523394,"about_ca_system_score_codex":0.00072135235,"about_ca_system_score_gemma":0.00092852593,"threshold_uncertainty_score":0.02092427},"labels":[],"label_agreement":null},{"id":"W4281287539","doi":"10.1111/bjd.21673","title":"The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"H. Lundbeck A/S; Lundbeckfonden","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Drug; MEDLINE; Internal medicine; Pharmacology; Disease","score_opus":0.013532170588659397,"score_gpt":0.2619211913445645,"score_spread":0.24838902075590508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281287539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99698573,0.00095694955,0.000059059807,0.000105101695,0.0000071855347,0.000016079837,0.0012418511,0.000001827513,0.0006262747],"genre_scores_gemma":[0.9984516,0.00048371017,0.00010035692,0.000063076004,0.000009498399,0.000017941067,0.0007941468,0.0000014288672,0.00007818526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889463,0.00025191336,0.0002601599,0.00021031995,0.00020989135,0.00017306553],"domain_scores_gemma":[0.99724895,0.00036718848,0.0017136193,0.0001257316,0.00023894207,0.00030543734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009001735,0.00012630729,0.00032254105,0.000898824,0.0005378574,0.0008922499,0.00034332814,0.0004101375,0.0011209811],"category_scores_gemma":[0.0027226887,0.00033660975,0.0006312928,0.0024955391,0.00022646502,0.0006493475,0.0006750444,0.00062532496,0.00022615408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003470522,0.000022166098,0.99908876,0.000021683307,0.000033739263,0.00003305105,0.00007367274,0.000010695369,0.000031354954,0.000013999675,0.00008263177,0.00055347115],"study_design_scores_gemma":[0.0000048882366,0.000040827497,0.9987789,0.000026843694,0.000036744626,0.00016274204,0.0004000494,0.0000926099,0.000015652191,0.000008944029,0.00042828431,0.0000035976216],"about_ca_topic_score_codex":0.017859098,"about_ca_topic_score_gemma":0.023847014,"teacher_disagreement_score":0.017859098,"about_ca_system_score_codex":0.00070211256,"about_ca_system_score_gemma":0.00096448197,"threshold_uncertainty_score":0.0355103},"labels":[],"label_agreement":null},{"id":"W4281382713","doi":"10.1111/bjd.21677","title":"Biomarkers of systemic treatment response in people with psoriasis: a scoping review","year":2022,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Banting and Best Diabetes Centre, University of Toronto; Canadian Institutes of Health Research; Innovative Medicines Initiative; Astellas Pharma; Novo Nordisk; National Institute for Health and Care Research; Department of Medicine, University of Toronto; Psoriasis Association; Department of Health and Social Care; European Commission; Sanofi; Kidney Foundation of Canada; Merck Canada; University of Toronto; European Federation of Pharmaceutical Industries and Associations; AstraZeneca; Eli Lilly and Company; King's College London; Gilead Sciences; Vifor Pharma; Heart and Stroke Foundation of Canada; Amgen","keywords":"Psoriasis; Medicine; Intensive care medicine; Dermatology","score_opus":0.031994865585863876,"score_gpt":0.29623763703079387,"score_spread":0.26424277144492997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281382713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090439414,0.99695504,0.00025410907,0.0005097248,0.00016308409,0.0005651207,0.00029386423,0.0000087796425,0.00034582862],"genre_scores_gemma":[0.008747836,0.98784685,0.0010450893,0.00049277674,0.000107907625,0.0012493352,0.00037486778,0.0000062841887,0.00012908263],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.981344,0.0062804087,0.008353455,0.0010785757,0.0025743104,0.00036925773],"domain_scores_gemma":[0.9169461,0.060529217,0.013701377,0.0012683437,0.0071388944,0.00041602875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026834592,0.0019028552,0.007960086,0.023482759,0.0010499661,0.004524216,0.0024462244,0.0036925285,0.0035278276],"category_scores_gemma":[0.09225881,0.0014841789,0.008043812,0.02255439,0.0015027863,0.004441003,0.0024260576,0.0016080514,0.00046740132],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021072503,0.0000282627,0.001009021,0.9052798,0.0037610377,0.00014287948,0.0005471557,0.00016089916,0.00021596781,0.00043510812,0.0022054412,0.08600367],"study_design_scores_gemma":[0.00006029987,0.000111527006,0.002246993,0.967513,0.015068365,0.00024772153,0.00034229338,0.000079109304,0.00012193844,0.0003092249,0.013875606,0.000023894832],"about_ca_topic_score_codex":0.006545278,"about_ca_topic_score_gemma":0.011757597,"teacher_disagreement_score":0.026834592,"about_ca_system_score_codex":0.0052299653,"about_ca_system_score_gemma":0.016555365,"threshold_uncertainty_score":0.14191657},"labels":[],"label_agreement":null},{"id":"W4283835003","doi":"10.1111/bjd.21222","title":"P100: Efficacy of current treatments under study in patients with alopecia areata","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alopecia areata; Medicine; Dermatology; Current (fluid); Hair disease","score_opus":0.014126487937245262,"score_gpt":0.2733089600141399,"score_spread":0.25918247207689465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283835003","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014520641,0.983135,0.00008882992,0.00035554206,0.00012722625,0.00015202016,0.00061153277,0.0000058071123,0.0010034456],"genre_scores_gemma":[0.25284046,0.7424531,0.0006805053,0.0011462732,0.0004672085,0.00058218115,0.001476408,0.000009896606,0.00034386577],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.995596,0.0016262067,0.0015752403,0.00040747155,0.0006949275,0.000100127465],"domain_scores_gemma":[0.98792934,0.007863312,0.002986345,0.00012789825,0.0008859697,0.00020710976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004336154,0.00042989742,0.0047990326,0.0033047162,0.0003177977,0.0016480631,0.000641487,0.0010738545,0.003480461],"category_scores_gemma":[0.012894422,0.00033825779,0.0040983893,0.005002083,0.0005551989,0.0018558203,0.0006410143,0.00091346184,0.00030163868],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034879845,0.0003190551,0.027959721,0.4951645,0.03765962,0.00037582102,0.0005124448,0.00028313173,0.0015193451,0.00041239097,0.005017305,0.39589676],"study_design_scores_gemma":[0.040699493,0.013843577,0.2740815,0.34115046,0.25364748,0.0042212433,0.0022761077,0.000754001,0.001991933,0.0018127185,0.06527147,0.0002501253],"about_ca_topic_score_codex":0.0010696092,"about_ca_topic_score_gemma":0.0025907403,"teacher_disagreement_score":0.0047990326,"about_ca_system_score_codex":0.00070058927,"about_ca_system_score_gemma":0.001512242,"threshold_uncertainty_score":0.022931993},"labels":[],"label_agreement":null},{"id":"W4285085766","doi":"10.1111/bjd.21774","title":"Heterozygous variants in the integrin subunit beta 4 gene (ITGB4) cause autosomal dominant nail dystrophy","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"Israel Science Foundation","keywords":"BETA (programming language); Gene; Genetics; Integrin; Dystrophy; Protein subunit; Nail (fastener); Biology; Medicine; Molecular biology; Receptor","score_opus":0.02450000851162791,"score_gpt":0.280548452866202,"score_spread":0.2560484443545741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285085766","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3728452,0.004741521,0.002618176,0.5061474,0.02841829,0.00018698336,0.0008631934,0.00036311697,0.08381624],"genre_scores_gemma":[0.8514458,0.0019900757,0.0015838359,0.08125765,0.024515701,0.0000706695,0.00023157938,0.00012873486,0.038776],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993979,0.00013904896,0.000057689864,0.00011483442,0.00012972573,0.00016088803],"domain_scores_gemma":[0.9985197,0.00093639514,0.000098072596,0.0000506419,0.0001504393,0.00024469482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044550138,0.0012969947,0.0009735948,0.00055091083,0.0014049252,0.0008780161,0.0006402145,0.011317834,0.0044165202],"category_scores_gemma":[0.0041741887,0.0003899076,0.0007053296,0.00042848528,0.001046785,0.00085308845,0.00039690596,0.0047571454,0.0011689896],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004230899,0.00008186237,0.006524821,0.00007943208,0.000053307125,0.9371509,0.0002826096,0.00021901635,0.0038282978,0.0016177618,0.045106955,0.0046319934],"study_design_scores_gemma":[0.0005182716,0.00050210615,0.026978366,0.0002653249,0.00024036881,0.8856602,0.0008778752,0.004537692,0.0037458565,0.008506006,0.06806686,0.000101148245],"about_ca_topic_score_codex":0.0035714912,"about_ca_topic_score_gemma":0.0027148372,"teacher_disagreement_score":0.011317834,"about_ca_system_score_codex":0.0011684034,"about_ca_system_score_gemma":0.00051555404,"threshold_uncertainty_score":0.01477474},"labels":[],"label_agreement":null},{"id":"W4288855303","doi":"10.1111/bjd.21798","title":"Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"Eli Lilly and Company","keywords":"Hidradenitis suppurativa; Medicine; Patient satisfaction; MEDLINE; Dermatology; Internal medicine; Surgery; Biology; Disease","score_opus":0.024259246157149444,"score_gpt":0.25464233170054423,"score_spread":0.2303830855433948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288855303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854434,0.0002314182,0.000080226855,0.0000822526,0.000003485843,0.000021207883,0.0006286098,0.0000030598283,0.00040542058],"genre_scores_gemma":[0.99905866,0.000090966256,0.00008116179,0.00004045147,0.0000059342683,0.000020856021,0.00064248237,0.0000015200806,0.000058000005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987369,0.00059469667,0.0001542072,0.00010632906,0.00026550965,0.00014233029],"domain_scores_gemma":[0.99585104,0.0011626193,0.001969198,0.00011771605,0.0004078244,0.00049165514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002486285,0.00019248942,0.00034242138,0.00080170843,0.00024751827,0.0005927331,0.00023817035,0.00033326098,0.0012919621],"category_scores_gemma":[0.005742409,0.00011765335,0.0008033189,0.0011205316,0.0002567662,0.00038685882,0.0009002618,0.00042626922,0.00016197891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006483459,0.00001667278,0.9979163,0.000012622717,0.000036710928,0.000011710199,0.000068678775,0.00001893097,0.000028420867,0.0000040745012,0.00007332092,0.0017477882],"study_design_scores_gemma":[0.000006467628,0.00008284921,0.999424,0.0000060384523,0.000021364076,0.000066851455,0.00020359449,0.00007471103,0.000015051071,0.000004110623,0.000093160976,0.0000018496042],"about_ca_topic_score_codex":0.0014669555,"about_ca_topic_score_gemma":0.0016375055,"teacher_disagreement_score":0.002486285,"about_ca_system_score_codex":0.00021641732,"about_ca_system_score_gemma":0.00027683462,"threshold_uncertainty_score":0.013148904},"labels":[],"label_agreement":null},{"id":"W4289711506","doi":"10.1111/bjd.21793","title":"Where’s the colour? Advocating for morphological and antioppressive fluencies in dermatology","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre; Women's College Hospital; Queen's University; University of Toronto; University Health Network; Hotel Dieu Hospital; Public Health Ontario","funders":"","keywords":"Dermatology; Medicine","score_opus":0.020930577054448476,"score_gpt":0.2837741085101155,"score_spread":0.262843531455667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289711506","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011022637,0.014872784,0.00071275514,0.9569293,0.004594861,0.000007649774,0.0000076240785,0.000013935503,0.011838453],"genre_scores_gemma":[0.4326839,0.034126475,0.0028219235,0.5130734,0.011245929,0.00003740153,0.000025570509,0.000079642436,0.0059057423],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9837884,0.010741097,0.0006323826,0.00055539893,0.002810398,0.0014723206],"domain_scores_gemma":[0.96364367,0.021958634,0.0025637222,0.0010505023,0.0034273304,0.0073562153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021643816,0.00021988942,0.00044412017,0.0010568877,0.009054041,0.00720274,0.0010051678,0.0072963163,0.0076767057],"category_scores_gemma":[0.045680642,0.0003266942,0.00048322452,0.0006619078,0.022959761,0.0103097055,0.008041909,0.017428271,0.0014293187],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017786953,0.00037471138,0.018700622,0.0012399202,0.00008204955,0.0015257228,0.0816882,0.00014969255,0.0023037726,0.09837486,0.48593712,0.30944553],"study_design_scores_gemma":[0.0000802259,0.00020225225,0.006933647,0.005967745,0.0000767196,0.0033907413,0.086648814,0.00016707715,0.0006988907,0.118761614,0.7769743,0.000097994656],"about_ca_topic_score_codex":0.0041462006,"about_ca_topic_score_gemma":0.009411202,"teacher_disagreement_score":0.021643816,"about_ca_system_score_codex":0.0035242473,"about_ca_system_score_gemma":0.0086476235,"threshold_uncertainty_score":0.11446482},"labels":[],"label_agreement":null},{"id":"W4292063299","doi":"10.1111/bjd.21822","title":"The sound of silence: where are the voices of patients in eczema guideline development?","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance","funders":"","keywords":"Guideline; Silence; Sound (geography); Medicine; Audiology; Acoustics; Pathology; Physics","score_opus":0.061049813637790565,"score_gpt":0.3929239920716602,"score_spread":0.3318741784338696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292063299","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009001572,0.019629205,0.0026551993,0.9597279,0.0036043734,0.000079638914,0.00009139376,0.000061361214,0.0051494595],"genre_scores_gemma":[0.30167344,0.034117173,0.0074929763,0.64637625,0.006211641,0.0008563366,0.00027981587,0.00041485686,0.0025774762],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.68987095,0.2641218,0.012372732,0.0067085703,0.01927891,0.0076471088],"domain_scores_gemma":[0.5782904,0.3412083,0.02149395,0.00806821,0.028596682,0.022342438],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14359729,0.0009382738,0.0024390032,0.0021281932,0.01646812,0.031249985,0.005920025,0.023536572,0.010149201],"category_scores_gemma":[0.42503345,0.0018713324,0.002011838,0.002430174,0.03268765,0.045931842,0.02270084,0.036414985,0.0033035085],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003323107,0.00014716267,0.008743815,0.0046453155,0.00025015982,0.0031890802,0.57563555,0.00015770839,0.0007396146,0.027497556,0.17213759,0.2065242],"study_design_scores_gemma":[0.00026377547,0.00026548075,0.0034222002,0.024764856,0.00033811224,0.0025396948,0.5756579,0.00050199206,0.00080274814,0.0898343,0.30123672,0.00037213953],"about_ca_topic_score_codex":0.017073542,"about_ca_topic_score_gemma":0.021392522,"teacher_disagreement_score":0.8564027,"about_ca_system_score_codex":0.013476724,"about_ca_system_score_gemma":0.04205577,"threshold_uncertainty_score":0.75942415},"labels":[],"label_agreement":null},{"id":"W4295083464","doi":"10.1111/bjd.21867","title":"Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Manchester Biomedical Research Centre; LEO Pharma; LEO Pharma Research Foundation; National Institute for Health and Care Research","keywords":"Placebo; Medicine; Atopic dermatitis; Internal medicine; Adverse effect; Upper respiratory tract infection; Confidence interval; Randomized controlled trial; Gastroenterology; Immunology; Pathology","score_opus":0.012012766408466076,"score_gpt":0.2885681162650966,"score_spread":0.2765553498566305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295083464","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2586634,0.7205767,0.0060741627,0.000866529,0.0008272484,0.0046649477,0.004818308,0.00026138916,0.0032473202],"genre_scores_gemma":[0.9058414,0.08286585,0.0027621593,0.0013162207,0.00063634507,0.0029470886,0.0030049924,0.000045526624,0.00058045285],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98488957,0.008627624,0.0032828238,0.0015678586,0.001334508,0.00029759356],"domain_scores_gemma":[0.98443073,0.0074112257,0.0059450604,0.0008471924,0.0009685105,0.0003971847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02350555,0.001922685,0.008354716,0.0016854457,0.0003504152,0.0019446596,0.00090679986,0.0018968713,0.0021966875],"category_scores_gemma":[0.020629406,0.00090862,0.01835829,0.0019973884,0.0006906889,0.001091386,0.000791682,0.001329914,0.00024764266],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38045958,0.00041596426,0.01856705,0.040138908,0.498616,0.00012483,0.00010969535,0.0015103314,0.001923824,0.00014493478,0.0016924186,0.056296457],"study_design_scores_gemma":[0.24500778,0.025672065,0.07125808,0.0036761877,0.6456423,0.00044129963,0.00009305532,0.0014444952,0.0011556391,0.00067496666,0.004825193,0.000109032],"about_ca_topic_score_codex":0.00066721527,"about_ca_topic_score_gemma":0.0014013649,"teacher_disagreement_score":0.02350555,"about_ca_system_score_codex":0.0008435702,"about_ca_system_score_gemma":0.0011830347,"threshold_uncertainty_score":0.12431073},"labels":[],"label_agreement":null},{"id":"W4301765318","doi":"10.1111/bjd.14560","title":"BSID Annual Meeting, Dalhousie Building, University of Dundee, 4-6 April 2016","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Urbanization and City Planning","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography; Library science; Computer science","score_opus":0.009236799012500721,"score_gpt":0.23653421177914846,"score_spread":0.22729741276664775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301765318","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02751277,0.090383045,0.0026345267,0.16114803,0.25303844,0.00172688,0.020785844,0.0012467953,0.44152373],"genre_scores_gemma":[0.017331013,0.01683827,0.0014663031,0.0036999758,0.011363946,0.00017212467,0.0049517616,0.00015339938,0.9440232],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989035,0.00011351043,0.00006178988,0.000096595584,0.00048713427,0.00033738863],"domain_scores_gemma":[0.997502,0.00011358871,0.000085515625,0.00006385247,0.0010269223,0.0012080753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023391172,0.0011280489,0.0007098852,0.0018292965,0.0019775575,0.0026487894,0.0010078576,0.0022619136,0.28047198],"category_scores_gemma":[0.001909358,0.00047201343,0.00068659795,0.00063417316,0.000529145,0.0007845183,0.002218788,0.0017047874,0.07003738],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004186142,0.00015197463,0.001448705,0.0003006267,0.00001544267,0.000211731,0.000046349956,0.00008328381,0.002407074,0.00038119726,0.9237433,0.07079163],"study_design_scores_gemma":[0.000028772814,0.00015096508,0.0078032133,0.00023271522,0.000009389789,0.00015497225,0.00014342763,0.000044737986,0.0008336567,0.00016308716,0.9904198,0.000015338344],"about_ca_topic_score_codex":0.01231617,"about_ca_topic_score_gemma":0.09176539,"teacher_disagreement_score":0.28047198,"about_ca_system_score_codex":0.0028883175,"about_ca_system_score_gemma":0.0054087285,"threshold_uncertainty_score":0.93827224},"labels":[],"label_agreement":null},{"id":"W4302283101","doi":"10.1111/bjd.21880","title":"How will brepocitinib cream compare with established treatments for mild-to-moderate eczema?","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Medicine; Dermatology","score_opus":0.019419140307171286,"score_gpt":0.2663980559441169,"score_spread":0.24697891563694563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302283101","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024094742,0.003779286,0.000087155124,0.97653073,0.009094231,0.00002368791,0.00011260193,0.000024045774,0.007938789],"genre_scores_gemma":[0.04161768,0.00844818,0.00068369595,0.8717303,0.06047107,0.00008540846,0.00018330569,0.000041183506,0.016739175],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987748,0.00036415024,0.00020073276,0.000118734395,0.0003508039,0.00019072686],"domain_scores_gemma":[0.9963911,0.0018174732,0.00024514965,0.00006422566,0.00076725055,0.0007148073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023592554,0.000355193,0.0010719565,0.00057941396,0.0013293542,0.0021248145,0.000763798,0.01746508,0.007000589],"category_scores_gemma":[0.017034328,0.00023317698,0.00096342206,0.00049259746,0.0008682975,0.0026523708,0.0004927259,0.010219661,0.0067097335],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008972904,0.0001973797,0.0037159373,0.0002058489,0.00007275188,0.009092749,0.00013677582,0.00021978804,0.0007898524,0.0028658824,0.8922024,0.08960332],"study_design_scores_gemma":[0.0009770595,0.0007441453,0.006807844,0.0010185296,0.00014795421,0.01799238,0.0006558582,0.0013237402,0.00077438005,0.0149629805,0.9544912,0.00010397942],"about_ca_topic_score_codex":0.0037186018,"about_ca_topic_score_gemma":0.0067459866,"teacher_disagreement_score":0.01746508,"about_ca_system_score_codex":0.0034590913,"about_ca_system_score_gemma":0.0020526014,"threshold_uncertainty_score":0.025097609},"labels":[],"label_agreement":null},{"id":"W4313728090","doi":"10.1093/bjd/ljac040","title":"Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Secukinumab; Medicine; Psoriasis Area and Severity Index; Placebo; Randomized controlled trial; Psoriasis; Clinical trial; Internal medicine; Dermatology; Psoriatic arthritis","score_opus":0.022812531839389194,"score_gpt":0.28525301356138516,"score_spread":0.26244048172199597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313728090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96060926,0.020154042,0.0012304442,0.001387313,0.0007388986,0.00793413,0.00365501,0.00016423814,0.0041265585],"genre_scores_gemma":[0.9755651,0.008446999,0.0017099073,0.0013699089,0.00069442403,0.0069088214,0.0027038297,0.00004674771,0.002554345],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99635774,0.0024506676,0.00023487638,0.000346844,0.0003030253,0.00030687897],"domain_scores_gemma":[0.99498427,0.0013057844,0.0016865093,0.00059681735,0.0005707461,0.00085581176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009119418,0.001487926,0.0028340006,0.0004486478,0.00062663807,0.0014028817,0.0008453014,0.0018685893,0.005574192],"category_scores_gemma":[0.005554972,0.00058235583,0.0038958052,0.0006280632,0.0010457713,0.0012831796,0.00061232346,0.0030422793,0.0009022265],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9688043,0.0055878153,0.0012032053,0.00065458013,0.0022376617,0.00003097275,0.00006910372,0.00021618354,0.0017399404,0.00010106667,0.001439333,0.01791588],"study_design_scores_gemma":[0.9026068,0.08574554,0.0070292293,0.00011446812,0.0018952638,0.00006801398,0.000037221304,0.0001830162,0.0005239256,0.00014950985,0.0016246284,0.000022468983],"about_ca_topic_score_codex":0.0007961876,"about_ca_topic_score_gemma":0.0017303308,"teacher_disagreement_score":0.009119418,"about_ca_system_score_codex":0.0008704574,"about_ca_system_score_gemma":0.0013468253,"threshold_uncertainty_score":0.04822868},"labels":[],"label_agreement":null},{"id":"W4313729039","doi":"10.1093/bjd/ljac021","title":"Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"Cilag; LEO Pharma; Novo Nordisk; Galderma; Bristol-Myers Squibb; Eli Lilly and Company; Ortho Dermatologics; Sanofi Genzyme; Incyte; Dermira; UCB Pharma; Sun Pharma; Regeneron Pharmaceuticals; Celgene; Samsung; Valeant Pharmaceuticals International; Sanofi; Amgen; Meiji Seika Pharma; Pfizer","keywords":"Open label; Randomized controlled trial; Plaque psoriasis; Medicine; Term (time); Psoriasis; Extension (predicate logic); Surgery; Dermatology; Computer science","score_opus":0.018578486234398846,"score_gpt":0.2485509443510118,"score_spread":0.22997245811661296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313729039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770989,0.01616214,0.00057336764,0.0009273752,0.00043576228,0.0014894032,0.0010573583,0.000064487256,0.0021912444],"genre_scores_gemma":[0.98591775,0.004533303,0.0011207632,0.0015323868,0.0008388551,0.0025936693,0.0015968203,0.000023634642,0.0018429019],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99620724,0.0023950674,0.00025513725,0.00045257335,0.00039749217,0.00029253776],"domain_scores_gemma":[0.9942662,0.0016514456,0.0019540058,0.00065772113,0.00042658878,0.0010440154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008025527,0.0009981617,0.0033189685,0.00036508136,0.0006974582,0.0014585374,0.00090436876,0.002365371,0.0047650808],"category_scores_gemma":[0.0066383015,0.0006942099,0.0038854545,0.00052991824,0.0011739541,0.001974146,0.00074684626,0.0041816067,0.000724773],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9751883,0.005821005,0.00190837,0.0005672074,0.0016416948,0.0000204138,0.000048723028,0.00016867634,0.0008524692,0.00008117288,0.00074383046,0.012958199],"study_design_scores_gemma":[0.86429656,0.11416741,0.016729936,0.0001404064,0.0021857452,0.000059234942,0.00003508841,0.00039341836,0.00040221467,0.00023161028,0.0013211684,0.00003724535],"about_ca_topic_score_codex":0.00050218473,"about_ca_topic_score_gemma":0.00092716806,"teacher_disagreement_score":0.008025527,"about_ca_system_score_codex":0.00064692425,"about_ca_system_score_gemma":0.0011627898,"threshold_uncertainty_score":0.042443573},"labels":[],"label_agreement":null},{"id":"W4317360689","doi":"10.1093/bjd/ljac017","title":"Granzyme K contributes to endothelial microvascular damage and leakage during skin inflammation","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University; International Collaboration On Repair Discoveries; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Inflammation; Angiogenesis; Granzyme A; Immunology; Medicine; Pathogenesis; Granzyme; Vascular permeability; Erythema; Immune system; Pathology; Granzyme B; T cell; CD8; Cancer research","score_opus":0.004902850591071911,"score_gpt":0.2159892521330893,"score_spread":0.2110864015420174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317360689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98562163,0.009466502,0.0028702111,0.00040832208,0.00005891367,0.00004225978,0.00023917927,0.00012513627,0.0011679105],"genre_scores_gemma":[0.9964393,0.0015607851,0.00085218495,0.00007696016,0.000022626675,0.000021737998,0.00012586011,0.000013032896,0.0008875255],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997836,0.000056230037,0.000021997163,0.000036838177,0.00004150368,0.000059844235],"domain_scores_gemma":[0.99970406,0.00003494796,0.00013860941,0.00002949997,0.000035461562,0.00005733244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003086357,0.000320484,0.00032179037,0.0003093663,0.00014789245,0.00056925754,0.00022891881,0.00052917906,0.0017677064],"category_scores_gemma":[0.00046063116,0.00015430716,0.00030822871,0.00017386365,0.00032893498,0.00033756756,0.00047031353,0.0009311771,0.00048673278],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028273065,0.000115805844,0.0073071592,0.00033727306,0.00005247309,0.00096034573,0.00010633724,0.0002029204,0.9759694,0.00032588321,0.0003477356,0.011447425],"study_design_scores_gemma":[0.00036177004,0.0028984817,0.2369953,0.0001752469,0.00028329212,0.012159622,0.0005056119,0.004034686,0.7282952,0.002143151,0.012106823,0.000040862302],"about_ca_topic_score_codex":0.00013946403,"about_ca_topic_score_gemma":0.00011938198,"teacher_disagreement_score":0.0017677064,"about_ca_system_score_codex":0.00036260215,"about_ca_system_score_gemma":0.00017182679,"threshold_uncertainty_score":0.0059135556},"labels":[],"label_agreement":null},{"id":"W4317646215","doi":"10.1093/bjd/ljac080","title":"Safety of baricitinib in patients with alopecia areata","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Alopecia areata; Dermatology; Medicine","score_opus":0.005759247926343786,"score_gpt":0.20826884686696745,"score_spread":0.20250959894062368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317646215","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34586725,0.06544167,0.0014420887,0.5076509,0.0061039813,0.000091709335,0.001100067,0.00021513079,0.07208718],"genre_scores_gemma":[0.9079495,0.0057021854,0.0003582502,0.072596714,0.0076148096,0.000030237006,0.00033065115,0.000029528965,0.0053880783],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99922836,0.00024789787,0.000091377275,0.000062629406,0.00024267205,0.00012716021],"domain_scores_gemma":[0.99698776,0.001883592,0.00043996202,0.00007205323,0.00031201402,0.00030466213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008053991,0.00017755559,0.00080823794,0.00025564496,0.000679631,0.0011650049,0.00038259107,0.003907792,0.0023090523],"category_scores_gemma":[0.0064705024,0.00012326121,0.0005604978,0.00042658325,0.00037913653,0.00057957583,0.0002259543,0.0033100368,0.0008647404],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018787669,0.0008135361,0.14625332,0.0013707655,0.00063450227,0.13691998,0.00089021877,0.002543376,0.015989413,0.005143281,0.25171134,0.41894257],"study_design_scores_gemma":[0.0061376076,0.008989149,0.17964764,0.0016641516,0.0009805287,0.3411725,0.0013781883,0.008035103,0.009464655,0.012866456,0.42947355,0.00019055934],"about_ca_topic_score_codex":0.0015069684,"about_ca_topic_score_gemma":0.0021078745,"teacher_disagreement_score":0.003907792,"about_ca_system_score_codex":0.001560907,"about_ca_system_score_gemma":0.00070603203,"threshold_uncertainty_score":0.01132524},"labels":[],"label_agreement":null},{"id":"W4317646773","doi":"10.1093/bjd/ljac052","title":"Does bimekizumab stand the test of time for psoriasis?","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Psoriasis; Test (biology); Medicine; Dermatology; Biology","score_opus":0.010099609438465305,"score_gpt":0.21994090026958446,"score_spread":0.20984129083111916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317646773","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010420557,0.083008945,0.0008645748,0.7316105,0.1487017,0.00006556136,0.00069012825,0.00038146047,0.033635024],"genre_scores_gemma":[0.018590683,0.12801288,0.0021288572,0.46268067,0.31342122,0.00010950546,0.0010821074,0.0007212265,0.073252834],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99790144,0.00044244857,0.00023536863,0.00021284011,0.0009128235,0.00029506724],"domain_scores_gemma":[0.99049383,0.0034745068,0.00092166377,0.000501512,0.0020415008,0.0025669225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004834693,0.0004477734,0.0017664866,0.0011847019,0.0011852483,0.005387493,0.0020060502,0.0072649713,0.07564381],"category_scores_gemma":[0.014967452,0.00044203154,0.0009927389,0.0011622212,0.0021066875,0.004959197,0.0015537079,0.011000137,0.040893007],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032932952,0.00007447029,0.0005368037,0.00030789548,0.000034843924,0.00015928016,0.000021941005,0.00003455803,0.00017189475,0.0036547547,0.79753,0.19714428],"study_design_scores_gemma":[0.00021285882,0.000105358595,0.00077484146,0.00088743557,0.000035960165,0.00043256668,0.00007684059,0.0001289694,0.0001542111,0.005819886,0.9913481,0.000022994278],"about_ca_topic_score_codex":0.0018214987,"about_ca_topic_score_gemma":0.004313936,"teacher_disagreement_score":0.07564381,"about_ca_system_score_codex":0.0028082244,"about_ca_system_score_gemma":0.0032274874,"threshold_uncertainty_score":0.25305372},"labels":[],"label_agreement":null},{"id":"W4317646803","doi":"10.1093/bjd/ljac038","title":"Comorbid diagnosis of systemic lupus erythematosus in vitiligo: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Vitiligo; Medicine; Meta-analysis; Dermatology; Lupus erythematosus; MEDLINE; Immunology; Pathology; Antibody; Biology","score_opus":0.04082151094400545,"score_gpt":0.3156295654674686,"score_spread":0.2748080545234632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317646803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00510876,0.99394715,0.00016504605,0.00009865525,0.00008961238,0.000046083343,0.00041192494,0.000009387074,0.00012332329],"genre_scores_gemma":[0.19767852,0.79868245,0.0011653188,0.00085136003,0.00024999928,0.00023084864,0.00077864405,0.00001749408,0.00034528357],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970438,0.000982529,0.0009383949,0.00054715684,0.00031409366,0.00017399083],"domain_scores_gemma":[0.9939167,0.00424214,0.0011867153,0.00019362493,0.00033524437,0.00012562377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003467717,0.0015756838,0.010998214,0.0029666033,0.00040958895,0.0018601223,0.0016694617,0.0020565884,0.004708538],"category_scores_gemma":[0.009431361,0.0011399834,0.017076328,0.005361485,0.000468479,0.0012644244,0.0014460655,0.0013669534,0.00032150917],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024522792,0.00005484276,0.0170279,0.4001313,0.5565173,0.00033393994,0.00013654913,0.00039026048,0.00038775595,0.00014434049,0.0014991569,0.02092431],"study_design_scores_gemma":[0.0008036317,0.00018058825,0.019969746,0.022519456,0.95298123,0.00027152794,0.00010420018,0.00013905679,0.00008311113,0.00017558805,0.002722797,0.00004902],"about_ca_topic_score_codex":0.006440406,"about_ca_topic_score_gemma":0.021403562,"teacher_disagreement_score":0.010998214,"about_ca_system_score_codex":0.0010284166,"about_ca_system_score_gemma":0.0017145844,"threshold_uncertainty_score":0.018339276},"labels":[],"label_agreement":null},{"id":"W4317952699","doi":"10.1093/bjd/ljac140.009","title":"309 Tralokinumab demonstrated a consistent safety profile with up to 42 months of treatment in moderate-to-severe atopic dermatitis: including adverse events of special interest","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SKiN Health; Queen's University; Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Adverse effect; Atopic dermatitis; Placebo; Dosing; Interim analysis; Internal medicine; Clinical trial; Pediatrics; Dermatology; Alternative medicine","score_opus":0.027450819459691467,"score_gpt":0.28470093458630624,"score_spread":0.2572501151266148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96901333,0.00766019,0.003436202,0.00048248004,0.00018337711,0.00071179145,0.0034183674,0.00048506807,0.014609284],"genre_scores_gemma":[0.9891668,0.0009363688,0.0013092324,0.00028587977,0.00004306628,0.00015765407,0.0015051336,0.000029530793,0.0065663606],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997036,0.00008050389,0.00003258936,0.00005305214,0.00009255361,0.00003770213],"domain_scores_gemma":[0.9996051,0.00010687908,0.00007474303,0.000049227507,0.000112979214,0.00005108658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005248757,0.00025116978,0.00059225736,0.00012165378,0.00017990565,0.00034737992,0.00018293453,0.0003788919,0.0063822675],"category_scores_gemma":[0.0006271268,0.000102636266,0.00054714934,0.00014271871,0.0001205505,0.00022866274,0.00009962727,0.0008373205,0.0021901533],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031672392,0.0058884663,0.014428581,0.0018664644,0.00048134202,0.00070485834,0.0002033914,0.0017742948,0.48696122,0.0003751823,0.014993996,0.44064975],"study_design_scores_gemma":[0.014799711,0.18145038,0.34061867,0.0004041624,0.0012933678,0.009615377,0.00021275188,0.0087635955,0.31307775,0.0006532378,0.12895645,0.00015442655],"about_ca_topic_score_codex":0.0006502154,"about_ca_topic_score_gemma":0.001953533,"teacher_disagreement_score":0.0063822675,"about_ca_system_score_codex":0.00029433574,"about_ca_system_score_gemma":0.0004129839,"threshold_uncertainty_score":0.021350801},"labels":[],"label_agreement":null},{"id":"W4317952701","doi":"10.1093/bjd/ljac140.005","title":"301 Tapinarof cream 1% once daily for the treatment of extensive atopic dermatitis in adolescents and children: 4-week maximal use trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Atopic dermatitis; Medicine; Eczema Area and Severity Index; Adverse effect; Psoriasis; Body surface area; Clinical trial; Randomized controlled trial; Clinical endpoint; Pediatrics; Dermatology; Internal medicine","score_opus":0.025587148880056212,"score_gpt":0.2834103890511923,"score_spread":0.2578232401711361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98726976,0.005419688,0.00023457748,0.00047512975,0.00014193029,0.0018845461,0.0015051365,0.000065091444,0.0030040527],"genre_scores_gemma":[0.9906289,0.0026883215,0.0006761495,0.0007523341,0.0001645051,0.0017147056,0.0010887833,0.000014821139,0.002271472],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99975973,0.00009774517,0.000012091191,0.00004949046,0.00002952337,0.000051485888],"domain_scores_gemma":[0.99962103,0.00008129945,0.00006310214,0.000024183997,0.000029984021,0.00018023419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007490663,0.0007356065,0.0015507775,0.00018321279,0.00028652445,0.0007609077,0.00055744237,0.0010010173,0.0063353786],"category_scores_gemma":[0.00052314554,0.00035712228,0.0011823738,0.00017853225,0.00052280654,0.00065010454,0.0002826489,0.0023926538,0.00079930975],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8323552,0.03554546,0.0060949125,0.0027906552,0.0016444137,0.0004808544,0.00029461266,0.001326335,0.015626943,0.00059094426,0.0076559973,0.095593646],"study_design_scores_gemma":[0.7388361,0.23617603,0.016502786,0.00025154356,0.0006166184,0.0003538116,0.00009122615,0.0010414355,0.0015026692,0.00023916014,0.0043625426,0.000025977639],"about_ca_topic_score_codex":0.00089122227,"about_ca_topic_score_gemma":0.0026308594,"teacher_disagreement_score":0.0063353786,"about_ca_system_score_codex":0.00070120045,"about_ca_system_score_gemma":0.00088280905,"threshold_uncertainty_score":0.021193922},"labels":[],"label_agreement":null},{"id":"W4317952709","doi":"10.1093/bjd/ljac140.031","title":"337 Dupilumab treatment is not associated with an increased overall risk of infections in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Dupilumab; Placebo; Atopic dermatitis; Medicine; Concomitant; Incidence (geometry); Internal medicine; Eczema Area and Severity Index; Randomized controlled trial; Adverse effect; Dermatology; Pathology; Alternative medicine","score_opus":0.008691247916455452,"score_gpt":0.2401094852616762,"score_spread":0.23141823734522074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98308414,0.014634679,0.000116880234,0.00017117857,0.0001178583,0.00010634001,0.00044517108,0.000012953901,0.0013106992],"genre_scores_gemma":[0.9980332,0.0011082875,0.000104942665,0.0001876124,0.000061660736,0.00004429108,0.00023575514,0.0000014189928,0.00022283584],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9993544,0.00030588056,0.00007316175,0.000086543245,0.00009917294,0.000080886195],"domain_scores_gemma":[0.99907434,0.00030849312,0.00037572678,0.00003389189,0.00006195086,0.00014551978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008880367,0.00026440542,0.0010573257,0.00019686585,0.0002481331,0.000441469,0.00018101084,0.0005294197,0.0032359876],"category_scores_gemma":[0.0014095012,0.00019275332,0.0017451057,0.00022087556,0.00021279928,0.00023679597,0.00017302913,0.00066014385,0.00018488133],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5776082,0.0033264516,0.25077525,0.003238108,0.007839772,0.0006497679,0.00015722937,0.00060056784,0.015045245,0.00018075827,0.004456035,0.13612264],"study_design_scores_gemma":[0.059906058,0.104731254,0.82058144,0.00040029848,0.005665908,0.0009665939,0.00013675526,0.0010732759,0.0021170548,0.00014006175,0.004235594,0.0000456917],"about_ca_topic_score_codex":0.00080852996,"about_ca_topic_score_gemma":0.0019838656,"teacher_disagreement_score":0.0032359876,"about_ca_system_score_codex":0.00028471387,"about_ca_system_score_gemma":0.00036103945,"threshold_uncertainty_score":0.010825455},"labels":[],"label_agreement":null},{"id":"W4317952713","doi":"10.1093/bjd/ljac140.023","title":"328 Understanding the impact of atopic dermatitis on patients: a large international, ethnically diverse survey-based qualitative study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Ethnically diverse; Atopic dermatitis; Population; Disease; Qualitative research; Telephone interview; Family medicine; Environmental health; Pathology","score_opus":0.07348607169088718,"score_gpt":0.39905004627109814,"score_spread":0.32556397458021097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533075,0.0004050619,0.0003401121,0.0014936731,0.000025370147,0.00016427608,0.00020776861,0.00000568027,0.0020271533],"genre_scores_gemma":[0.9972263,0.0006053153,0.0002801643,0.0009892298,0.000009064286,0.00026771324,0.00006869192,0.000007463876,0.0005460173],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9940666,0.004218682,0.00026238186,0.00025551987,0.000375997,0.00082086935],"domain_scores_gemma":[0.98895544,0.0072680213,0.0010670149,0.0003209867,0.00094581244,0.0014426094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01010522,0.0003849928,0.00075067516,0.0014622415,0.0054017943,0.0033241068,0.0013369954,0.0010920995,0.0036306924],"category_scores_gemma":[0.014412114,0.00063670136,0.0005151515,0.001474374,0.003681175,0.0032195202,0.0045590973,0.0023328918,0.00043288377],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003260245,0.0000918635,0.02302405,0.00019854915,0.000010574871,0.00043569275,0.9716593,0.000023679688,0.00035396378,0.0003745017,0.0006343804,0.003160782],"study_design_scores_gemma":[0.0000030040185,0.00004365733,0.0046033077,0.00012846637,0.000004084954,0.00009561398,0.99306935,0.00004158214,0.000048248734,0.000070156915,0.001882848,0.00000960257],"about_ca_topic_score_codex":0.015611014,"about_ca_topic_score_gemma":0.020641468,"teacher_disagreement_score":0.015611014,"about_ca_system_score_codex":0.0043891077,"about_ca_system_score_gemma":0.0045928564,"threshold_uncertainty_score":0.05344218},"labels":[],"label_agreement":null},{"id":"W4317952733","doi":"10.1093/bjd/ljac140.004","title":"288 Once-daily crisaborole as a long-term maintenance treatment in patients with mild-to-moderate atopic dermatitis: A 52-week clinical trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Medicine; Atopic dermatitis; Maintenance therapy; Adverse effect; Randomized controlled trial; Internal medicine; Surgery; Dermatology; Chemotherapy","score_opus":0.02956280420410868,"score_gpt":0.32864235440599526,"score_spread":0.2990795502018866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897271,0.004171093,0.0003715382,0.0004320089,0.00029969733,0.0018166828,0.00063039846,0.00014484514,0.002406709],"genre_scores_gemma":[0.9927549,0.0016001405,0.0006333702,0.0007365003,0.00021827308,0.0012346563,0.00057936617,0.000013344706,0.0022295672],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99973553,0.000112806614,0.000018563926,0.000053316468,0.000027054537,0.000052628413],"domain_scores_gemma":[0.99961627,0.00007149222,0.00006229422,0.00004070681,0.000044578344,0.00016465392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007842877,0.00068150094,0.0016473933,0.00024769342,0.00038672512,0.0008485285,0.00053886964,0.0012667828,0.005725],"category_scores_gemma":[0.0006147086,0.000340814,0.0011822641,0.0002124753,0.00051121745,0.0006240749,0.00025019416,0.0021297287,0.0009774086],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9085399,0.025029125,0.0013008218,0.0010385194,0.000817209,0.00008642988,0.00007512711,0.0004002822,0.011725526,0.00012797906,0.0022697048,0.048589338],"study_design_scores_gemma":[0.7825774,0.20939259,0.005172816,0.000053050844,0.00033777428,0.000060635793,0.000030766343,0.0005630613,0.0007069693,0.00006515602,0.001020584,0.0000191755],"about_ca_topic_score_codex":0.00052537845,"about_ca_topic_score_gemma":0.0010776971,"teacher_disagreement_score":0.005725,"about_ca_system_score_codex":0.00031951413,"about_ca_system_score_gemma":0.00058129965,"threshold_uncertainty_score":0.019152045},"labels":[],"label_agreement":null},{"id":"W4317952754","doi":"10.1093/bjd/ljac140.016","title":"320 Study design and interim recruitment into the post-authorization safety study to monitor pregnancy and infant outcomes following administration of dupilumab during planned or unexpected pregnancy in North America","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Medicine; Pregnancy; Atopic dermatitis; Asthma; Prospective cohort study; Obstetrics; Pediatrics; Immunology; Internal medicine","score_opus":0.03629529792572218,"score_gpt":0.3312989481729265,"score_spread":0.2950036502472043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952754","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9336744,0.00062061235,0.0030356213,0.0005871649,0.00019269138,0.045032162,0.008021013,0.000058588364,0.008777785],"genre_scores_gemma":[0.9133402,0.0003063646,0.00496697,0.0017845198,0.00020605806,0.06788655,0.004769431,0.000021423777,0.0067184395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99485993,0.003054666,0.0002999235,0.0007270665,0.000585239,0.00047317008],"domain_scores_gemma":[0.99708337,0.00064848654,0.00084704114,0.000501276,0.00048692926,0.00043289884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050506205,0.0008012067,0.0007187082,0.0004417864,0.0009862864,0.00068601745,0.0006272954,0.0010365617,0.0062700775],"category_scores_gemma":[0.0056551225,0.00055593916,0.0011356875,0.00043036978,0.0005515079,0.00051510514,0.00055180606,0.0011082808,0.0017354772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3568885,0.024250254,0.5185665,0.0010374866,0.0016130266,0.0010363576,0.0013457164,0.00063247076,0.007043879,0.0017381564,0.01306361,0.07278406],"study_design_scores_gemma":[0.06450148,0.28106132,0.6169496,0.00026754325,0.001501806,0.00070137857,0.0005969472,0.0015633,0.0031380502,0.00095193187,0.028674036,0.00009259186],"about_ca_topic_score_codex":0.0021885578,"about_ca_topic_score_gemma":0.0033337178,"teacher_disagreement_score":0.0062700775,"about_ca_system_score_codex":0.001033777,"about_ca_system_score_gemma":0.003292624,"threshold_uncertainty_score":0.02671051},"labels":[],"label_agreement":null},{"id":"W4317952775","doi":"10.1093/bjd/ljac140.017","title":"321 Cancer risk with topical pimecrolimus and tacrolimus for atopic dermatitis: systematic review and Bayesian meta-analysis","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina; University of Ottawa; University of Toronto; McMaster University","funders":"","keywords":"Pimecrolimus; Medicine; Calcineurin; Atopic dermatitis; Randomized controlled trial; Dermatology; Tacrolimus; Relative risk; Odds ratio; Skin cancer; Population; Meta-analysis; Absolute risk reduction; Cancer; Confidence interval; Internal medicine; Environmental health; Transplantation","score_opus":0.020288888898497507,"score_gpt":0.29775498489498087,"score_spread":0.27746609599648336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952775","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004946481,0.9904957,0.0022176348,0.00032884005,0.00017072218,0.00039997487,0.0010060595,0.000037125592,0.00039753687],"genre_scores_gemma":[0.3911818,0.5940216,0.007973394,0.0016061174,0.0005155151,0.002163939,0.0018951262,0.00007301518,0.0005694946],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9778047,0.012830477,0.0051367152,0.0018970544,0.0020030087,0.00032801315],"domain_scores_gemma":[0.9489823,0.04224145,0.0050090086,0.0013644083,0.0020696723,0.0003331439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023681719,0.0026161254,0.013806515,0.010191156,0.00055427256,0.002931871,0.0022609958,0.0021904337,0.004275104],"category_scores_gemma":[0.0583885,0.0017717547,0.044765037,0.008054159,0.0007259294,0.0018760113,0.0016134828,0.0019852729,0.00040062677],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009384126,0.000020732294,0.005765178,0.20037585,0.7818037,0.00011812821,0.000046623914,0.0010195989,0.00012935782,0.00018668997,0.0006260939,0.008969584],"study_design_scores_gemma":[0.0003003067,0.000117728705,0.0035611407,0.01958776,0.97384465,0.00011679359,0.00002578399,0.00050878496,0.00008402873,0.00039054005,0.0014405622,0.000021996682],"about_ca_topic_score_codex":0.0061121727,"about_ca_topic_score_gemma":0.008885382,"teacher_disagreement_score":0.023681719,"about_ca_system_score_codex":0.002209467,"about_ca_system_score_gemma":0.0029501352,"threshold_uncertainty_score":0.12524235},"labels":[],"label_agreement":null},{"id":"W4317952776","doi":"10.1093/bjd/ljac140.033","title":"339 Dupilumab 16-week efficacy and safety are robust and consistent in adults over 60 years of age with moderate-to-severe atopic dermatitis","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; University of Toronto","funders":"","keywords":"Eczema Area and Severity Index; Medicine; Dupilumab; Atopic dermatitis; Dermatology Life Quality Index; Placebo; Quality of life (healthcare); Population; Internal medicine; Randomized controlled trial; Dermatology; Disease; Alternative medicine; Pathology","score_opus":0.012251911398168747,"score_gpt":0.2342836336024542,"score_spread":0.22203172220428544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94571424,0.041207027,0.0013266613,0.000332047,0.00015399544,0.0006191749,0.0048872563,0.00011216075,0.005647545],"genre_scores_gemma":[0.99510163,0.0017152549,0.00047770038,0.00031463738,0.00008903985,0.00017813346,0.0015612658,0.000008446923,0.00055383594],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99812907,0.00066606014,0.00030527162,0.00033750554,0.0004106091,0.00015141947],"domain_scores_gemma":[0.99644154,0.0010703348,0.0015673824,0.0002806316,0.0004595391,0.00018048074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049019316,0.00030993842,0.0013666443,0.0003776174,0.00028922758,0.0007734019,0.00019600558,0.0004992004,0.0036814564],"category_scores_gemma":[0.004759702,0.00022130874,0.0013881326,0.00043960044,0.00026296114,0.00063433306,0.00034764578,0.00065161806,0.0005953154],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25295103,0.0026528288,0.25455067,0.0064730556,0.018853737,0.00026360064,0.00054024137,0.0013484702,0.051389493,0.00034857495,0.010624634,0.40000373],"study_design_scores_gemma":[0.015730407,0.04716543,0.9065495,0.00052111107,0.0082728565,0.00087674055,0.0001738656,0.0011205119,0.0050875754,0.00026945377,0.014171949,0.00006062244],"about_ca_topic_score_codex":0.0005857018,"about_ca_topic_score_gemma":0.0013314259,"teacher_disagreement_score":0.0049019316,"about_ca_system_score_codex":0.00030667958,"about_ca_system_score_gemma":0.00039146852,"threshold_uncertainty_score":0.025924206},"labels":[],"label_agreement":null},{"id":"W4317952779","doi":"10.1093/bjd/ljac140.008","title":"308 Tralokinumab provides other clinically meaningful improvements in adolescents with moderate-to-severe atopic dermatitis who did not achieve IGA 0/1 at week 16","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Placebo; Medicine; Atopic dermatitis; Clinical endpoint; Post-hoc analysis; Eczema Area and Severity Index; Internal medicine; Randomized controlled trial; Imputation (statistics); Gastroenterology; Dermatology; Missing data; Pathology","score_opus":0.016824153032463204,"score_gpt":0.2719084973916451,"score_spread":0.25508434435918187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953365,0.0023492605,0.0001525147,0.00016960556,0.000092589755,0.00028424748,0.000512744,0.000031139367,0.0010713954],"genre_scores_gemma":[0.99742967,0.00046740088,0.0003808951,0.00027165175,0.0000348125,0.00025737798,0.00038328016,0.0000048790407,0.00076999376],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99965405,0.00016062107,0.000025915711,0.00005155896,0.000046550333,0.00006134672],"domain_scores_gemma":[0.9996276,0.00009882952,0.000089705805,0.000022604303,0.00003812518,0.00012311549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011549906,0.00033706558,0.0012249799,0.000113786075,0.00019272797,0.00044023574,0.00023904668,0.00044736147,0.0033009474],"category_scores_gemma":[0.0006059963,0.00015303763,0.0011159398,0.000100139216,0.00022728724,0.00034628462,0.00014583378,0.0011561695,0.00057741936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6555451,0.019193778,0.04322914,0.0022983698,0.0028935273,0.00040296218,0.00029964515,0.0015468422,0.058091562,0.00047228415,0.0075340997,0.20849273],"study_design_scores_gemma":[0.28271738,0.49921244,0.19027178,0.00038591612,0.0022769868,0.00097028096,0.00020247448,0.0035653084,0.011212128,0.00037646623,0.00875438,0.00005452168],"about_ca_topic_score_codex":0.00047343373,"about_ca_topic_score_gemma":0.001990848,"teacher_disagreement_score":0.0033009474,"about_ca_system_score_codex":0.00034964038,"about_ca_system_score_gemma":0.00046759652,"threshold_uncertainty_score":0.011042714},"labels":[],"label_agreement":null},{"id":"W4317952794","doi":"10.1093/bjd/ljac140.022","title":"327 Optimizing the management of atopic dermatitis with a new minimal disease activity concept and criteria and consensus-based recommendations for systemic therapy","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Systemic therapy; Medicine; Atopic dermatitis; Disease; Family medicine; Intensive care medicine; Breast cancer; Immunology; Internal medicine; Cancer","score_opus":0.0601214467038856,"score_gpt":0.34576311969541956,"score_spread":0.285641672991534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952794","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06515587,0.06702665,0.16504176,0.5852293,0.012984069,0.015725646,0.0016069273,0.000569797,0.086660035],"genre_scores_gemma":[0.40075,0.02208614,0.52206475,0.03243785,0.0032467293,0.010584803,0.002223895,0.0001396241,0.006466302],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.90614146,0.06864177,0.012387078,0.001525558,0.009762198,0.0015419429],"domain_scores_gemma":[0.9239461,0.020083416,0.009967559,0.0026656224,0.03562359,0.0077137854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10029257,0.00077567296,0.0010940712,0.0040071993,0.0014758264,0.0049363268,0.003794111,0.003354692,0.002062457],"category_scores_gemma":[0.08682981,0.0004913482,0.0023475965,0.0014996021,0.0020790454,0.0027003505,0.0062855994,0.004971627,0.0008514869],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006915156,0.0012825449,0.025012778,0.008358188,0.00047323375,0.00071967853,0.007539592,0.0076282304,0.002441051,0.045334782,0.24379878,0.65671974],"study_design_scores_gemma":[0.0019657456,0.0021190417,0.036580574,0.056874346,0.0010299264,0.0017987501,0.015534345,0.031663492,0.0037438974,0.08158036,0.7666406,0.00046895375],"about_ca_topic_score_codex":0.0065856683,"about_ca_topic_score_gemma":0.009876866,"teacher_disagreement_score":0.10029257,"about_ca_system_score_codex":0.009602543,"about_ca_system_score_gemma":0.028244155,"threshold_uncertainty_score":0.53040415},"labels":[],"label_agreement":null},{"id":"W4317952800","doi":"10.1093/bjd/ljac140.019","title":"323 Onset of atopic comorbidities relative to atopic dermatitis diagnosis in a real-world setting using an Israeli claims database","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Atopic dermatitis; Interquartile range; Asthma; Diagnosis code; Pediatrics; Epidemiology; Cohort; Population; Retrospective cohort study; Database; Internal medicine; Dermatology","score_opus":0.044431792324268346,"score_gpt":0.33796408556239177,"score_spread":0.2935322932381234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915001,0.00018680925,0.000097983735,0.000067345805,0.0000070606307,0.000028369666,0.007498119,0.000005116609,0.0006090419],"genre_scores_gemma":[0.99532336,0.00009084231,0.00010970567,0.000045438243,0.000012943405,0.000029390456,0.004304545,0.0000014879813,0.00008239102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925655,0.00016259411,0.00017902759,0.00019040439,0.00012283375,0.000088619585],"domain_scores_gemma":[0.99759716,0.0004842462,0.001330331,0.0001681469,0.00022633155,0.00019373551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007281479,0.00019576726,0.00028486428,0.0017401569,0.0003044069,0.0009317873,0.0004178014,0.00031023435,0.0027588368],"category_scores_gemma":[0.0029519913,0.00024644283,0.0004246024,0.0024559877,0.00016528185,0.0005333633,0.00056713563,0.00050636195,0.00036036098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033238717,0.000017553719,0.99931765,0.00000870813,0.00003210679,0.00002318868,0.00001664681,0.000030842628,0.00002359441,0.000011788484,0.00018612109,0.0002985699],"study_design_scores_gemma":[0.000009980114,0.000022299939,0.99850625,0.000016944558,0.000026959753,0.0001638791,0.00018223928,0.00079286477,0.00003551327,0.000017739649,0.00022149613,0.0000037892057],"about_ca_topic_score_codex":0.013923568,"about_ca_topic_score_gemma":0.010793498,"teacher_disagreement_score":0.013923568,"about_ca_system_score_codex":0.00055872725,"about_ca_system_score_gemma":0.00044506587,"threshold_uncertainty_score":0.027685046},"labels":[],"label_agreement":null},{"id":"W4318183967","doi":"10.1093/bjd/ljac145","title":"Core outcome domains for lichen sclerosus: a CORALS initiative consensus statement","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genital Health and Disease","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Nottingham; British Association of Dermatologists; National Institute for Health and Care Research","keywords":"Lichen sclerosus; Statement (logic); Outcome (game theory); Medicine; Core (optical fiber); Dermatology; Political science; Computer science; Mathematics","score_opus":0.24404855591048868,"score_gpt":0.4286747833372107,"score_spread":0.18462622742672202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318183967","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024958193,0.15541863,0.10692214,0.5529635,0.03920932,0.06937806,0.01140532,0.0010190228,0.038725864],"genre_scores_gemma":[0.13627663,0.0887512,0.5159869,0.08332422,0.007792837,0.13645363,0.02274346,0.0005175108,0.008153565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8061439,0.10424221,0.05163329,0.0038806004,0.028794782,0.005305285],"domain_scores_gemma":[0.67274565,0.14835295,0.028354656,0.0097427,0.12475417,0.01604992],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.28981626,0.0023968234,0.006119306,0.010248017,0.003888942,0.0059032147,0.009247527,0.010192902,0.0035813062],"category_scores_gemma":[0.24930379,0.0013090656,0.012732864,0.00566761,0.004151145,0.0046633626,0.015000037,0.013168387,0.0019819923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017891561,0.0007457672,0.011636365,0.12505502,0.0021691206,0.00087958,0.009460092,0.002808174,0.0029414878,0.026140532,0.23887749,0.5774972],"study_design_scores_gemma":[0.0025818706,0.0013875499,0.025276052,0.29977188,0.0044511748,0.0020690942,0.009404347,0.00428719,0.003515629,0.047567546,0.5990945,0.00059314986],"about_ca_topic_score_codex":0.0049159327,"about_ca_topic_score_gemma":0.0052922196,"teacher_disagreement_score":0.28981626,"about_ca_system_score_codex":0.011124625,"about_ca_system_score_gemma":0.065262616,"threshold_uncertainty_score":0.87578297},"labels":[],"label_agreement":null},{"id":"W4319460830","doi":"10.1093/bjd/ljac089","title":"Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"UCB Pharma; Manchester Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Ustekinumab; Medicine; Secukinumab; Adalimumab; Psoriasis Area and Severity Index; Discontinuation; Adverse effect; Psoriasis; Dermatology; Dermatology Life Quality Index; Clinical trial; Internal medicine; Psoriatic arthritis; Disease","score_opus":0.019078634734313493,"score_gpt":0.25183596524701773,"score_spread":0.23275733051270425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319460830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9261376,0.06310607,0.00044936896,0.0015669253,0.00034604207,0.0010907878,0.0015258574,0.000101529346,0.0056758365],"genre_scores_gemma":[0.97731256,0.014662078,0.00087421224,0.002312266,0.00035977477,0.0010338677,0.002289494,0.000025628548,0.001130154],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99899477,0.00052324357,0.00009714413,0.0001328692,0.0001428358,0.000109195535],"domain_scores_gemma":[0.99829835,0.0005536974,0.0005039749,0.000121657686,0.00013712575,0.00038520302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003557815,0.0005762236,0.0018078329,0.00020163454,0.0003295257,0.0012485773,0.00055392843,0.0010254303,0.0024259572],"category_scores_gemma":[0.0025804501,0.0002904991,0.0021872472,0.00042552585,0.0005387192,0.0006034022,0.0002950218,0.0025202793,0.00047549114],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6811826,0.0107162595,0.025452906,0.007370838,0.010862157,0.00017314153,0.00030626036,0.0013429106,0.010230677,0.00043413352,0.010918614,0.24100956],"study_design_scores_gemma":[0.73287064,0.14983284,0.089571126,0.0013270412,0.0065388163,0.00088331744,0.00017041895,0.0014663918,0.0028949978,0.0009413731,0.013425995,0.000076962686],"about_ca_topic_score_codex":0.00039841092,"about_ca_topic_score_gemma":0.0009366548,"teacher_disagreement_score":0.003557815,"about_ca_system_score_codex":0.0005231308,"about_ca_system_score_gemma":0.0006908015,"threshold_uncertainty_score":0.018815756},"labels":[],"label_agreement":null},{"id":"W4319978914","doi":"10.1093/bjd/ljac057","title":"Efficacy of downtitration or treatment withdrawal compared with continuous dosing after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis in a randomized substudy from the long-term extension study BREEZE-AD3","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Eli Lilly and Company","keywords":"Dosing; Medicine; Placebo; Atopic dermatitis; Cohort; Internal medicine; Anesthesia; Dermatology","score_opus":0.009185506710510306,"score_gpt":0.24559622675844336,"score_spread":0.23641072004793307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319978914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892051,0.006895215,0.00033564732,0.00022315857,0.00016048114,0.0014588401,0.0007729992,0.00003765848,0.00091090426],"genre_scores_gemma":[0.9951598,0.0013049634,0.00040858076,0.00029427622,0.00014930114,0.0013068725,0.00081627833,0.000008418127,0.00055143546],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99782336,0.0013137702,0.00023804182,0.00026873327,0.00016583136,0.00019031725],"domain_scores_gemma":[0.9968953,0.000974544,0.0011179053,0.00032396516,0.00023313648,0.0004550287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059709293,0.0011269029,0.0029909697,0.0003737589,0.00052871415,0.00094334106,0.0007422981,0.0013679022,0.0023970888],"category_scores_gemma":[0.003528319,0.00047571462,0.0044023525,0.0004407237,0.0005991754,0.0008399984,0.00047239286,0.002466061,0.00045605068],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.945398,0.0049435017,0.012619467,0.0011049141,0.007103787,0.00005850887,0.00014395922,0.00043384693,0.004764431,0.00004186632,0.0006969909,0.022690726],"study_design_scores_gemma":[0.6132842,0.27280527,0.095001884,0.00021567823,0.012700359,0.00025857482,0.00012230015,0.0012701853,0.002220128,0.00019129491,0.001859722,0.00007032825],"about_ca_topic_score_codex":0.0009263195,"about_ca_topic_score_gemma":0.0030954415,"teacher_disagreement_score":0.0059709293,"about_ca_system_score_codex":0.00083735725,"about_ca_system_score_gemma":0.00073434156,"threshold_uncertainty_score":0.031577647},"labels":[],"label_agreement":null},{"id":"W4323035929","doi":"10.1093/bjd/ljad053","title":"Atopic dermatitis in 2023 and beyond","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Epidemiology; Atopic dermatitis; Medicine; Dermatology; Pathogenesis; Family medicine; Immunology; Pathology","score_opus":0.010257209674156343,"score_gpt":0.2631347770804324,"score_spread":0.2528775674062761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323035929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001040844,0.72476506,0.00012708889,0.13305008,0.11900109,0.000009464565,0.00023661728,0.000036079535,0.021733625],"genre_scores_gemma":[0.016877485,0.6381107,0.0004345759,0.12813033,0.17323172,0.0000249841,0.0005486253,0.000037467176,0.04260407],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930096,0.0001483122,0.00010068714,0.00008546951,0.0002407806,0.00012377657],"domain_scores_gemma":[0.99881494,0.00027451655,0.000127131,0.00004466959,0.00037619457,0.00036265538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013319236,0.00034821316,0.0006007496,0.0007290412,0.00077383756,0.002305133,0.0003912344,0.0034152255,0.013132824],"category_scores_gemma":[0.0026924557,0.00013334662,0.0005085427,0.0007981117,0.00072402944,0.0018830738,0.00092939247,0.0034487727,0.004071725],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016320236,0.00003972112,0.0011747903,0.0011157846,0.00003271533,0.0007556022,0.0001842746,0.00004003327,0.00049921876,0.013415076,0.7507822,0.23179735],"study_design_scores_gemma":[0.000007194318,0.000015259655,0.0012146574,0.00086298323,0.000008574236,0.0006987732,0.000092980416,0.000008698636,0.000029020406,0.0014972407,0.9955596,0.000005064708],"about_ca_topic_score_codex":0.0052844062,"about_ca_topic_score_gemma":0.010796875,"teacher_disagreement_score":0.013132824,"about_ca_system_score_codex":0.0016629385,"about_ca_system_score_gemma":0.002898751,"threshold_uncertainty_score":0.04393363},"labels":[],"label_agreement":null},{"id":"W4323652381","doi":"10.1093/bjd/ljad060","title":"Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research; Lynde Centre for Dermatology; University of Toronto","funders":"","keywords":"Intertriginous; Medicine; Roflumilast; Psoriasis; Dermatology; Post-hoc analysis; Randomized controlled trial; Discontinuation; Reactogenicity; Internal medicine; Immunology; Disease; COPD","score_opus":0.009377737268086021,"score_gpt":0.226653947008203,"score_spread":0.21727620974011697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323652381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98483527,0.0040305997,0.0014854245,0.00040681768,0.00048034004,0.004622576,0.001962943,0.00012664843,0.0020494284],"genre_scores_gemma":[0.98652065,0.0017995135,0.0020768675,0.000504661,0.0005606644,0.0043793702,0.0015131847,0.0000754042,0.0025697376],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99367625,0.0040517785,0.0005230119,0.0006388513,0.00042423254,0.0006859811],"domain_scores_gemma":[0.9914454,0.0048038745,0.001637843,0.00080364104,0.0006687404,0.0006404833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010668212,0.0021474722,0.0072576986,0.00065822084,0.0005732507,0.0016481354,0.0010251416,0.0018439613,0.007235562],"category_scores_gemma":[0.0077055,0.0008003558,0.007104244,0.00074092386,0.0012130736,0.0012825076,0.00051800493,0.0033608256,0.0008893878],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9866151,0.0023644269,0.0006845141,0.00035893914,0.0027268436,0.00003018133,0.000023172146,0.00027244794,0.0022772446,0.00003685944,0.000282284,0.004327967],"study_design_scores_gemma":[0.8050958,0.1747857,0.009124813,0.00004585503,0.006746344,0.000057637706,0.00004184053,0.00088209077,0.002094578,0.00015384324,0.0009224214,0.000049037742],"about_ca_topic_score_codex":0.00071440305,"about_ca_topic_score_gemma":0.0013091954,"teacher_disagreement_score":0.010668212,"about_ca_system_score_codex":0.0010135619,"about_ca_system_score_gemma":0.0015689333,"threshold_uncertainty_score":0.05641961},"labels":[],"label_agreement":null},{"id":"W4323653032","doi":"10.1093/bjd/ljad069","title":"Factors associated with disease-specific life impact in patients with hidradenitis suppurativa: results from the Global VOICE project","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"Cilag; Sanofi Genzyme; InflaRx; Regeneron Pharmaceuticals; Sanofi; LEO Pharma; Galderma; Bayer HealthCare; Incyte; Amgen","keywords":"Hidradenitis suppurativa; Medicine; Comorbidity; Depression (economics); Anxiety; Disease; Quality of life (healthcare); Dermatology; Psychiatry; Internal medicine","score_opus":0.0380878632547377,"score_gpt":0.27690628934001854,"score_spread":0.23881842608528084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323653032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603856,0.0014797681,0.00006941714,0.00012025096,0.000009991927,0.000025957554,0.0011988848,0.0000046950977,0.0010525419],"genre_scores_gemma":[0.9983177,0.00033973283,0.000075223405,0.0000396797,0.000009655132,0.000017793871,0.0010487732,0.0000020754699,0.00014935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933964,0.00030443462,0.00009464101,0.000044746706,0.00012511808,0.000091533984],"domain_scores_gemma":[0.9986351,0.00044866395,0.00050903653,0.00004927043,0.00013493939,0.00022287222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001075343,0.00018619985,0.0003720059,0.00063579326,0.0002179682,0.00048158015,0.00020496643,0.0003351772,0.0014379066],"category_scores_gemma":[0.003442983,0.00009178027,0.00097216316,0.0007884146,0.00014940769,0.00035912704,0.00082803145,0.00042024557,0.00020183458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046715728,0.00006771767,0.98931074,0.0000995279,0.0002300896,0.000086386106,0.00017537377,0.00011863759,0.0000978127,0.000013132202,0.00022817365,0.00910522],"study_design_scores_gemma":[0.00001378363,0.00020491151,0.99890494,0.000026245736,0.00008294925,0.0001587504,0.00023458386,0.00006458991,0.000024318708,0.000011545333,0.00026865996,0.0000047116814],"about_ca_topic_score_codex":0.0020113238,"about_ca_topic_score_gemma":0.0025933501,"teacher_disagreement_score":0.0020113238,"about_ca_system_score_codex":0.00019359305,"about_ca_system_score_gemma":0.0001522878,"threshold_uncertainty_score":0.0056869984},"labels":[],"label_agreement":null},{"id":"W4324130045","doi":"10.1093/bjd/ljad073","title":"We are not ‘Other’ populations: building research, education and clinical capacity around gender variance in dermatology","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"LGBTQ Health, Identity, and Policy","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre; University Health Network; Women's College Hospital; University of Toronto","funders":"University of Toronto","keywords":"Transgender; Dignity; Curriculum; Equity (law); Gender equity; Health equity; Medicine; Capacity building; Medical education; Psychology; Public relations; Political science; Sociology; Nursing; Pedagogy; Public health; Gender studies; Law","score_opus":0.294102398181579,"score_gpt":0.509031748550382,"score_spread":0.214929350368803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324130045","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21782127,0.015961232,0.0054411134,0.6991988,0.00275103,0.0001742342,0.000036072484,0.000068788475,0.058547527],"genre_scores_gemma":[0.9236666,0.007831493,0.0033737582,0.06030817,0.00071331486,0.00018664145,0.000015687472,0.000035339086,0.0038689976],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.9511778,0.040709734,0.00058807974,0.0012647003,0.0030998064,0.003159909],"domain_scores_gemma":[0.8715647,0.0944257,0.005582473,0.004608343,0.0054504564,0.01836832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.070556216,0.00026765474,0.000702404,0.001827167,0.010085724,0.012030661,0.0017838803,0.0036584262,0.00480672],"category_scores_gemma":[0.07103645,0.00049270125,0.0004840119,0.0012155771,0.032114845,0.016224427,0.013599411,0.009209214,0.00077389134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014333204,0.0010680975,0.026030159,0.0007995825,0.00006002302,0.00044427757,0.57263017,0.00015234554,0.0011170671,0.092980996,0.037580904,0.26699305],"study_design_scores_gemma":[0.000057040343,0.00056049885,0.018244222,0.0039437865,0.000053057633,0.0007942044,0.7132568,0.00017121137,0.0010421044,0.12758651,0.13420923,0.00008137183],"about_ca_topic_score_codex":0.004944475,"about_ca_topic_score_gemma":0.011214493,"teacher_disagreement_score":0.070556216,"about_ca_system_score_codex":0.0056311013,"about_ca_system_score_gemma":0.035666972,"threshold_uncertainty_score":0.3731414},"labels":[],"label_agreement":null},{"id":"W4328052704","doi":"10.1093/bjd/ljad081","title":"Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"Janssen Research and Development; St Vincent's Hospital Melbourne; Pusan National University Hospital; Humboldt-Universität zu Berlin; Janssen Scientific Affairs; Freie Universität Berlin; Pusan National University; Berlin Institute of Health; University of Melbourne","keywords":"Medicine; Malignancy; Psoriasis; Dermatology; Skin cancer; Breast cancer; Cancer; Population; Family history; Internal medicine","score_opus":0.01635308347776333,"score_gpt":0.21098835684000225,"score_spread":0.19463527336223893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328052704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9500015,0.04335068,0.00080879976,0.0006202105,0.00019181112,0.0003322964,0.0010962111,0.000035716763,0.003562848],"genre_scores_gemma":[0.9909813,0.005915407,0.0002739816,0.0005799963,0.00020468948,0.00014929785,0.0009715525,0.000009067916,0.0009147486],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9985258,0.00085517677,0.00011766045,0.000119747674,0.00018644883,0.00019527262],"domain_scores_gemma":[0.9961559,0.0014867008,0.0012078576,0.00026835175,0.00028283,0.00059831253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005188866,0.0004716361,0.0017700706,0.00037055224,0.00042372014,0.0012589775,0.00038445424,0.0015015018,0.0017485864],"category_scores_gemma":[0.0034094413,0.000215425,0.0025809961,0.0004972353,0.00042791077,0.0009803645,0.00032013343,0.0022592023,0.00034233963],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7446378,0.008142327,0.047281656,0.0032518466,0.009302882,0.00049657235,0.0005132348,0.0029822583,0.013862734,0.00041641918,0.0031951996,0.16591719],"study_design_scores_gemma":[0.23431972,0.39491647,0.32981822,0.00096456165,0.011785119,0.0015893904,0.0004596559,0.0025264963,0.0062721903,0.0010758344,0.016119009,0.0001533575],"about_ca_topic_score_codex":0.0006189673,"about_ca_topic_score_gemma":0.0012167072,"teacher_disagreement_score":0.005188866,"about_ca_system_score_codex":0.00050469034,"about_ca_system_score_gemma":0.00048538478,"threshold_uncertainty_score":0.02744168},"labels":[],"label_agreement":null},{"id":"W4361009497","doi":"10.1093/bjd/ljad035","title":"Bimekizumab maintenance of response through 3 years in patients with moderate-to-severe plaque psoriasis: results from the BE BRIGHT open-label extension trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"UCB Pharma","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Plaque psoriasis; Body surface area; Open label; Imputation (statistics); Randomized controlled trial; Internal medicine; Surgery; Dermatology; Missing data","score_opus":0.028912431949101897,"score_gpt":0.2601819524444339,"score_spread":0.23126952049533198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361009497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906651,0.004650013,0.00025131882,0.00042178793,0.00009616314,0.00057566987,0.0010630056,0.000043369426,0.0022336403],"genre_scores_gemma":[0.9928377,0.001538628,0.0007228267,0.0006250519,0.00018564449,0.0008850554,0.001803391,0.000016936257,0.0013847752],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99851066,0.0009408704,0.000053861386,0.00013026335,0.00015934149,0.00020497153],"domain_scores_gemma":[0.9978575,0.0005842406,0.0005394391,0.00023780942,0.00016194073,0.0006190173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051445067,0.000600756,0.0019672015,0.00021250447,0.00040801105,0.0012146055,0.0006530247,0.0010459616,0.0031033119],"category_scores_gemma":[0.0031957517,0.00036506256,0.0015896125,0.0003026446,0.0005873649,0.0007209796,0.0005043287,0.0025206855,0.00067855895],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9343484,0.009948875,0.0069082654,0.0006944685,0.0015814158,0.0000759493,0.00019099387,0.00062450004,0.003967025,0.00021704532,0.0032643229,0.03817872],"study_design_scores_gemma":[0.7731529,0.15510584,0.062423784,0.00020176888,0.0020582506,0.0002879295,0.000121590965,0.0010910757,0.0009703864,0.00053028436,0.0040084748,0.00004768446],"about_ca_topic_score_codex":0.0005613166,"about_ca_topic_score_gemma":0.0010567744,"teacher_disagreement_score":0.0051445067,"about_ca_system_score_codex":0.00044975188,"about_ca_system_score_gemma":0.0009844862,"threshold_uncertainty_score":0.027207077},"labels":[],"label_agreement":null},{"id":"W4362657980","doi":"10.1093/bjd/ljad115","title":"Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposure","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Janssen Research and Development; Janssen Scientific Affairs","keywords":"Medicine; Psoriasis; Clinical trial; Dermatology; Internal medicine","score_opus":0.0560023929324294,"score_gpt":0.35370666446939775,"score_spread":0.2977042715369683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362657980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49097085,0.4848255,0.009752462,0.00042071697,0.0004452529,0.002411947,0.008082204,0.00028321493,0.0028079178],"genre_scores_gemma":[0.96630883,0.025240073,0.002294483,0.0002858301,0.0002740321,0.0015368538,0.0036029117,0.00005598136,0.00040104284],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96691215,0.01958031,0.006819243,0.0031199192,0.0030516714,0.00051673246],"domain_scores_gemma":[0.96421146,0.018534483,0.012481713,0.0024524685,0.0018901897,0.00042964055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041706804,0.0022291564,0.009728884,0.0038288753,0.00043581042,0.0023694343,0.0010495186,0.0016772354,0.0017716459],"category_scores_gemma":[0.02634202,0.0011177554,0.030484866,0.0038980446,0.0006970865,0.00145845,0.0014355102,0.0012521811,0.00021885533],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.109283514,0.000209906,0.06416107,0.019073326,0.77944976,0.00013664173,0.00015514961,0.0030049344,0.0019378457,0.00008736192,0.0006628535,0.021837734],"study_design_scores_gemma":[0.017573565,0.011653825,0.15512636,0.0016923232,0.8068806,0.00041043336,0.00011533144,0.0014676312,0.0014198185,0.0003910329,0.0031572394,0.00011178199],"about_ca_topic_score_codex":0.0007483959,"about_ca_topic_score_gemma":0.0013071863,"teacher_disagreement_score":0.041706804,"about_ca_system_score_codex":0.00073628576,"about_ca_system_score_gemma":0.0009542547,"threshold_uncertainty_score":0.22056925},"labels":[],"label_agreement":null},{"id":"W4366452142","doi":"10.1093/bjd/ljad071","title":"The Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) score: online assessment and validation study of a specific measure of GPP disease activity","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Boehringer Ingelheim","keywords":"Medicine; Psoriasis; Generalized pustular psoriasis; Erythema; Dermatology; Disease; Severity of illness; Pustular psoriasis; Internal medicine","score_opus":0.030948719773450945,"score_gpt":0.3016663221667482,"score_spread":0.2707176023932973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366452142","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215525,0.00061910006,0.001818951,0.00008123955,0.000049768605,0.0012829801,0.0011670855,0.000044457094,0.0027811008],"genre_scores_gemma":[0.9911249,0.00029570053,0.0029092643,0.0001674554,0.000051002677,0.0010401594,0.0026603637,0.000033530643,0.0017175402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961377,0.001717712,0.00034343725,0.0004859094,0.0011359059,0.00017929808],"domain_scores_gemma":[0.99325764,0.0020612732,0.0019569276,0.0006691932,0.0013609127,0.00069403695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071495655,0.00074299204,0.000817911,0.00083557423,0.0005219802,0.00082775846,0.00068898813,0.0010268986,0.002129291],"category_scores_gemma":[0.009220432,0.00035887535,0.00075785856,0.0008399332,0.000648085,0.0009300374,0.0011744822,0.0011747658,0.001090844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016562412,0.008675603,0.88694733,0.00046668432,0.0015588669,0.00020425879,0.0009828543,0.0012247934,0.0045319474,0.0003627986,0.002607733,0.07587453],"study_design_scores_gemma":[0.0017769111,0.012963167,0.9784176,0.000059593043,0.0003117831,0.0006807885,0.0001652085,0.0019064674,0.00085040834,0.0001516371,0.002678021,0.00003847073],"about_ca_topic_score_codex":0.0010395031,"about_ca_topic_score_gemma":0.0010569033,"teacher_disagreement_score":0.0071495655,"about_ca_system_score_codex":0.00044913922,"about_ca_system_score_gemma":0.00043552677,"threshold_uncertainty_score":0.03781092},"labels":[],"label_agreement":null},{"id":"W4377134024","doi":"10.1093/bjd/ljad166","title":"Patient-reported influences on COVID-19 vaccine acceptance and hesitancy in people with hidradenitis suppurativa","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health","keywords":"Hidradenitis suppurativa; Coronavirus disease 2019 (COVID-19); Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Cross-sectional study; Vaccination; MEDLINE; Disease; Family medicine; Internal medicine; Immunology; Virology; Infectious disease (medical specialty); Pathology; Outbreak","score_opus":0.015301931450041842,"score_gpt":0.285011617472612,"score_spread":0.26970968602257017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377134024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988689,0.0001505232,0.000015038122,0.00012854995,0.000006521951,0.0000073920446,0.00008425993,0.0000010283072,0.0007377685],"genre_scores_gemma":[0.9996635,0.000091751404,0.000026422993,0.000058075202,0.000006941937,0.000005689294,0.000047698202,6.493881e-7,0.00009936714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872404,0.00062374305,0.0001441202,0.00007872667,0.00023771627,0.00019151473],"domain_scores_gemma":[0.99389946,0.0021351564,0.0024142954,0.00015412175,0.00045029251,0.00094657816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013441184,0.00014767151,0.00028536172,0.00059439044,0.0005926698,0.0009834414,0.00018929785,0.0005255683,0.0025015075],"category_scores_gemma":[0.007885215,0.00019330753,0.00059217465,0.0005940265,0.00037540082,0.00049131847,0.00061554404,0.00076757104,0.00026046342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014866739,0.0001600626,0.9922955,0.00004221323,0.000069089176,0.00013270896,0.0031196785,0.00002531054,0.000117623305,0.000025406742,0.00019559244,0.0036682873],"study_design_scores_gemma":[0.000008825806,0.00018038199,0.9941048,0.000030565014,0.000027103153,0.00018631322,0.004914138,0.00010948863,0.00003871496,0.000024191253,0.00036626437,0.000009242486],"about_ca_topic_score_codex":0.0046948255,"about_ca_topic_score_gemma":0.0053877453,"teacher_disagreement_score":0.0046948255,"about_ca_system_score_codex":0.00032468772,"about_ca_system_score_gemma":0.0002669468,"threshold_uncertainty_score":0.009334981},"labels":[],"label_agreement":null},{"id":"W4378781272","doi":"10.1093/bjd/ljad070","title":"Relative impact of traditional vs. newer oral antifungals for dermatophyte toenail onychomycosis: a network meta-analysis study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Terbinafine; Dermatophyte; Discontinuation; Internal medicine; Adverse effect; Odds ratio; Itraconazole; Fluconazole; Regimen; Dermatology; Surgery; Antifungal","score_opus":0.1208888193358796,"score_gpt":0.369089752367413,"score_spread":0.2482009330315334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378781272","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06553011,0.9178495,0.00888882,0.001419476,0.0007409293,0.0007485876,0.0031180442,0.00016154232,0.0015429868],"genre_scores_gemma":[0.8601256,0.1270462,0.0076921023,0.0009237572,0.00040766282,0.0012394899,0.0018576079,0.00010126928,0.0006062789],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96455795,0.02772411,0.0028025482,0.0028234662,0.0015741049,0.0005177911],"domain_scores_gemma":[0.9330511,0.058897022,0.0037945707,0.0018876217,0.0016983056,0.00067138096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03221916,0.003422278,0.012780955,0.00602518,0.0005687895,0.0034569832,0.002616266,0.0022984082,0.0046089594],"category_scores_gemma":[0.057179637,0.0013474027,0.050638996,0.00577251,0.0006466977,0.002143437,0.0021828546,0.002563286,0.0003015481],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045861155,0.000029639932,0.009780857,0.023069525,0.9553748,0.00007603426,0.000033618813,0.0022340051,0.00012587597,0.00015344833,0.00025049932,0.0042856405],"study_design_scores_gemma":[0.0007789213,0.00027409493,0.0039690123,0.0018357902,0.99005616,0.00006109402,0.00002750091,0.0019130686,0.00006669037,0.00041779326,0.0005824023,0.000017401437],"about_ca_topic_score_codex":0.0067686355,"about_ca_topic_score_gemma":0.0077437116,"teacher_disagreement_score":0.03221916,"about_ca_system_score_codex":0.0021494431,"about_ca_system_score_gemma":0.0020018162,"threshold_uncertainty_score":0.17039323},"labels":[],"label_agreement":null},{"id":"W4379600190","doi":"10.1093/bjd/ljad182","title":"Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research; Calgary Laboratory Services; SKiN Health","funders":"","keywords":"Scalp; Tolerability; Roflumilast; Medicine; Psoriasis; Randomized controlled trial; Clinical endpoint; Adverse effect; Randomization; Dermatology; Surgery; Internal medicine","score_opus":0.02527273897059209,"score_gpt":0.2932965594720684,"score_spread":0.26802382050147633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379600190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9531961,0.01444941,0.002758328,0.0011298317,0.0007715073,0.01933357,0.0030694555,0.0006099305,0.0046818387],"genre_scores_gemma":[0.95083296,0.0108889565,0.00466529,0.002552675,0.0007601713,0.021202473,0.0026757685,0.000100591096,0.0063209655],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99939024,0.00028871876,0.000043553824,0.00010822298,0.000062215186,0.000107010506],"domain_scores_gemma":[0.9993587,0.0001510357,0.00017948217,0.00006118086,0.0000748742,0.00017470426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022180101,0.0015486453,0.0034179825,0.00053522113,0.0004223162,0.0010618783,0.0010859604,0.0019722597,0.009448228],"category_scores_gemma":[0.0013118122,0.00084583194,0.0016402331,0.00060816517,0.0008955358,0.0008898201,0.00028181958,0.0020464426,0.0018365094],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9398752,0.016219618,0.00048449764,0.0018236946,0.0010399908,0.00007217524,0.000079541605,0.00028180672,0.011497226,0.00012198456,0.0018867087,0.026617529],"study_design_scores_gemma":[0.9537834,0.043896373,0.0008711864,0.00003938365,0.00026991338,0.000034138327,0.0000122158535,0.00017528342,0.00028168154,0.000051033985,0.00057698635,0.00000851088],"about_ca_topic_score_codex":0.0008994203,"about_ca_topic_score_gemma":0.0017181155,"teacher_disagreement_score":0.009448228,"about_ca_system_score_codex":0.00052532717,"about_ca_system_score_gemma":0.0011961437,"threshold_uncertainty_score":0.03160751},"labels":[],"label_agreement":null},{"id":"W4379601097","doi":"10.1093/bjd/ljad192","title":"Gender disparity in Canadian Institutes of Health Research grant funding decisions among recipients from dermatology departments: a retrospective study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of Calgary; University of Toronto; University of British Columbia","funders":"University of British Columbia","keywords":"Family medicine; Gender disparity; Medicine; Grant funding; Medical education; Political science; Demography; Sociology; Public administration","score_opus":0.17155686528485584,"score_gpt":0.40606068931544204,"score_spread":0.2345038240305862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379601097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963666,0.0006466628,0.00006886139,0.00024821502,0.000010194417,0.000032766682,0.001211005,0.0000029555897,0.0014126698],"genre_scores_gemma":[0.99917173,0.00022481168,0.0000501905,0.00007319709,0.00000507621,0.000014688922,0.0003223634,0.0000018572034,0.00013606173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662435,0.00041212086,0.0002611794,0.00042797875,0.0010088641,0.0012655414],"domain_scores_gemma":[0.9949582,0.0005394694,0.0019511094,0.0002595418,0.0012833303,0.0010082971],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0023077037,0.00026399738,0.00047750282,0.002397423,0.0022833962,0.0010773983,0.0010722567,0.00063471193,0.0022061225],"category_scores_gemma":[0.007228502,0.00037833283,0.00047135408,0.0048910812,0.0009688724,0.0005595176,0.0011816955,0.00079138746,0.00017937124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045765377,0.000020218382,0.9967084,0.000019438601,0.000025385329,0.00007787938,0.00093071867,0.000020718722,0.000055822406,0.000109472516,0.0003688058,0.0016173304],"study_design_scores_gemma":[0.0000032039118,0.00003276209,0.99656916,0.000033352684,0.000016636846,0.00013068282,0.0021724813,0.000071102,0.000034945115,0.00002573182,0.00089868484,0.000011210042],"about_ca_topic_score_codex":0.78676075,"about_ca_topic_score_gemma":0.7950386,"teacher_disagreement_score":0.9976923,"about_ca_system_score_codex":0.00708379,"about_ca_system_score_gemma":0.011389466,"threshold_uncertainty_score":0.42899007},"labels":[],"label_agreement":null},{"id":"W4381336619","doi":"10.1093/bjd/ljad162.036","title":"416 Long-term efficacy of dupilumab in adults with moderate-to-severe atopic dermatitis: results from an open-label extension trial up to 5 years","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Eczema Area and Severity Index; Regimen; Concomitant; Adverse effect; Dermatology; Internal medicine; Clinical endpoint; Clinical trial","score_opus":0.0289953219994888,"score_gpt":0.31603454749335846,"score_spread":0.2870392254938697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904389,0.0052196486,0.00025277678,0.00022462095,0.000153935,0.001388432,0.0010523532,0.00003533337,0.0012340812],"genre_scores_gemma":[0.991789,0.0018711986,0.00068178005,0.00075985276,0.0003014244,0.0015112831,0.0016983995,0.000009189029,0.0013778484],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99889046,0.000445777,0.00012928645,0.00018936164,0.00012965614,0.00021540174],"domain_scores_gemma":[0.99846375,0.00028962427,0.00039178276,0.00015609626,0.00019989743,0.00049892906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029957301,0.00086052547,0.0018627741,0.00026951358,0.0005955833,0.0010196834,0.00042943071,0.0014700637,0.003052079],"category_scores_gemma":[0.0015060712,0.00035437688,0.0026729757,0.00033429038,0.0007468555,0.0010016108,0.0004162131,0.0022242037,0.000849688],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8833354,0.03469584,0.009924949,0.0012422922,0.002561148,0.00021417331,0.00025209037,0.00043305123,0.014416952,0.000114117094,0.0016603759,0.051149603],"study_design_scores_gemma":[0.33978787,0.60718745,0.04339782,0.00013930663,0.0023947475,0.00025739725,0.000117892254,0.0005165977,0.002272007,0.00016118803,0.0037181256,0.00004950074],"about_ca_topic_score_codex":0.00046251295,"about_ca_topic_score_gemma":0.001301876,"teacher_disagreement_score":0.003052079,"about_ca_system_score_codex":0.0005845179,"about_ca_system_score_gemma":0.0009259445,"threshold_uncertainty_score":0.015843093},"labels":[],"label_agreement":null},{"id":"W4381336722","doi":"10.1093/bjd/ljad162.013","title":"386 Complete/near-complete itch response observed in adult and adolescent patients with moderate-to-severe atopic dermatitis initiating dupilumab treatment in real-world practice","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lynde Centre for Dermatology; University of Toronto","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Concomitant; Interim analysis; Quality of life (healthcare); Internal medicine; Young adult; Dosing; Rating scale; Dermatology; Interim; Eczema Area and Severity Index; Severity of illness; Pediatrics; Randomized controlled trial; Psychology","score_opus":0.0333704723240458,"score_gpt":0.2890839369807879,"score_spread":0.25571346465674205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990402,0.00020306904,0.000040179668,0.00002573503,0.0000029830433,0.000022030481,0.00020985308,0.0000023147988,0.00045358622],"genre_scores_gemma":[0.9996038,0.000078392775,0.000047353846,0.000031518754,0.0000064633837,0.000013417639,0.00014855013,5.5968445e-7,0.00006989814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994361,0.00018513984,0.000073729345,0.00012265166,0.00009482505,0.000087543245],"domain_scores_gemma":[0.9987226,0.0002930938,0.00063478213,0.00004065382,0.00010129921,0.00020749442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060897315,0.00011095344,0.00036898904,0.00025862854,0.00030128573,0.00045554992,0.00010761185,0.00026879532,0.0020550487],"category_scores_gemma":[0.0020235481,0.00010835497,0.00029069415,0.00033302087,0.0001685637,0.00027725854,0.00022378306,0.00039090915,0.0002569459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005098513,0.00013155754,0.9935488,0.000032582593,0.000030855175,0.0003365611,0.00015177573,0.000027296775,0.0003217345,0.00001784274,0.00023042434,0.0046608294],"study_design_scores_gemma":[0.000042830943,0.0010465354,0.99612397,0.00001972595,0.000030788604,0.0016014733,0.00031531285,0.00021975783,0.000089371446,0.000020158313,0.00048501385,0.0000050720037],"about_ca_topic_score_codex":0.0010765197,"about_ca_topic_score_gemma":0.0018566303,"teacher_disagreement_score":0.0020550487,"about_ca_system_score_codex":0.00023825963,"about_ca_system_score_gemma":0.0002445357,"threshold_uncertainty_score":0.0068747997},"labels":[],"label_agreement":null},{"id":"W4381336753","doi":"10.1093/bjd/ljad162.043","title":"423 Long-term efficacy of abrocitinib up to 96 weeks in adults with moderate-to-severe atopic dermatitis stratified by age: a post hoc analysis of the JADE EXTEND phase 3 trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University","funders":"","keywords":"Medicine; JADE (particle detector); Post-hoc analysis; Atopic dermatitis; Placebo; Blinding; Clinical trial; Eczema Area and Severity Index; Randomized controlled trial; Internal medicine; Pediatrics; Dermatology","score_opus":0.03138261134272837,"score_gpt":0.35866921129217444,"score_spread":0.3272865999494461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917672,0.003340694,0.00045001155,0.00017777631,0.00017888106,0.0005863802,0.0018592512,0.00003828729,0.0016015325],"genre_scores_gemma":[0.99452114,0.00064586435,0.00048695432,0.0003084829,0.0001780856,0.0007429846,0.0015391879,0.000019617186,0.0015577605],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99705124,0.0017076934,0.0002387626,0.00041048773,0.00026132318,0.00033037085],"domain_scores_gemma":[0.9965809,0.0015326643,0.00076209346,0.00050390733,0.00025240038,0.00036801383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006323847,0.0010126618,0.0027162693,0.00030240836,0.0004002675,0.0012263772,0.00066072476,0.00084959046,0.0039787553],"category_scores_gemma":[0.0037421712,0.00033510118,0.006552093,0.00031437623,0.00044296525,0.0011775469,0.0006133652,0.002025929,0.00058450224],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9549776,0.0022316838,0.015143688,0.0006062271,0.0080937855,0.00009806999,0.00009659156,0.00066419906,0.00479334,0.00007729912,0.0013498155,0.01186767],"study_design_scores_gemma":[0.28311685,0.38008615,0.28664646,0.00024260349,0.030729467,0.00040274492,0.00032667856,0.0037161333,0.0063408823,0.00055295153,0.0076901074,0.00014890532],"about_ca_topic_score_codex":0.00043361788,"about_ca_topic_score_gemma":0.0011994861,"teacher_disagreement_score":0.006323847,"about_ca_system_score_codex":0.00041430682,"about_ca_system_score_gemma":0.0007306464,"threshold_uncertainty_score":0.033444107},"labels":[],"label_agreement":null},{"id":"W4381336787","doi":"10.1093/bjd/ljad162.045","title":"425 Effect of upadacitinib on SCORAD intensity items: analysis from the Measure Up 1 and Measure Up 2 studies","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; University of Calgary","funders":"","keywords":"Medicine; SCORAD; Placebo; Erythema; Atopic dermatitis; Edema; Post-hoc analysis; Internal medicine; Randomized controlled trial; Dermatology; Anesthesia; Gastroenterology; Dermatology Life Quality Index; Pathology; Disease","score_opus":0.030158721334944506,"score_gpt":0.3072472176860344,"score_spread":0.2770884963510899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972712,0.015830193,0.0014864674,0.00021852582,0.00026193756,0.0016032169,0.0050804345,0.00010051483,0.0027066958],"genre_scores_gemma":[0.9920093,0.0014514778,0.0013606126,0.00021731041,0.0001107516,0.0016244925,0.0022761475,0.000037400077,0.0009124508],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9798545,0.014454418,0.0015544335,0.0012174214,0.0021375848,0.0007815351],"domain_scores_gemma":[0.9664188,0.024074692,0.0058331573,0.0013291851,0.0012708532,0.00107335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016524667,0.0017858122,0.004769101,0.0013500468,0.00039178177,0.0014583687,0.0010526492,0.0011475491,0.004518784],"category_scores_gemma":[0.018141665,0.0005557214,0.011684786,0.0013191818,0.00069729844,0.001353178,0.0016092039,0.002283446,0.00031663518],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8114809,0.0023763345,0.051151343,0.0047221617,0.09297492,0.00019298185,0.00023988957,0.0017648946,0.004698159,0.00017231521,0.0017870556,0.028439023],"study_design_scores_gemma":[0.100041784,0.19842993,0.5523983,0.0005315212,0.13149649,0.0004929288,0.00041592572,0.003705759,0.005108269,0.00039393597,0.006746778,0.0002384139],"about_ca_topic_score_codex":0.0004556726,"about_ca_topic_score_gemma":0.0009083473,"teacher_disagreement_score":0.016524667,"about_ca_system_score_codex":0.0005640978,"about_ca_system_score_gemma":0.0006814,"threshold_uncertainty_score":0.08739185},"labels":[],"label_agreement":null},{"id":"W4381336812","doi":"10.1093/bjd/ljad162.037","title":"417 Safety of long-term dupilumab treatment in adults with moderate-to-severe atopic dermatitis: results from an open-label extension trial up to 5 years","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Eczema Area and Severity Index; Concomitant; Adverse effect; Internal medicine; Clinical trial; Open label; Dermatology; Randomized controlled trial; Population","score_opus":0.028853905519966125,"score_gpt":0.31236463918444207,"score_spread":0.28351073366447593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880356,0.007376306,0.0003270038,0.00031047914,0.00015645735,0.0009400584,0.0011662383,0.000037906975,0.0016499766],"genre_scores_gemma":[0.9928484,0.0019946226,0.00054649846,0.0007527989,0.00023235797,0.0008522532,0.0016537042,0.000008157227,0.0011110813],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9988933,0.00050285546,0.00011938574,0.00017410425,0.00013873614,0.00017154761],"domain_scores_gemma":[0.9982566,0.00040136155,0.0004770579,0.00018001786,0.00023431717,0.00045065867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025826737,0.00064189767,0.0014008732,0.00022035115,0.0004714048,0.00096751854,0.00040708308,0.0013450154,0.0031393243],"category_scores_gemma":[0.0018020014,0.0002669735,0.0025135607,0.0002683454,0.00065105694,0.00087936944,0.00036256103,0.002097647,0.0007506956],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.857347,0.022820618,0.010576886,0.0013504253,0.0025841224,0.00020832942,0.00022470146,0.00050885405,0.015439891,0.00016466451,0.0022183957,0.08655615],"study_design_scores_gemma":[0.3322194,0.59975123,0.054227043,0.00021014128,0.0028165265,0.00039446627,0.000120258395,0.0007853807,0.0033005446,0.00023178334,0.0058875,0.000055664404],"about_ca_topic_score_codex":0.00044743845,"about_ca_topic_score_gemma":0.0011414732,"teacher_disagreement_score":0.0031393243,"about_ca_system_score_codex":0.00063862297,"about_ca_system_score_gemma":0.0008321199,"threshold_uncertainty_score":0.013658643},"labels":[],"label_agreement":null},{"id":"W4381336836","doi":"10.1093/bjd/ljad162.016","title":"390 Efficacy and safety of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis in two phase 3 trials (INTEGUMENT-1 and INTEGUMENT-2)","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Probity Medical Research; Queen's University","funders":"","keywords":"Integument; Atopic dermatitis; Roflumilast; Medicine; Eczema Area and Severity Index; Clinical endpoint; Randomized controlled trial; Internal medicine; Dermatology; Anatomy","score_opus":0.012896441509989458,"score_gpt":0.3020527063558678,"score_spread":0.2891562648458783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98531324,0.010183014,0.00022647865,0.0003804813,0.00013035936,0.00119981,0.0012388136,0.000038351136,0.0012894737],"genre_scores_gemma":[0.99125975,0.0037414918,0.00068233575,0.0006624604,0.00014883166,0.0013724137,0.0013758136,0.000010934986,0.00074605347],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992568,0.00034524608,0.0000717695,0.000117902106,0.00009006257,0.00011828987],"domain_scores_gemma":[0.99925965,0.0001690468,0.0002244604,0.00003451985,0.000065834894,0.00024652458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019051479,0.0006700701,0.0018197143,0.00024249534,0.00036034177,0.00067450735,0.00046503637,0.0010631345,0.0030573765],"category_scores_gemma":[0.0014036909,0.00041122726,0.0016678197,0.0002613308,0.00041615972,0.00052354083,0.00033052085,0.001677597,0.0004895031],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8167467,0.02108268,0.028150039,0.0022820218,0.0024791555,0.0004832245,0.0004784753,0.00042247208,0.02079145,0.00020433811,0.0037119992,0.10316733],"study_design_scores_gemma":[0.6098678,0.26774174,0.11169865,0.00024490128,0.0016986383,0.00065722334,0.0002253155,0.00042386857,0.0024155588,0.00011343998,0.0048697446,0.000043072232],"about_ca_topic_score_codex":0.0014665386,"about_ca_topic_score_gemma":0.0047509954,"teacher_disagreement_score":0.0030573765,"about_ca_system_score_codex":0.00066791446,"about_ca_system_score_gemma":0.0010879786,"threshold_uncertainty_score":0.010227978},"labels":[],"label_agreement":null},{"id":"W4381336840","doi":"10.1093/bjd/ljad162.027","title":"405 Understanding patient experience and factors influencing patient preference in the treatment of moderate-to-severe atopic dermatitis through in-depth qualitative patient interviews","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Atopic dermatitis; Affect (linguistics); Systemic therapy; Preference; Patient experience; Adverse effect; Qualitative research; Physical therapy; Family medicine; Dermatology; Internal medicine; Psychology; Health care","score_opus":0.102094130900106,"score_gpt":0.34169060742493335,"score_spread":0.23959647652482735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792604,0.0009127817,0.007429697,0.004675444,0.00009983306,0.0009938881,0.00043849114,0.000030425126,0.006159036],"genre_scores_gemma":[0.9910512,0.0007957538,0.0039027575,0.0013850585,0.000021881591,0.0011831772,0.00010013972,0.000017518716,0.0015425574],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.97745913,0.019195773,0.0005726477,0.0005599999,0.0007864083,0.0014261012],"domain_scores_gemma":[0.9567513,0.037116364,0.0021274188,0.0006027924,0.0020430388,0.0013590597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02638944,0.0006110045,0.0006034778,0.0015884753,0.00467077,0.0036295988,0.0017124206,0.0015720632,0.0046967515],"category_scores_gemma":[0.03394259,0.000536237,0.00063534564,0.001150523,0.005393866,0.003516018,0.004936247,0.0025272113,0.000530729],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008307004,0.00008109714,0.004204342,0.00031663245,0.000009385875,0.00050749944,0.9857487,0.00008131724,0.0011471752,0.0009964093,0.0006326959,0.006191625],"study_design_scores_gemma":[0.000014414686,0.00007779408,0.0010154842,0.00021909758,0.000006976286,0.00019139778,0.9921164,0.00018829264,0.00042881517,0.0006169896,0.005106054,0.00001821791],"about_ca_topic_score_codex":0.0037259401,"about_ca_topic_score_gemma":0.0060292827,"teacher_disagreement_score":0.02638944,"about_ca_system_score_codex":0.0047434615,"about_ca_system_score_gemma":0.005193114,"threshold_uncertainty_score":0.13956237},"labels":[],"label_agreement":null},{"id":"W4381336871","doi":"10.1093/bjd/ljad162.030","title":"409 Efficacy and safety of upadacitinib in adults and adolescents with moderate-to-severe atopic dermatitis: subgroup analysis of the Measure Up 1, Measure Up 2 and AD Up phase 3 clinical trials at 52 weeks","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; University of Calgary","funders":"","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Discontinuation; Dermatology Life Quality Index; Adverse effect; Placebo; Randomized controlled trial; Internal medicine; Concomitant; Clinical trial; Quality of life (healthcare); Pediatrics; Dermatology; Disease","score_opus":0.037969130427281804,"score_gpt":0.3412072024070543,"score_spread":0.30323807197977254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780662,0.017168665,0.00045377258,0.00027192218,0.00011304538,0.0014158712,0.0012470686,0.00003023868,0.0012330818],"genre_scores_gemma":[0.99485576,0.001932059,0.00044972403,0.000335272,0.00009013299,0.0010257306,0.0009581151,0.0000070859523,0.00034602897],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99866354,0.0007228742,0.0002180121,0.00013049219,0.0001330455,0.00013196998],"domain_scores_gemma":[0.9988471,0.00041337652,0.00035276866,0.00011924731,0.000101338606,0.000166036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003071149,0.000709804,0.002819765,0.00041907743,0.000264321,0.001056931,0.0004238169,0.00092881575,0.0016851962],"category_scores_gemma":[0.0024297682,0.00029487585,0.004438794,0.0004877318,0.0002878993,0.0005934383,0.00039919215,0.0013382911,0.00017792793],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8984315,0.0021895352,0.020215794,0.0023287907,0.019992262,0.00015585641,0.00014311506,0.0010632711,0.006411037,0.00019327198,0.001474975,0.04740051],"study_design_scores_gemma":[0.5604245,0.21347216,0.16412926,0.0007546345,0.045245603,0.00072392425,0.00032935254,0.0032400405,0.0036459984,0.000849381,0.0070694895,0.00011568646],"about_ca_topic_score_codex":0.0005409634,"about_ca_topic_score_gemma":0.0019983295,"teacher_disagreement_score":0.003071149,"about_ca_system_score_codex":0.0004936591,"about_ca_system_score_gemma":0.00071463425,"threshold_uncertainty_score":0.016241968},"labels":[],"label_agreement":null},{"id":"W4381336888","doi":"10.1093/bjd/ljad162.014","title":"388 Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a phase 3 trial: assessment of pruritus","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Roflumilast; Tolerability; Medicine; Clinical endpoint; Randomized controlled trial; Internal medicine; Randomization; Scalp; Adverse effect; Gastroenterology; Dermatology","score_opus":0.009345976654062928,"score_gpt":0.3023906144160007,"score_spread":0.29304463776193773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884299,0.0047516758,0.0005300054,0.0004900627,0.0002352259,0.0023558836,0.0009163799,0.00015475618,0.0021361518],"genre_scores_gemma":[0.9908818,0.0019348129,0.0010977495,0.00070066866,0.00019524914,0.0024971524,0.00076744886,0.000023699651,0.0019015621],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996263,0.00018062383,0.00002473854,0.000055545002,0.000036969555,0.00007576782],"domain_scores_gemma":[0.99958664,0.00012992258,0.00008331397,0.00002506592,0.000040540992,0.00013462249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012331571,0.0009957127,0.0017933667,0.00037408294,0.00035405793,0.00079660316,0.00062575773,0.0013210123,0.0063336734],"category_scores_gemma":[0.0008574647,0.00044272566,0.001339232,0.00027790695,0.0005602724,0.000676136,0.0002246461,0.0020878809,0.0010327027],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88532746,0.02706787,0.0012992964,0.0012425629,0.0007085114,0.0001424676,0.00014961763,0.0005846934,0.026027761,0.00016937188,0.0023780225,0.05490234],"study_design_scores_gemma":[0.74995077,0.24278261,0.003460993,0.000054418673,0.0002523891,0.000093769486,0.000043874417,0.00070945045,0.0013327567,0.00011457837,0.001183558,0.000020734791],"about_ca_topic_score_codex":0.00058657274,"about_ca_topic_score_gemma":0.0014907754,"teacher_disagreement_score":0.0063336734,"about_ca_system_score_codex":0.00044358912,"about_ca_system_score_gemma":0.0007544628,"threshold_uncertainty_score":0.02118826},"labels":[],"label_agreement":null},{"id":"W4381336927","doi":"10.1093/bjd/ljad162.039","title":"419 Patient satisfaction with treatments for moderate-to-severe atopic dermatitis according to degree and speed of skin and itch improvements: results from a patient survey in the United States","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Dry skin; Dermatology; Patient satisfaction; Disease; Internal medicine; Surgery","score_opus":0.02916834198608426,"score_gpt":0.2715352545625309,"score_spread":0.24236691257644666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978015,0.00017255511,0.00005151011,0.00015987422,0.000005135768,0.000029927445,0.00090610946,0.000004687381,0.00086861535],"genre_scores_gemma":[0.99932635,0.00006893046,0.00007381327,0.000103033155,0.000004299083,0.000016219603,0.0002903656,0.0000010663296,0.000115896444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988047,0.00049610407,0.00021109614,0.00010958868,0.00026122364,0.000117299],"domain_scores_gemma":[0.99606776,0.0010857196,0.0019562754,0.0000788406,0.00039034087,0.00042105044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014441746,0.00012042252,0.0003343436,0.00055059534,0.00033041817,0.00054518436,0.00016034524,0.00041039387,0.0028384605],"category_scores_gemma":[0.0036029832,0.00016636874,0.0007214088,0.00092297216,0.00023687996,0.0004279387,0.000423105,0.0005168481,0.000364147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010934901,0.000091057285,0.9969331,0.000021523967,0.000055649674,0.00002754538,0.00015799385,0.000048177822,0.00008565166,0.00000940638,0.00030962235,0.002150979],"study_design_scores_gemma":[0.000011407411,0.00022396963,0.9986308,0.000008856068,0.00001551868,0.00009277871,0.00043794583,0.00025108183,0.000037520433,0.0000063198936,0.00027902727,0.000004732447],"about_ca_topic_score_codex":0.004033403,"about_ca_topic_score_gemma":0.0043246304,"teacher_disagreement_score":0.004033403,"about_ca_system_score_codex":0.00039401857,"about_ca_system_score_gemma":0.00026284307,"threshold_uncertainty_score":0.009495616},"labels":[],"label_agreement":null},{"id":"W4381383503","doi":"10.1093/bjd/ljad162.010","title":"382 Lebrikizumab provides clinically meaningful improvements in atopic dermatitis in patients previously treated with dupilumab","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Discontinuation; Placebo; Eczema Area and Severity Index; Randomized controlled trial; Dermatology; Adverse effect; Internal medicine; Pathology","score_opus":0.010076684446063744,"score_gpt":0.2611501223975873,"score_spread":0.25107343795152354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956067,0.0025171798,0.000076159675,0.00015281791,0.00006428627,0.00009669158,0.00023053327,0.000026249869,0.0012293812],"genre_scores_gemma":[0.9982185,0.0004767286,0.00014298489,0.0002038794,0.00008691714,0.00005962942,0.00025709244,0.000002224684,0.0005521622],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9997539,0.00009445954,0.000019607176,0.000035994526,0.00003987371,0.000056117908],"domain_scores_gemma":[0.99964535,0.00011436857,0.000065434775,0.000018676426,0.000025869826,0.00013027938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005324642,0.00030056163,0.0010300959,0.00018605059,0.00025850305,0.00036285323,0.00017143058,0.00035293572,0.0037423063],"category_scores_gemma":[0.00065376883,0.00013671683,0.0009622465,0.00013111428,0.00016450921,0.00027144508,0.00016423258,0.00090327463,0.0003900089],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4673333,0.0239353,0.06656293,0.0011354709,0.0019526685,0.0008314998,0.00020144625,0.0007616567,0.083759956,0.00014940035,0.0073073767,0.34606913],"study_design_scores_gemma":[0.07980217,0.42407936,0.47104126,0.0001363524,0.0021121483,0.0017162862,0.00021116219,0.0024993822,0.011715634,0.00014566904,0.0064800973,0.00006045411],"about_ca_topic_score_codex":0.0006477513,"about_ca_topic_score_gemma":0.001988801,"teacher_disagreement_score":0.0037423063,"about_ca_system_score_codex":0.00028775693,"about_ca_system_score_gemma":0.00024808862,"threshold_uncertainty_score":0.01251924},"labels":[],"label_agreement":null},{"id":"W4381383517","doi":"10.1093/bjd/ljad162.025","title":"402 Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Medicine; Atopic dermatitis; Placebo; Eczema Area and Severity Index; Randomized controlled trial; Clinical endpoint; Internal medicine; Clinical trial; Population; Clinical efficacy; Gastroenterology; Dermatology; Pathology","score_opus":0.06020217488123019,"score_gpt":0.36108435542954853,"score_spread":0.30088218054831833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770686,0.015484272,0.000906154,0.0004476499,0.00017449816,0.003415313,0.0010360279,0.00006338973,0.0014040237],"genre_scores_gemma":[0.98554415,0.0055002444,0.0019661137,0.0010169588,0.00021677781,0.00369273,0.001127805,0.000017677481,0.00091758254],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99854374,0.0008687506,0.00017323127,0.00013805788,0.00016866057,0.00010762966],"domain_scores_gemma":[0.99813616,0.0006870613,0.0005657412,0.00015240409,0.00017679555,0.000281735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047807936,0.00081102626,0.0023259835,0.00023948264,0.0004401015,0.0009874137,0.0004865739,0.0012293169,0.0024035263],"category_scores_gemma":[0.0024042514,0.00036993297,0.0031129862,0.00031733993,0.0006161985,0.00063663675,0.0003473458,0.002014628,0.0003544176],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87121177,0.015237341,0.014281616,0.0035301673,0.007362569,0.00014199215,0.00021557491,0.0007809639,0.015332089,0.00018380022,0.0020862091,0.06963581],"study_design_scores_gemma":[0.736732,0.22874479,0.024844259,0.00030725487,0.003158525,0.0002155048,0.00009127301,0.00052207476,0.0021597915,0.00022932052,0.0029579073,0.000037290953],"about_ca_topic_score_codex":0.00042900763,"about_ca_topic_score_gemma":0.0016293848,"teacher_disagreement_score":0.0047807936,"about_ca_system_score_codex":0.00046873718,"about_ca_system_score_gemma":0.0009315579,"threshold_uncertainty_score":0.025283575},"labels":[],"label_agreement":null},{"id":"W4381383525","doi":"10.1093/bjd/ljad162.041","title":"421 The role of itch resolution and skin clearance in patient-reported atopic dermatitis severity and quality of life: real-world insights from TARGET-DERM AD","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology Life Quality Index; Quality of life (healthcare); Eczema Area and Severity Index; Observational study; Severity of illness; Logistic regression; Telephone interview; Dermatology; Disease; Internal medicine","score_opus":0.014471423984876634,"score_gpt":0.2671026630371674,"score_spread":0.2526312390522908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922639,0.0029849245,0.0003771413,0.0004069775,0.000024520627,0.000033169476,0.0016610373,0.000010022119,0.0022383912],"genre_scores_gemma":[0.99877423,0.00032119962,0.00022074276,0.00005510801,0.00002283705,0.000018700626,0.00046487254,0.000003354958,0.00011899188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677074,0.0019021377,0.00025743837,0.0003734699,0.0005043264,0.00019195124],"domain_scores_gemma":[0.9886736,0.0040073995,0.004858605,0.00062959234,0.0010557311,0.0007749944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036967408,0.00033076326,0.0006824043,0.001010996,0.00045660156,0.001942169,0.00054781727,0.0005873912,0.0030855995],"category_scores_gemma":[0.013115419,0.00025295516,0.0015273781,0.0017539574,0.00039903712,0.0009784927,0.0009795037,0.0012203035,0.00045336696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002710161,0.00012953885,0.99153954,0.00010560852,0.00040399574,0.000035483215,0.00021069044,0.00023132957,0.00008469519,0.00006187599,0.00026785405,0.0066584423],"study_design_scores_gemma":[0.000008669092,0.0001289498,0.99825627,0.000038066777,0.000079559155,0.000071855065,0.00020806018,0.00078719866,0.000030286337,0.00010682672,0.00027344903,0.0000108689455],"about_ca_topic_score_codex":0.0049669067,"about_ca_topic_score_gemma":0.0066191764,"teacher_disagreement_score":0.0049669067,"about_ca_system_score_codex":0.0005544553,"about_ca_system_score_gemma":0.0004914276,"threshold_uncertainty_score":0.019550443},"labels":[],"label_agreement":null},{"id":"W4381383527","doi":"10.1093/bjd/ljad162.033","title":"413 Improvement in itch, symptoms and quality of life with upadacitinib through week 16 in adults and adolescents with atopic dermatitis: results from phase 3 studies (Measure Up 1, Measure Up 2 and AD Up)","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Placebo; Atopic dermatitis; Post-hoc analysis; Internal medicine; Quality of life (healthcare); Dermatology","score_opus":0.03351757199696836,"score_gpt":0.3050932978455515,"score_spread":0.27157572584858314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903349,0.0075806137,0.00020147665,0.00010278013,0.00003244723,0.00047882562,0.0006905147,0.000017375804,0.0005610428],"genre_scores_gemma":[0.99592364,0.001994471,0.0004634284,0.0001943828,0.00003247641,0.00039047294,0.0006974525,0.000004319238,0.0002993296],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992964,0.00033565747,0.00009442325,0.00008529519,0.00011118767,0.0000770389],"domain_scores_gemma":[0.9992436,0.00017153677,0.00029202184,0.000043292646,0.00011156437,0.0001379257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021737195,0.0003434028,0.001345852,0.00025562206,0.00023023107,0.00057649886,0.0002308584,0.00040279937,0.0013904341],"category_scores_gemma":[0.0011146092,0.0001912472,0.0016862265,0.00035069126,0.00024418902,0.00037792692,0.00027250644,0.0009074593,0.00016950286],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52460235,0.021209868,0.10679968,0.0049564694,0.009168276,0.00027895885,0.0005116468,0.001405943,0.041707598,0.00015443626,0.0037194267,0.28548536],"study_design_scores_gemma":[0.12654273,0.37806925,0.46590742,0.00054964144,0.00876403,0.0006005892,0.00033538256,0.0015367328,0.0117553715,0.00016700894,0.0056979735,0.00007389684],"about_ca_topic_score_codex":0.0006024442,"about_ca_topic_score_gemma":0.0015826683,"teacher_disagreement_score":0.0021737195,"about_ca_system_score_codex":0.00037835538,"about_ca_system_score_gemma":0.00051717757,"threshold_uncertainty_score":0.011495888},"labels":[],"label_agreement":null},{"id":"W4381383531","doi":"10.1093/bjd/ljad162.004","title":"373 Safety of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis: data from eight trials","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Placebo; Atopic dermatitis; MedDRA; Adverse effect; Clinical trial; Incidence (geometry); Dermatology; Internal medicine; Pharmacovigilance","score_opus":0.026858656466248947,"score_gpt":0.2885990372914035,"score_spread":0.26174038082515455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73671913,0.22023897,0.0019651977,0.0019837054,0.00028911475,0.0045214915,0.020105774,0.00012222402,0.014054365],"genre_scores_gemma":[0.94094276,0.04110137,0.0017077099,0.0023094928,0.0003029346,0.0025471353,0.009209225,0.00003071251,0.0018486711],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9959578,0.0019344786,0.0008878499,0.0003642582,0.0006881223,0.0001675069],"domain_scores_gemma":[0.9917857,0.004131273,0.0024675266,0.00045099264,0.0008370661,0.00032734775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053788326,0.00050145766,0.0017067922,0.00047835585,0.0002968385,0.0010449492,0.00042027305,0.0009129586,0.0038850855],"category_scores_gemma":[0.00672713,0.00025955835,0.0037311479,0.00073981856,0.0003891304,0.0005834864,0.00044167583,0.0012764686,0.00045746635],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44469947,0.0032320158,0.083972745,0.035572328,0.05633999,0.00046625055,0.0003884747,0.0019491725,0.013820662,0.0006109432,0.019080237,0.3398678],"study_design_scores_gemma":[0.43802252,0.11538429,0.27426273,0.012921182,0.07566333,0.0018054683,0.0004391237,0.0017617651,0.007822365,0.001737705,0.07001359,0.00016583959],"about_ca_topic_score_codex":0.00057894055,"about_ca_topic_score_gemma":0.002134624,"teacher_disagreement_score":0.0053788326,"about_ca_system_score_codex":0.0005157322,"about_ca_system_score_gemma":0.00079552294,"threshold_uncertainty_score":0.028446317},"labels":[],"label_agreement":null},{"id":"W4381383538","doi":"10.1093/bjd/ljad162.018","title":"393 Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Placebo; Internal medicine; Randomized controlled trial; Clinical endpoint; Discontinuation; Physical therapy; Dermatology; Alternative medicine","score_opus":0.061003503598004674,"score_gpt":0.3326872160313547,"score_spread":0.27168371243335004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383538","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030128883,0.94307184,0.010266291,0.0016257013,0.0012972462,0.00093821355,0.009465137,0.0002563652,0.0029504145],"genre_scores_gemma":[0.8128156,0.1583295,0.011786469,0.003511294,0.0010145704,0.0023637074,0.008365601,0.00031304522,0.0015002609],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9752008,0.01566986,0.004023944,0.002753979,0.0019324031,0.00041899536],"domain_scores_gemma":[0.97312117,0.020670978,0.0026047782,0.0018214881,0.001489064,0.00029258028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02679486,0.0026942715,0.011266329,0.004504406,0.00043019687,0.0033748655,0.0019807026,0.0018050856,0.006811182],"category_scores_gemma":[0.042833082,0.0011935845,0.047643315,0.0043410915,0.0004817783,0.0019729573,0.0019140628,0.0023008522,0.0007279859],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028671296,0.000013987626,0.0047933673,0.025729526,0.95976675,0.0000514301,0.00002350054,0.0007787563,0.0001784375,0.00017349602,0.00088558224,0.0047380533],"study_design_scores_gemma":[0.0012110799,0.00014582173,0.0047001275,0.002254063,0.9882012,0.00006131843,0.000019804396,0.00068728946,0.00008022219,0.00054895,0.002067008,0.000023016133],"about_ca_topic_score_codex":0.004769128,"about_ca_topic_score_gemma":0.006712048,"teacher_disagreement_score":0.02679486,"about_ca_system_score_codex":0.0014997678,"about_ca_system_score_gemma":0.0016785229,"threshold_uncertainty_score":0.14170647},"labels":[],"label_agreement":null},{"id":"W4381383541","doi":"10.1093/bjd/ljad162.026","title":"403 Achievement of minimal disease activity is associated with improvements in symptoms, quality of life and treatment satisfaction in patients with atopic dermatitis","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Eczema Area and Severity Index; Atopic dermatitis; Medicine; Quality of life (healthcare); Dermatology Life Quality Index; Rating scale; Physical therapy; Minimal clinically important difference; Severity of illness; Anxiety; Disease; Pediatrics; Internal medicine; Dermatology; Randomized controlled trial; Psychology; Psychiatry","score_opus":0.012430668346969126,"score_gpt":0.2620752754936429,"score_spread":0.24964460714667377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964585,0.0016319534,0.00015674844,0.00013511903,0.000015585461,0.000039211405,0.0005099305,0.000006586039,0.0010464422],"genre_scores_gemma":[0.99937636,0.00012795595,0.00007848152,0.00007259129,0.000010503815,0.000022006687,0.00021698164,0.0000010277764,0.00009416066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900997,0.0004961147,0.0001216823,0.00012920357,0.00013667012,0.00010626546],"domain_scores_gemma":[0.99789965,0.0008397324,0.00080591824,0.00009441869,0.00017003794,0.00019023016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013304366,0.00013810454,0.00074595545,0.00024631267,0.00028619875,0.0008197719,0.00015213223,0.0003337379,0.0034064064],"category_scores_gemma":[0.00361289,0.00011841634,0.0008840692,0.00046474766,0.00019270317,0.00033352288,0.00032194963,0.00063772587,0.00027408727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011378632,0.00088187325,0.9530134,0.00034207114,0.0010216751,0.00008714503,0.00016185241,0.00031178,0.0010174246,0.000067409725,0.00093042763,0.030786302],"study_design_scores_gemma":[0.00043543894,0.0025926826,0.99433494,0.00006535862,0.000383031,0.0002091751,0.00018187492,0.0007439521,0.00016634387,0.0001525584,0.00072179723,0.000013040905],"about_ca_topic_score_codex":0.0006991229,"about_ca_topic_score_gemma":0.001042177,"teacher_disagreement_score":0.0034064064,"about_ca_system_score_codex":0.00030172814,"about_ca_system_score_gemma":0.00024163128,"threshold_uncertainty_score":0.011395574},"labels":[],"label_agreement":null},{"id":"W4381383603","doi":"10.1093/bjd/ljad162.021","title":"396 Rapid, substantial and sustained reduction of itch in adults with atopic dermatitis applying ruxolitinib cream 1.5% (SCRATCH-AD)","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Ruxolitinib; Medicine; Atopic dermatitis; Dermatology; Clinical endpoint; Eczema Area and Severity Index; Janus kinase inhibitor; Clinical trial; Medical prescription; Internal medicine; Janus kinase; Pharmacology; Cytokine","score_opus":0.008613113508923725,"score_gpt":0.24791926878416548,"score_spread":0.23930615527524177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99315006,0.0029335415,0.0002644765,0.00016492818,0.000058818896,0.00039892888,0.00068207725,0.000050510895,0.002296655],"genre_scores_gemma":[0.9968297,0.00076051196,0.00055797613,0.00022835286,0.0000323065,0.00018743066,0.00044197397,0.000003810019,0.00095785887],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9998627,0.000038811293,0.000013001766,0.000029639881,0.000029796096,0.000026114829],"domain_scores_gemma":[0.99987876,0.000027188371,0.00002571319,0.000007176757,0.000024981546,0.000036094247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041732553,0.00023238263,0.00069645763,0.00013181454,0.00019785926,0.00022995881,0.000112272,0.00027536863,0.003206466],"category_scores_gemma":[0.00047087803,0.00009587522,0.00044768353,0.000097385724,0.000066521236,0.00021094277,0.00013083241,0.00051375566,0.0006932783],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11345382,0.022727339,0.095622435,0.0026071807,0.0008535797,0.0011685892,0.0005550261,0.0004562935,0.14124544,0.00022164435,0.016113788,0.6049749],"study_design_scores_gemma":[0.022082612,0.25980318,0.67158496,0.0004694308,0.0010714148,0.0036100019,0.000666594,0.001959397,0.016385052,0.00025251627,0.022062698,0.00005215783],"about_ca_topic_score_codex":0.0005966156,"about_ca_topic_score_gemma":0.0015340538,"teacher_disagreement_score":0.003206466,"about_ca_system_score_codex":0.00017243635,"about_ca_system_score_gemma":0.00018018017,"threshold_uncertainty_score":0.01072669},"labels":[],"label_agreement":null},{"id":"W4382025202","doi":"10.1093/bjd/ljad113.088","title":"P60 Intralesional steroids vs. liquid nitrogen cryotherapy vs. 595 nm pulsed dye laser in the management of chest keloids: a comparative study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cryotherapy; Triamcinolone acetonide; Keloid; Surgery; Acne; Dermatology","score_opus":0.0418323033147149,"score_gpt":0.34603540771581104,"score_spread":0.30420310440109616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382025202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960658,0.0028991227,0.00015868066,0.000038906775,0.000071347415,0.00027195012,0.000064289365,0.0000065905865,0.0004233345],"genre_scores_gemma":[0.9965088,0.0020229802,0.00034689408,0.00008997494,0.0003508142,0.00022443115,0.00011716862,0.0000032862413,0.00033571565],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990293,0.00053310447,0.00011941964,0.00011241248,0.00011711175,0.0000887294],"domain_scores_gemma":[0.99806076,0.0010135104,0.00031116858,0.0001461205,0.00012672778,0.0003417313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016087735,0.00062412873,0.0018628449,0.0006857501,0.00028175348,0.0005043607,0.0006629899,0.00088108174,0.0030417556],"category_scores_gemma":[0.0014582104,0.00028621865,0.0013256769,0.0005886037,0.0007890392,0.00065347756,0.00025339134,0.0008155439,0.00062897726],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78851694,0.085550174,0.009348112,0.0018613434,0.0013947707,0.0007105143,0.00042319458,0.00061814237,0.031758603,0.00021118391,0.00031609883,0.07929105],"study_design_scores_gemma":[0.04980441,0.9314019,0.013942536,0.000054791213,0.00067391683,0.00028854952,0.00015511175,0.00035133102,0.0027727354,0.00004727678,0.00048018174,0.00002727263],"about_ca_topic_score_codex":0.00041631094,"about_ca_topic_score_gemma":0.00049329904,"teacher_disagreement_score":0.0030417556,"about_ca_system_score_codex":0.00034342927,"about_ca_system_score_gemma":0.00037137343,"threshold_uncertainty_score":0.010175645},"labels":[],"label_agreement":null},{"id":"W4382025342","doi":"10.1093/bjd/ljad113.278","title":"GD04 Patient education for all! Skin of colour under-represented again","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dermatology; Medicine; Acne; Atopic dermatitis; Rosacea; Hidradenitis suppurativa; Skin cancer; Psoriasis; Skin type; Disease; Family medicine; Pathology; Cancer","score_opus":0.021256719263957197,"score_gpt":0.3089806242613739,"score_spread":0.28772390499741674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382025342","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09898464,0.0032688533,0.0012096148,0.16893308,0.0057997424,0.0010185336,0.07193956,0.001927329,0.64691865],"genre_scores_gemma":[0.3443783,0.0072442675,0.006807599,0.098555535,0.004114271,0.0018399257,0.024939187,0.0010338296,0.5110871],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991399,0.0003086002,0.00005274987,0.000073363444,0.00017942645,0.00024596244],"domain_scores_gemma":[0.99520594,0.0011191891,0.00045540708,0.00024132182,0.00078887003,0.0021892805],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092768675,0.00015377867,0.00020736622,0.0009119379,0.0009653327,0.0015104911,0.000420373,0.0008577887,0.3156982],"category_scores_gemma":[0.0077131446,0.00012904366,0.00030310603,0.0010313144,0.00030308895,0.0011024263,0.0023738455,0.0012788225,0.050779853],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053040192,0.00011274782,0.00999606,0.00023034644,0.0000035721523,0.00015311783,0.00051089685,0.00001885014,0.000103125625,0.0007379569,0.8977382,0.090341926],"study_design_scores_gemma":[0.00003860392,0.00011765646,0.03083422,0.00061552937,0.000008460446,0.00043827848,0.0026173098,0.000058367506,0.00016318182,0.000551097,0.964543,0.000014302235],"about_ca_topic_score_codex":0.00619742,"about_ca_topic_score_gemma":0.010007748,"teacher_disagreement_score":0.3156982,"about_ca_system_score_codex":0.001419854,"about_ca_system_score_gemma":0.0027119855,"threshold_uncertainty_score":0.97607344},"labels":[],"label_agreement":null},{"id":"W4382025359","doi":"10.1093/bjd/ljad113.105","title":"P77 Deucravacitinib, an oral selective allosteric tyrosine kinase 2 inhibitor, vs. placebo and apremilast in moderate-to-severe plaque psoriasis: achievement of absolute Psoriasis Area and Severity Index thresholds in two phase III trials","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"European League Against Rheumatism; Bristol-Myers Squibb","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Apremilast; Internal medicine; Plaque psoriasis; Randomized controlled trial; Gastroenterology; Dermatology; Psoriatic arthritis; Pathology","score_opus":0.029527391441481896,"score_gpt":0.29683082332800753,"score_spread":0.2673034318865256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382025359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.886315,0.06080749,0.0030786726,0.0039623086,0.0018867204,0.0115510635,0.0059482125,0.0006568339,0.025793696],"genre_scores_gemma":[0.95809066,0.014163954,0.0024841654,0.003027275,0.0006826049,0.008296705,0.0041685496,0.000058037353,0.0090280445],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999281,0.00030663642,0.000065481145,0.00012231761,0.000101097125,0.00012346815],"domain_scores_gemma":[0.9994252,0.00018403778,0.00011588901,0.000044347016,0.00005073362,0.00017975827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019017862,0.0015623621,0.0026640948,0.00043690065,0.00044899646,0.0014340661,0.0009001722,0.001902744,0.008486796],"category_scores_gemma":[0.0014076721,0.0005135973,0.003149877,0.00042958403,0.0007221204,0.0010348728,0.00032767645,0.0031699017,0.0017739555],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87087524,0.009922769,0.0006346143,0.0036789745,0.0031151965,0.0001640943,0.000110857065,0.00088291516,0.012316952,0.0005647004,0.0064076083,0.09132607],"study_design_scores_gemma":[0.91300553,0.07810852,0.0019380099,0.0001464204,0.00090462295,0.00014387391,0.000027584483,0.00049397995,0.001337941,0.00034963142,0.0035200568,0.000023709475],"about_ca_topic_score_codex":0.0006973685,"about_ca_topic_score_gemma":0.0016621683,"teacher_disagreement_score":0.008486796,"about_ca_system_score_codex":0.0008601029,"about_ca_system_score_gemma":0.0012071127,"threshold_uncertainty_score":0.028391182},"labels":[],"label_agreement":null},{"id":"W4382025379","doi":"10.1093/bjd/ljad113.366","title":"PS14 Bimekizumab response up to 3 years in patients with moderate-to-severe plaque psoriasis who responded at week 16: post hoc results from the BE BRIGHT open-label extension trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Dermatology Life Quality Index; Medicine; Plaque psoriasis; Psoriasis Area and Severity Index; Psoriasis; Quality of life (healthcare); Open label; Randomized controlled trial; Internal medicine; Dermatology","score_opus":0.027861972868238737,"score_gpt":0.25728290783648694,"score_spread":0.2294209349682482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382025379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946523,0.0014420336,0.0001681352,0.00027303613,0.00010543359,0.0006963476,0.0010631813,0.000039925442,0.0015595297],"genre_scores_gemma":[0.9935456,0.0006886014,0.00039944283,0.00045430052,0.00021488781,0.0010287407,0.0018232048,0.000014755035,0.0018304961],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990515,0.00055126706,0.00003771846,0.000107624226,0.00008073483,0.00017111022],"domain_scores_gemma":[0.9988715,0.00027412607,0.00024743672,0.00012411845,0.0000856916,0.00039703894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029753072,0.0008249965,0.0019076003,0.00022757651,0.0004062825,0.0011469753,0.0005057392,0.000825265,0.004190424],"category_scores_gemma":[0.0015978393,0.00039144442,0.0020574636,0.00028660204,0.000595585,0.000988191,0.00054875406,0.002537092,0.0009262445],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9620196,0.0077587888,0.0049483674,0.00024495446,0.0009976214,0.000045820703,0.000071662136,0.0004349282,0.0034558286,0.00007442734,0.0016401765,0.018307826],"study_design_scores_gemma":[0.6121144,0.32350168,0.05619593,0.00007381241,0.0018381021,0.0001354261,0.000109411274,0.0010606791,0.0013804361,0.0003233656,0.0032281775,0.000038531412],"about_ca_topic_score_codex":0.0005875945,"about_ca_topic_score_gemma":0.0013228391,"teacher_disagreement_score":0.004190424,"about_ca_system_score_codex":0.0005069847,"about_ca_system_score_gemma":0.0010640342,"threshold_uncertainty_score":0.01573509},"labels":[],"label_agreement":null},{"id":"W4382025478","doi":"10.1093/bjd/ljad113.068","title":"P40 Dupilumab treatment restores skin barrier function in lesional and nonlesional skin of patients with atopic dermatitis and improves patient-reported outcomes","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Atopic dermatitis; Dupilumab; Eczema Area and Severity Index; Medicine; Transepidermal water loss; Dermatology Life Quality Index; Dermatology; Internal medicine; Severity of illness; Quality of life (healthcare); Gastroenterology; Psoriasis; Pathology","score_opus":0.007596004494175723,"score_gpt":0.23629260642762745,"score_spread":0.22869660193345173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382025478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770963,0.001534712,0.00006318506,0.000023169194,0.000007677896,0.00002276203,0.00016565344,0.000006584047,0.00046663894],"genre_scores_gemma":[0.99943227,0.00018969018,0.00008122574,0.000031676143,0.0000076076767,0.000011605489,0.00014589226,7.9284393e-7,0.00009920933],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99979883,0.00007985501,0.000022153838,0.00003206764,0.000031563137,0.000035491958],"domain_scores_gemma":[0.9997037,0.00006830909,0.00011841717,0.000018556819,0.0000298106,0.000061187166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048405532,0.00020475608,0.00052018074,0.00015112001,0.00011986631,0.00027895204,0.00008698644,0.00010594486,0.0009335121],"category_scores_gemma":[0.00060506363,0.000056657256,0.0004109026,0.00015412807,0.000075171396,0.0001697385,0.00014027371,0.0002520997,0.000110050205],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051087193,0.0028392153,0.66025615,0.0010517609,0.0021990123,0.0005799638,0.00021457145,0.00055213954,0.0318336,0.00009072471,0.0017642553,0.24753141],"study_design_scores_gemma":[0.0016150217,0.01778795,0.97244036,0.00005935927,0.0006822437,0.0011006802,0.00015693528,0.0008911413,0.0033143861,0.000041392326,0.0018997483,0.000010697959],"about_ca_topic_score_codex":0.00042211195,"about_ca_topic_score_gemma":0.0010178132,"teacher_disagreement_score":0.0009335121,"about_ca_system_score_codex":0.00015383646,"about_ca_system_score_gemma":0.00015734337,"threshold_uncertainty_score":0.0031228662},"labels":[],"label_agreement":null},{"id":"W4382058417","doi":"10.1093/bjd/ljad113.250","title":"DS11 A double-blinded randomized control study to compare the effectiveness and safety of intralesional vitamin D3 with intralesional triamcinolone and its correlation with tissue expression of vitamin D receptors in patients with keloid","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Triamcinolone acetonide; Keloid; Vitamin D and neurology; Calcitriol receptor; Internal medicine; Vitamin; Randomized controlled trial; Surgery; Urology; Gastroenterology","score_opus":0.013200268053003682,"score_gpt":0.28314024974648505,"score_spread":0.2699399816934814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382058417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862461,0.0012960342,0.0009014536,0.00026138412,0.0006785299,0.00881832,0.00069185003,0.00007362265,0.0010327379],"genre_scores_gemma":[0.9768397,0.0007487107,0.0028825852,0.0008918709,0.00092223857,0.014333062,0.000726571,0.000017681272,0.0026375623],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965593,0.0019630112,0.00037258817,0.0005070855,0.00027922602,0.00031888706],"domain_scores_gemma":[0.9953707,0.0016707181,0.0008739352,0.0005233921,0.00043586318,0.0011254543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004569444,0.0017694893,0.0048588812,0.0008116184,0.00089835486,0.0010200833,0.0009735726,0.0028370735,0.008768758],"category_scores_gemma":[0.0041172174,0.000979159,0.001695319,0.0006401406,0.0027289041,0.0010146904,0.00053259847,0.0021049979,0.0013272226],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97943753,0.0134768365,0.0005008661,0.00016417763,0.0002771165,0.000018780249,0.000022160195,0.000054070584,0.0019479896,0.0000335794,0.00015361761,0.0039133225],"study_design_scores_gemma":[0.7426065,0.2547073,0.0015578752,0.00001117498,0.00014717369,0.000015513073,0.000015591519,0.00015654236,0.00042770695,0.000041069834,0.00030116286,0.000012444877],"about_ca_topic_score_codex":0.0006383583,"about_ca_topic_score_gemma":0.0009243592,"teacher_disagreement_score":0.008768758,"about_ca_system_score_codex":0.0007907302,"about_ca_system_score_gemma":0.0019949689,"threshold_uncertainty_score":0.029334426},"labels":[],"label_agreement":null},{"id":"W4382058787","doi":"10.1093/bjd/ljad113.335","title":"PA31 Congenital alopecia areata: a systematic review","year":2023,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Alopecia areata; Medicine; Alopecia universalis; Minoxidil; Dermatology; Hair loss; Scalp; Family history; Placebo; Internal medicine; Pathology","score_opus":0.04401743594222972,"score_gpt":0.34399788179182567,"score_spread":0.29998044584959593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382058787","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001755578,0.99622846,0.00006359094,0.00022069768,0.00007760994,0.0001564863,0.0011136476,0.0000079793435,0.00037593066],"genre_scores_gemma":[0.022756103,0.9751948,0.00025472842,0.0004648087,0.00013656283,0.00034796516,0.00067351345,0.000005096446,0.00016645844],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.997577,0.0005412738,0.0010205448,0.00026212583,0.00048746009,0.00011154603],"domain_scores_gemma":[0.9888076,0.0073473314,0.0024575144,0.00013718179,0.0010884389,0.0001619634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019684227,0.00092884316,0.0047763893,0.009748718,0.00050850125,0.0016024688,0.0011924527,0.0013546468,0.009540068],"category_scores_gemma":[0.011746549,0.0004900988,0.0032125483,0.01059144,0.00048755496,0.0016474521,0.0010065923,0.0006421987,0.00053567253],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001820155,0.000018585084,0.0025375972,0.95371825,0.0043119774,0.00022712418,0.00012688215,0.000051357212,0.00018177889,0.00018534064,0.0038299293,0.034629256],"study_design_scores_gemma":[0.00032547174,0.00026159623,0.023104751,0.88927466,0.040685583,0.0023125594,0.00039960624,0.00011216532,0.00018380544,0.00039401487,0.0428977,0.000048158316],"about_ca_topic_score_codex":0.003954014,"about_ca_topic_score_gemma":0.010112849,"teacher_disagreement_score":0.009748718,"about_ca_system_score_codex":0.0012649954,"about_ca_system_score_gemma":0.0041638096,"threshold_uncertainty_score":0.03191477},"labels":[],"label_agreement":null},{"id":"W4382059161","doi":"10.1093/bjd/ljad113.214","title":"DP01 Survey on the management of dysplastic naevus","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atypia; Cohort; Dermatology; Excise; General surgery; Surgery; Pathology","score_opus":0.012276107501609223,"score_gpt":0.24145163007853793,"score_spread":0.2291755225769287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382059161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9575187,0.0051382086,0.0003098649,0.011225936,0.00018040491,0.00017303236,0.0067940108,0.00006274208,0.018597212],"genre_scores_gemma":[0.9846785,0.004147363,0.00055340346,0.0039276946,0.00018106514,0.00017241671,0.0026638,0.000022304754,0.003653428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689746,0.0013237757,0.00050187606,0.00022472648,0.0006807023,0.0003715082],"domain_scores_gemma":[0.98749894,0.0036414627,0.004694971,0.00018960147,0.0022488253,0.0017261592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027367247,0.00012876022,0.00021421492,0.0010248345,0.00041532808,0.0005718327,0.0004571845,0.0007410622,0.004934964],"category_scores_gemma":[0.010415232,0.00020637938,0.00024648136,0.0015844338,0.0003072939,0.00064231415,0.000904548,0.0006982863,0.0014422877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016827017,0.00016824449,0.9096388,0.0008766993,0.000036538877,0.00081138714,0.0039000064,0.00018236677,0.0015048782,0.00023396467,0.028853334,0.053625375],"study_design_scores_gemma":[0.000013145294,0.0003731543,0.95785546,0.0003402443,0.000007546116,0.0012206401,0.0042507453,0.00011281322,0.0002122215,0.000034734785,0.035561014,0.00001817779],"about_ca_topic_score_codex":0.0068979883,"about_ca_topic_score_gemma":0.0063310093,"teacher_disagreement_score":0.0068979883,"about_ca_system_score_codex":0.0011477874,"about_ca_system_score_gemma":0.00077826733,"threshold_uncertainty_score":0.016509116},"labels":[],"label_agreement":null},{"id":"W4383293155","doi":"10.1093/bjd/ljad220","title":"Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"European Academy of Dermatology and Venereology; Sun Pharma; EMBO; National Institutes of Health; Helsinn; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Universität Zürich; Narodowe Centrum Nauki; Swiss Cancer Research Foundation; European Commission; National Science Foundation; Les Laboratories Pierre Fabre; Promedica Stiftung; Cancer Research Foundation; Bristol-Myers Squibb","keywords":"Medicine; Extracorporeal Photopheresis; Cutaneous T-cell lymphoma; Immunology; Photopheresis; Peripheral blood mononuclear cell; Cytokine; Tumor necrosis factor alpha; Immune system; Lymphoma; Internal medicine; Mycosis fungoides; Graft-versus-host disease; Transplantation; Biology","score_opus":0.008715627945288308,"score_gpt":0.2617786532048653,"score_spread":0.253063025259577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383293155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990828,0.00049439527,0.0000949774,0.000017159136,0.0000035361522,0.000013261286,0.00009341988,0.000004152507,0.00019627332],"genre_scores_gemma":[0.99964356,0.000066781904,0.0000866461,0.0000177958,0.000007943768,0.000011211004,0.00010270528,7.231313e-7,0.000062612075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977654,0.000053899028,0.00003465847,0.00006418994,0.00003723112,0.000033460154],"domain_scores_gemma":[0.99941874,0.00012760419,0.00026899434,0.000033040596,0.00006631013,0.00008530498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003559829,0.00023266488,0.0003255817,0.00043573213,0.00021853045,0.00042625298,0.00017208961,0.00030122628,0.0008552338],"category_scores_gemma":[0.00092419796,0.00011533707,0.00017929242,0.00038255,0.00015885857,0.00026092003,0.00018038161,0.00036717768,0.00015437456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090487755,0.00006837197,0.99086773,0.00003025101,0.000024471208,0.00035211985,0.00007570643,0.000059213915,0.0040182048,0.000011560329,0.00006666907,0.0035208121],"study_design_scores_gemma":[0.00004445003,0.00092158344,0.99383163,0.000012819188,0.00006989991,0.0026246621,0.00016227047,0.00035664643,0.0015418084,0.0000308283,0.00039821936,0.0000051150323],"about_ca_topic_score_codex":0.00026446063,"about_ca_topic_score_gemma":0.00028673894,"teacher_disagreement_score":0.0008552338,"about_ca_system_score_codex":0.00018399533,"about_ca_system_score_gemma":0.00013273617,"threshold_uncertainty_score":0.0028610826},"labels":[],"label_agreement":null},{"id":"W4383499400","doi":"10.1093/bjd/ljad174.020","title":"O20 Advanced melanoma is associated with distinct circulating B-cell profiles enriched with immunoregulatory and autoreactive features","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Immunology; Antibody; B cell; Isotype; Melanoma; Autoantibody; Immune system; Population; Biology; Medicine; Cancer research; Monoclonal antibody","score_opus":0.009355883340755076,"score_gpt":0.254630042186687,"score_spread":0.24527415884593193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383499400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994448,0.00014095503,0.0000931138,0.0000055700907,0.0000017301838,0.0000036594718,0.000039798706,0.0000063096513,0.0002640385],"genre_scores_gemma":[0.99948525,0.000049052152,0.000120664205,0.000009622175,0.000006791884,0.0000033112303,0.00009608599,0.0000030436602,0.00022613429],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999151,0.000010785783,0.0000075477355,0.000028317092,0.000015651103,0.000022645529],"domain_scores_gemma":[0.9997626,0.000028118546,0.000088603185,0.000015442378,0.000021541335,0.00008373906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117623735,0.00026031272,0.0002432157,0.00066010293,0.00016027431,0.00028250852,0.00008657169,0.00024320805,0.0027135257],"category_scores_gemma":[0.0002397769,0.00013192142,0.00010843104,0.00024020228,0.00015064984,0.00013084625,0.00019995606,0.00022473841,0.00040216438],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001765551,0.00016653822,0.39703524,0.000059106496,0.000045407818,0.0022719256,0.00025144962,0.000068789384,0.59131205,0.000093088725,0.00014290636,0.0067879483],"study_design_scores_gemma":[0.000027381724,0.00077015837,0.9811705,0.000007669349,0.000025138146,0.007590068,0.00013881444,0.00026493013,0.00925733,0.00008108365,0.00066193036,0.0000051190127],"about_ca_topic_score_codex":0.0004514206,"about_ca_topic_score_gemma":0.00039411717,"teacher_disagreement_score":0.0027135257,"about_ca_system_score_codex":0.00009470054,"about_ca_system_score_gemma":0.00004949273,"threshold_uncertainty_score":0.009077668},"labels":[],"label_agreement":null},{"id":"W4383980227","doi":"10.1093/bjd/ljad237","title":"Reporting of Harmonising Outcome Measures for Eczema (HOME) core outcome set instruments in randomized clinical trials for systemic treatments in atopic dermatitis","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Atopic dermatitis; Medicine; Randomized controlled trial; Clinical trial; Outcome (game theory); Meta-analysis; Set (abstract data type); Core (optical fiber); Physical therapy; MEDLINE; Systematic review; Intensive care medicine; Pediatrics; Surgery; Dermatology; Internal medicine; Computer science","score_opus":0.33727410059929286,"score_gpt":0.4874199634092887,"score_spread":0.15014586280999587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383980227","genre_codex":"review","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055533633,0.41755426,0.28000224,0.02181596,0.012381861,0.13039565,0.055631816,0.0016736474,0.025010927],"genre_scores_gemma":[0.3801548,0.045775607,0.2666051,0.012076434,0.001960048,0.26991674,0.021327239,0.00076592114,0.0014181305],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.20127644,0.49729112,0.2581184,0.010709716,0.03077828,0.001826057],"domain_scores_gemma":[0.25136748,0.45601898,0.12902758,0.10716493,0.054713987,0.0017071348],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.57111347,0.0019654443,0.00813054,0.008367608,0.0017645614,0.0090633845,0.003631065,0.0043571494,0.0035555402],"category_scores_gemma":[0.730613,0.0017207135,0.015832406,0.00982381,0.0032463814,0.0058274306,0.008128641,0.0046400023,0.0007006777],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011237079,0.00031733804,0.034028903,0.4580767,0.15050773,0.00025929665,0.0050912914,0.0046603237,0.0014463606,0.02499584,0.03322155,0.2761576],"study_design_scores_gemma":[0.033879787,0.0044786097,0.11104011,0.300731,0.24682738,0.0011641083,0.0019653165,0.0066513605,0.007548796,0.05798245,0.22673206,0.0009990876],"about_ca_topic_score_codex":0.0023492074,"about_ca_topic_score_gemma":0.0035164375,"teacher_disagreement_score":0.42888653,"about_ca_system_score_codex":0.0046795146,"about_ca_system_score_gemma":0.013941682,"threshold_uncertainty_score":0.5288935},"labels":[],"label_agreement":null},{"id":"W4385230266","doi":"10.1093/bjd/ljad252","title":"Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse)","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Dermatrials Research; Probity Medical Research; University of British Columbia","funders":"National Institutes of Health; AbbVie; Boehringer Ingelheim","keywords":"Apremilast; Medicine; Psoriasis Area and Severity Index; Psoriasis; Randomized controlled trial; Internal medicine; Secukinumab; Clinical endpoint; Dermatology; Psoriatic arthritis","score_opus":0.06904877460295726,"score_gpt":0.35285259864049323,"score_spread":0.28380382403753596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385230266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909458,0.0031675575,0.00065349793,0.00035176793,0.00026055903,0.0025601392,0.0008384664,0.00008056147,0.0011416423],"genre_scores_gemma":[0.99003404,0.0018090691,0.002109187,0.0008204398,0.00047182487,0.002502052,0.001026124,0.0000224965,0.0012046746],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980597,0.0011499816,0.00017997809,0.00028856407,0.00017683429,0.00014496082],"domain_scores_gemma":[0.99740064,0.00075420755,0.0007597754,0.0002190153,0.00018706183,0.00067939487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041893735,0.0012673633,0.0026697197,0.00037403894,0.0003568116,0.0011653068,0.00088335556,0.0017949893,0.0048557697],"category_scores_gemma":[0.0031497513,0.00077075686,0.0025638617,0.00033800313,0.0009581347,0.0012094019,0.00045714225,0.0026436953,0.00078912725],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97313404,0.009292628,0.0007478206,0.00032036286,0.00094480696,0.000018157565,0.00005143964,0.00012871831,0.0033851347,0.00004484455,0.00031224618,0.011619806],"study_design_scores_gemma":[0.8470243,0.14885706,0.0026298144,0.000020263506,0.0005082826,0.0000279087,0.0000148179015,0.00019916908,0.00036064052,0.000056477646,0.00029071092,0.000010378318],"about_ca_topic_score_codex":0.00039798234,"about_ca_topic_score_gemma":0.0009856246,"teacher_disagreement_score":0.0048557697,"about_ca_system_score_codex":0.0007005669,"about_ca_system_score_gemma":0.001276561,"threshold_uncertainty_score":0.022155762},"labels":[],"label_agreement":null},{"id":"W4385751891","doi":"10.1093/bjd/ljad275","title":"Risk factors for subsequent primary melanoma in patients with previous melanoma: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council; Melanoma Institute Australia","keywords":"Meta-analysis; Melanoma; Medicine; Primary (astronomy); Oncology; Dermatology; MEDLINE; Internal medicine; Cancer research; Biology","score_opus":0.038073957090055434,"score_gpt":0.2915269607715725,"score_spread":0.253453003681517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385751891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036426485,0.99516463,0.00028976225,0.00013269181,0.00008605017,0.00019981197,0.00029659222,0.000015296411,0.00017254856],"genre_scores_gemma":[0.11150514,0.8842441,0.0015519357,0.00059385115,0.0001974179,0.0009385886,0.00069190876,0.000018294328,0.00025884842],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99298674,0.0030077477,0.0020064304,0.0008131528,0.0009033903,0.00028247572],"domain_scores_gemma":[0.984304,0.011217506,0.0025501382,0.00041137464,0.0012877784,0.00022922402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011057139,0.0025879657,0.017489225,0.0062019704,0.00064144784,0.0032737416,0.0020092805,0.002468361,0.0034751],"category_scores_gemma":[0.027331673,0.0015086369,0.04456782,0.0067799673,0.0005867402,0.0017066875,0.0013756577,0.0020439064,0.0002630908],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017188742,0.000038283488,0.005291719,0.45340478,0.52534443,0.00017252224,0.000098096425,0.000577304,0.0001562171,0.000113127855,0.00067922426,0.012405525],"study_design_scores_gemma":[0.00041905284,0.00020021743,0.0049257805,0.038665082,0.9537355,0.00015292317,0.000054128377,0.00020479254,0.000082241975,0.00014387329,0.0013886702,0.000027752605],"about_ca_topic_score_codex":0.008538705,"about_ca_topic_score_gemma":0.017527409,"teacher_disagreement_score":0.017489225,"about_ca_system_score_codex":0.0027073608,"about_ca_system_score_gemma":0.0040691425,"threshold_uncertainty_score":0.058476448},"labels":[],"label_agreement":null},{"id":"W4385752045","doi":"10.1093/bjd/ljad284","title":"Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Atopic dermatitis; Placebo; Medicine; Dupilumab; Randomized controlled trial; Young adult; Double blinded; Anesthesia; Internal medicine; Dermatology","score_opus":0.01621801280966888,"score_gpt":0.26303766098546305,"score_spread":0.24681964817579416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385752045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853258,0.009183532,0.00048516263,0.00028488867,0.0002559589,0.0026482905,0.0009308537,0.000096861484,0.00078860146],"genre_scores_gemma":[0.98829657,0.0043831305,0.0014196176,0.00070078805,0.00040713706,0.002650358,0.0009311141,0.000019231087,0.0011920123],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99910384,0.0004266309,0.000106170606,0.00015173396,0.00009567541,0.000115968476],"domain_scores_gemma":[0.99903035,0.00024252887,0.0002695954,0.00009445575,0.000105122075,0.00025782915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023542272,0.0013045657,0.0030308303,0.00041574656,0.0004891563,0.00087558123,0.0007363847,0.0016743962,0.0028554641],"category_scores_gemma":[0.001823387,0.00057883334,0.0021240362,0.0003400544,0.00076916174,0.00066814746,0.00030739003,0.0016169971,0.0004942571],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.932657,0.015786765,0.0013367486,0.001137143,0.0015993316,0.00006383806,0.000076278855,0.00018924606,0.0065383604,0.000029301149,0.0008116501,0.039774444],"study_design_scores_gemma":[0.8149406,0.17275281,0.009491941,0.00005645821,0.000967966,0.00006410287,0.000026256204,0.00022652677,0.00079116406,0.000032410586,0.0006298444,0.000019934932],"about_ca_topic_score_codex":0.00084717746,"about_ca_topic_score_gemma":0.0019508963,"teacher_disagreement_score":0.0030308303,"about_ca_system_score_codex":0.0005818168,"about_ca_system_score_gemma":0.0007860655,"threshold_uncertainty_score":0.012450516},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4386154925","doi":"10.1093/bjd/ljad308","title":"Failure of scabies treatment: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatological diseases and infestations","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Impact","funders":"Robert Koch Institut","keywords":"Medicine; Ivermectin; Meta-analysis; Internal medicine; Scabies; Confidence interval; Permethrin; Observational study; Randomized controlled trial; Pediatrics; Dermatology; Veterinary medicine","score_opus":0.11766982122767836,"score_gpt":0.3879529429545716,"score_spread":0.2702831217268933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386154925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028674363,0.99501365,0.00052829215,0.00017987081,0.00013934019,0.000584096,0.0004465369,0.000027900027,0.00021289253],"genre_scores_gemma":[0.117458366,0.87534547,0.0027910562,0.00085284223,0.00021128489,0.0022053386,0.00077228766,0.000037119844,0.00032621273],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98448944,0.0074721277,0.0044155763,0.0013941918,0.001758125,0.00047048746],"domain_scores_gemma":[0.97282344,0.0191934,0.0047479672,0.00069056137,0.0021590986,0.00038550684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02003691,0.0035059184,0.027231997,0.009344901,0.00087860815,0.004216797,0.0030044743,0.0030152646,0.0047564143],"category_scores_gemma":[0.046376497,0.0022560863,0.050881978,0.008803845,0.0010548045,0.0025256576,0.002199954,0.0023433005,0.0003834915],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010934336,0.000026767444,0.0015384207,0.5202235,0.4681105,0.000106744126,0.00007367337,0.00040086868,0.00011332346,0.00010027397,0.0004466268,0.0077658016],"study_design_scores_gemma":[0.00057114277,0.00019469447,0.0017590725,0.045649305,0.9499482,0.00009962312,0.00004827094,0.00018124051,0.00008176703,0.00014812395,0.0012932144,0.000025244823],"about_ca_topic_score_codex":0.010042419,"about_ca_topic_score_gemma":0.021059096,"teacher_disagreement_score":0.027231997,"about_ca_system_score_codex":0.004864794,"about_ca_system_score_gemma":0.0069782995,"threshold_uncertainty_score":0.10596657},"labels":[],"label_agreement":null},{"id":"W4386305920","doi":"10.1093/bjd/ljad305","title":"Metformin has anti-inflammatory effects and induces immunometabolic reprogramming via multiple mechanisms in hidradenitis suppurativa","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"National Institutes of Health; LEO Pharma; British Skin Foundation; UCB Pharma; Wellcome Trust; Celgene; Irish Research Council; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; Biogen","keywords":"Hidradenitis suppurativa; Medicine; Metformin; Reprogramming; Dermatology; Dandruff; Disease; Internal medicine; Diabetes mellitus; Biology; Pathology; Endocrinology","score_opus":0.014738504729396354,"score_gpt":0.2523786805294522,"score_spread":0.23764017580005586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386305920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820889,0.014209769,0.0012977654,0.00028077335,0.00017884032,0.00006687013,0.00048857194,0.000045132045,0.001343334],"genre_scores_gemma":[0.99211836,0.004737798,0.0013841453,0.00023428953,0.00006925361,0.00008756497,0.0006030821,0.000010144486,0.0007552717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984777,0.000036261772,0.000018196772,0.00002785454,0.000033802557,0.0000359802],"domain_scores_gemma":[0.9998921,0.00001580367,0.000043224052,0.000012317326,0.00000983093,0.000026655176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022169313,0.00036809663,0.0003511454,0.00036104635,0.00019698846,0.00029578505,0.0001301009,0.00030368482,0.0016257276],"category_scores_gemma":[0.0001516171,0.00014512769,0.00063793344,0.00021213036,0.00020022508,0.00018399148,0.00019452246,0.0006749569,0.00023410592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024700803,0.0003751179,0.0055244053,0.0004560089,0.00007801872,0.0007658406,0.000036258345,0.00016286477,0.97403616,0.000106280255,0.00026905895,0.015719866],"study_design_scores_gemma":[0.0008308741,0.009467064,0.3544454,0.0001485412,0.0004137446,0.0059240526,0.00032908324,0.0026521177,0.609229,0.00042757983,0.016081562,0.000050953204],"about_ca_topic_score_codex":0.00017226185,"about_ca_topic_score_gemma":0.00031391767,"teacher_disagreement_score":0.0016257276,"about_ca_system_score_codex":0.00019318555,"about_ca_system_score_gemma":0.00013860401,"threshold_uncertainty_score":0.005438566},"labels":[],"label_agreement":null},{"id":"W4386390585","doi":"10.1093/bjd/ljad320","title":"A detailed evaluation of the effect of dupilumab on sleep in adults with atopic dermatitis","year":2023,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Atopic dermatitis; Conceptualization; Medicine; Family medicine; Library science; Dermatology","score_opus":0.009283254884598417,"score_gpt":0.2560187303331278,"score_spread":0.24673547544852936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386390585","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14183348,0.6198929,0.001467105,0.0664108,0.013509045,0.0046002995,0.061816428,0.00034377174,0.09012611],"genre_scores_gemma":[0.68257576,0.2146319,0.008002035,0.02969963,0.010693344,0.0039053983,0.02067114,0.00026078953,0.02955997],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9933877,0.0031765006,0.0011633304,0.0003150975,0.0016386494,0.0003186987],"domain_scores_gemma":[0.97300804,0.013823481,0.003459415,0.00094648864,0.007453729,0.0013088314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072728824,0.00027494074,0.001142721,0.0010641067,0.00045237644,0.0013083422,0.00050701783,0.0007710753,0.022329886],"category_scores_gemma":[0.034335155,0.00019082554,0.002744573,0.0012933286,0.00026785463,0.00081018155,0.000502747,0.001179738,0.0018974737],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028894065,0.00063026114,0.029181452,0.036910366,0.0046247724,0.00041913934,0.00055835966,0.0003611891,0.0012445792,0.0013946823,0.246724,0.64905727],"study_design_scores_gemma":[0.011281518,0.01795358,0.33275455,0.054839924,0.015389217,0.00150377,0.0010683883,0.00041456026,0.002788379,0.0010703035,0.5607383,0.0001975124],"about_ca_topic_score_codex":0.0064249514,"about_ca_topic_score_gemma":0.013074403,"teacher_disagreement_score":0.022329886,"about_ca_system_score_codex":0.0018928213,"about_ca_system_score_gemma":0.0028318588,"threshold_uncertainty_score":0.07470095},"labels":[],"label_agreement":null},{"id":"W4386819540","doi":"10.1093/bjd/ljad281","title":"Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"British Association of Dermatologists; National Institute for Health and Care Research; National Institutes of Health; Medical Research Council; Barts Charity; Queen Mary University of London","keywords":"Medicine; Eczema Area and Severity Index; SCORAD; Atopic dermatitis; Randomized controlled trial; Ciclosporin; Methotrexate; Internal medicine; Quality of life (healthcare); Population; Adverse effect; Clinical trial; Dermatology Life Quality Index; Pediatrics; Dermatology; Transplantation; Disease","score_opus":0.03608489002482184,"score_gpt":0.3489702251065328,"score_spread":0.31288533508171096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386819540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749834,0.0038491138,0.00068420166,0.0005572176,0.00060109806,0.016279029,0.0012237376,0.00007270877,0.0017493945],"genre_scores_gemma":[0.97135377,0.0015913426,0.0022547834,0.00080413924,0.0006475835,0.021135597,0.00070071075,0.000018201115,0.001493783],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99465734,0.003546358,0.00044617846,0.0006743033,0.00031358254,0.0003621586],"domain_scores_gemma":[0.9945839,0.0014501909,0.0017974684,0.00057395396,0.0005142587,0.0010803731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009051436,0.0017171394,0.004388139,0.0005432296,0.0009673379,0.0015282953,0.0010144197,0.0031308387,0.0057333177],"category_scores_gemma":[0.008421773,0.000869693,0.0035563007,0.0005104289,0.001790917,0.0012370958,0.0008261612,0.0027773385,0.0009017057],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98758954,0.0050728647,0.00085233094,0.0005161035,0.00085202616,0.00002453091,0.000064716936,0.00011014928,0.00060170767,0.000033841035,0.00022043232,0.004061765],"study_design_scores_gemma":[0.93295085,0.06428204,0.001669287,0.000037532296,0.00050254713,0.000022386652,0.000020748643,0.00010422199,0.000121739366,0.000052393316,0.00022691888,0.000009254039],"about_ca_topic_score_codex":0.0013656593,"about_ca_topic_score_gemma":0.0023227194,"teacher_disagreement_score":0.009051436,"about_ca_system_score_codex":0.0014740841,"about_ca_system_score_gemma":0.0024062297,"threshold_uncertainty_score":0.047869146},"labels":[],"label_agreement":null},{"id":"W4386979770","doi":"10.1093/bjd/ljad347","title":"British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023: a pragmatic update","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Institute for Health and Care Research; Psoriasis Association","keywords":"Psoriasis; Medicine; Dermatology; Association (psychology); Dermatologic agents; Plaque psoriasis; MEDLINE; Family medicine; Psychology; Psychotherapist; Political science","score_opus":0.03792392213837212,"score_gpt":0.3033003803270341,"score_spread":0.26537645818866196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386979770","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00087063207,0.2375811,0.005295793,0.6707586,0.04750458,0.0002700987,0.0010050286,0.00033414437,0.036379956],"genre_scores_gemma":[0.026332987,0.45640785,0.057371125,0.37474737,0.05205522,0.0009524132,0.0036677928,0.00072841335,0.027736897],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9677605,0.010440908,0.0064824494,0.0006728032,0.013596748,0.0010467223],"domain_scores_gemma":[0.9308006,0.022448096,0.0048382133,0.0014050105,0.03699729,0.003510751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02858724,0.0009382121,0.002384685,0.004460153,0.0015268597,0.005480701,0.0026169866,0.009669682,0.007424039],"category_scores_gemma":[0.0731135,0.0009905853,0.002153749,0.0035701087,0.0021761057,0.0035123043,0.0020881083,0.0149038015,0.0051924167],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012319458,0.0001098338,0.00032372406,0.0025654305,0.00006265069,0.00021507083,0.00018475557,0.00020941759,0.00040192076,0.005613016,0.7839819,0.20620905],"study_design_scores_gemma":[0.00008694381,0.000043293818,0.0008418321,0.005351472,0.00007878425,0.00047017878,0.000110809866,0.00011405302,0.000101503865,0.0022047032,0.9905614,0.000035026245],"about_ca_topic_score_codex":0.02205032,"about_ca_topic_score_gemma":0.04745006,"teacher_disagreement_score":0.02858724,"about_ca_system_score_codex":0.0059909406,"about_ca_system_score_gemma":0.018053366,"threshold_uncertainty_score":0.15118557},"labels":[],"label_agreement":null},{"id":"W4387331497","doi":"10.1093/bjd/ljad361","title":"Harmonization of outcomes in epidermolysis bullosa: report of the Core Outcome Sets for Epidermolysis Bullosa (COSEB) kick-off meeting","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Epidermolysis bullosa; Harmonization; Medicine; Outcome (game theory); Comparability; Pooling; Dermatology; Computer science","score_opus":0.14280767770682123,"score_gpt":0.43731526210306115,"score_spread":0.2945075843962399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387331497","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43678415,0.03328196,0.27194875,0.08853674,0.0068815066,0.07870696,0.032725256,0.0006573896,0.05047736],"genre_scores_gemma":[0.63379514,0.006702137,0.20489272,0.0051798895,0.00077461544,0.10308295,0.042422112,0.00048505922,0.002665425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.70986897,0.19206244,0.048793428,0.0041059284,0.039176702,0.005992587],"domain_scores_gemma":[0.6799022,0.13154182,0.026783565,0.03467313,0.11970007,0.0073991967],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.45793965,0.0013702934,0.0031069282,0.00696157,0.002479985,0.00413781,0.0033098985,0.0021197915,0.0012815197],"category_scores_gemma":[0.29648697,0.0009084936,0.005249189,0.0058713835,0.002191152,0.0036868877,0.013067101,0.0038982208,0.00033948652],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005692503,0.0015156553,0.14187515,0.018917933,0.0039541153,0.00044289164,0.016803589,0.010534378,0.0033769323,0.05133897,0.08140635,0.66414154],"study_design_scores_gemma":[0.002820221,0.00575068,0.6992734,0.025096916,0.003740949,0.00067977625,0.01955302,0.015251173,0.012932002,0.04783035,0.16634196,0.0007294639],"about_ca_topic_score_codex":0.012376514,"about_ca_topic_score_gemma":0.005479815,"teacher_disagreement_score":0.5420604,"about_ca_system_score_codex":0.011704787,"about_ca_system_score_gemma":0.034827698,"threshold_uncertainty_score":0.6684569},"labels":[],"label_agreement":null},{"id":"W4387564463","doi":"10.1093/bjd/ljad388","title":"Treatment of Hidradenitis Suppurativa Evaluation Study (THESEUS): a prospective cohort study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"UCB Pharma; University of Oxford; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK; Insmed; Pfizer","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Prospective cohort study; Cohort; Cohort study; Surgery; Disease; Pathology","score_opus":0.030725119389069133,"score_gpt":0.3402123620377406,"score_spread":0.30948724264867145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387564463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908297,0.00101189,0.00037494357,0.00016336981,0.000042245847,0.0015726248,0.0047946116,0.000008194637,0.0012022826],"genre_scores_gemma":[0.9924563,0.00064013683,0.0007966244,0.00033357873,0.000056981255,0.0018497624,0.0030549618,0.000009535009,0.00080201414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753404,0.0010819255,0.00033894854,0.00040839813,0.00034683198,0.00028987494],"domain_scores_gemma":[0.9958144,0.0005812035,0.0017213061,0.00058234396,0.0005705063,0.00073023903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043889033,0.00047618826,0.0007799381,0.000664446,0.0008728843,0.0009963794,0.0005515282,0.0007195488,0.0035315626],"category_scores_gemma":[0.0052431445,0.0006202683,0.001290421,0.0011860342,0.00033639016,0.0007686609,0.0010703441,0.0010114165,0.00079419214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048429333,0.0010913168,0.9863158,0.00033331037,0.0006378048,0.00024783937,0.0005048739,0.00004125007,0.00027604558,0.00012261255,0.0014224091,0.0041638315],"study_design_scores_gemma":[0.0016124897,0.0037961928,0.99051017,0.00023336834,0.00044539338,0.0005765069,0.00064946874,0.00016705749,0.0000917904,0.000066901775,0.0018226218,0.000027920341],"about_ca_topic_score_codex":0.0041311225,"about_ca_topic_score_gemma":0.0056999587,"teacher_disagreement_score":0.0043889033,"about_ca_system_score_codex":0.00047342404,"about_ca_system_score_gemma":0.0010552789,"threshold_uncertainty_score":0.023211002},"labels":[],"label_agreement":null},{"id":"W4387613843","doi":"10.1093/bjd/ljad393","title":"Comparing binary efficacy outcomes for systemic immunomodulatory treatments for atopic dermatitis in a living systematic review and network meta-analysis","year":2023,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; University of Ottawa; McMaster University; Women's College Hospital; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Atopic dermatitis; Meta-analysis; Medicine; Dermatology; MEDLINE; Internal medicine; Biology","score_opus":0.10706416343727936,"score_gpt":0.37075712512574593,"score_spread":0.26369296168846657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387613843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007534786,0.9849029,0.0029889373,0.0004256744,0.00036041846,0.0015386266,0.0015601218,0.00008542144,0.00060306716],"genre_scores_gemma":[0.40204304,0.5621707,0.016279927,0.0025371609,0.00062899146,0.012034619,0.003346955,0.00013174252,0.0008268694],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.94409734,0.034172274,0.012676538,0.0041695526,0.0041965838,0.00068769377],"domain_scores_gemma":[0.9230216,0.061747245,0.009355509,0.0021739767,0.0032239128,0.00047763853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04478238,0.0032797218,0.023286242,0.01338223,0.00077692576,0.0045800274,0.0027019125,0.0024727865,0.004314725],"category_scores_gemma":[0.111148685,0.0016922777,0.045378413,0.009889314,0.0010969834,0.0030558608,0.0028718766,0.002343497,0.00036428348],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010488475,0.000014800671,0.0026854821,0.22960204,0.7601886,0.00006903084,0.00006674657,0.00044809052,0.00008462345,0.00018238355,0.0004062441,0.005203149],"study_design_scores_gemma":[0.00082269823,0.00013149652,0.0019424243,0.020752871,0.974428,0.00006495317,0.00003815645,0.000290394,0.00006658189,0.00044683536,0.000991878,0.000023673221],"about_ca_topic_score_codex":0.0051926086,"about_ca_topic_score_gemma":0.011040434,"teacher_disagreement_score":0.04478238,"about_ca_system_score_codex":0.0034930413,"about_ca_system_score_gemma":0.0046364185,"threshold_uncertainty_score":0.2368347},"labels":[],"label_agreement":null},{"id":"W4387847520","doi":"10.1093/bjd/ljad398","title":"Skin Investigation Network of Canada (SkIN Canada) Priority Setting Initiative ranks the top 10 evidence uncertainties for Merkel cell carcinoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Toronto; BC Children's Hospital; McGill University; Canadian Arthritis Patient Alliance; University of British Columbia; SKiN Health; Women's College Hospital; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Merkel cell carcinoma; Alliance; Skin cancer; Medicine; Dermatology; Merkel cell; Family medicine; Carcinoma; Political science; Pathology; Cancer; Internal medicine","score_opus":0.018688191998823836,"score_gpt":0.24677560154316544,"score_spread":0.2280874095443416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387847520","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036970053,0.053690147,0.007293944,0.8324007,0.004022524,0.00164819,0.010069329,0.0002337916,0.053671293],"genre_scores_gemma":[0.6670352,0.09505205,0.10300341,0.09999916,0.0028314688,0.0017065686,0.015629426,0.00035777967,0.014385016],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.92944,0.023866907,0.00719969,0.0020747103,0.028039794,0.009378863],"domain_scores_gemma":[0.6597209,0.055637993,0.013662528,0.0029127297,0.21776411,0.0503017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08969133,0.00068246253,0.0019859069,0.007188947,0.009653636,0.015761621,0.0029814,0.0028576034,0.00745307],"category_scores_gemma":[0.1617244,0.00075697043,0.001914058,0.006865046,0.0025043385,0.004044407,0.008272349,0.008240711,0.0008831704],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009846989,0.00026112734,0.102057554,0.010019935,0.0009996325,0.0005528077,0.0045231655,0.0016632641,0.0010513898,0.024949249,0.5190393,0.33389795],"study_design_scores_gemma":[0.00053362356,0.00064948644,0.1535688,0.03509925,0.001959964,0.0007934176,0.03394615,0.0031829607,0.0028801882,0.041877113,0.7247291,0.00077985437],"about_ca_topic_score_codex":0.65488654,"about_ca_topic_score_gemma":0.84979546,"teacher_disagreement_score":0.92267174,"about_ca_system_score_codex":0.07732828,"about_ca_system_score_gemma":0.38174593,"threshold_uncertainty_score":0.6942918},"labels":[],"label_agreement":null},{"id":"W4387900889","doi":"10.1093/bjd/ljad404","title":"Incidence, mortality and survival of Merkel cell carcinoma: a systematic review of population-based studies","year":2023,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Ottawa Hospital; Women's College Hospital; Queen's University; Ontario Council of University Libraries; University of Toronto","funders":"C.R. Younger Foundation","keywords":"Medicine; Population; Merkel cell carcinoma; Incidence (geometry); Systematic review; Cochrane Library; Epidemiology; Demography; MEDLINE; Relative survival; Checklist; Mortality rate; Meta-analysis; Cancer registry; Internal medicine; Carcinoma; Environmental health; Biology","score_opus":0.08332795147480887,"score_gpt":0.3870284469297087,"score_spread":0.30370049545489985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387900889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018864711,0.9959847,0.00018441553,0.0002540252,0.000098933786,0.0004501208,0.0009025015,0.000010832978,0.00022803334],"genre_scores_gemma":[0.031187125,0.9653055,0.0009498249,0.0005535625,0.00008943379,0.0012346331,0.00056794396,0.000009018196,0.00010299285],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.982703,0.0050986544,0.007954759,0.001258894,0.0025667662,0.00041790286],"domain_scores_gemma":[0.95100415,0.032496214,0.010596506,0.0007393607,0.00477632,0.00038739617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013315021,0.0017711046,0.00969011,0.015454814,0.00073241437,0.0028069469,0.0020328572,0.0017610289,0.0037057912],"category_scores_gemma":[0.067578144,0.0013292371,0.011732636,0.016069056,0.0009883859,0.0025534714,0.0019616429,0.0014795694,0.00025421867],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001473917,0.000008306394,0.0014258369,0.9695887,0.015670102,0.00008546288,0.00019834685,0.00007874869,0.0000791947,0.00010463594,0.0007984739,0.0118147945],"study_design_scores_gemma":[0.00024583447,0.00017365407,0.008263733,0.83169395,0.14910604,0.00043460223,0.0003476624,0.00007895817,0.00013738792,0.00026666484,0.009209243,0.000042344072],"about_ca_topic_score_codex":0.009339336,"about_ca_topic_score_gemma":0.026508128,"teacher_disagreement_score":0.015454814,"about_ca_system_score_codex":0.004330468,"about_ca_system_score_gemma":0.01318663,"threshold_uncertainty_score":0.070417404},"labels":[],"label_agreement":null},{"id":"W4388486845","doi":"10.1093/bjd/ljad439","title":"Digital biobanks are underutilized in dermatology and create opportunities to reduce the burden of skin disease","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"U.S. National Library of Medicine; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute; Data Science Institute, Columbia University","keywords":"Biobank; Repurposing; Disease; Medicine; Psychological intervention; Pharmacogenomics; Drug repositioning; Data science; Bioinformatics; Drug; Computer science; Biology; Pathology; Pharmacology","score_opus":0.03254179545910678,"score_gpt":0.2741890844147064,"score_spread":0.24164728895559962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388486845","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.066381864,0.113981806,0.12255262,0.3232206,0.013790796,0.0034454095,0.08336944,0.0089790365,0.26427838],"genre_scores_gemma":[0.32063428,0.14194834,0.22540964,0.10272223,0.019280106,0.0054776995,0.102428176,0.0035121308,0.07858748],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97272724,0.012788025,0.0032203358,0.0033941297,0.0069822045,0.0008879874],"domain_scores_gemma":[0.7856962,0.105062775,0.032741945,0.040113073,0.023092827,0.013293211],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03556065,0.0006135315,0.0012607174,0.006505897,0.0021843286,0.010541577,0.0039270516,0.0031574052,0.059529502],"category_scores_gemma":[0.11781313,0.0007392876,0.00095134164,0.011436546,0.0034150064,0.013163852,0.0076739425,0.0038687824,0.018988954],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073083054,0.000254649,0.016533371,0.003039777,0.00029356356,0.0005229171,0.0013242962,0.0006701287,0.0018324608,0.061300278,0.34412178,0.56937593],"study_design_scores_gemma":[0.00016036996,0.00012371788,0.015623889,0.0037183748,0.00010363431,0.0011556431,0.0018100105,0.00063058705,0.00083924906,0.03922676,0.9365172,0.00009062943],"about_ca_topic_score_codex":0.0026820197,"about_ca_topic_score_gemma":0.0025376051,"teacher_disagreement_score":0.96443933,"about_ca_system_score_codex":0.002870443,"about_ca_system_score_gemma":0.006665874,"threshold_uncertainty_score":0.19914603},"labels":[],"label_agreement":null},{"id":"W4388586208","doi":"10.1093/bjd/ljad429","title":"Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3 years of treatment in randomized phase III trials","year":2023,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"UCB Pharma; LEO Pharma; Sun Pharma; Eisai; National Institute for Health and Care Research; Manchester Biomedical Research Centre; Eli Lilly and Company; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Discontinuation; Adverse effect; Psoriasis; Incidence (geometry); Internal medicine; Plaque psoriasis; Gastroenterology; Dermatology","score_opus":0.06127394202515896,"score_gpt":0.32844693045013756,"score_spread":0.2671729884249786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388586208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4197998,0.55138075,0.007983609,0.0013275633,0.0009782118,0.0043444894,0.008745163,0.00040634882,0.0050341426],"genre_scores_gemma":[0.93339413,0.050637487,0.0033599492,0.0017118019,0.0007709498,0.003524746,0.005953591,0.00010841291,0.00053891825],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9706509,0.0190556,0.0046193074,0.002499156,0.002452498,0.0007225226],"domain_scores_gemma":[0.95759654,0.02174514,0.014511361,0.003368241,0.0017785406,0.0010002253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.047375813,0.0014625987,0.0071890997,0.0014898549,0.00049158407,0.002693968,0.0010175621,0.0022068743,0.0024627035],"category_scores_gemma":[0.039031316,0.0009880451,0.020011114,0.00278389,0.00091375876,0.0017963492,0.0011715166,0.0021099045,0.0003426333],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47494915,0.00078874046,0.053627603,0.025178205,0.3557152,0.00016793214,0.00021405805,0.0029323674,0.0025936533,0.00025853864,0.0040759984,0.07949858],"study_design_scores_gemma":[0.3076724,0.05209342,0.22992578,0.005699187,0.385546,0.0009126524,0.00016558064,0.0022382122,0.001575748,0.002035602,0.011904603,0.00023080573],"about_ca_topic_score_codex":0.00049950817,"about_ca_topic_score_gemma":0.0010720325,"teacher_disagreement_score":0.047375813,"about_ca_system_score_codex":0.0008232759,"about_ca_system_score_gemma":0.0017803159,"threshold_uncertainty_score":0.25055027},"labels":[],"label_agreement":null},{"id":"W4389471935","doi":"10.1093/bjd/ljad487","title":"Further refinement of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure using classical test theory and item response theory","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Jikei University School of Medicine; Clalit Health Services; University of Leeds; Cardiff University; Yale University","keywords":"Rasch model; Patient-reported outcome; Item response theory; Classical test theory; Cronbach's alpha; Exploratory factor analysis; Confirmatory factor analysis; Differential item functioning; Clinical psychology; Psychometrics; Reliability (semiconductor); Medicine; Structural equation modeling; Psychology; Quality of life (healthcare); Statistics; Developmental psychology","score_opus":0.01913950425351802,"score_gpt":0.25884221246329886,"score_spread":0.23970270820978085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389471935","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.743602,0.0012803037,0.22279418,0.0033137512,0.0005111802,0.008716175,0.0040471074,0.00052649574,0.015208812],"genre_scores_gemma":[0.83651114,0.00042017773,0.15178284,0.0005656881,0.0001032759,0.007899952,0.001842036,0.00004848414,0.0008263945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98179364,0.012718801,0.001852655,0.0008933855,0.002460223,0.00028131175],"domain_scores_gemma":[0.9288236,0.050815742,0.0045781275,0.005563146,0.009503513,0.000715934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031673506,0.00063595327,0.0007658106,0.002248257,0.00037937282,0.0013327409,0.0011857457,0.0006047823,0.004349922],"category_scores_gemma":[0.06022905,0.00025366666,0.0022870917,0.0023619977,0.00068236014,0.0019377512,0.0015011644,0.0019149364,0.0004984919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042674397,0.0018187359,0.6230101,0.0017736421,0.000980078,0.0001128715,0.0023528098,0.0044723875,0.0016628063,0.008452782,0.0053797085,0.34955743],"study_design_scores_gemma":[0.00050286757,0.0036392272,0.91230017,0.0009037526,0.0005434674,0.00055608276,0.0016448649,0.045284107,0.0025262174,0.01432666,0.017659545,0.00011295901],"about_ca_topic_score_codex":0.00091079605,"about_ca_topic_score_gemma":0.0015560716,"teacher_disagreement_score":0.031673506,"about_ca_system_score_codex":0.0010945377,"about_ca_system_score_gemma":0.001790219,"threshold_uncertainty_score":0.16750753},"labels":[],"label_agreement":null},{"id":"W4389975898","doi":"10.1093/bjd/ljad387","title":"Top 10 research priorities for cutaneous squamous cell carcinoma: results of the Skin Investigation Network of Canada Priority Setting Initiative","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Alliance; Medicine; Basal cell; Family medicine; Political science; Pathology","score_opus":0.0337852476999843,"score_gpt":0.2944195852117961,"score_spread":0.2606343375118118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389975898","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29354948,0.08944355,0.003167055,0.45262414,0.0022245266,0.004458087,0.06011954,0.00029246567,0.09412111],"genre_scores_gemma":[0.89313453,0.041730966,0.018810382,0.020686794,0.000465646,0.001780201,0.018745618,0.000092802926,0.004553059],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.94530904,0.017126175,0.0041560223,0.0011840586,0.023106178,0.009118593],"domain_scores_gemma":[0.8261704,0.029247308,0.0074929674,0.0018217621,0.096789144,0.038478397],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06694906,0.0006921211,0.0016010809,0.0046912823,0.006735885,0.011209868,0.0028067906,0.0016193327,0.0037743447],"category_scores_gemma":[0.08404523,0.000641961,0.0018310159,0.008953567,0.0013376698,0.0021431146,0.0066354307,0.0038638662,0.00039893578],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002812683,0.0006278617,0.39730367,0.01730267,0.0017031272,0.00060308643,0.013115064,0.002557627,0.00096600177,0.015340496,0.28774512,0.2599226],"study_design_scores_gemma":[0.0010176281,0.00077787985,0.73405826,0.012558152,0.0022958533,0.00026397317,0.05624156,0.0025306076,0.001623105,0.009876918,0.17813241,0.0006237123],"about_ca_topic_score_codex":0.936282,"about_ca_topic_score_gemma":0.96903014,"teacher_disagreement_score":0.93305093,"about_ca_system_score_codex":0.10467017,"about_ca_system_score_gemma":0.45474878,"threshold_uncertainty_score":0.75943875},"labels":[],"label_agreement":null},{"id":"W4390015928","doi":"10.1093/bjd/ljad504","title":"Infectious disease among adults with allergic contact dermatitis: a propensity score-matched case–control study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Impetigo; Atopic dermatitis; Cohort; Scabies; Dermatology; Immunology; Contact dermatitis; Disease; Staphylococcal Skin Infections; Allergic contact dermatitis; Allergy; Skin infection; Internal medicine; Staphylococcus aureus; Biology","score_opus":0.012275583859629046,"score_gpt":0.2351843151550525,"score_spread":0.22290873129542346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390015928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968732,0.0009882413,0.0007631244,0.000054235134,0.00002952495,0.000114446935,0.0005322376,0.0000113762735,0.00063373684],"genre_scores_gemma":[0.9987613,0.00024088571,0.00023314424,0.000058284837,0.000029283514,0.000046921476,0.00046328784,0.0000037209716,0.00016319766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876994,0.00026267092,0.0001822994,0.00046641103,0.0001913709,0.00012728201],"domain_scores_gemma":[0.998602,0.00020457838,0.0004578785,0.00042094258,0.00016627807,0.00014840944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013008348,0.00038096635,0.0006056767,0.0008694639,0.0007772271,0.0009253686,0.0004209657,0.00075468,0.0022356852],"category_scores_gemma":[0.0029358002,0.00060176454,0.00079351733,0.0019867064,0.00040089246,0.0005696556,0.0004919539,0.00053637073,0.0004141264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012198909,0.00026545,0.99423003,0.000048445836,0.0005809981,0.000329198,0.00011469114,0.000082156155,0.0006727841,0.00013529921,0.00033635742,0.001984643],"study_design_scores_gemma":[0.00028813744,0.0007031487,0.99554586,0.000021525299,0.00042222333,0.0009349472,0.00016272937,0.0006347775,0.00009378598,0.00013020918,0.0010495798,0.000013059763],"about_ca_topic_score_codex":0.0040167873,"about_ca_topic_score_gemma":0.0031404914,"teacher_disagreement_score":0.0040167873,"about_ca_system_score_codex":0.00032263636,"about_ca_system_score_gemma":0.00035214474,"threshold_uncertainty_score":0.007986784},"labels":[],"label_agreement":null},{"id":"W4390062445","doi":"10.1093/bjd/ljad497","title":"How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users’ guide","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eli Lilly Japan; Mitsubishi Tanabe Pharma Corporation; Genentech; National Jewish Health; Torii Pharmaceutical; University of Oxford; Taiho Pharmaceutical; Kyowa Kirin Pharmaceutical Development; Boehringer Ingelheim Japan; LEO Pharma; Castle Biosciences; Sun Pharma; Dermira; Pfizer; Incyte; Regeneron Pharmaceuticals; Amgen; Celgene; Valeant Pharmaceuticals International; Sanofi; Galderma; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Outcome (game theory); Clinical trial; Atopic dermatitis; Medicine; Set (abstract data type); Alternative medicine; Sample (material); MEDLINE; Sample size determination; Family medicine; Medical physics; Core (optical fiber); Medical education; Computer science; Dermatology; Statistics; Pathology","score_opus":0.26502457919956474,"score_gpt":0.4130602091502216,"score_spread":0.1480356299506569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390062445","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023453755,0.026376342,0.54839003,0.05864686,0.009759513,0.112692006,0.14658809,0.041498683,0.053703092],"genre_scores_gemma":[0.0038766428,0.008756293,0.847257,0.011769583,0.0015865166,0.093135044,0.014175546,0.0066188634,0.012824451],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.85981137,0.09066148,0.034136295,0.0028874625,0.011522082,0.0009813361],"domain_scores_gemma":[0.5948544,0.3045746,0.01608506,0.024225466,0.056149658,0.004110772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15000898,0.0043574516,0.006948973,0.013210136,0.0011948154,0.008625524,0.0061665545,0.0073047,0.09271608],"category_scores_gemma":[0.36796415,0.0051879236,0.010762598,0.012881253,0.0024370225,0.0071344655,0.004673007,0.010432634,0.05685788],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008241889,0.0001671429,0.0011009467,0.017502058,0.000708127,0.00025237343,0.00087153364,0.001576764,0.0007977168,0.0067229248,0.76352674,0.2059495],"study_design_scores_gemma":[0.0024868816,0.00036171474,0.0035733178,0.016600529,0.0006966352,0.00046877537,0.00046613606,0.004438494,0.0012814004,0.03288406,0.93630713,0.00043504068],"about_ca_topic_score_codex":0.0046776338,"about_ca_topic_score_gemma":0.008810418,"teacher_disagreement_score":0.15000898,"about_ca_system_score_codex":0.0026379896,"about_ca_system_score_gemma":0.013298624,"threshold_uncertainty_score":0.79333276},"labels":[],"label_agreement":null},{"id":"W4390114814","doi":"10.1093/bjd/ljad527","title":"Skin photoageing following sun exposure is associated with decreased epigenetic and biologic age, and correlates with basal cell carcinoma phenotype","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; University of Toronto; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Cancer Research Society; Canadian Dermatology Foundation","keywords":"Epigenetics; Skin cancer; DNA methylation; Basal cell carcinoma; Basal (medicine); Biology; Phenotype; Sun exposure; Ageing; Pathology; Cancer; Basal cell; Medicine; Genetics; Dermatology; Endocrinology; Gene","score_opus":0.007521355220395408,"score_gpt":0.21194446863509983,"score_spread":0.20442311341470443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390114814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973894,0.0006140733,0.0010569827,0.000018240584,0.0000085183865,0.000010783202,0.00037020905,0.00002020503,0.0005116723],"genre_scores_gemma":[0.9988558,0.00017069648,0.00032665898,0.000010701567,0.0000049563287,0.000004152906,0.00020564436,0.000005043342,0.00041622994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987197,0.000021252188,0.000009009305,0.00005463182,0.000031109932,0.000011936345],"domain_scores_gemma":[0.9995198,0.00006616017,0.00022718836,0.000055906934,0.00007930337,0.000051502604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021597226,0.00016697042,0.00019449818,0.00037086997,0.00015523632,0.00039753396,0.00011374235,0.00017677345,0.001553693],"category_scores_gemma":[0.00076575956,0.00008199803,0.00017390691,0.00034145208,0.0001301102,0.000164983,0.00020804114,0.00024435998,0.00024435113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077615975,0.000046971843,0.90075374,0.0000803056,0.00014567436,0.00022834957,0.00026301254,0.00017151577,0.07978094,0.00005950507,0.00013643323,0.017557396],"study_design_scores_gemma":[0.0000013866982,0.00009660111,0.99595743,0.0000031326201,0.000027005657,0.00041603486,0.00006629667,0.00010237898,0.0030222503,0.00003768705,0.00026678218,0.0000030097508],"about_ca_topic_score_codex":0.0008971299,"about_ca_topic_score_gemma":0.0012441048,"teacher_disagreement_score":0.001553693,"about_ca_system_score_codex":0.000108790635,"about_ca_system_score_gemma":0.00007149642,"threshold_uncertainty_score":0.0051975846},"labels":[],"label_agreement":null},{"id":"W4390521397","doi":"10.1093/bjd/ljad483.039","title":"P31 Association of atopic dermatitis with thyroid diseases: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atopic dermatitis; Odds ratio; Meta-analysis; Confidence interval; Internal medicine; Thyroid disease; Thyroid; Subgroup analysis; Graves' disease; Disease; Dermatology","score_opus":0.02266863664459263,"score_gpt":0.3119836416970684,"score_spread":0.28931500505247576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390521397","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028575715,0.99522096,0.00036593102,0.00024883758,0.00013260484,0.00022553312,0.00068527774,0.000017044937,0.0002462758],"genre_scores_gemma":[0.12851232,0.8654307,0.001826162,0.0010979215,0.00038662006,0.0012301393,0.0010413318,0.000023229833,0.00045152105],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9923103,0.0032292984,0.0022565871,0.0008478249,0.0010425621,0.00031358993],"domain_scores_gemma":[0.9819463,0.013680451,0.0025896742,0.00032454246,0.0012610675,0.00019804138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008848647,0.0023611058,0.015163927,0.0066640372,0.0006759227,0.0033745624,0.0020408363,0.0024076356,0.0072425217],"category_scores_gemma":[0.02416512,0.0012077021,0.030252123,0.00805592,0.0007438808,0.0017411379,0.0013324947,0.0018888911,0.0004324911],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011037213,0.000027564507,0.0053841947,0.63072157,0.34794086,0.00020064482,0.000084079395,0.00041949668,0.00018595108,0.00015694725,0.0010300949,0.012744837],"study_design_scores_gemma":[0.00052187353,0.00018075657,0.005851377,0.0581869,0.93133503,0.00020587312,0.00005687123,0.00023960725,0.00010847157,0.00029520353,0.002990082,0.000027971797],"about_ca_topic_score_codex":0.006815716,"about_ca_topic_score_gemma":0.013448612,"teacher_disagreement_score":0.015163927,"about_ca_system_score_codex":0.0023917218,"about_ca_system_score_gemma":0.0040982435,"threshold_uncertainty_score":0.04679668},"labels":[],"label_agreement":null},{"id":"W4390595023","doi":"10.1093/bjd/ljae006","title":"Neonatal epidermolysis bullosa: a clinical practice guideline","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Debra International; Dystrophic Epidermolysis Bullosa Research Association","keywords":"Medicine; Psychosocial; Guideline; Epidermolysis bullosa; Multidisciplinary approach; Nursing; Clinical Practice; Intervention (counseling); Presentation (obstetrics); Family medicine; Pathology; Psychiatry; Surgery","score_opus":0.04017778618231954,"score_gpt":0.41401753382030504,"score_spread":0.3738397476379855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390595023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001112916,0.88509554,0.007085789,0.07502445,0.007646739,0.003232101,0.0027260035,0.00029299388,0.017783385],"genre_scores_gemma":[0.0068667475,0.91610056,0.040839367,0.020154042,0.0012888412,0.0028383906,0.0053263386,0.000052615498,0.006533038],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956846,0.0012523107,0.0013654276,0.00029696943,0.0012216781,0.00017897434],"domain_scores_gemma":[0.9909271,0.0025489917,0.0012472068,0.0001846383,0.0045591006,0.00053300196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065604476,0.0015204201,0.0031766891,0.0067129727,0.0010006102,0.0021938444,0.0047965553,0.005617045,0.0046424693],"category_scores_gemma":[0.015587693,0.0008739362,0.0027958665,0.0071596797,0.00082629424,0.0022243117,0.0018831734,0.0041623884,0.0031583451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006251438,0.00014011873,0.00066511665,0.06347863,0.0002891686,0.0008110128,0.00044101317,0.00095542974,0.0006432683,0.003935484,0.42680064,0.50177765],"study_design_scores_gemma":[0.0001788755,0.00009082441,0.0029261734,0.2212021,0.00076835585,0.0017384131,0.00037674513,0.00057102717,0.00027494712,0.005235876,0.76655775,0.00007878675],"about_ca_topic_score_codex":0.014753462,"about_ca_topic_score_gemma":0.026939316,"teacher_disagreement_score":0.014753462,"about_ca_system_score_codex":0.004018352,"about_ca_system_score_gemma":0.01675987,"threshold_uncertainty_score":0.034695387},"labels":[],"label_agreement":null},{"id":"W4390652292","doi":"10.1093/bjd/ljad391","title":"Top 10 research priorities for basal cell carcinoma: results of the Skin Investigation Network of Canada Priority Setting Initiative","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Toronto; BC Children's Hospital; University of British Columbia; SKiN Health; Women's College Hospital; McGill University; Canadian Arthritis Patient Alliance; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Alliance; Basal cell carcinoma; Medicine; Basal cell; Family medicine; Political science; Pathology","score_opus":0.04074082435344616,"score_gpt":0.3031091863920118,"score_spread":0.2623683620385656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390652292","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27278495,0.08214493,0.0031374658,0.47152653,0.0024073033,0.004099479,0.058549415,0.00027663005,0.105073385],"genre_scores_gemma":[0.8922635,0.039204158,0.017644243,0.02354175,0.0004825301,0.0017453756,0.0194965,0.00010645935,0.005515538],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9415316,0.016818557,0.004092138,0.0012503498,0.026890477,0.009416769],"domain_scores_gemma":[0.8083054,0.030905709,0.007960993,0.0021723728,0.108835384,0.041820165],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06560732,0.0006360751,0.0015211087,0.004402221,0.007268184,0.011385236,0.002851966,0.0015980973,0.003928596],"category_scores_gemma":[0.08698149,0.0006209565,0.0017339579,0.008856207,0.0013902652,0.0021772576,0.0062681437,0.0042392537,0.00040093847],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002684177,0.00057227304,0.37540343,0.013669087,0.0013510733,0.0005554458,0.013818708,0.002109251,0.00083947263,0.01576312,0.31790787,0.2553261],"study_design_scores_gemma":[0.00081983506,0.0006310592,0.7194964,0.010382631,0.0017924263,0.00022616638,0.05313768,0.0019995293,0.0013412592,0.008542079,0.20107874,0.00055218884],"about_ca_topic_score_codex":0.94994587,"about_ca_topic_score_gemma":0.97454154,"teacher_disagreement_score":0.9343927,"about_ca_system_score_codex":0.11379131,"about_ca_system_score_gemma":0.45940003,"threshold_uncertainty_score":0.8256176},"labels":[],"label_agreement":null},{"id":"W4391134082","doi":"10.1093/bjd/ljae019","title":"Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Dystrophic Epidermolysis Bullosa Research Association of America","keywords":"Medicine; Patient-reported outcome; Epidermolysis bullosa; Varimax rotation; Convergent validity; Cronbach's alpha; Psychometrics; Physical therapy; Clinical psychology; Internal consistency; Quality of life (healthcare); Dermatology; Nursing","score_opus":0.13684400318416517,"score_gpt":0.37962887471434187,"score_spread":0.2427848715301767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391134082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969115,0.001329032,0.010145603,0.0011046918,0.00016337047,0.0030115403,0.0052657085,0.00011955608,0.009745468],"genre_scores_gemma":[0.97645205,0.0004632393,0.013998123,0.0002756933,0.000054643027,0.0046937773,0.0034456945,0.000034645454,0.0005821801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98768604,0.006462868,0.0014899864,0.0005628772,0.0034842736,0.0003138398],"domain_scores_gemma":[0.9708592,0.014154971,0.0067092245,0.0013254001,0.0055551715,0.0013961097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01820218,0.00046223705,0.0008774244,0.0018127046,0.0004071126,0.00089557684,0.0007263148,0.00080775877,0.0023278885],"category_scores_gemma":[0.03377766,0.00022750667,0.0013729301,0.002298115,0.0005640419,0.0008116571,0.0016176577,0.0010783282,0.0005032514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013085,0.0009811944,0.8820315,0.00058781315,0.0007069961,0.00007330101,0.0010045107,0.0014997529,0.0013550055,0.0006469933,0.004087702,0.10571683],"study_design_scores_gemma":[0.00022088987,0.0017294348,0.98995847,0.00021299794,0.00014472089,0.0002694907,0.00052825495,0.0027308366,0.00042296766,0.0005478957,0.0031990884,0.000035030705],"about_ca_topic_score_codex":0.00054645375,"about_ca_topic_score_gemma":0.0006247164,"teacher_disagreement_score":0.01820218,"about_ca_system_score_codex":0.0005095665,"about_ca_system_score_gemma":0.0014211654,"threshold_uncertainty_score":0.09626353},"labels":[],"label_agreement":null},{"id":"W4391462927","doi":"10.1093/bjd/ljae037","title":"Towards a patient-centred definition for atopic dermatitis flare: a qualitative study of adults with atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; Women's College Hospital; Public Health Ontario; University of Toronto","funders":"Pfizer; National Eczema Association","keywords":"Flare; Atopic dermatitis; Perspective (graphical); Medicine; Focus group; Qualitative research; Psychology; Dermatology; Computer science; Physics","score_opus":0.02076233669328348,"score_gpt":0.2885976772240937,"score_spread":0.2678353405308102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391462927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979443,0.0013590853,0.004334349,0.008219793,0.00020694465,0.0009605399,0.0003242088,0.000044773533,0.0051074107],"genre_scores_gemma":[0.9882045,0.0011644259,0.0029418422,0.0034652634,0.00004595445,0.0011835126,0.0001254642,0.00005802404,0.0028110542],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9788673,0.016619118,0.00066811376,0.0010699212,0.0008970138,0.0018784662],"domain_scores_gemma":[0.96638083,0.0245404,0.0017542478,0.0007805793,0.0027400532,0.0038038353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024596745,0.0008579162,0.0014237392,0.0016922865,0.010994552,0.005138136,0.0026856994,0.0030533543,0.005093223],"category_scores_gemma":[0.030826438,0.0011692953,0.0007354856,0.0014621315,0.012387412,0.0073588453,0.008298114,0.0068937335,0.0007418367],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017233824,0.000036196638,0.0006477849,0.00011112112,0.000001962597,0.00026075428,0.996741,0.0000113007745,0.00022203005,0.00037394912,0.0003347894,0.0012419466],"study_design_scores_gemma":[0.0000056287768,0.000048728227,0.00041216143,0.00015069934,0.000002387674,0.000119986886,0.99501675,0.00003902469,0.0000742637,0.00021985192,0.0039008947,0.000009521786],"about_ca_topic_score_codex":0.009213747,"about_ca_topic_score_gemma":0.016779691,"teacher_disagreement_score":0.024596745,"about_ca_system_score_codex":0.007090904,"about_ca_system_score_gemma":0.008346644,"threshold_uncertainty_score":0.1300816},"labels":[],"label_agreement":null},{"id":"W4391463518","doi":"10.1093/bjd/ljae042","title":"Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Ustekinumab; Adalimumab; Secukinumab; Hidradenitis suppurativa; Infliximab; Dermatology; Cohort; Danish; Internal medicine; Cohort study; Psoriasis; Psoriatic arthritis; Disease","score_opus":0.010357359291368582,"score_gpt":0.28216271813481447,"score_spread":0.27180535884344587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391463518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878234,0.00037522096,0.000046314763,0.000012618103,0.000004828908,0.0000044170956,0.0005998871,9.931298e-7,0.00017339711],"genre_scores_gemma":[0.99843854,0.00020231328,0.000044473534,0.00001582313,0.00000506451,0.0000073224573,0.0010678541,0.0000016769096,0.00021702418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927706,0.00015888769,0.00010248293,0.00020456115,0.00009935506,0.00015771271],"domain_scores_gemma":[0.9986106,0.00020998521,0.0005678546,0.00023244087,0.00014129748,0.0002377403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092230627,0.00021172661,0.00045773594,0.00047523962,0.0005239667,0.00079264864,0.0003453765,0.0004912365,0.0010647273],"category_scores_gemma":[0.0016374008,0.00045722612,0.0008095256,0.000846982,0.0002583668,0.00053522695,0.0005350138,0.00059143605,0.00026558051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012559012,0.00009419087,0.99533147,0.000022754206,0.00031331572,0.00018853229,0.00016376204,0.00008746902,0.00060102396,0.000029534187,0.0001576307,0.0017543811],"study_design_scores_gemma":[0.00004360392,0.00022705439,0.9981534,0.00001042269,0.00016885679,0.00035552814,0.00016705306,0.00015481403,0.0001202254,0.000014043934,0.0005745758,0.000010429431],"about_ca_topic_score_codex":0.0108074015,"about_ca_topic_score_gemma":0.009433103,"teacher_disagreement_score":0.0108074015,"about_ca_system_score_codex":0.00050717423,"about_ca_system_score_gemma":0.00042632,"threshold_uncertainty_score":0.021488965},"labels":[],"label_agreement":null},{"id":"W4391609148","doi":"10.1093/bjd/ljad498.030","title":"525 - Real-world effectiveness of upadacitinib in moderate-to-severe atopic dermatitis (AD): Results from cross-sectional analyses of the CorEvitas AD Registry","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Cross-sectional study; Pathology","score_opus":0.0290146320203819,"score_gpt":0.34344441457034375,"score_spread":0.31442978254996184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98912394,0.00047765282,0.00023548336,0.00008539377,0.000020274056,0.00010239828,0.009136025,0.0000122204965,0.0008066524],"genre_scores_gemma":[0.9917292,0.00012768077,0.00024374868,0.00007921493,0.00002857457,0.00017687594,0.007460015,0.000007187782,0.00014736892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930507,0.0030968646,0.0010658476,0.0014418015,0.0009645683,0.00038023505],"domain_scores_gemma":[0.9769856,0.004669365,0.013396558,0.0017224979,0.0021970929,0.0010288295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006297053,0.0003383513,0.00055407576,0.0013846456,0.00046772492,0.0012448379,0.00074075017,0.0005059376,0.0017999395],"category_scores_gemma":[0.01472438,0.00029251177,0.0013238683,0.0022029746,0.00034073685,0.0009587493,0.0010188178,0.0006576706,0.00043286887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034267924,0.00007741438,0.99786913,0.000030830393,0.00028906311,0.000016222928,0.000037912996,0.000060515842,0.00002407953,0.000018239718,0.00041293693,0.00082094636],"study_design_scores_gemma":[0.00006938082,0.0002688481,0.9982145,0.000026139698,0.00022034885,0.00014373203,0.00016145037,0.00033502158,0.000063898995,0.000022473288,0.00046483008,0.00000943809],"about_ca_topic_score_codex":0.0059406636,"about_ca_topic_score_gemma":0.0072467504,"teacher_disagreement_score":0.006297053,"about_ca_system_score_codex":0.00071017543,"about_ca_system_score_gemma":0.00072317885,"threshold_uncertainty_score":0.033302367},"labels":[],"label_agreement":null},{"id":"W4391609152","doi":"10.1093/bjd/ljad498.017","title":"509 - Dupilumab improves disease severity in children less than 12 years of age with moderate-severe AD: interim results from PEDISTAD real-world registry","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital; Université de Montréal; University of Calgary","funders":"","keywords":"Dupilumab; Interim; Medicine; Disease; Pediatrics; Internal medicine; Dermatology; Geography; Atopic dermatitis","score_opus":0.0060213165000120635,"score_gpt":0.22587338896184234,"score_spread":0.21985207246183028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9653513,0.0052361544,0.0007887661,0.00049466756,0.00008906522,0.0008102103,0.0226108,0.00015356926,0.0044655455],"genre_scores_gemma":[0.96449715,0.0027116856,0.0026760888,0.0006755371,0.00012309567,0.0011605802,0.026155226,0.000042950003,0.001957593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843496,0.0007589967,0.00015258354,0.00021916027,0.00024372504,0.0001905478],"domain_scores_gemma":[0.9969023,0.0006066545,0.001344608,0.00044007535,0.00036384608,0.00034251506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004072336,0.00060246926,0.0009067001,0.00029690104,0.00034922312,0.0011805919,0.000607618,0.0005507625,0.0031358523],"category_scores_gemma":[0.0030821913,0.00028361255,0.0019730276,0.00044937435,0.0003224485,0.00054396124,0.0004916623,0.0011129577,0.000786222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3112349,0.0112522775,0.4748302,0.0018999953,0.0068553034,0.00077020336,0.00038528367,0.003090735,0.011484815,0.00040254943,0.02379283,0.15400088],"study_design_scores_gemma":[0.070354626,0.14872085,0.74269736,0.00050465035,0.0060963174,0.0022939427,0.0002928672,0.0019456748,0.007803036,0.00025486175,0.018933428,0.000102307145],"about_ca_topic_score_codex":0.0019701368,"about_ca_topic_score_gemma":0.0038870068,"teacher_disagreement_score":0.004072336,"about_ca_system_score_codex":0.0006660342,"about_ca_system_score_gemma":0.0012316926,"threshold_uncertainty_score":0.021536827},"labels":[],"label_agreement":null},{"id":"W4391609172","doi":"10.1093/bjd/ljad498.046","title":"546 - Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Health and Medical Studies","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Atopic dermatitis; Dermatology; Medicine","score_opus":0.06984277296128534,"score_gpt":0.41046835691850186,"score_spread":0.34062558395721654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437535,0.000036934438,0.0011134853,0.00020709385,0.000038495615,0.0021113814,0.00036074262,0.000013995527,0.0017424878],"genre_scores_gemma":[0.9810657,0.0000809398,0.006178192,0.00045512838,0.000035220444,0.010634426,0.00023982974,0.0000047675144,0.0013058357],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99115187,0.0065066624,0.0006886383,0.0005157091,0.0006432443,0.0004939362],"domain_scores_gemma":[0.9527204,0.039588675,0.0034815357,0.0016949698,0.0008165739,0.0016977863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013818043,0.00074890384,0.0009455898,0.00037579847,0.0008685924,0.0017695348,0.000732131,0.001712834,0.014288956],"category_scores_gemma":[0.030274376,0.00052001886,0.0014636089,0.00036720498,0.0012921798,0.0011742992,0.0009273925,0.0022836656,0.0011682715],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22919121,0.34216848,0.19143434,0.003271864,0.0014189663,0.000809945,0.019268509,0.01850558,0.023685712,0.012595515,0.007961173,0.14968869],"study_design_scores_gemma":[0.09346621,0.4924826,0.22019766,0.0009787676,0.0014628335,0.0005081391,0.011354591,0.10667178,0.021421608,0.025404483,0.02527033,0.00078093086],"about_ca_topic_score_codex":0.00058715924,"about_ca_topic_score_gemma":0.00062153646,"teacher_disagreement_score":0.014288956,"about_ca_system_score_codex":0.0009590664,"about_ca_system_score_gemma":0.0013574687,"threshold_uncertainty_score":0.07307768},"labels":[],"label_agreement":null},{"id":"W4391609515","doi":"10.1093/bjd/ljad498.028","title":"523 - Efficacy and safety of amlitelimab (an anti-OX40 ligand antibody) in patients with moderate-to-severe atopic dermatitis: 24-week results from a phase 2b trial (STREAM-AD)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Internal medicine; Antibody; Gastroenterology; Pediatrics; Immunology","score_opus":0.011121274891763164,"score_gpt":0.2772268404591704,"score_spread":0.2661055655674072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914944,0.0029688147,0.0002752016,0.00036651737,0.0001227457,0.0019045478,0.0010259107,0.00007147569,0.0017704844],"genre_scores_gemma":[0.990202,0.0011860045,0.0011609806,0.00069978274,0.00027116982,0.0019178592,0.0015995159,0.000016447539,0.0029463386],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995216,0.00025021622,0.000033746284,0.00007461195,0.00004591635,0.00007399863],"domain_scores_gemma":[0.9994295,0.00011045301,0.00013357158,0.000044431876,0.00006248033,0.00021952591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017006974,0.00087220466,0.0015195402,0.0002577517,0.00029517204,0.0007411569,0.00047151023,0.0009609286,0.005122893],"category_scores_gemma":[0.0010068902,0.0002919167,0.0011756306,0.00018232297,0.00055186497,0.0006046454,0.0002438268,0.0017089302,0.0010319725],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8769125,0.026183037,0.005964437,0.0007427308,0.000878579,0.00011835296,0.000118624615,0.0004902697,0.020327762,0.00013098906,0.0041282917,0.06400434],"study_design_scores_gemma":[0.7561589,0.22230256,0.015209937,0.000047373524,0.00049136,0.00016656963,0.000027804503,0.00066287705,0.0023292007,0.00012781718,0.0024553225,0.000020344283],"about_ca_topic_score_codex":0.00044544894,"about_ca_topic_score_gemma":0.0012411884,"teacher_disagreement_score":0.005122893,"about_ca_system_score_codex":0.0006131802,"about_ca_system_score_gemma":0.00073093513,"threshold_uncertainty_score":0.017137825},"labels":[],"label_agreement":null},{"id":"W4391609609","doi":"10.1093/bjd/ljad498.009","title":"498 - Real-world use and effectiveness of upadacitinib in adults and adolescents with atopic dermatitis: preliminary analysis of the real-world multicountry AD-VISE study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Probity Medical Research; Ottawa Hospital; University of Ottawa; Lynde Centre for Dermatology; University of Toronto; Queen's University; McMaster University","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology","score_opus":0.008681572346317041,"score_gpt":0.2729348112004093,"score_spread":0.26425323885409224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875152,0.00047761053,0.00023986286,0.00008323644,0.000011203055,0.0005679891,0.010310619,0.000012302998,0.00078194414],"genre_scores_gemma":[0.9882045,0.00015605966,0.00064158195,0.0001413453,0.00003962504,0.0009913604,0.009510377,0.00000760327,0.00030762528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99370307,0.0034754397,0.00082957925,0.00068342267,0.00091909984,0.00038940916],"domain_scores_gemma":[0.98751915,0.0034680718,0.0059402343,0.0010306016,0.0013723464,0.0006694916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006477462,0.00053874607,0.00088663114,0.0012992604,0.00047599652,0.0010931044,0.0008140458,0.00065822864,0.0020934779],"category_scores_gemma":[0.01164127,0.000325582,0.0022992427,0.0016905683,0.00032849,0.0009785406,0.001019837,0.0006947906,0.0005347461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005954719,0.00081688026,0.9827641,0.00027326398,0.0016142539,0.00007305643,0.00020251267,0.00028526256,0.00016079689,0.000055691256,0.0012765185,0.006522903],"study_design_scores_gemma":[0.00069115264,0.002410805,0.9938491,0.000056393048,0.00059655675,0.00018766282,0.00023441573,0.0007418048,0.00012286109,0.000022487744,0.0010684241,0.000018256567],"about_ca_topic_score_codex":0.005626345,"about_ca_topic_score_gemma":0.008741289,"teacher_disagreement_score":0.006477462,"about_ca_system_score_codex":0.0010266649,"about_ca_system_score_gemma":0.0008439948,"threshold_uncertainty_score":0.034256518},"labels":[],"label_agreement":null},{"id":"W4391609642","doi":"10.1093/bjd/ljad498.044","title":"544 - Cost-per-responder analysis of tralokinumab versus dupilumab in patients with moderate-to-severe atopic dermatitis in the US and Canada","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Guenther Dermatology Research Centre","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Dermatology","score_opus":0.007080068110595989,"score_gpt":0.23802930912656284,"score_spread":0.23094924101596684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97767264,0.005805711,0.00063129445,0.00055332977,0.00004248879,0.0010445815,0.009616577,0.000026718188,0.0046064993],"genre_scores_gemma":[0.99500835,0.00065073604,0.0006307893,0.00011823814,0.000011039873,0.00015825091,0.0022619497,0.0000076674705,0.0011529563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975122,0.00096629176,0.00016670839,0.00023660123,0.00052358507,0.0005946187],"domain_scores_gemma":[0.9967794,0.0012690984,0.00059104513,0.00009642319,0.00083169126,0.00043246654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031439506,0.0008644681,0.0019405625,0.0018696329,0.0006909503,0.0017755353,0.0014861821,0.00062788517,0.004403676],"category_scores_gemma":[0.007516762,0.00047914372,0.0056144674,0.0027459252,0.00057072786,0.00039670808,0.00092263985,0.0013726687,0.00017525678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14234081,0.0023677102,0.496252,0.005825947,0.040284432,0.0012038101,0.00054563535,0.21192111,0.002018592,0.009553741,0.009001185,0.07868506],"study_design_scores_gemma":[0.017467322,0.012572663,0.6820052,0.0011445506,0.03020131,0.0009428888,0.0019693654,0.23851228,0.0017988338,0.0021487132,0.01086843,0.00036846157],"about_ca_topic_score_codex":0.8571926,"about_ca_topic_score_gemma":0.85203636,"teacher_disagreement_score":0.14280742,"about_ca_system_score_codex":0.043537132,"about_ca_system_score_gemma":0.021965135,"threshold_uncertainty_score":0.31588548},"labels":[],"label_agreement":null},{"id":"W4391609649","doi":"10.1093/bjd/ljad498.058","title":"562 - Dupilumab treatment provides long-term improvement in itch in pediatric patients with moderate-to-severe atopic dermatitis over 1 year","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Dupilumab; Atopic dermatitis; Dermatology; Medicine; Pediatrics","score_opus":0.006500198555793528,"score_gpt":0.24331996491118812,"score_spread":0.2368197663553946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689794,0.0017027266,0.000109176966,0.000057501667,0.00002449694,0.0000822245,0.00024166849,0.000030245847,0.0008540688],"genre_scores_gemma":[0.99832815,0.00047867306,0.0002672161,0.00009422908,0.000023555047,0.00006148661,0.00028561268,0.000004402918,0.00045658599],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997967,0.000053180887,0.000015043393,0.000048165402,0.000029405935,0.000057470344],"domain_scores_gemma":[0.9997662,0.00004246287,0.000069912094,0.000017348955,0.000019544088,0.000084545725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046929918,0.00027071495,0.0008389877,0.00012670647,0.00018683991,0.00035641907,0.0001790546,0.0002171426,0.0024045876],"category_scores_gemma":[0.00048938947,0.0001233527,0.0004639284,0.00012262979,0.00015906835,0.00032108006,0.00015004557,0.000608264,0.000367636],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23715584,0.017865429,0.108100854,0.0017751856,0.0012582329,0.0008914479,0.0004538041,0.0020717704,0.10544985,0.00028939144,0.00952958,0.51515865],"study_design_scores_gemma":[0.05213637,0.36295068,0.5439349,0.00024428035,0.001252424,0.0030843287,0.00040660717,0.0049957237,0.02012683,0.00017771045,0.010634082,0.00005612509],"about_ca_topic_score_codex":0.0006652673,"about_ca_topic_score_gemma":0.0023148498,"teacher_disagreement_score":0.0024045876,"about_ca_system_score_codex":0.00033281426,"about_ca_system_score_gemma":0.00034730707,"threshold_uncertainty_score":0.008044183},"labels":[],"label_agreement":null},{"id":"W4391609698","doi":"10.1093/bjd/ljad498.022","title":"515 - Rapid and early onset of itch relief with tapinarof cream 1% once daily in two pivotal phase 3 trials in adults and children down to two years of age with atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Pediatrics; Atopic dermatitis; Dermatology","score_opus":0.009066299799720973,"score_gpt":0.2946682499661268,"score_spread":0.2856019501664058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708731,0.012759797,0.0009645986,0.0008261168,0.0004356617,0.009255048,0.0020611463,0.000118699536,0.0027057945],"genre_scores_gemma":[0.9780462,0.0062788324,0.0026367747,0.0012367888,0.00034366403,0.00679289,0.0020138554,0.000026722484,0.0026242738],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990308,0.000489631,0.00009533272,0.00013531845,0.00008915603,0.00015973968],"domain_scores_gemma":[0.9988881,0.00031585508,0.00023887419,0.00007553265,0.00013510209,0.00034656102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030488612,0.0012540438,0.0022852784,0.0004330474,0.00045387485,0.0010805401,0.0006965804,0.0017078058,0.0052799336],"category_scores_gemma":[0.0018801391,0.00061425177,0.0021665248,0.00035455887,0.00074378046,0.00084981835,0.000323521,0.0021088147,0.00074106257],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8602795,0.029611355,0.0031434703,0.0032769912,0.0018347893,0.00030626982,0.0003480865,0.00052368944,0.037846457,0.00030583987,0.003922303,0.058601134],"study_design_scores_gemma":[0.73798114,0.25069374,0.005607115,0.00011650588,0.000576297,0.00018187525,0.000047832298,0.00023380388,0.0016392291,0.00010507927,0.0027925195,0.000024844097],"about_ca_topic_score_codex":0.0006287088,"about_ca_topic_score_gemma":0.0023947444,"teacher_disagreement_score":0.0052799336,"about_ca_system_score_codex":0.0005714788,"about_ca_system_score_gemma":0.001114055,"threshold_uncertainty_score":0.017663121},"labels":[],"label_agreement":null},{"id":"W4391609703","doi":"10.1093/bjd/ljad498.050","title":"551 - Continuous tralokinumab treatment over 4 years in adults with moderate-to-severe atopic dermatitis provides long-term disease control","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University; Dalhousie University","funders":"","keywords":"Atopic dermatitis; Medicine; Term (time); Dermatology; Pediatrics; Disease; Internal medicine","score_opus":0.005581683353862343,"score_gpt":0.24207949996426323,"score_spread":0.2364978166104009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385,0.0035003906,0.00027878524,0.000081669095,0.000050246974,0.0003216056,0.00055877696,0.000021682132,0.001336873],"genre_scores_gemma":[0.99811435,0.00039187953,0.00024906624,0.000109557535,0.000046961344,0.00018809832,0.00044577254,0.000002311626,0.00045186692],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9993042,0.00022693428,0.0000810953,0.0001557764,0.00008395424,0.00014797812],"domain_scores_gemma":[0.99954504,0.00009170598,0.00015050749,0.000048209884,0.000048519007,0.00011606395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015077407,0.00032752185,0.0012361223,0.00018945945,0.00037025614,0.0006181546,0.00025303572,0.00033602363,0.0030792535],"category_scores_gemma":[0.0008359135,0.0001523783,0.0017255825,0.00022129335,0.00020130107,0.00038080022,0.00024397888,0.0005662285,0.00040489604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59549767,0.0076200794,0.15200445,0.0018511575,0.006686027,0.00037363483,0.00023606826,0.0013660479,0.03213938,0.00018902055,0.0031783353,0.19885817],"study_design_scores_gemma":[0.057785552,0.25844893,0.6589818,0.00025061678,0.0075772745,0.0006990498,0.00020095668,0.0019343749,0.0061321217,0.00019062374,0.007745177,0.000053589443],"about_ca_topic_score_codex":0.00066623895,"about_ca_topic_score_gemma":0.0020504175,"teacher_disagreement_score":0.0030792535,"about_ca_system_score_codex":0.0003959823,"about_ca_system_score_gemma":0.0005539118,"threshold_uncertainty_score":0.010301173},"labels":[],"label_agreement":null},{"id":"W4391609714","doi":"10.1093/bjd/ljad498.012","title":"504 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research; Probity Medical Research; Queen's University","funders":"","keywords":"Tolerability; Medicine; Dermatology; Seborrheic dermatitis; Roflumilast; Atopic dermatitis; Psoriasis; Adverse effect; Internal medicine","score_opus":0.011133358368482414,"score_gpt":0.2689921600853896,"score_spread":0.2578588017169072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987568,0.0049473275,0.00044823054,0.00033705428,0.000110944624,0.0038123673,0.0009849451,0.00006138671,0.001729819],"genre_scores_gemma":[0.99295527,0.0010196028,0.00088769756,0.00041642404,0.00016545581,0.0032655774,0.00066780485,0.000009159922,0.0006130229],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99602795,0.0028088547,0.0003824232,0.0002563182,0.0002513934,0.00027312626],"domain_scores_gemma":[0.99655735,0.0013712212,0.0010353453,0.00018918041,0.0002716117,0.0005754178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073615005,0.0011688815,0.0022874868,0.0004626684,0.0005648211,0.0008501654,0.00057617447,0.0011640504,0.0045530396],"category_scores_gemma":[0.0047898726,0.0006090222,0.0030434376,0.00049598154,0.0006335226,0.0009923866,0.0003576088,0.0019911807,0.0006724932],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8546734,0.027732722,0.023224847,0.0018270913,0.004128063,0.00021880466,0.00036999834,0.0010404418,0.017742248,0.00011948437,0.002343039,0.06657988],"study_design_scores_gemma":[0.5630158,0.39397794,0.03681516,0.00007612852,0.0013549812,0.00022525998,0.00008075587,0.00074822636,0.0018555543,0.00009822624,0.0017177799,0.000034165438],"about_ca_topic_score_codex":0.0005171413,"about_ca_topic_score_gemma":0.0016004134,"teacher_disagreement_score":0.0073615005,"about_ca_system_score_codex":0.00068630907,"about_ca_system_score_gemma":0.0010501887,"threshold_uncertainty_score":0.038931787},"labels":[],"label_agreement":null},{"id":"W4391609744","doi":"10.1093/bjd/ljad498.054","title":"555 - Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Atopic dermatitis; Medicine; Clinical trial; Dermatology; Safety profile; Pediatrics; Adverse effect; Internal medicine","score_opus":0.034957255479298906,"score_gpt":0.3602132351540593,"score_spread":0.3252559796747604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609744","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3004908,0.16397274,0.012968502,0.0034075216,0.00042807325,0.004909476,0.5030246,0.00092269544,0.009875683],"genre_scores_gemma":[0.6051338,0.017620524,0.011872589,0.0020672649,0.00037873804,0.0051664547,0.35579652,0.0002591973,0.0017049626],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9680292,0.01274084,0.006745871,0.00574339,0.0059971334,0.0007436636],"domain_scores_gemma":[0.9363834,0.028635284,0.023815261,0.0051201936,0.0051321313,0.00091375684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03421306,0.0009825063,0.004345824,0.003469703,0.0004191192,0.0030295078,0.0016596137,0.0011206532,0.0045127096],"category_scores_gemma":[0.04832541,0.0006573707,0.009863864,0.0046696523,0.00037229006,0.0014855051,0.002058347,0.0014209043,0.00084315514],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05613644,0.0005246844,0.3922907,0.05072863,0.225273,0.00033543183,0.00032068632,0.010940609,0.0038538019,0.001516499,0.045860473,0.21221909],"study_design_scores_gemma":[0.014665662,0.005197666,0.6905492,0.0076154647,0.17047441,0.0015310517,0.0001446162,0.00838552,0.0018755493,0.0026729738,0.096632294,0.0002556293],"about_ca_topic_score_codex":0.0015848917,"about_ca_topic_score_gemma":0.0039010323,"teacher_disagreement_score":0.03421306,"about_ca_system_score_codex":0.001478975,"about_ca_system_score_gemma":0.0020774077,"threshold_uncertainty_score":0.18093807},"labels":[],"label_agreement":null},{"id":"W4391609834","doi":"10.1093/bjd/ljad498.035","title":"530 - Treatment efficacy in patients with moderate-to-severe atopic dermatitis who switched from dupilumab to abrocitinib in JADE EXTEND, a phase 3 long-term extension study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Dermatology; JADE (particle detector); Term (time)","score_opus":0.01331149872286157,"score_gpt":0.29755227670613027,"score_spread":0.2842407779832687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947233,0.0031593263,0.00007167366,0.00014220839,0.00007547353,0.0002937113,0.0005564032,0.00002388105,0.000954043],"genre_scores_gemma":[0.9961538,0.0008299186,0.00022538913,0.0006229292,0.00011157157,0.00041673958,0.00094898936,0.0000042454926,0.00068639545],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9994715,0.00019815877,0.0000485822,0.00010464874,0.0000698539,0.00010726097],"domain_scores_gemma":[0.99879104,0.0002328643,0.0003141392,0.00009822357,0.000117103475,0.0004466707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017975783,0.0006831979,0.0018839451,0.00023886557,0.00051007845,0.001158179,0.00047826648,0.0010708837,0.002096136],"category_scores_gemma":[0.0011664589,0.00029150897,0.0019897285,0.00023955893,0.00040342347,0.0008291696,0.00029976922,0.0019487529,0.00042296544],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.800125,0.028929617,0.066430084,0.0020580993,0.005204844,0.00062202255,0.0003168804,0.0009719181,0.02134997,0.0001739582,0.00402437,0.06979329],"study_design_scores_gemma":[0.441596,0.31610113,0.22482607,0.0002358454,0.005036405,0.0011463388,0.0002014701,0.0015214253,0.0031825048,0.00022708238,0.005827385,0.00009837183],"about_ca_topic_score_codex":0.00046184813,"about_ca_topic_score_gemma":0.0013133729,"teacher_disagreement_score":0.002096136,"about_ca_system_score_codex":0.0005241982,"about_ca_system_score_gemma":0.00050690933,"threshold_uncertainty_score":0.009506583},"labels":[],"label_agreement":null},{"id":"W4391609906","doi":"10.1093/bjd/ljad498.033","title":"528 - Rapid skin clearance and itch improvement with upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: results from a phase 3b head-to-head clinical trial (Heads Up)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; University of Calgary","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Clinical trial; Internal medicine","score_opus":0.028388796192635218,"score_gpt":0.34113680935194335,"score_spread":0.3127480131593081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98533094,0.007534111,0.0003197429,0.0005505049,0.00025434745,0.002107375,0.0015042414,0.00015454047,0.0022443174],"genre_scores_gemma":[0.99102837,0.0028186152,0.0006562693,0.0009735906,0.0002125853,0.0013611903,0.0013092156,0.00001625069,0.0016239885],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996846,0.00012860193,0.00002169363,0.00005386498,0.000033982913,0.0000772729],"domain_scores_gemma":[0.99959475,0.00008359088,0.00008449489,0.000027614682,0.00004715113,0.00016243414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011815379,0.00086109876,0.0019039996,0.00029203584,0.0003736743,0.0009006573,0.0005087437,0.0008839841,0.0062609334],"category_scores_gemma":[0.0007216168,0.00034415937,0.0019393786,0.00028343688,0.00052771607,0.00060655276,0.00025955786,0.002007778,0.0009161378],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86666167,0.019521764,0.0032326193,0.0022614805,0.0026974126,0.00014438608,0.00015286349,0.00074132707,0.012389368,0.00014599781,0.0049015083,0.08714963],"study_design_scores_gemma":[0.82454336,0.15933058,0.010465051,0.00010948181,0.0014233615,0.00019478604,0.00005684632,0.00061912497,0.0014562404,0.000144727,0.0016260098,0.00003048204],"about_ca_topic_score_codex":0.0009662115,"about_ca_topic_score_gemma":0.003157767,"teacher_disagreement_score":0.0062609334,"about_ca_system_score_codex":0.000534859,"about_ca_system_score_gemma":0.00082504994,"threshold_uncertainty_score":0.020944893},"labels":[],"label_agreement":null},{"id":"W4391609907","doi":"10.1093/bjd/ljad498.013","title":"505 - Once-daily roflumilast cream 0.15% for atopic dermatitis: pooled results from INTEGUMENT-1/2 phase 3 trials","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Roflumilast; Atopic dermatitis; Medicine; Dermatology; Integument; Internal medicine","score_opus":0.030491434103701774,"score_gpt":0.33832378134111074,"score_spread":0.307832347237409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609907","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38145378,0.5905184,0.0047372547,0.0012686233,0.001279487,0.006185446,0.005912695,0.00052961113,0.008114657],"genre_scores_gemma":[0.89795446,0.088394575,0.00275833,0.0018481219,0.00073823956,0.003123562,0.0031280827,0.00008412595,0.0019704774],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9971187,0.0016105267,0.00042600662,0.00039307165,0.0002776496,0.00017399993],"domain_scores_gemma":[0.997894,0.0009449842,0.0006777903,0.00012990709,0.0001936378,0.00015969216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070891115,0.0016245091,0.0048600757,0.0010222245,0.00027499738,0.0017811881,0.000689741,0.001161557,0.0043018176],"category_scores_gemma":[0.004559965,0.0006075314,0.008191923,0.001190254,0.00050171174,0.00094328844,0.000503374,0.0012678335,0.00058978976],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63536555,0.0018628457,0.0049476107,0.03822357,0.15504944,0.00019120451,0.00013916621,0.0014372794,0.011389726,0.00023967786,0.0060625435,0.14509138],"study_design_scores_gemma":[0.6951579,0.06309301,0.032355737,0.0036314148,0.19163145,0.00040971092,0.00011344314,0.0011218732,0.0026548647,0.00058512116,0.009128953,0.00011648409],"about_ca_topic_score_codex":0.0008767362,"about_ca_topic_score_gemma":0.003193606,"teacher_disagreement_score":0.0070891115,"about_ca_system_score_codex":0.00063730666,"about_ca_system_score_gemma":0.0009944855,"threshold_uncertainty_score":0.037491262},"labels":[],"label_agreement":null},{"id":"W4391609911","doi":"10.1093/bjd/ljad498.064","title":"569 - Impact of therapeutic inertia on patient-reported outcomes in moderate-to-severe atopic dermatitis: a 12-month longitudinal study from the TARGET-DERM AD registry","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atopic dermatitis; Medicine; Longitudinal study; Dermatology; Patient registry; Pediatrics; Physical therapy; Physical medicine and rehabilitation; Pathology","score_opus":0.022876064237182733,"score_gpt":0.30679196578588536,"score_spread":0.2839159015487026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979227,0.0002416022,0.00009151593,0.000058614398,0.0000067899896,0.000025649602,0.0012462403,0.0000039061156,0.00040299245],"genre_scores_gemma":[0.99841475,0.000062634244,0.00006715829,0.000036902784,0.000009501654,0.000024438703,0.0012808891,0.0000020222647,0.000101647274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976361,0.0008338275,0.00032945717,0.00045513455,0.0004553564,0.00029018012],"domain_scores_gemma":[0.98941326,0.0014394468,0.005836004,0.0008900379,0.0014660453,0.00095505983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042092735,0.000240633,0.0004406785,0.00075999746,0.00068889424,0.0009494147,0.0004460795,0.0004379623,0.0010364071],"category_scores_gemma":[0.008089524,0.00018815984,0.0009253007,0.0012978598,0.00027731672,0.0007068642,0.00077869685,0.0009154676,0.00025778534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002257052,0.0000642157,0.9984548,0.000008325753,0.00008021354,0.000021273658,0.0000620187,0.000029712062,0.00003636352,0.000008152293,0.00011645763,0.0008927886],"study_design_scores_gemma":[0.000018390576,0.00018107641,0.99918693,0.000008259296,0.000052361003,0.00006787556,0.00010843349,0.00015281033,0.00003375362,0.000011265254,0.00017382739,0.000005090152],"about_ca_topic_score_codex":0.015504733,"about_ca_topic_score_gemma":0.017280519,"teacher_disagreement_score":0.015504733,"about_ca_system_score_codex":0.00087235385,"about_ca_system_score_gemma":0.00090633554,"threshold_uncertainty_score":0.030828953},"labels":[],"label_agreement":null},{"id":"W4391609915","doi":"10.1093/bjd/ljad498.067","title":"519 - Efficacy of prolonged ruxolitinib cream treatment for vitiligo among patients with limited or no initial response at 6 months","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group; SKiN Health","funders":"","keywords":"Vitiligo; Ruxolitinib; Medicine; Dermatology; Internal medicine; Myelofibrosis; Bone marrow","score_opus":0.011547635017653334,"score_gpt":0.27608910092722333,"score_spread":0.26454146590957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98512846,0.011879828,0.00025908428,0.00014626274,0.000060045346,0.00016665479,0.00063127896,0.000030756615,0.0016976462],"genre_scores_gemma":[0.9978319,0.0008450529,0.00018442872,0.0001086458,0.00004866105,0.00007358321,0.00051634386,0.000002422511,0.0003889429],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99958605,0.0001397075,0.00005293937,0.00010042161,0.0000627174,0.00005819966],"domain_scores_gemma":[0.99951434,0.00014819879,0.00019030734,0.000032878477,0.000044155404,0.00007013399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010942568,0.00022261219,0.0009909029,0.00020492033,0.00015979973,0.00044537525,0.00019986914,0.00032820983,0.0025710955],"category_scores_gemma":[0.0010175975,0.00011425959,0.0011611731,0.00016822072,0.00010077539,0.00026953773,0.00014571994,0.00042644131,0.00033675288],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28854135,0.004177837,0.19165732,0.003025991,0.009062497,0.0004198955,0.00018217221,0.0020465665,0.044769756,0.00029622586,0.005772966,0.45004743],"study_design_scores_gemma":[0.040391825,0.11880501,0.811729,0.00047420777,0.0075244494,0.0011513203,0.00015928491,0.0041768346,0.0071933437,0.00022043224,0.008107819,0.00006650351],"about_ca_topic_score_codex":0.0003757886,"about_ca_topic_score_gemma":0.00132085,"teacher_disagreement_score":0.0025710955,"about_ca_system_score_codex":0.00034720893,"about_ca_system_score_gemma":0.00029477887,"threshold_uncertainty_score":0.008601189},"labels":[],"label_agreement":null},{"id":"W4391609952","doi":"10.1093/bjd/ljad498.021","title":"514 - Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto; Innovaderm (Canada)","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Pediatrics","score_opus":0.017326852808123214,"score_gpt":0.3330302427429552,"score_spread":0.31570338993483194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96275485,0.02264722,0.0013665305,0.0010464909,0.0004165918,0.004823955,0.0024836222,0.000205025,0.0042556436],"genre_scores_gemma":[0.9801769,0.008452642,0.0025448033,0.0011979458,0.0003599588,0.0024884588,0.0021167588,0.0000385985,0.0026239033],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994709,0.00024023114,0.0000474708,0.00008969353,0.00006857009,0.00008309785],"domain_scores_gemma":[0.99938893,0.00016406308,0.00016031775,0.000034157063,0.000080107326,0.00017236151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018834117,0.00072191225,0.001442035,0.00028069495,0.00027811155,0.00079983205,0.00050815044,0.0010803918,0.0059229643],"category_scores_gemma":[0.0010489578,0.0003311198,0.0012558611,0.00027273022,0.00042525496,0.00056084385,0.00020647011,0.0014519154,0.0006627407],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.638305,0.021054775,0.0059297844,0.0049997927,0.0026341558,0.00049312337,0.00030046314,0.00083950534,0.110724576,0.00058803457,0.0094531635,0.2046777],"study_design_scores_gemma":[0.7220177,0.24824981,0.014366969,0.00023897548,0.00096831046,0.00053756154,0.00005097587,0.00058856147,0.005319959,0.00016940679,0.0074532134,0.000038542577],"about_ca_topic_score_codex":0.00041436075,"about_ca_topic_score_gemma":0.0016383334,"teacher_disagreement_score":0.0059229643,"about_ca_system_score_codex":0.00041316423,"about_ca_system_score_gemma":0.0007658081,"threshold_uncertainty_score":0.019814312},"labels":[],"label_agreement":null},{"id":"W4391609975","doi":"10.1093/bjd/ljad498.031","title":"526 - Efficacy of upadacitinib vs dupilumab for moderate-to-severe atopic dermatitis: analysis of time spent in itch response state from the Heads Up study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Dermatology","score_opus":0.015528948431389281,"score_gpt":0.30415394753365244,"score_spread":0.28862499910226314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652785,0.0011736451,0.00016998925,0.00005622252,0.00006427669,0.0005484252,0.000787331,0.000017971304,0.0006542478],"genre_scores_gemma":[0.9974256,0.0002968196,0.00021033715,0.0001230591,0.00007774286,0.0004747015,0.00082397775,0.000004109782,0.0005636448],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.998543,0.00080655474,0.000112642614,0.00019076715,0.0001719027,0.00017520894],"domain_scores_gemma":[0.9980634,0.0007592064,0.0004489629,0.0001301932,0.00012220039,0.00047614932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025562807,0.0007918687,0.0025540239,0.0003732588,0.00033439972,0.0006965057,0.0006868934,0.000794532,0.0051418985],"category_scores_gemma":[0.0020389704,0.00038517726,0.003407397,0.00039623166,0.00058214826,0.0006692395,0.00040843015,0.0015096047,0.00047280843],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95401067,0.004839603,0.013540189,0.00049519725,0.0032987867,0.000042507225,0.000059623068,0.00074311846,0.0027448472,0.0000623706,0.0006853028,0.019477846],"study_design_scores_gemma":[0.34998763,0.4619814,0.16154477,0.00015068782,0.013292639,0.00024611736,0.00019520204,0.0052578445,0.004660991,0.00039567225,0.0021619964,0.0001250358],"about_ca_topic_score_codex":0.0010034002,"about_ca_topic_score_gemma":0.0016474796,"teacher_disagreement_score":0.0051418985,"about_ca_system_score_codex":0.00056109653,"about_ca_system_score_gemma":0.0008423063,"threshold_uncertainty_score":0.017201304},"labels":[],"label_agreement":null},{"id":"W4391610049","doi":"10.1093/bjd/ljad498.005","title":"494 - Efficacy and safety of lebrikizumab is maintained to two years in patients with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology","score_opus":0.005036598918240202,"score_gpt":0.24310895892761222,"score_spread":0.238072360009372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954507,0.0018622462,0.000107012995,0.00012795448,0.00005060169,0.0001737385,0.00021685545,0.000018991603,0.0019921204],"genre_scores_gemma":[0.99852556,0.00024874648,0.00011066495,0.00015742857,0.000043903765,0.00007440762,0.00022049806,0.000001577887,0.00061720895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962974,0.00012795861,0.000037620266,0.000070273054,0.000056019988,0.00007829767],"domain_scores_gemma":[0.9995672,0.00011238369,0.00009467872,0.000031979936,0.00004225754,0.0001514242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090986537,0.00025960585,0.00091160694,0.00013806293,0.00036103564,0.00043753703,0.00021858195,0.00048429132,0.0031701562],"category_scores_gemma":[0.00074214605,0.0001255357,0.0009960405,0.0001531712,0.0002263381,0.0004093918,0.000206528,0.0007947361,0.00065142964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26466194,0.016973142,0.3882229,0.00090874435,0.0012352159,0.001559593,0.00023940044,0.00066828745,0.04288049,0.0002386853,0.00573818,0.27667338],"study_design_scores_gemma":[0.04094637,0.22890566,0.709804,0.00014153258,0.0009681816,0.00251595,0.00024755648,0.0012948439,0.006361919,0.00022605566,0.00854454,0.000043321135],"about_ca_topic_score_codex":0.00044257502,"about_ca_topic_score_gemma":0.001010605,"teacher_disagreement_score":0.0031701562,"about_ca_system_score_codex":0.00038079714,"about_ca_system_score_gemma":0.0003709946,"threshold_uncertainty_score":0.010605276},"labels":[],"label_agreement":null},{"id":"W4391610118","doi":"10.1093/bjd/ljad498.063","title":"568 - Persistent inadequate disease control and therapeutic inertia in moderate-to-severe atopic dermatitis: a 12-month longitudinal analysis of real-world outcomes from TARGET-DERM registry","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atopic dermatitis; Medicine; Disease; Pediatrics; Dermatology; Internal medicine","score_opus":0.017066640563585585,"score_gpt":0.2725842717194319,"score_spread":0.2555176311558463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977429,0.00016235834,0.00010653743,0.000043940825,0.0000050123713,0.000027195829,0.0016271021,0.0000044730136,0.00028042734],"genre_scores_gemma":[0.9977628,0.000053793385,0.00009778783,0.00002634852,0.00000631599,0.000030523363,0.0019294068,0.000002399656,0.000090658985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981413,0.00058024196,0.00025125666,0.00038935026,0.0003607112,0.0002772035],"domain_scores_gemma":[0.9907616,0.0010471724,0.0046428787,0.00090232346,0.001671364,0.0009747868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003593343,0.0002702219,0.00045840183,0.0011100512,0.000871415,0.0010218988,0.00058193825,0.00048006471,0.000930622],"category_scores_gemma":[0.0060029468,0.00023246973,0.0008116706,0.001849638,0.0003626364,0.00075761596,0.00097391533,0.00092108955,0.0002795239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013494362,0.000033733075,0.999079,0.0000056440012,0.000048272777,0.000018426997,0.00006001814,0.000023607994,0.000035672718,0.0000064180367,0.00009187107,0.00046241848],"study_design_scores_gemma":[0.000013699805,0.00014455018,0.99898857,0.000008411759,0.00004305258,0.00010375637,0.0001912216,0.000228604,0.00004112665,0.000011686604,0.00021918227,0.0000061855185],"about_ca_topic_score_codex":0.042120777,"about_ca_topic_score_gemma":0.044227473,"teacher_disagreement_score":0.042120777,"about_ca_system_score_codex":0.0013003808,"about_ca_system_score_gemma":0.001495248,"threshold_uncertainty_score":0.0837512},"labels":[],"label_agreement":null},{"id":"W4391610224","doi":"10.1093/bjd/ljad498.049","title":"549 - Laboratory parameters in adolescent patients aged 12–17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Pediatrics","score_opus":0.01779111773238026,"score_gpt":0.26270154198818757,"score_spread":0.2449104242558073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198747,0.0054634176,0.00010122878,0.00019017904,0.000083228435,0.00032568874,0.0006081958,0.000014847213,0.0012257069],"genre_scores_gemma":[0.9965593,0.0012812618,0.00020944218,0.000325871,0.00008830877,0.00024018323,0.0007874107,0.0000033362137,0.0005048669],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99951994,0.00022930262,0.00005038047,0.00008143121,0.000052382155,0.00006654415],"domain_scores_gemma":[0.9994124,0.00012552162,0.00020741962,0.000037501555,0.000060476697,0.00015659138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011122047,0.00039060795,0.0011232803,0.00013429177,0.00025700105,0.0007251598,0.0003243483,0.00067703327,0.0027011312],"category_scores_gemma":[0.0010081937,0.00020933468,0.0014451185,0.0001920238,0.00025011782,0.00043371686,0.00016359272,0.0013338425,0.00047848007],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7736272,0.008534068,0.120122574,0.0017825813,0.005154738,0.00031052632,0.00015143097,0.0005341925,0.010305868,0.00014169245,0.004186546,0.075148486],"study_design_scores_gemma":[0.46013635,0.14719366,0.37358797,0.00052404153,0.0065887757,0.0011864626,0.00019130026,0.0013078738,0.0026451694,0.00027632606,0.0063007087,0.00006135732],"about_ca_topic_score_codex":0.00053197675,"about_ca_topic_score_gemma":0.0015899084,"teacher_disagreement_score":0.0027011312,"about_ca_system_score_codex":0.0003738268,"about_ca_system_score_gemma":0.00039162845,"threshold_uncertainty_score":0.009036183},"labels":[],"label_agreement":null},{"id":"W4391610232","doi":"10.1093/bjd/ljad498.029","title":"524 - Efficacy of upadacitinib and dupilumab on achieving stringent and composite skin and itch outcomes: an indirect comparison of adults with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Dermatology","score_opus":0.013450096456945896,"score_gpt":0.2888462188151257,"score_spread":0.2753961223581798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627643,0.014795632,0.003422401,0.0006924284,0.00073970045,0.0016087601,0.011017884,0.000083678635,0.0048752534],"genre_scores_gemma":[0.9905269,0.0010147783,0.0019931418,0.00045880183,0.00014870604,0.0013584713,0.003114951,0.000015392805,0.0013687845],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98883235,0.008307321,0.00069214375,0.0012816292,0.00054142444,0.0003451518],"domain_scores_gemma":[0.9893138,0.006595773,0.0022158623,0.0009266063,0.00058132934,0.00036665378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011123576,0.001895811,0.0029575133,0.00065685436,0.00048299404,0.001626179,0.0014195159,0.0017291543,0.01118537],"category_scores_gemma":[0.01991303,0.00077838224,0.014199539,0.0007417656,0.0007376493,0.001234889,0.0017716317,0.0033697626,0.000986942],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5678477,0.004056141,0.134162,0.012327664,0.22817822,0.00028573113,0.0005239828,0.00696483,0.001275233,0.0020809567,0.004008906,0.03828864],"study_design_scores_gemma":[0.17449442,0.09724324,0.28789523,0.002749052,0.394396,0.0009412702,0.0007365964,0.01992151,0.0038428463,0.0059912256,0.011476208,0.0003124602],"about_ca_topic_score_codex":0.0034626615,"about_ca_topic_score_gemma":0.003057023,"teacher_disagreement_score":0.01118537,"about_ca_system_score_codex":0.0010485312,"about_ca_system_score_gemma":0.00076277676,"threshold_uncertainty_score":0.058827817},"labels":[],"label_agreement":null},{"id":"W4391610246","doi":"10.1093/bjd/ljad498.043","title":"542 - Validation of the skin pain numerical rating scale of the Pruritus and Symptoms Assessment for Atopic Dermatitis for adults and adolescents with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Rating scale; Psychology","score_opus":0.005299054279597985,"score_gpt":0.24960116038948596,"score_spread":0.24430210610988798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96912485,0.0004619147,0.0066800765,0.00024648538,0.00010204037,0.011343309,0.0021721858,0.000048199956,0.009820926],"genre_scores_gemma":[0.9594519,0.00039540054,0.021263761,0.000251446,0.000036037924,0.013698517,0.0027995699,0.000023329356,0.0020800557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99108875,0.004257644,0.0013749835,0.0004981271,0.0024898374,0.00029068714],"domain_scores_gemma":[0.9918316,0.0031107333,0.0011045749,0.00041832717,0.0033061125,0.00022869487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01734916,0.00029082192,0.0004807438,0.00081043056,0.00043210515,0.00051752647,0.00047993704,0.00032583228,0.002317449],"category_scores_gemma":[0.020212337,0.00021968636,0.0011547793,0.00049687375,0.00031823094,0.0003754028,0.0006982656,0.00076588686,0.0010025147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075958954,0.0025891063,0.8243975,0.000858696,0.0002332817,0.00028458706,0.0084691895,0.0004848832,0.009662649,0.0006328241,0.0039699837,0.14765772],"study_design_scores_gemma":[0.00020746334,0.002303712,0.9822641,0.00026080362,0.00007708348,0.0004649629,0.0028821277,0.0010391703,0.0021480166,0.00013259925,0.0081942035,0.000025742482],"about_ca_topic_score_codex":0.0011729018,"about_ca_topic_score_gemma":0.0026420408,"teacher_disagreement_score":0.01734916,"about_ca_system_score_codex":0.0004900007,"about_ca_system_score_gemma":0.001323855,"threshold_uncertainty_score":0.09175217},"labels":[],"label_agreement":null},{"id":"W4391610330","doi":"10.1093/bjd/ljad498.047","title":"547 - Clinical burden and work productivity impairment in moderate-to-severe atopic dermatitis patients in the United States","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Atopic dermatitis; Work productivity; Medicine; Dermatology; Productivity; Economics","score_opus":0.014862991524857953,"score_gpt":0.29560359648252826,"score_spread":0.28074060495767034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907657,0.0006113644,0.00003712289,0.0003717389,0.000019913858,0.000029017465,0.0063089184,0.0000076020824,0.0018484816],"genre_scores_gemma":[0.99774194,0.00022911203,0.000045861398,0.00018018005,0.000018757455,0.000026422702,0.0015727849,0.0000011728129,0.00018371662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952483,0.00010739361,0.000095129304,0.00009663033,0.000096197444,0.00007988164],"domain_scores_gemma":[0.99880195,0.00009992438,0.00065460836,0.000033922937,0.00013511105,0.00027446295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004303443,0.0001793521,0.0002527888,0.00085745484,0.00043537296,0.00059515936,0.00030376617,0.00036802574,0.0037506714],"category_scores_gemma":[0.0014501261,0.0001385213,0.00035605993,0.0014424394,0.00018968341,0.00038288292,0.00046192898,0.00043759446,0.0006093401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019954954,0.000028924267,0.99825436,0.000016945018,0.000018311364,0.000021509331,0.0000440016,0.00001574015,0.000038576596,0.000006791469,0.0005994362,0.0009354029],"study_design_scores_gemma":[0.000003998788,0.00002328571,0.9994037,0.000016206184,0.000007847345,0.00006328794,0.00016596066,0.00003889594,0.000010831153,0.000009049741,0.0002552653,0.0000015978175],"about_ca_topic_score_codex":0.015307756,"about_ca_topic_score_gemma":0.02145974,"teacher_disagreement_score":0.015307756,"about_ca_system_score_codex":0.0004367012,"about_ca_system_score_gemma":0.0004283542,"threshold_uncertainty_score":0.03043729},"labels":[],"label_agreement":null},{"id":"W4391610379","doi":"10.1093/bjd/ljad498.010","title":"502 - Efficacy and safety of upadacitinib through 140 weeks in adolescents and adults with moderate-to-severe atopic dermatitis: phase 3 randomized clinical trial results","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"","keywords":"Atopic dermatitis; Medicine; Randomized controlled trial; Clinical trial; Dermatology; Pediatrics; Internal medicine","score_opus":0.019839577528294707,"score_gpt":0.3326478991868297,"score_spread":0.312808321658535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830256,0.004842466,0.0006153931,0.00053955294,0.00027311104,0.0058727944,0.002089202,0.00016467115,0.0025770157],"genre_scores_gemma":[0.9861202,0.0019792882,0.0012935364,0.0010075206,0.00021616544,0.0056908224,0.0015402954,0.000027490032,0.002124718],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99949014,0.00020052608,0.000039159855,0.00010392397,0.000055953704,0.00011012764],"domain_scores_gemma":[0.9993813,0.00010514104,0.00013965864,0.000046030204,0.00006135134,0.00026646297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016699098,0.0009793171,0.0021510413,0.00028102484,0.00043805453,0.0010289282,0.0006233429,0.0012728373,0.006119628],"category_scores_gemma":[0.0010801572,0.00052439887,0.0017539138,0.00034178444,0.0005633171,0.00088197074,0.000341345,0.0026691444,0.0010895774],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9264261,0.020954201,0.0024248287,0.00091310655,0.0015131668,0.00007792321,0.00010014168,0.0004851998,0.0075683994,0.00014556723,0.0029389088,0.036452595],"study_design_scores_gemma":[0.8473779,0.1407419,0.007341371,0.0000759528,0.0008422882,0.000102879836,0.00003355894,0.00058325485,0.0010530285,0.0001867474,0.0016369952,0.000024292229],"about_ca_topic_score_codex":0.00059104775,"about_ca_topic_score_gemma":0.0020417734,"teacher_disagreement_score":0.006119628,"about_ca_system_score_codex":0.0006367432,"about_ca_system_score_gemma":0.001147477,"threshold_uncertainty_score":0.020472229},"labels":[],"label_agreement":null},{"id":"W4391610433","doi":"10.1093/bjd/ljad498.023","title":"516 - Comparative efficacy of targeted systemic therapies with topical corticosteroids for moderate-to-severe atopic dermatitis: an updated network meta-analysis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Atopic dermatitis; Medicine; Meta-analysis; Dermatology; Internal medicine","score_opus":0.04241401709714,"score_gpt":0.31451518762114616,"score_spread":0.2721011705240062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610433","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02355929,0.9512204,0.008828682,0.001551831,0.0013675623,0.0008885435,0.009748546,0.00025481769,0.002580338],"genre_scores_gemma":[0.7388861,0.22991246,0.012872791,0.0031494608,0.0012602402,0.0029889932,0.008784493,0.00028421453,0.0018612705],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97131324,0.019017179,0.004255953,0.002873467,0.0021518501,0.00038831556],"domain_scores_gemma":[0.9685353,0.024825156,0.002759451,0.0019056827,0.0017202292,0.00025420467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02687836,0.0027798237,0.010720314,0.0050338916,0.0004409277,0.00337707,0.002163561,0.0018027913,0.0065681473],"category_scores_gemma":[0.059196044,0.0012966489,0.05089757,0.0051246723,0.0005220218,0.0018708362,0.0016350959,0.0023312243,0.0006163163],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027627232,0.0000130777435,0.005396044,0.03554572,0.9474112,0.000059372735,0.000026103346,0.0011564266,0.00015183483,0.00018617265,0.0011719081,0.006119466],"study_design_scores_gemma":[0.0013676224,0.0001537509,0.0051383832,0.0030198097,0.9863566,0.00007115335,0.000017724378,0.00086334365,0.00009751142,0.0006414601,0.0022462176,0.00002645631],"about_ca_topic_score_codex":0.0069515035,"about_ca_topic_score_gemma":0.008719904,"teacher_disagreement_score":0.02687836,"about_ca_system_score_codex":0.0015755361,"about_ca_system_score_gemma":0.0018998799,"threshold_uncertainty_score":0.14214802},"labels":[],"label_agreement":null},{"id":"W4391610449","doi":"10.1093/bjd/ljad498.059","title":"563 - Dupilumab improves skin lipid composition in atopic dermatitis irrespective of patient filaggrin (<i>FLG</i>) mutation status","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Filaggrin; Atopic dermatitis; Dupilumab; Dermatology; Medicine","score_opus":0.004815963464652381,"score_gpt":0.24678462230956394,"score_spread":0.24196865884491156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985006,0.000794107,0.00004013848,0.00002836638,0.000019803265,0.000023633645,0.000087713146,0.000022095002,0.00048365875],"genre_scores_gemma":[0.99855524,0.0002620743,0.00014962094,0.00006604774,0.000009721894,0.000018282382,0.00013597829,0.0000036046179,0.00079941255],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999378,0.000012610095,0.0000055151872,0.00001348157,0.00000945652,0.000021276888],"domain_scores_gemma":[0.9999429,0.000007095874,0.000014647375,0.000004551678,0.0000067093,0.000024139492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012375775,0.00029096226,0.0004558607,0.0001503297,0.00016716206,0.00022738933,0.0001426753,0.00021158272,0.0025101795],"category_scores_gemma":[0.00012940384,0.00009716959,0.00021808129,0.000086284956,0.00008344104,0.00017672036,0.00008779729,0.0003623848,0.00033809335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11960199,0.013304539,0.018981189,0.0006416555,0.0004821193,0.00042896613,0.00013106018,0.00056987413,0.61592865,0.00008472855,0.0025675795,0.22727768],"study_design_scores_gemma":[0.022819187,0.3090097,0.45096537,0.0001848746,0.001578133,0.0032052223,0.00049007335,0.0049293498,0.19664042,0.00019301071,0.009910067,0.00007453704],"about_ca_topic_score_codex":0.00062293484,"about_ca_topic_score_gemma":0.0012382865,"teacher_disagreement_score":0.0025101795,"about_ca_system_score_codex":0.00019110576,"about_ca_system_score_gemma":0.000114869836,"threshold_uncertainty_score":0.0083974},"labels":[],"label_agreement":null},{"id":"W4391886200","doi":"10.1093/bjd/ljae057","title":"Feasibility of daily pain measurement using text messages in hidradenitis suppurativa clinical trials; data from the THESEUS study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"UCB Pharma; University of Oxford; National Institute for Health and Care Research; Department of Health and Social Care; Insmed; Pfizer","keywords":"Hidradenitis suppurativa; Observational study; Medicine; Clinical trial; Physical therapy; Intervention (counseling); Dermatology; Internal medicine; Psychiatry","score_opus":0.4187291487448562,"score_gpt":0.4764521067916969,"score_spread":0.05772295804684069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391886200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9303209,0.011241123,0.00502157,0.0027165122,0.0006153518,0.031263012,0.011147635,0.00020427871,0.00746949],"genre_scores_gemma":[0.957715,0.0017232711,0.005727261,0.00069793046,0.0005155761,0.029032318,0.0036358123,0.000055027678,0.00089783967],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.75266474,0.21960518,0.01704334,0.002499064,0.0068505015,0.0013371474],"domain_scores_gemma":[0.6689524,0.24078903,0.063934825,0.011493282,0.010795802,0.0040348023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14256087,0.00086798554,0.002790068,0.0011599063,0.0007076396,0.0017980087,0.0008085234,0.0021331932,0.0060346145],"category_scores_gemma":[0.19940951,0.0006614875,0.0028980935,0.002342614,0.00090926,0.0022236418,0.0013392072,0.0017574881,0.0011762399],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74272203,0.010570915,0.078888185,0.013806243,0.0075624017,0.00013763321,0.0019445114,0.0020504314,0.0023894883,0.0007669692,0.005479863,0.13368131],"study_design_scores_gemma":[0.286628,0.26121998,0.42226854,0.0021913582,0.0054926905,0.0003017634,0.0006391042,0.0038587458,0.0022903646,0.0009412029,0.013857284,0.00031088368],"about_ca_topic_score_codex":0.0004354126,"about_ca_topic_score_gemma":0.00054682477,"teacher_disagreement_score":0.14256087,"about_ca_system_score_codex":0.0007759668,"about_ca_system_score_gemma":0.0014549543,"threshold_uncertainty_score":0.75394297},"labels":[],"label_agreement":null},{"id":"W4392344528","doi":"10.1093/bjd/ljae088","title":"Review of global epidemiology data for alopecia areata highlights gaps and a call for action","year":2024,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Alopecia areata; Medicine; Dermatology; Epidemiology; Call to action; Library science; Family medicine; Pathology; Computer science","score_opus":0.09303245027282371,"score_gpt":0.38536783926222123,"score_spread":0.29233538898939754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392344528","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024611823,0.19040449,0.0004803097,0.66559345,0.13946669,0.000042359763,0.0005119699,0.000109005356,0.0031455983],"genre_scores_gemma":[0.008092983,0.3503632,0.0027128435,0.3734984,0.25491127,0.00012409239,0.0010631777,0.00022531707,0.009008621],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9719201,0.00927837,0.0067984047,0.0019421777,0.008928268,0.001132591],"domain_scores_gemma":[0.677457,0.15696537,0.023986183,0.007334331,0.12667033,0.0075868675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027097989,0.0009905461,0.003071961,0.0069609107,0.0013972903,0.005699194,0.0027691755,0.0076267156,0.016095458],"category_scores_gemma":[0.16075796,0.0009979055,0.0023163843,0.0056130295,0.0033943662,0.009161796,0.0019947002,0.01516325,0.009644095],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000377847,0.000008562506,0.00034797826,0.0024058968,0.00006527827,0.00040351713,0.00009649149,0.000057733538,0.000070963906,0.0011232882,0.9519724,0.04341016],"study_design_scores_gemma":[0.00005119499,0.000035599274,0.001978192,0.013815626,0.00016600976,0.0022896528,0.0005169557,0.00007930802,0.000096884556,0.003994088,0.97691214,0.00006438166],"about_ca_topic_score_codex":0.009491543,"about_ca_topic_score_gemma":0.012626547,"teacher_disagreement_score":0.027097989,"about_ca_system_score_codex":0.0067579076,"about_ca_system_score_gemma":0.01228785,"threshold_uncertainty_score":0.14330953},"labels":[],"label_agreement":null},{"id":"W4392703525","doi":"10.1093/bjd/ljae098","title":"Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"European Academy of Dermatology and Venereology; Novartis Pharma; Regeneron Pharmaceuticals; Incyte; Amgen","keywords":"Hidradenitis suppurativa; Medicine; Secukinumab; Dermatology; Sunrise; Internal medicine; Psoriasis; Disease","score_opus":0.018167058827639727,"score_gpt":0.2935851276832833,"score_spread":0.27541806885564357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392703525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9393374,0.05370785,0.00050654355,0.000823517,0.00022315714,0.0013687304,0.0008820323,0.00004113244,0.0031095704],"genre_scores_gemma":[0.9907838,0.006189877,0.00037415055,0.0007069291,0.00016141715,0.0005300489,0.00087525486,0.0000058482465,0.00037261087],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99885035,0.00070090906,0.000144618,0.00009658667,0.00011048021,0.00009691682],"domain_scores_gemma":[0.99812657,0.0006958668,0.00056276884,0.00012434043,0.00012475556,0.00036577936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00382474,0.0005690427,0.0017878124,0.00031857094,0.00031147344,0.0008013632,0.00040282012,0.0007450823,0.002251558],"category_scores_gemma":[0.0017500027,0.00029304269,0.0028185023,0.00040067697,0.00043489842,0.0005344643,0.00032625004,0.001485941,0.00024764598],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78260577,0.0072875493,0.036486648,0.00494663,0.010672408,0.00024527166,0.0001961625,0.0012464186,0.014349241,0.00030896263,0.002682772,0.13897206],"study_design_scores_gemma":[0.58521557,0.26494387,0.12637204,0.0008232254,0.008075715,0.00091477385,0.00014458358,0.0015100138,0.0030882114,0.0005311416,0.008312614,0.0000682786],"about_ca_topic_score_codex":0.00021268283,"about_ca_topic_score_gemma":0.0010742085,"teacher_disagreement_score":0.00382474,"about_ca_system_score_codex":0.00036978736,"about_ca_system_score_gemma":0.0005669349,"threshold_uncertainty_score":0.020227432},"labels":[],"label_agreement":null},{"id":"W4392866757","doi":"10.1093/bjd/ljae065","title":"A guide to improving the design and analysis of observational studies on the long-term safety of topical corticosteroids","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Women's College Hospital","funders":"","keywords":"Observational study; Confounding; Medicine; Term (time); Intensive care medicine; Risk analysis (engineering); Pathology","score_opus":0.054797153083419786,"score_gpt":0.3413586370917474,"score_spread":0.2865614840083276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392866757","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021093602,0.04445802,0.6906927,0.07545409,0.01952223,0.09037129,0.032174125,0.01523335,0.029984728],"genre_scores_gemma":[0.0020640169,0.012418951,0.91272,0.011305525,0.0028795288,0.048241895,0.0026117375,0.0010967371,0.0066615567],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.7355002,0.18777233,0.052641317,0.0039657694,0.018668694,0.0014516492],"domain_scores_gemma":[0.35267845,0.4878501,0.026101664,0.036264878,0.08986314,0.0072417],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.24325438,0.004035802,0.006067147,0.011723449,0.0015929539,0.00600839,0.008264158,0.008360414,0.050432302],"category_scores_gemma":[0.43412888,0.0067202738,0.0068174396,0.01104336,0.0033239978,0.0045039398,0.0036822103,0.0143769495,0.03546219],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013600703,0.0006522003,0.0018621853,0.019862205,0.001047787,0.0006762857,0.001136912,0.002112343,0.001584119,0.008807081,0.60313815,0.3577608],"study_design_scores_gemma":[0.0044834414,0.0020515996,0.011618227,0.054285094,0.0014266886,0.0017607753,0.0010468117,0.006807993,0.0018561509,0.03954309,0.8745986,0.00052148564],"about_ca_topic_score_codex":0.006766629,"about_ca_topic_score_gemma":0.015094369,"teacher_disagreement_score":0.75674564,"about_ca_system_score_codex":0.0027798251,"about_ca_system_score_gemma":0.02156003,"threshold_uncertainty_score":0.9332021},"labels":[],"label_agreement":null},{"id":"W4393192973","doi":"10.1093/bjd/ljae132","title":"Psychometric evaluation of the multidimensional Uraemic Pruritus in Dialysis patients (UP-Dial) scale: comparison of haemodialysis and peritoneal dialysis patients with chronic pruritus","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Ottawa Hospital; University of Ottawa","funders":"Faculty of Medicine, Chiang Mai University; Health Systems Research Institute; National Research Council of Thailand","keywords":"Medicine; Hemodialysis; Dialysis; Quality of life (healthcare); Peritoneal dialysis; Itching; Kidney disease; Physical therapy; Dermatology Life Quality Index; Internal medicine; Surgery; Disease; Nursing","score_opus":0.012456072155962741,"score_gpt":0.2871093384831004,"score_spread":0.27465326632713766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393192973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830556,0.00032153304,0.00023733606,0.00007179081,0.000013164096,0.00010801524,0.00030839248,0.000004728745,0.00062941643],"genre_scores_gemma":[0.9992236,0.00006732118,0.00023956799,0.000035677367,0.000008265186,0.00006798325,0.00029419045,0.0000012629354,0.00006223685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723023,0.0012126582,0.0005245552,0.00022785802,0.0006577483,0.00014682549],"domain_scores_gemma":[0.9916922,0.0027056967,0.003726105,0.00033864618,0.00079444645,0.0007429679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004728751,0.00026531477,0.00054385315,0.0010821518,0.00034239446,0.0006367259,0.00040910993,0.0005128669,0.0011591006],"category_scores_gemma":[0.013755615,0.00018492239,0.001061982,0.0010076741,0.0004011805,0.000760109,0.0012973481,0.0007327222,0.00017163814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033410967,0.00017397905,0.99234337,0.00006898722,0.00021137446,0.000026203306,0.00033106506,0.00011620823,0.000134295,0.000028083774,0.00014384439,0.006088427],"study_design_scores_gemma":[0.000053523105,0.0005524684,0.9982008,0.000023976492,0.00003180804,0.00013760725,0.00030751142,0.00038371497,0.00005527206,0.000029698724,0.00021708137,0.000006540665],"about_ca_topic_score_codex":0.00075995404,"about_ca_topic_score_gemma":0.00069004967,"teacher_disagreement_score":0.004728751,"about_ca_system_score_codex":0.0003867434,"about_ca_system_score_gemma":0.00030425252,"threshold_uncertainty_score":0.02500832},"labels":[],"label_agreement":null},{"id":"W4394641975","doi":"10.1093/bjd/ljae150","title":"Paediatric-onset lymphomatoid papulosis: results of a multicentre retrospective cohort study on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; University of Alberta","funders":"Promedica Stiftung; Université de Lausanne; Swiss Cancer Research Foundation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Lymphomatoid papulosis; Medicine; Retrospective cohort study; Cutaneous lymphoma; Dermatology; Lymphoma; Cohort; Internal medicine; Oncology; Mycosis fungoides","score_opus":0.009270253234477352,"score_gpt":0.27515249364312666,"score_spread":0.26588224040864933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394641975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99910504,0.00019618578,0.00007149813,0.000012569566,0.00000310246,0.000019087314,0.00046211004,0.0000023180532,0.00012816445],"genre_scores_gemma":[0.99891186,0.0002026748,0.00009675803,0.000013270503,0.0000075682665,0.00002281625,0.00069128646,0.0000038866547,0.00004983204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989058,0.00031713504,0.00011797033,0.00026955432,0.0002177657,0.00017169426],"domain_scores_gemma":[0.9975472,0.00040167384,0.0011867745,0.00026387998,0.00024725858,0.0003531943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014603246,0.0004383668,0.00062193675,0.0012313947,0.00044201704,0.0008974672,0.0005692529,0.0005009983,0.001309552],"category_scores_gemma":[0.0029432157,0.0005228666,0.0005910951,0.0019024615,0.00036904815,0.0008286874,0.0008847602,0.0005178136,0.00030259063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010254554,0.000023345312,0.99870396,0.000011471764,0.000034957375,0.00034296964,0.0001239246,0.000018178347,0.00010732568,0.000007804523,0.00005855174,0.00046500613],"study_design_scores_gemma":[0.000015040021,0.0001624544,0.99759173,0.000010995374,0.000038617593,0.0015687381,0.00032409222,0.00008490885,0.000033622844,0.0000066546927,0.0001591156,0.000004107163],"about_ca_topic_score_codex":0.0043637347,"about_ca_topic_score_gemma":0.0031077433,"teacher_disagreement_score":0.0043637347,"about_ca_system_score_codex":0.00040544043,"about_ca_system_score_gemma":0.0004727519,"threshold_uncertainty_score":0.008676708},"labels":[],"label_agreement":null},{"id":"W4394748593","doi":"10.1093/bjd/ljae069","title":"Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate-to-severe psoriasis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada; Newcastle upon Tyne Hospitals NHS Foundation Trust; National Institute for Health and Care Research; Psoriasis Association; American Institute of Mathematics","keywords":"Methotrexate; Psoriasis; Medicine; Cumulative dose; Fibrosis; Internal medicine; Dermatology; Liver fibrosis; Gastroenterology","score_opus":0.015903414195897782,"score_gpt":0.22267481643709014,"score_spread":0.20677140224119236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394748593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812526,0.00085972523,0.00006908662,0.00007911444,0.000010690712,0.000006128302,0.00014667248,0.0000042759234,0.000699021],"genre_scores_gemma":[0.9997116,0.00008284706,0.000029537267,0.00002453934,0.0000146801885,0.0000023321722,0.00006587819,9.2655637e-7,0.00006774547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994405,0.00017787408,0.00008243484,0.00011698132,0.00011524493,0.000066953755],"domain_scores_gemma":[0.99583364,0.0009551521,0.0023431142,0.00018903583,0.00019821215,0.0004807256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061263377,0.00016593006,0.00034773463,0.00047421874,0.00032724248,0.0005854244,0.00021596198,0.0005305232,0.0034434274],"category_scores_gemma":[0.003948586,0.00023719069,0.0004180201,0.0006121846,0.00019591796,0.0003558633,0.0002470651,0.0005869874,0.00041013144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019814394,0.000018994218,0.998765,0.0000085893425,0.000026822183,0.00005804027,0.000017617684,0.000009238768,0.00013700378,0.0000040425716,0.00003344173,0.00072304276],"study_design_scores_gemma":[0.000012850701,0.00019545846,0.99870145,0.00000824518,0.000035730212,0.0007304087,0.000050921666,0.000087087,0.000031708994,0.000011331611,0.0001325484,0.0000022539953],"about_ca_topic_score_codex":0.00078886666,"about_ca_topic_score_gemma":0.0012725355,"teacher_disagreement_score":0.0034434274,"about_ca_system_score_codex":0.00015560369,"about_ca_system_score_gemma":0.00019093348,"threshold_uncertainty_score":0.011519372},"labels":[],"label_agreement":null},{"id":"W4395674289","doi":"10.1093/bjd/ljae164","title":"Expanding global health dermatology leadership: launching the GLODERM international mentorship programme","year":2024,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital; University of Toronto","funders":"","keywords":"Mentorship; Medicine; Global health; Dermatology; Political science; Medical education; Family medicine; Nursing; Public health","score_opus":0.06971886026226405,"score_gpt":0.34543845984069715,"score_spread":0.2757195995784331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395674289","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011218879,0.0008037949,0.00010614079,0.98405474,0.009855738,0.000027996783,0.000008400517,0.000026089278,0.0039952393],"genre_scores_gemma":[0.0140887005,0.0016345539,0.00082635455,0.95135933,0.016020851,0.000120417535,0.000020140033,0.00003573365,0.015893979],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958171,0.0015438414,0.00024180739,0.00024603892,0.0012948432,0.0008562423],"domain_scores_gemma":[0.9806142,0.005465601,0.00061605347,0.00049517245,0.0019822621,0.010826706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061213016,0.00062086066,0.0006183064,0.00053319556,0.005423172,0.0039075897,0.0018831134,0.03678434,0.009739447],"category_scores_gemma":[0.018835697,0.00062314776,0.0011275568,0.00035788844,0.0037930773,0.005360481,0.0043438026,0.035065647,0.003840024],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051007468,0.00018053113,0.0014648734,0.00008874625,0.000012372895,0.006422333,0.00043936502,0.000079063415,0.0006179758,0.0028760715,0.9659729,0.021794891],"study_design_scores_gemma":[0.00012387242,0.00024036484,0.0027428803,0.0004337732,0.0000121104795,0.005045011,0.0018143887,0.0005592072,0.00024062558,0.005069652,0.98366064,0.000057405465],"about_ca_topic_score_codex":0.004529943,"about_ca_topic_score_gemma":0.014830297,"teacher_disagreement_score":0.03678434,"about_ca_system_score_codex":0.0036103155,"about_ca_system_score_gemma":0.010149383,"threshold_uncertainty_score":0.032581747},"labels":[],"label_agreement":null},{"id":"W4396846587","doi":"10.1093/bjd/ljae173","title":"Impact of pruritus on patient fatigue: a cross-sectional study","year":2024,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Ethnic group; Medicine; Race (biology); Cross-sectional study; Physical therapy; Gerontology; Pathology","score_opus":0.025500199275782336,"score_gpt":0.3427987053360124,"score_spread":0.3172985060602301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396846587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817634,0.0002516921,0.000087798966,0.00060286315,0.00001864464,0.000012648846,0.00037762654,0.0000024974129,0.00046986595],"genre_scores_gemma":[0.99872607,0.0001057655,0.00009620714,0.00063970627,0.000057854595,0.000013836603,0.00020352975,9.598672e-7,0.0001559154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988174,0.0006717381,0.00011326611,0.00014707237,0.00014849796,0.00010204635],"domain_scores_gemma":[0.99657047,0.0014101561,0.00083432934,0.00028036907,0.00052740844,0.00037733864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013211004,0.00016375986,0.00033252058,0.0003995152,0.00038080933,0.00046432344,0.00025453177,0.0010707338,0.0015548297],"category_scores_gemma":[0.005021626,0.00029227426,0.00037420832,0.00070723076,0.00026820373,0.0004691339,0.00024019358,0.0006177889,0.00040131668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000924831,0.000029935774,0.99846196,0.000007924176,0.000034056557,0.00019185232,0.00007809902,0.000011000579,0.00012172312,0.0000062102677,0.00017859205,0.0007861922],"study_design_scores_gemma":[0.000012224614,0.00024461988,0.9982815,0.0000059966774,0.00001984847,0.0009122785,0.00013757244,0.00009684555,0.00002974648,0.000009602588,0.00024627312,0.0000036919241],"about_ca_topic_score_codex":0.0032015292,"about_ca_topic_score_gemma":0.004071506,"teacher_disagreement_score":0.0032015292,"about_ca_system_score_codex":0.000263344,"about_ca_system_score_gemma":0.00021457979,"threshold_uncertainty_score":0.0069867373},"labels":[],"label_agreement":null},{"id":"W4399202770","doi":"10.1093/bjd/ljae225","title":"Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Debra International; Université de Fribourg; Ministry of Health, British Columbia","keywords":"Histone deacetylase; Cancer research; Fibrosis; Fibroblast; Acetylation; Biology; Histone; Pathology; Medicine; Gene; Cell culture; Biochemistry; Genetics","score_opus":0.007677624783542499,"score_gpt":0.2851203799187281,"score_spread":0.27744275513518557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399202770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531823,0.0023528405,0.0009264228,0.00008080758,0.000047732476,0.000032823544,0.00032069106,0.00015358659,0.00076686055],"genre_scores_gemma":[0.99479467,0.001328247,0.0012259501,0.000055685105,0.000015514275,0.000044716384,0.00045424182,0.000030553278,0.0020504552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998852,0.000017785982,0.000015630245,0.000023417033,0.000028830429,0.0000290642],"domain_scores_gemma":[0.9998847,0.000015129349,0.000036138692,0.000011162131,0.000012044053,0.000040813575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018957852,0.00041611947,0.00041957412,0.00029789767,0.0001310163,0.00022796742,0.00029749237,0.00029913854,0.0015168996],"category_scores_gemma":[0.00013015376,0.00013863097,0.0002779297,0.00011458266,0.00020118919,0.00014836267,0.0001388171,0.00052363164,0.00025745796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005570152,0.00012596548,0.00019131317,0.00006325484,0.000019331308,0.00003807753,0.000011101863,0.000053014002,0.9964701,0.00002568092,0.00006782218,0.0023772612],"study_design_scores_gemma":[0.00035107808,0.005851885,0.012729935,0.000026673126,0.00010327648,0.00046962796,0.000071608854,0.0011783228,0.97625273,0.00006070674,0.0028921077,0.000012082693],"about_ca_topic_score_codex":0.00061265915,"about_ca_topic_score_gemma":0.0012654406,"teacher_disagreement_score":0.0015168996,"about_ca_system_score_codex":0.00017756982,"about_ca_system_score_gemma":0.00015332858,"threshold_uncertainty_score":0.0050745606},"labels":[],"label_agreement":null},{"id":"W4399509792","doi":"10.1093/bjd/ljae243","title":"Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Medical Research Council Canada","keywords":"Immune privilege; Hair follicle; Immune system; Mitogen-activated protein kinase; Medicine; Immunology; Cancer research; Kinase; Biology; Internal medicine; Cell biology","score_opus":0.0172735129031925,"score_gpt":0.2651910212484439,"score_spread":0.2479175083452514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399509792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985019,0.00066480215,0.00015518267,0.000016029428,0.0000072768626,0.000025557365,0.000066748136,0.00001381259,0.00054868154],"genre_scores_gemma":[0.9994784,0.00016473721,0.00010047478,0.00002115049,0.0000067177825,0.00001201482,0.00007855685,0.0000013984213,0.00013658486],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999062,0.00001251319,0.0000055940513,0.000017801884,0.000021410046,0.000036488167],"domain_scores_gemma":[0.9999236,0.000012417106,0.000029701081,0.000008266039,0.000005480275,0.000020552807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091849084,0.00018112893,0.00025880663,0.00013858986,0.0001246618,0.00017483684,0.00007699743,0.0001789527,0.0011992964],"category_scores_gemma":[0.000109611596,0.00006387395,0.0002345881,0.000091596485,0.00015335987,0.000102999045,0.000115721436,0.00028319538,0.00017106353],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012305318,0.00021569109,0.010904799,0.000089423855,0.00003568431,0.00069849903,0.000048811427,0.000058252284,0.9776594,0.000032404565,0.00012970595,0.008896919],"study_design_scores_gemma":[0.00033021226,0.013827742,0.6039229,0.000026626647,0.00010168116,0.009342591,0.00040124275,0.0005788551,0.36784047,0.00010823243,0.0035079971,0.000011409398],"about_ca_topic_score_codex":0.00016285469,"about_ca_topic_score_gemma":0.00031388475,"teacher_disagreement_score":0.0011992964,"about_ca_system_score_codex":0.00015368471,"about_ca_system_score_gemma":0.00009795872,"threshold_uncertainty_score":0.0040120482},"labels":[],"label_agreement":null},{"id":"W4399963617","doi":"10.1093/bjd/ljae262","title":"Inflammasomes: emerging therapeutic targets in hidradenitis suppurativa?","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"British Skin Foundation","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Pathology; Disease","score_opus":0.034768231747152205,"score_gpt":0.3544695209095369,"score_spread":0.31970128916238466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399963617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008603887,0.9993162,0.000035179863,0.00015169458,0.00012855172,0.0000025535883,0.000008742542,0.0000028915863,0.0002681175],"genre_scores_gemma":[0.0005486685,0.99880254,0.00009135819,0.00015799377,0.000103488936,0.0000048738934,0.000018853621,8.2371133e-7,0.00027142055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998264,0.000036737238,0.000029794392,0.00002781983,0.00005771719,0.000021647578],"domain_scores_gemma":[0.9998,0.00009744596,0.00003441558,0.000005119841,0.00004516704,0.000017813187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005144368,0.00068449095,0.00136358,0.0015162049,0.00022644213,0.0009959457,0.0005914718,0.001195474,0.0036928952],"category_scores_gemma":[0.0005742079,0.00023551816,0.0006613926,0.0013804231,0.000348904,0.0010999176,0.0005794007,0.0018131118,0.0014570346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022854611,0.000101537415,0.00013247534,0.041892607,0.00016509228,0.00024387565,0.000100418416,0.0003455887,0.00255237,0.003008744,0.02439105,0.9268376],"study_design_scores_gemma":[0.000064730506,0.00023044227,0.00092031446,0.01018265,0.00024335166,0.0015801381,0.000115601346,0.000115739684,0.0005656817,0.0021630495,0.98379636,0.000022007678],"about_ca_topic_score_codex":0.00053952873,"about_ca_topic_score_gemma":0.001171971,"teacher_disagreement_score":0.0036928952,"about_ca_system_score_codex":0.00042154957,"about_ca_system_score_gemma":0.0007012215,"threshold_uncertainty_score":0.012353957},"labels":[],"label_agreement":null},{"id":"W4400030395","doi":"10.1093/bjd/ljae267","title":"Measurement properties and interpretability of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance","funders":"Jikei University School of Medicine; Clalit Health Services; University of Leeds; Cardiff University; Yale University","keywords":"Patient-reported outcome; Intraclass correlation; Construct validity; Criterion validity; Physical therapy; Medicine; Interpretability; Ceiling effect; Reliability (semiconductor); Convergent validity; Content validity; Quality of life (healthcare); Psychology; Clinical psychology; Psychometrics; Internal consistency; Pathology; Alternative medicine; Nursing; Computer science","score_opus":0.035422669925068366,"score_gpt":0.23313437663996328,"score_spread":0.1977117067148949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400030395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94842374,0.0010229513,0.0382152,0.00072447094,0.00019777875,0.0015215918,0.0013417894,0.000115531,0.008436918],"genre_scores_gemma":[0.9850546,0.00012706527,0.012584586,0.00010897944,0.000045490695,0.0011106065,0.0007286463,0.00002807683,0.0002119946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.94019943,0.03830702,0.006486283,0.0030735154,0.011380183,0.00055349607],"domain_scores_gemma":[0.7928689,0.16243197,0.018981192,0.011779392,0.013017154,0.0009214502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07225042,0.00062338175,0.00068637513,0.0018423024,0.00054373156,0.0018336367,0.0009002575,0.0008754928,0.0016652596],"category_scores_gemma":[0.1511561,0.00030044274,0.002234625,0.0018317498,0.0015428197,0.0012952215,0.0019461828,0.0013424546,0.00031316528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066285516,0.00037012526,0.9287046,0.00043643534,0.001127411,0.000071433344,0.002750494,0.001566952,0.0010969964,0.0011319165,0.00086331746,0.06121756],"study_design_scores_gemma":[0.00011974191,0.001657142,0.98247105,0.00026587598,0.00032988278,0.00037611095,0.0011510456,0.007716277,0.0015860593,0.00200699,0.0022555792,0.00006424395],"about_ca_topic_score_codex":0.0005294225,"about_ca_topic_score_gemma":0.00060378906,"teacher_disagreement_score":0.07225042,"about_ca_system_score_codex":0.0007049039,"about_ca_system_score_gemma":0.0007565118,"threshold_uncertainty_score":0.3821013},"labels":[],"label_agreement":null},{"id":"W4400125399","doi":"10.1093/bjd/ljae090.150","title":"BH03 Do patients with afro-textured hair who are experiencing hair loss feel understood by their dermatologists? A cross-sectional study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Changi General Hospital; NYU Grossman School of Medicine; Uniwersytet Warszawski; Victoria University; Università di Bologna; Universidade de São Paulo; University of Pennsylvania; Inyuvesi Yakwazulu-Natali; York University; Warszawski Uniwersytet Medyczny; University of Minnesota; Yale University","keywords":"Medicine; Hair loss; Dermatology; Family medicine","score_opus":0.012024287407721377,"score_gpt":0.2646408259889136,"score_spread":0.2526165385811922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400125399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982175,0.00028288504,0.000023846684,0.00017062321,0.00001184798,0.000023007326,0.00019362522,0.0000013538854,0.0010751849],"genre_scores_gemma":[0.999164,0.00018449519,0.000034206154,0.00017603043,0.000013133577,0.000028679122,0.000100977086,0.0000010535945,0.00029756414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992692,0.00021779341,0.000084583204,0.00008623986,0.00017423405,0.00016790158],"domain_scores_gemma":[0.9986118,0.00020650256,0.00067405414,0.000036112448,0.00017693058,0.00029459436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082718756,0.00015926916,0.00034689292,0.00076785416,0.0008962397,0.0011911001,0.00030562736,0.00063868996,0.0048523056],"category_scores_gemma":[0.0021819335,0.00032650706,0.0005447854,0.000775039,0.0003879631,0.0011434305,0.0005406345,0.00083342404,0.00074570667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007006692,0.00019175636,0.9946503,0.00007758017,0.000045888646,0.00019062536,0.0022165207,0.000009279222,0.00014056196,0.000025827705,0.00031241975,0.0020691545],"study_design_scores_gemma":[0.000013307561,0.0004883758,0.9834478,0.000084275714,0.000029468529,0.0007970789,0.01413555,0.00006796354,0.000038364884,0.000028485983,0.00085744535,0.000011946946],"about_ca_topic_score_codex":0.0058263587,"about_ca_topic_score_gemma":0.0056471224,"teacher_disagreement_score":0.0058263587,"about_ca_system_score_codex":0.00043951807,"about_ca_system_score_gemma":0.0003495469,"threshold_uncertainty_score":0.01623255},"labels":[],"label_agreement":null},{"id":"W4400125475","doi":"10.1093/bjd/ljae090.089","title":"P062 A multicentre retrospective observational study reviewing the management of severely dysplastic naevi","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Histopathology; Medical diagnosis; Retrospective cohort study; Multidisciplinary team; Margin (machine learning); Dermatology; Surgery; General surgery; Radiology; Pathology; Nursing","score_opus":0.03699043018520979,"score_gpt":0.29972084157905854,"score_spread":0.26273041139384873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400125475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976145,0.0011032015,0.000058243073,0.000057616147,0.000008350826,0.00005153519,0.00068524235,0.0000021304165,0.00041922554],"genre_scores_gemma":[0.99899644,0.00033291712,0.00008864081,0.0000659324,0.000015128354,0.000037787304,0.0003760201,0.000002156044,0.00008486209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979419,0.00047714222,0.0005371263,0.00042593793,0.00034804095,0.00026975176],"domain_scores_gemma":[0.9925208,0.0010119347,0.005064144,0.00024430553,0.0005230653,0.000635771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010975735,0.00024168426,0.000610359,0.0014447537,0.0006800898,0.00086491846,0.0005852593,0.00046975096,0.0027129387],"category_scores_gemma":[0.005757931,0.0004936758,0.0005566953,0.002746347,0.00042137862,0.0008601975,0.0008390685,0.0004336104,0.000337403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053486518,0.000019111078,0.9980884,0.00013863639,0.000036744485,0.0005078906,0.00027310022,0.000009176786,0.000085611195,0.00001414439,0.00015652689,0.0006171415],"study_design_scores_gemma":[0.000009962622,0.00023789542,0.9946339,0.00013206723,0.000051076895,0.0026035993,0.0017015797,0.000058735797,0.000033524306,0.000015240261,0.0005143184,0.0000079693],"about_ca_topic_score_codex":0.009409744,"about_ca_topic_score_gemma":0.010004211,"teacher_disagreement_score":0.009409744,"about_ca_system_score_codex":0.0009548245,"about_ca_system_score_gemma":0.0010081433,"threshold_uncertainty_score":0.018709958},"labels":[],"label_agreement":null},{"id":"W4400125530","doi":"10.1093/bjd/ljae090.151","title":"BH04 A global survey to assess practice of laboratory testing in alopecia areata by hair specialists","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Changi General Hospital; NYU Grossman School of Medicine; Uniwersytet Warszawski; Victoria University; Università di Bologna; Universidade de São Paulo; University of Pennsylvania; Inyuvesi Yakwazulu-Natali; York University; Warszawski Uniwersytet Medyczny; University of Minnesota; Yale University","keywords":"Alopecia areata; Medicine; Hair loss; Dermatology; Subspecialty; Disease; Alopecia universalis; Thyroid disease; Family medicine; Pediatrics; Internal medicine; Thyroid","score_opus":0.03234239558445554,"score_gpt":0.3361293212804224,"score_spread":0.3037869256959668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400125530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920699,0.0008566146,0.00015198633,0.0012577617,0.0000249033,0.00006480626,0.0018880214,0.000023210747,0.003662621],"genre_scores_gemma":[0.9975975,0.0005394519,0.0002656667,0.0006324874,0.000023205574,0.00004838182,0.0005308986,0.000004922146,0.00035746617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975551,0.0011033195,0.00032680534,0.00023180975,0.000523515,0.00025950075],"domain_scores_gemma":[0.98921365,0.0029384573,0.0044860896,0.0002689302,0.0015578979,0.0015350393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023177566,0.000117431984,0.00016452679,0.0014913197,0.00032970734,0.0005180846,0.00035740616,0.0004998727,0.0023439073],"category_scores_gemma":[0.007131119,0.00019615458,0.00025256522,0.0016228503,0.0003536538,0.0007410884,0.00081138295,0.0004629459,0.0005814997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023412516,0.000052729778,0.98758954,0.00011683338,0.000016958524,0.00012538827,0.0015747895,0.00003347735,0.0002667646,0.000038798607,0.002426721,0.0077346116],"study_design_scores_gemma":[0.000005470875,0.000116531985,0.99345994,0.00008118324,0.0000056328377,0.000359579,0.0034473413,0.00016460825,0.000050563052,0.000017874048,0.002285339,0.0000058360474],"about_ca_topic_score_codex":0.0069973487,"about_ca_topic_score_gemma":0.0060841367,"teacher_disagreement_score":0.0069973487,"about_ca_system_score_codex":0.00062832364,"about_ca_system_score_gemma":0.0006526965,"threshold_uncertainty_score":0.013913214},"labels":[],"label_agreement":null},{"id":"W4400125623","doi":"10.1093/bjd/ljae090.057","title":"P030 Implementing the Edmonton Obesity Staging System: a cross-sectional study of the prevalence and management of obesity in a systemic therapies clinic","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Overweight; Obesity; Body mass index; Psoriasis; Cross-sectional study; Population; Hidradenitis suppurativa; Incidence (geometry); Internal medicine; Dermatology; Environmental health; Pathology; Disease","score_opus":0.018026244068118973,"score_gpt":0.2790227932212983,"score_spread":0.2609965491531793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400125623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99924797,0.000059843158,0.000053717955,0.000026779882,0.0000034914476,0.000024333158,0.00016306603,0.000001728298,0.00041904868],"genre_scores_gemma":[0.99945945,0.0000466231,0.00008026722,0.000058177142,0.000006020151,0.00003310313,0.00017473969,0.0000020629402,0.0001395468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988741,0.0004309651,0.00010641164,0.00017070158,0.000269724,0.00014798061],"domain_scores_gemma":[0.99747986,0.00053368486,0.0010038961,0.00013874068,0.00035826865,0.00048547878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018585959,0.00022151502,0.00024624553,0.00075518934,0.00079409784,0.00084900577,0.00045504796,0.00049489044,0.002468409],"category_scores_gemma":[0.0030149163,0.00054785097,0.0004293564,0.0012679019,0.0003434411,0.00090665475,0.00075598934,0.0008711486,0.0006968287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003107783,0.000060164362,0.99916995,0.000003537543,0.000008882508,0.00003297081,0.00015933755,0.000005261668,0.000047538222,0.000004614865,0.00006642836,0.0004101126],"study_design_scores_gemma":[0.000005351947,0.00019759838,0.9987544,0.0000064113883,0.0000069140356,0.00017392788,0.00061368546,0.00008673918,0.00001886469,0.0000058930796,0.00012777891,0.0000026017124],"about_ca_topic_score_codex":0.008135183,"about_ca_topic_score_gemma":0.00716054,"teacher_disagreement_score":0.008135183,"about_ca_system_score_codex":0.00040476845,"about_ca_system_score_gemma":0.00056400424,"threshold_uncertainty_score":0.016175628},"labels":[],"label_agreement":null},{"id":"W4400125754","doi":"10.1093/bjd/ljae090.072","title":"P045 An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Delphi method; Facilitator; Medicine; Psoriasis; Disease; Likert scale; Delphi; Family medicine; Intensive care medicine; Psychology; Pathology; Dermatology; Computer science; Artificial intelligence","score_opus":0.0435485983189179,"score_gpt":0.30582179960449596,"score_spread":0.2622732012855781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400125754","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14842413,0.030285625,0.3680592,0.16476965,0.010657378,0.16306137,0.0028748536,0.00054464414,0.111323155],"genre_scores_gemma":[0.50423706,0.008883467,0.3859185,0.016227156,0.00075152906,0.07980555,0.0012396034,0.00019233832,0.0027447168],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.6596841,0.28660873,0.028946389,0.003920691,0.015784305,0.0050557447],"domain_scores_gemma":[0.81213623,0.11484674,0.010615753,0.0064249425,0.050867837,0.005108482],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2986754,0.0016512186,0.0018153777,0.007440149,0.004612886,0.0059006717,0.004272578,0.0045240573,0.0058772424],"category_scores_gemma":[0.2426579,0.0014524196,0.003962517,0.004181698,0.00910299,0.007626405,0.019497152,0.0066881864,0.001772988],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010047375,0.00057086704,0.017127449,0.041590508,0.00062718795,0.0019273205,0.2862278,0.004321003,0.008407843,0.14456461,0.108580135,0.38505062],"study_design_scores_gemma":[0.0010110241,0.0021800955,0.024346713,0.090026,0.0005144213,0.0039444286,0.26192024,0.016001068,0.0053479215,0.1653223,0.4284918,0.0008940168],"about_ca_topic_score_codex":0.0032357723,"about_ca_topic_score_gemma":0.0020516426,"teacher_disagreement_score":0.2986754,"about_ca_system_score_codex":0.01026599,"about_ca_system_score_gemma":0.039865963,"threshold_uncertainty_score":0.8648581},"labels":[],"label_agreement":null},{"id":"W4400125898","doi":"10.1093/bjd/ljae090.149","title":"BH02 (P100) Critically appraised topic: is dupilumab a cause or a treatment for alopecia areata? A case series and literature review to guide discussions in clinical practice","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Changi General Hospital; NYU Grossman School of Medicine; Uniwersytet Warszawski; Victoria University; Università di Bologna; Universidade de São Paulo; University of Pennsylvania; Inyuvesi Yakwazulu-Natali; York University; Warszawski Uniwersytet Medyczny; University of Minnesota; Yale University","keywords":"Alopecia areata; Dupilumab; Dermatology; Medicine; Clinical Practice; Family medicine; Atopic dermatitis","score_opus":0.03473036972189514,"score_gpt":0.4212446598299633,"score_spread":0.38651429010806815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400125898","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015436718,0.8834303,0.004471261,0.04497851,0.023198051,0.0030151969,0.00086704275,0.00018728506,0.024415534],"genre_scores_gemma":[0.16614272,0.7312195,0.015223339,0.038796317,0.034777805,0.0030001039,0.0014948469,0.00018160958,0.009163852],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9920562,0.0026253422,0.0034633572,0.00027857575,0.0013597282,0.0002168255],"domain_scores_gemma":[0.94672275,0.02771483,0.011997498,0.0011129908,0.010698231,0.0017537208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006439887,0.0008158991,0.0016532503,0.012079273,0.0011402555,0.0031057203,0.0011110817,0.003571841,0.0065797097],"category_scores_gemma":[0.049181603,0.00051221077,0.0009274883,0.005402868,0.0020899542,0.003583361,0.0018691854,0.00206542,0.0026653719],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068162737,0.00018157627,0.01304418,0.18358749,0.0004308533,0.10421833,0.004744476,0.00033463715,0.004993491,0.003394385,0.27751523,0.4068738],"study_design_scores_gemma":[0.00018221766,0.00034332194,0.010680516,0.23766793,0.0010054689,0.17186654,0.0068505546,0.00049710064,0.0016838884,0.0050432314,0.56399065,0.00018863493],"about_ca_topic_score_codex":0.00078104786,"about_ca_topic_score_gemma":0.0011955143,"teacher_disagreement_score":0.012079273,"about_ca_system_score_codex":0.0018087435,"about_ca_system_score_gemma":0.0042868378,"threshold_uncertainty_score":0.034057736},"labels":[],"label_agreement":null},{"id":"W4400126202","doi":"10.1093/bjd/ljae090.360","title":"H12 A history of evidence-based medicine and dermatology as an early adopter","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Early adopter; Dermatology; Medicine; Business; Marketing","score_opus":0.086125059983983,"score_gpt":0.32258545766525754,"score_spread":0.23646039768127453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400126202","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005208301,0.26387045,0.0023856827,0.6784305,0.034489673,0.000035194957,0.00007325444,0.000037125563,0.020157274],"genre_scores_gemma":[0.03694003,0.2954256,0.0068769553,0.5639867,0.081233315,0.0002234777,0.00010665924,0.00017737667,0.015029923],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.979258,0.011071825,0.001729092,0.0018572365,0.005383959,0.00069983467],"domain_scores_gemma":[0.9170467,0.055159952,0.0024301694,0.0031009752,0.016566474,0.005695682],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.032172356,0.0007629934,0.001666925,0.005622206,0.0033500907,0.011203227,0.0016242872,0.014123284,0.008928375],"category_scores_gemma":[0.060975414,0.0006737014,0.00095524435,0.0035001226,0.025711337,0.018067691,0.006174871,0.030253006,0.0037907679],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016814166,0.00017887974,0.0009821691,0.0024238452,0.00007803722,0.00045921703,0.003305098,0.00019047188,0.00032157157,0.38033426,0.4242625,0.18729591],"study_design_scores_gemma":[0.000042113694,0.0000782761,0.0006085605,0.0049945954,0.000013602812,0.0005815835,0.0007714353,0.00010169984,0.00010789324,0.08721745,0.90542805,0.000054728025],"about_ca_topic_score_codex":0.004632228,"about_ca_topic_score_gemma":0.00330831,"teacher_disagreement_score":0.9966499,"about_ca_system_score_codex":0.010530677,"about_ca_system_score_gemma":0.009130343,"threshold_uncertainty_score":0.17014569},"labels":[],"label_agreement":null},{"id":"W4400126522","doi":"10.1093/bjd/ljae090.282","title":"PA27 Expanding the phenotype of congenital erosive and vesicular dermatosis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Neonatal skin health care","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Phenotype; Biology; Dermatology; Medicine; Genetics; Gene","score_opus":0.023230449203279078,"score_gpt":0.3603552881156795,"score_spread":0.3371248389124004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400126522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97106117,0.0025696373,0.002116993,0.0011733284,0.00023996727,0.00013503707,0.000554004,0.00028204924,0.02186775],"genre_scores_gemma":[0.9950324,0.0007890906,0.001052478,0.00029499098,0.00012654356,0.00002453416,0.00026595072,0.00005763964,0.00235635],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99962664,0.000041299212,0.000028482396,0.000085590604,0.00007157975,0.00014633105],"domain_scores_gemma":[0.9991322,0.00018637675,0.00018416886,0.00006273182,0.000110404144,0.00032419083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019486366,0.0015206097,0.00058250624,0.0013757173,0.0009011977,0.0010366302,0.0008507728,0.0018882792,0.0056208624],"category_scores_gemma":[0.0019257374,0.00043646796,0.00064742664,0.0008131027,0.00068010046,0.000832064,0.0011063525,0.0018284424,0.0022695917],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005321843,0.000059059592,0.015908688,0.00005100027,0.000011721238,0.96852154,0.0001764442,0.00015537739,0.008000523,0.0006424908,0.000995158,0.005424748],"study_design_scores_gemma":[0.0000071718623,0.000057318764,0.012211978,0.000020471656,0.0000064119654,0.984772,0.000097644595,0.00023704105,0.0007898136,0.00020516854,0.0015838176,0.000011144883],"about_ca_topic_score_codex":0.0019404071,"about_ca_topic_score_gemma":0.0014316712,"teacher_disagreement_score":0.0056208624,"about_ca_system_score_codex":0.0004954269,"about_ca_system_score_gemma":0.00047148706,"threshold_uncertainty_score":0.018803656},"labels":[],"label_agreement":null},{"id":"W4400126687","doi":"10.1093/bjd/ljae090.229","title":"DP07 Diagnostic implication of skin biopsy for a rare neurodegenerative disorder","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Skin biopsy; Medicine; Dermatology; Biopsy; Pathology","score_opus":0.01592835470188757,"score_gpt":0.28068188734154764,"score_spread":0.26475353263966006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400126687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9385363,0.007823562,0.008770967,0.002907771,0.00065802137,0.0002657316,0.00070613733,0.00039555583,0.03993607],"genre_scores_gemma":[0.99428904,0.0008551535,0.0024179476,0.00080567325,0.00026810056,0.00002073461,0.00019004977,0.000018172805,0.0011351043],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99935204,0.00015517816,0.0000625475,0.00014048541,0.0001134946,0.00017624786],"domain_scores_gemma":[0.9992512,0.00021760678,0.00007905495,0.000054937715,0.00014241552,0.0002546698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004559309,0.00082251645,0.00040882846,0.0017910055,0.0010959243,0.00092964666,0.0006029403,0.0021244688,0.0041936305],"category_scores_gemma":[0.0013370329,0.0003139018,0.00037240153,0.0005123231,0.00059287436,0.0008396607,0.0006812851,0.0010553679,0.0017903424],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072480056,0.00007340993,0.02749326,0.00009264587,0.000015829053,0.95553243,0.00011590015,0.00006967421,0.009529405,0.0002498842,0.0013971829,0.005357942],"study_design_scores_gemma":[0.00001631649,0.00012888298,0.013834379,0.00008202792,0.00002466474,0.977495,0.0003724918,0.0007277108,0.003424115,0.0003126012,0.0035705287,0.000011156119],"about_ca_topic_score_codex":0.00089966453,"about_ca_topic_score_gemma":0.0010381606,"teacher_disagreement_score":0.0041936305,"about_ca_system_score_codex":0.00039586716,"about_ca_system_score_gemma":0.00034637313,"threshold_uncertainty_score":0.014029086},"labels":[],"label_agreement":null},{"id":"W4400639687","doi":"10.1093/bjd/ljae289","title":"Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"LEO Pharma; Galderma; ZonMw; Sanofi; Novartis; Pfizer","keywords":"Dupilumab; Eosinophilia; Medicine; Atopic dermatitis; Hypereosinophilia; Eosinophil; Cohort; Incidence (geometry); Dermatology; Eczema Area and Severity Index; SCORAD; Single Center; Internal medicine; Immunology; Dermatology Life Quality Index; Asthma","score_opus":0.007402441772108903,"score_gpt":0.22091670103209543,"score_spread":0.21351425925998652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400639687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99831235,0.00018557848,0.000096841155,0.000016754919,0.0000066214457,0.000027506103,0.00092009665,0.0000038106782,0.00043045377],"genre_scores_gemma":[0.99827623,0.00013115171,0.00010458002,0.000025793135,0.000014301055,0.000035772064,0.0011497326,0.000004228791,0.0002582256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999046,0.00037348797,0.00008590756,0.0002347441,0.0001667728,0.00009309787],"domain_scores_gemma":[0.99849916,0.00024479153,0.0007166904,0.00022311173,0.00014760983,0.00016871192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009228104,0.00028787655,0.00041621228,0.0006419136,0.0004392318,0.0006976394,0.00035270635,0.00030299506,0.0013702954],"category_scores_gemma":[0.0023069747,0.00033932476,0.00051920064,0.00084589364,0.00020187926,0.000531994,0.0004996517,0.00038188085,0.00040311032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035754667,0.00009349066,0.99697185,0.00001901424,0.000120709876,0.00016487067,0.000106862375,0.000027915159,0.00031643533,0.000012640198,0.0003214733,0.0014870907],"study_design_scores_gemma":[0.000066967536,0.00024983083,0.997592,0.000011268885,0.0001271582,0.00083431636,0.00022976918,0.00018023477,0.00009487873,0.000009120323,0.0005961189,0.000008333772],"about_ca_topic_score_codex":0.006756855,"about_ca_topic_score_gemma":0.011321229,"teacher_disagreement_score":0.006756855,"about_ca_system_score_codex":0.0003342005,"about_ca_system_score_gemma":0.0003154468,"threshold_uncertainty_score":0.013435006},"labels":[],"label_agreement":null},{"id":"W4401322385","doi":"10.1093/bjd/ljae316","title":"Addressing the unmet care needs of people with hidradenitis suppurativa","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital; University of Calgary","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Quality of life (healthcare); Perspective (graphical); Health professionals; Health care; MEDLINE; Family medicine; Nursing; Disease; Pathology","score_opus":0.025502725536028482,"score_gpt":0.2946934402149817,"score_spread":0.26919071467895317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401322385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5071124,0.06692831,0.0011476739,0.36178562,0.0036477332,0.00013072406,0.00036234042,0.00008354316,0.058801744],"genre_scores_gemma":[0.9092518,0.038190667,0.0032166995,0.04140826,0.0012589727,0.00010234424,0.00020128142,0.000024165047,0.006345814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820304,0.00089081004,0.00011202608,0.00005266705,0.00026092862,0.00048056373],"domain_scores_gemma":[0.99796474,0.00040377345,0.00034169367,0.000029664163,0.00027502494,0.0009851572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001336688,0.00018653019,0.0005057204,0.00031090082,0.0021500723,0.00153579,0.00036519291,0.0019192667,0.0047502965],"category_scores_gemma":[0.0043749507,0.0001603451,0.00048255618,0.00038875555,0.0006858994,0.0013866561,0.0022927762,0.0021697774,0.0006057497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050107087,0.0011744655,0.14480415,0.0053943247,0.00031735995,0.012533116,0.06546374,0.0005342857,0.006567663,0.007273443,0.18640386,0.5690326],"study_design_scores_gemma":[0.0002495205,0.0023056648,0.2332601,0.006259156,0.0002624156,0.023199743,0.2306973,0.00085530774,0.000970673,0.017581027,0.48408917,0.0002698212],"about_ca_topic_score_codex":0.0030173282,"about_ca_topic_score_gemma":0.008483502,"teacher_disagreement_score":0.0047502965,"about_ca_system_score_codex":0.00085132057,"about_ca_system_score_gemma":0.0024612283,"threshold_uncertainty_score":0.015891254},"labels":[],"label_agreement":null},{"id":"W4401435844","doi":"10.1093/bjd/ljae266.035","title":"656 - Systemic exposure and safety profile of delgocitinib cream in adults with moderate to severe chronic hand eczema in the phase 3 DELTA-2 trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dupuytren's Contracture and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Adverse effect; Cmax; Pharmacokinetics; Randomized controlled trial; Janus kinase inhibitor; Oral administration; Double blind; Internal medicine; Gastroenterology; Placebo; Pathology","score_opus":0.007961776991061527,"score_gpt":0.2664089137337084,"score_spread":0.25844713674264685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636877,0.001182163,0.00019343311,0.000108724606,0.00002953918,0.00058447407,0.000520238,0.000021447522,0.0009911113],"genre_scores_gemma":[0.99717134,0.00032475716,0.00031424413,0.00023955546,0.000046905207,0.00042119666,0.0006480179,0.0000041031817,0.0008298245],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996593,0.0001544157,0.000024808465,0.00006689119,0.00004685415,0.00004783188],"domain_scores_gemma":[0.99974006,0.00006382928,0.00007159982,0.000017530818,0.000029906365,0.000077067954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009444264,0.00036562956,0.0008277699,0.00012612052,0.00019481833,0.00044160726,0.00018990709,0.00044973023,0.0026257357],"category_scores_gemma":[0.00061096664,0.00015467957,0.00054310664,0.00010765587,0.00018691563,0.00026683634,0.00014861993,0.0007395684,0.00040797933],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7858526,0.014239039,0.03355283,0.00088889955,0.0011440865,0.000360135,0.00016886031,0.0011220418,0.063464396,0.0001501372,0.003464387,0.095592536],"study_design_scores_gemma":[0.4082109,0.46696198,0.09921467,0.0000946505,0.0012799846,0.0008929002,0.00010817718,0.002530259,0.014166398,0.0002527758,0.006246722,0.000040560913],"about_ca_topic_score_codex":0.00021286319,"about_ca_topic_score_gemma":0.00065102556,"teacher_disagreement_score":0.0026257357,"about_ca_system_score_codex":0.00027765613,"about_ca_system_score_gemma":0.00039159748,"threshold_uncertainty_score":0.0087839365},"labels":[],"label_agreement":null},{"id":"W4401435845","doi":"10.1093/bjd/ljae266.024","title":"644 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an interim analysis of week 20-32 data from a real-world multicenter retrospective review","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Probity Medical Research; Sunnybrook Health Science Centre; SKiN Health; University of Toronto; University of Calgary","funders":"","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Adverse effect; Body surface area; Dermatology Life Quality Index; Incidence (geometry); Interim analysis; Internal medicine; Clinical endpoint; Retrospective cohort study; Dermatology; Clinical trial; Disease","score_opus":0.016441301462157786,"score_gpt":0.30373617075410314,"score_spread":0.28729486929194537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8703676,0.11197834,0.0011800043,0.00033775272,0.00005683874,0.0017374534,0.012034352,0.000026328038,0.002281435],"genre_scores_gemma":[0.980698,0.011068008,0.0012956499,0.00025734832,0.00006972563,0.00093257445,0.005385555,0.00000866402,0.00028449862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99000084,0.004099068,0.0029084296,0.0010544786,0.0016417057,0.00029541817],"domain_scores_gemma":[0.9659529,0.0108429,0.01674236,0.001821427,0.004177933,0.00046265463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0147052575,0.00030629447,0.0013195763,0.0019625148,0.00032610825,0.0015431885,0.00056929956,0.0005149382,0.0014153376],"category_scores_gemma":[0.02045356,0.00032982178,0.0036107479,0.0027680788,0.00032257146,0.000668459,0.0003716649,0.00038157063,0.00025009853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013608238,0.00026521698,0.8906426,0.014422478,0.02362193,0.0007014199,0.00040174654,0.0004464274,0.0014601722,0.00019602665,0.0018941418,0.052339572],"study_design_scores_gemma":[0.0029360317,0.004912583,0.9244589,0.0057589104,0.041680288,0.0027888364,0.00057207514,0.0007480879,0.0020692935,0.00012679672,0.013865242,0.000082916325],"about_ca_topic_score_codex":0.0022330957,"about_ca_topic_score_gemma":0.0049630054,"teacher_disagreement_score":0.0147052575,"about_ca_system_score_codex":0.0012010187,"about_ca_system_score_gemma":0.002430632,"threshold_uncertainty_score":0.07776976},"labels":[],"label_agreement":null},{"id":"W4401435846","doi":"10.1093/bjd/ljae266.014","title":"630 - Efficacy comparison of targeted systemic monotherapies including lebrikizumab for moderate-to-severe atopic dermatitis: a network meta-analysis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Internal medicine; Placebo; Randomized controlled trial; Psoriasis Area and Severity Index; SCORAD; Confidence interval; Clinical endpoint; Clinical trial; Dermatology Life Quality Index; Dermatology; Disease; Psoriasis","score_opus":0.0637753858043968,"score_gpt":0.3434577313322313,"score_spread":0.2796823455278345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435846","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037779752,0.9501193,0.0046835146,0.000620778,0.00082503905,0.0015735639,0.0029865806,0.0001737584,0.0012377239],"genre_scores_gemma":[0.805126,0.1775866,0.0066787936,0.0015350351,0.00052075274,0.003988624,0.003186684,0.00012127775,0.0012562026],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9812227,0.012461605,0.0027358227,0.002064862,0.0011665965,0.00034850862],"domain_scores_gemma":[0.9811307,0.014586035,0.0021974084,0.0007652998,0.0010125235,0.0003080131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021182528,0.003440271,0.019196793,0.0045583677,0.00057248765,0.003807347,0.0023358213,0.002463081,0.0057295403],"category_scores_gemma":[0.03164937,0.0015623829,0.063650824,0.004037836,0.00071369944,0.002043007,0.0017488735,0.0025867412,0.0005963882],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055664405,0.000024894172,0.0019045514,0.04284357,0.9459074,0.000039061568,0.000020915128,0.00076733733,0.000120597935,0.00007074647,0.00022691244,0.002507599],"study_design_scores_gemma":[0.002279258,0.00027119555,0.0017440156,0.0021162224,0.9923022,0.000025129457,0.000014608969,0.0005407451,0.000054447966,0.00018534611,0.00045178962,0.000015088051],"about_ca_topic_score_codex":0.005199816,"about_ca_topic_score_gemma":0.006224539,"teacher_disagreement_score":0.021182528,"about_ca_system_score_codex":0.0021073201,"about_ca_system_score_gemma":0.001966406,"threshold_uncertainty_score":0.1120252},"labels":[],"label_agreement":null},{"id":"W4401435862","doi":"10.1093/bjd/ljae266.060","title":"686 - Impact of dupilumab treatment on seasonal disease severity in adults with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Dermatology; Disease; Internal medicine","score_opus":0.00808920633286845,"score_gpt":0.26858783542475456,"score_spread":0.2604986290918861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994464,0.003346976,0.000065384425,0.00012544518,0.000057076217,0.00017894903,0.00036517857,0.00001739568,0.0013796898],"genre_scores_gemma":[0.9984787,0.0005335036,0.00016179848,0.00013369301,0.000056138284,0.000082103856,0.00021876142,0.0000013447315,0.00033404885],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99978226,0.00010127844,0.00001978822,0.000027411721,0.000028079385,0.00004116808],"domain_scores_gemma":[0.9997162,0.00006986827,0.000076757315,0.000011508114,0.000025649475,0.00010002625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005041129,0.00024831816,0.0008118779,0.000120360535,0.00020303458,0.00022754418,0.00014283675,0.00026628436,0.0029736424],"category_scores_gemma":[0.00058352953,0.00008664395,0.0006941298,0.00012216294,0.00013505817,0.00019217766,0.00011732889,0.00038605402,0.00023968573],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57104963,0.010441459,0.06949779,0.0021809435,0.001705365,0.00023053253,0.00014287849,0.0009246072,0.03107459,0.00013563284,0.0055452203,0.30707136],"study_design_scores_gemma":[0.11123336,0.37074018,0.503085,0.00021699478,0.001972628,0.00060516543,0.00016378533,0.0018851775,0.004327305,0.0001342827,0.005607709,0.000028273682],"about_ca_topic_score_codex":0.00086449867,"about_ca_topic_score_gemma":0.002506467,"teacher_disagreement_score":0.0029736424,"about_ca_system_score_codex":0.00018703633,"about_ca_system_score_gemma":0.0002997092,"threshold_uncertainty_score":0.009947836},"labels":[],"label_agreement":null},{"id":"W4401435864","doi":"10.1093/bjd/ljae266.021","title":"640 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research; Probity Medical Research; Queen's University","funders":"","keywords":"Tolerability; Medicine; Dermatology; Roflumilast; Dermis; Atopic dermatitis; Erythema; Psoriasis; Adverse effect; Transepidermal water loss; Stratum corneum; Pharmacology; Pathology; Internal medicine","score_opus":0.01592771776821899,"score_gpt":0.2840045594220336,"score_spread":0.2680768416538146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98791367,0.0059185135,0.0004611135,0.00027219113,0.00008928051,0.0029444536,0.00085809233,0.00006276327,0.0014799221],"genre_scores_gemma":[0.9942199,0.0010930995,0.0007397357,0.00036619013,0.000121582445,0.0024100903,0.0006053644,0.000009621207,0.0004344097],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99596477,0.0028455444,0.00038515785,0.00028339046,0.000264316,0.00025684145],"domain_scores_gemma":[0.99620676,0.0014672155,0.0012313557,0.0002022042,0.00029682353,0.0005956779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007410989,0.0010291267,0.002318447,0.00045677676,0.00054086535,0.0008659084,0.00057205895,0.0010406694,0.003407292],"category_scores_gemma":[0.0051498762,0.00055637804,0.0029730236,0.00054482545,0.00061036716,0.0009907845,0.00036470825,0.0019949963,0.0005135307],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85992455,0.021331793,0.026713949,0.001963819,0.0046731303,0.00021801062,0.0004013502,0.0012122883,0.016059583,0.000102597645,0.0018716594,0.06552724],"study_design_scores_gemma":[0.5403187,0.4012171,0.050812572,0.00009271851,0.0021180452,0.0002772819,0.000112543574,0.0009888654,0.002025966,0.00013809737,0.0018555273,0.00004264732],"about_ca_topic_score_codex":0.00048107086,"about_ca_topic_score_gemma":0.0016064331,"teacher_disagreement_score":0.007410989,"about_ca_system_score_codex":0.00066298235,"about_ca_system_score_gemma":0.0010909749,"threshold_uncertainty_score":0.03919351},"labels":[],"label_agreement":null},{"id":"W4401435875","doi":"10.1093/bjd/ljae266.045","title":"671 - Rapid and early onset of itch relief with tapinarof cream 1% once daily in two pivotal phase 3 trials in adults and children down to two years of age with atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Eczema Area and Severity Index; Atopic dermatitis; Randomized controlled trial; Quality of life (healthcare); Dermatology Life Quality Index; Clinical trial; Young adult; Severity of illness; Dermatology; Internal medicine; Disease","score_opus":0.008924834989019722,"score_gpt":0.29425078418172296,"score_spread":0.2853259491927032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98010844,0.009142067,0.0005693669,0.00060572615,0.00032226095,0.0054328465,0.0016301088,0.00007708012,0.002112056],"genre_scores_gemma":[0.9815155,0.005765562,0.001920207,0.0010167107,0.00034699318,0.0052264077,0.0018529056,0.000021488979,0.0023342043],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991216,0.00042648107,0.00008729306,0.00009952509,0.00008286483,0.00018218576],"domain_scores_gemma":[0.9990182,0.00023057435,0.00020417472,0.000051615774,0.00011168375,0.00038374437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024578727,0.0012432911,0.0019726567,0.00041632578,0.00043695522,0.0009952342,0.00055974536,0.0015325746,0.0053182757],"category_scores_gemma":[0.0015081255,0.0004947586,0.002048201,0.0003661416,0.00065132877,0.0008052307,0.00032442718,0.001833208,0.00071497855],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87545246,0.026343422,0.004313967,0.0021520643,0.0014223246,0.00025408895,0.0002724573,0.00037775366,0.02353158,0.00025670114,0.0031388607,0.062484346],"study_design_scores_gemma":[0.7127441,0.27574363,0.0068838615,0.0001167656,0.0005378471,0.00016524117,0.000054380544,0.00018230277,0.0012683765,0.00010239892,0.0021791214,0.000021928563],"about_ca_topic_score_codex":0.00078420405,"about_ca_topic_score_gemma":0.0028582092,"teacher_disagreement_score":0.0053182757,"about_ca_system_score_codex":0.00053918175,"about_ca_system_score_gemma":0.0011332672,"threshold_uncertainty_score":0.01779145},"labels":[],"label_agreement":null},{"id":"W4401435878","doi":"10.1093/bjd/ljae266.097","title":"724 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled study to evaluate the efficacy and safety of rezpegaldesleukin in adults with severe to very-severe alopecia areata","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; University of Toronto","funders":"","keywords":"Alopecia areata; Medicine; Hair loss; Placebo; Atopic dermatitis; Internal medicine; Dermatology; Psoriasis; Gastroenterology; Immunology; Pathology","score_opus":0.014839006785408579,"score_gpt":0.30632501857114464,"score_spread":0.2914860117857361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9583856,0.007133019,0.0017569747,0.0009805292,0.0011142754,0.02377389,0.002554386,0.00038976263,0.0039115534],"genre_scores_gemma":[0.9500623,0.0037829352,0.0046435925,0.0031452077,0.0012275527,0.026831439,0.0023209872,0.000061563784,0.007924466],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99918324,0.0003852978,0.000051183295,0.00016546706,0.00008156859,0.00013318166],"domain_scores_gemma":[0.9992902,0.00014501363,0.00014211026,0.00006001515,0.000083123574,0.00027941237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022733773,0.0024032989,0.0038001286,0.0005408994,0.0006337575,0.0011281435,0.0011961847,0.0024852504,0.012248098],"category_scores_gemma":[0.0012551765,0.0008886458,0.0015898803,0.0003733672,0.0012566587,0.001229071,0.00037337857,0.0029370273,0.0021537798],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9454146,0.027613433,0.0004710125,0.0008512301,0.0006373835,0.00005954891,0.000042592645,0.00019258038,0.007333683,0.000104149825,0.0010557541,0.01622415],"study_design_scores_gemma":[0.8940819,0.10419673,0.0006486686,0.000015412154,0.000120689234,0.000023745659,0.000007953367,0.00014428845,0.00023712244,0.000051183415,0.00046303007,0.000009322748],"about_ca_topic_score_codex":0.00062985404,"about_ca_topic_score_gemma":0.0012721586,"teacher_disagreement_score":0.012248098,"about_ca_system_score_codex":0.00074444525,"about_ca_system_score_gemma":0.0014636647,"threshold_uncertainty_score":0.04097396},"labels":[],"label_agreement":null},{"id":"W4401435885","doi":"10.1093/bjd/ljae266.036","title":"657 - Impact of pruritus on patient fatigue: a case-control study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology Life Quality Index; Quality of life (healthcare); Internal medicine; Odds ratio; Depression (economics); Cohort; Itching; Disease; Dermatology","score_opus":0.014405252670214572,"score_gpt":0.3146136763410321,"score_spread":0.3002084236708175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663216,0.0010579766,0.00059031235,0.000044155066,0.00001874374,0.00022789038,0.00070155563,0.0000087518165,0.00071847544],"genre_scores_gemma":[0.9983758,0.00021242812,0.00034294216,0.000069193586,0.0000340416,0.0001527591,0.00064286817,0.0000030581537,0.00016692719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979272,0.00076992833,0.0002625697,0.0006227749,0.0002773135,0.00014022023],"domain_scores_gemma":[0.99764305,0.00069552637,0.0007847675,0.0003902575,0.00027301142,0.00021325694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019453216,0.0004084169,0.00056807866,0.0013209601,0.000801959,0.00074486644,0.0006475911,0.0008012185,0.003323486],"category_scores_gemma":[0.0043184324,0.0004232454,0.000880316,0.0014036248,0.0004698882,0.00046778042,0.0005188692,0.00045755424,0.0004529268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010067407,0.0006263007,0.99283147,0.00017923651,0.00051650894,0.00048337868,0.0002274387,0.000053170053,0.00050179515,0.000100370235,0.00035375953,0.0031197637],"study_design_scores_gemma":[0.00029576637,0.0015353343,0.99381715,0.00006370481,0.00050619326,0.0017289221,0.0002347834,0.00049527857,0.00014393072,0.00008447077,0.0010768097,0.0000176741],"about_ca_topic_score_codex":0.0035745965,"about_ca_topic_score_gemma":0.0036632125,"teacher_disagreement_score":0.0035745965,"about_ca_system_score_codex":0.00045277894,"about_ca_system_score_gemma":0.00039582356,"threshold_uncertainty_score":0.011118174},"labels":[],"label_agreement":null},{"id":"W4401435911","doi":"10.1093/bjd/ljae266.034","title":"655 - Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with chronic hand eczema: results of the phase 3 open-label extension DELTA-3 trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dupuytren's Contracture and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Queen's University","funders":"","keywords":"Medicine; Adverse effect; Clinical endpoint; Open label; Clinical trial; Delta; Internal medicine; Pediatrics","score_opus":0.022100597746292694,"score_gpt":0.33353116274289446,"score_spread":0.31143056499660177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287766,0.0029591487,0.0001792023,0.00024483795,0.000087589295,0.0009160757,0.0012452982,0.000038454316,0.0014518482],"genre_scores_gemma":[0.99415624,0.0009997996,0.0003943932,0.00055627164,0.0001211752,0.00086926814,0.001464099,0.000006774588,0.0014319998],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995328,0.00018849125,0.00004603455,0.00008511123,0.000058569272,0.00008894818],"domain_scores_gemma":[0.9991555,0.00015865262,0.00024423748,0.00006648685,0.00009118172,0.00028379937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019338892,0.000595824,0.001243535,0.00017919276,0.00043019545,0.0006546667,0.00040772717,0.00095482083,0.0034236868],"category_scores_gemma":[0.0009781665,0.00023265554,0.001329867,0.00018622063,0.00039794078,0.0006868352,0.00026323003,0.0019511554,0.00079559267],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85743624,0.023240156,0.012562299,0.0010462768,0.0014842311,0.00018111615,0.00017615642,0.00062776543,0.017042574,0.00010149246,0.0031145257,0.08298716],"study_design_scores_gemma":[0.5348753,0.40315172,0.051971518,0.00013067145,0.0014203815,0.00030799687,0.00008993218,0.00095043494,0.0031438381,0.00021551298,0.0037043311,0.00003845961],"about_ca_topic_score_codex":0.0006333074,"about_ca_topic_score_gemma":0.0019343494,"teacher_disagreement_score":0.0034236868,"about_ca_system_score_codex":0.00051756494,"about_ca_system_score_gemma":0.00062223466,"threshold_uncertainty_score":0.01145339},"labels":[],"label_agreement":null},{"id":"W4401435914","doi":"10.1093/bjd/ljae266.039","title":"661 - Efficacy and safety of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis (AD): a phase 2b trial (STREAM-AD)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Placebo; Clinical endpoint; Atopic dermatitis; Internal medicine; Clinical trial; Randomized controlled trial; Eczema Area and Severity Index; Double blind; Gastroenterology; Immunology; Pathology","score_opus":0.008430683096162642,"score_gpt":0.28471864149805526,"score_spread":0.27628795840189263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905771,0.0039884388,0.00019874923,0.00039578773,0.00020076531,0.0017416372,0.0007176454,0.00006413994,0.002115821],"genre_scores_gemma":[0.9893037,0.0022467677,0.0010413792,0.0009634182,0.00037855405,0.001816531,0.0013658243,0.000013041936,0.0028708014],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997068,0.00014926828,0.000020904588,0.000046489786,0.000029808049,0.0000468181],"domain_scores_gemma":[0.99968874,0.00006459487,0.00006729646,0.000017823337,0.000033209137,0.00012833328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011991896,0.00094436173,0.0014496779,0.00026491113,0.00027358157,0.00069109414,0.00039192612,0.00087877817,0.0052791825],"category_scores_gemma":[0.00064668665,0.0003152899,0.0009916915,0.00019765995,0.00047662467,0.00058896147,0.00022054998,0.0015108495,0.0010059414],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89192307,0.01952887,0.00384677,0.0012256032,0.0008304012,0.0000989546,0.00007719067,0.00043152936,0.018597586,0.00017957606,0.0032440394,0.06001634],"study_design_scores_gemma":[0.8238606,0.16377026,0.0079112705,0.000057349538,0.00043186013,0.00010843692,0.000022442428,0.0005009202,0.0012005507,0.00011450873,0.002008411,0.000013437279],"about_ca_topic_score_codex":0.00038732673,"about_ca_topic_score_gemma":0.0010933018,"teacher_disagreement_score":0.0052791825,"about_ca_system_score_codex":0.0004929227,"about_ca_system_score_gemma":0.0007766588,"threshold_uncertainty_score":0.017660618},"labels":[],"label_agreement":null},{"id":"W4401435925","doi":"10.1093/bjd/ljae266.068","title":"694 - Dupilumab improves itch and skin lesions in North American patients with prurigo nodularis: a subset analysis of the pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Probity Medical Research; University of British Columbia","funders":"","keywords":"Medicine; Dupilumab; Prurigo nodularis; Dermatology Life Quality Index; Eczema Area and Severity Index; Atopic dermatitis; Placebo; Internal medicine; Subgroup analysis; Quality of life (healthcare); Clinical trial; Dermatology; Clinical endpoint; Disease; Confidence interval; Pathology","score_opus":0.009748969031384842,"score_gpt":0.2840902866512158,"score_spread":0.27434131761983094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90381676,0.08517956,0.0012685473,0.0006540271,0.0003567747,0.0016060175,0.004019452,0.00010861563,0.002990248],"genre_scores_gemma":[0.98730075,0.0074191354,0.00084868603,0.00067953864,0.00023888722,0.0008151525,0.002164718,0.000021297898,0.0005118578],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964664,0.0021810776,0.0004295562,0.00045619893,0.00028389983,0.00018290766],"domain_scores_gemma":[0.99765515,0.0010472249,0.0006637695,0.00022615872,0.0002394985,0.00016816932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00651335,0.0013886839,0.0037310787,0.000667862,0.00037788154,0.0011423358,0.00046623856,0.000746503,0.0027555593],"category_scores_gemma":[0.005105212,0.0005679506,0.009261155,0.0008827779,0.00032099616,0.0006187927,0.0006241463,0.0008967966,0.00027449522],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6146593,0.00086966547,0.044868942,0.009351448,0.24016626,0.0003258862,0.00020568693,0.0010744128,0.0061365883,0.00013527462,0.0044034123,0.07780304],"study_design_scores_gemma":[0.3009487,0.045618303,0.25017327,0.0011625331,0.3867841,0.001085397,0.0003420978,0.0024558776,0.0019466167,0.0006104796,0.008698223,0.00017435144],"about_ca_topic_score_codex":0.0011579429,"about_ca_topic_score_gemma":0.005067335,"teacher_disagreement_score":0.00651335,"about_ca_system_score_codex":0.0005229493,"about_ca_system_score_gemma":0.0008385294,"threshold_uncertainty_score":0.03444636},"labels":[],"label_agreement":null},{"id":"W4401435930","doi":"10.1093/bjd/ljae266.003","title":"603 - Ruxolitinib cream 1.5% twice daily for the treatment of extensive atopic dermatitis in children aged 2–11 years: 52 week results from a maximum-use trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Tolerability; Discontinuation; Ruxolitinib; Adverse effect; Atopic dermatitis; Clinical trial; Janus kinase inhibitor; Internal medicine; Surgery; Pediatrics; Dermatology; Janus kinase; Myelofibrosis; Cytokine","score_opus":0.02266750183778903,"score_gpt":0.2817145184424843,"score_spread":0.25904701660469526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921687,0.004772505,0.00022884527,0.00022741545,0.00006148893,0.0006929141,0.00065108004,0.00002751891,0.0011693519],"genre_scores_gemma":[0.9952561,0.0016366916,0.00047661611,0.00035324835,0.00011152877,0.0006623811,0.00076755707,0.000009070394,0.0007266648],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990784,0.00047605933,0.00007228232,0.00013451172,0.000111066765,0.00012764665],"domain_scores_gemma":[0.99915624,0.00022972908,0.00021969057,0.00007971879,0.00006602972,0.00024865184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021113679,0.0006031035,0.0015179696,0.000178715,0.00028201792,0.0008665473,0.00049949146,0.0010019414,0.0026109447],"category_scores_gemma":[0.0011441306,0.0002785818,0.0016921641,0.00023027694,0.00043462616,0.0005996487,0.00030084114,0.0016837168,0.0004006105],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82790536,0.024874551,0.016160075,0.0028101448,0.003932758,0.00044608652,0.0003063502,0.0011920687,0.024238065,0.00022261856,0.0036783998,0.094233505],"study_design_scores_gemma":[0.71796906,0.21725668,0.054363597,0.00022546899,0.0020435036,0.0006430093,0.00012359172,0.0009030511,0.0030139093,0.00014108533,0.0032773055,0.000039764294],"about_ca_topic_score_codex":0.0005340587,"about_ca_topic_score_gemma":0.0018737315,"teacher_disagreement_score":0.0026109447,"about_ca_system_score_codex":0.00050391164,"about_ca_system_score_gemma":0.0005014615,"threshold_uncertainty_score":0.011166096},"labels":[],"label_agreement":null},{"id":"W4401435949","doi":"10.1093/bjd/ljae266.023","title":"643 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an analysis of short-term (week 8-20) data from a real-world multicenter retrospective review","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Probity Medical Research; Sunnybrook Health Science Centre; SKiN Health; University of Toronto; University of Calgary","funders":"","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Dermatology Life Quality Index; Body surface area; Adverse effect; Internal medicine; Clinical endpoint; Quality of life (healthcare); Dermatology; Clinical trial; Pediatrics; Disease","score_opus":0.015502671122553865,"score_gpt":0.2991949706967398,"score_spread":0.2836922995741859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435949","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46001425,0.5297788,0.00030857854,0.00037042671,0.000074468415,0.00049858144,0.007752741,0.0000096572285,0.0011926087],"genre_scores_gemma":[0.91802204,0.076579146,0.00064092135,0.0004290911,0.00012791756,0.000390412,0.003673797,0.0000068841787,0.00012982954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98814094,0.0028775726,0.005249092,0.0013596638,0.0021777279,0.00019500288],"domain_scores_gemma":[0.94896084,0.015601219,0.02857737,0.001386785,0.00488478,0.00058906374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00945803,0.00032821545,0.0018396762,0.004315653,0.00034017372,0.0016593301,0.00076609786,0.00066290936,0.0012420849],"category_scores_gemma":[0.022805553,0.00038084053,0.0027751273,0.0065210937,0.0005195705,0.00085352984,0.000430259,0.00036675594,0.00020465672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029237901,0.00013475496,0.88030607,0.048224058,0.026157489,0.000761392,0.0004390543,0.00018799803,0.0007426204,0.00017247522,0.0016189258,0.03833138],"study_design_scores_gemma":[0.0009096001,0.0014623763,0.9195946,0.01773791,0.04206478,0.003922482,0.00091146276,0.00041482528,0.0008039282,0.00008634671,0.012021554,0.000070189075],"about_ca_topic_score_codex":0.003413423,"about_ca_topic_score_gemma":0.008775441,"teacher_disagreement_score":0.00945803,"about_ca_system_score_codex":0.0013109684,"about_ca_system_score_gemma":0.0023155767,"threshold_uncertainty_score":0.050019443},"labels":[],"label_agreement":null},{"id":"W4401435959","doi":"10.1093/bjd/ljae266.067","title":"693 - Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Placebo; Atopic dermatitis; Internal medicine; Tolerability; Apremilast; Population; Clinical endpoint; Psoriasis; Randomized controlled trial; Gastroenterology; Clinical trial; Adverse effect; Immunology; Disease; Psoriatic arthritis; Pathology","score_opus":0.018068436978460722,"score_gpt":0.3136291326597535,"score_spread":0.2955606956812928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98236644,0.0068761627,0.00046118323,0.000583473,0.00047883674,0.004758602,0.0019891267,0.00010425907,0.00238188],"genre_scores_gemma":[0.98294294,0.003323986,0.0018826552,0.0013994843,0.00068389386,0.0048154923,0.0018732358,0.00001860922,0.0030597735],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993868,0.00029979213,0.00006280736,0.00010687296,0.00006477704,0.00007898579],"domain_scores_gemma":[0.9994211,0.00013610479,0.00015227,0.000032796775,0.000066630855,0.00019119403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023103037,0.0014731424,0.0025260542,0.00035052447,0.0003757415,0.0007841823,0.0005639978,0.0015876823,0.008873611],"category_scores_gemma":[0.0011406395,0.0005674514,0.0018658023,0.0002717579,0.0006665514,0.0007237773,0.00028166512,0.0019702963,0.0011371971],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96756506,0.009756155,0.0011112075,0.0009028623,0.0007688097,0.00003923411,0.00003569636,0.00014167957,0.0051171,0.00006349526,0.00092661317,0.013572221],"study_design_scores_gemma":[0.8908549,0.10405155,0.0030923034,0.00003951372,0.00047321894,0.000036209793,0.000010600667,0.00018080843,0.00049061165,0.000058649268,0.0007014105,0.000010103774],"about_ca_topic_score_codex":0.00030495154,"about_ca_topic_score_gemma":0.00087422726,"teacher_disagreement_score":0.008873611,"about_ca_system_score_codex":0.00035735607,"about_ca_system_score_gemma":0.00077377784,"threshold_uncertainty_score":0.0296852},"labels":[],"label_agreement":null},{"id":"W4401435984","doi":"10.1093/bjd/ljae266.026","title":"647 - Upadacitinib dose alterations in adolescent and adult patients with atopic dermatitis: a real-world multicenter retrospective review","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Probity Medical Research; Sunnybrook Health Science Centre; SKiN Health; University of Calgary; University of Toronto","funders":"","keywords":"Medicine; Eczema Area and Severity Index; Dosing; Atopic dermatitis; Adverse effect; Dermatology Life Quality Index; Context (archaeology); Body surface area; Incidence (geometry); Retrospective cohort study; Internal medicine; Dermatology; Disease","score_opus":0.0215756722092803,"score_gpt":0.3361874794010688,"score_spread":0.3146118071917885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.617862,0.37018868,0.0006618138,0.00052123994,0.00012270038,0.000678829,0.0066545047,0.000015777736,0.003294415],"genre_scores_gemma":[0.9154477,0.07934896,0.0006361141,0.00061986304,0.0001669702,0.00029295214,0.0032304723,0.000009842973,0.00024714798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966229,0.00061293633,0.0013482562,0.0006399781,0.0006541241,0.00012182007],"domain_scores_gemma":[0.988639,0.0029682594,0.005832363,0.00045643753,0.0018317112,0.0002721233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027318643,0.0002171598,0.000922149,0.0024915459,0.00040674073,0.0009921282,0.0005922895,0.00042339304,0.0017302486],"category_scores_gemma":[0.0068195607,0.00029405244,0.00085201405,0.0048812022,0.0004622743,0.000565516,0.00039807206,0.000303278,0.00028763484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004523049,0.00008221788,0.9391952,0.013127541,0.0015662628,0.0023534913,0.0004546105,0.00007181594,0.00045313063,0.00025150177,0.002984518,0.03900748],"study_design_scores_gemma":[0.0001695486,0.0004992646,0.93812144,0.008942282,0.0045644054,0.017352076,0.0017877877,0.00024006377,0.000610295,0.00008928961,0.027576337,0.000047286416],"about_ca_topic_score_codex":0.010104395,"about_ca_topic_score_gemma":0.014091516,"teacher_disagreement_score":0.010104395,"about_ca_system_score_codex":0.0011895003,"about_ca_system_score_gemma":0.002518689,"threshold_uncertainty_score":0.020091176},"labels":[],"label_agreement":null},{"id":"W4401436000","doi":"10.1093/bjd/ljae266.066","title":"692 - Dupilumab reduces atopic dermatitis lesion severity and extent in children &amp;lt;12 years of age with moderate-to-severe AD: interim results from the PEDISTAD real-world registry","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital; Université de Montréal; University of Calgary","funders":"","keywords":"Dupilumab; Eczema Area and Severity Index; Medicine; Atopic dermatitis; Methotrexate; Adverse effect; Observational study; Internal medicine; Dermatology; Pediatrics","score_opus":0.01726805268602429,"score_gpt":0.27635244748895926,"score_spread":0.259084394802935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832376,0.0024605682,0.00019521998,0.00024763416,0.000034376582,0.0002955286,0.011246231,0.00005826528,0.0022245147],"genre_scores_gemma":[0.982133,0.0013820565,0.00097605883,0.00027538446,0.00006561372,0.00044379217,0.013454706,0.000012886539,0.0012565618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865675,0.00066542096,0.00011767139,0.00017929182,0.00022649007,0.00015450748],"domain_scores_gemma":[0.9974547,0.0003804993,0.0013327225,0.00025240378,0.00026903857,0.00031063578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026640478,0.0004431608,0.00064834266,0.00031957997,0.0003044275,0.001038543,0.0005126086,0.00044058886,0.0031291011],"category_scores_gemma":[0.0022897688,0.00024041836,0.0011290776,0.0005374974,0.0003065121,0.0004031257,0.00050771085,0.00066443277,0.0007571681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13613676,0.0064940415,0.7244065,0.0010189835,0.003452199,0.0005493504,0.00026453647,0.0013009504,0.004544341,0.00016424175,0.01353744,0.108130775],"study_design_scores_gemma":[0.026612394,0.046341155,0.9137726,0.00019842021,0.002034494,0.0012135999,0.00026083362,0.0007047083,0.0019104801,0.000058855407,0.0068552084,0.000037224],"about_ca_topic_score_codex":0.0030975568,"about_ca_topic_score_gemma":0.007873748,"teacher_disagreement_score":0.0031291011,"about_ca_system_score_codex":0.00073249073,"about_ca_system_score_gemma":0.0008886322,"threshold_uncertainty_score":0.014088988},"labels":[],"label_agreement":null},{"id":"W4401436011","doi":"10.1093/bjd/ljae266.022","title":"641 - Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 trials of adults and children with atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research; University of Calgary","funders":"","keywords":"Atopic dermatitis; Medicine; Roflumilast; SCORAD; Dermatology Life Quality Index; Eczema Area and Severity Index; Tolerability; Randomized controlled trial; Internal medicine; Quality of life (healthcare); Adverse effect; Dermatology; Disease","score_opus":0.00957381112976554,"score_gpt":0.27291981456588693,"score_spread":0.2633460034361214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8551333,0.118237376,0.0018219117,0.00077626616,0.000653942,0.006387456,0.0122057805,0.00018322049,0.0046007517],"genre_scores_gemma":[0.97631,0.010096827,0.0012141551,0.0007583728,0.00034891017,0.0038974688,0.0060130265,0.000026599091,0.0013345573],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9948479,0.0032688656,0.0007185951,0.00056351855,0.00036963887,0.00023149372],"domain_scores_gemma":[0.9972982,0.00096435385,0.0010773977,0.00019198212,0.00026952583,0.00019865214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008632291,0.001555085,0.003901142,0.0009826462,0.00033573402,0.0014061119,0.0005690126,0.0011165789,0.0046718074],"category_scores_gemma":[0.005373478,0.0005961182,0.00935643,0.0008878984,0.00044461852,0.00080026855,0.0005272517,0.0011196076,0.00053784053],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83979416,0.0014932177,0.012124831,0.008232725,0.096320316,0.00012553915,0.00010904524,0.0009313712,0.004953611,0.00013257112,0.0028356337,0.032946963],"study_design_scores_gemma":[0.7790118,0.061459254,0.05417709,0.0008750556,0.09714646,0.00028343746,0.00008786858,0.00082232646,0.0014513098,0.00030511044,0.004308323,0.00007192446],"about_ca_topic_score_codex":0.00121185,"about_ca_topic_score_gemma":0.00275617,"teacher_disagreement_score":0.008632291,"about_ca_system_score_codex":0.0006833467,"about_ca_system_score_gemma":0.0012020722,"threshold_uncertainty_score":0.04565245},"labels":[],"label_agreement":null},{"id":"W4401436015","doi":"10.1093/bjd/ljae266.070","title":"696 - Sustained improvements over 140 weeks in signs, symptoms, and quality of life with upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis: integrated results from the phase 3 Measure Up 1 and Measure Up 2 studies","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Calgary","funders":"","keywords":"Medicine; Eczema Area and Severity Index; Placebo; Atopic dermatitis; Dermatology Life Quality Index; Quality of life (healthcare); Randomized controlled trial; Severity of illness; Internal medicine; Dermatology; Disease","score_opus":0.02017044620747292,"score_gpt":0.2930086273057454,"score_spread":0.27283818109827246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98654616,0.008290122,0.00033726954,0.00018620376,0.00007059817,0.0009801114,0.0020273821,0.00003418039,0.0015279581],"genre_scores_gemma":[0.99377704,0.0022478772,0.0005834276,0.0003114865,0.000053800355,0.000886074,0.0016289012,0.0000063431107,0.0005050231],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99907124,0.00041288257,0.00010339513,0.00012145731,0.00016139688,0.00012965537],"domain_scores_gemma":[0.9990447,0.00016500641,0.00036073342,0.00006754859,0.00016450361,0.0001975128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021755674,0.00043385645,0.0013270957,0.00028101358,0.0003026988,0.00082819,0.0003403356,0.0005124608,0.0021353238],"category_scores_gemma":[0.0014886659,0.00023599829,0.002684208,0.00041724398,0.00026771548,0.00056343013,0.00039910487,0.0012041654,0.00028158753],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56333673,0.017884316,0.0898224,0.005129195,0.017959937,0.00020574755,0.00044127216,0.0012769011,0.016181724,0.00029147122,0.0056502046,0.28182003],"study_design_scores_gemma":[0.21455634,0.30477044,0.4357062,0.0011744588,0.019271607,0.0008602311,0.00049070024,0.001749739,0.009522666,0.00047568147,0.011284583,0.00013732773],"about_ca_topic_score_codex":0.0007803604,"about_ca_topic_score_gemma":0.0025077034,"teacher_disagreement_score":0.0021755674,"about_ca_system_score_codex":0.00055441225,"about_ca_system_score_gemma":0.00080162013,"threshold_uncertainty_score":0.011505663},"labels":[],"label_agreement":null},{"id":"W4401436017","doi":"10.1093/bjd/ljae266.107","title":"734 - Efficacy and safety of upadacitinib vs dupliumab in adults and adolescents with moderate-to-severe atopic dermatitis: results of an open-label, efficacy assessor-blinded head-to-head phase 3b/4 study (Level Up)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Dupilumab; Eczema Area and Severity Index; Medicine; Atopic dermatitis; Internal medicine; Randomized controlled trial; Clinical trial; Dermatology; Gastroenterology","score_opus":0.040689143248115046,"score_gpt":0.35857249122525336,"score_spread":0.3178833479771383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99170154,0.0028921943,0.0002588954,0.0002883112,0.00019586182,0.0020317703,0.0012212825,0.00007540135,0.0013347123],"genre_scores_gemma":[0.9937588,0.0010998787,0.0006561162,0.0005891389,0.00021248356,0.0013433768,0.0008811265,0.0000142373165,0.0014447662],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99928814,0.00032293424,0.000055474557,0.00012561305,0.0000689605,0.00013886977],"domain_scores_gemma":[0.9988902,0.0002443781,0.00025348493,0.00007967674,0.00011648076,0.0004158174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015775347,0.0011124081,0.002751533,0.00042617111,0.00045794298,0.0011428059,0.0008706926,0.0016729278,0.0054048286],"category_scores_gemma":[0.0013265919,0.0005795206,0.0020881463,0.00032307438,0.00092934945,0.0011010708,0.00032729367,0.0030704322,0.0010485996],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93522966,0.01990126,0.002063959,0.0005955499,0.0014114819,0.00008299988,0.000080404985,0.00048219878,0.008421365,0.00009187565,0.00154038,0.030098801],"study_design_scores_gemma":[0.6484361,0.33868656,0.007197956,0.000053702202,0.0012190767,0.00012839817,0.00004738055,0.00069261726,0.002150281,0.00014323741,0.0012122076,0.000032426608],"about_ca_topic_score_codex":0.00080150564,"about_ca_topic_score_gemma":0.0020796799,"teacher_disagreement_score":0.0054048286,"about_ca_system_score_codex":0.0010850189,"about_ca_system_score_gemma":0.0012194489,"threshold_uncertainty_score":0.01808095},"labels":[],"label_agreement":null},{"id":"W4401436023","doi":"10.1093/bjd/ljae266.091","title":"718 - Dupilumab reduces the number of lesions in adult patients with prurigo nodularis presenting with multiple lesion morphologies: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Dupilumab; Medicine; Prurigo nodularis; Placebo; Adverse effect; Lesion; Eczema Area and Severity Index; Clinical trial; Internal medicine; Atopic dermatitis; Dermatology; Dermatology Life Quality Index; Surgery; Pathology; Disease","score_opus":0.01998264709892643,"score_gpt":0.3112154386162995,"score_spread":0.2912327915173731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85342747,0.13436471,0.0014580919,0.00075976626,0.0005050801,0.0025200045,0.0030067984,0.00018666609,0.0037713519],"genre_scores_gemma":[0.9797989,0.014812739,0.0011772558,0.0006697778,0.00036626527,0.0008631419,0.0016393393,0.000016164682,0.0006564077],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99856263,0.00078108057,0.00014628042,0.00023424238,0.0001624716,0.0001132342],"domain_scores_gemma":[0.99850607,0.00054414576,0.00047999868,0.00010700968,0.0001555416,0.00020714043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040924675,0.0012737105,0.0035611535,0.00042271576,0.0002580854,0.0010933533,0.0005685496,0.0009008349,0.0025759644],"category_scores_gemma":[0.002830626,0.00053811,0.005429577,0.00057994545,0.0004049458,0.00075119786,0.0003642522,0.0013383968,0.0003046197],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78899974,0.0025078384,0.014614023,0.008620486,0.05772614,0.00018813829,0.00012014824,0.001292213,0.0068528163,0.00011358711,0.0035662644,0.115398616],"study_design_scores_gemma":[0.73386496,0.13091165,0.077750325,0.0006477727,0.0484008,0.0006785363,0.000086509084,0.0015260722,0.0017298906,0.00025078232,0.004053927,0.000098685836],"about_ca_topic_score_codex":0.000723518,"about_ca_topic_score_gemma":0.0022685844,"teacher_disagreement_score":0.0040924675,"about_ca_system_score_codex":0.0005388814,"about_ca_system_score_gemma":0.0006481023,"threshold_uncertainty_score":0.021643281},"labels":[],"label_agreement":null},{"id":"W4401436033","doi":"10.1093/bjd/ljae266.020","title":"639 - Efficacy and safety of once-daily roflumilast cream 0.05% in pediatric patients 2 to 5 years of age with mild to moderate atopic dermatitis (INTEGUMENT-PED): a phase 3 randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; University of Calgary","funders":"","keywords":"Roflumilast; Eczema Area and Severity Index; Medicine; Atopic dermatitis; Tolerability; Adverse effect; Vomiting; Clinical endpoint; Randomized controlled trial; Internal medicine; Dermatology Life Quality Index; Fluticasone propionate; Gastroenterology; Asthma; Dermatology","score_opus":0.00699859495050022,"score_gpt":0.2653204882726066,"score_spread":0.2583218933221064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98183835,0.011694662,0.00041214193,0.00040386175,0.0002537678,0.0023033689,0.00092788023,0.000106253174,0.002059736],"genre_scores_gemma":[0.98805875,0.004860926,0.001087998,0.0008709235,0.0002702231,0.0027069862,0.00080404046,0.000018489234,0.0013216232],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995664,0.00019419016,0.00004201948,0.00008481169,0.00005161495,0.000060967795],"domain_scores_gemma":[0.99956244,0.00012329686,0.00011622525,0.00002051253,0.000033717486,0.00014383005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010369509,0.00090116204,0.002312789,0.00027477462,0.00030658193,0.0007014564,0.00054020435,0.001246004,0.006192051],"category_scores_gemma":[0.00079014525,0.0004308365,0.0015303727,0.0002884744,0.0005012304,0.0005427462,0.00019168372,0.0016170146,0.0008434621],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90257275,0.017931303,0.0039323075,0.002389947,0.0016791867,0.00028355984,0.00011424263,0.00040439502,0.012012762,0.000180105,0.0021457716,0.056353632],"study_design_scores_gemma":[0.8512591,0.13851984,0.006868316,0.000102582184,0.00069473725,0.00014137008,0.000030406056,0.00037625592,0.0007037076,0.000059431135,0.0012316068,0.00001265269],"about_ca_topic_score_codex":0.0008210619,"about_ca_topic_score_gemma":0.0022092748,"teacher_disagreement_score":0.006192051,"about_ca_system_score_codex":0.0005232709,"about_ca_system_score_gemma":0.0010445028,"threshold_uncertainty_score":0.020714521},"labels":[],"label_agreement":null},{"id":"W4401436035","doi":"10.1093/bjd/ljae266.029","title":"650 - Stability of long-term therapeutic responses to tralokinumab in adults with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University; University of British Columbia","funders":"","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Clinical trial; Post-hoc analysis; Quality of life (healthcare); Clinical endpoint; Dupilumab; Pediatrics; Internal medicine; Dermatology","score_opus":0.01436139911004404,"score_gpt":0.27611169599113256,"score_spread":0.26175029688108853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813724,0.00068556156,0.00008866615,0.000025089634,0.000005126885,0.000032811327,0.0005131904,0.000003186906,0.00050912297],"genre_scores_gemma":[0.99933666,0.000066870554,0.00004961783,0.000027907288,0.000014591607,0.000023692244,0.00039171282,9.330015e-7,0.00008808379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988232,0.00032956523,0.0001995543,0.00028075883,0.00021062283,0.00015621948],"domain_scores_gemma":[0.99703264,0.000860098,0.0013506473,0.00014469375,0.00028422996,0.00032772098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015192335,0.00020500943,0.0005522002,0.0005180106,0.00037755817,0.00055798324,0.0002873531,0.0003756937,0.003143767],"category_scores_gemma":[0.0034110295,0.00012330482,0.0006749903,0.0004954344,0.00022387995,0.00038690714,0.0003439439,0.00045217463,0.00033615998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052951737,0.00014623789,0.98594123,0.000067930116,0.00024555885,0.00007666151,0.000073198935,0.0000916259,0.00061291753,0.000022927214,0.00023763366,0.0071888166],"study_design_scores_gemma":[0.00013287234,0.0011556426,0.9974808,0.000009840762,0.000118998934,0.00030433235,0.00006244337,0.00019333402,0.00016833392,0.000021440133,0.00034751903,0.000004388169],"about_ca_topic_score_codex":0.0006980081,"about_ca_topic_score_gemma":0.0010182918,"teacher_disagreement_score":0.003143767,"about_ca_system_score_codex":0.0002910891,"about_ca_system_score_gemma":0.00023781821,"threshold_uncertainty_score":0.010516942},"labels":[],"label_agreement":null},{"id":"W4401436060","doi":"10.1093/bjd/ljae266.078","title":"704 - Effectiveness of atopic dermatitis patient education programs – a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Atopic dermatitis; Meta-analysis; Psychological intervention; Systematic review; SCORAD; Dermatology Life Quality Index; MEDLINE; Cochrane Library; Quality of life (healthcare); Modalities; Physical therapy; Disease; Pediatrics; Family medicine; Dermatology; Internal medicine; Psychiatry; Nursing","score_opus":0.03127070906240224,"score_gpt":0.34294951743209773,"score_spread":0.31167880836969547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008771228,0.9887136,0.0006260326,0.0001889965,0.00017871523,0.00066250726,0.0005286723,0.000029870784,0.00030038747],"genre_scores_gemma":[0.30010515,0.6907271,0.003397163,0.0010237702,0.00034994728,0.0029341439,0.0009963942,0.00003262813,0.00043362964],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.9908268,0.0042587114,0.0026744462,0.0009329964,0.0010168507,0.00029021094],"domain_scores_gemma":[0.9841834,0.011846832,0.0022292838,0.0004169713,0.0010675838,0.00025601857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012481469,0.0026116937,0.019115537,0.005708873,0.00072903733,0.0029083414,0.002127875,0.0024360628,0.00585873],"category_scores_gemma":[0.028214501,0.0015180613,0.04675834,0.005142784,0.00073301524,0.0019356644,0.001448223,0.0022866314,0.00036092175],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003376827,0.00011634086,0.0026564258,0.3905263,0.5891777,0.00009075233,0.000076760414,0.00047495848,0.0001359387,0.00012407923,0.0003722817,0.0128716435],"study_design_scores_gemma":[0.0011222285,0.00038762172,0.0026926126,0.023679843,0.9707718,0.000054312517,0.000041335374,0.00016236416,0.00008817111,0.0001275233,0.00085324416,0.000018886978],"about_ca_topic_score_codex":0.006335301,"about_ca_topic_score_gemma":0.0122349635,"teacher_disagreement_score":0.019115537,"about_ca_system_score_codex":0.0027745718,"about_ca_system_score_gemma":0.0037504947,"threshold_uncertainty_score":0.066009104},"labels":[],"label_agreement":null},{"id":"W4401436063","doi":"10.1093/bjd/ljae266.025","title":"645 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an analysis of long-term (week 52) data from a real-world multicenter retrospective review","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Health Sciences Centre; Probity Medical Research; Sunnybrook Health Science Centre; SKiN Health; Women's College Hospital; University of Toronto","funders":"","keywords":"Eczema Area and Severity Index; Atopic dermatitis; Medicine; Dermatology Life Quality Index; Body surface area; Adverse effect; Incidence (geometry); Internal medicine; Dermatology; Disease","score_opus":0.01451922208765543,"score_gpt":0.30003038764977336,"score_spread":0.2855111655621179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71243984,0.27864265,0.0003922034,0.00033207456,0.00004702369,0.00039806863,0.0064674136,0.000010316365,0.0012703609],"genre_scores_gemma":[0.961742,0.034404445,0.00052022695,0.00026853086,0.00007976899,0.00023972623,0.0026265618,0.0000049813702,0.000113749215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9900041,0.0028192033,0.0040043616,0.0011805691,0.0018036896,0.00018810476],"domain_scores_gemma":[0.9457859,0.015315871,0.031437907,0.0015850724,0.0052568866,0.0006184145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008833785,0.00026358766,0.0012950925,0.003679916,0.0003370847,0.0015174493,0.0006487123,0.0005356598,0.00095543603],"category_scores_gemma":[0.020641534,0.00030483786,0.0018159715,0.0059336224,0.0004953695,0.00065707444,0.00039831313,0.0002959633,0.00015613786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015702588,0.00007652261,0.94178396,0.016111184,0.010444937,0.0005365565,0.00033985858,0.000121269506,0.00061067875,0.00010521316,0.0008942718,0.027405316],"study_design_scores_gemma":[0.00046900162,0.0010351171,0.96175146,0.007348211,0.016442675,0.0030756397,0.0007281292,0.00031630872,0.00066914904,0.000051215775,0.008068311,0.00004468005],"about_ca_topic_score_codex":0.0040377364,"about_ca_topic_score_gemma":0.0092492355,"teacher_disagreement_score":0.008833785,"about_ca_system_score_codex":0.0011864026,"about_ca_system_score_gemma":0.0021110564,"threshold_uncertainty_score":0.04671806},"labels":[],"label_agreement":null},{"id":"W4401436065","doi":"10.1093/bjd/ljae266.083","title":"709 - Greater levels of itch relief and skin clearance correlate with improved patient outcomes in atopic dermatitis – real-world insights from TARGET-DERM AD","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology Life Quality Index; Quality of life (healthcare); Eczema Area and Severity Index; Observational study; Severity of illness; Patient-reported outcome; Physical therapy; Disease; Dermatology; Internal medicine","score_opus":0.007798387773227206,"score_gpt":0.23865282969070606,"score_spread":0.23085444191747886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968652,0.0005307902,0.000139772,0.00013718847,0.00001064049,0.000017099934,0.00053091475,0.0000069652847,0.0017612115],"genre_scores_gemma":[0.9994753,0.00008780664,0.00008238882,0.000034078603,0.000011522096,0.000006220728,0.00019843505,0.0000014654277,0.00010283068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924016,0.00028114536,0.00007092845,0.00017989115,0.00013884019,0.000089075686],"domain_scores_gemma":[0.9967032,0.0006443301,0.001848162,0.00018321686,0.0003217145,0.0002992641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013048601,0.00021205148,0.00031597988,0.0004791718,0.00032475925,0.0010333316,0.00023677992,0.00035592928,0.0039778147],"category_scores_gemma":[0.003581536,0.000117960255,0.0005156735,0.00076061697,0.0003664601,0.00053002354,0.00044701854,0.0005719194,0.00045234003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030469414,0.00011596294,0.9929969,0.00004191017,0.00010836679,0.000049480303,0.00008389083,0.000089321176,0.0002474907,0.00004300695,0.00022868684,0.005690268],"study_design_scores_gemma":[0.000009595062,0.00009317916,0.9991634,0.000010713829,0.00002773634,0.00011838252,0.00010905649,0.00016937374,0.000046934594,0.00007564424,0.00017175198,0.0000042407632],"about_ca_topic_score_codex":0.003272197,"about_ca_topic_score_gemma":0.0038337817,"teacher_disagreement_score":0.0039778147,"about_ca_system_score_codex":0.00043363977,"about_ca_system_score_gemma":0.00026899914,"threshold_uncertainty_score":0.013307095},"labels":[],"label_agreement":null},{"id":"W4401436072","doi":"10.1093/bjd/ljae266.076","title":"702 - IMG-007, a nondepleting OX40 monoclonal antibody with an extended half-life, improves skin lesions in adults with moderate-to-severe atopic dermatitis: interim results from a phase 2a trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Eczema Area and Severity Index; SCORAD; Atopic dermatitis; Body surface area; Internal medicine; Clinical trial; Antibody; Gastroenterology; Immunology; Dermatology Life Quality Index; Disease","score_opus":0.015276068778094258,"score_gpt":0.3079531878510824,"score_spread":0.29267711907298816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860908,0.0061964323,0.00052777596,0.00056164426,0.00014159136,0.0017764466,0.0013386451,0.00019993077,0.00316676],"genre_scores_gemma":[0.98630655,0.0030463408,0.0013854797,0.0018334521,0.00022387244,0.0017132997,0.002264752,0.000030076742,0.0031961584],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997749,0.000070679154,0.000014740939,0.00003447243,0.00002765015,0.000077578356],"domain_scores_gemma":[0.9996675,0.000055372755,0.00005348038,0.000018271285,0.000031900472,0.00017341762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012862423,0.0011496586,0.0012505787,0.00029512477,0.00027744312,0.0008097447,0.00058212,0.001149869,0.0027272215],"category_scores_gemma":[0.00035792272,0.0002672781,0.0011164864,0.00020904507,0.0004753139,0.0006665238,0.00023349754,0.0019647419,0.0006710508],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5334803,0.059538264,0.01372669,0.0023332667,0.0030953328,0.00070297706,0.00039098418,0.002280854,0.095952936,0.000606167,0.015001563,0.2728907],"study_design_scores_gemma":[0.51150626,0.4466852,0.02419516,0.00012325705,0.0010659194,0.0007109498,0.00006581614,0.0013243429,0.008046438,0.00033213076,0.00589738,0.000047144586],"about_ca_topic_score_codex":0.000530299,"about_ca_topic_score_gemma":0.0015445637,"teacher_disagreement_score":0.0027272215,"about_ca_system_score_codex":0.00047885402,"about_ca_system_score_gemma":0.000644895,"threshold_uncertainty_score":0.009123445},"labels":[],"label_agreement":null},{"id":"W4401436075","doi":"10.1093/bjd/ljae266.019","title":"638 - Long-term safety and efficacy of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis: a 52-week, phase 3, open-label extension trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; Queen's University; Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Adverse effect; Roflumilast; Clinical endpoint; Dosing; Internal medicine; Randomized controlled trial; Dermatology","score_opus":0.016784349340504354,"score_gpt":0.30022435900811295,"score_spread":0.2834400096676086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915782,0.0036872295,0.00016806438,0.0002906513,0.000105423154,0.0012352298,0.0012574507,0.00006353614,0.00161415],"genre_scores_gemma":[0.9920413,0.0018246376,0.00053038617,0.0007410708,0.0001401562,0.0016290192,0.0015594106,0.000013848167,0.0015202508],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995683,0.00015539983,0.000043927277,0.000094822215,0.00005276735,0.00008473602],"domain_scores_gemma":[0.99949074,0.00008358211,0.00012627877,0.00002549441,0.00005254538,0.00022132897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010950743,0.0007744727,0.0018544482,0.00021036333,0.00040829685,0.00065846834,0.00050172035,0.001109827,0.0051649543],"category_scores_gemma":[0.00072910724,0.00034701003,0.0012977745,0.00022556835,0.00039872646,0.00050975307,0.00023727778,0.0017228492,0.001546921],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80343,0.040835384,0.022360394,0.001823792,0.0018366374,0.00062692165,0.0003136244,0.0005100022,0.028117543,0.00013496647,0.005557747,0.094453],"study_design_scores_gemma":[0.6022949,0.3285392,0.06024449,0.00015272005,0.0009989247,0.0005829616,0.000114545895,0.00045481225,0.0019808072,0.000083090046,0.004524314,0.000029159257],"about_ca_topic_score_codex":0.0011013236,"about_ca_topic_score_gemma":0.003036387,"teacher_disagreement_score":0.0051649543,"about_ca_system_score_codex":0.00054193696,"about_ca_system_score_gemma":0.00093001925,"threshold_uncertainty_score":0.017278492},"labels":[],"label_agreement":null},{"id":"W4401436077","doi":"10.1093/bjd/ljae266.005","title":"619 - Lebrikizumab improves signs and symptoms of moderate-to-severe atopic dermatitis in patients not adequately controlled or non-eligible for cyclosporine: a placebo-controlled, randomized phase 3 clinical study (ADvantage)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Adverse effect; Placebo; Clinical endpoint; Concomitant; Randomized controlled trial; Randomization; Body surface area; Internal medicine; Potency; Dermatology","score_opus":0.014506074665990314,"score_gpt":0.33507238343301954,"score_spread":0.32056630876702924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336666,0.0024560005,0.00027896737,0.00030344905,0.00021716225,0.0020425739,0.00040113667,0.000068290785,0.000865806],"genre_scores_gemma":[0.9922701,0.0014605244,0.0010468282,0.0007068534,0.0003841382,0.0021622132,0.00048878696,0.000014246172,0.0014662505],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99946266,0.00024231957,0.000051965635,0.00008195912,0.000051418487,0.00010967457],"domain_scores_gemma":[0.99925715,0.00018479029,0.00016360804,0.00006490307,0.00006044055,0.00026913712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018299165,0.0010329738,0.0024425338,0.00034379622,0.0004601223,0.0008164533,0.00057178474,0.0011178033,0.006261699],"category_scores_gemma":[0.0009829918,0.0004993501,0.0016578506,0.000269132,0.0008576163,0.0008264021,0.00030448582,0.001988923,0.0006879351],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9478665,0.018670514,0.0016997597,0.0006059455,0.00052283116,0.000076583965,0.000047934485,0.00013908291,0.009676128,0.00008226586,0.0006569258,0.019955486],"study_design_scores_gemma":[0.82577443,0.16909204,0.0034133627,0.000025274823,0.00024717615,0.00006130561,0.000018962835,0.00019394919,0.0006873667,0.000046208123,0.00043059106,0.00000935214],"about_ca_topic_score_codex":0.00033193716,"about_ca_topic_score_gemma":0.001001398,"teacher_disagreement_score":0.006261699,"about_ca_system_score_codex":0.00039900574,"about_ca_system_score_gemma":0.00095507334,"threshold_uncertainty_score":0.020947516},"labels":[],"label_agreement":null},{"id":"W4401436082","doi":"10.1093/bjd/ljae266.051","title":"677 - Establishing a patient-centered definition of atopic dermatitis flare: insights from a modified eDelphi study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; Women's College Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Flare; Atopic dermatitis; Perspective (graphical); Anxiety; Rating scale; Delphi method; Focus group; Patient-reported outcome; Disease; Family medicine; Clinical psychology; Psychology; Quality of life (healthcare); Psychiatry; Nursing; Dermatology; Internal medicine; Developmental psychology","score_opus":0.023235446533182085,"score_gpt":0.26004902039709454,"score_spread":0.23681357386391247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697313,0.00034600298,0.007708591,0.0071117585,0.00013647805,0.0024580078,0.0001939008,0.000026543657,0.012287437],"genre_scores_gemma":[0.98595715,0.00035870285,0.0071557546,0.002559298,0.000029842355,0.0023883665,0.00008412227,0.000023226892,0.0014436052],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9376397,0.05461833,0.0015815246,0.0009988848,0.002625672,0.0025358254],"domain_scores_gemma":[0.9400707,0.047031283,0.0021259214,0.00135507,0.0070837867,0.0023333144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.070963025,0.00056056195,0.00050805433,0.0018007837,0.0048026163,0.0046985797,0.0017316138,0.0015469195,0.003555598],"category_scores_gemma":[0.06474155,0.0006234394,0.0007012856,0.0011469038,0.005083116,0.0041229483,0.008677499,0.0038315172,0.0006491573],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085939566,0.00024915198,0.011129285,0.00051504717,0.000018026285,0.00070896023,0.95650065,0.00014465732,0.00091009855,0.0033074282,0.0023530987,0.024077687],"study_design_scores_gemma":[0.000021427002,0.00026053694,0.0066759973,0.00054612936,0.000009580721,0.00035222768,0.9784963,0.000638073,0.00044888692,0.001789484,0.010710725,0.000050565028],"about_ca_topic_score_codex":0.0026215906,"about_ca_topic_score_gemma":0.003700635,"teacher_disagreement_score":0.070963025,"about_ca_system_score_codex":0.0043614395,"about_ca_system_score_gemma":0.007389081,"threshold_uncertainty_score":0.37529284},"labels":[],"label_agreement":null},{"id":"W4401436098","doi":"10.1093/bjd/ljae266.008","title":"624 - Vitiligo biomarker CXCL10 correlates with clinical response in the phase 2 randomized, double-blind, vehicle-controlled TRuE-V mechanism of action study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group; Lynde Centre for Dermatology","funders":"Astellas Pharma; LEO Pharma; Galderma; Incyte; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Vitiligo; Medicine; Ruxolitinib; Tolerability; Biomarker; Internal medicine; Randomized controlled trial; Clinical trial; Dermatology; Gastroenterology; Oncology; Adverse effect; Myelofibrosis","score_opus":0.036421545958138866,"score_gpt":0.36755087238286055,"score_spread":0.3311293264247217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854434,0.0023770754,0.00092587195,0.0003561173,0.00029730776,0.007120353,0.0016209974,0.0001674327,0.0016914032],"genre_scores_gemma":[0.98675144,0.0008185625,0.001906143,0.0006425296,0.0003562392,0.005522553,0.0010964571,0.000026353031,0.0028796725],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992084,0.000363854,0.000043185228,0.000177128,0.00008416953,0.00012316025],"domain_scores_gemma":[0.99924755,0.00013540912,0.0002430197,0.00007167683,0.00008137859,0.00022098221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021822024,0.0013729185,0.0022226402,0.00036736674,0.00031229708,0.0009858673,0.0008382329,0.0014920677,0.0072445655],"category_scores_gemma":[0.001134791,0.00067852665,0.0012925263,0.00027827997,0.00071909494,0.0008833648,0.00033140212,0.0015416654,0.0011825344],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9178337,0.028316177,0.002952847,0.00086784526,0.0008476301,0.000055602348,0.000052840016,0.00043390854,0.023007428,0.00010240481,0.0016234287,0.02390626],"study_design_scores_gemma":[0.71832955,0.269569,0.00735071,0.000025192177,0.00046080333,0.0000680216,0.000018860856,0.0006816444,0.0023899553,0.00009413984,0.0009882126,0.000023820923],"about_ca_topic_score_codex":0.00026799768,"about_ca_topic_score_gemma":0.00065861206,"teacher_disagreement_score":0.0072445655,"about_ca_system_score_codex":0.00058988726,"about_ca_system_score_gemma":0.0009324223,"threshold_uncertainty_score":0.024235487},"labels":[],"label_agreement":null},{"id":"W4401436102","doi":"10.1093/bjd/ljae266.106","title":"733 - Nemolizumab elicits fast itch response in atopic dermatitis within 2 days: a post hoc analysis of ARCADIA 1 and 2 data","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Atopic dermatitis; Placebo; Arcadia; Randomized controlled trial; Internal medicine; Post-hoc analysis; Clinical endpoint; Anesthesia; Dermatology","score_opus":0.01626430918366514,"score_gpt":0.2993289737933812,"score_spread":0.2830646646097161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969811,0.00047325075,0.0006051417,0.000033591885,0.00006133528,0.0005044892,0.00076215126,0.000034892542,0.00054409745],"genre_scores_gemma":[0.9948777,0.00015901751,0.0011188808,0.000075095355,0.000057065226,0.0009869504,0.0009991839,0.000023446517,0.0017027516],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99655944,0.0017759127,0.00026962688,0.000481885,0.0004513463,0.00046171356],"domain_scores_gemma":[0.99635893,0.0018931474,0.00057306635,0.0004979718,0.00031670195,0.00036014573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051940205,0.0008902967,0.0030786067,0.0006320953,0.00039169847,0.00093317864,0.0006034022,0.00052103697,0.0074919253],"category_scores_gemma":[0.0028657464,0.00030541996,0.0030747384,0.00055575214,0.0006090974,0.0005743029,0.000556183,0.0013415675,0.0006156118],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8953413,0.011366351,0.013352884,0.0007055317,0.0032199193,0.00017963206,0.00016072489,0.0007982071,0.057358135,0.000105618565,0.0006533956,0.01675835],"study_design_scores_gemma":[0.056933384,0.577559,0.31787515,0.00006003927,0.0074381414,0.00045330974,0.00032612617,0.0063539175,0.028188786,0.00024445285,0.004427008,0.00014068591],"about_ca_topic_score_codex":0.0011982511,"about_ca_topic_score_gemma":0.0016070534,"teacher_disagreement_score":0.0074919253,"about_ca_system_score_codex":0.0006767974,"about_ca_system_score_gemma":0.001078525,"threshold_uncertainty_score":0.02746892},"labels":[],"label_agreement":null},{"id":"W4401436130","doi":"10.1093/bjd/ljae266.102","title":"729 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled, international, multicenter, study to evaluate the efficacy and safety of rezpegaldesleukin in adults with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group; Lynde Centre for Dermatology; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Eczema Area and Severity Index; Atopic dermatitis; Placebo; Internal medicine; Randomized controlled trial; Body surface area; Adverse effect; Dosing; Gastroenterology; Immunology; Pathology","score_opus":0.014972394820659766,"score_gpt":0.3125974713425097,"score_spread":0.29762507652184994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553925,0.0071098097,0.0017368086,0.001178818,0.0011210539,0.02557761,0.0034086849,0.00029393597,0.0041807215],"genre_scores_gemma":[0.9536906,0.0033922705,0.0052978606,0.0035492508,0.0012639358,0.023765804,0.0026531564,0.00006326412,0.006323794],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988838,0.00054458843,0.00007348446,0.00023058732,0.000112495094,0.00015507986],"domain_scores_gemma":[0.99910235,0.00017839465,0.0001917518,0.00007865246,0.00009227099,0.0003565993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031632984,0.0027697403,0.003114052,0.00050276547,0.00072757393,0.0011190211,0.0011622548,0.002376632,0.011338369],"category_scores_gemma":[0.0014777172,0.0009245437,0.0014725855,0.0004053438,0.0014290035,0.0012564409,0.00037178947,0.0032755458,0.001980974],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9422132,0.03294983,0.0007775927,0.0006384635,0.0005697256,0.000048962967,0.00004068687,0.0001645044,0.008181823,0.000118908494,0.0013648927,0.0129314335],"study_design_scores_gemma":[0.8985385,0.09936475,0.0008042487,0.00001650695,0.00014644618,0.000024930028,0.000008830143,0.00010359031,0.00036395903,0.000051340478,0.00056838023,0.000008528598],"about_ca_topic_score_codex":0.00056089513,"about_ca_topic_score_gemma":0.0014581049,"teacher_disagreement_score":0.011338369,"about_ca_system_score_codex":0.00082271907,"about_ca_system_score_gemma":0.0017775596,"threshold_uncertainty_score":0.037930667},"labels":[],"label_agreement":null},{"id":"W4401506767","doi":"10.1093/bjd/ljae312","title":"Pustular mycosis fungoides has a poor outcome: a multicentric clinicopathological and molecular case series","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Mycosis fungoides; Pathological; Internal medicine; Gastroenterology; Stage (stratigraphy); Cumulative incidence; Cohort; Incidence (geometry); Multivariate analysis; Peripheral T-cell lymphoma; Dermatology; Lymphoma; Immunology; T cell","score_opus":0.03614740506937778,"score_gpt":0.34180196940525753,"score_spread":0.30565456433587973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401506767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973099,0.0012172341,0.0003411357,0.00012400752,0.000020513358,0.000041363975,0.000080439226,0.000015753598,0.00084961887],"genre_scores_gemma":[0.9993011,0.00030838812,0.00015250224,0.00003748333,0.000055613473,0.000010624743,0.000055492786,0.0000036418385,0.00007511397],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99935657,0.00009739596,0.00009498893,0.00018210248,0.00009114451,0.00017780642],"domain_scores_gemma":[0.99848145,0.00034142032,0.00045810273,0.00019078796,0.00010127224,0.0004268847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005185355,0.0008858311,0.00066889776,0.0016282527,0.0016181067,0.0010852184,0.00060179294,0.001607348,0.0014843683],"category_scores_gemma":[0.0021252767,0.00063253316,0.00049212744,0.0012151322,0.0011786226,0.00091031444,0.0010486166,0.0006909776,0.00049488456],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023236049,0.00015347078,0.43592885,0.000111371526,0.000077832796,0.5503048,0.0008070677,0.00021916667,0.0031101438,0.0002152203,0.00080841855,0.008031369],"study_design_scores_gemma":[0.00002737815,0.00023462,0.21459827,0.00003425426,0.000052250984,0.7827357,0.0005636384,0.0003679905,0.00034661492,0.00012554352,0.00088266225,0.000031112628],"about_ca_topic_score_codex":0.0012626636,"about_ca_topic_score_gemma":0.0015517687,"teacher_disagreement_score":0.0016282527,"about_ca_system_score_codex":0.0005788369,"about_ca_system_score_gemma":0.00038287873,"threshold_uncertainty_score":0.0049657226},"labels":[],"label_agreement":null},{"id":"W4401566375","doi":"10.1093/bjd/ljae321","title":"Recent progress in Stevens–Johnson syndrome/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Ministry of Health, Labour and Welfare; Japan Agency for Medical Research and Development","keywords":"Toxic epidermal necrolysis; Medicine; Mucocutaneous zone; Disease; Immunology; Drug development; Drug; Intensive care medicine; Dermatology; Pathology; Pharmacology","score_opus":0.04020037571583161,"score_gpt":0.34639283790205094,"score_spread":0.3061924621862193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401566375","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007544584,0.9992055,0.000039526552,0.0002038717,0.0001220652,0.0000015175228,0.000005689476,0.0000030620618,0.00034327302],"genre_scores_gemma":[0.00071080937,0.99853647,0.00012561341,0.000213302,0.00018712916,0.0000025478826,0.00001984485,0.0000010869472,0.0002032822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965274,0.00007439889,0.00008324957,0.00004936996,0.000115846546,0.000024314968],"domain_scores_gemma":[0.9992576,0.0004000496,0.00011003096,0.000019406882,0.00017189616,0.00004097512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008173099,0.000758175,0.001488568,0.0024368265,0.00022486638,0.001013261,0.0007180626,0.00094367366,0.0027105026],"category_scores_gemma":[0.001334699,0.00026179865,0.0006040769,0.0020325428,0.00046698668,0.0011245646,0.0005732177,0.0018399582,0.0010251293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104444116,0.000056756748,0.00027053204,0.032589655,0.000113966096,0.0003142635,0.00008675773,0.00034389074,0.0010101752,0.002934029,0.028416904,0.9337586],"study_design_scores_gemma":[0.000029267923,0.00011835842,0.0016079637,0.011898081,0.00029818653,0.0048162695,0.00012052868,0.00012685877,0.00042097262,0.0022214472,0.9783135,0.000028655222],"about_ca_topic_score_codex":0.0012852455,"about_ca_topic_score_gemma":0.0018356433,"teacher_disagreement_score":0.0027105026,"about_ca_system_score_codex":0.00070139294,"about_ca_system_score_gemma":0.0011517303,"threshold_uncertainty_score":0.009067476},"labels":[],"label_agreement":null},{"id":"W4402217252","doi":"10.1093/bjd/ljae350","title":"Management of dupilumab-related ocular surface disorders","year":2024,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Dupilumab; Medicine; Dermatology; Atopic dermatitis","score_opus":0.004848859978758261,"score_gpt":0.21373847114722366,"score_spread":0.2088896111684654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402217252","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10799859,0.1528403,0.0042147515,0.6370468,0.02105206,0.000120480254,0.00015022521,0.00031494006,0.076261826],"genre_scores_gemma":[0.7004182,0.037468374,0.0033911327,0.16891968,0.06448764,0.00012581401,0.00015782056,0.000055609475,0.024975797],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995834,0.000094851144,0.000051179777,0.000034299843,0.00013548385,0.00010066874],"domain_scores_gemma":[0.9994649,0.00026112198,0.000056132565,0.00002623732,0.00005552571,0.00013613762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042855862,0.00040573327,0.00064785744,0.00052215887,0.0009909392,0.0008392964,0.0004482314,0.004407225,0.0014812858],"category_scores_gemma":[0.0025153237,0.00018642492,0.0005761275,0.00024005506,0.000690948,0.0006318315,0.000473841,0.0043050237,0.0008163401],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000883266,0.00024724955,0.012095161,0.0007265973,0.00013162104,0.59539723,0.00034136337,0.00078278815,0.007611368,0.007690135,0.20655702,0.16753612],"study_design_scores_gemma":[0.0003758173,0.00038627806,0.009247507,0.00044910258,0.00008606191,0.76495,0.00025123227,0.0025325886,0.0024222613,0.008717975,0.21053703,0.00004426185],"about_ca_topic_score_codex":0.00066905294,"about_ca_topic_score_gemma":0.0015260479,"teacher_disagreement_score":0.004407225,"about_ca_system_score_codex":0.0011446391,"about_ca_system_score_gemma":0.0003593865,"threshold_uncertainty_score":0.008304954},"labels":[],"label_agreement":null},{"id":"W4402348974","doi":"10.1093/bjd/ljae342","title":"A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Innovaderm (Canada)","funders":"Eli Lilly Japan; Sanofi Genzyme; Otsuka Pharmaceutical; Genentech; National Jewish Health; Torii Pharmaceutical; Kiniksa Pharmaceuticals; Taiho Pharmaceutical; Kyowa Kirin Pharmaceutical Development; Castle Biosciences; Celgene; BioCryst; Sun Pharma; Dermira; Valeant Pharmaceuticals International; Pfizer; Incyte; Regeneron Pharmaceuticals; Galderma; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; LEO Pharma; Gilead Sciences; Sanofi; GlaxoSmithKline; Amgen","keywords":"Medicine; Atopic dermatitis; Dosing; Pharmacovigilance; Omalizumab; Adverse effect; MEDLINE; Expert opinion; Clinical trial; Intensive care medicine; Internal medicine; Dermatology; Immunology","score_opus":0.05098543487854836,"score_gpt":0.34486040565998033,"score_spread":0.293874970781432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402348974","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022309062,0.129072,0.047994822,0.4427665,0.07480811,0.0039561936,0.005457337,0.008571791,0.28514242],"genre_scores_gemma":[0.010346051,0.14977287,0.1683425,0.2701658,0.03793538,0.0055791503,0.006498965,0.0027216808,0.34863758],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933264,0.0024368335,0.0014068625,0.00040408532,0.0021375387,0.0002882487],"domain_scores_gemma":[0.9799697,0.006049777,0.0017766646,0.00085216406,0.008849817,0.002501952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006693685,0.0012808967,0.0014585139,0.0038643985,0.0014544603,0.004372544,0.0019855977,0.0057956176,0.0795322],"category_scores_gemma":[0.030064212,0.00086195866,0.0015258386,0.0022844633,0.0010207273,0.004342951,0.002459751,0.006694887,0.08524445],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002666199,0.00005907791,0.00012232731,0.00038273193,0.000004777538,0.00024074319,0.00018645395,0.000029172006,0.00028395662,0.00064853707,0.89262694,0.10538865],"study_design_scores_gemma":[0.00002315236,0.00004327143,0.00026796025,0.00081233034,0.000005402023,0.00061474333,0.00014129459,0.000032403113,0.000060209895,0.00079569593,0.9971902,0.000013360831],"about_ca_topic_score_codex":0.0021579436,"about_ca_topic_score_gemma":0.006235293,"teacher_disagreement_score":0.0795322,"about_ca_system_score_codex":0.0011553542,"about_ca_system_score_gemma":0.0054891524,"threshold_uncertainty_score":0.26606172},"labels":[],"label_agreement":null},{"id":"W4402580517","doi":"10.1093/bjd/ljae361","title":"Sexual dysfunction following retinoid treatment: a systematic review","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; University of Ottawa","funders":"","keywords":"Medicine; Sexual dysfunction; Systematic review; MEDLINE; Dermatology; Internal medicine; Biology","score_opus":0.02778182518277294,"score_gpt":0.33667438710238196,"score_spread":0.308892561919609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402580517","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047505216,0.998971,0.00003419384,0.00008911939,0.00004279051,0.000059895934,0.0001519082,0.0000027779795,0.00017328108],"genre_scores_gemma":[0.0055446215,0.9938368,0.00010766985,0.00021925221,0.000035042467,0.000073809475,0.00009490339,0.000001729474,0.00008615963],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9981706,0.00063428335,0.00058491604,0.00017227112,0.0003601261,0.000077789875],"domain_scores_gemma":[0.9909101,0.0066010314,0.0017026735,0.000103110084,0.0005722378,0.00011094173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024988463,0.0009630852,0.004941656,0.004017676,0.00047711402,0.0016717376,0.0010405504,0.001407943,0.006990705],"category_scores_gemma":[0.012878917,0.00060662907,0.0046933,0.005767961,0.00055939413,0.0013565245,0.0010249136,0.0009505294,0.00033177424],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025929994,0.000017789625,0.00047125635,0.94371456,0.0060689617,0.00011553305,0.00011493127,0.000078830286,0.000110587265,0.00014993938,0.0023448148,0.046553392],"study_design_scores_gemma":[0.0003520174,0.00025825002,0.0052532917,0.8905677,0.06479978,0.0008913165,0.0002737872,0.00007418417,0.00016449956,0.00037370028,0.036949005,0.000042428757],"about_ca_topic_score_codex":0.0069490517,"about_ca_topic_score_gemma":0.022270989,"teacher_disagreement_score":0.006990705,"about_ca_system_score_codex":0.0017585023,"about_ca_system_score_gemma":0.004603839,"threshold_uncertainty_score":0.02338624},"labels":[],"label_agreement":null},{"id":"W4403129964","doi":"10.1093/bjd/ljae377","title":"Do large language model chatbots perform better than established patient information resources in answering patient questions? A comparative study on melanoma","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Les Laboratories Pierre Fabre; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Readability; Medicine; Computer science","score_opus":0.047603648428009106,"score_gpt":0.3650601324547645,"score_spread":0.31745648402675536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403129964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977016,0.00025080153,0.0006360143,0.00011619102,0.0000138924515,0.00013574354,0.00021658787,0.00006077251,0.0008683193],"genre_scores_gemma":[0.9975061,0.00013901768,0.0012029309,0.000094608906,0.000018870818,0.00017676182,0.00035540128,0.00002725316,0.0004790714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9882648,0.00827353,0.00087407517,0.0009425641,0.0013111928,0.00033389957],"domain_scores_gemma":[0.8924744,0.08740216,0.0073216674,0.004055268,0.0062729004,0.002473556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01716257,0.0003939686,0.00075913436,0.0010100809,0.00037022724,0.0012273613,0.0006471355,0.00061656185,0.0024325994],"category_scores_gemma":[0.091432236,0.00024696265,0.0006918883,0.0006380271,0.00072919717,0.0017767155,0.0012805985,0.00060731085,0.0007742587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026455928,0.0056695906,0.6120129,0.00399328,0.0013561902,0.00085162604,0.04559113,0.004969118,0.0072788293,0.00041341112,0.0044436264,0.28696436],"study_design_scores_gemma":[0.0012244041,0.023524143,0.92660254,0.000588132,0.0009774275,0.0010755445,0.011166091,0.021496532,0.0058985953,0.00063200726,0.0066260328,0.00018850893],"about_ca_topic_score_codex":0.0032686219,"about_ca_topic_score_gemma":0.0034593726,"teacher_disagreement_score":0.01716257,"about_ca_system_score_codex":0.0011356496,"about_ca_system_score_gemma":0.0008136678,"threshold_uncertainty_score":0.090765476},"labels":[],"label_agreement":null},{"id":"W4403202892","doi":"10.1093/bjd/ljae381","title":"Dr James Alastair Carruthers, 1945–2024","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Obituary; Philosophy; Medicine; Theology","score_opus":0.008943873608809808,"score_gpt":0.3311130863782508,"score_spread":0.322169212769441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403202892","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005314279,0.17030875,0.0017724088,0.4649515,0.22425047,0.00012505281,0.00044100801,0.00043260108,0.13240395],"genre_scores_gemma":[0.042748388,0.11493382,0.001547416,0.13565245,0.060476966,0.0001055247,0.00037490187,0.00026798306,0.6438925],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933475,0.00008485805,0.00003496715,0.00016138465,0.0002677619,0.000116124895],"domain_scores_gemma":[0.9983175,0.00012258613,0.00007833491,0.00003075935,0.00056539755,0.0008854416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008765098,0.0006151845,0.00040977076,0.0012203093,0.0013910825,0.0016064981,0.0006647767,0.0016693408,0.041143633],"category_scores_gemma":[0.0047800383,0.00032123955,0.00027572725,0.00043019056,0.0007149343,0.0012017825,0.0010145652,0.005128398,0.0129222125],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032450407,0.000016360515,0.0008575589,0.000057792804,0.0000056009976,0.00071589334,0.00012643615,0.00003073729,0.00018631831,0.0010974073,0.93997926,0.056894302],"study_design_scores_gemma":[0.000005595878,0.000028639462,0.00089909084,0.00018748727,0.0000030999838,0.00370695,0.00011589606,0.000027863878,0.00011651234,0.00044605255,0.9944507,0.000012146387],"about_ca_topic_score_codex":0.013852636,"about_ca_topic_score_gemma":0.022747952,"teacher_disagreement_score":0.041143633,"about_ca_system_score_codex":0.002400963,"about_ca_system_score_gemma":0.0028133164,"threshold_uncertainty_score":0.13763916},"labels":[],"label_agreement":null},{"id":"W4403329069","doi":"10.1093/bjd/ljae386","title":"Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIH Office of the Director; National Heart, Lung, and Blood Institute; National Institute of Mental Health; Medical Research Council; National Cancer Institute; National Institutes of Health; Medical Research Council Canada; Common Fund; Wellcome Trust","keywords":"Copy number analysis; Biology; Copy-number variation; PTEN; Gene duplication; Comparative genomic hybridization; Exome sequencing; Chromosomal translocation; Genetics; Chromosome; Cancer research; Gene; Mutation; Genome","score_opus":0.019732912421197842,"score_gpt":0.29447862983088224,"score_spread":0.2747457174096844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403329069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99877304,0.00025786916,0.00043345487,0.000011301933,7.5983786e-7,0.0000066058656,0.00026124026,0.000020219326,0.0002355313],"genre_scores_gemma":[0.998727,0.0001067519,0.00065399706,0.000010294304,0.0000018181688,0.000007048737,0.0003910401,0.000006331422,0.00009574921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983764,0.000018298913,0.000018594064,0.000049462982,0.000050667648,0.000025366933],"domain_scores_gemma":[0.99962926,0.00011312297,0.00013865482,0.00002974656,0.000047401867,0.000041754593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026363993,0.00018956499,0.0001880022,0.0011613767,0.00014466333,0.00029910146,0.0001745793,0.00020382731,0.0011625782],"category_scores_gemma":[0.00069764775,0.00012066714,0.00017064078,0.0005229197,0.00017609917,0.00013082717,0.00029265627,0.0001222585,0.00022733645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041476794,0.00003965222,0.60573816,0.00013475462,0.000122169,0.0042567304,0.00026622688,0.0009334656,0.36717823,0.00013405553,0.00022859345,0.020553108],"study_design_scores_gemma":[0.000014094892,0.0001818716,0.94262296,0.000021255331,0.00018468722,0.012761716,0.00019406066,0.002193808,0.04030664,0.0002236176,0.0012850049,0.000010167363],"about_ca_topic_score_codex":0.00035511583,"about_ca_topic_score_gemma":0.0008359823,"teacher_disagreement_score":0.0011625782,"about_ca_system_score_codex":0.00017827656,"about_ca_system_score_gemma":0.00010207233,"threshold_uncertainty_score":0.0038892627},"labels":[],"label_agreement":null},{"id":"W4403501334","doi":"10.1093/bjd/ljae382","title":"Overtreatment of dysplastic naevi: results of a multiregional UK questionnaire study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Plant Pathogens and Fungal Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dermatology; Family medicine","score_opus":0.007731717279609807,"score_gpt":0.24565735486320597,"score_spread":0.23792563758359617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403501334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99195534,0.0027138647,0.00013421882,0.0012395303,0.000072923205,0.000045883135,0.0024744107,0.0000066784814,0.0013571583],"genre_scores_gemma":[0.9970143,0.000899175,0.000120649296,0.00055674784,0.00005526035,0.000034626555,0.00081877614,0.000006713143,0.00049367524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805176,0.0009003219,0.00030832022,0.00022247135,0.00029378542,0.00022340726],"domain_scores_gemma":[0.9900164,0.0025785759,0.004892423,0.00047387838,0.0011365698,0.0009022831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017179243,0.00028620556,0.00056174985,0.0011949326,0.00033318409,0.0010857085,0.0005855182,0.0012318804,0.0046940283],"category_scores_gemma":[0.010070435,0.00043227407,0.0007361205,0.0027314825,0.0004342133,0.0010111516,0.00082276535,0.0009382448,0.00079689885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076252036,0.000036361736,0.99663913,0.00006683859,0.00006239318,0.00022816665,0.00044395676,0.000014395787,0.000056684887,0.000018708886,0.0007094229,0.0016476182],"study_design_scores_gemma":[0.000008164078,0.00008436246,0.998607,0.00004659124,0.000019230309,0.0003511139,0.0005037443,0.000036705802,0.0000071236886,0.0000078332405,0.00032193118,0.0000062108084],"about_ca_topic_score_codex":0.013685442,"about_ca_topic_score_gemma":0.010471023,"teacher_disagreement_score":0.013685442,"about_ca_system_score_codex":0.00050530216,"about_ca_system_score_gemma":0.00033159272,"threshold_uncertainty_score":0.027211547},"labels":[],"label_agreement":null},{"id":"W4403623250","doi":"10.1093/bjd/ljae406","title":"Deucravacitinib, an oral selective allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan and South Korea with moderate-to-severe plaque psoriasis: a phase III randomized clinical trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Discontinuation; Internal medicine; Psoriasis Area and Severity Index; Adverse effect; Psoriasis; Placebo; Plaque psoriasis; Randomized controlled trial; Clinical trial; Gastroenterology; Dermatology; Pathology","score_opus":0.014479805038292212,"score_gpt":0.2706572667441224,"score_spread":0.25617746170583017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403623250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950906,0.0018780016,0.00013057707,0.0003098549,0.00008110669,0.0013179663,0.0003758947,0.000029746197,0.0007861056],"genre_scores_gemma":[0.9943434,0.001141584,0.0003563771,0.0006636656,0.00009041466,0.0016103691,0.00082276354,0.000006674364,0.0009646153],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99951804,0.0002084599,0.000043421816,0.000087999935,0.000041192932,0.00010093574],"domain_scores_gemma":[0.99931455,0.000088066474,0.00014689418,0.000042083597,0.000058329304,0.000350082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019617716,0.0011575542,0.0017783451,0.0002946103,0.00050156115,0.00074719335,0.0005365936,0.00094014406,0.0029783794],"category_scores_gemma":[0.00089986174,0.00047893755,0.001756391,0.00040330656,0.0006952947,0.0005533311,0.00029413574,0.0018202125,0.00041548902],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9152724,0.016809179,0.013470019,0.00095172937,0.0028295168,0.00020042676,0.0002360895,0.0007906564,0.010593944,0.00010878252,0.0025367388,0.036200557],"study_design_scores_gemma":[0.87157303,0.09933346,0.024442676,0.00004346431,0.0012978413,0.00019864099,0.00008217002,0.0007057055,0.00091453583,0.000081067476,0.001300233,0.000027172773],"about_ca_topic_score_codex":0.0017685293,"about_ca_topic_score_gemma":0.0057660965,"teacher_disagreement_score":0.0029783794,"about_ca_system_score_codex":0.0009932554,"about_ca_system_score_gemma":0.0022940724,"threshold_uncertainty_score":0.010374963},"labels":[],"label_agreement":null},{"id":"W4403665664","doi":"10.1093/bjd/ljae402","title":"Efficacy and safety of the ustekinumab biosimilar ABP 654 in patients with moderate-to-severe plaque psoriasis: a randomized double-blinded active-controlled comparative clinical study over 52 weeks","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Amgen","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Randomized controlled trial; Clinical endpoint; Adverse effect; Internal medicine; Psoriasis; Randomization; Gastroenterology; Dermatology; Adalimumab; Disease","score_opus":0.027337013886964728,"score_gpt":0.3263798375749371,"score_spread":0.29904282368797236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403665664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98898894,0.0024267517,0.0006319783,0.00022864173,0.00020895361,0.0056966892,0.0005712725,0.00007666812,0.0011700769],"genre_scores_gemma":[0.987783,0.0012990067,0.0017366592,0.000579907,0.00035187494,0.006019659,0.0005322815,0.000018411522,0.0016790994],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99853146,0.0007083406,0.00014369775,0.0002788176,0.00018124536,0.00015639742],"domain_scores_gemma":[0.9980896,0.00042833952,0.0005903688,0.0001680354,0.00020950791,0.00051413197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034864563,0.0016415939,0.0033419745,0.00054704974,0.0006469465,0.0010264682,0.0011488535,0.0021636998,0.0064116386],"category_scores_gemma":[0.00265592,0.0009900522,0.0018534731,0.0004957247,0.0012758237,0.0013839094,0.0004816444,0.0022005434,0.0010011881],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96262866,0.021179918,0.0005371538,0.00045743168,0.00051375915,0.000025687586,0.000060003462,0.00016347601,0.004625989,0.000040731382,0.0002517856,0.009515387],"study_design_scores_gemma":[0.7839866,0.21162269,0.002647374,0.00002401655,0.00038498905,0.00002843264,0.000020640551,0.00021742166,0.0006305251,0.000065160595,0.0003567383,0.000015341171],"about_ca_topic_score_codex":0.0005160494,"about_ca_topic_score_gemma":0.0011916596,"teacher_disagreement_score":0.0064116386,"about_ca_system_score_codex":0.0007410033,"about_ca_system_score_gemma":0.0013575772,"threshold_uncertainty_score":0.021449089},"labels":[],"label_agreement":null},{"id":"W4403667407","doi":"10.1093/bjd/ljae404","title":"Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Clinical endpoint; Randomized controlled trial; Dupilumab; Adverse effect; Internal medicine; Dermatology; Clinical trial; Dermatology Life Quality Index; Severity of illness; Disease","score_opus":0.04700225101236575,"score_gpt":0.359323760572684,"score_spread":0.31232150956031823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403667407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929844,0.0021208646,0.00028189513,0.0003029224,0.0001458511,0.002250982,0.0009930728,0.00006318537,0.00085681985],"genre_scores_gemma":[0.9930876,0.0010383495,0.0009489214,0.0005203465,0.00018636235,0.0023040504,0.0007760461,0.000016789943,0.0011216186],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99881124,0.0006384388,0.000095590316,0.00018887626,0.00010131554,0.00016450408],"domain_scores_gemma":[0.99751854,0.0005903653,0.0007132223,0.00018066308,0.00020803117,0.00078922807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002975464,0.0013120982,0.0034149091,0.00038976397,0.0005000703,0.001299339,0.00097069534,0.001695043,0.0048848516],"category_scores_gemma":[0.0028937662,0.00082341116,0.0023375978,0.00032307868,0.001021458,0.0014076547,0.00047271157,0.0036583098,0.0008007109],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9722725,0.010404831,0.0010585703,0.00034582987,0.0008552819,0.000025791414,0.00006154695,0.0002505782,0.0025134657,0.000032431784,0.00055766146,0.011621377],"study_design_scores_gemma":[0.749407,0.24112806,0.0059365337,0.000051909454,0.0010977153,0.0000587484,0.000034985987,0.00054569327,0.0010798284,0.000081207356,0.00055427087,0.000024175684],"about_ca_topic_score_codex":0.0007557577,"about_ca_topic_score_gemma":0.0019345235,"teacher_disagreement_score":0.0048848516,"about_ca_system_score_codex":0.0011475605,"about_ca_system_score_gemma":0.0014616688,"threshold_uncertainty_score":0.016341388},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4403976052","doi":"10.1093/bjd/ljae428","title":"The future of patient-reported outcome measurement in hyperhidrosis lies in thoughtful, evidence-based implementation","year":2024,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Hyperhidrosis; Medicine; Patient-reported outcome; Outcome (game theory); MEDLINE; Intensive care medicine; Medical physics; Family medicine; Dermatology; Quality of life (healthcare); Nursing; Political science","score_opus":0.05520966782668938,"score_gpt":0.3184707973099928,"score_spread":0.2632611294833034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403976052","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013877818,0.28039092,0.17810592,0.46555814,0.0160051,0.0067715175,0.0041651307,0.0012329445,0.033892594],"genre_scores_gemma":[0.23802225,0.14333802,0.45824194,0.11210659,0.01954495,0.020806354,0.0048620803,0.0007765089,0.0023012443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.60385936,0.30580473,0.03727291,0.010220452,0.04052472,0.0023178002],"domain_scores_gemma":[0.15634286,0.70053905,0.035380654,0.023593249,0.07815768,0.00598653],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.5078865,0.0023069694,0.007677981,0.00750604,0.0019660888,0.015425342,0.007260317,0.007885767,0.010829288],"category_scores_gemma":[0.63048697,0.0013646777,0.0050390055,0.008071671,0.0065104687,0.01969079,0.00920145,0.012400253,0.002706265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075621455,0.001786835,0.027875861,0.01954019,0.0020237109,0.00012737095,0.003377796,0.0017597629,0.00025305193,0.03241274,0.04825298,0.8618335],"study_design_scores_gemma":[0.0025352128,0.004690538,0.08230028,0.29402235,0.004097917,0.00084762834,0.008156646,0.013317937,0.0015343254,0.18299349,0.40411493,0.0013887383],"about_ca_topic_score_codex":0.0062731146,"about_ca_topic_score_gemma":0.0056142327,"teacher_disagreement_score":0.5078865,"about_ca_system_score_codex":0.010909261,"about_ca_system_score_gemma":0.02375966,"threshold_uncertainty_score":0.60686356},"labels":[],"label_agreement":null},{"id":"W4404149846","doi":"10.1093/bjd/ljae432","title":"Exploration of the mutational landscape of cutaneous leiomyoma confirms <i>FH</i> as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategy","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Urinary and Genital Oncology Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Institute for Health and Care Research; Medical Research Council Canada; Wellcome Trust","keywords":"Purine; Leiomyoma; Gene; Biology; Purine analogue; Computational biology; Cancer research; Bioinformatics; Medicine; Genetics; Pathology; Biochemistry; Enzyme","score_opus":0.012709794551547308,"score_gpt":0.2679911303786871,"score_spread":0.2552813358271398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404149846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973909,0.00045727915,0.0010694187,0.000031621785,8.6928355e-7,0.000008043965,0.000095660966,0.000019030635,0.00092712266],"genre_scores_gemma":[0.99904567,0.00015235948,0.0006081824,0.000013611809,0.000002005057,0.0000023583432,0.00006573881,0.00000329782,0.00010666077],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999404,0.00001208292,0.000005430018,0.000017206177,0.000011395344,0.000013425152],"domain_scores_gemma":[0.9998461,0.000058135134,0.00004104044,0.0000148292165,0.000018737825,0.000021178843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018534306,0.00012308656,0.00012553822,0.0004435524,0.00010772313,0.00021918946,0.000107248066,0.00010642998,0.0012398851],"category_scores_gemma":[0.00034459456,0.00008778256,0.00008051914,0.00019919699,0.00016062545,0.00014085784,0.00015301997,0.00013107253,0.00010718488],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044546268,0.000031364118,0.2629784,0.000091521935,0.000044726352,0.006962519,0.0002022718,0.0004365364,0.7048662,0.00022222713,0.00011435693,0.02360444],"study_design_scores_gemma":[0.000014378517,0.00049355644,0.8207786,0.000032770964,0.00013007282,0.04921144,0.00055597536,0.002274963,0.123454124,0.00044972997,0.0025925254,0.000011863878],"about_ca_topic_score_codex":0.00039720422,"about_ca_topic_score_gemma":0.00075723225,"teacher_disagreement_score":0.0012398851,"about_ca_system_score_codex":0.00009648872,"about_ca_system_score_gemma":0.00006846784,"threshold_uncertainty_score":0.004147887},"labels":[],"label_agreement":null},{"id":"W4404200238","doi":"10.1093/bjd/ljae443","title":"Disabling pansclerotic morphoea: a century of discovery","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Department of Paediatrics, University of Melbourne; National Institute of Allergy and Infectious Diseases; American Academy of Allergy, Asthma and Immunology Foundation","keywords":"Morphea; Medicine; Dermatology","score_opus":0.038371095859378236,"score_gpt":0.3223701915766471,"score_spread":0.28399909571726883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404200238","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012877731,0.992939,0.00013705823,0.003892712,0.0008547264,0.0000066651533,0.00005601983,0.0000091617285,0.0008168876],"genre_scores_gemma":[0.007882098,0.9857949,0.0006697435,0.0027137795,0.0024449513,0.00001657416,0.00009646003,0.000008117278,0.00037335616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983399,0.00027817825,0.0005671406,0.00020479951,0.0005127672,0.000097171134],"domain_scores_gemma":[0.98465145,0.010391087,0.0019499471,0.0003561543,0.002302495,0.00034883493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003070666,0.00051806687,0.0016001505,0.008942517,0.00068755524,0.0032102435,0.00087618374,0.0017731957,0.0024005738],"category_scores_gemma":[0.009612203,0.00043436355,0.00080465357,0.0083968155,0.0017784821,0.0063234787,0.0012362453,0.0022622452,0.00057772844],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028392262,0.000078850135,0.004688701,0.058267925,0.00031616696,0.0024207877,0.0020111003,0.00022508737,0.0011752497,0.007105689,0.045383636,0.8780429],"study_design_scores_gemma":[0.000048311136,0.00022666839,0.01408568,0.10612456,0.0007403541,0.018598527,0.003660034,0.0002507696,0.00072917837,0.014573342,0.8408099,0.00015276672],"about_ca_topic_score_codex":0.0017765387,"about_ca_topic_score_gemma":0.00306835,"teacher_disagreement_score":0.008942517,"about_ca_system_score_codex":0.0015672714,"about_ca_system_score_gemma":0.0030506963,"threshold_uncertainty_score":0.016239464},"labels":[],"label_agreement":null},{"id":"W4404403485","doi":"10.1093/bjd/ljae441","title":"Haematogenous seeding in mycosis fungoides and Sézary syndrome: current evidence and clinical implications","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Kyowa Kirin International; Université de Lausanne; Canadian Dermatology Foundation; Swiss Cancer Research Foundation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Mycosis fungoides; Pathogenesis; Erythroderma; Pathology; Cutaneous T-cell lymphoma; Disease; Medicine; Bone marrow; Epidermis (zoology); Biology; Lymphoma; Immunology","score_opus":0.17278817015948203,"score_gpt":0.4877713858132075,"score_spread":0.31498321565372545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404403485","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006447248,0.99847955,0.000057196612,0.0003935507,0.00006760561,0.0000015269587,0.0000103979355,0.0000026489902,0.00034272094],"genre_scores_gemma":[0.008704544,0.99004,0.00014749778,0.00042182638,0.000534661,0.0000043803493,0.000032831136,0.0000015257555,0.0001127392],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9994854,0.00013329614,0.00013761308,0.00009433075,0.00011118377,0.00003824568],"domain_scores_gemma":[0.9967816,0.0020818699,0.0006419684,0.000037894326,0.00034399488,0.000112596616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010164067,0.0004279024,0.0011675662,0.0020491516,0.00023081856,0.0013178285,0.0005444171,0.0013776644,0.0019233632],"category_scores_gemma":[0.00306916,0.00021486357,0.00053545175,0.0022864148,0.00079070416,0.0016867226,0.00049937033,0.0009439492,0.0005991714],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004912951,0.00005750273,0.009985319,0.029854434,0.0004789864,0.003823918,0.0003027014,0.00021386445,0.0013932612,0.0027992113,0.012216413,0.938383],"study_design_scores_gemma":[0.0001283419,0.00067289843,0.045766998,0.038491543,0.0033061905,0.059998684,0.0011456097,0.00041855947,0.0012629908,0.0077506,0.84095275,0.00010483485],"about_ca_topic_score_codex":0.0007460681,"about_ca_topic_score_gemma":0.0010989697,"teacher_disagreement_score":0.0020491516,"about_ca_system_score_codex":0.0004111422,"about_ca_system_score_gemma":0.0007600851,"threshold_uncertainty_score":0.006434262},"labels":[],"label_agreement":null},{"id":"W4404410709","doi":"10.1093/bjd/ljae447","title":"Exploring the genetic driver events of eccrine poromas and porocarcinomas: a retrospective, cross-institutional study of 54 cases","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Institute for Health and Care Research; Medical Research Council Canada; Wellcome Trust","keywords":"Carcinogenesis; Somatic cell; Fusion gene; YAP1; Gene; Biology; Mutation; Cancer research; Genetics; Somatic fusion; Transcription factor","score_opus":0.046430757716539456,"score_gpt":0.3075137331645374,"score_spread":0.26108297544799797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404410709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989644,0.00027799013,0.00019243038,0.0000075515986,0.0000017724947,0.000016711012,0.00012381787,0.000004179937,0.00041108797],"genre_scores_gemma":[0.9994153,0.00014846957,0.00011876092,0.0000133923295,0.00000409732,0.000014571922,0.00014742772,0.000003657811,0.00013438419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919814,0.00012976637,0.00012976748,0.00025592325,0.00013107232,0.00015546916],"domain_scores_gemma":[0.9983816,0.00034336388,0.000583897,0.0003293903,0.000173025,0.00018865464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007925757,0.00033333345,0.0003767564,0.0014674433,0.00066490466,0.00065889047,0.00032926287,0.00038685882,0.0016949606],"category_scores_gemma":[0.0024215968,0.00055739295,0.00038498914,0.0010944402,0.00065709976,0.00054754165,0.00095742574,0.00031736837,0.0004155752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052561292,0.000019629597,0.9964419,0.0000109208495,0.000027522858,0.0011008591,0.00018833659,0.00003358832,0.00069984846,0.000024114233,0.000030976993,0.0013696103],"study_design_scores_gemma":[0.000005245421,0.00017093809,0.9872649,0.00001534438,0.00008337628,0.009937083,0.0008476995,0.00011605329,0.00062754244,0.00003160613,0.00089161657,0.000008540425],"about_ca_topic_score_codex":0.0028148284,"about_ca_topic_score_gemma":0.002172448,"teacher_disagreement_score":0.0028148284,"about_ca_system_score_codex":0.00035945122,"about_ca_system_score_gemma":0.0002767346,"threshold_uncertainty_score":0.00567019},"labels":[],"label_agreement":null},{"id":"W4404532483","doi":"10.1093/bjd/ljae454","title":"Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Portugal; Janssen Australia; Caisse nationale de l'Assurance Maladie; Bristol-Myers Squibb Canada; AbbVie Canada; Psoriasis Association; LEO Pharma; Assistance publique-Hôpitaux de Paris; Cilag; University of Manchester; British Association of Dermatologists; Almirall; Boehringer Ingelheim España; Assistance Publique - Hôpitaux de Paris; Manchester Biomedical Research Centre","keywords":"Biosimilar; Adalimumab; Medicine; Psoriasis; Multinational corporation; Cohort; Internal medicine; Cohort study; Oncology; Family medicine; Dermatology; Business; Disease","score_opus":0.013596104107275651,"score_gpt":0.2890731079822312,"score_spread":0.27547700387495555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404532483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995226,0.0023984427,0.00030219162,0.0000608901,0.000025511074,0.00005756416,0.001712607,0.000007034935,0.00020971426],"genre_scores_gemma":[0.9968646,0.0006716961,0.00026638783,0.00008779236,0.000032701064,0.00007462546,0.0018147724,0.000008240414,0.00017918559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99558735,0.001863488,0.00049918226,0.0012380248,0.0005817291,0.00023011057],"domain_scores_gemma":[0.98666185,0.0028580679,0.005508815,0.0032915724,0.0009694899,0.0007101637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009483469,0.00075399166,0.0012450372,0.0010751345,0.0006428475,0.0013281944,0.0009639871,0.00095351174,0.0020965044],"category_scores_gemma":[0.010359579,0.00053749024,0.0047794417,0.00226984,0.00039705276,0.00067020906,0.00080981996,0.0011042409,0.00027223403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016750183,0.0002816101,0.95970875,0.0002426344,0.0178583,0.00012904147,0.00016383384,0.00024116489,0.0005225118,0.0000529773,0.00041323263,0.0036358181],"study_design_scores_gemma":[0.0029070221,0.0023597458,0.974195,0.00009827095,0.017383987,0.0004553112,0.00016985156,0.0010017378,0.00028165773,0.00011104644,0.0009910931,0.000045279903],"about_ca_topic_score_codex":0.0047193947,"about_ca_topic_score_gemma":0.0036910167,"teacher_disagreement_score":0.009483469,"about_ca_system_score_codex":0.0006964361,"about_ca_system_score_gemma":0.0007334858,"threshold_uncertainty_score":0.05015397},"labels":[],"label_agreement":null},{"id":"W4404568156","doi":"10.1093/bjd/ljae457","title":"Tailored bioengineering and nanomedicine strategies for sex-specific healing of chronic wounds","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Wound Healing and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Wound healing; Modalities; Clinical trial; Health care; Healthcare system; Intensive care medicine; Chronic wound; Surgery; Pathology","score_opus":0.04389997851501952,"score_gpt":0.3444212572089619,"score_spread":0.30052127869394235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404568156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023729751,0.99807584,0.00023824899,0.00023006157,0.0001740205,0.000009910884,0.000010326713,0.00000578463,0.0010184969],"genre_scores_gemma":[0.0020255987,0.9965229,0.00044887912,0.00020726972,0.000096661664,0.000015126486,0.000020034695,0.0000021136964,0.0006613701],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974245,0.000063186584,0.000034583067,0.000039970873,0.00008820667,0.000031666037],"domain_scores_gemma":[0.9997274,0.00016198478,0.000041894076,0.0000098383225,0.000043788663,0.000015097611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000688118,0.00066491705,0.0009725143,0.0016460434,0.0002673775,0.00088527077,0.0006270715,0.0013420314,0.004400182],"category_scores_gemma":[0.0008518529,0.00022732669,0.00069963885,0.0009556031,0.0004566207,0.0010824745,0.0006580235,0.0016098974,0.0013012561],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007105415,0.00011640212,0.00016243516,0.036293983,0.000105347564,0.00019572652,0.00011013313,0.00037860416,0.005161524,0.0061858594,0.014375745,0.93684316],"study_design_scores_gemma":[0.000028928507,0.00021823443,0.0010941899,0.008802221,0.00017261527,0.00217337,0.0001357405,0.00016192276,0.0023430337,0.0025175863,0.9823287,0.000023430772],"about_ca_topic_score_codex":0.0005052562,"about_ca_topic_score_gemma":0.001158718,"teacher_disagreement_score":0.004400182,"about_ca_system_score_codex":0.00041892545,"about_ca_system_score_gemma":0.00081150274,"threshold_uncertainty_score":0.014720142},"labels":[],"label_agreement":null},{"id":"W4404646375","doi":"10.1093/bjd/ljae462","title":"Genome sequencing reveals novel <i>IKBKG</i> structural variants associated with incontinentia pigmenti","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Genome Canada","funders":"Paul Foundation","keywords":"Incontinentia pigmenti; Genetics; Genome; Biology; DNA sequencing; Gene; Whole genome sequencing; Computational biology","score_opus":0.006453289211267948,"score_gpt":0.21746943278972014,"score_spread":0.2110161435784522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404646375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761355,0.00016976596,0.0009481064,0.00030071754,0.000024589734,0.000010813485,0.0003064554,0.000048960108,0.00057706743],"genre_scores_gemma":[0.9988067,0.00006704422,0.00069937814,0.0001133999,0.000017764698,0.0000043333575,0.0001273338,0.000012875167,0.00015125604],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99981326,0.000023434583,0.00002023301,0.000058898582,0.000043815606,0.000040264404],"domain_scores_gemma":[0.99960274,0.00017464912,0.00008709513,0.000022459966,0.000027625809,0.00008544323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104424726,0.0005314309,0.00027950364,0.00068917824,0.00038387836,0.00055365474,0.00025834734,0.00095475354,0.0010781884],"category_scores_gemma":[0.0008503842,0.00019281179,0.0003672134,0.00040075352,0.00039305683,0.00013653953,0.00028013272,0.00059088354,0.00021017608],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001216803,0.0002687555,0.14965932,0.00018979955,0.00019802904,0.22498094,0.0019092395,0.0020242226,0.5894753,0.0014681665,0.0018101155,0.026799303],"study_design_scores_gemma":[0.00018795085,0.00063839386,0.6074433,0.00008281381,0.0003032874,0.29511178,0.0010174442,0.005476201,0.08170716,0.0020104267,0.005903467,0.00011782085],"about_ca_topic_score_codex":0.0013586617,"about_ca_topic_score_gemma":0.0013742305,"teacher_disagreement_score":0.0013586617,"about_ca_system_score_codex":0.00025081704,"about_ca_system_score_gemma":0.00013334294,"threshold_uncertainty_score":0.0036069155},"labels":[],"label_agreement":null},{"id":"W4405227144","doi":"10.1093/bjd/ljae439","title":"Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"LEO Pharma","keywords":"Medicine; Dosing; Eczema Area and Severity Index; Atopic dermatitis; Post-hoc analysis; Population; Internal medicine; Adverse effect; Dermatology; Environmental health","score_opus":0.006344643202463898,"score_gpt":0.2356969828714622,"score_spread":0.22935233966899832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405227144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913424,0.0002224087,0.00011248134,0.000049784983,0.000006012031,0.000012805635,0.00011966545,0.0000048740108,0.00033781852],"genre_scores_gemma":[0.99964166,0.000042074334,0.000113613925,0.00001631417,0.000008720079,0.000005990914,0.000112659276,0.0000011087807,0.00005779216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999273,0.00023182396,0.00010279672,0.00017359584,0.000137413,0.00008128765],"domain_scores_gemma":[0.99589634,0.0018148149,0.0014820566,0.00017753648,0.00023832096,0.0003909185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001466948,0.00032559846,0.00042789118,0.00046251892,0.0002933703,0.00061605143,0.000363726,0.0005207021,0.0012475365],"category_scores_gemma":[0.004526289,0.00014116481,0.0006751325,0.00041953727,0.00020438118,0.0005081485,0.00027373212,0.0008448943,0.0003312783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008357737,0.00008560261,0.9948486,0.000012247474,0.000057042613,0.000036150832,0.000019345605,0.0003166803,0.00025210326,0.00001025687,0.000111875575,0.0034144213],"study_design_scores_gemma":[0.000053246073,0.00095036655,0.99340457,0.000012237408,0.00010141845,0.00037190705,0.00008484559,0.0044173966,0.00029687487,0.000046547626,0.00025334806,0.000007336331],"about_ca_topic_score_codex":0.001038931,"about_ca_topic_score_gemma":0.0013857393,"teacher_disagreement_score":0.001466948,"about_ca_system_score_codex":0.0003524979,"about_ca_system_score_gemma":0.00035700822,"threshold_uncertainty_score":0.0077580214},"labels":[],"label_agreement":null},{"id":"W4405229307","doi":"10.1093/bjd/ljae360.126","title":"P96 Effectiveness and safety of bimekizumab for adult patients with plaque psoriasis: an interim analysis of 2-year data from a real-world, multicentre, retrospective study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Interim analysis; Plaque psoriasis; Interim; Psoriasis; Retrospective cohort study; Dermatology; Internal medicine; Clinical trial; History","score_opus":0.01386349948587046,"score_gpt":0.27420053712202475,"score_spread":0.2603370376361543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405229307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975439,0.0006156907,0.000598716,0.00002809127,0.000006776158,0.00008115822,0.0007504781,0.000012489796,0.00036266618],"genre_scores_gemma":[0.9979964,0.00010611007,0.00040276072,0.000038779286,0.000017329974,0.00006186826,0.0012441407,0.000004456193,0.00012811457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972703,0.0011362294,0.0003349079,0.00035990818,0.0006777893,0.00022090993],"domain_scores_gemma":[0.99518955,0.00152715,0.0017563406,0.0008285248,0.0004551115,0.00024342912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007237884,0.00037675243,0.00093673303,0.0005312787,0.00031516363,0.0009969348,0.00035654922,0.0004571102,0.0010155583],"category_scores_gemma":[0.005360824,0.00027221636,0.0019999708,0.0006550003,0.0003427127,0.00064480986,0.00036318458,0.0009481036,0.00029993214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03301129,0.0010282084,0.9208122,0.00016154343,0.001947162,0.00051888084,0.00024955612,0.0011588699,0.003467251,0.00007513585,0.0007307305,0.036839154],"study_design_scores_gemma":[0.0021204054,0.018961413,0.96912515,0.00003793758,0.0015601778,0.001280261,0.00014278822,0.0024557745,0.0026896466,0.00009308703,0.0014909698,0.00004228782],"about_ca_topic_score_codex":0.0005673828,"about_ca_topic_score_gemma":0.00045710802,"teacher_disagreement_score":0.007237884,"about_ca_system_score_codex":0.00044525045,"about_ca_system_score_gemma":0.00055891764,"threshold_uncertainty_score":0.038278043},"labels":[],"label_agreement":null},{"id":"W4405229310","doi":"10.1093/bjd/ljae360.051","title":"P21 Development of a novel multidisciplinary care model for screening and managing patients with psoriatic arthritis: consensus guidance for primary care providers in Canada","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psoriatic arthritis; Multidisciplinary approach; Medicine; Primary care; Arthritis; Intensive care medicine; Family medicine; Internal medicine","score_opus":0.012021041866497151,"score_gpt":0.24146255019775067,"score_spread":0.2294415083312535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405229310","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41614947,0.0065844273,0.08439293,0.31855896,0.0025255496,0.021725917,0.0025394345,0.0007747626,0.14674851],"genre_scores_gemma":[0.8027767,0.002241223,0.1731037,0.00899734,0.00011673458,0.00282411,0.00067880447,0.00007867255,0.009182663],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9739603,0.012849434,0.0017856923,0.0014140762,0.0065528546,0.003437649],"domain_scores_gemma":[0.9425247,0.007323135,0.002373446,0.001092461,0.03366152,0.0130247865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02959084,0.00048598222,0.00052369403,0.0018829448,0.010075484,0.005591099,0.0031546643,0.002059753,0.0042758426],"category_scores_gemma":[0.0414042,0.0005566353,0.0009940634,0.0020656283,0.0029663118,0.0018836447,0.0064451615,0.0025579177,0.0005315507],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005556507,0.0016935209,0.15548566,0.004512201,0.00025440415,0.006249101,0.13237496,0.011672435,0.005648118,0.03659253,0.20057718,0.44438437],"study_design_scores_gemma":[0.00088000705,0.0014956875,0.17753218,0.010635685,0.0002969065,0.0019956673,0.23683222,0.05396629,0.0039773607,0.020606706,0.49095407,0.00082718855],"about_ca_topic_score_codex":0.8957587,"about_ca_topic_score_gemma":0.94535494,"teacher_disagreement_score":0.9096261,"about_ca_system_score_codex":0.09037385,"about_ca_system_score_gemma":0.43174785,"threshold_uncertainty_score":0.6557113},"labels":[],"label_agreement":null},{"id":"W4405229326","doi":"10.1093/bjd/ljae360.064","title":"P34 The incidence and prevalence of psoriasis in Newfoundland and Labrador, Canada","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psoriasis; Incidence (geometry); Medicine; Geography; Demography; Epidemiology; Dermatology; Pathology; Sociology","score_opus":0.007111329557458947,"score_gpt":0.2156186800416515,"score_spread":0.20850735048419256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405229326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89146775,0.014913983,0.00030165925,0.0032137535,0.00016324918,0.00019459004,0.06606141,0.000119306096,0.023564251],"genre_scores_gemma":[0.98453957,0.0028303834,0.00032887407,0.00045634917,0.000035790283,0.00004728992,0.00753911,0.000018246186,0.004204455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984653,0.00010487682,0.00012312338,0.00022547414,0.0005954326,0.00048577867],"domain_scores_gemma":[0.9959252,0.00017910603,0.00088676816,0.00007916336,0.0020388016,0.0008910148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005795371,0.00034471808,0.00041118532,0.0038398944,0.002316609,0.0018027459,0.0015809243,0.00036938692,0.0045343232],"category_scores_gemma":[0.0020741858,0.00035013436,0.00070320035,0.0071094264,0.00061913335,0.00043450418,0.0008177633,0.0005858749,0.00056477805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007329183,0.000038752903,0.97820115,0.0001172465,0.00009762122,0.00016061039,0.00035382865,0.0001043997,0.00015338871,0.00013240322,0.011336362,0.00923103],"study_design_scores_gemma":[0.0000082599045,0.00000946564,0.9964684,0.00007178619,0.000029834207,0.00010980716,0.0007676288,0.00014523962,0.000034638168,0.000012966281,0.0023319528,0.000010062274],"about_ca_topic_score_codex":0.9975897,"about_ca_topic_score_gemma":0.9985964,"teacher_disagreement_score":0.03772953,"about_ca_system_score_codex":0.03772953,"about_ca_system_score_gemma":0.0336384,"threshold_uncertainty_score":0.27374822},"labels":[],"label_agreement":null},{"id":"W4405229705","doi":"10.1093/bjd/ljae360.145","title":"P115 Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-23 inhibitors: a 52-week multicentre retrospective review","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; Women's College Hospital; McMaster University","keywords":"Medicine; Discontinuation; Psoriasis; Internal medicine; Psoriasis Area and Severity Index; Adverse effect; Plaque psoriasis; Body surface area; Gastroenterology; Interleukin 17; Retrospective cohort study; Dermatology; Cytokine","score_opus":0.008607231824469994,"score_gpt":0.24633820757110672,"score_spread":0.23773097574663674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405229705","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29140273,0.69513077,0.002242573,0.0007416219,0.0002156245,0.00074745563,0.005781715,0.000037069778,0.0037004137],"genre_scores_gemma":[0.7994171,0.19336484,0.0013331305,0.0009246619,0.00054060284,0.00040902887,0.0034355652,0.00003145027,0.0005435913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99323046,0.0020812599,0.0024251079,0.0006020952,0.001555589,0.000105486186],"domain_scores_gemma":[0.96459097,0.013268154,0.01696802,0.001253322,0.0035365042,0.0003830484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005635337,0.00034024293,0.0011807515,0.0027192766,0.00025257102,0.0013995876,0.00058744976,0.0007167954,0.0030727189],"category_scores_gemma":[0.016563373,0.00035144715,0.0013833059,0.0055395444,0.0005293944,0.0009894219,0.00053332286,0.00053454685,0.0007558899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022393002,0.00023325722,0.66006786,0.07172854,0.007824144,0.012114051,0.0014617321,0.00027725773,0.0015697604,0.00045605566,0.010397651,0.23163041],"study_design_scores_gemma":[0.00050057255,0.0028943743,0.79753697,0.031342566,0.009817072,0.07293454,0.002137765,0.0005299184,0.0016533078,0.00022362183,0.08032566,0.00010366664],"about_ca_topic_score_codex":0.000921323,"about_ca_topic_score_gemma":0.0008530238,"teacher_disagreement_score":0.005635337,"about_ca_system_score_codex":0.0004887419,"about_ca_system_score_gemma":0.0010916746,"threshold_uncertainty_score":0.029802859},"labels":[],"label_agreement":null},{"id":"W4405229751","doi":"10.1093/bjd/ljae360.045","title":"P15 Evaluating risankizumab for moderate-to-severe plaque psoriasis: real-world outcomes from an international study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psoriasis Area and Severity Index; Ustekinumab; Psoriasis; Plaque psoriasis; Adalimumab; Adverse effect; Internal medicine; Randomized controlled trial; Severity of illness; Dermatology; Disease","score_opus":0.04039434091804939,"score_gpt":0.33980244830136674,"score_spread":0.29940810738331736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405229751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98819155,0.004061825,0.00091993285,0.00027557008,0.000044734712,0.00060842774,0.0029515973,0.000014258611,0.0029321099],"genre_scores_gemma":[0.9949444,0.0009880769,0.0005841982,0.00014701615,0.00008432321,0.0002864285,0.0027763494,0.000007590674,0.0001815551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99516654,0.002911252,0.0004672837,0.00047154547,0.00073817745,0.00024521266],"domain_scores_gemma":[0.9835143,0.0038303358,0.0064799027,0.0014569975,0.0030144579,0.0017038876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009942758,0.00066988333,0.00075130136,0.0005584006,0.0005642992,0.0013718056,0.00053182617,0.00074029993,0.0019107142],"category_scores_gemma":[0.010493551,0.00021655914,0.0015841238,0.0015785234,0.00070614176,0.0005949864,0.0008112925,0.00085999793,0.0004085762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05781754,0.0044614747,0.871021,0.0028236555,0.005293867,0.00060000096,0.0015632397,0.0010833223,0.0020084574,0.00045820346,0.0046070167,0.048262224],"study_design_scores_gemma":[0.007910863,0.023067474,0.95150197,0.00067121134,0.00431051,0.0010154304,0.0012648721,0.001184096,0.0014118663,0.0001666304,0.0073975907,0.000097536824],"about_ca_topic_score_codex":0.005493949,"about_ca_topic_score_gemma":0.0052553527,"teacher_disagreement_score":0.009942758,"about_ca_system_score_codex":0.0010446238,"about_ca_system_score_gemma":0.0017290721,"threshold_uncertainty_score":0.05258292},"labels":[],"label_agreement":null},{"id":"W4405665962","doi":"10.1093/bjd/ljae502","title":"Guselkumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients: results of the phase III randomized placebo-controlled PROTOSTAR study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Calgary Laboratory Services; SKiN Health; University of Calgary","funders":"Janssen Research and Development; LEO Pharma; Janssen Scientific Affairs; Celgene; Amgen; Pfizer; Eli Lilly and Company; Language Literacy and Culture, University of Maryland, Baltimore County","keywords":"Medicine; Placebo; Psoriasis; Internal medicine; Randomized controlled trial; Psoriasis Area and Severity Index; Dermatology; Pathology","score_opus":0.011350609452663618,"score_gpt":0.2568854939495789,"score_spread":0.24553488449691527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405665962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96583796,0.018749794,0.001360818,0.0011626055,0.00035842077,0.006610086,0.0031030776,0.00018021456,0.0026371016],"genre_scores_gemma":[0.9637801,0.016678842,0.004968557,0.002064108,0.0004509727,0.0066214367,0.0033337614,0.000084432366,0.0020178012],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99886,0.0007274293,0.000078682286,0.00010982702,0.00012229127,0.000101702695],"domain_scores_gemma":[0.99860173,0.00030886548,0.00044808196,0.00009395032,0.00011772923,0.00042959335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034129445,0.0011049348,0.0027631996,0.00024616384,0.00035012802,0.0009395217,0.0008094966,0.0011591851,0.0033755023],"category_scores_gemma":[0.0018618184,0.00052791624,0.0018818304,0.0004675114,0.00085426663,0.00071597577,0.0003624679,0.0029938153,0.000582737],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8858951,0.020891048,0.0033807545,0.0025687017,0.0031503893,0.00022448278,0.0002462042,0.0007730027,0.014540159,0.00023728676,0.004423552,0.06366929],"study_design_scores_gemma":[0.8570576,0.12549305,0.011730393,0.00013763063,0.0010434989,0.0002666971,0.00004882183,0.0003001675,0.0009961871,0.00012069191,0.0027827488,0.000022553713],"about_ca_topic_score_codex":0.0009081192,"about_ca_topic_score_gemma":0.0024093702,"teacher_disagreement_score":0.0034129445,"about_ca_system_score_codex":0.0008113324,"about_ca_system_score_gemma":0.0020604508,"threshold_uncertainty_score":0.018049598},"labels":[],"label_agreement":null},{"id":"W4405962344","doi":"10.1093/bjd/ljae433","title":"Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Deutsche Forschungsgemeinschaft","keywords":"Melanoma; Immune system; Cancer research; Sirtuin; Infiltration (HVAC); Proteome; Sirtuin 1; Immune checkpoint; Proteomics; Biology; Immunology; Medicine; Computational biology; Immunotherapy; Bioinformatics; Genetics; Gene; Downregulation and upregulation","score_opus":0.013698859260636203,"score_gpt":0.28508294349239865,"score_spread":0.27138408423176247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405962344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996333,0.0013459302,0.0014455878,0.000036355385,0.0000051824427,0.000008236028,0.00043361558,0.000038774433,0.0003532549],"genre_scores_gemma":[0.9981598,0.00028771668,0.00093559356,0.000019508445,0.0000034304915,0.000006783641,0.00034641963,0.0000058534883,0.0002348407],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999362,0.000006949376,0.0000037988323,0.00002670597,0.000015168269,0.00001122186],"domain_scores_gemma":[0.9999311,0.000010616224,0.000026719004,0.000006770489,0.000013646458,0.000011279505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000933234,0.00014316414,0.00014376057,0.00047447943,0.00015002597,0.0002798855,0.00009292839,0.00020671674,0.00093159644],"category_scores_gemma":[0.00014949974,0.00012177425,0.00021573335,0.00032799618,0.00014733437,0.00011386021,0.0001352524,0.00019128223,0.00031263698],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030520605,0.00001585849,0.017607845,0.000072286166,0.00003583575,0.00012144323,0.000041334348,0.0001406688,0.97798723,0.000039020724,0.000087511995,0.0035458333],"study_design_scores_gemma":[0.000024084587,0.00028830054,0.7036043,0.000012653556,0.000120318364,0.0025517922,0.00028822385,0.0043511726,0.28628892,0.00023219967,0.0022263858,0.000011672131],"about_ca_topic_score_codex":0.0007285786,"about_ca_topic_score_gemma":0.0009142647,"teacher_disagreement_score":0.00093159644,"about_ca_system_score_codex":0.00016701485,"about_ca_system_score_gemma":0.00008378532,"threshold_uncertainty_score":0.0031164885},"labels":[],"label_agreement":null},{"id":"W4406207363","doi":"10.1093/bjd/ljaf019","title":"Mechanistic insights into ruxolitinib cream for mild hidradenitis suppurativa","year":2025,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Hidradenitis suppurativa; Ruxolitinib; Medicine; Dermatology; Family medicine; Internal medicine; Disease","score_opus":0.01721475976789652,"score_gpt":0.2843255510579181,"score_spread":0.2671107912900216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406207363","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04250825,0.17695436,0.00154095,0.68858564,0.013602299,0.000117096155,0.00041476614,0.000103266066,0.07617333],"genre_scores_gemma":[0.5813655,0.09623536,0.0030391482,0.23002878,0.034604467,0.00022219885,0.0003073362,0.00005741563,0.054139692],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948454,0.00018726288,0.000040729054,0.000044847697,0.00014914345,0.00009345673],"domain_scores_gemma":[0.99956316,0.00026156162,0.000051352497,0.000020921927,0.00005493244,0.000048024544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008144411,0.00034090612,0.0008055219,0.00027038582,0.000843272,0.0019295206,0.0004237183,0.0054090363,0.005581296],"category_scores_gemma":[0.0014704654,0.00016677439,0.0007256479,0.00015996926,0.00075868017,0.0009745915,0.0004967234,0.005273937,0.0017029608],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042507923,0.0012282322,0.0060384143,0.0027659193,0.0004363946,0.07285335,0.0009859932,0.0014732364,0.06175617,0.07760913,0.44356015,0.3270422],"study_design_scores_gemma":[0.0013848371,0.000989547,0.0052743736,0.0008655612,0.00026227513,0.035080615,0.00052066846,0.0017463928,0.009791719,0.04186989,0.9021438,0.000070472546],"about_ca_topic_score_codex":0.00063183694,"about_ca_topic_score_gemma":0.0011619101,"teacher_disagreement_score":0.005581296,"about_ca_system_score_codex":0.0014677466,"about_ca_system_score_gemma":0.0007553937,"threshold_uncertainty_score":0.018671274},"labels":[],"label_agreement":null},{"id":"W4406249011","doi":"10.1093/bjd/ljaf015","title":"Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health; National Center for Advancing Translational Sciences; Epidermolysis Bullosa Medical Research Foundation; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Academy of Nutrition and Dietetics; Georgia Clinical and Translational Science Alliance","keywords":"Missense mutation; splice; Splice site mutation; Genotype; Genetics; Disease; Exon; Medicine; Biology; Internal medicine; Mutation; Gene; Alternative splicing","score_opus":0.013163642067973907,"score_gpt":0.2655083367997697,"score_spread":0.25234469473179577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406249011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983065,0.00026881622,0.00031562874,0.000042067215,0.000010754453,0.000012214398,0.00035093294,0.000010385986,0.0006827402],"genre_scores_gemma":[0.99911267,0.00004968805,0.00035599846,0.000008231822,0.0000057493526,0.0000068409836,0.00038039044,0.0000030229162,0.0000774256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943,0.00017421706,0.00007354673,0.00007820039,0.00014281724,0.00010122643],"domain_scores_gemma":[0.9970727,0.0010716937,0.0012009186,0.0001057101,0.0002391264,0.00030982733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011777781,0.0004726388,0.00025337032,0.0016998241,0.00024807488,0.000677324,0.00034609734,0.00038895034,0.0025186434],"category_scores_gemma":[0.0031364814,0.0000996517,0.00056832936,0.00079029216,0.00040556857,0.00024439866,0.0005893762,0.00033551417,0.0003629316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023415303,0.000012933718,0.9967044,0.000011590315,0.000041111536,0.00009349624,0.00003927105,0.00014133165,0.00044523517,0.000035238554,0.00008658129,0.0021546262],"study_design_scores_gemma":[0.000013944017,0.00012288964,0.99752456,0.000015984426,0.000045033652,0.0007478059,0.00012852222,0.000807305,0.0002217795,0.00019034556,0.00017572149,0.0000059958807],"about_ca_topic_score_codex":0.0013496721,"about_ca_topic_score_gemma":0.0016020401,"teacher_disagreement_score":0.0025186434,"about_ca_system_score_codex":0.00024373637,"about_ca_system_score_gemma":0.00022727858,"threshold_uncertainty_score":0.008425713},"labels":[],"label_agreement":null},{"id":"W4406283031","doi":"10.1093/bjd/ljaf020","title":"Prevalence of chronic hand eczema in adults: a cross-sectional survey of over 60 000 respondents from the general population of Canada, France, Germany, Italy, Spain and the UK","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hotel Dieu Hospital; Queen's University","funders":"Incyte; Sanofi; LEO Pharma; Pfizer","keywords":"Medicine; Epidemiology; Demography; Population; Cross-sectional study; Observational study; Confidence interval; Ethnic group; Gerontology; Environmental health","score_opus":0.0063731671370814685,"score_gpt":0.2589601847066724,"score_spread":0.25258701756959095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406283031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345374,0.00040290394,0.000055254586,0.00006025577,0.0000046679447,0.000049385235,0.0050508226,0.000008290246,0.00091479253],"genre_scores_gemma":[0.9956475,0.000469146,0.00015416885,0.00009936761,0.000006270692,0.000038567476,0.003067693,0.0000022306704,0.0005149441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999453,0.00004565667,0.00007141772,0.00010527391,0.00022859142,0.00009607336],"domain_scores_gemma":[0.99926466,0.000045152672,0.0002270684,0.00002420682,0.00024240029,0.00019652914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047546052,0.00021644992,0.00030360807,0.0011326785,0.00047750436,0.000644635,0.00035254264,0.00033502225,0.0010920204],"category_scores_gemma":[0.0009169237,0.00019672832,0.0002873706,0.0018084128,0.00034061747,0.00031145918,0.0003743612,0.00031072364,0.00026535144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018372384,0.000016166372,0.99858415,0.000019834142,0.000025808573,0.00003156014,0.00019011411,0.000013881037,0.00006955945,0.0000046750292,0.00023609142,0.0007899551],"study_design_scores_gemma":[0.000001431903,0.000013254202,0.9995944,0.0000055495125,0.0000051329794,0.000036274752,0.00019042607,0.000014835455,0.000007272497,0.0000010629782,0.00012920113,0.0000012273625],"about_ca_topic_score_codex":0.66886806,"about_ca_topic_score_gemma":0.6281583,"teacher_disagreement_score":0.33113194,"about_ca_system_score_codex":0.0017789267,"about_ca_system_score_gemma":0.0016176361,"threshold_uncertainty_score":0.66616404},"labels":[],"label_agreement":null},{"id":"W4406733220","doi":"10.1093/bjd/ljae491","title":"Global Delphi consensus on treatment goals for generalized pustular psoriasis","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University","funders":"Boehringer Ingelheim España; Biogen; Amgen","keywords":"Medicine; Delphi method; Disease; Intensive care medicine; Delphi; Psoriasis; Physical therapy; Dermatology; Internal medicine","score_opus":0.039593174392979484,"score_gpt":0.3227014374868438,"score_spread":0.28310826309386433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406733220","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07153598,0.048725683,0.33004946,0.28682208,0.020693317,0.12135881,0.0046744915,0.0012723713,0.11486786],"genre_scores_gemma":[0.3577377,0.025311192,0.39631358,0.05109545,0.0023946655,0.154904,0.0042699,0.0006353583,0.0073381085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.5551535,0.37345216,0.037328526,0.005541048,0.019831408,0.008693369],"domain_scores_gemma":[0.7552267,0.13479699,0.012079753,0.008653419,0.08053607,0.008707029],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.37362042,0.0026936927,0.0025996282,0.007243289,0.005505895,0.006720462,0.005096935,0.006716064,0.0080895545],"category_scores_gemma":[0.27852276,0.0021016572,0.0070083006,0.003704473,0.007005158,0.0071687526,0.01893389,0.011420649,0.00324686],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022714438,0.00048681488,0.0045906175,0.059173286,0.0012610668,0.0012867752,0.14565498,0.008430967,0.007794455,0.08070416,0.24770783,0.4406376],"study_design_scores_gemma":[0.0015784921,0.0012464329,0.008358884,0.11340592,0.00118663,0.0021785973,0.07639337,0.008799904,0.005499615,0.17030182,0.60999095,0.0010593291],"about_ca_topic_score_codex":0.0029507957,"about_ca_topic_score_gemma":0.0026314326,"teacher_disagreement_score":0.37362042,"about_ca_system_score_codex":0.013116703,"about_ca_system_score_gemma":0.060832717,"threshold_uncertainty_score":0.7724376},"labels":[],"label_agreement":null},{"id":"W4406785134","doi":"10.1093/bjd/ljae507","title":"Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Manchester Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Atopic dermatitis; Placebo; Medicine; Dose-ranging study; Multicenter study; Dermatology; Internal medicine; Randomized controlled trial; Double blind; Alternative medicine; Pathology","score_opus":0.006689492097948261,"score_gpt":0.2768975909451721,"score_spread":0.2702080988472238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406785134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98635674,0.005525105,0.00051043445,0.00037794528,0.00014205635,0.00465791,0.0011291204,0.00008094643,0.0012196784],"genre_scores_gemma":[0.98542225,0.003476072,0.0019682972,0.0009748806,0.00033203312,0.0043601566,0.0016316387,0.000023493198,0.0018113453],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990613,0.00052326993,0.00007947097,0.00012754592,0.00008609505,0.00012239983],"domain_scores_gemma":[0.99886143,0.00023859825,0.00030017167,0.000102091544,0.000103403385,0.00039430487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041560777,0.001586317,0.0025123416,0.000523346,0.00047414147,0.0009024063,0.0009304273,0.0015455179,0.0050096],"category_scores_gemma":[0.0017990557,0.0007996149,0.0020839474,0.00052977784,0.0009734988,0.00082577433,0.00046485176,0.0022577485,0.00066244515],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93737257,0.019036006,0.0027203404,0.0010698403,0.0013080409,0.000076855365,0.000116285104,0.00042335645,0.012593723,0.00006145076,0.0009906708,0.024230808],"study_design_scores_gemma":[0.85573196,0.13589728,0.0062468583,0.00003423288,0.0005929344,0.00006518892,0.000016712052,0.00014284064,0.0006252741,0.000047631736,0.00058649865,0.000012703025],"about_ca_topic_score_codex":0.0005491828,"about_ca_topic_score_gemma":0.001831185,"teacher_disagreement_score":0.0050096,"about_ca_system_score_codex":0.0005365799,"about_ca_system_score_gemma":0.0011081024,"threshold_uncertainty_score":0.02197975},"labels":[],"label_agreement":null},{"id":"W4406822184","doi":"10.1093/bjd/ljaf032","title":"Bimekizumab efficacy and safety through 3 years in patients with moderate-to-severe plaque psoriasis: long-term results from the BE RADIANT phase IIIb trial open-label extension period","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"Cilag; Manchester Biomedical Research Centre; Sanofi Genzyme; Genentech; Medac; L'Oreal USA; Bausch Health; Celltrion; Astellas Pharma; National Institute for Health and Care Research; Pfizer; Biogen; Incyte; Castle Biosciences; Dermira; Sun Pharma; Regeneron Pharmaceuticals; Celgene; Sanofi; Amgen; Meiji Seika Pharma; Les Laboratories Pierre Fabre; Galderma; LEO Pharma; Ortho Dermatologics; AstraZeneca; Eli Lilly and Company; Samsung; Bristol-Myers Squibb","keywords":"Secukinumab; Medicine; Psoriasis; Adverse effect; Psoriasis Area and Severity Index; Interleukin 17; Plaque psoriasis; Open label; Dosing; Clinical trial; Internal medicine; Dermatology; Psoriatic arthritis; Cytokine","score_opus":0.02186603706440261,"score_gpt":0.27622659060136234,"score_spread":0.25436055353695974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406822184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855715,0.009199642,0.0004416666,0.00056370226,0.00015987502,0.0012445388,0.0010854113,0.00008772961,0.001645915],"genre_scores_gemma":[0.9884293,0.0029980906,0.000827701,0.0012036652,0.0004346903,0.0020516461,0.0021853317,0.000028137416,0.0018414988],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9985682,0.0006346615,0.00008179078,0.00023962579,0.00018689148,0.00028877993],"domain_scores_gemma":[0.9981061,0.00028278815,0.00057001255,0.00020723743,0.00016146842,0.00067231106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044546453,0.0013816041,0.0035508908,0.0004403214,0.0008208675,0.0015149111,0.00097225996,0.0019523974,0.0029672284],"category_scores_gemma":[0.0021636433,0.0006707263,0.0028797786,0.0005561098,0.0010153822,0.0014629617,0.0005741682,0.004608172,0.0009625312],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93102986,0.022575615,0.0045905337,0.0004740123,0.0015021967,0.00008450267,0.000107234664,0.00044611306,0.0056064827,0.00008930208,0.0017890205,0.031705093],"study_design_scores_gemma":[0.6668933,0.2927735,0.03371471,0.00008078339,0.0017755849,0.00022827275,0.00004650393,0.00062785874,0.0014706791,0.00023424032,0.0021115153,0.000043106917],"about_ca_topic_score_codex":0.0007659818,"about_ca_topic_score_gemma":0.0012827237,"teacher_disagreement_score":0.0044546453,"about_ca_system_score_codex":0.0009563531,"about_ca_system_score_gemma":0.0012970633,"threshold_uncertainty_score":0.023558676},"labels":[],"label_agreement":null},{"id":"W4406933768","doi":"10.1093/bjd/ljaf039","title":"The UK-Irish Atopic eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohort","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council","keywords":"Register (sociolinguistics); Medicine; Baseline (sea); Systemic therapy; Cohort; Prospective cohort study; Cohort study; Irish; Pediatrics; Internal medicine","score_opus":0.00918654019646863,"score_gpt":0.26044836561917856,"score_spread":0.2512618254227099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406933768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87092465,0.0016817948,0.0017311508,0.0025283343,0.00039807928,0.0006212128,0.1094846,0.000091366244,0.012538867],"genre_scores_gemma":[0.906796,0.0009753372,0.0024560322,0.0018076258,0.00024071881,0.0011237941,0.078946926,0.000088733206,0.0075648734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976036,0.0005842928,0.0004703166,0.00040569002,0.00059666525,0.0003394612],"domain_scores_gemma":[0.9964059,0.0004934088,0.0012087728,0.0006689736,0.0009132992,0.00030968565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026303388,0.0002433493,0.0005933243,0.0013253468,0.0004093395,0.000817042,0.00057617883,0.0006475985,0.003174813],"category_scores_gemma":[0.008687896,0.00026946067,0.0005242987,0.0019738504,0.0002501777,0.0005796982,0.0005903769,0.0006988308,0.0015683614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022208763,0.00017167143,0.9339368,0.000115588045,0.00020304877,0.0003833861,0.00022950146,0.00020255405,0.00071364397,0.0003727698,0.043441534,0.018008668],"study_design_scores_gemma":[0.00024062984,0.000374787,0.9757372,0.00008458331,0.00008114842,0.001011967,0.00024107427,0.00043765715,0.00019326172,0.00013607234,0.021415863,0.000045683795],"about_ca_topic_score_codex":0.048914004,"about_ca_topic_score_gemma":0.05316144,"teacher_disagreement_score":0.048914004,"about_ca_system_score_codex":0.0013508133,"about_ca_system_score_gemma":0.001742068,"threshold_uncertainty_score":0.09725863},"labels":[],"label_agreement":null},{"id":"W4407108020","doi":"10.1093/bjd/ljae455","title":"Hidradenitis suppurativa<i>: BJD</i> state-of-the-art review series","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Hidradenitis suppurativa; Series (stratigraphy); Dermatology; Medicine; Internal medicine; Biology; Paleontology","score_opus":0.006343718646888987,"score_gpt":0.26077806615088006,"score_spread":0.2544343475039911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407108020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000120912715,0.99778855,0.00003884149,0.00028940383,0.00077996316,0.000005834138,0.00003842732,0.0000051635866,0.00093300856],"genre_scores_gemma":[0.0014457755,0.99575174,0.00013894099,0.00061180984,0.001286882,0.0000069668063,0.00008896922,0.0000034901052,0.0006653133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956495,0.0000694876,0.000101662525,0.00006570802,0.00014992514,0.000048262555],"domain_scores_gemma":[0.997965,0.0011542276,0.00039418024,0.00004595945,0.00030780546,0.00013297032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006674159,0.0005539102,0.001821555,0.0025778103,0.00033167555,0.0020914415,0.00069814286,0.0010161835,0.010190434],"category_scores_gemma":[0.0020344153,0.00026736705,0.0007914837,0.00362513,0.00054294954,0.001614135,0.00069246616,0.0013158758,0.0031369599],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032273514,0.000112502785,0.0007086958,0.06884219,0.00026279877,0.0005146415,0.00011226934,0.00016416084,0.0013489176,0.0011793053,0.13953617,0.78689563],"study_design_scores_gemma":[0.000049290855,0.00010520427,0.003247589,0.024826663,0.0006602419,0.0037896212,0.00013344306,0.000073193885,0.00033559295,0.00068004965,0.9660655,0.00003345048],"about_ca_topic_score_codex":0.0017530184,"about_ca_topic_score_gemma":0.0038233555,"teacher_disagreement_score":0.010190434,"about_ca_system_score_codex":0.0006225494,"about_ca_system_score_gemma":0.0015704056,"threshold_uncertainty_score":0.0340904},"labels":[],"label_agreement":null},{"id":"W4407853068","doi":"10.1093/bjd/ljaf066","title":"High prevalence of chronic hand eczema in Europe and Canada","year":2025,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Family medicine; Medicine; Allergy; Dermatology; Library science","score_opus":0.005345158504312348,"score_gpt":0.21109936650581454,"score_spread":0.20575420800150218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407853068","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8981782,0.006010848,0.00019191744,0.04043093,0.00063780166,0.000048087102,0.003112703,0.00005958085,0.051329907],"genre_scores_gemma":[0.9838823,0.0015615064,0.00014213157,0.006851193,0.00020745404,0.000009320304,0.000314742,0.000019905532,0.0070114634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991616,0.00006741105,0.000072063594,0.000072372975,0.00027445814,0.00035215524],"domain_scores_gemma":[0.99773705,0.00020312023,0.00026356097,0.00003833581,0.001014311,0.0007436535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003482678,0.00018054663,0.00040566872,0.0011128183,0.0029590097,0.0014007197,0.0006660609,0.0021341343,0.006542286],"category_scores_gemma":[0.0019279032,0.00025994444,0.0003896152,0.0026116364,0.00068925705,0.00045769036,0.0004754399,0.0012658167,0.00036406144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001971773,0.000072990675,0.9432726,0.000108496606,0.000097999065,0.0076550604,0.0016326389,0.00011669985,0.0008434512,0.000622754,0.03027237,0.015107782],"study_design_scores_gemma":[0.000030228017,0.000033370936,0.9739095,0.00013026221,0.000052140495,0.005509714,0.0067505166,0.00024766452,0.00012111184,0.00016651116,0.013010628,0.000038273138],"about_ca_topic_score_codex":0.97074157,"about_ca_topic_score_gemma":0.9810968,"teacher_disagreement_score":0.02925843,"about_ca_system_score_codex":0.008879244,"about_ca_system_score_gemma":0.012028021,"threshold_uncertainty_score":0.06442374},"labels":[],"label_agreement":null},{"id":"W4407853073","doi":"10.1093/bjd/ljaf068","title":"Dermatological care in Muslim patients: a perspective on gender and cultural considerations","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Islamic Studies and History","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; University of Toronto; St Joseph's Health Centre; Queen's University","funders":"","keywords":"Ethnic group; Limiting; Medicine; Islam; Perspective (graphical); Diversity (politics); Population; Family medicine; Alternative medicine; Culturally sensitive; Cultural diversity; Dermatology; Psychology; Sociology; Environmental health; Geography; Pathology; Social psychology","score_opus":0.015981294863556518,"score_gpt":0.3032407317707475,"score_spread":0.28725943690719097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407853073","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35340393,0.04961497,0.0009387203,0.5143153,0.004819117,0.00004130566,0.000090351255,0.000018431803,0.07675789],"genre_scores_gemma":[0.9250758,0.02605723,0.0005404071,0.04213687,0.0016678309,0.000025275018,0.000021093916,0.000011934998,0.0044634915],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.99843436,0.0009955831,0.000054305772,0.000042252665,0.00016476316,0.0003087504],"domain_scores_gemma":[0.9982571,0.0005144814,0.00016814152,0.00002736771,0.00020807942,0.000824726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024614716,0.00017012836,0.00025174543,0.00047773248,0.0038421717,0.0022646107,0.00045439843,0.0013623136,0.0054858443],"category_scores_gemma":[0.0033644647,0.00011579583,0.00024620985,0.0003924043,0.0033815792,0.0018550042,0.0025938412,0.0027517998,0.00037040972],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025301994,0.000586488,0.1598829,0.0013368495,0.00007831231,0.022884391,0.37190002,0.00034426677,0.0027227108,0.09004002,0.10167338,0.2482976],"study_design_scores_gemma":[0.000029194622,0.0003927953,0.038199045,0.0027343726,0.00003481439,0.017316775,0.7157116,0.00018542698,0.0003104053,0.01832719,0.20669006,0.00006837864],"about_ca_topic_score_codex":0.0063630855,"about_ca_topic_score_gemma":0.017226858,"teacher_disagreement_score":0.0063630855,"about_ca_system_score_codex":0.0021263773,"about_ca_system_score_gemma":0.0031535386,"threshold_uncertainty_score":0.018351912},"labels":[],"label_agreement":null},{"id":"W4408142413","doi":"10.1093/bjd/ljaf061","title":"Congenital melanocytic naevi initiated by <i>BRAF</i> fusion oncogene with firmness, pruritus and desmoplastic stroma","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Cancer Institute; Fonds de Recherche du Québec - Santé; Melanoma Research Alliance","keywords":"Stroma; Medicine; Dermatology; Nevus; Pathology; Melanoma; Cancer research; Immunohistochemistry","score_opus":0.006758010627951715,"score_gpt":0.2305361639152335,"score_spread":0.22377815328728176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408142413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688774,0.0003982239,0.0004468784,0.000040124272,0.0000054662214,0.000016932976,0.000042923097,0.000026200256,0.0021353734],"genre_scores_gemma":[0.99949026,0.00005422925,0.0002768968,0.000019359652,0.0000073633523,0.0000022107401,0.000025289437,0.000004443404,0.00011999555],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99980515,0.000016744085,0.00001852447,0.000054434917,0.000044411667,0.000060808714],"domain_scores_gemma":[0.9990402,0.00023873564,0.00036906908,0.00006602785,0.000043401924,0.00024255856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020047896,0.00037452954,0.0002367754,0.0005206835,0.0005401954,0.00034525205,0.00020899547,0.0003870584,0.0015908433],"category_scores_gemma":[0.00090770447,0.0001862517,0.00021182558,0.00044271996,0.0005920172,0.00027850506,0.00044728795,0.00049463037,0.00023469099],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025642425,0.000064783155,0.6163769,0.00014478219,0.0000670091,0.3292124,0.0004059996,0.00036785676,0.039476603,0.00042742674,0.0007054354,0.012494379],"study_design_scores_gemma":[0.000008717734,0.00012734561,0.15773818,0.000012716557,0.00001693055,0.83681536,0.00014749473,0.00025334925,0.004211551,0.00008585294,0.0005757935,0.0000066679922],"about_ca_topic_score_codex":0.00079811027,"about_ca_topic_score_gemma":0.0019234822,"teacher_disagreement_score":0.0015908433,"about_ca_system_score_codex":0.00047264012,"about_ca_system_score_gemma":0.00028245733,"threshold_uncertainty_score":0.00532192},"labels":[],"label_agreement":null},{"id":"W4408725089","doi":"10.1093/bjd/ljaf046","title":"A qualitative interview study exploring patients’ views and experiences of treatment for hidradenitis suppurativa in the UK","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Health Technology Assessment Programme; Department of Health and Social Care; National Institute for Health and Care Research","keywords":"Hidradenitis suppurativa; Qualitative research; Medicine; Nonprobability sampling; Patient satisfaction; Health care; Grounded theory; Family medicine; Psychology; Nursing; Disease; Population","score_opus":0.1390809064629161,"score_gpt":0.40525111564292193,"score_spread":0.26617020918000583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408725089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815305,0.0017877662,0.0027865113,0.006038829,0.00017243519,0.00055947114,0.0004518802,0.000029559069,0.0066429437],"genre_scores_gemma":[0.99190897,0.0013122716,0.0015006507,0.0018238131,0.000036698668,0.00058240286,0.00013617158,0.000025331148,0.0026736024],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98076415,0.014988182,0.0007777201,0.0007243117,0.0008046011,0.0019410213],"domain_scores_gemma":[0.9654884,0.025587175,0.0023633428,0.0006288597,0.0023421124,0.0035901754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016422732,0.000673315,0.0010725872,0.001464078,0.007897359,0.0045834724,0.0017267318,0.002748466,0.004714631],"category_scores_gemma":[0.023875922,0.00085040485,0.0005937263,0.0018006808,0.00794452,0.0045830677,0.0053961333,0.004095564,0.0006200097],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048829213,0.000031459535,0.0013059896,0.0001671982,0.0000038982334,0.0007460831,0.994696,0.000035287077,0.0003130291,0.0004973892,0.0004900322,0.0016647849],"study_design_scores_gemma":[0.0000072664375,0.00006912144,0.0009020355,0.00020160299,0.0000029258103,0.00021680577,0.992385,0.00006974446,0.00008334798,0.00016791889,0.005881615,0.00001255365],"about_ca_topic_score_codex":0.013489772,"about_ca_topic_score_gemma":0.018847652,"teacher_disagreement_score":0.016422732,"about_ca_system_score_codex":0.008215815,"about_ca_system_score_gemma":0.00667144,"threshold_uncertainty_score":0.08685273},"labels":[],"label_agreement":null},{"id":"W4409088865","doi":"10.1093/bjd/ljaf092","title":"Characteristics of patients seeking skin-related minor ailment pharmacy services in Ontario, Canada: a population-based cross-sectional study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Women's College Hospital; University of Toronto","funders":"Strategy for Patient-Oriented Research; Leslie Dan Faculty of Pharmacy, University of Toronto; Canadian Institutes of Health Research; Mitacs; Institute of Chemical and Engineering Sciences; University of Toronto; Ontario Ministry of Health and Long-Term Care","keywords":"Minor (academic); Pharmacy; Medicine; Healthcare system; Service (business); Population; Cross-sectional study; Health care; Family medicine; Health services; Business; Environmental health; Marketing; Economic growth; Political science; Pathology","score_opus":0.07400207882187795,"score_gpt":0.359630796639295,"score_spread":0.28562871781741705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409088865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99180096,0.00070368085,0.00007191206,0.0005860647,0.000011667532,0.00008295566,0.004415183,0.0000056828203,0.0023218745],"genre_scores_gemma":[0.9974433,0.00042538013,0.00007096823,0.00021120685,0.000008135596,0.000028735129,0.0011554335,0.0000031444524,0.00065372785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988876,0.00007233215,0.00011636021,0.00013866326,0.00043968591,0.000345487],"domain_scores_gemma":[0.99784887,0.00016314532,0.0006539809,0.00007154191,0.00063731044,0.00062516204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058005296,0.00023986815,0.0004531341,0.0011208706,0.0021009082,0.0013242831,0.0009534364,0.000740747,0.0027658853],"category_scores_gemma":[0.0022213883,0.00043274552,0.00063731696,0.00416853,0.00082716625,0.0005761437,0.00075586536,0.0007944892,0.00032987964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040037972,0.000040802704,0.9968681,0.000033208988,0.000030663745,0.00007284121,0.0007192362,0.000033019503,0.000094668845,0.00004554419,0.0008144544,0.0012074141],"study_design_scores_gemma":[0.0000039430965,0.000023084867,0.99838793,0.000020208907,0.000010613708,0.00004730306,0.0008528028,0.000068475674,0.000008901054,0.000009748829,0.0005606978,0.000006338829],"about_ca_topic_score_codex":0.97747564,"about_ca_topic_score_gemma":0.9834171,"teacher_disagreement_score":0.022524357,"about_ca_system_score_codex":0.019792955,"about_ca_system_score_gemma":0.014280114,"threshold_uncertainty_score":0.14360863},"labels":[],"label_agreement":null},{"id":"W4409118828","doi":"10.1093/bjd/ljaf119","title":"Transcriptomic skin niches in systemic sclerosis underpin a role for mitochondrial dysfunction","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"Arthritis Society; Canadian Institutes of Health Research; National Scleroderma Foundation; Institute of Musculoskeletal Health and Arthritis; Natural Sciences and Engineering Research Council of Canada; Canadian Dermatology Foundation","keywords":"Transcriptome; Niche; Biology; Medicine; Genetics; Ecology; Gene","score_opus":0.013128727620917423,"score_gpt":0.2446767411643741,"score_spread":0.23154801354345667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409118828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932534,0.0024914104,0.002110159,0.00012959258,0.000013831859,0.000011107589,0.0011155051,0.00004813417,0.0008268104],"genre_scores_gemma":[0.99720335,0.0004845437,0.0011445513,0.000067790694,0.000011335068,0.000015756903,0.00055347075,0.000012013014,0.00050726766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987555,0.00001959666,0.000008496176,0.00004445204,0.000026012485,0.000025988755],"domain_scores_gemma":[0.99981827,0.000058940626,0.000058033143,0.000013302573,0.000021676118,0.000029834524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015402434,0.00014664046,0.00022456962,0.00062078726,0.00025547197,0.00044612054,0.00006137268,0.00021388632,0.0018256911],"category_scores_gemma":[0.00024340709,0.00009618823,0.00016665595,0.00053201325,0.0003239534,0.00021302523,0.00037927934,0.000246304,0.00031000373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060391077,0.000019035517,0.045312636,0.00018695476,0.00005140854,0.00081714184,0.00047900647,0.00025171984,0.94073415,0.00020478267,0.00026168185,0.011077771],"study_design_scores_gemma":[0.000032107306,0.00031320276,0.9199992,0.00011041967,0.00016215,0.006673409,0.002289789,0.0022123957,0.059112865,0.001957523,0.007097831,0.00003913349],"about_ca_topic_score_codex":0.00029502518,"about_ca_topic_score_gemma":0.0007895262,"teacher_disagreement_score":0.0018256911,"about_ca_system_score_codex":0.00010389958,"about_ca_system_score_gemma":0.00012377817,"threshold_uncertainty_score":0.0061075687},"labels":[],"label_agreement":null},{"id":"W4409146806","doi":"10.1093/bjd/ljaf127","title":"Measurement properties of the Comprehensive Quality-of-Life Measure for Acne (CompAQ): a cohort study at three international sites","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Windsor Clinical Research; Brock University; Western University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Australian College of Perioperative Nurses","keywords":"Construct validity; Cronbach's alpha; Medicine; Quality of life (healthcare); Cohort; Cohort study; Differential item functioning; Clinical psychology; Confirmatory factor analysis; Criterion validity; Acne; Convergent validity; Psychometrics; Item response theory; Internal consistency; Structural equation modeling; Internal medicine; Statistics","score_opus":0.10567993091205796,"score_gpt":0.3221930553069158,"score_spread":0.21651312439485781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409146806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99880886,0.00013021518,0.00019733589,0.000026450503,0.000005055876,0.000076303855,0.000558449,0.0000015656145,0.00019577277],"genre_scores_gemma":[0.99841905,0.00007432856,0.00025467816,0.00003790886,0.000005377707,0.000115995914,0.0009924278,0.0000030772533,0.00009727638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977042,0.0007051639,0.0003420625,0.0005258902,0.00047603788,0.00024675849],"domain_scores_gemma":[0.9953838,0.0007622222,0.0018203177,0.0005954296,0.0009083938,0.0005298917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005935721,0.00047136415,0.0005327996,0.0009197579,0.000989476,0.0009538547,0.0005921896,0.0004868604,0.001340457],"category_scores_gemma":[0.00730106,0.00033460956,0.0011510809,0.0014302267,0.0005100955,0.00081427273,0.0011231155,0.00083450956,0.00031751665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014502429,0.000045874254,0.99813396,0.000013897054,0.00007526998,0.00004202907,0.00042461787,0.000013867199,0.00009498878,0.000013311852,0.0000704428,0.0009267239],"study_design_scores_gemma":[0.000027806493,0.00020111093,0.99840975,0.000020398917,0.00008017344,0.00017157808,0.0006292037,0.00010825754,0.00007418319,0.000017679587,0.0002506834,0.000009066133],"about_ca_topic_score_codex":0.009797786,"about_ca_topic_score_gemma":0.011849859,"teacher_disagreement_score":0.009797786,"about_ca_system_score_codex":0.0006851125,"about_ca_system_score_gemma":0.0008525923,"threshold_uncertainty_score":0.03139144},"labels":[],"label_agreement":null},{"id":"W4409522276","doi":"10.1093/bjd/ljaf144","title":"Monoclonal gammopathy of thrombotic significance","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Women's College Hospital; University of Toronto","funders":"","keywords":"Monoclonal gammopathy; Medicine; Monoclonal gammopathy of undetermined significance; Differential diagnosis; Monoclonal; Dermatology; Pathology; Monoclonal antibody; Immunology; Antibody","score_opus":0.01133759398230168,"score_gpt":0.30098992309151007,"score_spread":0.2896523291092084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409522276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9506239,0.008872546,0.0019260673,0.010219666,0.00080006546,0.00022720442,0.0007973028,0.00019290259,0.026340226],"genre_scores_gemma":[0.9927941,0.0024911491,0.00035795994,0.0014339059,0.00051602395,0.00001657395,0.00014388227,0.000013153493,0.0022332966],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997943,0.000021672022,0.000017863442,0.000054973865,0.000033299293,0.00007798905],"domain_scores_gemma":[0.999537,0.00013550933,0.00007370192,0.000024250368,0.00004128492,0.00018825705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018791136,0.0012736777,0.0006747259,0.0017261468,0.0014743655,0.000711569,0.0005437492,0.002440058,0.0028495586],"category_scores_gemma":[0.0014877504,0.00053216564,0.00044603233,0.001180183,0.00048374254,0.0009997907,0.0005258266,0.0018871047,0.00067767163],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007625385,0.00006747204,0.018689096,0.000037574195,0.000015108999,0.9761346,0.0002319583,0.000107205546,0.0011604769,0.00018291823,0.0008192442,0.002478027],"study_design_scores_gemma":[0.000028104942,0.00022469282,0.03712173,0.00006503912,0.000035345278,0.9586346,0.00021560637,0.00035329274,0.0004125523,0.0004145003,0.0024761967,0.000018335299],"about_ca_topic_score_codex":0.0027248077,"about_ca_topic_score_gemma":0.0028183884,"teacher_disagreement_score":0.0028495586,"about_ca_system_score_codex":0.0005548188,"about_ca_system_score_gemma":0.00046291278,"threshold_uncertainty_score":0.00953269},"labels":[],"label_agreement":null},{"id":"W4409591467","doi":"10.1093/bjd/ljaf151","title":"The association between hidradenitis suppurativa and psychiatric disease: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hidradenitis suppurativa; Meta-analysis; Medicine; Association (psychology); Psychiatry; Psychiatric Disease; Disease; Dermatology; MEDLINE; Psychology; Psychotherapist; Pathology; Biology","score_opus":0.030247697519285657,"score_gpt":0.3377231107443181,"score_spread":0.30747541322503247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409591467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037640862,0.9948084,0.00037426804,0.00013901005,0.00010784297,0.0003041269,0.00031267124,0.00001611849,0.00017342417],"genre_scores_gemma":[0.113214016,0.88126266,0.002338001,0.0006246766,0.00022825818,0.0014045932,0.0006178477,0.00001741479,0.00029249396],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99215513,0.0037451573,0.0021942472,0.00072469155,0.0009105112,0.00027037528],"domain_scores_gemma":[0.98033226,0.01471048,0.0029102857,0.0004622653,0.0013280321,0.00025667815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013090779,0.002603028,0.01759382,0.006743306,0.0007570098,0.0033853902,0.0020750584,0.0023879986,0.0036726417],"category_scores_gemma":[0.02877142,0.0015074357,0.036449354,0.007059696,0.000705574,0.0017658268,0.0015095097,0.0017229937,0.00025664992],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012972816,0.00003287178,0.003790247,0.50662607,0.4776497,0.00016124264,0.000092268056,0.00043731407,0.00017759042,0.000109203,0.00047754392,0.009148728],"study_design_scores_gemma":[0.00035161787,0.00021645306,0.0034367044,0.035726104,0.9583638,0.00013507117,0.000048950755,0.00017510039,0.000077769495,0.00012357977,0.0013239254,0.0000209849],"about_ca_topic_score_codex":0.0060493364,"about_ca_topic_score_gemma":0.01399746,"teacher_disagreement_score":0.01759382,"about_ca_system_score_codex":0.0027719806,"about_ca_system_score_gemma":0.0040111714,"threshold_uncertainty_score":0.06923145},"labels":[],"label_agreement":null},{"id":"W4409839579","doi":"10.1093/bjd/ljaf158","title":"Atopic dermatitis starting in childhood has a stronger impact on adults: results from the ‘Scars of Life’ international project in 27 countries","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"Universidade Tiradentes; Roche","keywords":"Atopic dermatitis; Scars; Medicine; Dermatology; Pediatrics; Surgery","score_opus":0.009297849098293946,"score_gpt":0.2745553851064156,"score_spread":0.26525753600812163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409839579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985399,0.00037161424,0.000026295787,0.000053341453,0.000005580939,0.000018963407,0.00046213195,0.0000012578238,0.0005208731],"genre_scores_gemma":[0.9990426,0.0003252437,0.00003943348,0.00005180438,0.00000382742,0.00001888223,0.00040291023,0.0000019706513,0.00011340667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985166,0.0006298708,0.00016861114,0.00014777284,0.00018911665,0.00034798044],"domain_scores_gemma":[0.99788034,0.00032921738,0.0009736494,0.00016791064,0.0002726049,0.00037625176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018174128,0.00037783364,0.00046890473,0.00063429924,0.00073087664,0.0010906808,0.000332097,0.00055749895,0.0012697822],"category_scores_gemma":[0.0028341166,0.00033469984,0.00096279714,0.0013472794,0.0006816,0.00074037863,0.0018983207,0.00075002306,0.00022016991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021381777,0.00012931442,0.9891244,0.00011336386,0.0001400304,0.00026070292,0.003983233,0.00004172066,0.000080294456,0.000054145083,0.00047988072,0.0053790193],"study_design_scores_gemma":[0.000009036909,0.00012891684,0.99480814,0.000047743244,0.00003479482,0.00017643746,0.0043920767,0.000011672546,0.000017165632,0.000012050633,0.00035669483,0.0000053360545],"about_ca_topic_score_codex":0.018830653,"about_ca_topic_score_gemma":0.019319912,"teacher_disagreement_score":0.018830653,"about_ca_system_score_codex":0.0005669149,"about_ca_system_score_gemma":0.0005787257,"threshold_uncertainty_score":0.037442088},"labels":[],"label_agreement":null},{"id":"W4410050643","doi":"10.1093/bjd/ljaf156","title":"Efficacy and safety of rilzabrutinib in patients with moderate-to-severe atopic dermatitis: 16-week results from a proof-of-concept phase II clinical trial","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Sanofi","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Placebo; Clinical endpoint; Adverse effect; Internal medicine; Regimen; Dermatology Life Quality Index; Clinical trial; Randomized controlled trial; Dermatology; Disease","score_opus":0.01982358497355226,"score_gpt":0.3147354051382038,"score_spread":0.29491182016465156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410050643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97235715,0.013380803,0.0010932289,0.001246023,0.00033821212,0.0058656456,0.002226533,0.00020897617,0.0032834236],"genre_scores_gemma":[0.977756,0.0056310333,0.002771669,0.0018553635,0.00038123157,0.0057702344,0.0021410435,0.00003965007,0.003653685],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992981,0.00030984377,0.000058791204,0.000108964836,0.00009540041,0.00012877122],"domain_scores_gemma":[0.99878687,0.00021400045,0.00033371724,0.000115842384,0.00010494871,0.00044461337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046145306,0.0016507171,0.0025625436,0.00029808603,0.000427683,0.0014401363,0.0011464702,0.0018460635,0.0050440882],"category_scores_gemma":[0.0017623797,0.00060275925,0.0024694037,0.0003327673,0.0008298774,0.0011644707,0.00048989354,0.004028294,0.001340842],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79191726,0.04813391,0.004806852,0.0032803977,0.0031752614,0.0002537501,0.00029424945,0.0016789131,0.04322855,0.0002488711,0.00608052,0.096901335],"study_design_scores_gemma":[0.7759939,0.20824978,0.009005357,0.00014556017,0.00089081883,0.00028168963,0.000035060402,0.0005616921,0.0018089688,0.00020513537,0.002791584,0.000030431243],"about_ca_topic_score_codex":0.0003327679,"about_ca_topic_score_gemma":0.000992685,"teacher_disagreement_score":0.0050440882,"about_ca_system_score_codex":0.00088866317,"about_ca_system_score_gemma":0.0012351084,"threshold_uncertainty_score":0.024404287},"labels":[],"label_agreement":null},{"id":"W4410050705","doi":"10.1093/bjd/ljaf173","title":"Mutation burden of narrowband ultraviolet B phototherapy (NB-UVB) in human skin: relevance to NB-UVB lifetime exposures and skin cancer surveillance","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Psoriasis Association; Medical Research Council Canada; Wellcome Trust","keywords":"Ultraviolet b; Dermatology; Medicine; Skin cancer; Ultraviolet radiation; Ultraviolet B radiation; Cancer; Human skin; Internal medicine; Genetics; Biology; Chemistry","score_opus":0.0062283563374657125,"score_gpt":0.2928336131970718,"score_spread":0.2866052568596061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410050705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752086,0.0013841882,0.00039569914,0.000021262314,0.0000025448905,0.0000057455377,0.0002962518,0.000008826387,0.00036460033],"genre_scores_gemma":[0.99862266,0.0003591388,0.00056811277,0.000009291896,0.0000025829647,0.000007236212,0.00025500375,0.0000050135727,0.00017097952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997068,0.000063442705,0.000022668291,0.00009591337,0.00009110205,0.000020147085],"domain_scores_gemma":[0.9994824,0.00013903114,0.00021140219,0.000034023058,0.0000795069,0.00005373435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002887377,0.00011086154,0.00024615257,0.00081788254,0.00020063383,0.0003861256,0.00012471614,0.0002378876,0.0015483976],"category_scores_gemma":[0.00079021073,0.00011454409,0.00019610708,0.00041547616,0.00016841268,0.000206726,0.0001856425,0.00017084622,0.00019283201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011462406,0.000089522044,0.583433,0.0001915089,0.00018979689,0.0003046453,0.0002485203,0.0009810166,0.38380858,0.00010699417,0.0001950992,0.029305123],"study_design_scores_gemma":[0.000008476812,0.00025831372,0.9737292,0.000016006037,0.00006217482,0.0015139766,0.00011063192,0.0009835543,0.022656921,0.000077060184,0.00057728164,0.000006489561],"about_ca_topic_score_codex":0.001230677,"about_ca_topic_score_gemma":0.0011270231,"teacher_disagreement_score":0.0015483976,"about_ca_system_score_codex":0.00024813923,"about_ca_system_score_gemma":0.00011515322,"threshold_uncertainty_score":0.0051799417},"labels":[],"label_agreement":null},{"id":"W4410149816","doi":"10.1093/bjd/ljaf166","title":"Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; Women's College Hospital; University of Toronto","funders":"Medical Research Council; National Institutes of Health; Canadian Institutes of Health Research; National Institute for Health and Care Research; Eczema Society of Canada; Canadian Dermatology Foundation; 100,000 Strong in the Americas Innovation Fund; National Eczema Association","keywords":"Atopic dermatitis; Medicine; Meta-analysis; Dermatology; Systemic therapy; Perspective (graphical); Internal medicine; Computer science","score_opus":0.033701468053319895,"score_gpt":0.29721364000184375,"score_spread":0.26351217194852383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410149816","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056729447,0.9220329,0.0077236677,0.00195978,0.0016780578,0.0005515324,0.005027169,0.00018908187,0.0041083572],"genre_scores_gemma":[0.8721045,0.111732714,0.0067587504,0.0028408288,0.0008474664,0.00091565924,0.0029065837,0.00012392573,0.0017694285],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99077845,0.007029336,0.0007351711,0.0007231003,0.00050695805,0.00022708702],"domain_scores_gemma":[0.98590785,0.011778756,0.00087648106,0.00068157696,0.00057046924,0.00018471987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011111812,0.0016230249,0.0050488026,0.001544788,0.00034485926,0.0015435001,0.0008728826,0.0010180459,0.0052657756],"category_scores_gemma":[0.027541509,0.0004484575,0.02169318,0.0016582499,0.0002955939,0.0011888609,0.001095378,0.0019892221,0.0004084113],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009466202,0.00003897572,0.0087167155,0.046069417,0.9144115,0.00010245903,0.000054913544,0.0020683263,0.000488295,0.0004890056,0.0021382,0.015956074],"study_design_scores_gemma":[0.0025720107,0.0005886611,0.006565026,0.003248021,0.9810805,0.00009122731,0.00003330088,0.00094992126,0.00019734494,0.001113943,0.0035366062,0.000023530614],"about_ca_topic_score_codex":0.004803913,"about_ca_topic_score_gemma":0.010543378,"teacher_disagreement_score":0.011111812,"about_ca_system_score_codex":0.0010646608,"about_ca_system_score_gemma":0.00085007504,"threshold_uncertainty_score":0.05876559},"labels":[],"label_agreement":null},{"id":"W4410458691","doi":"10.1093/bjd/ljaf189","title":"Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Medical Research Council Canada; King's Health Partners; Times Higher Education; Pfizer","keywords":"Psychosocial; Anxiety; Quality of life (healthcare); Hospital Anxiety and Depression Scale; Medicine; Psychiatry; Stigma (botany); Depression (economics); Dermatology Life Quality Index; Alopecia areata; Clinical psychology; Severity of illness; Disease; Internal medicine","score_opus":0.014269740545942357,"score_gpt":0.3243911310333227,"score_spread":0.3101213904873803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410458691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883574,0.0004794495,0.000026762733,0.00005361996,0.000003966723,0.000030836312,0.00034119913,8.8461957e-7,0.00022770657],"genre_scores_gemma":[0.9991899,0.0002259806,0.00005352492,0.00003104436,0.000008832719,0.000032824828,0.00037553845,9.3429975e-7,0.00008145898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922276,0.00041855942,0.00009213296,0.00006822969,0.00012902297,0.00006938371],"domain_scores_gemma":[0.9976981,0.00079939276,0.0007984571,0.00009977921,0.0002328583,0.00037143216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001932958,0.0002472296,0.00040397226,0.0006076779,0.00032759804,0.00058944867,0.00022766051,0.00039831235,0.0010461874],"category_scores_gemma":[0.003761155,0.00018868966,0.0011852499,0.0007431917,0.00022791528,0.00042795972,0.00096493406,0.00056118873,0.00014920082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003947917,0.00016797427,0.9937069,0.00009684683,0.00030934435,0.00006865465,0.0006996716,0.000044557168,0.000087208246,0.000010670879,0.00016391846,0.004249611],"study_design_scores_gemma":[0.000030285428,0.00015153953,0.9991768,0.000017721977,0.000061749575,0.00007205981,0.00031346313,0.000043275348,0.000009538252,0.000008508834,0.00011145164,0.0000035140672],"about_ca_topic_score_codex":0.0039570625,"about_ca_topic_score_gemma":0.0058902116,"teacher_disagreement_score":0.0039570625,"about_ca_system_score_codex":0.0002884513,"about_ca_system_score_gemma":0.00020953357,"threshold_uncertainty_score":0.010222614},"labels":[],"label_agreement":null},{"id":"W4410531072","doi":"10.1093/bjd/ljaf191","title":"Management of oesophageal strictures in inherited epidermolysis bullosa: a clinical practice guideline","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; Hospital for Sick Children","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Debra International; Ministero della Salute; Ospedale Pediatrico Bambino Gesù","keywords":"Medicine; Epidermolysis bullosa; Guideline; Dysphagia; Intensive care medicine; Quality of life (healthcare); Population; Intervention (counseling); Disease; Pediatrics; Dermatology; Surgery; Internal medicine; Nursing; Pathology","score_opus":0.01360680705887383,"score_gpt":0.3546153173724265,"score_spread":0.34100851031355267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410531072","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01492766,0.39530665,0.06221961,0.3375831,0.012509675,0.017885905,0.006218435,0.001436402,0.15191261],"genre_scores_gemma":[0.063923694,0.45402688,0.33179107,0.087501794,0.006913281,0.0156217655,0.0121126855,0.00021458582,0.027894195],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956547,0.0019234143,0.0010677353,0.00020576484,0.0008880399,0.00026030446],"domain_scores_gemma":[0.9928053,0.0017559694,0.00077172444,0.00011836425,0.0037165189,0.00083208247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046192985,0.0011016924,0.0015788781,0.003369508,0.0010013273,0.0016756025,0.0026375568,0.0053921444,0.0042945426],"category_scores_gemma":[0.012360141,0.0004206993,0.0022747654,0.0022516008,0.0005892501,0.0016217313,0.0017736279,0.0039928923,0.0029718787],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011928122,0.00062028493,0.0031033938,0.013882406,0.00019402908,0.0029801955,0.0014075884,0.0016215958,0.0014119929,0.003208556,0.46701407,0.50443655],"study_design_scores_gemma":[0.00039617583,0.00030062307,0.011904294,0.08680643,0.00045307612,0.0047916663,0.0012673402,0.0019670457,0.0005873978,0.005422086,0.8859865,0.00011741912],"about_ca_topic_score_codex":0.010889259,"about_ca_topic_score_gemma":0.019263582,"teacher_disagreement_score":0.010889259,"about_ca_system_score_codex":0.0025616798,"about_ca_system_score_gemma":0.00745217,"threshold_uncertainty_score":0.0244295},"labels":[],"label_agreement":null},{"id":"W4410841064","doi":"10.1093/bjd/ljaf205","title":"Efficacy and safety of rigosertib in patients with recessive dystrophic epidermolysis bullosa-associated advanced/metastatic cutaneous squamous cell carcinoma","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Digital Technology Supercluster; DEBRA Austria; Debra International; Cure EB; Dystrophic Epidermolysis Bullosa Research Association of America","keywords":"Medicine; Epidermolysis bullosa; Dermatology; Basal cell; Epidermolysis bullosa dystrophica; Pathology; Oncology; Cancer research","score_opus":0.003818697452522538,"score_gpt":0.22600070437693148,"score_spread":0.22218200692440895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410841064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554354,0.002618852,0.00018613163,0.00010836366,0.000012925469,0.00018879108,0.00020148154,0.000026129295,0.0011138216],"genre_scores_gemma":[0.998519,0.00051361736,0.00026321821,0.00013909399,0.000018007522,0.00011370202,0.0002541012,0.0000026037474,0.00017667288],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997639,0.00010920616,0.000026694697,0.000030807212,0.000029140712,0.0000402016],"domain_scores_gemma":[0.99962056,0.000111089845,0.00011537512,0.00002826704,0.000026981244,0.000097814926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009454271,0.00034334074,0.00083258987,0.00016870051,0.00019808917,0.0004365066,0.00025241286,0.0003947152,0.0009796222],"category_scores_gemma":[0.0008417579,0.00011734445,0.00074884575,0.00020625544,0.00022378711,0.0002828988,0.00015590756,0.0008909077,0.00020699779],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34277683,0.018275302,0.10123911,0.0014589045,0.002311492,0.002117468,0.00070647424,0.0055553666,0.09551438,0.00030509292,0.0034944788,0.42624506],"study_design_scores_gemma":[0.13652839,0.54487544,0.28217015,0.00022222486,0.002130302,0.005173922,0.00028876233,0.004970351,0.015405895,0.00035288077,0.007804135,0.00007758566],"about_ca_topic_score_codex":0.00039089963,"about_ca_topic_score_gemma":0.0009923384,"teacher_disagreement_score":0.0009796222,"about_ca_system_score_codex":0.00053601194,"about_ca_system_score_gemma":0.00045439106,"threshold_uncertainty_score":0.004999995},"labels":[],"label_agreement":null},{"id":"W4411162776","doi":"10.1093/bjd/ljaf222","title":"Menopausal age, hormone therapy and risk of psoriasis: a prospective cohort study applying inverse probability of treatment weighting analysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Hunan Provincial Innovation Foundation for Postgraduate; Central South University; National Natural Science Foundation of China","keywords":"Medicine; Psoriasis; Prospective cohort study; Hormone therapy; Cohort; Cohort study; Marginal structural model; Inverse probability weighting; Internal medicine; Oncology; Dermatology; Observational study; Cancer; Breast cancer","score_opus":0.10988797068105641,"score_gpt":0.3655859878935787,"score_spread":0.2556980172125223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411162776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835391,0.003307042,0.00876378,0.0016930545,0.00026739872,0.00014035145,0.0013636937,0.000027650782,0.0008979173],"genre_scores_gemma":[0.9938944,0.00082632917,0.003245296,0.00027821894,0.00012729787,0.000080716454,0.00066491263,0.00001867903,0.00086425216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944278,0.004030479,0.00033229784,0.0005499295,0.00037388125,0.0002856457],"domain_scores_gemma":[0.9820555,0.009203815,0.002693824,0.0042678597,0.0011122128,0.00066688337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014776346,0.0004084683,0.0005496193,0.00088584545,0.0005172762,0.0010386943,0.0008549242,0.0010933497,0.003223287],"category_scores_gemma":[0.037121627,0.00057156594,0.002558924,0.0017315906,0.0003971461,0.00073247193,0.0008577511,0.0019413235,0.000293513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004437522,0.00048525166,0.95516384,0.00017927124,0.008664115,0.00032972664,0.0004909543,0.0009191989,0.00026625933,0.0018239209,0.0036125432,0.02362731],"study_design_scores_gemma":[0.0013388214,0.002675561,0.9416091,0.0003019051,0.01323863,0.0014402604,0.0011386353,0.023547813,0.00027516467,0.004972532,0.009307623,0.00015397643],"about_ca_topic_score_codex":0.0156041365,"about_ca_topic_score_gemma":0.009387011,"teacher_disagreement_score":0.0156041365,"about_ca_system_score_codex":0.0004354778,"about_ca_system_score_gemma":0.0007199452,"threshold_uncertainty_score":0.07814574},"labels":[],"label_agreement":null},{"id":"W4411687990","doi":"10.1093/bjd/ljaf250","title":"Assessing the performance of artificial intelligence models in evaluating inflammatory skin disease severity: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); McGill University Health Centre; Université de Montréal","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Mental Health; National Institutes of Health","keywords":"Medicine; Meta-analysis; Contingency table; Bivariate analysis; Atopic dermatitis; Internal medicine; Systematic review; MEDLINE; Disease; Dermatology; Machine learning; Computer science","score_opus":0.0970255586441627,"score_gpt":0.3885096566984381,"score_spread":0.29148409805427544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411687990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004737017,0.99274737,0.000997012,0.0002687423,0.00012373227,0.00035239186,0.0005158162,0.000029194423,0.00022866252],"genre_scores_gemma":[0.21774569,0.7718843,0.005200161,0.0011016498,0.0004272012,0.0020975417,0.0012217326,0.000045068628,0.00027673016],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9797061,0.009927511,0.0060738344,0.001682316,0.0022446148,0.00036566769],"domain_scores_gemma":[0.935093,0.052426737,0.0071880356,0.0016758577,0.003265521,0.00035077002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029374575,0.0028943098,0.016483018,0.009918426,0.0006935499,0.0042253695,0.0025305022,0.0023062374,0.002319099],"category_scores_gemma":[0.073466726,0.0014116465,0.041449122,0.009099661,0.0010187464,0.0024506534,0.0016097164,0.0018994443,0.00029323608],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014323619,0.000033214044,0.009527884,0.36819974,0.599531,0.00009995511,0.00009622303,0.0009189283,0.00016833271,0.0001576396,0.00066743913,0.019167295],"study_design_scores_gemma":[0.000371603,0.00020459236,0.00466439,0.03934598,0.95329046,0.000086509484,0.000045255358,0.0004116708,0.00011358181,0.00028031107,0.0011552295,0.000030400864],"about_ca_topic_score_codex":0.005220014,"about_ca_topic_score_gemma":0.0111091295,"teacher_disagreement_score":0.029374575,"about_ca_system_score_codex":0.0028100584,"about_ca_system_score_gemma":0.003816854,"threshold_uncertainty_score":0.15534943},"labels":[],"label_agreement":null},{"id":"W4411696664","doi":"10.1093/bjd/ljaf245","title":"Culprit allergens in diabetes technology-associated allergic contact dermatitis: investigation remains challenging","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Culprit; Medicine; Dermatology; Allergic contact dermatitis; Diabetes mellitus; Immunology; Contact dermatitis; Allergy; Internal medicine","score_opus":0.007997982548241429,"score_gpt":0.2371688922132767,"score_spread":0.22917090966503526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411696664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46591046,0.39522707,0.0073396624,0.07802722,0.0015924047,0.00023149393,0.0006510464,0.0002554034,0.05076519],"genre_scores_gemma":[0.87033147,0.1069379,0.0056454805,0.010164448,0.0035530755,0.00005687396,0.00049573364,0.00004610443,0.0027688327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848384,0.00029258284,0.00028878334,0.00015712457,0.0004237572,0.0003539456],"domain_scores_gemma":[0.9963315,0.0016372926,0.0005374256,0.00013644468,0.0009938019,0.0003635833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016632194,0.00046003284,0.0010192202,0.0016707057,0.0009163608,0.0027586808,0.0010011533,0.0025731728,0.002786996],"category_scores_gemma":[0.005918695,0.00042795035,0.0006198756,0.0011818317,0.00093182013,0.003062281,0.0007335925,0.002439956,0.0016326397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023793826,0.0006610134,0.657552,0.0012545792,0.0001065773,0.058843847,0.00091846875,0.00026426784,0.0030262736,0.0021937771,0.018820673,0.25612062],"study_design_scores_gemma":[0.00008391559,0.00066051073,0.50793284,0.01248152,0.00038144962,0.36646405,0.0142711,0.003453511,0.0028346388,0.012488852,0.07884112,0.000106536994],"about_ca_topic_score_codex":0.0049240664,"about_ca_topic_score_gemma":0.0058072326,"teacher_disagreement_score":0.0049240664,"about_ca_system_score_codex":0.0006797982,"about_ca_system_score_gemma":0.0014514426,"threshold_uncertainty_score":0.009790778},"labels":[],"label_agreement":null},{"id":"W4411712121","doi":"10.1093/bjd/ljaf085.526","title":"BT01 The effectiveness of telemedicine in dermatology services: a systematic review","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Telemedicine; Dermatology; Medicine; Teledermatology; MEDLINE; Health care; Political science","score_opus":0.019737523510117715,"score_gpt":0.3709661474405102,"score_spread":0.3512286239303925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411712121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029457852,0.99527466,0.00010225386,0.00024652996,0.00008709107,0.00042931427,0.0005613268,0.0000071555887,0.00034591],"genre_scores_gemma":[0.058211483,0.9385808,0.0007480324,0.00063616416,0.00011928669,0.0011574477,0.00038791628,0.000010056711,0.00014873598],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.984641,0.0061199516,0.0051890784,0.00090476224,0.0027459192,0.0003992194],"domain_scores_gemma":[0.92793065,0.055269066,0.011366142,0.0006167091,0.0042452533,0.00057213544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011852333,0.001288939,0.00907469,0.010312635,0.0007657668,0.0033412564,0.0019122126,0.0021839764,0.007263403],"category_scores_gemma":[0.06626247,0.0010132954,0.010479449,0.011857925,0.0010514581,0.0027503541,0.0018015913,0.0014248183,0.00033408267],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030649238,0.00002257149,0.00087796134,0.97003144,0.011153253,0.000054785967,0.00012606355,0.00006946345,0.000055559576,0.000095737596,0.00060215476,0.016604375],"study_design_scores_gemma":[0.0004979823,0.00037200405,0.0060054045,0.90828514,0.077456556,0.00026309307,0.00032838932,0.000114365546,0.00011439751,0.00016912838,0.0063626096,0.00003094566],"about_ca_topic_score_codex":0.010216227,"about_ca_topic_score_gemma":0.024762414,"teacher_disagreement_score":0.011852333,"about_ca_system_score_codex":0.006692163,"about_ca_system_score_gemma":0.0121044675,"threshold_uncertainty_score":0.06268191},"labels":[],"label_agreement":null},{"id":"W4411712151","doi":"10.1093/bjd/ljaf085.415","title":"BI06 Global perspective on skin cancer in organ transplant recipients with skin of colour: a systematic review","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Organ transplantation; Skin cancer; Perspective (graphical); Cancer; Dermatology; Intensive care medicine; Transplantation; Internal medicine; Computer science","score_opus":0.014940730729723193,"score_gpt":0.34710926926582997,"score_spread":0.3321685385361068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411712151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058482465,0.9977335,0.000074447365,0.00049549993,0.0001553279,0.00021617567,0.00043798477,0.000006146308,0.00029600764],"genre_scores_gemma":[0.007892437,0.9897334,0.00036949487,0.0009818185,0.00013518556,0.0005053045,0.00025882473,0.000004837055,0.00011863158],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9904925,0.0034839772,0.0032978824,0.0006448979,0.0017085121,0.00037222344],"domain_scores_gemma":[0.9717414,0.01806955,0.0056791576,0.00039007378,0.0036515684,0.0004682149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009524748,0.0016799297,0.008708432,0.017134773,0.0007466748,0.0041238316,0.0017497686,0.002520327,0.008003857],"category_scores_gemma":[0.039166342,0.0011857491,0.0070284153,0.01543176,0.0008597182,0.0034550007,0.0020696812,0.0015641848,0.0006487138],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098030156,0.000010691225,0.00060128135,0.971126,0.004810935,0.00006700375,0.00017103873,0.00004520093,0.000103533464,0.00020578918,0.0018124351,0.02094808],"study_design_scores_gemma":[0.000105972365,0.00008875822,0.0026441019,0.9589387,0.02535179,0.00025016133,0.0002286036,0.00003362113,0.000050595972,0.00018832093,0.012097693,0.000021706543],"about_ca_topic_score_codex":0.011100536,"about_ca_topic_score_gemma":0.028781721,"teacher_disagreement_score":0.017134773,"about_ca_system_score_codex":0.004384988,"about_ca_system_score_gemma":0.015509791,"threshold_uncertainty_score":0.050372303},"labels":[],"label_agreement":null},{"id":"W4411712184","doi":"10.1093/bjd/ljaf085.094","title":"P066 Core outcome set implementation in vitiligo clinical trials: barriers and facilitators from a survey of lead researchers","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Vitiligo; Outcome (game theory); Core (optical fiber); Set (abstract data type); Medicine; Clinical trial; Medical physics; Dermatology; Computer science; Pathology","score_opus":0.5967871668851944,"score_gpt":0.6481919008067792,"score_spread":0.051404733921584844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411712184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7192478,0.060572393,0.030009834,0.14742759,0.0018724115,0.016962105,0.004415561,0.0005610089,0.018931365],"genre_scores_gemma":[0.9269309,0.009964698,0.026941225,0.018253915,0.00036904195,0.015803602,0.0007042486,0.00022210077,0.0008101818],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.37521386,0.45713568,0.10682597,0.010312075,0.043237567,0.007274813],"domain_scores_gemma":[0.1023438,0.7280688,0.09115115,0.01889834,0.052409664,0.0071283104],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.53548795,0.0008137399,0.0021652675,0.0035765108,0.0039770855,0.009001855,0.002978817,0.0032444503,0.0047799787],"category_scores_gemma":[0.74205786,0.0016710254,0.003155059,0.006543799,0.0044112024,0.011669647,0.011279355,0.004049189,0.0010100477],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022213247,0.0005304801,0.30021065,0.07412905,0.0018914492,0.00084132055,0.23779699,0.0006827329,0.0010530215,0.0068786335,0.027835973,0.34592843],"study_design_scores_gemma":[0.0028115627,0.005997778,0.32214478,0.16533819,0.0035218548,0.002450902,0.31397906,0.0058806506,0.003470916,0.01733607,0.15606013,0.0010080645],"about_ca_topic_score_codex":0.0062817414,"about_ca_topic_score_gemma":0.007239005,"teacher_disagreement_score":0.46451205,"about_ca_system_score_codex":0.009003858,"about_ca_system_score_gemma":0.044470016,"threshold_uncertainty_score":0.5728261},"labels":[],"label_agreement":null},{"id":"W4411722122","doi":"10.1093/bjd/ljaf229","title":"Impact of Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on the health-related quality of life (HRQoL) experiences of adults with SJS/TEN: a mixed-methods systematic review","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Health Research Board","keywords":"PsycINFO; CINAHL; Toxic epidermal necrolysis; MEDLINE; Medicine; Quality of life (healthcare); Cochrane Library; Systematic review; Gerontology; Alternative medicine; Psychological intervention; Psychiatry; Dermatology; Nursing; Pathology","score_opus":0.0354337495392775,"score_gpt":0.3926762546159824,"score_spread":0.35724250507670485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411722122","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025584903,0.9948066,0.00023927153,0.0002818345,0.00012498771,0.00096690806,0.0005170027,0.000008663894,0.00049628544],"genre_scores_gemma":[0.032523215,0.96212655,0.0014566374,0.000719538,0.00007019773,0.0025604994,0.00033411087,0.0000067302185,0.0002025115],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98297274,0.0072598704,0.005757148,0.0009099827,0.0026854451,0.00041485592],"domain_scores_gemma":[0.95683914,0.033392273,0.0057953037,0.00054290873,0.0030540936,0.00037629888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016334083,0.0015829944,0.008982865,0.01104522,0.0009243116,0.0043950817,0.0019708234,0.002583171,0.004218894],"category_scores_gemma":[0.06591724,0.0012975977,0.009143099,0.012268848,0.0010792012,0.0028506373,0.0024518173,0.0013754251,0.00027499607],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016721927,0.000016909853,0.0007881084,0.96454406,0.01029908,0.000087961525,0.00039419965,0.00005951456,0.000066859044,0.00020761296,0.000566313,0.022802085],"study_design_scores_gemma":[0.00019970645,0.00021488729,0.0033687293,0.9098364,0.077331714,0.00025423738,0.0007300605,0.00007526711,0.000106849395,0.00024644608,0.0076017417,0.000033950142],"about_ca_topic_score_codex":0.00915567,"about_ca_topic_score_gemma":0.02963351,"teacher_disagreement_score":0.016334083,"about_ca_system_score_codex":0.0056668147,"about_ca_system_score_gemma":0.015565252,"threshold_uncertainty_score":0.08638394},"labels":[],"label_agreement":null},{"id":"W4411732496","doi":"10.1093/bjd/ljaf085.161","title":"P133 Perceptions of patients and physicians from the UK of the burden of chronic spontaneous urticaria: results from the Urticaria Voices study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic urticaria; Medicine; Dermatology; Perception; Family medicine; Psychology","score_opus":0.005063736603835319,"score_gpt":0.23587782810495864,"score_spread":0.2308140915011233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998607,0.0001806964,0.000014441031,0.00018326806,0.000009752075,0.00001895826,0.00020849028,0.0000010189874,0.0007764341],"genre_scores_gemma":[0.9994635,0.00009700184,0.000024725572,0.000099667064,0.000011028504,0.000019882074,0.00013667544,7.9800657e-7,0.00014666592],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9969227,0.0016655655,0.00032611142,0.00016033335,0.00058217143,0.00034309647],"domain_scores_gemma":[0.98861235,0.0034474987,0.005163435,0.00025657934,0.0011208224,0.0013993502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023117254,0.00022772978,0.00043895075,0.0007547023,0.0006629195,0.0012845375,0.00028726461,0.00079582474,0.003150253],"category_scores_gemma":[0.010759806,0.00032535705,0.00073144305,0.0009365473,0.0005559757,0.0008786923,0.0013280743,0.00065786584,0.00039300421],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022079742,0.00015061458,0.98648757,0.000072940675,0.000057264024,0.00020076781,0.007872693,0.000030466224,0.00015009793,0.000020837215,0.00087608193,0.0038597228],"study_design_scores_gemma":[0.00003219385,0.00026502268,0.9896548,0.000034316225,0.000010185734,0.00019389583,0.009273731,0.000054594424,0.00002158647,0.000009753893,0.00044091744,0.000008999446],"about_ca_topic_score_codex":0.009685366,"about_ca_topic_score_gemma":0.009456087,"teacher_disagreement_score":0.009685366,"about_ca_system_score_codex":0.00068842305,"about_ca_system_score_gemma":0.00053392665,"threshold_uncertainty_score":0.019257963},"labels":[],"label_agreement":null},{"id":"W4411732515","doi":"10.1093/bjd/ljaf085.133","title":"P105 Lebrikizumab improves quality of life and wellbeing of patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin: German extension results (week 76) of the ADvantage study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ciclosporin; Atopic dermatitis; Medicine; German; Quality of life (healthcare); Dermatology; Internal medicine; Transplantation","score_opus":0.014146575069906981,"score_gpt":0.2923844091531926,"score_spread":0.2782378340832856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976841,0.0014898508,0.000032408592,0.00006245722,0.000018400886,0.00006636786,0.00017005083,0.0000053845524,0.00047095693],"genre_scores_gemma":[0.99903095,0.0003153801,0.0000845087,0.00008968458,0.000021456726,0.000034114037,0.00024637886,8.315979e-7,0.00017673952],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99978846,0.000113602764,0.000016514143,0.000022697965,0.000024039398,0.000034657958],"domain_scores_gemma":[0.9997249,0.000063760475,0.000092072085,0.00002160321,0.000020292324,0.0000772657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006561627,0.00034440143,0.0006015985,0.00011582631,0.000109241686,0.00033401322,0.00018579654,0.0002372122,0.0016942087],"category_scores_gemma":[0.00044965243,0.00009898835,0.00067121675,0.00013275731,0.00016429288,0.00021563297,0.00019634639,0.00046967308,0.00015635164],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6731161,0.014124431,0.094739646,0.001230356,0.0021706745,0.00047235648,0.00020238911,0.0007679437,0.039635044,0.00015812472,0.0040936535,0.16928935],"study_design_scores_gemma":[0.16316101,0.28908092,0.5339073,0.00016238938,0.0019778602,0.0007760044,0.00020935581,0.0014127671,0.004704398,0.00010734499,0.0044575552,0.000043144406],"about_ca_topic_score_codex":0.0003969366,"about_ca_topic_score_gemma":0.00081906485,"teacher_disagreement_score":0.0016942087,"about_ca_system_score_codex":0.0002337096,"about_ca_system_score_gemma":0.00018660972,"threshold_uncertainty_score":0.0056676865},"labels":[],"label_agreement":null},{"id":"W4411732595","doi":"10.1093/bjd/ljaf085.410","title":"British Society for Skin Care in Immunosuppressed IndividualsOral presentationsBI01 Persistent nonpruritic scabies in a patient on nemolizumab for the treatment of prurigo nodularis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatological diseases and infestations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Prurigo nodularis; Scabies; Dermatology; Medicine; Prurigo; Dermatologic agents; Biology","score_opus":0.012596032333014184,"score_gpt":0.2938436234916678,"score_spread":0.2812475911586536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732595","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20584902,0.09834581,0.0014299357,0.07246746,0.015081588,0.0005506094,0.0012917967,0.00038240192,0.6046014],"genre_scores_gemma":[0.7780228,0.04108813,0.0027037938,0.017558271,0.0043249093,0.0001941477,0.0013747475,0.00012344157,0.1546097],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99962616,0.0001092211,0.000039338087,0.000028608316,0.000098203935,0.00009842145],"domain_scores_gemma":[0.999421,0.00008532909,0.00007567111,0.000028537952,0.000180304,0.00020922354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031821153,0.00028111032,0.00025887793,0.00055135635,0.000919251,0.0007785996,0.0002561163,0.0011046387,0.040039413],"category_scores_gemma":[0.0010637257,0.00014432536,0.00025157313,0.00037433926,0.00031254816,0.00030717734,0.0005280869,0.0015821236,0.0058798282],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041972633,0.00085250865,0.12957741,0.0010418905,0.00010271069,0.1260307,0.0006892708,0.00018967206,0.006639715,0.0020415455,0.46453673,0.26787806],"study_design_scores_gemma":[0.0001417269,0.000448553,0.22113788,0.0019258579,0.00006808911,0.1798846,0.0009205444,0.00055861083,0.00086974003,0.0008643806,0.59314185,0.000038137274],"about_ca_topic_score_codex":0.0071468414,"about_ca_topic_score_gemma":0.013996255,"teacher_disagreement_score":0.040039413,"about_ca_system_score_codex":0.00084551284,"about_ca_system_score_gemma":0.0009888008,"threshold_uncertainty_score":0.13394523},"labels":[],"label_agreement":null},{"id":"W4411732624","doi":"10.1093/bjd/ljaf085.132","title":"P104 Lebrikizumab improves quality of life in patients with moderate-to-severe atopic dermatitis inadequately controlled or ineligible for ciclosporin (ADvantage study)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ciclosporin; Atopic dermatitis; Medicine; Dermatology; Quality of life (healthcare); Pediatrics; Surgery; Transplantation","score_opus":0.014271004617189564,"score_gpt":0.30194686396652193,"score_spread":0.2876758593493324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639386,0.0025321476,0.000037808524,0.00011279233,0.000030022286,0.0001112739,0.00020193036,0.00000860184,0.00057158305],"genre_scores_gemma":[0.998747,0.00046085936,0.00009794124,0.00015628563,0.000040951447,0.00007573186,0.00021649951,0.0000010070535,0.00020367731],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99981433,0.00009151277,0.000016822316,0.000022847253,0.000021337595,0.000033182532],"domain_scores_gemma":[0.99971217,0.00007344749,0.00008379371,0.000015896923,0.000020822825,0.00009382768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060343987,0.00033866966,0.0008950317,0.00014157798,0.00017934218,0.0004050545,0.00022768482,0.0003716114,0.0022804912],"category_scores_gemma":[0.0004872801,0.00013671984,0.00078939757,0.00015100045,0.00018138955,0.00027757435,0.00019166654,0.00064682565,0.00016953534],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62545305,0.020786818,0.16126676,0.0017462039,0.002776965,0.0006263426,0.00021762002,0.00059482973,0.022853369,0.00019424352,0.004500078,0.15898363],"study_design_scores_gemma":[0.19430646,0.35591054,0.43930596,0.00023711829,0.0015838293,0.0010580221,0.0002179121,0.001503187,0.0022737104,0.00015044583,0.0034185764,0.000034182325],"about_ca_topic_score_codex":0.000336952,"about_ca_topic_score_gemma":0.00091861014,"teacher_disagreement_score":0.0022804912,"about_ca_system_score_codex":0.00022861455,"about_ca_system_score_gemma":0.00021610226,"threshold_uncertainty_score":0.007629037},"labels":[],"label_agreement":null},{"id":"W4411732719","doi":"10.1093/bjd/ljaf085.156","title":"P128 the risk of atopic eczema in breastfed offspring whose mothers were supplemented with vitamin D during pregnancy","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Offspring; Pregnancy; Medicine; Vitamin; Obstetrics; Pediatrics; Endocrinology; Biology","score_opus":0.005900744541400474,"score_gpt":0.2482169902473604,"score_spread":0.24231624570595994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732719","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01673096,0.9751535,0.00023071765,0.001462041,0.00056222396,0.00020907109,0.0036512772,0.00002202152,0.0019781243],"genre_scores_gemma":[0.34015572,0.65248996,0.0011443687,0.0019230754,0.0008970747,0.00063542125,0.0016558614,0.000023937007,0.001074588],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9977551,0.00074270595,0.0007081639,0.0002648283,0.00044563483,0.00008354493],"domain_scores_gemma":[0.9876232,0.008934241,0.0025724294,0.000106986074,0.00064522034,0.00011782327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017684823,0.00076239265,0.003922041,0.0032499249,0.00021211174,0.0012391879,0.0007849165,0.0017311926,0.012618768],"category_scores_gemma":[0.017664542,0.0004722157,0.006729323,0.004541938,0.00039165313,0.00088033034,0.0006642507,0.0011775224,0.0006190119],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036194804,0.00006044149,0.03519513,0.8152443,0.0534337,0.0006466803,0.0002761129,0.00023892355,0.00045628918,0.00046435397,0.008564186,0.081800446],"study_design_scores_gemma":[0.0058923243,0.0013134262,0.17606148,0.4712851,0.2959586,0.0047827065,0.00068831875,0.0009619409,0.00072690926,0.0029050997,0.039279774,0.00014433745],"about_ca_topic_score_codex":0.0048316563,"about_ca_topic_score_gemma":0.0037201636,"teacher_disagreement_score":0.012618768,"about_ca_system_score_codex":0.00073211355,"about_ca_system_score_gemma":0.0013811884,"threshold_uncertainty_score":0.042214036},"labels":[],"label_agreement":null},{"id":"W4411732750","doi":"10.1093/bjd/ljaf085.499","title":"PS01 Dermatitis artefacta in a paediatric population: clinical insights from a retrospective review","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Child Abuse and Related Trauma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Dermatology; Retrospective cohort study; Population; Environmental health; Surgery","score_opus":0.022670182386521,"score_gpt":0.3467218910526485,"score_spread":0.3240517086661275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732750","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8779372,0.11266978,0.00080369075,0.00072801067,0.00010307441,0.00032051213,0.0026805894,0.000031525717,0.0047256164],"genre_scores_gemma":[0.94804573,0.049214438,0.000597415,0.0003901139,0.0001726158,0.00013349531,0.0011402485,0.000013992077,0.00029207565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978648,0.00048508248,0.0006979634,0.00029478446,0.000514831,0.00014261533],"domain_scores_gemma":[0.9914396,0.0029502292,0.0041001732,0.00031463918,0.00085679727,0.00033860415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016009925,0.0002682935,0.00059167703,0.004610237,0.00058232894,0.0012215141,0.0005851477,0.00068667514,0.0028321769],"category_scores_gemma":[0.00693056,0.00040484045,0.00039826243,0.0070327525,0.00068471505,0.0011961346,0.00087576685,0.0004220164,0.00068145583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015126295,0.0000757439,0.8589772,0.0074637197,0.00027532942,0.07726655,0.0038874964,0.00010658868,0.0011406657,0.0005645108,0.0045620296,0.045528807],"study_design_scores_gemma":[0.000025933481,0.000296189,0.66171205,0.0040504434,0.0004383355,0.30316085,0.006962693,0.0001560723,0.00042213994,0.00018152905,0.022552593,0.000041232248],"about_ca_topic_score_codex":0.0022722043,"about_ca_topic_score_gemma":0.0027429902,"teacher_disagreement_score":0.004610237,"about_ca_system_score_codex":0.0005994741,"about_ca_system_score_gemma":0.0013065714,"threshold_uncertainty_score":0.0094745755},"labels":[],"label_agreement":null},{"id":"W4411732774","doi":"10.1093/bjd/ljaf085.270","title":"CD01 Contact allergy to alkyl glucosides: a multicentre audit in the UK and Ireland","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Contact allergy; Audit; Allergy; Medicine; Alkyl; Contact dermatitis; Immunology; Chemistry; Organic chemistry; Business; Accounting","score_opus":0.006691761065815924,"score_gpt":0.2542137386438112,"score_spread":0.24752197757799527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931676,0.0011539835,0.00007584626,0.00025740862,0.000021488995,0.00014823236,0.00046529536,0.000016341293,0.004693783],"genre_scores_gemma":[0.99793684,0.0007164135,0.00009685367,0.0002862895,0.0000140468865,0.000033177253,0.0002629664,0.000005588292,0.00064779964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956321,0.00094701326,0.00055502134,0.00035863605,0.0016462518,0.00086104753],"domain_scores_gemma":[0.99466324,0.0009180939,0.0018689772,0.00036051715,0.0014933484,0.00069582555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019573253,0.00032185606,0.0005007579,0.0015279155,0.00059374893,0.000948892,0.00074845226,0.00083895214,0.0024071033],"category_scores_gemma":[0.0042029466,0.00051518047,0.00053010817,0.0019454872,0.0006719352,0.0005541838,0.001748529,0.0005642244,0.0005186017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003517293,0.00021882776,0.9654228,0.0002754969,0.000027804117,0.008547443,0.0020556878,0.000059967268,0.0013827161,0.000054810967,0.002411516,0.01919122],"study_design_scores_gemma":[0.000026495196,0.0004593384,0.98410827,0.00011382805,0.000019562844,0.009235535,0.001770025,0.0001024794,0.00032149587,0.0000085418105,0.0038230773,0.000011338422],"about_ca_topic_score_codex":0.026915066,"about_ca_topic_score_gemma":0.030575536,"teacher_disagreement_score":0.026915066,"about_ca_system_score_codex":0.0025295492,"about_ca_system_score_gemma":0.0017104058,"threshold_uncertainty_score":0.053516805},"labels":[],"label_agreement":null},{"id":"W4411732797","doi":"10.1093/bjd/ljaf085.372","title":"PA13 Comparison of oral minipulse dexamethasone and tofacitinib in progressive nonsegmental childhood vitiligo","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Atherosclerosis and Cardiovascular Diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Victoria University; King's College London; Nottingham University Hospitals NHS Trust; University of Nottingham; University of Southampton; University of Sussex","keywords":"Vitiligo; Medicine; Tofacitinib; Dermatology; Dexamethasone; Pediatrics; Internal medicine","score_opus":0.008643234890038003,"score_gpt":0.2681140334908631,"score_spread":0.2594707986008251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420255,0.0036071192,0.00022094375,0.0001226329,0.000111403795,0.0005751837,0.00028115802,0.000021870115,0.00085706665],"genre_scores_gemma":[0.99641454,0.0015731382,0.00039377075,0.00011278176,0.000082499515,0.00040014778,0.00028485103,0.0000049902314,0.0007332805],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99948454,0.00021062385,0.000045155153,0.000093184746,0.00008365551,0.00008279586],"domain_scores_gemma":[0.9992787,0.00023957733,0.00014265448,0.00004847038,0.000048734117,0.00024178403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086564064,0.0005847252,0.0020309195,0.00039852317,0.00020075192,0.00073210284,0.0007135529,0.0009204798,0.004635283],"category_scores_gemma":[0.0010405936,0.0003317214,0.0010847228,0.00040071554,0.0006247426,0.000788471,0.00029911232,0.0020188293,0.0005615363],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8735911,0.025834842,0.0019246899,0.0007766193,0.0008449545,0.00009257632,0.000085290674,0.00087786326,0.017901698,0.00024873004,0.0005330096,0.07728856],"study_design_scores_gemma":[0.21836084,0.76578987,0.008247774,0.00005695182,0.00052641775,0.00015732372,0.00007144231,0.0010188731,0.0041785627,0.00017186679,0.0013954921,0.000024483348],"about_ca_topic_score_codex":0.0006173219,"about_ca_topic_score_gemma":0.0012742002,"teacher_disagreement_score":0.004635283,"about_ca_system_score_codex":0.0005516917,"about_ca_system_score_gemma":0.000865684,"threshold_uncertainty_score":0.015506566},"labels":[],"label_agreement":null},{"id":"W4411732817","doi":"10.1093/bjd/ljaf085.505","title":"PS07 (P113) Perceptions of patients and physicians from the UK of the burden of chronic spontaneous urticaria: results from the Urticaria Voices study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic urticaria; Medicine; Dermatology; Perception; Family medicine; Psychology","score_opus":0.005122337496385051,"score_gpt":0.23687961043041514,"score_spread":0.2317572729340301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986186,0.00011578919,0.000012885885,0.0001756609,0.000008383646,0.000017451304,0.00030698156,0.0000011648407,0.0007430283],"genre_scores_gemma":[0.9993112,0.00008748398,0.00002324271,0.00011563359,0.000012076492,0.000022789221,0.00022216783,0.0000010181298,0.00020443999],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99784744,0.0010790593,0.00024077571,0.00013452419,0.0004376803,0.0002605662],"domain_scores_gemma":[0.99078256,0.0025727125,0.00405099,0.00018515125,0.000963435,0.0014451649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016492272,0.0001816187,0.00038112458,0.0005933198,0.00055802526,0.0009032221,0.0002642109,0.00073032104,0.0034362176],"category_scores_gemma":[0.009114529,0.00023667589,0.0005741601,0.0008076555,0.0004019674,0.0006748469,0.0010958727,0.00056903105,0.00047772453],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002357389,0.00013721576,0.9886432,0.00006663807,0.000049915227,0.00021257788,0.0047809933,0.00003680097,0.00015338154,0.000020239058,0.0014450614,0.0042182123],"study_design_scores_gemma":[0.000022557206,0.0002123819,0.9950374,0.000022950397,0.0000081399785,0.00016330322,0.0041354746,0.00004202594,0.00001526345,0.0000067448495,0.00032877762,0.0000049928717],"about_ca_topic_score_codex":0.012051741,"about_ca_topic_score_gemma":0.011687236,"teacher_disagreement_score":0.012051741,"about_ca_system_score_codex":0.00053671486,"about_ca_system_score_gemma":0.00052144687,"threshold_uncertainty_score":0.023963153},"labels":[],"label_agreement":null},{"id":"W4411732819","doi":"10.1093/bjd/ljaf085.213","title":"AI16 Performance of a deep neural network in diagnosing lesions referred on the suspected skin cancer pathway: a prospective observational study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MetaOptima Technology (Canada)","funders":"","keywords":"Observational study; Medicine; Skin cancer; Cancer; Prospective cohort study; Dermatology; Internal medicine","score_opus":0.03225364000346986,"score_gpt":0.2923897812691514,"score_spread":0.2601361412656815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994228,0.00013008041,0.00006722892,0.000025273648,0.000005207421,0.000012683254,0.0001488722,0.0000013311794,0.00018640484],"genre_scores_gemma":[0.9995024,0.000048701768,0.000064691005,0.000021910633,0.0000069855096,0.000013837497,0.00024857034,0.0000013155648,0.000091550726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991352,0.00026909247,0.00011322114,0.00023024427,0.00013682681,0.000115397204],"domain_scores_gemma":[0.99651635,0.0011432591,0.0010534853,0.00028228984,0.00055534206,0.00044930403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012213634,0.0002923317,0.0004323598,0.0005422013,0.00047138127,0.0010976191,0.0005934074,0.0008003329,0.0021106417],"category_scores_gemma":[0.0054511954,0.00029040631,0.0006754646,0.00055706315,0.00035366966,0.0008729949,0.00053399435,0.001019377,0.00046310833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044560156,0.00021054581,0.9976774,0.000018569874,0.00007643273,0.00011332624,0.000051505125,0.00008659534,0.00013041818,0.000013179484,0.00012522367,0.0010512127],"study_design_scores_gemma":[0.000056025685,0.001348779,0.9943363,0.000035285688,0.00014766322,0.0007320885,0.00050012884,0.0023318238,0.00016971264,0.00005166499,0.00027431862,0.000016270387],"about_ca_topic_score_codex":0.0023387244,"about_ca_topic_score_gemma":0.002122149,"teacher_disagreement_score":0.0023387244,"about_ca_system_score_codex":0.0005217827,"about_ca_system_score_gemma":0.00030335897,"threshold_uncertainty_score":0.007060766},"labels":[],"label_agreement":null},{"id":"W4411732835","doi":"10.1093/bjd/ljaf085.148","title":"P120 Climate change: impact on cutaneous carcinogenesis and dermatological practice","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dermatological diseases; Medicine; Dermatology","score_opus":0.02557687890981433,"score_gpt":0.369522982113814,"score_spread":0.3439461032039997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732835","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014497173,0.98195237,0.00012890714,0.007333576,0.0015048762,0.00013906411,0.0010426956,0.000014268793,0.0064345296],"genre_scores_gemma":[0.036443353,0.952508,0.00046704986,0.005827891,0.0021847943,0.0002933203,0.0005941456,0.000013242995,0.0016683125],"study_design_codex":"systematic_review","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9960445,0.0018240884,0.0006195569,0.00024543417,0.0011241891,0.00014214845],"domain_scores_gemma":[0.9724803,0.019332211,0.004432355,0.00021179386,0.0031899977,0.00035340778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026216966,0.00053959637,0.0016559749,0.0027975303,0.00043395755,0.0025562053,0.00094498094,0.0016231207,0.04953371],"category_scores_gemma":[0.027280742,0.00036171454,0.0030380993,0.0051336093,0.0007854627,0.0022975183,0.0012990204,0.0015734462,0.00234986],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004085218,0.000093151226,0.006252339,0.4452751,0.0019495098,0.0003942528,0.00054560794,0.0003384169,0.00014125543,0.0043482403,0.13335073,0.4069029],"study_design_scores_gemma":[0.0004065838,0.0002798395,0.032169044,0.68398184,0.0036135816,0.0019284387,0.0011012886,0.00022407889,0.00013013453,0.005665318,0.27044284,0.000057077996],"about_ca_topic_score_codex":0.0066636144,"about_ca_topic_score_gemma":0.007872243,"teacher_disagreement_score":0.04953371,"about_ca_system_score_codex":0.00266593,"about_ca_system_score_gemma":0.004667794,"threshold_uncertainty_score":0.16570675},"labels":[],"label_agreement":null},{"id":"W4411732855","doi":"10.1093/bjd/ljaf085.373","title":"PA14 Spironolactone for the treatment of acne vulgaris affecting female patients aged 18 years and under: results from a UK and Irish survey","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University Hospital Foundation","funders":"Queen's University; Victoria University; King's College London; Nottingham University Hospitals NHS Trust; University of Nottingham; University of Southampton; University of Sussex","keywords":"Spironolactone; Irish; Acne; Medicine; Dermatology; Family medicine; Internal medicine","score_opus":0.024131853723676665,"score_gpt":0.295327146444146,"score_spread":0.2711952927204693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895544,0.0017301332,0.000105500665,0.00054614013,0.000044070955,0.0003460631,0.004324331,0.000006531307,0.003342867],"genre_scores_gemma":[0.9949826,0.0011277186,0.00019013409,0.0008845182,0.00004352634,0.00023400078,0.0018017603,0.000006672925,0.00072907156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968702,0.0014459777,0.00045563927,0.0002660255,0.00067650346,0.00028568527],"domain_scores_gemma":[0.9963825,0.00075838255,0.0014807655,0.0001267504,0.0007240458,0.00052744214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023792835,0.00024518825,0.0005687602,0.0005536988,0.0002494717,0.0005529818,0.0003006923,0.0005660054,0.0017092616],"category_scores_gemma":[0.0052784737,0.0002702835,0.0009855748,0.0011768232,0.00024304276,0.00040442482,0.0005794548,0.00047925563,0.0006017439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012672925,0.0002839325,0.9803822,0.00031004302,0.00014315087,0.00023813912,0.0007971365,0.0000649222,0.00037684673,0.000013261133,0.0018089686,0.014314119],"study_design_scores_gemma":[0.00010318616,0.0006207078,0.9974021,0.000044621207,0.000048705166,0.00016006616,0.00042798585,0.00004838891,0.000030992713,0.0000025400536,0.0011028326,0.000007988858],"about_ca_topic_score_codex":0.027768943,"about_ca_topic_score_gemma":0.031911794,"teacher_disagreement_score":0.027768943,"about_ca_system_score_codex":0.0007859995,"about_ca_system_score_gemma":0.0008644801,"threshold_uncertainty_score":0.055214584},"labels":[],"label_agreement":null},{"id":"W4411732876","doi":"10.1093/bjd/ljaf085.430","title":"BI21 Intermittent and progressive pustular psoriasis during chemotherapy cycles in a toddler","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Toddler; Pustular psoriasis; Medicine; Psoriasis; Chemotherapy; Pediatrics; Dermatology; Surgery; Psychology; Developmental psychology","score_opus":0.009912229357831513,"score_gpt":0.29934590807549233,"score_spread":0.2894336787176608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452233,0.0011147652,0.00048326587,0.00047023103,0.00007465481,0.000056602323,0.00019995704,0.0000672034,0.00301099],"genre_scores_gemma":[0.99848205,0.00027888754,0.00019200591,0.00022187046,0.000025007483,0.000006024832,0.00007613717,0.0000094054285,0.00070862786],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99970335,0.000037913058,0.00003552456,0.00007447039,0.000049580114,0.00009913163],"domain_scores_gemma":[0.9996018,0.000042472006,0.00010081028,0.000028061253,0.00005396294,0.00017292134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017816799,0.0006548398,0.0005205101,0.000723154,0.0013949801,0.0005777431,0.00039015786,0.0008975271,0.0015058739],"category_scores_gemma":[0.0010975929,0.00045102293,0.00056160183,0.00049990276,0.00036939324,0.00036419265,0.0004935977,0.0010703584,0.00046677174],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028249962,0.00022290506,0.16106926,0.000065654385,0.000045413362,0.8271735,0.0004571273,0.000085221065,0.0035042278,0.000097015996,0.0009731535,0.0060240617],"study_design_scores_gemma":[0.000031438634,0.00090258813,0.18183562,0.000041764695,0.000057740406,0.8133035,0.00067995716,0.00044873453,0.0009548307,0.00009969353,0.0016208716,0.000023304374],"about_ca_topic_score_codex":0.0076145804,"about_ca_topic_score_gemma":0.0108039975,"teacher_disagreement_score":0.0076145804,"about_ca_system_score_codex":0.00080748356,"about_ca_system_score_gemma":0.00037895804,"threshold_uncertainty_score":0.015140533},"labels":[],"label_agreement":null},{"id":"W4411732890","doi":"10.1093/bjd/ljaf085.486","title":"HX23 Illuminating the skin: the enduring legacy of the wood lamp in dermatology","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Dermatology; Medicine","score_opus":0.008337448967818453,"score_gpt":0.25406756541529746,"score_spread":0.245730116447479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732890","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049754004,0.9042858,0.0064755753,0.040952597,0.013353144,0.00002622254,0.00011655547,0.00023580826,0.029579004],"genre_scores_gemma":[0.07813132,0.80583125,0.013043421,0.03178846,0.02609776,0.00007142094,0.0002006581,0.00035293002,0.044482876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875486,0.00038697972,0.00006316969,0.00016719455,0.00053304137,0.00009476395],"domain_scores_gemma":[0.996011,0.0018712215,0.00012339577,0.00023399037,0.0014055994,0.00035481987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030813096,0.0005572538,0.0006617965,0.001377309,0.0009397115,0.0031771346,0.0008826576,0.0024350178,0.01180315],"category_scores_gemma":[0.0032434682,0.00031058563,0.0006868545,0.0009813444,0.0024693157,0.003646037,0.0017102739,0.00671978,0.0045609735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030325394,0.0001881305,0.0010751946,0.0026097114,0.00007093247,0.0009632368,0.00075872865,0.00043075823,0.00973971,0.045686558,0.15731941,0.78085434],"study_design_scores_gemma":[0.00001576496,0.0001782319,0.0007263063,0.001015544,0.00002813304,0.0017696106,0.0003339798,0.000204629,0.004663548,0.008644721,0.9823669,0.000052541647],"about_ca_topic_score_codex":0.0017763628,"about_ca_topic_score_gemma":0.0016657044,"teacher_disagreement_score":0.01180315,"about_ca_system_score_codex":0.001473957,"about_ca_system_score_gemma":0.0009444126,"threshold_uncertainty_score":0.039485455},"labels":[],"label_agreement":null},{"id":"W4411732967","doi":"10.1093/bjd/ljaf085.126","title":"P098 Asthma control in patients receiving systemic therapy for atopic eczema: results from the UK Atopic eczema Systemic TherApy Register (A-STAR)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"NIHR Newcastle Biomedical Research Centre; Directorate for Biological Sciences; Newcastle University; University of Manchester; University of Oxford; King's College London; University of Southampton; National Institute for Health and Care Research","keywords":"Systemic therapy; Medicine; Register (sociolinguistics); Asthma; Dermatology; Pediatrics; Immunology; Internal medicine","score_opus":0.010892786146812597,"score_gpt":0.25556748180046335,"score_spread":0.24467469565365074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874478,0.0010321657,0.000071872535,0.000058615693,0.000013533393,0.000043174277,0.01056796,0.000012061083,0.0007527933],"genre_scores_gemma":[0.9907644,0.00032224,0.000061780986,0.000043394833,0.000014848394,0.000044628632,0.00842503,0.0000048247293,0.0003189472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810565,0.0005083684,0.00036474693,0.00030905788,0.0005578512,0.00015432163],"domain_scores_gemma":[0.9963271,0.00068809587,0.0020385955,0.00017184771,0.00050001545,0.000274269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010495976,0.00021591339,0.00060962763,0.001306052,0.0001630909,0.00061755016,0.00042993858,0.000574538,0.002998225],"category_scores_gemma":[0.0036413784,0.0002512409,0.0008172834,0.0023897667,0.00015301222,0.00044682046,0.00073638046,0.00041104012,0.0007746019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005780638,0.000029653864,0.99692875,0.00008726543,0.000089561865,0.000049944043,0.00003752885,0.00003613695,0.00011095724,0.000007652392,0.00053991575,0.0015046067],"study_design_scores_gemma":[0.000030884883,0.0001055185,0.99947816,0.0000118222515,0.000026975471,0.000063780855,0.000031553467,0.00008793326,0.000016100204,0.0000027518179,0.00014215785,0.000002357378],"about_ca_topic_score_codex":0.009874572,"about_ca_topic_score_gemma":0.008020499,"teacher_disagreement_score":0.009874572,"about_ca_system_score_codex":0.00043699433,"about_ca_system_score_gemma":0.0002502335,"threshold_uncertainty_score":0.019634187},"labels":[],"label_agreement":null},{"id":"W4411733095","doi":"10.1093/bjd/ljaf085.130","title":"P102 Raising the bar of efficacy in atopic dermatitis: lebrikizumab provides deep clinical and itch responses up to 16 weeks (ADvantage study)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Bar (unit); Raising (metalworking); Materials science","score_opus":0.02221577409191623,"score_gpt":0.3558559011643451,"score_spread":0.3336401270724289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939184,0.0027964497,0.00026605456,0.00033753342,0.000118597236,0.00045777523,0.00032173176,0.000059082115,0.0017242727],"genre_scores_gemma":[0.99600476,0.0009402947,0.00055775314,0.00039448723,0.00015779451,0.00025453375,0.00029385163,0.000011310814,0.0013853029],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99975544,0.000104734885,0.000018245795,0.000031960495,0.00002860053,0.000061013703],"domain_scores_gemma":[0.999556,0.00014954366,0.000077003446,0.000032549855,0.000028163615,0.00015684466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096424203,0.00048633743,0.0010744941,0.00021241512,0.00019490549,0.0005059053,0.0003961254,0.0007304515,0.0050675273],"category_scores_gemma":[0.00060879556,0.00025114272,0.00071395794,0.00013097045,0.0004701826,0.0006765182,0.0002928173,0.0020020485,0.00058530644],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.674257,0.034601375,0.004303246,0.0014749437,0.00048432132,0.00035564642,0.00015435806,0.0006951922,0.10519003,0.00043942273,0.0041130837,0.17393133],"study_design_scores_gemma":[0.36179888,0.6098857,0.013630735,0.00007325973,0.00030644683,0.0004629559,0.000066292414,0.00083251955,0.009549613,0.00019628574,0.0031710002,0.00002626254],"about_ca_topic_score_codex":0.0002073763,"about_ca_topic_score_gemma":0.0006879347,"teacher_disagreement_score":0.0050675273,"about_ca_system_score_codex":0.0002557332,"about_ca_system_score_gemma":0.00034339592,"threshold_uncertainty_score":0.016952574},"labels":[],"label_agreement":null},{"id":"W4411733096","doi":"10.1093/bjd/ljaf085.153","title":"P125 International incidence trends for melanoma in children, teenagers and young adults: a systematic review","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Medicine; Pediatrics; Demography; Sociology","score_opus":0.008673762937583023,"score_gpt":0.2931664391241949,"score_spread":0.28449267618661184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001663804,0.9935632,0.00011922676,0.00026394738,0.00011753357,0.0005029095,0.003059511,0.000015833082,0.00069411605],"genre_scores_gemma":[0.023093613,0.9731204,0.0005769826,0.00053583254,0.0001004289,0.0010991802,0.0012081544,0.000009918662,0.00025545777],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9941776,0.0011485217,0.0026087721,0.00054422446,0.0012423171,0.00027862669],"domain_scores_gemma":[0.9815965,0.010749056,0.005279802,0.0002038173,0.0019485486,0.00022226303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042666458,0.0012612201,0.007574069,0.016385248,0.00056183635,0.0022937057,0.001639205,0.0013241791,0.00884843],"category_scores_gemma":[0.026244411,0.00093093,0.0088483505,0.019546133,0.0007341869,0.0026528097,0.0014665758,0.0011034732,0.00044135074],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118340526,0.000006701839,0.0015576745,0.97419226,0.0057870187,0.00007176956,0.00012378182,0.00005385564,0.00007281986,0.000110617846,0.0018495921,0.01605554],"study_design_scores_gemma":[0.00022572048,0.00014350911,0.010673136,0.92384785,0.04900031,0.000504001,0.0002503082,0.00007015726,0.00010759103,0.00020771295,0.014936553,0.00003315904],"about_ca_topic_score_codex":0.017292785,"about_ca_topic_score_gemma":0.037882667,"teacher_disagreement_score":0.017292785,"about_ca_system_score_codex":0.004547279,"about_ca_system_score_gemma":0.010308982,"threshold_uncertainty_score":0.03438431},"labels":[],"label_agreement":null},{"id":"W4411733197","doi":"10.1093/bjd/ljaf085.421","title":"BI12 Systematic review of checkpoint inhibitor-induced epidermal necrolysis: a clinical entity distinct from ‘classic’ Stevens–Johnson syndrome/toxic epidermal necrolysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Toxic epidermal necrolysis; Dermatology; Medicine; Erythroderma","score_opus":0.02318165474011521,"score_gpt":0.31872012790244386,"score_spread":0.2955384731623287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018411244,0.99474937,0.00013259724,0.00026232805,0.00024613985,0.00038131757,0.0014626874,0.000012056242,0.00091237924],"genre_scores_gemma":[0.011374081,0.985128,0.0006297604,0.00058454316,0.0001976497,0.0005883277,0.0010027444,0.000010189783,0.00048473827],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99476683,0.0009788629,0.002765628,0.00034764866,0.0009887724,0.00015227718],"domain_scores_gemma":[0.9843472,0.00852154,0.0043199332,0.00022959463,0.0023109205,0.00027081926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035226,0.0013458361,0.007078566,0.023770215,0.0009130886,0.0020458302,0.001759477,0.0016046612,0.008813324],"category_scores_gemma":[0.013393335,0.0006638153,0.0034973014,0.029777035,0.00086653116,0.0023624033,0.0014155882,0.00068061304,0.0010435624],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015758004,0.0000141800265,0.0010159477,0.9641114,0.0023817783,0.0003838169,0.00016595444,0.000036277677,0.0003282046,0.00016934237,0.003642137,0.027593361],"study_design_scores_gemma":[0.00020712623,0.00028162153,0.00885484,0.90275073,0.025200494,0.0018998174,0.00038202672,0.000080428705,0.00036329188,0.00021514419,0.059718993,0.00004547417],"about_ca_topic_score_codex":0.0045590387,"about_ca_topic_score_gemma":0.013844671,"teacher_disagreement_score":0.023770215,"about_ca_system_score_codex":0.0028761907,"about_ca_system_score_gemma":0.008655238,"threshold_uncertainty_score":0.029483497},"labels":[],"label_agreement":null},{"id":"W4411733218","doi":"10.1093/bjd/ljaf085.500","title":"PS02 (P135) Patient satisfaction in virtual support group meetings for vitiligo: a service evaluation","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Vitiligo; Patient satisfaction; Medicine; Service (business); Psychology; Dermatology; Nursing; Business","score_opus":0.007747618350989182,"score_gpt":0.2739550690753969,"score_spread":0.2662074507244077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96879244,0.00038997113,0.00049312017,0.00084778975,0.00013397349,0.021730967,0.0019993705,0.00006826968,0.0055441647],"genre_scores_gemma":[0.9519598,0.0009012788,0.003279785,0.00066989684,0.00015958081,0.039331846,0.0013348777,0.000029774114,0.002333178],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9953674,0.0030978182,0.00027102648,0.00013040965,0.00054605765,0.0005873398],"domain_scores_gemma":[0.99227685,0.0024454263,0.0007779809,0.00028942173,0.0016227098,0.0025876372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008519673,0.0005541254,0.0007966411,0.0006696092,0.0013836214,0.0012793946,0.0007166502,0.0009564301,0.0140052335],"category_scores_gemma":[0.012326285,0.00023649543,0.0014123396,0.0011151561,0.0007533503,0.0007866409,0.0016383819,0.001326117,0.0015165955],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12744175,0.1697699,0.053804096,0.007016878,0.000844332,0.0008367125,0.011024572,0.0018679528,0.0027357687,0.0013016798,0.023655156,0.59970117],"study_design_scores_gemma":[0.07348211,0.7080618,0.16912958,0.0016186972,0.00077269535,0.00037528362,0.011830449,0.0025766047,0.0022911713,0.0005249745,0.029212061,0.00012452292],"about_ca_topic_score_codex":0.0035746794,"about_ca_topic_score_gemma":0.0042287656,"teacher_disagreement_score":0.0140052335,"about_ca_system_score_codex":0.0023486163,"about_ca_system_score_gemma":0.0059610996,"threshold_uncertainty_score":0.04685223},"labels":[],"label_agreement":null},{"id":"W4411733287","doi":"10.1093/bjd/ljaf085.016","title":"O01 The UK–Irish Atopic Eczema Systemic Therapy Register (A-STAR): a pilot descriptive analysis of healthcare resource use, costs and health-related quality of life in patients on systemic treatments for atopic eczema","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Systemic therapy; Register (sociolinguistics); Irish; Quality of life (healthcare); Health care; Family medicine; Nursing; Internal medicine","score_opus":0.05956655509467911,"score_gpt":0.33198797557917215,"score_spread":0.272421420484493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.920655,0.0003747909,0.00025025394,0.0001159076,0.000017325485,0.00055565685,0.07570895,0.000021335745,0.0023008592],"genre_scores_gemma":[0.9185196,0.00027218697,0.00065301766,0.00019280307,0.000039966657,0.0013575751,0.07721277,0.000023460125,0.0017286604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806935,0.0005108223,0.00052375736,0.0002722431,0.000338824,0.00028506137],"domain_scores_gemma":[0.99283254,0.0012216123,0.0042107096,0.00043968923,0.00092033,0.0003750832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015892424,0.0002970732,0.0006050449,0.002405226,0.0002580672,0.0008394271,0.00049966073,0.00039384488,0.0046945564],"category_scores_gemma":[0.005915963,0.00026498185,0.0010660706,0.0035802189,0.00030563376,0.00065306824,0.0009911804,0.00039850798,0.0011359433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011570823,0.00013348364,0.98633283,0.00028006424,0.00016680635,0.00013894128,0.00020161676,0.00014834478,0.00016764009,0.000060364186,0.005183058,0.006029762],"study_design_scores_gemma":[0.00007817914,0.00036949836,0.99679416,0.000057006586,0.000036581212,0.00015102253,0.00025327792,0.00016444168,0.00005819784,0.000012855132,0.0020143907,0.000010446934],"about_ca_topic_score_codex":0.025639556,"about_ca_topic_score_gemma":0.024948196,"teacher_disagreement_score":0.025639556,"about_ca_system_score_codex":0.0012589109,"about_ca_system_score_gemma":0.0013514502,"threshold_uncertainty_score":0.050980628},"labels":[],"label_agreement":null},{"id":"W4411733297","doi":"10.1093/bjd/ljaf085.021","title":"O06 Association between novel systemic immunomodulatory medications and achievement of super response in patients with moderate-to-severe atopic eczema: results from the UK–Irish Atopic Eczema Systemic Therapy Register (A-STAR)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Systemic therapy; Register (sociolinguistics); Dermatology; Internal medicine; Cancer","score_opus":0.010022716704644241,"score_gpt":0.24366606009335456,"score_spread":0.23364334338871032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697281,0.0031465152,0.00031482772,0.00017877306,0.00006223624,0.0001939255,0.023494301,0.00002449991,0.0028568194],"genre_scores_gemma":[0.98455346,0.0003360773,0.00027956115,0.00018661653,0.0000485303,0.00014387816,0.013881098,0.000012063222,0.0005587516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99520326,0.0015436227,0.0011489163,0.00081493874,0.00095565687,0.0003336848],"domain_scores_gemma":[0.9844662,0.0039660307,0.008510997,0.0009359217,0.0016264492,0.00049432454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038327347,0.0002507006,0.00095283554,0.001124217,0.00021034968,0.00081969966,0.0005272904,0.000529641,0.0030302599],"category_scores_gemma":[0.008928384,0.000245671,0.0019247145,0.002278254,0.00028382518,0.0006070779,0.00075020315,0.000593084,0.00057561044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008898928,0.00011901723,0.9824896,0.00044051942,0.0014551686,0.00004697785,0.00004272779,0.00008636355,0.00017910755,0.000036430192,0.001990397,0.004214814],"study_design_scores_gemma":[0.00057505403,0.0005635105,0.9966323,0.000042559193,0.00060214184,0.00009804221,0.00005186391,0.00018484931,0.00007415091,0.000020634641,0.0011449088,0.0000099001745],"about_ca_topic_score_codex":0.005229861,"about_ca_topic_score_gemma":0.008373201,"teacher_disagreement_score":0.005229861,"about_ca_system_score_codex":0.0006161533,"about_ca_system_score_gemma":0.00051899586,"threshold_uncertainty_score":0.020269632},"labels":[],"label_agreement":null},{"id":"W4411733317","doi":"10.1093/bjd/ljaf085.151","title":"P123 A novel self-referral enrolment pathway in a UK multicentre atopic dermatitis trial (BEACON trial): a single-site prospective observational study to assess feasibility and effectiveness","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Observational study; Medicine; Atopic dermatitis; Referral; Physical therapy; Pediatrics; Dermatology; Family medicine; Internal medicine","score_opus":0.06952446655235316,"score_gpt":0.34016026675537003,"score_spread":0.27063580020301686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94930416,0.0033886523,0.0036064726,0.0009831117,0.0003039975,0.034143995,0.0038457317,0.00012828046,0.00429563],"genre_scores_gemma":[0.95389336,0.0007006263,0.0042187506,0.00060426974,0.00039498915,0.0377908,0.0012197787,0.00003677326,0.0011405076],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.97709,0.016985454,0.0018247506,0.0014423577,0.0018087648,0.0008486857],"domain_scores_gemma":[0.9760383,0.007115997,0.00986395,0.0025494883,0.0024008246,0.002031513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016013188,0.0008603484,0.0018621172,0.00063922006,0.0010825028,0.0016076189,0.00081976416,0.0019238968,0.009362676],"category_scores_gemma":[0.030933848,0.00077206903,0.0016117556,0.0011507565,0.00096188486,0.0022295818,0.0011117714,0.0021877508,0.002260189],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58982843,0.04011022,0.18212259,0.0064046634,0.0028434943,0.0006308258,0.003178032,0.0010340394,0.0029059998,0.0009950696,0.017430779,0.15251584],"study_design_scores_gemma":[0.29040703,0.4311293,0.25356612,0.0013019019,0.00239901,0.0006525263,0.00093686394,0.0031880161,0.0011972951,0.0011474023,0.013814795,0.000259835],"about_ca_topic_score_codex":0.0017598582,"about_ca_topic_score_gemma":0.001997206,"teacher_disagreement_score":0.016013188,"about_ca_system_score_codex":0.001212,"about_ca_system_score_gemma":0.0028557316,"threshold_uncertainty_score":0.084686875},"labels":[],"label_agreement":null},{"id":"W4411733382","doi":"10.1093/bjd/ljaf085.322","title":"DS28 Left-handedness in dermatological surgery","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hemispheric Asymmetry in Neuroscience","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Dermatology; Surgery","score_opus":0.02318190960145816,"score_gpt":0.2812025967525991,"score_spread":0.25802068715114096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97193414,0.0026173198,0.00023148122,0.0029492553,0.0002614041,0.000018727736,0.00012337226,0.000018162003,0.021846088],"genre_scores_gemma":[0.99476236,0.00091688597,0.0001854109,0.0007011338,0.00006518436,0.000011102502,0.000047318143,0.0000087172375,0.00330172],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986903,0.00051149534,0.0000886434,0.000083359846,0.00035653348,0.0002695427],"domain_scores_gemma":[0.9951074,0.0010802286,0.0015820125,0.0001267392,0.00043039312,0.0016732288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087910646,0.00014718034,0.00015112261,0.0004006067,0.0007504892,0.00092108076,0.00022571097,0.00032940603,0.017073479],"category_scores_gemma":[0.00494749,0.000104803694,0.0002297929,0.00028702203,0.00091759634,0.00054493215,0.0011926049,0.0006008891,0.0017062698],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036581486,0.0003724722,0.73739487,0.0008599139,0.000044149165,0.014310221,0.026127886,0.00024526834,0.007875635,0.0014238476,0.022569697,0.18841021],"study_design_scores_gemma":[0.000035040004,0.0008076297,0.8098415,0.00091438356,0.000022321306,0.056111243,0.06800087,0.00024724842,0.0008686573,0.0012020607,0.061880693,0.0000682681],"about_ca_topic_score_codex":0.00296931,"about_ca_topic_score_gemma":0.004849221,"teacher_disagreement_score":0.017073479,"about_ca_system_score_codex":0.00065488066,"about_ca_system_score_gemma":0.0010942838,"threshold_uncertainty_score":0.05711651},"labels":[],"label_agreement":null},{"id":"W4411733394","doi":"10.1093/bjd/ljaf085.157","title":"P129 A prospective comparative audit of outcomes in patients with basal cell carcinoma receiving 10 600-nm carbon dioxide laser-assisted photodynamic therapy with either methyl aminolaevulinate or 5-aminolaevulinic acid as a photosensitizer","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Photodynamic therapy; Carbon dioxide laser; Medicine; Basal cell carcinoma; Audit; Laser therapy; Basal (medicine); Basal cell; Dermatology; Laser; Internal medicine; Chemistry; Optics; Organic chemistry","score_opus":0.012569728245028314,"score_gpt":0.28725467866350896,"score_spread":0.2746849504184806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99893147,0.0002973386,0.000054937685,0.000008279697,0.000003909031,0.0000250439,0.0002490038,0.000002099247,0.00042794898],"genre_scores_gemma":[0.9993351,0.0001283251,0.000040655836,0.0000072691964,0.00000834515,0.000018874289,0.00038902118,0.0000014550433,0.00007085683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953747,0.000119766504,0.00006777076,0.00009391512,0.00011139229,0.00006969302],"domain_scores_gemma":[0.9986486,0.00035424376,0.0005639827,0.00005200374,0.00014400532,0.00023724695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046892668,0.00016748736,0.00039735282,0.00067705486,0.00026616175,0.0003958164,0.00018924587,0.0003269821,0.0022043765],"category_scores_gemma":[0.0014284878,0.00016402273,0.00047105446,0.0008182708,0.00025146763,0.00038699125,0.00030357076,0.00025168445,0.0004437915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023691112,0.00018959811,0.99204904,0.000050669478,0.000057781766,0.00029283672,0.000049747716,0.00005776964,0.00067558815,0.000014134854,0.00008974003,0.0041039796],"study_design_scores_gemma":[0.000108392254,0.0029452003,0.99485224,0.000011507202,0.000061537045,0.0011496776,0.00015366981,0.00013683105,0.0002698368,0.00001711905,0.00028691045,0.000007073443],"about_ca_topic_score_codex":0.0008334562,"about_ca_topic_score_gemma":0.00069635076,"teacher_disagreement_score":0.0022043765,"about_ca_system_score_codex":0.0003656531,"about_ca_system_score_gemma":0.00024672988,"threshold_uncertainty_score":0.007374406},"labels":[],"label_agreement":null},{"id":"W4411733402","doi":"10.1093/bjd/ljaf085.080","title":"P052 Nemolizumab elicits rapid itch-free state and sleep improvement in prurigo nodularis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Prurigo nodularis; Medicine; Prurigo; Dermatology; Sleep (system call); Computer science","score_opus":0.0049594348416102715,"score_gpt":0.24401873215008715,"score_spread":0.2390592973084769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974063,0.0015179212,0.000202296,0.000054873475,0.000024225876,0.00015435286,0.00016834623,0.0000124068065,0.000459298],"genre_scores_gemma":[0.99867517,0.00031832128,0.0002838467,0.00009709314,0.000024182598,0.000091340095,0.00024289254,0.00000238726,0.00026473877],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971265,0.00014571236,0.000032280426,0.000029773391,0.000035938574,0.000043558564],"domain_scores_gemma":[0.9996904,0.0000984475,0.00009926903,0.000022614717,0.00001593408,0.00007327007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079704734,0.00021554992,0.0008201247,0.00015450931,0.00011128373,0.00018878035,0.0001620129,0.0002123552,0.0013710291],"category_scores_gemma":[0.00079984614,0.00013547504,0.00045569384,0.00012862978,0.00020274615,0.00018993877,0.00013621741,0.00047896634,0.00016957252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31253776,0.01498891,0.0390687,0.0018190164,0.0010061454,0.00060401723,0.00015018295,0.0014256724,0.47035378,0.00017144416,0.0021634444,0.15571098],"study_design_scores_gemma":[0.06639553,0.48778692,0.40205503,0.00010730579,0.00072223064,0.0017434333,0.00013537197,0.0027077827,0.03449586,0.00014441223,0.003671342,0.000034817094],"about_ca_topic_score_codex":0.0003905847,"about_ca_topic_score_gemma":0.0009065648,"teacher_disagreement_score":0.0013710291,"about_ca_system_score_codex":0.00021032503,"about_ca_system_score_gemma":0.00020623105,"threshold_uncertainty_score":0.004586518},"labels":[],"label_agreement":null},{"id":"W4411733547","doi":"10.1093/bjd/ljaf085.163","title":"P135 Patient satisfaction in virtual support group meetings for vitiligo: a service evaluation","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Vitiligo; Patient satisfaction; Service (business); Medicine; Nursing; Dermatology; Business","score_opus":0.007636084267282979,"score_gpt":0.2738188487619751,"score_spread":0.26618276449469214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98964,0.0003426228,0.0002770024,0.00042197036,0.000054665088,0.0061023957,0.00061203784,0.00002927044,0.0025200604],"genre_scores_gemma":[0.9853035,0.00061333214,0.002132954,0.00027714882,0.00007820577,0.010221238,0.0004893575,0.000013306911,0.0008709218],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9945364,0.0036713646,0.00034796962,0.00015509603,0.00066403975,0.00062511157],"domain_scores_gemma":[0.992542,0.002755749,0.0009607508,0.00022178484,0.001207397,0.002312279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008752968,0.0005044237,0.0009887019,0.0007049086,0.0012404562,0.0013532218,0.0006835239,0.00082683575,0.008498066],"category_scores_gemma":[0.012716826,0.00021794428,0.0015739864,0.0010176309,0.00071165717,0.00073453295,0.001750681,0.0011784587,0.0007739194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10074549,0.14767694,0.116532385,0.008003852,0.001190558,0.0011466043,0.016469574,0.0020785858,0.0033776734,0.0012381532,0.012521039,0.58901924],"study_design_scores_gemma":[0.03570602,0.65197384,0.2605136,0.0017849589,0.0012336429,0.0006721563,0.01941305,0.0039051685,0.0031493434,0.0005378524,0.020914866,0.000195587],"about_ca_topic_score_codex":0.0019730567,"about_ca_topic_score_gemma":0.0023288645,"teacher_disagreement_score":0.008752968,"about_ca_system_score_codex":0.0023322161,"about_ca_system_score_gemma":0.0036822383,"threshold_uncertainty_score":0.046290696},"labels":[],"label_agreement":null},{"id":"W4411750799","doi":"10.1093/bjd/ljaf257","title":"Comprehensive profiling of the mutational landscape of hidradenoma papilliferum validates key role of alterations in the phosphoinositide 3-kinase/AKT pathway","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada; Wellcome Trust","keywords":"PI3K/AKT/mTOR pathway; Hidradenoma; Biology; Pathogenesis; Gene; Cancer research; Genetics; Protein kinase B; Computational biology; Bioinformatics; Signal transduction; Immunology","score_opus":0.009017301433216949,"score_gpt":0.25755170083050477,"score_spread":0.24853439939728783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411750799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907923,0.0018818883,0.0037725575,0.000040649968,0.0000070965925,0.00004830112,0.0015349765,0.000105969746,0.0018163621],"genre_scores_gemma":[0.9950955,0.0007796218,0.0021989532,0.00002512935,0.0000031000775,0.000019917836,0.0011120132,0.000018942832,0.00074690534],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998462,0.000013232531,0.000009134761,0.00004419594,0.00004455582,0.00004254191],"domain_scores_gemma":[0.9998331,0.00003494124,0.000037467427,0.000026834383,0.00003757531,0.000030158913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018792802,0.00016363188,0.0002072818,0.0009409326,0.00021890875,0.0003418941,0.00009851976,0.00022025536,0.0013161366],"category_scores_gemma":[0.00026306196,0.00011605914,0.00017631525,0.00049363414,0.00016026317,0.0001589301,0.00025232334,0.00024930856,0.0003309948],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002269422,0.000022401617,0.026558068,0.00009073088,0.000033342872,0.00042606218,0.000056954075,0.0001753625,0.96216,0.00008796924,0.00008055938,0.010081551],"study_design_scores_gemma":[0.000011977853,0.00047023923,0.63707316,0.000030122257,0.00018307894,0.010549169,0.0003258849,0.0019465899,0.34272003,0.00040815136,0.0062618167,0.00001984185],"about_ca_topic_score_codex":0.0006564254,"about_ca_topic_score_gemma":0.0012082671,"teacher_disagreement_score":0.0013161366,"about_ca_system_score_codex":0.0001466378,"about_ca_system_score_gemma":0.00012973891,"threshold_uncertainty_score":0.004402876},"labels":[],"label_agreement":null},{"id":"W4411928345","doi":"10.1093/bjd/ljaf236","title":"Efficacy and safety of upadacitinib dose escalation and reduction in adults with moderate-to-severe atopic dermatitis: results of a randomized blinded treat-to-target multicentre phase IIIb/IV study (Flex Up)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; Probity Medical Research; SKiN Health; Queen's University","funders":"AbbVie","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Clinical endpoint; Randomized controlled trial; Adverse effect; Internal medicine; Dermatology","score_opus":0.009325407154275793,"score_gpt":0.28987825642968496,"score_spread":0.2805528492754092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411928345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298483,0.002612841,0.0004977131,0.00023852583,0.00008946749,0.002190627,0.0005863397,0.000060564973,0.0007390433],"genre_scores_gemma":[0.99362904,0.0011786863,0.0015668027,0.0005028282,0.00012595637,0.0016406381,0.00072462147,0.000014828898,0.0006167082],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987864,0.0007286782,0.00009604078,0.00015162861,0.00012097906,0.00011620803],"domain_scores_gemma":[0.99870586,0.00027697862,0.0003887792,0.00014130557,0.00010685088,0.0003802403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036489207,0.0009737539,0.002275418,0.00030199465,0.00035833294,0.00073767244,0.00073107204,0.0010038624,0.002605038],"category_scores_gemma":[0.0018263151,0.00049363065,0.0014865962,0.0003242519,0.00074545474,0.0007786267,0.00039281146,0.002193979,0.00041527994],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91823536,0.018915832,0.0031328052,0.0005168959,0.0012799343,0.000042227155,0.000083254345,0.0004941106,0.009439741,0.000068220135,0.0011824875,0.046609234],"study_design_scores_gemma":[0.78044087,0.20442452,0.011255659,0.000033105745,0.0008469196,0.00009687903,0.00002301107,0.000521265,0.0014991243,0.000077337834,0.0007594335,0.000021955559],"about_ca_topic_score_codex":0.00042647994,"about_ca_topic_score_gemma":0.001165183,"teacher_disagreement_score":0.0036489207,"about_ca_system_score_codex":0.00067302055,"about_ca_system_score_gemma":0.0011198112,"threshold_uncertainty_score":0.0192976},"labels":[],"label_agreement":null},{"id":"W4412492661","doi":"10.1093/bjd/ljaf280","title":"Mendelian randomization identifies OX40 as a potential mediator of the effects of cigarette smoking on palmoplantar pustulosis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Norwegian Institute of Public Health; Faculty of Medicine and Health, University of Sydney; Fakultet for medisin og helsevitenskap, Norges Teknisk-Naturvitenskapelige Universitet; Sun Pharma; Astellas Pharma; Helse Midt-Norge; National Institute for Health and Care Research; Norges Teknisk-Naturvitenskapelige Universitet; Medical Research Council; Celgene; Biogen; China Scholarship Council; Leading Edge Endowment Fund; Sanofi; Amgen; Pfizer; King's College London; Galderma; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Mendelian randomization; Palmoplantar pustulosis; Mediator; Medicine; Randomization; Cigarette smoking; Dermatology; Internal medicine; Clinical trial; Immunology; Psoriasis; Genetics; Biology; Gene","score_opus":0.003880486165490858,"score_gpt":0.24154747806358992,"score_spread":0.23766699189809906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412492661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7597282,0.0015872825,0.22843683,0.0011098073,0.00036494152,0.0027246154,0.00193701,0.0007376603,0.0033737333],"genre_scores_gemma":[0.90224797,0.0004104186,0.090859376,0.00056042435,0.00006732598,0.0024865775,0.0004065873,0.00010571225,0.0028555787],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9743114,0.018090732,0.00094381755,0.0033053888,0.0022168055,0.0011318254],"domain_scores_gemma":[0.98250604,0.012545205,0.001437307,0.0029211177,0.00035895582,0.00023136997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018877065,0.0012223836,0.002247877,0.0012699733,0.0006192535,0.00095787377,0.0013067885,0.0018982539,0.0059647653],"category_scores_gemma":[0.027685728,0.00058083667,0.002074173,0.0012417625,0.0011423315,0.00057539623,0.0010146406,0.0013110727,0.00029339327],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07851351,0.0025079553,0.33695716,0.0033287206,0.02208281,0.020129345,0.0030718793,0.022372669,0.13324612,0.16528618,0.007900029,0.20460363],"study_design_scores_gemma":[0.018908,0.029234705,0.40297946,0.00055627915,0.021722581,0.02377119,0.000914274,0.27846703,0.049168658,0.13870643,0.03491698,0.0006544642],"about_ca_topic_score_codex":0.0014924194,"about_ca_topic_score_gemma":0.0012918758,"teacher_disagreement_score":0.018877065,"about_ca_system_score_codex":0.00057807134,"about_ca_system_score_gemma":0.0012442085,"threshold_uncertainty_score":0.099832654},"labels":[],"label_agreement":null},{"id":"W4412658675","doi":"10.1093/bjd/ljaf291","title":"A call to integrate specialized dermatology clinics into care of patients with inflammatory bowel disease","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Pyoderma gangrenosum; Inflammatory bowel disease; Dermatology; Psoriasis; Disease; Multidisciplinary approach; Population; Inflammatory Bowel Diseases; Intensive care medicine; Internal medicine","score_opus":0.005000307232274269,"score_gpt":0.26617756740490806,"score_spread":0.26117726017263376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412658675","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056252433,0.005168895,0.0015112216,0.9633897,0.012245222,0.00014915848,0.000060924012,0.0004537837,0.011395965],"genre_scores_gemma":[0.060242616,0.01450951,0.019791402,0.8636776,0.028279997,0.00059273955,0.00020880446,0.0002684308,0.012428951],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9858883,0.00611285,0.001318588,0.0011146242,0.0027538245,0.0028119308],"domain_scores_gemma":[0.8771873,0.025690662,0.0047924593,0.0047690975,0.014078691,0.07348168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011225317,0.0007732935,0.0010540923,0.0014427416,0.004227009,0.007038012,0.002974898,0.021795975,0.052222975],"category_scores_gemma":[0.024418715,0.0011030445,0.0024910683,0.00074680324,0.003241907,0.008339126,0.009306209,0.024409533,0.008012736],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027539517,0.0010996582,0.009724132,0.0013068918,0.00015179734,0.005326787,0.0024607286,0.0005861679,0.0030727503,0.0038201646,0.7889246,0.18325101],"study_design_scores_gemma":[0.0006750189,0.00060159445,0.04863913,0.00518871,0.00012703263,0.010370811,0.010264573,0.0006266439,0.0003953281,0.0074485885,0.9153747,0.00028792236],"about_ca_topic_score_codex":0.0058989436,"about_ca_topic_score_gemma":0.014953321,"teacher_disagreement_score":0.052222975,"about_ca_system_score_codex":0.0035923019,"about_ca_system_score_gemma":0.0165614,"threshold_uncertainty_score":0.17470324},"labels":[],"label_agreement":null},{"id":"W4412743752","doi":"10.1093/bjd/ljaf305","title":"Efficacy and safety of apremilast in paediatric patients with moderate-to-severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"Amgen","keywords":"Apremilast; Medicine; Placebo; Psoriasis; Randomized controlled trial; Internal medicine; Dermatology; Psoriatic arthritis; Alternative medicine; Pathology","score_opus":0.006006601279841326,"score_gpt":0.2054851770162141,"score_spread":0.1994785757363728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412743752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696223,0.017321112,0.0011634439,0.00095806253,0.00033760935,0.0057460815,0.0022969393,0.00015668357,0.002397795],"genre_scores_gemma":[0.9773052,0.007942031,0.003079331,0.0011397079,0.000473012,0.006420047,0.0017850334,0.000040974384,0.0018147004],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976291,0.001616074,0.00019658318,0.00024008223,0.00020790388,0.00011027906],"domain_scores_gemma":[0.997609,0.00067349937,0.0009464128,0.00021630172,0.00013672638,0.00041806404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045633903,0.0012129431,0.0029319602,0.00027907625,0.000375044,0.00083890266,0.00074002804,0.0014704417,0.0051690503],"category_scores_gemma":[0.0040586167,0.0006033001,0.0023574068,0.00040527448,0.0009015559,0.00081704947,0.0004197501,0.00243178,0.0005634285],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97169334,0.0038683699,0.0017902119,0.0012817124,0.00160718,0.00008466768,0.00007131583,0.00021666926,0.002212638,0.00007962945,0.0011521641,0.015942113],"study_design_scores_gemma":[0.9438695,0.04822254,0.005644619,0.000084040956,0.00073013466,0.00010290375,0.00001694018,0.00017994992,0.00033930494,0.000057400764,0.00073966477,0.0000129533555],"about_ca_topic_score_codex":0.0005187681,"about_ca_topic_score_gemma":0.0011426972,"teacher_disagreement_score":0.0051690503,"about_ca_system_score_codex":0.00054236123,"about_ca_system_score_gemma":0.0011906453,"threshold_uncertainty_score":0.024133801},"labels":[],"label_agreement":null},{"id":"W4412785444","doi":"10.1093/bjd/ljaf290","title":"Under the Arctic sun: assessment of skin cancer risk and sun-protection behaviours in Indigenous communities in Nunavik, an emerging at-risk population for skin cancers","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Makivik Corporation; Université de Montréal; McGill University Health Centre; St Mary's Hospital Centre; University of Ottawa","funders":"LEO Fondet; Canadian Institutes of Health Research; Réseau de cancérologie Rossy","keywords":"Skin cancer; Indigenous; Sun exposure; Sun protection; The arctic; Population; Environmental health; Medicine; Arctic; Cancer; Dermatology; Ecology; Biology; Internal medicine","score_opus":0.02053269997960226,"score_gpt":0.33587277365148693,"score_spread":0.31534007367188466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412785444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982132,0.00017674462,0.000090237285,0.00009266255,0.0000057279676,0.000024048786,0.00018585121,0.0000021939572,0.0012093909],"genre_scores_gemma":[0.99928266,0.00009561536,0.00013431229,0.00003452203,0.0000016130991,0.000009484083,0.000063985,0.0000015849585,0.00037613927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940217,0.000120091216,0.00003999036,0.00010345088,0.00014809598,0.00018616239],"domain_scores_gemma":[0.9993993,0.00005453121,0.00010001141,0.000035688474,0.00022331158,0.00018729032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066164037,0.00026933942,0.00022350415,0.00053309853,0.002608924,0.0008411682,0.00071514316,0.00033397376,0.0016095142],"category_scores_gemma":[0.0016821151,0.00020671732,0.00036043575,0.00082050066,0.0006737255,0.00038354564,0.0010553006,0.000540173,0.00016625726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005784771,0.000050680497,0.97852874,0.00007683745,0.000039502964,0.0001836341,0.015552681,0.00009003509,0.00079003815,0.00009257862,0.00024299139,0.0042944374],"study_design_scores_gemma":[0.0000021111598,0.000052064355,0.9706731,0.00007501472,0.000025769179,0.00017896126,0.027961565,0.0001839582,0.000104019186,0.00005146392,0.00067770644,0.000014296154],"about_ca_topic_score_codex":0.9387356,"about_ca_topic_score_gemma":0.9673209,"teacher_disagreement_score":0.061264396,"about_ca_system_score_codex":0.0045372793,"about_ca_system_score_gemma":0.0065888576,"threshold_uncertainty_score":0.123250365},"labels":[],"label_agreement":null},{"id":"W4413104618","doi":"10.1093/bjd/ljaf307","title":"The Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient-reported outcomes for hidradenitis suppurativa","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Novartis Pharmaceuticals UK Limited; Novartis Pharma","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Internal medicine; Disease","score_opus":0.03256686548980241,"score_gpt":0.3450716910055878,"score_spread":0.3125048255157854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413104618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9055764,0.00324608,0.032933265,0.0011254401,0.00035861006,0.032802165,0.014574874,0.00040316788,0.008980009],"genre_scores_gemma":[0.85008156,0.0017840976,0.09518475,0.00050393667,0.00013716982,0.042174287,0.009016396,0.000059858117,0.0010579282],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9880498,0.006106938,0.0023435235,0.00054081745,0.0026779657,0.00028096142],"domain_scores_gemma":[0.9705189,0.013121898,0.00848186,0.0015148087,0.005471766,0.00089076237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023152424,0.000625623,0.0011100359,0.0017220351,0.00041211376,0.0012297215,0.0008665872,0.0005417325,0.0012858919],"category_scores_gemma":[0.03543213,0.0003223864,0.0017142874,0.0013389316,0.000392576,0.0011536656,0.0015524885,0.0014382093,0.00026123118],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007998137,0.0039284406,0.46926212,0.004687712,0.0017541081,0.00020463928,0.0035869547,0.004849631,0.00590662,0.0014430869,0.011391444,0.4849872],"study_design_scores_gemma":[0.0021843524,0.012260353,0.9463481,0.0008035255,0.0007830098,0.0005201502,0.0011438908,0.011354101,0.0043609873,0.00076818437,0.019275296,0.00019803838],"about_ca_topic_score_codex":0.0007166721,"about_ca_topic_score_gemma":0.0016780053,"teacher_disagreement_score":0.023152424,"about_ca_system_score_codex":0.0008988325,"about_ca_system_score_gemma":0.0018005609,"threshold_uncertainty_score":0.1224432},"labels":[],"label_agreement":null},{"id":"W4413105160","doi":"10.1093/bjd/ljaf312","title":"European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lymphoproliferative disorders; Medicine; Dermatology; Intensive care medicine; Lymphoma; Pathology","score_opus":0.046720807417611206,"score_gpt":0.37185825501058295,"score_spread":0.32513744759297175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413105160","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003915015,0.5979287,0.029523958,0.13263293,0.03102689,0.0059060813,0.02712809,0.0012360095,0.17070231],"genre_scores_gemma":[0.0384519,0.603032,0.0870115,0.045891672,0.01205613,0.020460188,0.094591245,0.0016004392,0.09690499],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9847341,0.005687014,0.0020971005,0.001079339,0.005039777,0.0013627367],"domain_scores_gemma":[0.9530508,0.007230075,0.00824142,0.0019018793,0.026063822,0.0035119436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015797494,0.0015285966,0.0034772344,0.0072534257,0.00093857606,0.0044005746,0.004272338,0.0035354057,0.01978552],"category_scores_gemma":[0.024834752,0.0006560398,0.002703393,0.012335037,0.001960202,0.0021720973,0.003836589,0.00915058,0.010211411],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005872114,0.00022082623,0.004293398,0.0068348525,0.00046343572,0.0002731888,0.00021036499,0.0010881827,0.0009398254,0.0067220796,0.5392604,0.4391063],"study_design_scores_gemma":[0.00038503527,0.00017220221,0.010991174,0.0061964337,0.00026995293,0.0003480259,0.00020168663,0.0003621832,0.00028696083,0.0026482819,0.97808176,0.000056262892],"about_ca_topic_score_codex":0.014446032,"about_ca_topic_score_gemma":0.00828929,"teacher_disagreement_score":0.01978552,"about_ca_system_score_codex":0.0058642128,"about_ca_system_score_gemma":0.02239879,"threshold_uncertainty_score":0.08354616},"labels":[],"label_agreement":null},{"id":"W4413111259","doi":"10.1093/bjd/ljaf293","title":"Tyrosine kinase 2 inhibition improves clinical and molecular hallmarks in subtypes of cutaneous lupus","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Deutsche Forschungsgemeinschaft","keywords":"Cutaneous Lupus Erythematosus; Systemic lupus erythematosus; Medicine; Lupus erythematosus; Computational biology; Biology; Dermatology; Immunology; Disease; Pathology; Antibody","score_opus":0.010804504747582726,"score_gpt":0.309357202867814,"score_spread":0.2985526981202313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413111259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299556,0.0037392555,0.00090348395,0.00008396092,0.00006114598,0.000044816752,0.00021972612,0.00020283568,0.0017490708],"genre_scores_gemma":[0.9970305,0.0006815116,0.00046236638,0.000054161243,0.000019609712,0.000023251912,0.00033486984,0.000020633655,0.0013729768],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999045,0.000016811544,0.000009682586,0.000021463778,0.00001938146,0.000028092407],"domain_scores_gemma":[0.99989307,0.00001532777,0.00002952987,0.000013128554,0.000011725341,0.000037169822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014727763,0.0003866273,0.000515951,0.00017331725,0.000113507784,0.00028550514,0.00020587446,0.00023203084,0.0021104286],"category_scores_gemma":[0.0001556819,0.00006636758,0.00023484722,0.000083670035,0.00012043102,0.0001527749,0.000094487565,0.0006475103,0.00038668365],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063070497,0.0011864238,0.0015769141,0.00029628264,0.00007970728,0.00013952237,0.000027360811,0.00043336386,0.9494388,0.00008682288,0.00060686615,0.039820902],"study_design_scores_gemma":[0.0020392644,0.026514662,0.045807328,0.000072371586,0.00034245374,0.003401595,0.00010451427,0.003384377,0.9029738,0.00024607312,0.015085111,0.000028619079],"about_ca_topic_score_codex":0.00017115766,"about_ca_topic_score_gemma":0.0003468184,"teacher_disagreement_score":0.0021104286,"about_ca_system_score_codex":0.00015131467,"about_ca_system_score_gemma":0.0001379574,"threshold_uncertainty_score":0.007060051},"labels":[],"label_agreement":null},{"id":"W4413786495","doi":"10.1093/bjd/ljaf327","title":"SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvement","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Probity Medical Research; Dalhousie University; Innovaderm (Canada)","funders":"Johnson and Johnson; Dermira; Celgene; Teva Pharmaceutical Industries; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Intertriginous; Body surface area; Placebo; Psoriasis; Clinical endpoint; Psoriasis Area and Severity Index; Randomized controlled trial; Internal medicine; Dermatology; Disease; Pathology","score_opus":0.038585348085449125,"score_gpt":0.3233213397615486,"score_spread":0.2847359916760995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413786495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95917976,0.010273923,0.0020352944,0.0022567932,0.0004280491,0.011183764,0.005371015,0.00046465796,0.008806718],"genre_scores_gemma":[0.95951074,0.004703044,0.0053416626,0.0025843664,0.0003712243,0.01271039,0.0043714596,0.000094691306,0.010312524],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99960667,0.00020360877,0.000025748861,0.00006371999,0.000047960224,0.000052370164],"domain_scores_gemma":[0.99925715,0.00014417377,0.00021289829,0.00005393672,0.000096829324,0.00023501618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023222938,0.0010451175,0.0013126333,0.0002916452,0.00040525803,0.00093845266,0.0007451398,0.0015443675,0.009919311],"category_scores_gemma":[0.0017310558,0.00043195338,0.0010850116,0.00025542275,0.00075220724,0.0007655731,0.0003149291,0.0026975921,0.001557766],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8647882,0.019372698,0.002671332,0.0022390427,0.000994814,0.00013912737,0.00022351606,0.0009887193,0.029691296,0.0005213425,0.012446685,0.06592319],"study_design_scores_gemma":[0.8593332,0.12523682,0.0066085802,0.00015440874,0.00035245085,0.00017166487,0.000032655007,0.00050514145,0.0021798594,0.00032528074,0.0050811647,0.000018740324],"about_ca_topic_score_codex":0.00035040802,"about_ca_topic_score_gemma":0.0010371652,"teacher_disagreement_score":0.009919311,"about_ca_system_score_codex":0.0005806288,"about_ca_system_score_gemma":0.0012898447,"threshold_uncertainty_score":0.033183396},"labels":[],"label_agreement":null},{"id":"W4413811220","doi":"10.1093/bjd/ljaf309","title":"Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of eight clinical trials","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; Dalhousie University","funders":"Cilag; LEO Pharma; Galderma; National Institute for Health and Care Research; Celgene; Gilead Sciences; Amgen; Pfizer; Manchester Biomedical Research Centre; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Placebo; Medicine; Adverse effect; Incidence (geometry); Atopic dermatitis; Clinical trial; Safety profile; Pediatrics; Internal medicine; Dermatology; Alternative medicine","score_opus":0.025778084014918944,"score_gpt":0.35354159469447594,"score_spread":0.327763510679557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413811220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87770617,0.10995692,0.0030246193,0.00048194733,0.00007768528,0.0022901779,0.004641245,0.000099013734,0.0017222868],"genre_scores_gemma":[0.9850054,0.007312792,0.0023369924,0.00030133597,0.00008196846,0.00086069497,0.0038470768,0.000020504996,0.0002333657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97735673,0.012651692,0.0031931293,0.002692179,0.0034138628,0.00069246226],"domain_scores_gemma":[0.9589944,0.020239312,0.015229052,0.0019357691,0.002633698,0.00096771977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03304891,0.0009712503,0.0042557404,0.0020835458,0.00039196893,0.0023941475,0.0007983917,0.0010108824,0.0011875683],"category_scores_gemma":[0.02492803,0.0005354176,0.011690959,0.002349896,0.00050720223,0.0012679434,0.0010885643,0.0012381632,0.0001476939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2203335,0.0013533484,0.37969178,0.013870207,0.2541254,0.00027220472,0.00039379406,0.005839152,0.004403367,0.00031741254,0.0014585648,0.11794136],"study_design_scores_gemma":[0.039881714,0.04207886,0.68445265,0.0022183403,0.21470028,0.0009964406,0.00022801489,0.005714418,0.0022654189,0.00095668243,0.006356066,0.00015104907],"about_ca_topic_score_codex":0.00053969386,"about_ca_topic_score_gemma":0.0012576758,"teacher_disagreement_score":0.03304891,"about_ca_system_score_codex":0.001199205,"about_ca_system_score_gemma":0.0017752344,"threshold_uncertainty_score":0.17478144},"labels":[],"label_agreement":null},{"id":"W4413978744","doi":"10.1093/bjd/ljaf345","title":"Multiharmonic imaging-based automated recognition of cutaneous T-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Horizon 2020 Framework Programme; Swiss Cancer Research Foundation; Centre Hospitalier Universitaire Vaudois; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Mallinckrodt Pharmaceuticals; H2020 LEIT Information and Communication Technologies; Université de Lausanne; Université de Genève; Helsinn; H2020 Leadership in Enabling and Industrial Technologies; National Science Foundation","keywords":"Mycosis fungoides; Biopsy; Pathology; Medicine; Convolutional neural network; Skin biopsy; Lymphoma; Atypical Lymphocyte; Cutaneous T-cell lymphoma; Haematoxylin; Staining; Artificial intelligence; Computer science","score_opus":0.010961421461604802,"score_gpt":0.29063409823356623,"score_spread":0.27967267677196145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413978744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5751648,0.0014525441,0.4163721,0.0003075712,0.0000707275,0.00015484638,0.00039456878,0.0024077322,0.0036750506],"genre_scores_gemma":[0.9209354,0.00041560165,0.07615155,0.00012439463,0.000044358163,0.00004089885,0.00047340058,0.00007096511,0.0017433607],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99984753,0.000024248397,0.00000691399,0.000049840484,0.000042393855,0.000029056646],"domain_scores_gemma":[0.99977607,0.000070666036,0.00003957229,0.000022936738,0.00007077961,0.000019943696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030136044,0.0003450214,0.0002952635,0.0010050806,0.00008607564,0.0004782061,0.00046122517,0.00063155004,0.00087414985],"category_scores_gemma":[0.0007513121,0.00014045507,0.00039107742,0.00029389886,0.00015379657,0.0003108143,0.0003240136,0.0002865007,0.0004899928],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006474972,0.00018037326,0.015172878,0.00026417596,0.00010946108,0.0007913176,0.0001402089,0.12948203,0.33070153,0.00071943447,0.002602767,0.5191883],"study_design_scores_gemma":[0.000009397623,0.000054296943,0.0064167776,0.00000826279,0.000023553228,0.00034260124,0.00003085938,0.96300715,0.029043598,0.000402654,0.0006527083,0.000008142595],"about_ca_topic_score_codex":0.0013712216,"about_ca_topic_score_gemma":0.0015669664,"teacher_disagreement_score":0.0013712216,"about_ca_system_score_codex":0.00039494797,"about_ca_system_score_gemma":0.00017522903,"threshold_uncertainty_score":0.0029243827},"labels":[],"label_agreement":null},{"id":"W4414068914","doi":"10.1093/bjd/ljaf334","title":"Striking improvement with targeted therapy in an anaplastic lymphoma kinase-positive atypical giant congenital melanocytic naevus of the right lower limb: a case report","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Targeted therapy; Debulking; Anaplastic lymphoma kinase; Surgical excision; Congenital melanocytic nevus; Nevus","score_opus":0.006884219687841592,"score_gpt":0.25563872780463415,"score_spread":0.24875450811679256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414068914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809303,0.006040647,0.0033392091,0.002232523,0.00018751694,0.00008621613,0.00013980838,0.00018021412,0.0068635177],"genre_scores_gemma":[0.9957188,0.0015083682,0.0013466426,0.00029625546,0.00014235274,0.000010583899,0.000032804204,0.00001546316,0.00092884805],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997271,0.000048047445,0.000029047273,0.00006695936,0.000060854203,0.00006797329],"domain_scores_gemma":[0.99945027,0.000194496,0.000102982274,0.000057364312,0.000030355546,0.00016452675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021667108,0.0007115873,0.0006181676,0.0006825094,0.00081309344,0.0007449417,0.00043612169,0.002343741,0.0006908844],"category_scores_gemma":[0.001274903,0.0003564653,0.0004988903,0.00031655247,0.000812961,0.0006521944,0.000624204,0.0014347484,0.00031096724],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001970655,0.000018934188,0.0027064856,0.00002922344,0.0000056829813,0.9924763,0.00008180049,0.00007729396,0.0024156384,0.00009190632,0.000096922005,0.0019802016],"study_design_scores_gemma":[0.000002862517,0.000047598045,0.0018913246,0.00000526946,0.0000052237283,0.99668294,0.00002895449,0.00013316168,0.00088293495,0.000044038174,0.00027140693,0.0000042992783],"about_ca_topic_score_codex":0.0009277606,"about_ca_topic_score_gemma":0.0016843813,"teacher_disagreement_score":0.002343741,"about_ca_system_score_codex":0.00072038616,"about_ca_system_score_gemma":0.00035866344,"threshold_uncertainty_score":0.0052267313},"labels":[],"label_agreement":null},{"id":"W4414319101","doi":"10.1093/bjd/ljaf370","title":"Metformin in necrobiotic xanthogranuloma","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Infectious Disease Case Reports and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Institute of Nano Science and Technology; Medizinische Fakultät, Universität zu Köln; Deutsche Forschungsgemeinschaft; Mazak Foundation; Faraday Institution; Health Research","keywords":"Metformin; Macrophage; Disease; Repurposing; Granulomatous disease; Drug repositioning","score_opus":0.004630283056386433,"score_gpt":0.26956898308600125,"score_spread":0.26493870002961484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414319101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9491496,0.042558562,0.0007122098,0.0015042695,0.00022156067,0.000063346364,0.00006110329,0.000034096556,0.0056951274],"genre_scores_gemma":[0.9953543,0.0033296926,0.0002575496,0.00027728814,0.00007160042,0.000009813866,0.00004126523,0.0000024427713,0.00065615325],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9999131,0.00002956639,0.000012626559,0.000008539451,0.000020196629,0.000016053611],"domain_scores_gemma":[0.99987626,0.00004346336,0.000032724434,0.000007668608,0.000006273923,0.00003353646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021632966,0.000118292424,0.00027828396,0.0001648355,0.00018273528,0.00016371568,0.00012568675,0.00055130036,0.0004922323],"category_scores_gemma":[0.00044579236,0.000052046827,0.00018328511,0.00013538827,0.00011995012,0.00014237183,0.0001360305,0.0005584531,0.00012270208],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019419199,0.0018320411,0.082458206,0.0018766586,0.00045514214,0.24255419,0.00051665364,0.0017571768,0.1790968,0.0038445955,0.0050037024,0.4611857],"study_design_scores_gemma":[0.004921552,0.025212813,0.318054,0.0008530372,0.0010339348,0.39364234,0.0005538512,0.0065491176,0.09847022,0.002642216,0.14794473,0.00012212223],"about_ca_topic_score_codex":0.00028554627,"about_ca_topic_score_gemma":0.00051102036,"teacher_disagreement_score":0.00055130036,"about_ca_system_score_codex":0.00020449227,"about_ca_system_score_gemma":0.00015688958,"threshold_uncertainty_score":0.0016466975},"labels":[],"label_agreement":null},{"id":"W4414351583","doi":"10.1093/bjd/ljaf366","title":"Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"European Academy of Dermatology and Venereology; Universität zu Lübeck","keywords":"Clinical trial; Bullous pemphigoid; Pemphigoid; Alternative medicine; Clinical endpoint; Clinical research; Pemphigus","score_opus":0.26692924240803867,"score_gpt":0.5114426244138189,"score_spread":0.24451338200578027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414351583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52772695,0.0680173,0.056199625,0.32035545,0.0016578651,0.0038227043,0.0006188193,0.00024854369,0.0213528],"genre_scores_gemma":[0.90503085,0.010768194,0.034928817,0.044628784,0.0010261112,0.0019152367,0.00045346143,0.00018310772,0.0010654444],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.39873073,0.48941246,0.059158307,0.010106046,0.036338076,0.006254411],"domain_scores_gemma":[0.15181617,0.73160297,0.057398353,0.01506765,0.03446725,0.009647533],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.63416487,0.0005650007,0.00193694,0.004327851,0.0029268486,0.011602337,0.0023759448,0.004305702,0.0026428064],"category_scores_gemma":[0.6726865,0.0009184942,0.0013571746,0.0039305915,0.0051959204,0.011048404,0.0081439875,0.0054345387,0.0005534345],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022733714,0.0006636612,0.22786422,0.009517053,0.0015826458,0.0012177094,0.08280759,0.004694272,0.0017408225,0.018223926,0.024103895,0.62531084],"study_design_scores_gemma":[0.002151524,0.007693088,0.27400637,0.030740729,0.0022356333,0.00651727,0.16806187,0.013239737,0.0030898852,0.09152132,0.3994847,0.0012578173],"about_ca_topic_score_codex":0.0017359275,"about_ca_topic_score_gemma":0.0032548264,"teacher_disagreement_score":0.36583513,"about_ca_system_score_codex":0.0056247655,"about_ca_system_score_gemma":0.015521001,"threshold_uncertainty_score":0.45113987},"labels":[],"label_agreement":null},{"id":"W4414438945","doi":"10.1093/bjd/ljaf285","title":"Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Manchester Biomedical Research Centre","keywords":"Ciclosporin; Atopic dermatitis; Clinical study; Randomized controlled trial; Clinical trial; Signs and symptoms; Safety profile","score_opus":0.010542506242325422,"score_gpt":0.3139650421391255,"score_spread":0.30342253589680007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414438945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426705,0.0034301388,0.00016743991,0.00020437817,0.00007087972,0.0009857169,0.00032142285,0.000018007186,0.00053486216],"genre_scores_gemma":[0.9957669,0.0013485313,0.0005641688,0.00041269875,0.00016700829,0.0009254114,0.00037246378,0.0000047164726,0.000438162],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99942774,0.00029894017,0.000059251288,0.00008742371,0.000059922404,0.000066697095],"domain_scores_gemma":[0.99908197,0.00024559896,0.000259774,0.0000495431,0.00006919117,0.00029388964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018989588,0.00071694225,0.0016397022,0.00023038543,0.00028731884,0.0006068023,0.000482064,0.00091901235,0.0034957542],"category_scores_gemma":[0.0012827592,0.00043335216,0.0011801792,0.00021215017,0.00060505007,0.00053882314,0.00026946786,0.0016165591,0.00042804255],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92299247,0.017622128,0.011930132,0.00088713673,0.0010522077,0.0001183772,0.00009553594,0.00029065035,0.0096981395,0.00011047572,0.0010552264,0.03414748],"study_design_scores_gemma":[0.742795,0.23307636,0.020400321,0.00005986772,0.0007213651,0.00020260426,0.000050886032,0.0005239994,0.000996244,0.00008340292,0.0010749288,0.000014951552],"about_ca_topic_score_codex":0.0004027535,"about_ca_topic_score_gemma":0.0009788782,"teacher_disagreement_score":0.0034957542,"about_ca_system_score_codex":0.00054173346,"about_ca_system_score_gemma":0.0009369414,"threshold_uncertainty_score":0.011694431},"labels":[],"label_agreement":null},{"id":"W4414439665","doi":"10.1093/bjd/ljaf316","title":"Previous ineligibility for or treatment failure of ciclosporin does not influence lebrikizumab efficacy in atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada","keywords":"Ciclosporin; Atopic dermatitis; Cyclosporins; Immunopathology; MEDLINE","score_opus":0.011718045001764259,"score_gpt":0.3049830816555852,"score_spread":0.2932650366538209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414439665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650025,0.0014080176,0.00004651783,0.00018692645,0.00003663539,0.000005353033,0.0001585674,0.0000056693075,0.001652104],"genre_scores_gemma":[0.9995127,0.00008494669,0.000022708371,0.00006635982,0.000016874785,0.0000027733483,0.00009199374,0.0000030551146,0.00019851574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989686,0.00040040255,0.0001402792,0.0001446128,0.0001254137,0.0002206893],"domain_scores_gemma":[0.9936179,0.003501312,0.0016803526,0.00042692744,0.00018718347,0.0005864671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015574093,0.00012418142,0.0004817096,0.00018429612,0.00021974629,0.0006330425,0.00028554734,0.00046671435,0.003496193],"category_scores_gemma":[0.0065136743,0.00010854194,0.00087476394,0.00023884415,0.0003321581,0.00052415946,0.00020150673,0.0008370781,0.0005028994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039511602,0.0012874898,0.89218366,0.0002600192,0.000926196,0.0010325923,0.00030320976,0.0005425588,0.0065806196,0.00022385812,0.0011155459,0.056032594],"study_design_scores_gemma":[0.0006315696,0.0048019732,0.9886218,0.00007223942,0.00047907687,0.0011126173,0.0001247884,0.00042061057,0.001077029,0.00020072551,0.0024420642,0.000015569783],"about_ca_topic_score_codex":0.00068850437,"about_ca_topic_score_gemma":0.00084653427,"teacher_disagreement_score":0.003496193,"about_ca_system_score_codex":0.00037966078,"about_ca_system_score_gemma":0.00025122656,"threshold_uncertainty_score":0.011695981},"labels":[],"label_agreement":null},{"id":"W4414557178","doi":"10.1093/bjd/ljaf380","title":"Long-term morbidity and quality of life in survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Institutes of Health; InflaRx; Norges Idrettshøgskole; British Microcirculation Society; Medical Research Council; Biogen; Boehringer Ingelheim España; Novocure; Vanderbilt University; Canadian Dermatology Foundation; Physicians' Services Incorporated Foundation; Eli Lilly and Company; National Health and Medical Research Council; National Eczema Association; Vanderbilt University Medical Center; National Psoriasis Foundation; Dermatology Foundation","keywords":"Toxic epidermal necrolysis; Quality of life (healthcare); Population; MEDLINE; Complication; Chronic condition","score_opus":0.026644246104899547,"score_gpt":0.30812070967203503,"score_spread":0.28147646356713546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414557178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998611,0.00043313994,0.00003380369,0.00014121739,0.000013114022,0.000004524549,0.00014171262,0.0000024391518,0.00061915664],"genre_scores_gemma":[0.999577,0.00013388488,0.00001675007,0.00004440484,0.000008789294,0.000002364639,0.00009803591,6.9357014e-7,0.00011813576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969757,0.00009986006,0.00003447956,0.000021761858,0.00006235646,0.0000841133],"domain_scores_gemma":[0.9984479,0.00017412654,0.0006467076,0.00005277863,0.00020824365,0.0004702664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003477288,0.00011606766,0.00024890646,0.00044673143,0.00042299228,0.000385518,0.000105228595,0.00022638516,0.001428403],"category_scores_gemma":[0.0022019562,0.00006539831,0.00028455295,0.0004673592,0.0001720504,0.0003156818,0.0004078732,0.0006567079,0.0001678879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017171686,0.00007816563,0.99330854,0.000018679684,0.00007069136,0.0003215708,0.00018991416,0.00004833534,0.00015647513,0.000017718487,0.00023888638,0.0053792926],"study_design_scores_gemma":[0.000006787491,0.00046165506,0.99726737,0.000029449797,0.000051629788,0.0009783749,0.00055616547,0.00009570953,0.000049783364,0.00004195415,0.00045356769,0.0000076252786],"about_ca_topic_score_codex":0.0030239872,"about_ca_topic_score_gemma":0.0038504736,"teacher_disagreement_score":0.0030239872,"about_ca_system_score_codex":0.00023958656,"about_ca_system_score_gemma":0.0002345353,"threshold_uncertainty_score":0.0060127378},"labels":[],"label_agreement":null},{"id":"W4414619922","doi":"10.1093/bjd/ljaf358","title":"Grand challenges for skin health revisited: the International League of Dermatological Societies skin disease atlases","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Zoonotic diseases and public health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"LEO Fondet; Universidade Católica de Brasília; Boehringer Ingelheim; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Milestone; League; Public health; Global health; Health care; Disease; International health; Burden of disease","score_opus":0.026645296389563283,"score_gpt":0.3254258597116132,"score_spread":0.29878056332204994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414619922","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016091913,0.0782991,0.0015028622,0.8110424,0.059011284,0.000042682877,0.0022537054,0.00035379795,0.04588494],"genre_scores_gemma":[0.10679135,0.18298437,0.01723433,0.4982703,0.055664454,0.00034752753,0.009562378,0.0010891472,0.12805612],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954135,0.0011383051,0.00033151216,0.0002646973,0.002062861,0.00078918727],"domain_scores_gemma":[0.9911498,0.00251823,0.00074927823,0.0004553591,0.0023774663,0.0027498044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008634826,0.0010751857,0.0007175034,0.004111489,0.0034724672,0.011482514,0.0023496244,0.0052744295,0.021001091],"category_scores_gemma":[0.010754499,0.0004974249,0.00086417457,0.0047090654,0.003249378,0.011090868,0.0058183735,0.013460517,0.0053058295],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016257445,0.000023405339,0.00061252445,0.0003091089,0.000009240598,0.00007431126,0.0005446973,0.00010039537,0.00014157558,0.03787361,0.91678375,0.04351108],"study_design_scores_gemma":[0.0000041791463,0.000008529321,0.0013419728,0.00046103162,0.0000050619733,0.00012102516,0.0010604891,0.00005666863,0.00005156393,0.0055389204,0.9913366,0.00001379069],"about_ca_topic_score_codex":0.028445385,"about_ca_topic_score_gemma":0.04967025,"teacher_disagreement_score":0.028445385,"about_ca_system_score_codex":0.007649409,"about_ca_system_score_gemma":0.012664222,"threshold_uncertainty_score":0.0702557},"labels":[],"label_agreement":null},{"id":"W4415095336","doi":"10.1093/bjd/ljaf394","title":"Real-world evidence on palmoplantar pustulosis: patient characteristics, diagnostic challenges and predictive factors for treatment survival – a retrospective registry study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; UCB Pharma; Merck Sharp and Dohme; Sandoz Canada; UCB Pharma France; LEO Pharma; Boehringer Ingelheim España; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Concomitant; Ustekinumab; Comorbidity; Psoriatic arthritis; Psoriasis; Retrospective cohort study; Risk factor; Disease","score_opus":0.027414595998122626,"score_gpt":0.2692421529409907,"score_spread":0.24182755694286806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415095336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930167,0.002622604,0.00023741035,0.00015106327,0.000011669441,0.00002771713,0.0028962204,0.00000542756,0.0010310333],"genre_scores_gemma":[0.9965402,0.0010143316,0.00018481357,0.00007191457,0.00002859042,0.000035399902,0.002078895,0.0000040116274,0.00004198934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940201,0.0023903893,0.0014873268,0.0008500232,0.0009257004,0.00032639533],"domain_scores_gemma":[0.9459745,0.0145989135,0.032936547,0.0032005853,0.002267971,0.0010214043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005286592,0.00016527256,0.0006775257,0.0019708364,0.00036757765,0.0011385796,0.00052840734,0.0005630841,0.002411894],"category_scores_gemma":[0.016591264,0.00033114696,0.0006522935,0.0043688444,0.00055441225,0.001274018,0.0007401772,0.00050544407,0.00045759024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012696952,0.000018331666,0.99813336,0.000062219486,0.00008539163,0.0000618846,0.00006207582,0.00003205153,0.00003276995,0.000028545632,0.00010407876,0.0012522601],"study_design_scores_gemma":[0.00001969365,0.00018274589,0.9969933,0.000089917885,0.00013884358,0.0010320577,0.0003651396,0.00013637173,0.000057369623,0.00003496659,0.0009389758,0.000010662906],"about_ca_topic_score_codex":0.002051093,"about_ca_topic_score_gemma":0.00195984,"teacher_disagreement_score":0.005286592,"about_ca_system_score_codex":0.00049877,"about_ca_system_score_gemma":0.00082519854,"threshold_uncertainty_score":0.027958512},"labels":[],"label_agreement":null},{"id":"W4415105330","doi":"10.1093/bjd/ljaf398","title":"Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University; Hotel Dieu Hospital","funders":"Sanofi Genzyme; European Academy of Dermatology and Venereology; Idorsia Pharmaceuticals; Swedish Orphan Biovitrum; LEO Pharma; Servier; Genesis Pharma; UCB Pharma; Argenx; Galderma; XBiotech; InflaRx; Symphogen; Pfizer; Biogen; Incyte; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; Novartis Pharma; European Commission; Springworks Therapeutics; National Institutes of Health; Regeneron Pharmaceuticals; Bundesministerium für Bildung und Forschung; Cilag; Insmed; L'Oreal USA; Sanofi; AstraZeneca; Novocure; Celldex Therapeutics; Amgen; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Hidradenitis suppurativa; Randomized controlled trial; Post-hoc analysis; Post hoc; Clinical trial; Randomization","score_opus":0.03081501622689424,"score_gpt":0.3624890151933463,"score_spread":0.33167399896645205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415105330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798395,0.013241968,0.00053795706,0.000592223,0.0006522822,0.0025234793,0.00075363624,0.00006838437,0.0017905629],"genre_scores_gemma":[0.990185,0.003937004,0.00096292375,0.00069440523,0.00049867155,0.0019286964,0.0006449607,0.000014899141,0.001133322],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99899775,0.0006158861,0.00008044735,0.00013338799,0.000074128126,0.00009841626],"domain_scores_gemma":[0.9988187,0.00046848628,0.00026543037,0.00009213823,0.00008540072,0.00026991256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024537782,0.0011242336,0.002753352,0.00028617555,0.00034194023,0.0009948711,0.00055989256,0.0013384528,0.0041167154],"category_scores_gemma":[0.0021404508,0.00040174962,0.0023430153,0.00029875065,0.0008728232,0.00071365695,0.00032765238,0.0015683664,0.0004438237],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9821399,0.0026006014,0.0005350036,0.0011015293,0.001260392,0.000022258413,0.000029151457,0.00009851124,0.0017857894,0.000050469556,0.00029915414,0.0100772],"study_design_scores_gemma":[0.95215374,0.04422296,0.002058619,0.00006700509,0.00064418715,0.00002288994,0.000015234035,0.00015806506,0.00026055748,0.00005739212,0.00033116253,0.000008080525],"about_ca_topic_score_codex":0.00044544128,"about_ca_topic_score_gemma":0.00089998904,"teacher_disagreement_score":0.0041167154,"about_ca_system_score_codex":0.00044637598,"about_ca_system_score_gemma":0.00066443055,"threshold_uncertainty_score":0.013771772},"labels":[],"label_agreement":null},{"id":"W4415286230","doi":"10.1093/bjd/ljaf411","title":"Clinical severity and parent–child discrepancies in paediatric atopic dermatitis across the USA","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Atopic dermatitis; Psychosocial; Psychological intervention; Quality of life (healthcare); MEDLINE; Severity of illness","score_opus":0.014064043312604217,"score_gpt":0.3269075968946484,"score_spread":0.3128435535820442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415286230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695647,0.00092481094,0.000057482564,0.00039623163,0.000020969126,0.0000065017457,0.0004373312,0.0000041208755,0.0011962391],"genre_scores_gemma":[0.9990433,0.00042676437,0.000070408736,0.000091392765,0.00000628872,0.0000070470837,0.00027750296,0.0000020750974,0.0000752984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812216,0.00071507506,0.0002902686,0.00024170487,0.00048239357,0.00014836968],"domain_scores_gemma":[0.995605,0.0009869218,0.0022234106,0.00014372302,0.00066985615,0.00037109593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012435764,0.00011446285,0.0002613607,0.0007654225,0.0004330887,0.00058483524,0.00034413772,0.0003037181,0.0016221852],"category_scores_gemma":[0.006658796,0.00020087043,0.0002714544,0.0015003528,0.00033233583,0.0003728941,0.00070246257,0.00070299633,0.0001377602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027784135,0.000019202535,0.993803,0.000026999072,0.000034692668,0.00012685925,0.0010859972,0.000033329616,0.00005556051,0.000027505208,0.0007064963,0.0040525505],"study_design_scores_gemma":[8.4139475e-7,0.000009275008,0.9988821,0.000020154208,0.000004916579,0.00016558325,0.00062705885,0.000036227648,0.000012900587,0.000007435257,0.00023164666,0.0000018427418],"about_ca_topic_score_codex":0.04386432,"about_ca_topic_score_gemma":0.06227235,"teacher_disagreement_score":0.04386432,"about_ca_system_score_codex":0.00076920685,"about_ca_system_score_gemma":0.0005274686,"threshold_uncertainty_score":0.08721799},"labels":[],"label_agreement":null},{"id":"W4415854073","doi":"10.1093/bjd/ljaf404","title":"Psoriasis at high-impact sites: shifting the paradigm","year":2025,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada","keywords":"Psoriasis; MEDLINE; Immunopathology; Disease","score_opus":0.014956436982895206,"score_gpt":0.24276929069415865,"score_spread":0.22781285371126345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415854073","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006397682,0.0039427797,0.00015265628,0.981292,0.012221795,0.0000031052048,0.000005937331,0.000010402746,0.0017315297],"genre_scores_gemma":[0.017928816,0.0058813547,0.00046487825,0.7941784,0.17792071,0.00001711566,0.000011236955,0.000026650543,0.0035709473],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995909,0.0017092315,0.00048273313,0.0004650158,0.0009155054,0.0005185507],"domain_scores_gemma":[0.9874795,0.007512114,0.0005487323,0.00039390157,0.0020083454,0.0020574213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004636493,0.00061123923,0.0015587748,0.00088378956,0.0029573939,0.0045385417,0.0015914183,0.042319432,0.0060229935],"category_scores_gemma":[0.017751109,0.00058105536,0.000856353,0.0006895317,0.005249782,0.007978451,0.0022831908,0.04336859,0.004284689],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026140988,0.00012656156,0.0020112845,0.000308962,0.00003730596,0.01264718,0.0007799968,0.00018888,0.0008079145,0.016707864,0.92087543,0.04524718],"study_design_scores_gemma":[0.00043762906,0.00016596528,0.0035349228,0.0011025848,0.00006239292,0.030050283,0.0031452193,0.001282875,0.00035747344,0.09780012,0.86189085,0.00016961076],"about_ca_topic_score_codex":0.0027642418,"about_ca_topic_score_gemma":0.00456072,"teacher_disagreement_score":0.042319432,"about_ca_system_score_codex":0.0040996782,"about_ca_system_score_gemma":0.00229696,"threshold_uncertainty_score":0.0297454},"labels":[],"label_agreement":null},{"id":"W4416059453","doi":"10.1093/bjd/ljaf446","title":"Comment on ‘A call to integrate specialized dermatology clinics into care of patients with inflammatory bowel disease’: reply from authors","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multidisciplinary approach; Multidisciplinary team; Perspective (graphical); Mainstream; Health care; Inflammatory Bowel Diseases; Alternative medicine; Quality (philosophy)","score_opus":0.003994896320341049,"score_gpt":0.2416780378920913,"score_spread":0.23768314157175024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416059453","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022562826,0.0008662592,0.00009291168,0.9734036,0.024910448,0.000011794316,0.00006693064,0.000052351414,0.0003701106],"genre_scores_gemma":[0.0012140119,0.00037491828,0.00009867847,0.98487824,0.012483375,0.000027302638,0.000015604626,0.00001812521,0.0008897941],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99430966,0.001497788,0.0010534637,0.00082911964,0.0015602821,0.0007496918],"domain_scores_gemma":[0.9668997,0.016890487,0.0023276804,0.00089438725,0.009297097,0.003690685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007433627,0.0010810606,0.0017638534,0.0010310222,0.0037081796,0.0032758522,0.0033982962,0.05626801,0.00847922],"category_scores_gemma":[0.057824917,0.0011060765,0.0019398615,0.0010165544,0.004227015,0.006724435,0.002670301,0.060263418,0.0070339716],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005086263,0.000012464674,0.0004116384,0.00009322954,0.0000126337045,0.0005420403,0.00021619206,0.00003065799,0.000105683306,0.0004691127,0.99569124,0.002364313],"study_design_scores_gemma":[0.0001406071,0.00011371692,0.0027115168,0.00077586924,0.000073366355,0.0038523115,0.0023084143,0.0003828604,0.0007569666,0.004213339,0.98437274,0.0002982179],"about_ca_topic_score_codex":0.010961107,"about_ca_topic_score_gemma":0.0105280485,"teacher_disagreement_score":0.05626801,"about_ca_system_score_codex":0.0038944264,"about_ca_system_score_gemma":0.0056361575,"threshold_uncertainty_score":0.039313197},"labels":[],"label_agreement":null},{"id":"W4416243543","doi":"10.1093/bjd/ljaf463","title":"Sleep patterns and the risk of psoriatic disease: genetic predisposition and metabonomics","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Sleep and related disorders","field":"Psychology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Fundamental Research Funds for Central Universities of the Central South University; Huxiang Youth Talent Support Program; National Natural Science Foundation of China","keywords":"Genetic predisposition; Sleep (system call); Sleep patterns; Risk factor; Association (psychology); Psoriasis; Genetic association","score_opus":0.002697167001372717,"score_gpt":0.22287482733779543,"score_spread":0.22017766033642272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416243543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965647,0.0018203643,0.00042112631,0.0001520684,0.000007988075,0.000017993321,0.0005028954,0.0000075884896,0.00050532457],"genre_scores_gemma":[0.99858046,0.0006006024,0.0003389923,0.000026364556,0.000013319902,0.000009034658,0.00023546367,0.0000019491008,0.0001937453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996464,0.0001291597,0.0000383294,0.00007345035,0.000068765046,0.00004379731],"domain_scores_gemma":[0.9988285,0.00025257672,0.0006216762,0.00009357316,0.00008693402,0.00011674924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007686445,0.00029721568,0.00031566105,0.0005296256,0.0002759426,0.00061990187,0.00026329,0.00036137158,0.002123538],"category_scores_gemma":[0.001861138,0.00019769312,0.0004871805,0.0010092609,0.0003020246,0.0003036715,0.00044778577,0.00042428417,0.00017016275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024392756,0.00003523953,0.9945898,0.000044455224,0.00017749255,0.00008199033,0.00005647562,0.00010175272,0.000815381,0.000048383936,0.00006393456,0.0037412767],"study_design_scores_gemma":[0.0000051545235,0.00009460519,0.99913675,0.0000106312455,0.000051555533,0.00020375328,0.000032796543,0.00019811111,0.00007014554,0.00009276209,0.00010109507,0.0000026400896],"about_ca_topic_score_codex":0.0043328945,"about_ca_topic_score_gemma":0.005700913,"teacher_disagreement_score":0.0043328945,"about_ca_system_score_codex":0.00025784312,"about_ca_system_score_gemma":0.00047316257,"threshold_uncertainty_score":0.008615375},"labels":[],"label_agreement":null},{"id":"W4416538556","doi":"10.1093/bjd/ljaf468","title":"Darier disease is a syndromic epidermal differentiation disorder","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Darier's disease; Dyskeratosis; Darier Disease; Disease; Congenital disease","score_opus":0.0029644984604342084,"score_gpt":0.22480267157468375,"score_spread":0.22183817311424955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416538556","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019943066,0.04249312,0.001831958,0.8010384,0.106774695,0.000054100874,0.00037939215,0.00033789323,0.027147371],"genre_scores_gemma":[0.21171391,0.039482426,0.002707648,0.54905576,0.17571735,0.000063357824,0.00033471885,0.00016401314,0.020760763],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99870586,0.00020016455,0.00020732044,0.0002822436,0.0003667317,0.00023769923],"domain_scores_gemma":[0.99782974,0.0012723345,0.00033514982,0.00006756226,0.00029404968,0.0002010616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010910061,0.0007781035,0.0011783981,0.00067445496,0.0012520379,0.0014116942,0.0010015754,0.010730611,0.0019677484],"category_scores_gemma":[0.0057003913,0.00029708535,0.0007074849,0.0006257864,0.0022764858,0.001248685,0.0012715419,0.01037732,0.0015056559],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014973764,0.00004302462,0.0041085086,0.0005643392,0.00010074975,0.22540624,0.0014158299,0.0002468507,0.0035171355,0.023855928,0.7033716,0.03721999],"study_design_scores_gemma":[0.00010863025,0.00010070274,0.0029443016,0.00040802348,0.000078320336,0.3382291,0.00044945977,0.00034841802,0.0011751776,0.009890931,0.6461987,0.0000681955],"about_ca_topic_score_codex":0.002005153,"about_ca_topic_score_gemma":0.0022613315,"teacher_disagreement_score":0.010730611,"about_ca_system_score_codex":0.0007116412,"about_ca_system_score_gemma":0.00097096723,"threshold_uncertainty_score":0.0065827966},"labels":[],"label_agreement":null},{"id":"W4416661874","doi":"10.1093/bjd/ljaf479","title":"Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: development, validation and severity strata of the cNF-PUSH-D","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Neurofibromatosis; Prom; Stigma (botany); Disease; Clinical trial; MEDLINE","score_opus":0.008603104957457055,"score_gpt":0.24877802312726,"score_spread":0.24017491816980294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416661874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99380094,0.00020338717,0.0011266088,0.00012999387,0.000030129493,0.0016057428,0.0007595072,0.000015169114,0.002328542],"genre_scores_gemma":[0.9857976,0.000320443,0.008837866,0.00009055438,0.000020472267,0.002628357,0.0017258157,0.0000096836675,0.0005692681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969791,0.0011100713,0.0004248427,0.00025648146,0.0010511699,0.00017826815],"domain_scores_gemma":[0.99291104,0.002415914,0.0022342934,0.00051022985,0.0015184075,0.00041016872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071732574,0.0005446123,0.0005589262,0.0016267961,0.00064819003,0.0010369745,0.0008357271,0.0006137032,0.0011584207],"category_scores_gemma":[0.014063522,0.0002506184,0.0017076235,0.0008298892,0.0006014187,0.0007086492,0.002320133,0.00094680453,0.000233943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049401063,0.0005242512,0.93109125,0.00031672046,0.00024029156,0.0001612809,0.0034171913,0.0006216388,0.0009937512,0.00044831727,0.0013217063,0.06036954],"study_design_scores_gemma":[0.00006859126,0.000558358,0.9934865,0.0001652653,0.00007031435,0.00027927497,0.0014554765,0.0009348908,0.00052153994,0.00025810197,0.0021734273,0.000028107681],"about_ca_topic_score_codex":0.0024808522,"about_ca_topic_score_gemma":0.004438074,"teacher_disagreement_score":0.0071732574,"about_ca_system_score_codex":0.0011734014,"about_ca_system_score_gemma":0.0017609022,"threshold_uncertainty_score":0.03793627},"labels":[],"label_agreement":null},{"id":"W4416737953","doi":"10.1093/bjd/ljaf471","title":"Bullous pemphigoid outcome measurement: a scoping review of outcome heterogeneity and trends in clinical research of treatments","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cilag; UCB Pharma; Novartis Pharma; Celgene","keywords":"Outcome (game theory); Clinical research; Clinical trial; Bullous pemphigoid; MEDLINE; Relevance (law); Patient-reported outcome; Clinical significance","score_opus":0.1804567931965548,"score_gpt":0.4927175499689474,"score_spread":0.3122607567723926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416737953","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002081784,0.9932736,0.00097385934,0.0012546643,0.00018601972,0.0008483899,0.0008532298,0.000016873373,0.0005114826],"genre_scores_gemma":[0.039521635,0.9466435,0.004799492,0.0011616598,0.00019307986,0.0059797466,0.0015240082,0.000032081734,0.00014485554],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8637846,0.050341513,0.06407875,0.0053820102,0.014972708,0.0014404098],"domain_scores_gemma":[0.5684577,0.33823445,0.056413945,0.0065629026,0.029223755,0.0011071772],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1334107,0.0022079109,0.0133715635,0.055057984,0.0017891795,0.008077163,0.0034750984,0.0033862235,0.0026899904],"category_scores_gemma":[0.36270908,0.0019489875,0.013619305,0.049243763,0.0029612924,0.007063204,0.005468079,0.0026459957,0.00034528988],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023508031,0.00003478258,0.0035366619,0.85667753,0.012111999,0.00009249429,0.0012690705,0.00042883714,0.00016226798,0.0013990644,0.0023375785,0.1217147],"study_design_scores_gemma":[0.00008781848,0.00010888457,0.00568179,0.95325804,0.027341116,0.00015402793,0.0006854102,0.00018934198,0.00017217669,0.00094440137,0.01133931,0.00003775682],"about_ca_topic_score_codex":0.010143781,"about_ca_topic_score_gemma":0.01528061,"teacher_disagreement_score":0.8665893,"about_ca_system_score_codex":0.012272472,"about_ca_system_score_gemma":0.029649664,"threshold_uncertainty_score":0.7055517},"labels":[],"label_agreement":null},{"id":"W4416987386","doi":"10.1093/bjd/ljaf491","title":"The Inflammatory Skin Disease map: an interactive computational resource focused on molecular mechanisms in psoriasis and atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; UCB Pharma; University of Bristol; European Commission; King's College London; Medical Research Council; European Federation of Pharmaceutical Industries and Associations; Université du Luxembourg","keywords":"Atopic dermatitis; Psoriasis; Testbed; Disease; Representation (politics); Resource (disambiguation)","score_opus":0.0027973224414473983,"score_gpt":0.21390617384664806,"score_spread":0.21110885140520066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416987386","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034883272,0.008157126,0.42271143,0.009433428,0.001380372,0.0005888312,0.36627772,0.10533042,0.05123746],"genre_scores_gemma":[0.24755995,0.010727435,0.42082316,0.0023363493,0.00051153934,0.002429141,0.28900355,0.014623795,0.011985059],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999688,0.00010658136,0.000023855657,0.000070797134,0.00008351007,0.000027276148],"domain_scores_gemma":[0.9987233,0.00086284784,0.000052544805,0.00011666728,0.00010568042,0.00013895694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008740066,0.0011727124,0.0008604501,0.0020928304,0.0006035799,0.0021875852,0.0020406817,0.0011454904,0.038488068],"category_scores_gemma":[0.0048316107,0.0004622115,0.001451102,0.0019801182,0.00035626636,0.0010804321,0.0024128086,0.0011452247,0.0062985835],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013225655,0.00030180914,0.01040649,0.0052000354,0.00083930156,0.0018772436,0.00095735583,0.17758976,0.006450792,0.060852725,0.5881656,0.14603633],"study_design_scores_gemma":[0.00076864875,0.00011841287,0.0040266654,0.0007611049,0.00038506673,0.0008763402,0.00033654735,0.2899123,0.0048767305,0.10166725,0.59608275,0.00018821625],"about_ca_topic_score_codex":0.0064814184,"about_ca_topic_score_gemma":0.012743424,"teacher_disagreement_score":0.038488068,"about_ca_system_score_codex":0.0006541677,"about_ca_system_score_gemma":0.001904206,"threshold_uncertainty_score":0.12875539},"labels":[],"label_agreement":null},{"id":"W4417200615","doi":"10.1093/bjd/ljaf508","title":"Distinct bacterial facial cutaneous microbiota composition in adolescents with acne vulgaris: a population-based cross-sectional observational study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Erasmus Universiteit Rotterdam; Health Services Research and Development","keywords":"Acne; Microbiome; Observational study; Streptococcus; Staphylococcus epidermidis","score_opus":0.017367194349638147,"score_gpt":0.29862449021004045,"score_spread":0.2812572958604023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417200615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996124,0.00007923314,0.00007390978,0.000009060241,0.0000019384122,0.000009788202,0.00012362318,0.0000010227407,0.000089038695],"genre_scores_gemma":[0.99959534,0.00006552361,0.000114556715,0.000016825687,0.0000037912878,0.000011863305,0.00015608266,0.0000010160823,0.000035082463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994746,0.0001374318,0.000056757268,0.00016864628,0.0001020403,0.00006067845],"domain_scores_gemma":[0.99915516,0.00014745923,0.00032890507,0.00008350784,0.0001365757,0.00014840161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079493184,0.00027878265,0.00046444454,0.0005033663,0.00044431913,0.0006001559,0.00027325362,0.00044006878,0.00094472023],"category_scores_gemma":[0.0015125084,0.0003233671,0.00038470555,0.00055088196,0.00032440986,0.00054240413,0.00045783323,0.00063978235,0.00018513252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046209396,0.00003731314,0.99907076,0.000008191521,0.000028308508,0.00005287823,0.00011188281,0.000008281878,0.00018550635,0.000008232182,0.000031445306,0.00041109405],"study_design_scores_gemma":[0.000006832252,0.00017263227,0.9986904,0.000009041368,0.000040203387,0.00039928753,0.000433664,0.00007536813,0.00003733139,0.0000130170365,0.000119582066,0.0000025414654],"about_ca_topic_score_codex":0.0031902485,"about_ca_topic_score_gemma":0.004157349,"teacher_disagreement_score":0.0031902485,"about_ca_system_score_codex":0.00027045363,"about_ca_system_score_gemma":0.00026243893,"threshold_uncertainty_score":0.0063433647},"labels":[],"label_agreement":null},{"id":"W4417419178","doi":"10.1093/bjd/ljaf485","title":"Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Barrie Urology Group; University of Toronto","funders":"Incyte","keywords":"Ruxolitinib; Vitiligo; Clinical trial; Duration (music); Cohort","score_opus":0.04065782231475665,"score_gpt":0.3763890620810534,"score_spread":0.3357312397662967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417419178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98548555,0.008341115,0.0007233833,0.00037727796,0.00013318087,0.0010055315,0.0012309231,0.00007030424,0.0026326831],"genre_scores_gemma":[0.99103385,0.0029356666,0.0012075829,0.00067078025,0.00014971397,0.0006409444,0.0013958073,0.000017964401,0.0019477955],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993332,0.00034400675,0.000037477454,0.00007214928,0.0000946534,0.000118377124],"domain_scores_gemma":[0.99889416,0.00036683338,0.00023144629,0.0001340669,0.00008865684,0.00028479323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002383652,0.00041288513,0.0011766651,0.00019447294,0.00022791071,0.0007478469,0.0004523081,0.0008454827,0.0034963193],"category_scores_gemma":[0.0013037546,0.00020040882,0.0012154973,0.00019652901,0.00036552135,0.00070076017,0.00025942252,0.0020332655,0.0006372119],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46793124,0.045555603,0.008581733,0.0024663098,0.0028217814,0.00040415296,0.00044201862,0.0021014553,0.08425652,0.00047654862,0.0057678306,0.37919477],"study_design_scores_gemma":[0.30942893,0.6013112,0.062762804,0.00025534965,0.0014980341,0.0009355542,0.00019874732,0.0018433357,0.009392633,0.00043729294,0.011862253,0.000073816234],"about_ca_topic_score_codex":0.00040632585,"about_ca_topic_score_gemma":0.0016642031,"teacher_disagreement_score":0.0034963193,"about_ca_system_score_codex":0.00039045885,"about_ca_system_score_gemma":0.00045061985,"threshold_uncertainty_score":0.012606084},"labels":[],"label_agreement":null},{"id":"W7117359154","doi":"10.1093/bjd/ljaf519","title":"Randomized, double-blind treatment withdrawal or continuation with ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Barrie Urology Group; University of Toronto","funders":"Incyte","keywords":"Ruxolitinib; Continuation; Extension (predicate logic); Phase (matter); Phases of clinical research","score_opus":0.028534105601267228,"score_gpt":0.34988140367867215,"score_spread":0.3213472980774049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117359154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884455,0.0038541195,0.00088621286,0.0003247277,0.00035504557,0.0034743291,0.0011209279,0.00013085548,0.0014083236],"genre_scores_gemma":[0.9883405,0.0021946807,0.0017020125,0.0006000207,0.000350898,0.0032125476,0.0010970641,0.000031407697,0.002470965],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984457,0.0009945533,0.00010738165,0.0001738557,0.0001052525,0.0001733605],"domain_scores_gemma":[0.9978277,0.00080968725,0.00048967893,0.00026533802,0.00012476661,0.00048273557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033081044,0.0011105266,0.0027286704,0.00037430518,0.00038700656,0.0009603785,0.00090369396,0.0016804825,0.0047156806],"category_scores_gemma":[0.0025919282,0.000523066,0.0016257702,0.0003711485,0.0010161037,0.0009999713,0.00042733844,0.0025040205,0.0008305977],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96757686,0.008526084,0.0004467604,0.00035120675,0.00067029044,0.00002907581,0.00004514091,0.00016947459,0.00443924,0.0000589345,0.00041565948,0.017271306],"study_design_scores_gemma":[0.8792586,0.11597918,0.0028857857,0.000025876418,0.000382355,0.000035531957,0.000025906764,0.00021061358,0.0005749468,0.00009767166,0.00050821464,0.000015341333],"about_ca_topic_score_codex":0.00054153136,"about_ca_topic_score_gemma":0.0013690491,"teacher_disagreement_score":0.0047156806,"about_ca_system_score_codex":0.00048145413,"about_ca_system_score_gemma":0.00080023846,"threshold_uncertainty_score":0.017495155},"labels":[],"label_agreement":null}]}